Citrus Sinensis ID: 024401
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | 2.2.26 [Sep-21-2011] | |||||||
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.764 | 0.525 | 0.469 | 4e-51 | |
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.753 | 0.220 | 0.403 | 1e-38 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.746 | 0.214 | 0.430 | 6e-38 | |
| Q55A09 | 1331 | Probable serine/threonine | no | no | 0.742 | 0.149 | 0.423 | 1e-36 | |
| Q95UN8 | 1161 | Mitogen-activated protein | yes | no | 0.757 | 0.174 | 0.366 | 2e-33 | |
| Q66HA1 | 850 | Mitogen-activated protein | yes | no | 0.753 | 0.237 | 0.368 | 6e-33 | |
| Q80XI6 | 850 | Mitogen-activated protein | yes | no | 0.731 | 0.230 | 0.378 | 7e-33 | |
| Q16584 | 847 | Mitogen-activated protein | yes | no | 0.753 | 0.238 | 0.368 | 7e-33 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.742 | 0.172 | 0.369 | 3e-32 | |
| Q54I36 | 1338 | Dual specificity protein | no | no | 0.716 | 0.143 | 0.402 | 4e-32 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 201 bits (512), Expect = 4e-51, Method: Compositional matrix adjust.
Identities = 101/215 (46%), Positives = 137/215 (63%), Gaps = 10/215 (4%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++SR+ H N+V+F+ ACK P + I+TE + +LR YL P L + L ALDI+
Sbjct: 138 LLSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDIS 197
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
R M+ LH+ G+IHRDLK +NLLL D+ +K+ADFG + ET GTYRWMAPE
Sbjct: 198 RGMEYLHSQGVIHRDLKSNNLLLN-DEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPE 256
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ ++K Y KVDVYSFGIVLWEL T LPF+GM+ +QAA+A A K+ RP LP
Sbjct: 257 MI--------KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEKNERPPLP 308
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
P LA +++ CW E+P+ RP FS I+ +L +
Sbjct: 309 ASCQPALAHLIKRCWSENPSKRPDFSNIVAVLEKY 343
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 160 bits (404), Expect = 1e-38, Method: Composition-based stats.
Identities = 86/213 (40%), Positives = 132/213 (61%), Gaps = 11/213 (5%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++SR++H N+V + AC P + +TE LPG SL L S + K+++ + A+ IA
Sbjct: 711 ILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHS-KKIKMNMQLYKKLAIQIA 769
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
+ M+ LH +G+IHRD+K NLLL + ++K+ DFGL++ ++ + MT G+ WM+PE
Sbjct: 770 QGMNYLHLSGVIHRDIKSLNLLLD-EHMNVKICDFGLSKLKSKSTEMTKSIGSPIWMSPE 828
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
L GE Y KVDVY+FGI+LWEL T LP+ G+ ++Q A A K RP +P
Sbjct: 829 LL------MGED--YTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIP 880
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
L+ ++Q+CW +DP RPSF++I+ +LN
Sbjct: 881 NAWPYQLSHLIQACWHQDPLKRPSFTEILNLLN 913
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 157 bits (398), Expect = 6e-38, Method: Compositional matrix adjust.
Identities = 93/216 (43%), Positives = 134/216 (62%), Gaps = 16/216 (7%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDI 58
+M R++H N+V FLGA + P + IVTE LP SL Y + RP + +D + ALD+
Sbjct: 717 IMRRLRHPNVVFFLGAVTRPPNLSIVTEFLPRGSL--YRILHRPKSHIDERRRIKMALDV 774
Query: 59 ARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-GTYRW 115
A M+CLH + I+HRDLK NLL+ + ++K+ DFGL+R + T + + T GT W
Sbjct: 775 AMGMNCLHTSTPTIVHRDLKTPNLLVD-NNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEW 833
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE+ LR + N K DVYSFG++LWEL T RLP+ GM+ +Q A F++ R
Sbjct: 834 MAPEV-----LR---NEPSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNRR 885
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
+P+++ P + I+ CW DPNLRPSF+Q+ +L
Sbjct: 886 LEIPKELDPVVGRIILECWQTDPNLRPSFAQLTEVL 921
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 153 bits (387), Expect = 1e-36, Method: Composition-based stats.
Identities = 92/217 (42%), Positives = 123/217 (56%), Gaps = 18/217 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN------KLDLHVALNF 54
++ ++H NLV G +P M IV E LP +L + L+ +P+ KLD + L
Sbjct: 1123 LLGSLQHPNLVTCYGYSLNP-MCIVMEFLPSGNLFE-LIHSKPSEQQQSIKLDSTLILAI 1180
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 114
A DIAR M LH IIHRDLK NLL+ ++K+AD G+ARE + T+ MT GT
Sbjct: 1181 AFDIARGMQHLHTRNIIHRDLKSSNLLMD-KHFNIKIADLGIARETSFTQTMTT-IGTVA 1238
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 174
W APE+ LR + YN K DVYS+ IVL+ELLT P++G+ + A A K
Sbjct: 1239 WTAPEI-----LRH---ESYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGL 1290
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
RP LP++ P+ +V CW EDPN RPSF +I L
Sbjct: 1291 RPELPDNCDPNWKKLVVWCWSEDPNKRPSFEEITNYL 1327
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q95UN8|M3KSL_DROME Mitogen-activated protein kinase kinase kinase OS=Drosophila melanogaster GN=slpr PE=1 SV=1 | Back alignment and function description |
|---|
Score = 143 bits (360), Expect = 2e-33, Method: Compositional matrix adjust.
Identities = 84/229 (36%), Positives = 121/229 (52%), Gaps = 26/229 (11%)
Query: 5 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64
+KH+N+ G C + + +V E G SL + L K+ V +N+A+ IAR M+
Sbjct: 196 LKHENIAALRGVCLNTKLCLVMEYARGGSLNRILA----GKIPPDVLVNWAIQIARGMNY 251
Query: 65 LHANG---IIHRDLKPDNLLLTP-------DQKSLKLADFGLAREETVTEMMTAETGTYR 114
LH IIHRDLK N+L+ QK+LK+ DFGLARE T+ M+A GTY
Sbjct: 252 LHNEAPMSIIHRDLKSSNVLIYEAIEGNHLQQKTLKITDFGLAREMYNTQRMSA-AGTYA 310
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 174
WM PE+ S T Y+ DV+S+G++LWEL+T P++G L AY A
Sbjct: 311 WMPPEVISVST--------YSKFSDVWSYGVLLWELITGETPYKGFDPLSVAYGVAVNTL 362
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL---FTLRP 220
+P+ +++SCW DP+ RP F +I++ L + FTL P
Sbjct: 363 TLPIPKTCPETWGALMKSCWQTDPHKRPGFKEILKQLESIACSKFTLTP 411
|
Activates the JUN N-terminal pathway during dorsal closure. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q66HA1|M3K11_RAT Mitogen-activated protein kinase kinase kinase 11 OS=Rattus norvegicus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 141 bits (355), Expect = 6e-33, Method: Compositional matrix adjust.
Identities = 83/225 (36%), Positives = 119/225 (52%), Gaps = 23/225 (10%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ + + H N++ C ++P + +V E G L + L R + HV +N+A+ IA
Sbjct: 168 LFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIA 224
Query: 60 RAMDCLHANG---IIHRDLKPDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAE 109
R M LH +IHRDLK +N LLL P + K+LK+ DFGLARE T M+A
Sbjct: 225 RGMHYLHCEALVPVIHRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA- 283
Query: 110 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 169
GTY WMAPE+ T +G DV+SFG++LWELLT +P+ G+ L AY
Sbjct: 284 AGTYAWMAPEVIKASTFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGV 335
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
A +P A ++ CW +DP+ RP F+ I++ L A
Sbjct: 336 AVNKLTLPIPSTCPEPFAQLMADCWAQDPHRRPDFASILQQLEAL 380
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q80XI6|M3K11_MOUSE Mitogen-activated protein kinase kinase kinase 11 OS=Mus musculus GN=Map3k11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (354), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 83/219 (37%), Positives = 116/219 (52%), Gaps = 23/219 (10%)
Query: 7 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 65
H N++ C ++P + +V E G L + L R + HV +N+A+ IAR M L
Sbjct: 174 HPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIARGMHYL 230
Query: 66 HANG---IIHRDLKPDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAETGTYRW 115
H +IHRDLK +N LLL P + K+LK+ DFGLARE T M+A GTY W
Sbjct: 231 HCEALVPVIHRDLKSNNILLLQPIEGDDMEHKTLKITDFGLAREWHKTTQMSA-AGTYAW 289
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE+ T +G DV+SFG++LWELLT +P+ G+ L AY A
Sbjct: 290 MAPEVIKASTFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGVAVNKLT 341
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
+P A ++ CW +DP+ RP F+ I++ L A
Sbjct: 342 LPIPSTCPEPFAQLMADCWAQDPHRRPDFASILQQLEAL 380
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q16584|M3K11_HUMAN Mitogen-activated protein kinase kinase kinase 11 OS=Homo sapiens GN=MAP3K11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (354), Expect = 7e-33, Method: Compositional matrix adjust.
Identities = 83/225 (36%), Positives = 119/225 (52%), Gaps = 23/225 (10%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ + + H N++ C ++P + +V E G L + L R + HV +N+A+ IA
Sbjct: 167 LFAMLAHPNIIALKAVCLEEPNLCLVMEYAAGGPLSRALAGRR---VPPHVLVNWAVQIA 223
Query: 60 RAMDCLHANG---IIHRDLKPDN-LLLTP------DQKSLKLADFGLAREETVTEMMTAE 109
R M LH +IHRDLK +N LLL P + K+LK+ DFGLARE T M+A
Sbjct: 224 RGMHYLHCEALVPVIHRDLKSNNILLLQPIESDDMEHKTLKITDFGLAREWHKTTQMSA- 282
Query: 110 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 169
GTY WMAPE+ T +G DV+SFG++LWELLT +P+ G+ L AY
Sbjct: 283 AGTYAWMAPEVIKASTFSKGS--------DVWSFGVLLWELLTGEVPYRGIDCLAVAYGV 334
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
A +P A ++ CW +DP+ RP F+ I++ L A
Sbjct: 335 AVNKLTLPIPSTCPEPFAQLMADCWAQDPHRRPDFASILQQLEAL 379
|
Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 139 bits (349), Expect = 3e-32, Method: Composition-based stats.
Identities = 81/219 (36%), Positives = 117/219 (53%), Gaps = 20/219 (9%)
Query: 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN------KLDLHVALNFA 55
+ + H N+V F+GAC P I+TE + G SL Y + PN K + L A
Sbjct: 902 LKKGNHQNIVMFIGACYKP-ACIITEYMAGGSL--YNILHNPNSSTPKVKYSFPLVLKMA 958
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-- 113
D+A + LH+ I+HRDL N+LL + ++K++DFGL+RE++ MT G
Sbjct: 959 TDMALGLLHLHSITIVHRDLTSQNILLD-ELGNIKISDFGLSREKSREGSMTMTNGGICN 1017
Query: 114 -RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 172
RW PEL + HY+ KVDVY F +V+WE+LT +PF + QA+ A+
Sbjct: 1018 PRWRPPELTKNL-------GHYSEKVDVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYA 1070
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
RP +PE P+L ++ CW DPN RP F+ I+ L
Sbjct: 1071 GLRPPIPEYCDPELKLLLTQCWEADPNDRPPFTYIVNKL 1109
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 138 bits (348), Expect = 4e-32, Method: Composition-based stats.
Identities = 83/206 (40%), Positives = 122/206 (59%), Gaps = 14/206 (6%)
Query: 7 HDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 66
H N+V F+GAC DP I TE L G SL L ++ KL+ + D++ M+ LH
Sbjct: 1109 HPNVVTFMGACIDP-PCIFTEYLQGGSLYDVL-HIQKIKLNPLMMYKMIHDLSLGMEHLH 1166
Query: 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-RWMAPELYSTVT 125
+ ++HRDL N+LL + K++K+ADFGLA T+++ MT T RW +PEL +
Sbjct: 1167 SIQMLHRDLTSKNILLD-EFKNIKIADFGLA--TTLSDDMTLSGITNPRWRSPELTKGLV 1223
Query: 126 LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 185
YN KVDVYSFG+V++E+ T ++PFEG+ +A AAF++ RP +P D
Sbjct: 1224 --------YNEKVDVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVS 1275
Query: 186 LAFIVQSCWVEDPNLRPSFSQIIRML 211
L ++ CW DP+ RPSF++I+ L
Sbjct: 1276 LRKLITKCWASDPSQRPSFTEILTEL 1301
|
Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 2 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | ||||||
| 255584255 | 367 | protein kinase atn1, putative [Ricinus c | 0.992 | 0.724 | 0.898 | 1e-142 | |
| 225439671 | 374 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.716 | 0.847 | 1e-135 | |
| 224139346 | 356 | predicted protein [Populus trichocarpa] | 0.992 | 0.747 | 0.869 | 1e-135 | |
| 297735553 | 337 | unnamed protein product [Vitis vinifera] | 1.0 | 0.795 | 0.847 | 1e-135 | |
| 356532165 | 370 | PREDICTED: serine/threonine-protein kina | 0.992 | 0.718 | 0.865 | 1e-131 | |
| 388513773 | 360 | unknown [Medicago truncatula] | 0.977 | 0.727 | 0.840 | 1e-129 | |
| 449439809 | 373 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.718 | 0.830 | 1e-128 | |
| 449521717 | 373 | PREDICTED: serine/threonine-protein kina | 1.0 | 0.718 | 0.830 | 1e-128 | |
| 357506575 | 363 | Protein kinase, putative [Medicago trunc | 0.992 | 0.732 | 0.847 | 1e-128 | |
| 357506577 | 326 | Protein kinase, putative [Medicago trunc | 0.992 | 0.815 | 0.847 | 1e-128 |
| >gi|255584255|ref|XP_002532865.1| protein kinase atn1, putative [Ricinus communis] gi|223527377|gb|EEF29519.1| protein kinase atn1, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 508 bits (1309), Expect = e-142, Method: Compositional matrix adjust.
Identities = 239/266 (89%), Positives = 253/266 (95%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRVKHDNLVKF+GACK+PLMVIVTELLPGMSLRKYL+ +RPN+ DL +ALNFALDIAR
Sbjct: 101 MMSRVKHDNLVKFIGACKEPLMVIVTELLPGMSLRKYLIGIRPNQPDLRLALNFALDIAR 160
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AMDCLHANGIIHRDLKPDNLLLT +QKS+KLADFGLAREETVTEMMTAETGTYRWMAPEL
Sbjct: 161 AMDCLHANGIIHRDLKPDNLLLTANQKSVKLADFGLAREETVTEMMTAETGTYRWMAPEL 220
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK RP LPE
Sbjct: 221 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKQERPSLPE 280
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGA 240
D SPDLAFI+QSCWVEDPNLRPSFSQIIRMLNAFLFTL PPS SVPES T+EAAA+SNG
Sbjct: 281 DTSPDLAFIIQSCWVEDPNLRPSFSQIIRMLNAFLFTLSPPSTSVPESSTHEAAASSNGT 340
Query: 241 MTEFSARARGKFAFLRQLFTAKRTKN 266
++EFSARARGKFAFLRQLFTAKR +N
Sbjct: 341 VSEFSARARGKFAFLRQLFTAKRARN 366
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439671|ref|XP_002270753.1| PREDICTED: serine/threonine-protein kinase HT1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 487 bits (1254), Expect = e-135, Method: Compositional matrix adjust.
Identities = 228/269 (84%), Positives = 247/269 (91%), Gaps = 1/269 (0%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRVKH+NLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP ++D+HVAL+FALDIAR
Sbjct: 106 MMSRVKHENLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKRMDIHVALSFALDIAR 165
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AM+CLHANGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPEL
Sbjct: 166 AMECLHANGIIHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPEL 225
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIV WELLTNR+PFEGMSNLQAAYAAAFK RP LPE
Sbjct: 226 YSTVTLRQGEKKHYNNKVDVYSFGIVFWELLTNRMPFEGMSNLQAAYAAAFKQERPSLPE 285
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNG 239
DISPDLAFI+QSCWVEDPN+RPSFSQIIRMLN F F + PP S + ESDTN AA +SNG
Sbjct: 286 DISPDLAFIIQSCWVEDPNMRPSFSQIIRMLNTFHFKVTPPPSSLLEESDTNGAAMSSNG 345
Query: 240 AMTEFSARARGKFAFLRQLFTAKRTKNLQ 268
MTE SAR RGKF+FLRQLF AKRT+N Q
Sbjct: 346 TMTELSARTRGKFSFLRQLFAAKRTRNSQ 374
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224139346|ref|XP_002323067.1| predicted protein [Populus trichocarpa] gi|222867697|gb|EEF04828.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1252), Expect = e-135, Method: Compositional matrix adjust.
Identities = 233/268 (86%), Positives = 255/268 (95%), Gaps = 2/268 (0%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRVKH+NLVKF+GACKDP MVIVTELLPGMSLRKYLVS+RP +LDL+VA+NFALD+AR
Sbjct: 87 MMSRVKHENLVKFIGACKDPFMVIVTELLPGMSLRKYLVSIRPKQLDLYVAINFALDVAR 146
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AMDCLHANGIIHRDLKPDNLLLT +QKS+KLADFGLAREETVTEMMTAETGTYRWMAPEL
Sbjct: 147 AMDCLHANGIIHRDLKPDNLLLTANQKSVKLADFGLAREETVTEMMTAETGTYRWMAPEL 206
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP LPE
Sbjct: 207 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPALPE 266
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF--TLRPPSPSVPESDTNEAAATSN 238
D+SPDLAFI+QSCWVEDPNLRPSF+QIIRMLNAFLF + P+PS+PESDTNEAA++SN
Sbjct: 267 DVSPDLAFIMQSCWVEDPNLRPSFNQIIRMLNAFLFTLSPPSPTPSLPESDTNEAASSSN 326
Query: 239 GAMTEFSARARGKFAFLRQLFTAKRTKN 266
G +TEFS+R RGKFAFLRQLFTAK+T+N
Sbjct: 327 GTITEFSSRTRGKFAFLRQLFTAKKTRN 354
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297735553|emb|CBI18047.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1251), Expect = e-135, Method: Compositional matrix adjust.
Identities = 228/269 (84%), Positives = 247/269 (91%), Gaps = 1/269 (0%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRVKH+NLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP ++D+HVAL+FALDIAR
Sbjct: 69 MMSRVKHENLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKRMDIHVALSFALDIAR 128
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AM+CLHANGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPEL
Sbjct: 129 AMECLHANGIIHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPEL 188
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIV WELLTNR+PFEGMSNLQAAYAAAFK RP LPE
Sbjct: 189 YSTVTLRQGEKKHYNNKVDVYSFGIVFWELLTNRMPFEGMSNLQAAYAAAFKQERPSLPE 248
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNG 239
DISPDLAFI+QSCWVEDPN+RPSFSQIIRMLN F F + PP S + ESDTN AA +SNG
Sbjct: 249 DISPDLAFIIQSCWVEDPNMRPSFSQIIRMLNTFHFKVTPPPSSLLEESDTNGAAMSSNG 308
Query: 240 AMTEFSARARGKFAFLRQLFTAKRTKNLQ 268
MTE SAR RGKF+FLRQLF AKRT+N Q
Sbjct: 309 TMTELSARTRGKFSFLRQLFAAKRTRNSQ 337
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532165|ref|XP_003534644.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 473 bits (1218), Expect = e-131, Method: Compositional matrix adjust.
Identities = 232/268 (86%), Positives = 246/268 (91%), Gaps = 2/268 (0%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP LDL VA+NFALDIAR
Sbjct: 103 MMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKLLDLDVAINFALDIAR 162
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AMD LHANGIIHRDLKPDNLLLT DQKS+KLADFGLAREETVTEMMTAETGTYRWMAPEL
Sbjct: 163 AMDWLHANGIIHRDLKPDNLLLTADQKSVKLADFGLAREETVTEMMTAETGTYRWMAPEL 222
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RPG+P+
Sbjct: 223 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPGIPD 282
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN--EAAATSN 238
DISP+LAF++QSCWVEDPNLRPSFSQIIRMLNAFLFTL PPSP +P N E A TSN
Sbjct: 283 DISPELAFVIQSCWVEDPNLRPSFSQIIRMLNAFLFTLSPPSPPLPVPPDNEPEVATTSN 342
Query: 239 GAMTEFSARARGKFAFLRQLFTAKRTKN 266
G +TEFSAR RGKF FLRQLF++KRTKN
Sbjct: 343 GTITEFSARNRGKFGFLRQLFSSKRTKN 370
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388513773|gb|AFK44948.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 468 bits (1204), Expect = e-129, Method: Compositional matrix adjust.
Identities = 222/264 (84%), Positives = 240/264 (90%), Gaps = 2/264 (0%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP LD+HVA+NFALDIAR
Sbjct: 96 MMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKPLDIHVAINFALDIAR 155
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPEL
Sbjct: 156 AMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPEL 215
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P+
Sbjct: 216 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPKIPD 275
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS--N 238
DISPDLAF++QSCWVEDPNLRPSFSQIIRMLN FLFTL P P +PE D AAT+ N
Sbjct: 276 DISPDLAFVIQSCWVEDPNLRPSFSQIIRMLNEFLFTLSPLFPPLPEPDNEPKAATTSNN 335
Query: 239 GAMTEFSARARGKFAFLRQLFTAK 262
GA+TEFSAR +GKFAF RQLF++K
Sbjct: 336 GAITEFSARNKGKFAFFRQLFSSK 359
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449439809|ref|XP_004137678.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 465 bits (1196), Expect = e-128, Method: Compositional matrix adjust.
Identities = 225/271 (83%), Positives = 246/271 (90%), Gaps = 3/271 (1%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRVKH+NLVKF+GACK+PLMVIVTELLPGMSLRKYL++ R +LD +A+NFALD+AR
Sbjct: 103 MMSRVKHENLVKFIGACKEPLMVIVTELLPGMSLRKYLMNNRKQQLDPRMAINFALDVAR 162
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AMDCLHANGIIHRDLKPDNLLLT +Q+S+KLADFGLAREE+VTEMMTAETGTYRWMAPEL
Sbjct: 163 AMDCLHANGIIHRDLKPDNLLLTANQRSVKLADFGLAREESVTEMMTAETGTYRWMAPEL 222
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P
Sbjct: 223 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPSIPG 282
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL---RPPSPSVPESDTNEAAATS 237
DISP+LAFIVQSCWVEDPN+RPSFSQIIRMLNA+LFTL SPS P+SDT E A TS
Sbjct: 283 DISPELAFIVQSCWVEDPNMRPSFSQIIRMLNAYLFTLPPPSQSSPSSPKSDTTETATTS 342
Query: 238 NGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 268
N A+TEFS+RARGKF FLRQLF AKR KN Q
Sbjct: 343 NSAITEFSSRARGKFGFLRQLFAAKRAKNSQ 373
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449521717|ref|XP_004167876.1| PREDICTED: serine/threonine-protein kinase HT1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1195), Expect = e-128, Method: Compositional matrix adjust.
Identities = 225/271 (83%), Positives = 246/271 (90%), Gaps = 3/271 (1%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRVKH+NLVKF+GACK+PLMVIVTELLPGMSLRKYL++ R +LD +A+NFALD+AR
Sbjct: 103 MMSRVKHENLVKFIGACKEPLMVIVTELLPGMSLRKYLMNNRKQQLDPRMAINFALDVAR 162
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AMDCLHANGIIHRDLKPDNLLLT +Q+S+KLADFGLAREE+VTEMMTAETGTYRWMAPEL
Sbjct: 163 AMDCLHANGIIHRDLKPDNLLLTANQRSVKLADFGLAREESVTEMMTAETGTYRWMAPEL 222
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P
Sbjct: 223 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPSIPG 282
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL---RPPSPSVPESDTNEAAATS 237
DISP+LAFIVQSCWVEDPN+RPSFSQIIRMLNA+LFTL SPS P+SDT E A TS
Sbjct: 283 DISPELAFIVQSCWVEDPNMRPSFSQIIRMLNAYLFTLPPPSQSSPSSPKSDTTETATTS 342
Query: 238 NGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 268
N A+TEFS+RARGKF FLRQLF AKR KN Q
Sbjct: 343 NSAITEFSSRARGKFGFLRQLFAAKRAKNSQ 373
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506575|ref|XP_003623576.1| Protein kinase, putative [Medicago truncatula] gi|355498591|gb|AES79794.1| Protein kinase, putative [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1195), Expect = e-128, Method: Compositional matrix adjust.
Identities = 227/268 (84%), Positives = 245/268 (91%), Gaps = 2/268 (0%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP LD+HVA+NFALDIAR
Sbjct: 96 MMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKPLDIHVAINFALDIAR 155
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPEL
Sbjct: 156 AMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPEL 215
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P+
Sbjct: 216 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPKIPD 275
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS--N 238
DISPDLAF++QSCWVEDPNLRPSFSQIIRMLN FLFTL P SP +PE D AAT+ N
Sbjct: 276 DISPDLAFVIQSCWVEDPNLRPSFSQIIRMLNEFLFTLSPLSPPLPEPDNEPKAATTSNN 335
Query: 239 GAMTEFSARARGKFAFLRQLFTAKRTKN 266
GA+TEFSAR +GKFAFLRQLF++KR KN
Sbjct: 336 GAITEFSARNKGKFAFLRQLFSSKRIKN 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357506577|ref|XP_003623577.1| Protein kinase, putative [Medicago truncatula] gi|355498592|gb|AES79795.1| Protein kinase, putative [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 464 bits (1194), Expect = e-128, Method: Compositional matrix adjust.
Identities = 227/268 (84%), Positives = 245/268 (91%), Gaps = 2/268 (0%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRV HDNLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP LD+HVA+NFALDIAR
Sbjct: 59 MMSRVHHDNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPKPLDIHVAINFALDIAR 118
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
AMD LH NGIIHRDLKPDNLLLT +QKS+KLADFGLAREE+VTEMMTAETGTYRWMAPEL
Sbjct: 119 AMDWLHDNGIIHRDLKPDNLLLTANQKSVKLADFGLAREESVTEMMTAETGTYRWMAPEL 178
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +P+
Sbjct: 179 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPKIPD 238
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS--N 238
DISPDLAF++QSCWVEDPNLRPSFSQIIRMLN FLFTL P SP +PE D AAT+ N
Sbjct: 239 DISPDLAFVIQSCWVEDPNLRPSFSQIIRMLNEFLFTLSPLSPPLPEPDNEPKAATTSNN 298
Query: 239 GAMTEFSARARGKFAFLRQLFTAKRTKN 266
GA+TEFSAR +GKFAFLRQLF++KR KN
Sbjct: 299 GAITEFSARNKGKFAFLRQLFSSKRIKN 326
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 268 | ||||||
| TAIR|locus:2180992 | 333 | AT5G01850 [Arabidopsis thalian | 0.981 | 0.789 | 0.760 | 2.5e-104 | |
| TAIR|locus:2091423 | 356 | ATN1 [Arabidopsis thaliana (ta | 0.820 | 0.617 | 0.678 | 1.1e-78 | |
| TAIR|locus:2168778 | 353 | AT5G40540 [Arabidopsis thalian | 0.809 | 0.614 | 0.678 | 3.4e-77 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.843 | 0.653 | 0.647 | 1.3e-75 | |
| TAIR|locus:2173674 | 405 | AT5G66710 [Arabidopsis thalian | 0.895 | 0.592 | 0.491 | 1e-59 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.791 | 0.562 | 0.460 | 6e-48 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.761 | 0.496 | 0.439 | 9.1e-45 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.761 | 0.495 | 0.439 | 2.8e-43 | |
| TAIR|locus:2154573 | 525 | AT5G58950 [Arabidopsis thalian | 0.779 | 0.398 | 0.397 | 4.6e-41 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.75 | 0.349 | 0.433 | 1.1e-39 |
| TAIR|locus:2180992 AT5G01850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1033 (368.7 bits), Expect = 2.5e-104, P = 2.5e-104
Identities = 203/267 (76%), Positives = 221/267 (82%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
MMSRV+H NLVKF+GACKDPLMVIVTELLPGMSLRKYL S+RP L L +AL+FALDIAR
Sbjct: 69 MMSRVQHHNLVKFIGACKDPLMVIVTELLPGMSLRKYLTSIRPQLLHLPLALSFALDIAR 128
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 120
A+ CLHANGIIHRDLKPDNLLLT + KS+KLADFGLAR YRWMAPEL
Sbjct: 129 ALHCLHANGIIHRDLKPDNLLLTENHKSVKLADFGLAREESVTEMMTAETGTYRWMAPEL 188
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR+PFEGMSNLQAAYAAAFK RP +PE
Sbjct: 189 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRMPFEGMSNLQAAYAAAFKQERPVMPE 248
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNG 239
ISP LAFIVQSCWVEDPN+RPSFSQIIR+LN FL TL PP P +PE+ TN T+
Sbjct: 249 GISPSLAFIVQSCWVEDPNMRPSFSQIIRLLNEFLLTLTPPPPQPLPETATNR---TNGR 305
Query: 240 AMTEFSARARGKFAFLRQLFTAKRTKN 266
A+TEFS R +GKFAF+RQLF AKR N
Sbjct: 306 AITEFSIRPKGKFAFIRQLFAAKRNIN 332
|
|
| TAIR|locus:2091423 ATN1 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 791 (283.5 bits), Expect = 1.1e-78, P = 1.1e-78
Identities = 150/221 (67%), Positives = 180/221 (81%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
M+S+V+H NLVKF+GACK+P+MVIVTELL G +LRKYLVSLRP +LD+ +A+ FALDIAR
Sbjct: 77 MLSKVQHKNLVKFIGACKEPMMVIVTELLLGGTLRKYLVSLRPKRLDIRLAVGFALDIAR 136
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 120
AM+CLH++GIIHRDLKP+NL+L+ D K++KLADFGLAR YRWMAPEL
Sbjct: 137 AMECLHSHGIIHRDLKPENLILSADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLRQGEKKHYN+KVD YSF IVLWEL+ N+LPFEGMSNLQAAYAAAFK+ RP E
Sbjct: 197 YSTVTLRQGEKKHYNHKVDAYSFAIVLWELILNKLPFEGMSNLQAAYAAAFKNLRPSA-E 255
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221
D+ DL IV SCW EDPN RP+F++II+ML +L T+ P
Sbjct: 256 DLPGDLEMIVTSCWKEDPNERPNFTEIIQMLLRYLTTVSAP 296
|
|
| TAIR|locus:2168778 AT5G40540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 777 (278.6 bits), Expect = 3.4e-77, P = 3.4e-77
Identities = 148/218 (67%), Positives = 177/218 (81%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
M+SRV+H NLVKF+GACK+P+MVIVTELL G +LRKYLVSLRP LD+ VA+ +ALDIAR
Sbjct: 77 MLSRVQHKNLVKFIGACKEPIMVIVTELLLGGTLRKYLVSLRPGSLDIRVAVGYALDIAR 136
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 120
AM+CLH++G+IHRDLKP++L+LT D K++KLADFGLAR YRWMAPEL
Sbjct: 137 AMECLHSHGVIHRDLKPESLILTADYKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 196
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLR GEKKHYN+KVD YSF IVLWEL+ N+LPFEGMSNLQAAYAAAFK+ RP +
Sbjct: 197 YSTVTLRHGEKKHYNHKVDAYSFAIVLWELIHNKLPFEGMSNLQAAYAAAFKNVRPSA-D 255
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
D+ DLA IV SCW EDPN RP+F++II+ML L T+
Sbjct: 256 DLPKDLAMIVTSCWKEDPNDRPNFTEIIQMLLRCLSTI 293
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 1.3e-75, P = 1.3e-75
Identities = 147/227 (64%), Positives = 176/227 (77%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
M+SRV+H NLVKF+GACK+P+MVIVTELL G +LRKYL++LRP L+ VA+ FALDIAR
Sbjct: 71 MLSRVQHKNLVKFIGACKEPVMVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIAR 130
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 120
M+CLH++GIIHRDLKP+NLLLT D K++KLADFGLAR YRWMAPEL
Sbjct: 131 GMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLAREESLTEMMTAETGTYRWMAPEL 190
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
YSTVTLR GEKKHYN+KVD YSF IVLWELL N+LPFEGMSNLQAAYAAAFK+ RP E
Sbjct: 191 YSTVTLRLGEKKHYNHKVDAYSFAIVLWELLHNKLPFEGMSNLQAAYAAAFKNVRPSA-E 249
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 227
+ +L IV SCW EDPN RP+F+ II +L +L + P ++P+
Sbjct: 250 SLPEELGDIVTSCWNEDPNARPNFTHIIELLLNYLSKVGSPISAIPQ 296
|
|
| TAIR|locus:2173674 AT5G66710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 612 (220.5 bits), Expect = 1.0e-59, P = 1.0e-59
Identities = 120/244 (49%), Positives = 170/244 (69%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++S+ +H+N+V+F+GAC +P ++I+TEL+ G +L+K+++S+RP LDL ++++FALDIAR
Sbjct: 123 LLSKFRHENIVRFIGACIEPKLMIITELMEGNTLQKFMLSVRPKPLDLKLSISFALDIAR 182
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 120
M+ L+ANGIIHRDLKP N+LLT DQK +KLADFGLAR YRWMAPEL
Sbjct: 183 GMEFLNANGIIHRDLKPSNMLLTGDQKHVKLADFGLAREETKGFMTFEAGT-YRWMAPEL 241
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
+S TL GEKKHY++KVDVYSF IV WELLTN+ PF+G +N+ AYAA+ K+ RP + E
Sbjct: 242 FSYDTLEIGEKKHYDHKVDVYSFAIVFWELLTNKTPFKGKNNIFVAYAAS-KNQRPSV-E 299
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE-SDTNEAAATSNG 239
++ + I+QSCW E+P+ RP F +I L L +L + + S N A S
Sbjct: 300 NLPEGVVSILQSCWAENPDARPEFKEITYSLTNLLRSLSSDTDATSSNSKANIATEDSTS 359
Query: 240 AMTE 243
++ +
Sbjct: 360 SLVQ 363
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 501 (181.4 bits), Expect = 6.0e-48, P = 6.0e-48
Identities = 99/215 (46%), Positives = 142/215 (66%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++S +KH+N+V+F+GAC +P ++IVTEL+ G +L++++++ RP+ LDL V+L+FALDI+R
Sbjct: 100 VLSSMKHENIVRFVGACIEPQLMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSFALDISR 159
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPEL 120
AM+ LH+ GIIHRDL P N+L+T D K +KLADFGLAR YRWMAPE+
Sbjct: 160 AMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGLAREKTLGGMTCEAGT-YRWMAPEV 218
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
S LR GEKKHY+ K+DVYSF ++ W LLTN+ PF + ++ Y + RP L
Sbjct: 219 CSREPLRIGEKKHYDQKIDVYSFALIFWSLLTNKTPFSEIPSISIPYFVN-QGKRPSL-S 276
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+I ++ I++ CW D R F I L + L
Sbjct: 277 NIPDEVVPILECCWAADSKTRLEFKDITISLESLL 311
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 471 (170.9 bits), Expect = 9.1e-45, P = 9.1e-45
Identities = 94/214 (43%), Positives = 136/214 (63%)
Query: 1 MMSRVKHDNLVKFLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M++ +KH N+V+F+GAC+ P++ IVTE G S+R++L + + L +A+ ALD+A
Sbjct: 182 MLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKLAVKQALDVA 241
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPE 119
R M +H IHRDLK DNLL++ D KS+K+ADFG+AR YRWMAPE
Sbjct: 242 RGMAYVHGRNFIHRDLKSDNLLISAD-KSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 300
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ + + YN KVDVYSFGIVLWEL+T LPF+ M+ +QAA+A + RP +P
Sbjct: 301 MI--------QHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 352
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
D P L+ I+ CW +P +RP F +++++L A
Sbjct: 353 NDCLPVLSDIMTRCWDANPEVRPCFVEVVKLLEA 386
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 457 (165.9 bits), Expect = 2.8e-43, P = 2.8e-43
Identities = 94/214 (43%), Positives = 133/214 (62%)
Query: 1 MMSRVKHDNLVKFLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M++ +KH N+V+F+GAC P++ IVTE G S+R++L + + L +A+ ALD+A
Sbjct: 183 MLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVA 242
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPE 119
R M +H IHRDLK DNLL++ D +S+K+ADFG+AR YRWMAPE
Sbjct: 243 RGMAYVHERNFIHRDLKSDNLLISAD-RSIKIADFGVARIEVQTEGMTPETGTYRWMAPE 301
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ + + Y KVDVYSFGIVLWEL+T LPF+ M+ +QAA+A + RP +P
Sbjct: 302 MI--------QHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVP 353
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
D P L I+ CW DP +RP F++I+ +L A
Sbjct: 354 ADCLPVLGEIMTRCWDADPEVRPCFAEIVNLLEA 387
|
|
| TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 4.6e-41, P = 4.6e-41
Identities = 87/219 (39%), Positives = 133/219 (60%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++SR+ H N++KF+GA KDP + ++T+ LP SLR +L L L + FA+DIA
Sbjct: 261 LLSRLTHPNVIKFVGAYKDPPVYCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIA 320
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPE 119
R M+ +H+ IIHRDLKP+N+L+ ++ LK+ADFG+A YRWMAPE
Sbjct: 321 RGMEYIHSRRIIHRDLKPENVLID-EEFHLKIADFGIACEEEYCDMLADDPGTYRWMAPE 379
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ ++K + K DVYSFG+VLWE++ +P+E M+ +QAA+A K+ RP +P
Sbjct: 380 MI--------KRKPHGRKADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIP 431
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
D + +++ CW P+ RP F QI+++L F +L
Sbjct: 432 GDCPVAMKALIEQCWSVAPDKRPEFWQIVKVLEQFAISL 470
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 423 (154.0 bits), Expect = 1.1e-39, P = 1.1e-39
Identities = 92/212 (43%), Positives = 125/212 (58%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M +V+H N+V+F+GAC K P + IVTE +PG S+ YL + L A+DI
Sbjct: 338 IMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGGSVYDYLHKQK-GVFKLPTLFKVAIDIC 396
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARXXXXXXXXXXXXXXYRWMAPE 119
+ M LH N IIHRDLK NLL+ + + +K+ADFG+AR YRWMAPE
Sbjct: 397 KGMSYLHQNNIIHRDLKAANLLMD-ENEVVKVADFGVARVKAQTGVMTAETGTYRWMAPE 455
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ E K Y++K DV+S+GIVLWELLT +LP+E M+ LQAA K RP +P
Sbjct: 456 VI--------EHKPYDHKADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIP 507
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
++ P LA +++ W D RP FS+II L
Sbjct: 508 KNTHPKLAELLERLWEHDSTQRPDFSEIIEQL 539
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00037482001 | SubName- Full=Chromosome chr8 scaffold_88, whole genome shotgun sequence; (337 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 268 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 4e-64 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-63 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-60 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-59 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-59 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-54 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-44 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-35 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-35 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-33 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-33 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-33 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-33 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-32 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-32 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-32 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-31 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-31 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-30 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-30 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-29 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-29 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-28 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-28 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 6e-28 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-27 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-26 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-26 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-26 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-26 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-26 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-26 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-25 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-25 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-25 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-25 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-25 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-25 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-25 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-25 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-24 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-24 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-24 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-24 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-24 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-23 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-23 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-22 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-22 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-22 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-21 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-21 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-21 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-21 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-21 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-21 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 9e-21 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-20 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-20 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-20 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-20 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-20 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-20 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-20 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-20 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-20 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-20 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-19 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-19 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 6e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 8e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-18 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-18 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-18 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-18 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 9e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-17 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-17 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-16 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 6e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 7e-16 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-16 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-16 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-15 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-15 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-15 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-15 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-14 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-14 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-14 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-14 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-14 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 6e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-13 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-13 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 8e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 9e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-12 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-12 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-11 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 7e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 3e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-09 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-09 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 7e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-07 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-07 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-06 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 2e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-06 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 6e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 1e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 6e-04 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 4e-64
Identities = 81/215 (37%), Positives = 124/215 (57%), Gaps = 14/215 (6%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++ H N+VK LG C ++ ++IV E +PG L YL RP +L L L+FAL IA
Sbjct: 54 IMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIA 113
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWMA 117
R M+ L + IHRDL N L+ + +K++DFGL+R+ + + G RWMA
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMA 172
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 176
PE +L++G+ + +K DV+SFG++LWE+ T P+ GMSN + K R
Sbjct: 173 PE-----SLKEGK---FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-VLEYLKKGYRL 223
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
P + P+L ++ CW EDP RP+FS+++ +L
Sbjct: 224 PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 198 bits (505), Expect = 5e-63
Identities = 78/217 (35%), Positives = 120/217 (55%), Gaps = 19/217 (8%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALD 57
+M ++ H N+VK LG C ++ + IV E + G L YL RP L ++ L+FAL
Sbjct: 54 IMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK---LSLSDLLSFALQ 110
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRW 115
IAR M+ L + IHRDL N L+ + +K++DFGL+R+ + G RW
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRW 169
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
MAPE +L++G+ + +K DV+SFG++LWE+ T P+ GMSN +
Sbjct: 170 MAPE-----SLKEGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK-NGY 220
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
R P + P+L ++ CW EDP RP+FS+++ +L
Sbjct: 221 RLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 2e-60
Identities = 71/213 (33%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++KH N+V+ +D + +V E G L L +L A + I
Sbjct: 50 ILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG--RLSEDEARFYLRQIL 107
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A++ LH+ GI+HRDLKP+N+LL D +KLADFGLAR+ E +T GT +MAPE
Sbjct: 108 SALEYLHSKGIVHRDLKPENILLDED-GHVKLADFGLARQLDPGEKLTTFVGTPEYMAPE 166
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ K Y VD++S G++L+ELLT + PF G L + K P P
Sbjct: 167 VLL--------GKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP 218
Query: 180 E--DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
DISP+ +++ V+DP R + + ++
Sbjct: 219 PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-59
Identities = 76/217 (35%), Positives = 115/217 (52%), Gaps = 18/217 (8%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M ++ H N+V+ LG C +PL IVTE +PG L +L KL L L AL I
Sbjct: 54 IMKKLSHPNIVRLLGVCTQGEPLY-IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQI 111
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RW 115
A+ M+ L + +HRDL N L+T + +K++DFGL+R+ + G +W
Sbjct: 112 AKGMEYLESKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKW 170
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
MAPE L+ G+ + +K DV+SFG++LWE+ T P+ GMSN +
Sbjct: 171 MAPES-----LKDGK---FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-VLELLEDGY 221
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
R PE+ +L ++ CW DP RP+FS+++ L
Sbjct: 222 RLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (480), Expect = 3e-59
Identities = 78/224 (34%), Positives = 120/224 (53%), Gaps = 24/224 (10%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP-------NKLDLHVA 51
+M ++ H N+V+ LG C ++PL +V E + G L YL RP + L L
Sbjct: 49 VMKKLGHPNVVRLLGVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 111
L+FA+ IA+ M+ L + +HRDL N L+ D +K++DFGL+R+ + +TG
Sbjct: 108 LSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTG 166
Query: 112 TY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY 167
RWMAPE +L+ G + +K DV+SFG++LWE+ T P+ G+SN +
Sbjct: 167 GKLPIRWMAPE-----SLKDG---IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-VL 217
Query: 168 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
K R PE +L ++ SCW DP RP+FS+++ L
Sbjct: 218 EYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 4e-55
Identities = 76/215 (35%), Positives = 114/215 (53%), Gaps = 19/215 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ R+ H N+V+ + A +D + +V E G L YL P L A AL I
Sbjct: 51 ILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGP--LSEDEAKKIALQIL 108
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 118
R ++ LH+NGIIHRDLKP+N+LL + +K+ADFGLA++ + +T GT +MAP
Sbjct: 109 RGLEYLHSNGIIHRDLKPENILLDENG-VVKIADFGLAKKLLKSSSSLTTFVGTPWYMAP 167
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ L G Y KVDV+S G++L+ELLT + PF G N+ + P L
Sbjct: 168 EV-----LLGG--NGYGPKVDVWSLGVILYELLTGKPPFSG-ENILDQLQLIRRILGPPL 219
Query: 179 PED------ISPDLAFIVQSCWVEDPNLRPSFSQI 207
D S + +++ C +DP+ RP+ +I
Sbjct: 220 EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 8e-54
Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 43/213 (20%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++ H N+VK G +D + +V E G SL+ L KL L L I
Sbjct: 44 ILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQIL 102
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAP 118
++ LH+NGIIHRDLKP+N+LL D +KLADFGL++ T ++ GT +MAP
Sbjct: 103 EGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ K +Y+ K D++S G++L+EL
Sbjct: 163 EVLL-------GKGYYSEKSDIWSLGVILYEL---------------------------- 187
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
P+L +++ +DP RPS +I+ L
Sbjct: 188 -----PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 3e-44
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 18/213 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV---IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
++S ++H N+V++ G+ +D I E + G SL L KL V +
Sbjct: 52 ILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQ 109
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYR 114
I + LH+NGI+HRD+K N+L+ D +KLADFG A+ + E + GT
Sbjct: 110 ILEGLAYLHSNGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPY 168
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKH 173
WMAPE+ +R E Y D++S G + E+ T + P+ + N AA Y
Sbjct: 169 WMAPEV-----IRGEE---YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG 220
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206
P +PE +S + ++ C DP RP+ +
Sbjct: 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-36
Identities = 62/213 (29%), Positives = 109/213 (51%), Gaps = 14/213 (6%)
Query: 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDI 58
+ ++ H N++K+ + ++ + IV E G L + + + L++ + +
Sbjct: 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQL 112
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMA 117
A+ LH+ I+HRD+KP N+ LT + +KL DFG+++ + ++ GT +++
Sbjct: 113 CLALKYLHSRKILHRDIKPQNIFLTSNGL-VKLGDFGISKVLSSTVDLAKTVVGTPYYLS 171
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PEL + K YN K D++S G VL+EL T + PFEG + L+ A P
Sbjct: 172 PELC--------QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPP- 222
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
+P S +L +V S +DP RPS +QI++
Sbjct: 223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 3e-35
Identities = 74/218 (33%), Positives = 114/218 (52%), Gaps = 20/218 (9%)
Query: 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M+ ++H NLV+ LG +PL IVTE + SL YL S + L L FALD+
Sbjct: 54 MTTLRHPNLVQLLGVVLQGNPLY-IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVC 112
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMA 117
M+ L +HRDL N+L++ + K++DFGLA+E + + ++G +W A
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAKEASQGQ----DSGKLPVKWTA 167
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 176
PE LR +K ++ K DV+SFGI+LWE+ + R+P+ + L+ K R
Sbjct: 168 PE-----ALR---EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPHVEKGYRM 218
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
PE P++ +++ CW DP RP+F Q+ L
Sbjct: 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 7e-35
Identities = 71/218 (32%), Positives = 115/218 (52%), Gaps = 21/218 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++ H NLV+ G C K + IVTE + L YL R KL L+ D+
Sbjct: 52 VMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRE-RKGKLGTEWLLDMCSDVC 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
AM+ L +NG IHRDL N L+ + +K++DFGLAR + + T+ GT +W
Sbjct: 111 EAMEYLESNGFIHRDLAARNCLVG-EDNVVKVSDFGLAR-YVLDDQYTSSQGTKFPVKWA 168
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA--YAAAFKH 173
PE++ +++K DV+SFG+++WE+ + ++P+E SN + +A ++
Sbjct: 169 PPEVFD--------YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL 220
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
RP L ++ I+ SCW E P RP+F +++ L
Sbjct: 221 YRPKL---APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-34
Identities = 81/219 (36%), Positives = 111/219 (50%), Gaps = 30/219 (13%)
Query: 7 HDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDIARAM 62
H N+VK +G C K P+ IV EL+PG SL +L R K L V L +LD A M
Sbjct: 51 HPNIVKLIGVCVQKQPIY-IVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGM 106
Query: 63 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWMAP 118
+ L + IHRDL N L+ + LK++DFG++REE + T G +W AP
Sbjct: 107 EYLESKNCIHRDLAARNCLVG-ENNVLKISDFGMSREEE-GGIYTVSDGLKQIPIKWTAP 164
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA--AYAAAFKHAR 175
E L G Y ++ DV+S+GI+LWE + P+ GMSN Q + ++
Sbjct: 165 E-----ALNYGR---YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPA 216
Query: 176 PGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
P L PE+I ++ CW DP RPSFS+I L
Sbjct: 217 PQLCPEEIYR----LMLQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 2e-33
Identities = 70/211 (33%), Positives = 110/211 (52%), Gaps = 18/211 (8%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL-HVALNFALD 57
++ + KH N+VK+ G+ KD L IV E G SL+ L+ L +A +
Sbjct: 50 ILKKCKHPNIVKYYGSYLKKDELW-IVMEFCSGGSLKD-LLKSTNQTLTESQIAY-VCKE 106
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
+ + ++ LH+NGIIHRD+K N+LLT D + +KL DFGL+ + + T+ GT WMA
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLTSDGE-VKLIDFGLSAQLSDTKARNTMVGTPYWMA 165
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + K Y+ K D++S GI EL + P+ + ++A + A PG
Sbjct: 166 PEVIN--------GKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP-PG 216
Query: 178 L--PEDISPDLAFIVQSCWVEDPNLRPSFSQ 206
L PE S + ++ C ++P RP+ Q
Sbjct: 217 LRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 69/225 (30%), Positives = 108/225 (48%), Gaps = 27/225 (12%)
Query: 2 MSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNK--------LDLHVA 51
M ++V+ LG P +V++ EL+ L+ YL S RP L
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVM-ELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF 121
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 111
+ A +IA M L A +HRDL N ++ D ++K+ DFG+ R+ T+
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGK 180
Query: 112 TY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA-A 166
RWMAPE +L+ G + K DV+SFG+VLWE+ T P++G+SN +
Sbjct: 181 GLLPVRWMAPE-----SLKDG---VFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLK 232
Query: 167 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
+ H LPE+ L +++ CW +P +RP+F +I+ L
Sbjct: 233 FVIDGGHLD--LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 5e-33
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M KH N+V + + + +V E + G SL +++ +++ ++
Sbjct: 68 IMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVL 126
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 118
+ ++ LH+ +IHRD+K DN+LL+ D S+KLADFG A + T + GT WMAP
Sbjct: 127 QGLEYLHSQNVIHRDIKSDNILLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAP 185
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ +K Y KVD++S GI+ E+ P+ L+A + K G+
Sbjct: 186 EVIK--------RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK----GI 233
Query: 179 P-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P E SP+ + C V+DP RPS ++++
Sbjct: 234 PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 7e-33
Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 17/220 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M+ V H ++V+ LG C + ++T+L+P L Y+ + + N + LN+ + IA+
Sbjct: 62 VMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAK 120
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLARE-ETVTEMMTAETGTY--RWM 116
M L ++HRDL N+L+ TP +K+ DFGLA+ + + AE G +WM
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 175
A E ++ Y +K DV+S+G+ +WEL+T P+EG+ K R
Sbjct: 179 ALE-----SILHRI---YTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGER 229
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
P + D+ ++ CW+ D RP+F ++I +
Sbjct: 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-32
Identities = 66/216 (30%), Positives = 105/216 (48%), Gaps = 20/216 (9%)
Query: 2 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ +KH NLVK+ G + I E G +L + L R LD HV + L +
Sbjct: 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLE 110
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVT-EMMTAETGTYRW 115
+ LH++GI+HRD+KP N+ L +KL DFG L T E + + GT +
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAY 169
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHA 174
MAPE+ G+ K + D++S G V+ E+ T + P+ + N Q + H
Sbjct: 170 MAPEVI-----TGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH- 223
Query: 175 RPGLPE--DISPD-LAFIVQSCWVEDPNLRPSFSQI 207
+P +P+ +SP+ F+ + C DP RP+ S++
Sbjct: 224 KPPIPDSLQLSPEGKDFLDR-CLESDPKKRPTASEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 122 bits (305), Expect = 2e-32
Identities = 68/232 (29%), Positives = 104/232 (44%), Gaps = 21/232 (9%)
Query: 7 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDC 64
N+VK +D + +V E + G SL L + R L AL I A++
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAETGTYRWMA 117
LH+ GIIHRD+KP+N+LL D + +KL DFGLA+ ++ + + GT +MA
Sbjct: 117 LHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ L + ++ D++S GI L+ELLT PFEG N A + K
Sbjct: 177 PEV-----LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS-ATSQTLKIILEL 230
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 229
++ L+ + + S +++ L A R S S D
Sbjct: 231 PTPSLASPLSPSNP------ELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
|
Length = 384 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-32
Identities = 66/204 (32%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++SR+ H +VK A + + +V E PG L +L + A +A +I
Sbjct: 46 ILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG--RFSEERARFYAAEIV 103
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 117
A++ LH+ GII+RDLKP+N+LL +KL DFGLA+E +E T GT ++A
Sbjct: 104 LALEYLHSLGIIYRDLKPENILLD-ADGHIKLTDFGLAKEL-SSEGSRTNTFCGTPEYLA 161
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE V L +G Y VD +S G++L+E+LT + PF + + Y
Sbjct: 162 PE----VLLGKG----YGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIY-EKILKDPLR 211
Query: 178 LPEDISPDLAFIVQSCWVEDPNLR 201
PE +SP+ ++ +DP R
Sbjct: 212 FPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 9e-32
Identities = 71/217 (32%), Positives = 113/217 (52%), Gaps = 26/217 (11%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M +KH NLV+ LG C ++P I+TE + +L YL +++ V L A I+
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQIS 114
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT------- 112
AM+ L IHRDL N L+ + +K+ADFGL+R +MT +T T
Sbjct: 115 SAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSR------LMTGDTYTAHAGAKF 167
Query: 113 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYAAA 170
+W APE + ++ K DV++FG++LWE+ T + P+ G+ +L Y
Sbjct: 168 PIKWTAPESLAYNK--------FSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELL 218
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
K R PE P + ++++CW +P+ RPSF++I
Sbjct: 219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 21/217 (9%)
Query: 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 61
M+++ H +V+ +G CK +++V EL P L KYL R + A +A
Sbjct: 50 MAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK-RREIPVSDL-KELAHQVAMG 107
Query: 62 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETG---TYRWMA 117
M L + +HRDL N+LL ++ K++DFG++R ++ A T +W A
Sbjct: 108 MAYLESKHFVHRDLAARNVLLV-NRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYA 166
Query: 118 PEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 174
PE Y +++K DV+S+G+ LWE + P+ M + A
Sbjct: 167 PECINYGK----------FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-AMLESGE 215
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
R PE+ ++ I+ SCW P RP+FS++
Sbjct: 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-31
Identities = 68/224 (30%), Positives = 100/224 (44%), Gaps = 32/224 (14%)
Query: 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLD---LHVALNFALDI 58
M + H+NL++ G +++VTEL P SL L LR + L + ++A+ I
Sbjct: 50 MHSLDHENLIRLYGVVLTHPLMMVTELAPLGSL---LDRLRKDALGHFLISTLCDYAVQI 106
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR---- 114
A M L + IHRDL N+LL D K +K+ DFGL R E Y
Sbjct: 107 ANGMRYLESKRFIHRDLAARNILLASDDK-VKIGDFGLMRALPQNEDH------YVMEEH 159
Query: 115 ------WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 167
W APE T T +++ DV+ FG+ LWE+ T P+ G+S Q
Sbjct: 160 LKVPFAWCAPESLRTRT--------FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK 211
Query: 168 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
+ R PE D+ ++ CW +P RP+F+ + L
Sbjct: 212 KIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 73/212 (34%), Positives = 116/212 (54%), Gaps = 19/212 (8%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M++++H NLV+ LG + + IVTE + SL YL S + L L F+LD+
Sbjct: 52 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWM 116
AM+ L AN +HRDL N+L++ D + K++DFGL +E + T+ +TG +W
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVA-KVSDFGLTKEASSTQ----DTGKLPVKWT 166
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 175
APE LR+ K ++ K DV+SFGI+LWE+ + R+P+ + L+ K +
Sbjct: 167 APE-----ALRE---KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVVPRVEKGYK 217
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
P+ P + +++ CW D RPSF Q+
Sbjct: 218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQL 249
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-30
Identities = 71/212 (33%), Positives = 108/212 (50%), Gaps = 22/212 (10%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M +++H L++ C ++P + IVTEL+ SL +YL L L ++ A +
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEP-IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQV 112
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRW 115
A M L A IHRDL N+L+ + K+ADFGLAR ++ A G +W
Sbjct: 113 ASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLAR-VIKEDIYEAREGAKFPIKW 170
Query: 116 MAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 172
APE LY+ ++ K DV+SFGI+L E++T R+P+ GM+N +
Sbjct: 171 TAPEAALYNRFSI----------KSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG 220
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 204
+ P P +L I+ CW EDP+ RP+F
Sbjct: 221 YRMP-CPPGCPKELYDIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 4e-30
Identities = 77/241 (31%), Positives = 120/241 (49%), Gaps = 42/241 (17%)
Query: 1 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVA- 51
MM + KH N++ LG C + PL V+V E +LR +L + RP + D
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 52 --------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
++FA +AR M+ L + IHRDL N+L+T D +K+ADFGLAR+
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIADFGLARDIHHI 185
Query: 104 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158
+ T +WMAPE L+ V Y ++ DV+SFG++LWE+ T P+
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLLWEIFTLGGSPYP 236
Query: 159 GMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
G+ FK + G P++ + +L +++ CW E P+ RP+F Q++ L+
Sbjct: 237 GI-----PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
Query: 215 L 215
L
Sbjct: 292 L 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-30
Identities = 65/214 (30%), Positives = 110/214 (51%), Gaps = 16/214 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++H+ +V++ G +D + I E +PG S++ L + L V + I
Sbjct: 57 LLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA--LTETVTRKYTRQIL 114
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETV---TEMMTAETGTYRW 115
++ LH+N I+HRD+K N+L ++KL DFG + R +T+ M + TGT W
Sbjct: 115 EGVEYLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
M+PE+ S GE Y K DV+S G + E+LT + P+ + A + A +
Sbjct: 174 MSPEVIS------GEG--YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 225
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P LP +SPD ++ +VE+ RPS +++R
Sbjct: 226 PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-30
Identities = 74/221 (33%), Positives = 109/221 (49%), Gaps = 22/221 (9%)
Query: 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M +++HD LV+ C ++P+ IVTE + SL +L S KL L ++ A IA
Sbjct: 55 MKKLRHDKLVQLYAVCSEEEPIY-IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIA 113
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
M L + IHRDL N+L+ + K+ADFGLAR E TA G +W
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWT 171
Query: 117 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 173
APE Y T+ K DV+SFGI+L E++T R+P+ GM+N + +
Sbjct: 172 APEAANYGRFTI----------KSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY 221
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
P P + +L ++ CW +DP RP+F + L +
Sbjct: 222 RMP-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 21/215 (9%)
Query: 1 MMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
++S+++H N+V++LG + D L I EL+PG SL K L V + I
Sbjct: 55 LLSKLQHPNIVQYLGTEREEDNLY-IFLELVPGGSLAKLLKKYGS--FPEPVIRLYTRQI 111
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
++ LH +HRD+K N+L+ + +KLADFG+A++ + G+ WMAP
Sbjct: 112 LLGLEYLHDRNTVHRDIKGANILVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAP 170
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--- 175
E V +QG Y D++S G + E+ T + P+ S L+ AA FK R
Sbjct: 171 E----VIAQQGG---YGLAADIWSLGCTVLEMATGKPPW---SQLEG-VAAVFKIGRSKE 219
Query: 176 -PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P +P+ +S + + C DP+LRP+ ++++
Sbjct: 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 72/232 (31%), Positives = 114/232 (49%), Gaps = 33/232 (14%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK-----LDLHVALN 53
+MS H N+VK LG C +P +I+ EL+ G L YL R + L L L+
Sbjct: 52 LMSNFNHPNIVKLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAREETVTEMMTAE 109
LD+A+ L IHRDL N L++ +K+ DFGLAR+ ++ E
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 110 TG---TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 165
RWMAPE +L G+ + + DV+SFG+++WE+LT + P+ ++N +
Sbjct: 171 GEGLLPVRWMAPE-----SLLDGK---FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV 222
Query: 166 AYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
+H G PE+ + ++ +CW +DP+ RP+F +I +L
Sbjct: 223 -----LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 7e-29
Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 21/218 (9%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M ++ H LV+ G C + PL IVTE + L YL R KL + L+ D+
Sbjct: 52 VMMKLSHPKLVQLYGVCTQQKPLY-IVTEFMENGCLLNYLRQ-RQGKLSKDMLLSMCQDV 109
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWM 116
M+ L N IHRDL N L++ +K++DFG+ R E ++ + +W
Sbjct: 110 CEGMEYLERNSFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA--AYAAAFKH 173
PE+++ Y++K DV+SFG+++WE+ T ++PFE SN + + F+
Sbjct: 169 PPEVFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL 220
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
RP L S + ++ SCW E P RP+F++++R +
Sbjct: 221 YRPKLA---SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-29
Identities = 64/216 (29%), Positives = 107/216 (49%), Gaps = 16/216 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M + H ++VK +G + + IV EL P LR YL + LDL + ++ ++
Sbjct: 60 IMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYL-QVNKYSLDLASLILYSYQLST 118
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMA 117
A+ L + +HRD+ N+L+ +PD +KL DFGL+R A G +WMA
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPD--CVKLGDFGLSRYLEDESYYKASKGKLPIKWMA 176
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 176
PE ++ R+ + + DV+ FG+ +WE+L PF+G+ N R
Sbjct: 177 PE---SINFRR-----FTSASDVWMFGVCMWEILMLGVKPFQGVKN-NDVIGRIENGERL 227
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
+P + P L ++ CW DP+ RP F+++ L+
Sbjct: 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLS 263
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 67/219 (30%), Positives = 107/219 (48%), Gaps = 19/219 (8%)
Query: 2 MSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ R++H +L+ C +P+ I+TEL+ SL +L S L + ++ A +A
Sbjct: 56 LKRLRHKHLISLFAVCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVA 114
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT-YRWM 116
M L IHRDL N+L+ + K+ADFGLAR +E V ++++ Y+W
Sbjct: 115 EGMAYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWT 171
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 175
APE S ++ K DV+SFGI+L+E+ T ++P+ GM+N Y R
Sbjct: 172 APEAAS--------HGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQITAGYR 222
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
P ++ I+ CW +P RPSF + L+
Sbjct: 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 15/208 (7%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ + H LV + + M +V +LL G LR +L + K + +I
Sbjct: 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWICEIV 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
A++ LH+ GIIHRD+KPDN+LL D++ + + DF +A + T + T+ +GT +MAP
Sbjct: 111 LALEYLHSKGIIHRDIKPDNILL--DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAP 168
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHARPG 177
E+ + Y+ VD +S G+ +E L + P+ G S ++ A + A
Sbjct: 169 EVLCR--------QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL 220
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFS 205
P S + + DP R +
Sbjct: 221 YPATWSTEAIDAINKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 76/228 (33%), Positives = 113/228 (49%), Gaps = 37/228 (16%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFAL 56
++ + H N+VK +G C + P+ IV EL+PG +L LR K +L + FAL
Sbjct: 45 ILKQYDHPNIVKLIGVCTQRQPIY-IVMELVPGGD---FLSFLRKKKDELKTKQLVKFAL 100
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--- 113
D A M L + IHRDL N L+ + LK++DFG++R+E + G Y
Sbjct: 101 DAAAGMAYLESKNCIHRDLAARNCLVG-ENNVLKISDFGMSRQE--------DDGIYSSS 151
Query: 114 -------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 165
+W APE L G Y+++ DV+S+GI+LWE + P+ GM+N QA
Sbjct: 152 GLKQIPIKWTAPE-----ALNYGR---YSSESDVWSYGILLWETFSLGVCPYPGMTNQQA 203
Query: 166 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
K R P+ D+ ++Q CW P RP FS++ + L A
Sbjct: 204 REQVE-KGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 67/213 (31%), Positives = 111/213 (52%), Gaps = 17/213 (7%)
Query: 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 61
M+++ H NLV+ LG + IV EL+ +L +L + + + L F+LD+A
Sbjct: 53 MTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEG 112
Query: 62 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAPE 119
M+ L + ++HRDL N+L++ D + K++DFGLAR M + +W APE
Sbjct: 113 MEYLESKKLVHRDLAARNILVSEDGVA-KVSDFGLAR----VGSMGVDNSKLPVKWTAPE 167
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGL 178
L+ + +++K DV+S+G++LWE+ + R P+ MS L+ K R
Sbjct: 168 -----ALKHKK---FSSKSDVWSYGVLLWEVFSYGRAPYPKMS-LKEVKECVEKGYRMEP 218
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
PE D+ ++ SCW +P RPSF ++ L
Sbjct: 219 PEGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 65/239 (27%), Positives = 108/239 (45%), Gaps = 43/239 (17%)
Query: 2 MSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+ + H+N+VK+ G C+ P + ++ E LP SLR YL R ++L L F+ I
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ-INLKRLLLFSSQI 118
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----- 113
+ MD L + IHRDL N+L+ + +K++DFGLA+ ++ + Y
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESE-DLVKISDFGLAK------VLPEDKDYYYVKEP 171
Query: 114 -----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----NRLPFEGMSNLQ 164
W APE T +++ DV+SFG+ L+EL T ++ P +
Sbjct: 172 GESPIFWYAPECLRTSK--------FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMI 223
Query: 165 AAYAAAFKHAR--------PGLPE-DISPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNA 213
R LP PD + +++ CW +P RPSF+ +I +++
Sbjct: 224 GIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR 282
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 68/213 (31%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 2 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ +KH N+VK++G+ + + I+ E SLR+ + + + + + +
Sbjct: 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK--KFGPFPESLVAVYVYQVLQ 110
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPE 119
+ LH G+IHRD+K N+L T D +KLADFG+A + V++ + GT WMAPE
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE 169
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA---RP 176
V G + D++S G + ELLT P+ +L AA F+ P
Sbjct: 170 ----VIEMSG----ASTASDIWSLGCTVIELLTGNPPY---YDLNPM-AALFRIVQDDHP 217
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
LPE ISP+L + C+ +DPNLRP+ Q+++
Sbjct: 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-27
Identities = 71/221 (32%), Positives = 114/221 (51%), Gaps = 22/221 (9%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
++ + H N+V+ +G C K P+ IV EL+ G +L + P +L + + +
Sbjct: 46 ILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRTEGP-RLKVKELIQMVENA 103
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR---- 114
A M+ L + IHRDL N L+T ++ LK++DFG++REE + + A TG +
Sbjct: 104 AAGMEYLESKHCIHRDLAARNCLVT-EKNVLKISDFGMSREEE--DGVYASTGGMKQIPV 160
Query: 115 -WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 172
W APE L G Y+++ DV+SFGI+LWE + +P+ +SN Q A +
Sbjct: 161 KWTAPE-----ALNYGR---YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-Q 211
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
R PE + +++ CW DP RPSFS + + L +
Sbjct: 212 GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 73/222 (32%), Positives = 115/222 (51%), Gaps = 25/222 (11%)
Query: 1 MMSRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+MS + H+N+V LGAC P++VI TE L +L R + L L L+F+
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVI-TEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQ 149
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---R 114
+A+ M L + IHRDL N+LLT K +K+ DFGLAR+ + +
Sbjct: 150 VAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 115 WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM---SNLQAAYAA 169
WMAPE +++ V Y + DV+S+GI+LWE+ + P+ GM S
Sbjct: 209 WMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
++ A+P E ++ I+++CW DP RP+F QI++++
Sbjct: 260 GYRMAQP---EHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-27
Identities = 71/228 (31%), Positives = 104/228 (45%), Gaps = 34/228 (14%)
Query: 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALD 57
M + H N+++ G P+M I+TE + SL K+L R N V +
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVM-IITEYMENGSLDKFL---RENDGKFTVGQLVGMLRG 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---- 113
IA M L +HRDL N+L+ + K++DFGL+R +E TY
Sbjct: 115 IASGMKYLSEMNYVHRDLAARNILVNSNLVC-KVSDFGLSRRLEDSE------ATYTTKG 167
Query: 114 -----RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 167
RW APE + R + + DV+SFGIV+WE+++ P+ MSN Q
Sbjct: 168 GKIPIRWTAPE---AIAYR-----KFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDVI 218
Query: 168 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
A R P D L ++ CW +D N RP+FSQI+ L+ +
Sbjct: 219 KAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-26
Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 21/212 (9%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M+R+ H ++++ LGA C+D + E + G S+ L V +N+ +
Sbjct: 56 LMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYTEQLL 113
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-----TGTYR 114
R + LH N IIHRD+K NLL+ + L++ADFG A E GT
Sbjct: 114 RGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 174
+MAPE+ LR GE+ Y DV+S G V+ E+ T + P+ A FK A
Sbjct: 174 FMAPEV-----LR-GEQ--YGRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFKIA 224
Query: 175 R----PGLPEDISPDLAFIVQSCWVEDPNLRP 202
P +PE +SP L + C P RP
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 69/225 (30%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M +++H LV+ + I+TE + SL +L + KL ++ ++ A IA
Sbjct: 54 LMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAE 113
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAP 118
M + IHRDL+ N+L++ + K+ADFGLAR E E + +W AP
Sbjct: 114 GMAFIERKNYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 172
Query: 119 EL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS------NLQAAYAA 169
E Y T T+ K DV+SFGI+L E++T R+P+ GM+ NL+ Y
Sbjct: 173 EAINYGTFTI----------KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGY-- 220
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
R P++ +L +++ CW E P RP+F + +L F
Sbjct: 221 -----RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-26
Identities = 59/166 (35%), Positives = 86/166 (51%), Gaps = 16/166 (9%)
Query: 2 MSRVKHDNLVKFLG-ACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ +KH N+VK L + + +V E M L+KYL RP L ++ + + R
Sbjct: 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYL-DKRPGPLSPNLIKSIMYQLLR 109
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGT--YRWMA 117
+ H++ I+HRDLKP N+L+ D LKLADFGLAR + T E T YR A
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTYTHEVVTLWYR--A 166
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
PE+ G KHY+ VD++S G + E++T + F G S +
Sbjct: 167 PEIL------LGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-26
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 16/214 (7%)
Query: 3 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF-ALDIAR 60
S +KH N+V++LG+ ++ I E +PG SL L S D + F I
Sbjct: 60 SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAETGTYRWM 116
+ LH N I+HRD+K DN+L+ +K++DFG LA TE TGT ++M
Sbjct: 120 GLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF---TGTLQYM 176
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA-YAAAFKHAR 175
APE+ + +G + Y D++S G + E+ T + PF + QAA +
Sbjct: 177 APEV-----IDKGPRG-YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH 230
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P +PE +S + + C+ DP+ R S +++
Sbjct: 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-26
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 20/218 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +KH N+V++LG C D + I E +PG S+ L P L V + I
Sbjct: 55 LLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQIL 112
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-------ETVTEMMTAETGT 112
+ LH N ++HRD+K +N++L P+ +KL DFG AR T + M+ + GT
Sbjct: 113 DGVAYLHNNCVVHRDIKGNNVMLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAF 171
WMAPE+ + + Y K D++S G ++E+ T + P M L A + A
Sbjct: 172 PYWMAPEVIN--------ESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 172 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ P LP+ S V SC D + RPS Q++R
Sbjct: 224 RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 60/223 (26%), Positives = 106/223 (47%), Gaps = 22/223 (9%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLV-------SLRPNKLDLHVA 51
M ++ H N+V+ LG C +P ++ E L+++L L+P L
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEP-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAE 109
+ IA MD L +HRDL N L++ Q+ +K++ L+++ +E +
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVS-SQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 110 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 168
RW+APE +++ + ++ K DV+SFG+++WE+ T LPF G+S+ +
Sbjct: 179 LIPLRWLAPE-----AVQEDD---FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230
Query: 169 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
+PE L ++ CW +P RPSFS+++ L
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 68/218 (31%), Positives = 112/218 (51%), Gaps = 21/218 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++ H LV+ G C + + +V E + L YL + R K L LD+
Sbjct: 52 VMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVC 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
M L ++ +IHRDL N L+ +Q +K++DFG+ R + + T+ TGT +W
Sbjct: 111 EGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWS 168
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAA--YAAAFKH 173
+PE++S Y++K DV+SFG+++WE+ + + P+E SN + A F+
Sbjct: 169 SPEVFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRL 220
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
+P L S + ++Q CW E P RPSFS ++ L
Sbjct: 221 YKPRL---ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 1 MMSRVKHDNLVK----FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNF 54
+++ V H N++ FL K + IV E P L K + + + +
Sbjct: 52 ILASVNHPNIISYKEAFLDGNK---LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMT-AETGT 112
+ + R + LH I+HRDLK N+LL D +K+ D G+++ + + M + GT
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISK--VLKKNMAKTQIGT 164
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 172
+MAPE++ + Y+ K D++S G +L+E+ T PFE S +Q +
Sbjct: 165 PHYMAPEVWK--------GRPYSYKSDIWSLGCLLYEMATFAPPFEARS-MQDLRYKVQR 215
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
P +P S DL ++S P LRP+ +I+
Sbjct: 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 6e-26
Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 10/209 (4%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ + H N++++ +D ++IV E PG +L +Y+ + LD L+F + I
Sbjct: 52 VLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQIL 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A+ +H I+HRDLK N+LL + +K+ DFG+++ + GT +++PE
Sbjct: 112 LALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPE 171
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
L E K YN K D+++ G VL+EL + + FE +NL A +
Sbjct: 172 LC--------EGKPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGTFAPIS 222
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQII 208
+ SPDL ++ S DP+ RP SQI+
Sbjct: 223 DRYSPDLRQLILSMLNLDPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-26
Identities = 58/218 (26%), Positives = 111/218 (50%), Gaps = 19/218 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ + H N+V++LG + I E +PG S+ L + + + F +
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVL 118
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE----TVTEMMTAETGTYRW 115
+ LH+ GI+HRDLK DNLL+ D K++DFG++++ + M+ + G+ W
Sbjct: 119 EGLAYLHSKGILHRDLKADNLLVDAD-GICKISDFGISKKSDDIYDNDQNMSMQ-GSVFW 176
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE+ + + Y+ KVD++S G V+ E+ R P+ + A + K +
Sbjct: 177 MAPEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA 230
Query: 176 PGLPEDISPDLAFI----VQSCWVEDPNLRPSFSQIIR 209
P +P D+S +L+ + + +C+ +P+ RP+ ++++
Sbjct: 231 PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 7e-26
Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 21/215 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++ H+ LV+ G C K + IVTE + L YL + L D+
Sbjct: 52 VMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVC 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
M L + IHRDL N L+ DQ +K++DFGL+R + + T+ G+ RW
Sbjct: 111 EGMAYLESKQFIHRDLAARNCLVD-DQGCVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWS 168
Query: 117 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 173
PE LYS +++K DV++FG+++WE+ + ++P+E +N + +
Sbjct: 169 PPEVLLYSK----------FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL 218
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
R P S + I+ SCW E RP+F Q++
Sbjct: 219 -RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-26
Identities = 69/220 (31%), Positives = 112/220 (50%), Gaps = 18/220 (8%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++HD LV+ K+ + I+TE + SL +L S K+ L ++F+ IA
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIA 113
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMA 117
M + IHRDL+ N+L++ + K+ADFGLAR E E + +W A
Sbjct: 114 EGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTA 172
Query: 118 PEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 174
PE + + T+ K DV+SFGI+L+E++T ++P+ GMSN A +
Sbjct: 173 PEAINFGSFTI----------KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR 222
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
P E+ +L I+++CW E RP+F + +L+ F
Sbjct: 223 MP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 25/218 (11%)
Query: 2 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+S+ + +VK + + +V E LPG L L ++ LD VA + +I
Sbjct: 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVL 104
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---------TG 111
A++ LH+NGIIHRDLKPDN+L+ + LKL DFGL++ V + G
Sbjct: 105 ALEYLHSNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVG 163
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--A 169
T ++APE V L QG ++ VD +S G +L+E L PF G + +
Sbjct: 164 TPDYIAPE----VILGQG----HSKTVDWWSLGCILYEFLVGIPPFHG-ETPEEIFQNIL 214
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
K P E +S + ++ V DP R I
Sbjct: 215 NGKIEWPEDVE-VSDEAIDLISKLLVPDPEKRLGAKSI 251
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-25
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 14/214 (6%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++S ++H N++ + D ++I E G +L +V + + + L + I
Sbjct: 52 ILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIV 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 117
A+ +H GI+HRD+K N+ LT +KL DFG+++ +E AET GT +M+
Sbjct: 112 SAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILG-SEYSMAETVVGTPYYMS 169
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PEL QG K YN K D+++ G VL+ELLT + F+ +N +
Sbjct: 170 PELC------QGVK--YNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQGNYTP 220
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
+ S +L +V S +DP RP+ +++
Sbjct: 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 57/221 (25%), Positives = 100/221 (45%), Gaps = 23/221 (10%)
Query: 2 MSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFAL 56
+ +KH N+V++ D + IV E G L + + + + ++
Sbjct: 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112
Query: 57 DIARAMDCLH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET- 110
+ A+ H N ++HRDLKP N+ L ++KL DFGLA+ + A+T
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILG-HDSSFAKTY 170
Query: 111 -GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 169
GT +M+PE + Y+ K D++S G +++EL PF + LQ A
Sbjct: 171 VGTPYYMSPEQLN--------HMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI 222
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
R +P S +L +++S DP+ RPS +++++
Sbjct: 223 KEGKFRR-IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 78/237 (32%), Positives = 119/237 (50%), Gaps = 34/237 (14%)
Query: 1 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHV------- 50
MM + KH N++ LGAC PL V+V G +LR+YL + RP +D
Sbjct: 70 MMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG-NLREYLRARRPPGMDYSFDTCKLPE 128
Query: 51 -ALNF------ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
L F A +AR M+ L + IHRDL N+L+T D +K+ADFGLAR+
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN-VMKIADFGLARDVHNI 187
Query: 104 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158
+ T +WMAPE L+ V Y ++ DV+SFG++LWE+ T P+
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G+ ++ + + R P + + +L I++ CW P+ RP+F Q++ L+ L
Sbjct: 239 GIP-VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-25
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 9 NLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDIAR----AM 62
N+ K+ G+ K P + I+ E G S+R + + + ++++ I R A+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM---KAGPIAEKYISV-----IIREVLVAL 114
Query: 63 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAPELY 121
+H G+IHRD+K N+L+T +KL DFG+A + + GT WMAPE+
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVI 173
Query: 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPED 181
+ E K+Y+ K D++S GI ++E+ T P+ + +A K P L ++
Sbjct: 174 T-------EGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP-KSKPPRLEDN 225
Query: 182 -ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
S L V +C E+P R S ++++
Sbjct: 226 GYSKLLREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 33/231 (14%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHVALN 53
+MS+ H N+V+ +G + P I+ EL+ G L+ +L RP L + L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPD--QKSLKLADFGLAREETVTE------- 104
A D+A+ L N IHRD+ N LLT + K+ADFG+AR+
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 105 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 162
M+ +WM PE + + +K DV+SFG++LWE+ + +P+ G +N
Sbjct: 181 AMLPI-----KWMPPEAFLDGI--------FTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227
Query: 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
Q R P+ + I+ CW P RP+F+ I+ +
Sbjct: 228 -QEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-25
Identities = 75/237 (31%), Positives = 119/237 (50%), Gaps = 34/237 (14%)
Query: 1 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP-------------- 43
MM + KH N++ LGAC PL VIV E +LR+YL + RP
Sbjct: 76 MMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPE 134
Query: 44 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
+L ++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLAR+
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHI 193
Query: 104 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158
+ T +WMAPE L+ + Y ++ DV+SFG++LWE+ T P+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRI---------YTHQSDVWSFGVLLWEIFTLGGSPYP 244
Query: 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+ L
Sbjct: 245 GVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 5e-25
Identities = 68/228 (29%), Positives = 106/228 (46%), Gaps = 33/228 (14%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK-------------- 45
+MS ++H N+V LG C K+ ++ E L L ++LV P+
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS 120
Query: 46 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 104
LD L+ A+ IA M+ L ++ +HRDL N L+ + ++K++DFGL+R+ +
Sbjct: 121 LDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG-EGLTVKISDFGLSRDIYSADY 179
Query: 105 --MMTAETGTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEG 159
+ + RWM PE LY T D++SFG+VLWE+ + L P+ G
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTES----------DIWSFGVVLWEIFSYGLQPYYG 229
Query: 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
SN + + P PED + ++ CW E P RP F I
Sbjct: 230 FSNQEVIEMIRSRQLLPC-PEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 6e-25
Identities = 70/238 (29%), Positives = 107/238 (44%), Gaps = 43/238 (18%)
Query: 2 MSRVKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR----PNKLDLHV 50
M H N++K +G C K P +++ + L +L+ R P KL L
Sbjct: 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQT 114
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110
L F +DIA M+ L IHRDL N +L D + +ADFGL++ +
Sbjct: 115 LLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT-VCVADFGLSK--------KIYS 165
Query: 111 GTY-----------RWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157
G Y +W+A E L V Y +K DV++FG+ +WE+ T + P+
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRV---------YTSKSDVWAFGVTMWEIATRGQTPY 216
Query: 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G+ N + Y R PED +L ++ SCW DP RP+F+++ +L L
Sbjct: 217 PGVENHE-IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 8e-25
Identities = 69/237 (29%), Positives = 104/237 (43%), Gaps = 41/237 (17%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN------------KL 46
+++ +H+N+VKF G C DP + +V E + L K+L S P+ +L
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPI-MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 47 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 106
L L A+ IA M L + +HRDL N L+ D +K+ DFG++R+ T+
Sbjct: 120 TLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYY 178
Query: 107 TAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 160
T RWM PE +Y T DV+SFG+VLWE+ T + P+ G+
Sbjct: 179 RVGGHTMLPIRWMPPESIMYRKFTTES----------DVWSFGVVLWEIFTYGKQPWYGL 228
Query: 161 SNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
SN + + G P ++ I+ CW DP R + I L
Sbjct: 229 SNEE-----VIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (247), Expect = 1e-24
Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 11 VKFLGACKDPL-------------MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
++FL C+ P + I+ E G S L +P KLD +
Sbjct: 50 IQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL---KPGKLDETYIAFILRE 106
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRW 115
+ ++ LH G IHRD+K N+LL+ ++ +KLADFG++ + T+++ T GT W
Sbjct: 107 VLLGLEYLHEEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTF-VGTPFW 164
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE+ ++Q Y+ K D++S GI EL P + ++ + K+
Sbjct: 165 MAPEV-----IKQSG---YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP-KNNP 215
Query: 176 PGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P L + S V C +DP RPS ++++
Sbjct: 216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-24
Identities = 71/210 (33%), Positives = 103/210 (49%), Gaps = 19/210 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M +++HD LV+ + + IVTE + SL +L L L ++ A +A
Sbjct: 54 IMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAA 113
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWMA 117
M + IHRDL+ N+L+ D K+ADFGLAR E TA G +W A
Sbjct: 114 GMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTA 171
Query: 118 PE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
PE LY T+ K DV+SFGI+L EL+T R+P+ GM+N + +
Sbjct: 172 PEAALYGRFTI----------KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR 221
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSF 204
P P+D L ++ CW +DP RP+F
Sbjct: 222 MP-CPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 3e-24
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 4 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM 62
+ +V F GA + + I E + G SL K L ++ ++ + A+ + + +
Sbjct: 55 KCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGL 113
Query: 63 DCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELY 121
LH IIHRD+KP N+L+ + +KL DFG++ + V + GT +MAPE
Sbjct: 114 TYLHEKHKIIHRDVKPSNILVN-SRGQIKLCDFGVSGQ-LVNSLAKTFVGTSSYMAPE-- 169
Query: 122 STVTLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF-------KH 173
R QG Y+ K D++S G+ L EL T R P+ F
Sbjct: 170 -----RIQGN--DYSVKSDIWSLGLSLIELATGRFPY---PPENDPPDGIFELLQYIVNE 219
Query: 174 ARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQI 207
P LP SPD V C ++DP RPS+ ++
Sbjct: 220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-24
Identities = 55/146 (37%), Positives = 74/146 (50%), Gaps = 15/146 (10%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYS 122
LH+N IHRD+K N+LL + KLADFG++ + M T GT WMAPE
Sbjct: 115 LHSNKKIHRDIKAGNILLNEE-GQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAPE--- 169
Query: 123 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PE 180
V G YNNK D++S GI E+ + P+ + ++A + K P L PE
Sbjct: 170 -VIQEIG----YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLSDPE 223
Query: 181 DISPDLAFIVQSCWVEDPNLRPSFSQ 206
SP+ V+ C V+DP RPS Q
Sbjct: 224 KWSPEFNDFVKKCLVKDPEERPSAIQ 249
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 3e-24
Identities = 73/237 (30%), Positives = 118/237 (49%), Gaps = 34/237 (14%)
Query: 1 MMSRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
MM + KH N++ LGAC PL VIV G +LR+YL + RP ++ + D
Sbjct: 73 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG-NLREYLRARRPPGMEYSYDIARVPD 131
Query: 58 --------------IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
+AR M+ L + IHRDL N+L+T + +K+ADFGLAR+
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNI 190
Query: 104 EMMTAETG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158
+ T +WMAPE L+ V Y ++ DV+SFG+++WE+ T P+
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGVLMWEIFTLGGSPYP 241
Query: 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G+ ++ + + R P + + +L +++ CW P+ RP+F Q++ L+ L
Sbjct: 242 GIP-VEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 5e-24
Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 45/246 (18%)
Query: 1 MMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRP--------------- 43
++ +V H +++K GAC PL++IV G SLR +L R
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG-SLRSFLRESRKVGPSYLGSDGNRNSS 114
Query: 44 -------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 96
L + ++FA I+R M L ++HRDL N+L+ + + +K++DFGL
Sbjct: 115 YLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA-EGRKMKISDFGL 173
Query: 97 AR---EETVTEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152
+R EE + +WMA E L+ + Y + DV+SFG++LWE++T
Sbjct: 174 SRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI---------YTTQSDVWSFGVLLWEIVT 224
Query: 153 -NRLPFEGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P+ G++ L ++ RP E+ S ++ ++ +CW ++P+ RP+F+ I +
Sbjct: 225 LGGNPYPGIAPERLFNLLKTGYRMERP---ENCSEEMYNLMLTCWKQEPDKRPTFADISK 281
Query: 210 MLNAFL 215
L +
Sbjct: 282 ELEKMM 287
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 5e-24
Identities = 56/211 (26%), Positives = 95/211 (45%), Gaps = 12/211 (5%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+++++ ++++ + + IV E L K L R L F + I
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 118
+ LH+ I+HRD+K NL L ++K+ D G+A+ T GT +++P
Sbjct: 112 LGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTNFANTIVGTPYYLSP 170
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
EL E K YN K DV++ G+VL+E T + PF+ +N A + P +
Sbjct: 171 ELC--------EDKPYNEKSDVWALGVVLYECCTGKHPFDA-NNQGALILKIIRGVFPPV 221
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ S LA ++ C +D RP Q++R
Sbjct: 222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 6e-24
Identities = 76/235 (32%), Positives = 112/235 (47%), Gaps = 41/235 (17%)
Query: 6 KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHV--------ALNF- 54
KH N++ LG C PL VIV E +LR++L + RP D L+F
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 55 -----ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 109
A +AR M+ L + IHRDL N+L+T D +K+ADFGLAR +
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKT 193
Query: 110 TG---TYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 164
+ +WMAPE L+ V Y ++ DV+SFGI++WE+ T P+ G+
Sbjct: 194 SNGRLPVKWMAPEALFDRV---------YTHQSDVWSFGILMWEIFTLGGSPYPGIP--- 241
Query: 165 AAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
FK R G P + + +L +++ CW P RP+F Q++ L+ L
Sbjct: 242 --VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 9e-24
Identities = 71/241 (29%), Positives = 113/241 (46%), Gaps = 48/241 (19%)
Query: 9 NLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD--------LHVALNFALDIA 59
++V+ LG K ++V EL+ L+ YL SLRP + L + A +IA
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR----- 114
M L+A +HRDL N ++ D ++K+ DFG+ R+ ET YR
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRD-------IYETDYYRKGGKG 181
Query: 115 -----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 168
WMAPE +L+ G + D++SFG+VLWE+ + P++G+SN Q
Sbjct: 182 LLPVRWMAPE-----SLKDGVFTTSS---DMWSFGVVLWEITSLAEQPYQGLSNEQV--- 230
Query: 169 AAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPS 224
K G P++ + +++ CW +P +RP+F +I+ +L L P P
Sbjct: 231 --LKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKD---DLHPSFPE 285
Query: 225 V 225
V
Sbjct: 286 V 286
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 2e-23
Identities = 64/216 (29%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVALNFALD 57
++S KH N+V A + + I+ E G +L ++ L R + + L+
Sbjct: 55 ILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLE 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
A++ LH++ +IHRDLK N+LLT D +KLADFG++ + + + +T GT W
Sbjct: 115 ---ALNFLHSHKVIHRDLKAGNILLTLD-GDVKLADFGVSAKNK-STLQKRDTFIGTPYW 169
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE+ + T + Y+ K D++S GI L EL P ++ ++ K
Sbjct: 170 MAPEVVACETFKD---NPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL-KSEP 225
Query: 176 PGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P L P S ++SC V+DP+ RP+ +++++
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 2e-23
Identities = 50/159 (31%), Positives = 84/159 (52%), Gaps = 16/159 (10%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++H LV G+ +D + +V E +PG L +L + + VA +A +
Sbjct: 54 ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPVARFYAAQVV 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAP 118
A++ LH+ I++RDLKP+NLLL +K+ DFG A R + T + GT ++AP
Sbjct: 112 LALEYLHSLDIVYRDLKPENLLLD-SDGYIKITDFGFAKRVKGRTYTL---CGTPEYLAP 167
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
E + L +G Y VD ++ GI+++E+L PF
Sbjct: 168 E----IILSKG----YGKAVDWWALGILIYEMLAGYPPF 198
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 3e-23
Identities = 64/219 (29%), Positives = 101/219 (46%), Gaps = 31/219 (14%)
Query: 4 RVKHDNLVKFLGACKDPLMV-IVTELLPGMSL---RKYLVSLRPNKLDLHVALNFALDIA 59
+ +VK GA + IV E + G SL K + + L A I
Sbjct: 55 SCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-----IARQIL 109
Query: 60 RAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWM 116
+ +D LH IIHRD+KP NLL+ +K+ADFG+++ E T+ + T GT +M
Sbjct: 110 KGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFV-GTVTYM 167
Query: 117 APELYSTVTLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH-- 173
+PE R QGE Y+ D++S G+ L E + PF Q ++ +
Sbjct: 168 SPE-------RIQGE--SYSYAADIWSLGLTLLECALGKFPFL--PPGQPSFFELMQAIC 216
Query: 174 --ARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P LP + SP+ + +C +DP RPS +++++
Sbjct: 217 DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 3e-23
Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 42/241 (17%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ + H N++K L + + +V E + L K L+ R L + ++ +
Sbjct: 51 LLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYK-LIKDRQRGLPESLIKSYLYQLL 108
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWM-A 117
+ + H++GI+HRDLKP+NLL+ + LKLADFGLAR + T T RW A
Sbjct: 109 QGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVT-RWYRA 166
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------------------ 159
PEL + + Y+ VD++S G + ELL+ R F G
Sbjct: 167 PEL--LLGDKG-----YSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPD 219
Query: 160 ------MSNLQAAYAAAFKH-ARPGLPE---DISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
++L Y +F A LP+ + SP ++ DP+ R + Q +
Sbjct: 220 PEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279
Query: 210 M 210
Sbjct: 280 H 280
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 5e-23
Identities = 61/223 (27%), Positives = 100/223 (44%), Gaps = 25/223 (11%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDI 58
MS+ H N+VK+ + + +V L G SL + S P LD + ++
Sbjct: 52 AMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEV 111
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAET---GTY 113
+ ++ LH+NG IHRD+K N+LL D S+K+ADFG++ + GT
Sbjct: 112 LKGLEYLHSNGQIHRDIKAGNILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA--YAAAF 171
WMAPE+ + Y+ K D++SFGI EL T P+ S
Sbjct: 171 CWMAPEVME-------QVHGYDFKADIWSFGITAIELATGAAPY---SKYPPMKVLMLTL 220
Query: 172 KHARPGLPEDISPDL---AF--IVQSCWVEDPNLRPSFSQIIR 209
++ P L +F ++ C +DP+ RP+ ++++
Sbjct: 221 QNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 6e-23
Identities = 69/237 (29%), Positives = 112/237 (47%), Gaps = 33/237 (13%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M +H N+V+ + D L V V E L G +L + R N+ + L
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIATVCLAVL-- 125
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE---TGTYRW 115
+A+ LHA G+IHRD+K D++LLT D + +KL+DFG + V++ + GT W
Sbjct: 126 -KALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCAQ--VSKEVPRRKSLVGTPYW 181
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT------NRLPFEGMSNLQAAYAA 169
MAPE+ S + Y +VD++S GI++ E++ N P + M ++
Sbjct: 182 MAPEVIS--------RLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP 233
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
K+ +SP L + V DP R + ++++ + FL PPS VP
Sbjct: 234 KLKN-----LHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 7e-23
Identities = 70/219 (31%), Positives = 104/219 (47%), Gaps = 17/219 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M +++HD LV + + IVTE + SL +L L L ++ A IA
Sbjct: 54 IMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIAD 113
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAP 118
M + IHRDL+ N+L+ D K+ADFGLAR E + + +W AP
Sbjct: 114 GMAYIERMNYIHRDLRAANILVG-DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 119 E--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 175
E LY T+ K DV+SFGI+L EL+T R+P+ GM N + +
Sbjct: 173 EAALYGRFTI----------KSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM 222
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
P P+ L +++ CW +DP+ RP+F I L +
Sbjct: 223 P-CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 8e-23
Identities = 74/221 (33%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M ++HD LVK + I+TE + SL +L S +K L ++F+ IA
Sbjct: 54 VMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAE 113
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTAETGTY--RWM 116
M + IHRDL+ N+L++ SL K+ADFGLAR E E + +W
Sbjct: 114 GMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT 170
Query: 117 APEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 173
APE + + T+ K DV+SFGI+L E++T R+P+ GMSN + A +
Sbjct: 171 APEAINFGSFTI----------KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY 220
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
P PE+ +L I+ CW P RP+F I +L+ F
Sbjct: 221 RMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-22
Identities = 74/229 (32%), Positives = 108/229 (47%), Gaps = 34/229 (14%)
Query: 7 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-------------- 51
H N++ LGAC+ + + E P +L +L R + D A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 111
L+FA D+AR MD L IHRDL N+L+ + + K+ADFGL+R + V T
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRL 185
Query: 112 TYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS--NLQAA 166
RWMA E YS Y DV+S+G++LWE+++ P+ GM+ L
Sbjct: 186 PVRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 167 YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
++ +P +D DL ++ CW E P RPSF+QI+ LN L
Sbjct: 236 LPQGYRLEKPLNCDDEVYDL---MRQCWREKPYERPSFAQILVSLNRML 281
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-22
Identities = 66/230 (28%), Positives = 103/230 (44%), Gaps = 35/230 (15%)
Query: 7 HDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 63
H+N+VK+ G C + + ++ E +P SLR YL +KL+L L FA I M
Sbjct: 65 HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMA 121
Query: 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAP 118
LH+ IHRDL N+LL D + +K+ DFGLA+ E ++ + W A
Sbjct: 122 YLHSQHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF-WYAV 179
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-------RLPFEGMSNLQAAYAAAF 171
E E K DV+SFG+ L+ELLT+ FE M +
Sbjct: 180 ECLK-------ENKFSYAS-DVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231
Query: 172 -------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
+ R P++ ++ ++++CW + RP+F +I +L
Sbjct: 232 RLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-22
Identities = 75/227 (33%), Positives = 113/227 (49%), Gaps = 35/227 (15%)
Query: 1 MMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLD--------LHV 50
+M ++V+ LG P +VI+ EL+ L+ YL SLRP + L
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIM-ELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110
+ A +IA M L+AN +HRDL N ++ D ++K+ DFG+ R+ + E
Sbjct: 121 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRD--IYETDYYRK 177
Query: 111 G-----TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 164
G RWM+PE +L+ G + DV+SFG+VLWE+ T P++GMSN Q
Sbjct: 178 GGKGLLPVRWMSPE-----SLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
Query: 165 AAYAAAFKHARPGLPE--DISPDLAF-IVQSCWVEDPNLRPSFSQII 208
GL + D PD+ F +++ CW +P +RPSF +II
Sbjct: 230 VLRFVM----EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-22
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 11/211 (5%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+++++KH N+V F + ++ + IV E G L K + R L++ + I+
Sbjct: 52 LLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 118
+ +H I+HRD+K N+ L+ + KL DFG+AR+ E+ GT +++P
Sbjct: 112 LGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSP 171
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ + + YNNK D++S G VL+EL T + PFEG + Q + P
Sbjct: 172 EIC--------QNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS 223
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P + S DL ++ + P RPS + I++
Sbjct: 224 P-NFSRDLRSLISQLFKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-22
Identities = 64/172 (37%), Positives = 91/172 (52%), Gaps = 19/172 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 54
M+ KHDN++ L + P + +VTEL+ L K +VS +P D HV + F
Sbjct: 52 MLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSD-HVKV-F 108
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGT 112
I R + LH+ GI+HRD+KP NLL+ + LK+ DFGLAR E E MT E T
Sbjct: 109 LYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVT 167
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
+ APE+ +HY + VD++S G + ELL R+ F+ S +Q
Sbjct: 168 QYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 2e-22
Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 43/224 (19%)
Query: 7 HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDC 64
H ++K +D + V E P L +Y+ R LD +A +I A++
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEY 117
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-------------- 110
LH+ GIIHRDLKP+N+LL D +K+ DFG A+ +
Sbjct: 118 LHSKGIIHRDLKPENILLDKD-MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 111 -------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN- 162
GT +++PEL + +K D+++ G +++++LT + PF G +
Sbjct: 177 RRFASFVGTAEYVSPELLN--------EKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY 228
Query: 163 --LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 204
Q + P + PD +++ V DP R
Sbjct: 229 LTFQKILKLEYS-----FPPNFPPDAKDLIEKLLVLDPQDRLGV 267
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 3e-22
Identities = 58/172 (33%), Positives = 89/172 (51%), Gaps = 17/172 (9%)
Query: 46 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 105
LD L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR+ +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIR-NDS 268
Query: 106 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 159
G R WMAPE +++ V Y + DV+S+GI+LWE+ + P+ G
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCV---------YTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
M Y + R PE ++ I++SCW DP RP+F QI++++
Sbjct: 320 MPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-22
Identities = 67/243 (27%), Positives = 108/243 (44%), Gaps = 49/243 (20%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP--------------- 43
+M+ H N+VK LG C P+ ++ + G L ++L P
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYG-DLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 44 ---NKLDLHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98
N L L L A +A M L +HRDL N L+ + +K+ADFGL+R
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV-VKIADFGLSR 178
Query: 99 EETVTEMMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153
+ A RWM PE Y+ Y + DV+++G+VLWE+ +
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYN----------RYTTESDVWAYGVVLWEIFSY 228
Query: 154 RL-PFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
+ P+ GM++ + Y + R G P++ +L +++ CW + P+ RPSF+ I
Sbjct: 229 GMQPYYGMAHEEVIY-----YVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASIN 283
Query: 209 RML 211
R+L
Sbjct: 284 RIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-22
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 13/212 (6%)
Query: 1 MMSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
++S++KH N+V + + + D L+ IV G L L + L + + + + I
Sbjct: 52 LLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQI 111
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMA 117
A A+ LH I+HRDLK N+ LT +K+ D G+AR E +M + GT +M+
Sbjct: 112 AMALQYLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMS 170
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PEL+S K YN K DV++ G ++E+ T + F ++ + + P
Sbjct: 171 PELFSN--------KPYNYKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPP 221
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+P+D SP+L ++ + + P RPS I+R
Sbjct: 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 5e-22
Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 34/237 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
++ ++HDN+VK+ G C + +V E LP SLR YL R +LD L +A
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQ 116
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGT 112
I + M+ L + +HRDL N+L+ + + +K+ DFGL + +E E+
Sbjct: 117 ICKGMEYLGSKRYVHRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI 175
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----NRLP----FEGMSNLQ 164
+ W APE + E K ++ DV+SFG+VL+EL T + P M N +
Sbjct: 176 F-WYAPESLT-------ESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDK 226
Query: 165 AAYAAAF-------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
+ + R P ++ I++ CW DP+ RPSFS++ + A
Sbjct: 227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 5e-22
Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 26/228 (11%)
Query: 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 61
M + H +V+ LG C + +VT+L P SL ++ R + LD LN+ + IA+
Sbjct: 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDS-LDPQRLLNWCVQIAKG 121
Query: 62 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-------REETVTEMMTAETGTYR 114
M L + ++HR+L N+LL D +++ADFG+A ++ +E T +
Sbjct: 122 MYYLEEHRMVHRNLAARNILLKSDSI-VQIADFGVADLLYPDDKKYFYSEHKTP----IK 176
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 173
WMA E ++ + Y ++ DV+S+G+ +WE+++ P+ GM K
Sbjct: 177 WMALE---SILFGR-----YTHQSDVWSYGVTVWEMMSYGAEPYAGM-RPHEVPDLLEKG 227
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221
R P+ + D+ ++ CW+ D N+RP+F + + N F R P
Sbjct: 228 ERLAQPQICTIDVYMVMVKCWMIDENVRPTFKE---LANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 6e-22
Identities = 70/234 (29%), Positives = 114/234 (48%), Gaps = 38/234 (16%)
Query: 1 MMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMS---LRKYLVSLRPNKLDLHVALN- 53
++ + H N++ L C +P V L P M+ L+ +L R + + AL+
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFV----LYPYMNWGNLKLFLQQCRLGEANNPQALST 116
Query: 54 -----FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTA 108
A+ IA M LH G+IH+D+ N ++ ++ +K+ D L+R+ +
Sbjct: 117 QQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMDYHCL 175
Query: 109 ETGTYR---WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ 164
R WMA E +L K Y++ DV+SFG++LWEL+T + P+ + +
Sbjct: 176 GDNENRPVKWMALE-----SL---VNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227
Query: 165 -AAY-AAAFKHARPGLPEDIS-PDLAFIVQS-CWVEDPNLRPSFSQIIRMLNAF 214
AAY ++ A+P I+ PD F V + CW DP RPSFSQ+++ L F
Sbjct: 228 MAAYLKDGYRLAQP-----INCPDELFAVMACCWALDPEERPSFSQLVQCLTDF 276
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 7e-22
Identities = 53/171 (30%), Positives = 89/171 (52%), Gaps = 19/171 (11%)
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 111
++++ +AR M+ L + IHRDL N+LL+ + +K+ DFGLAR+ + G
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD-IYKDPDYVRKG 233
Query: 112 TYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 165
R WMAPE ++ V Y + DV+SFG++LWE+ + P+ G+ +
Sbjct: 234 DARLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QIDE 283
Query: 166 AYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ K R PE +P++ I+ CW +P RP+FS+++ +L L
Sbjct: 284 EFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-21
Identities = 61/213 (28%), Positives = 106/213 (49%), Gaps = 15/213 (7%)
Query: 4 RVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIAR 60
+++H N+V++ ++ + IV +L+ G L ++ SL+ K N + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124
Query: 61 AMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A+ LH I+HRDL P+N++L D K + + DFGLA+++ +T+ GT + PE
Sbjct: 125 ALRYLHKEKRIVHRDLTPNNIMLGEDDK-VTITDFGLAKQKQPESKLTSVVGTILYSCPE 183
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ + E Y K DV++FG +L+++ T + PF + L A P LP
Sbjct: 184 IV------KNEP--YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-LP 234
Query: 180 EDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
E + S D+ ++ SC D RP Q+ M+
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-21
Identities = 59/178 (33%), Positives = 89/178 (50%), Gaps = 14/178 (7%)
Query: 25 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84
V E L G L ++ S + D A +A +I + LH GII+RDLK DN+LL
Sbjct: 74 VMEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDK 131
Query: 85 DQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143
D +K+ADFG+ +E E + GT ++APE+ +G+K YN VD +SF
Sbjct: 132 DGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPEIL------KGQK--YNESVDWWSF 182
Query: 144 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
G++L+E+L + PF G + + + RP P IS + + + DP R
Sbjct: 183 GVLLYEMLIGQSPFHGEDEDELFD--SILNDRPHFPRWISKEAKDCLSKLFERDPTKR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 59/179 (32%), Positives = 93/179 (51%), Gaps = 23/179 (12%)
Query: 46 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 105
LDL L F+ +A+ MD L + IHRD+ N+LLT D + K+ DFGLAR + + +
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLAR-DIMNDS 266
Query: 106 MTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 159
G R WMAPE ++ V Y + DV+S+GI+LWE+ + + P+ G
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCV---------YTVQSDVWSYGILLWEIFSLGKSPYPG 317
Query: 160 M---SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ S ++ +RP P++ I++ CW +P RP+FSQI +++ L
Sbjct: 318 ILVNSKFYKMVKRGYQMSRPDFA---PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 2e-21
Identities = 64/225 (28%), Positives = 118/225 (52%), Gaps = 26/225 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++H+N+V++LG+ D + I E +PG S+ L + + + NF I
Sbjct: 59 LLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQIL 116
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYR---- 114
+ ++ LH GIIHRD+K N+L+ D K +K++DFG++++ + T T R
Sbjct: 117 KGLNYLHNRGIIHRDIKGANILV--DNKGGIKISDFGISKKLEANSLSTK-TNGARPSLQ 173
Query: 115 ----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 170
WMAPE+ ++ Y K D++S G ++ E+LT + PF + LQA +
Sbjct: 174 GSVFWMAPEVV--------KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
++A P +P +IS + ++ + D N RP+ +++ + + FL
Sbjct: 226 -ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAEL--LKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (223), Expect = 3e-21
Identities = 53/160 (33%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ H +VK KD + ++ E G L L D + A + +
Sbjct: 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVL 104
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A + LH GII+RDLKP+NLLL D +KL DFG A++ + GT ++APE
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLL--DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPE 162
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
+ K Y+ VD +S GI+L+ELLT R PF
Sbjct: 163 II--------LNKGYDFSVDYWSLGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-21
Identities = 72/235 (30%), Positives = 115/235 (48%), Gaps = 29/235 (12%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M +H+N+V+ + D L V++ E L G +L + R N+ + L +
Sbjct: 70 IMRDYQHENVVEMYNSYLVGDELWVVM-EFLEGGALTDIVTHTRMNEEQIAAV---CLAV 125
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMA 117
+A+ LHA G+IHRD+K D++LLT D + +KL+DFG A+ + GT WMA
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PEL S + Y +VD++S GI++ E++ P+ L+ A K R
Sbjct: 185 PELISRLP--------YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----AMKMIRDN 231
Query: 178 LP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
LP +SP L + V DP R + +++++ + FL PPS VP
Sbjct: 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAGPPSCIVP 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 3e-21
Identities = 73/230 (31%), Positives = 106/230 (46%), Gaps = 34/230 (14%)
Query: 6 KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------------- 51
H N++ LGAC++ + I E P +L +L R + D A
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 52 -LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110
L FA D+A M L IHRDL N+L+ + + K+ADFGL+R E V T
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVG-ENLASKIADFGLSRGEEVYVKKTMGR 179
Query: 111 GTYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 167
RWMA E YS Y K DV+SFG++LWE+++ P+ GM+ + Y
Sbjct: 180 LPVRWMAIESLNYSV----------YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE-LY 228
Query: 168 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII----RMLNA 213
+ R P + ++ +++ CW + P RP F+QI RML A
Sbjct: 229 EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 4e-21
Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 7/158 (4%)
Query: 55 ALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
A+ I +A++ LH+ +IHRD+KP N+L+ +KL DFG++ + T + G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCK 167
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
+MAPE + + +K Y+ K DV+S GI + EL T R P++ +
Sbjct: 168 PYMAPERINP----ELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223
Query: 174 ARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
P LP + SP+ V C ++ RP++ ++++
Sbjct: 224 PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 4e-21
Identities = 68/220 (30%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M +++H+ LV+ + + IVTE + SL +L L L ++ A IA
Sbjct: 54 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIAS 113
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMAP 118
M + +HRDL+ N+L+ + K+ADFGLAR E + + +W AP
Sbjct: 114 GMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 172
Query: 119 E--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 175
E LY T+ K DV+SFGI+L EL T R+P+ GM N + +
Sbjct: 173 EAALYGRFTI----------KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM 222
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
P P + L ++ CW ++P RP+F L AFL
Sbjct: 223 P-CPPECPESLHDLMCQCWRKEPEERPTF----EYLQAFL 257
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 5e-21
Identities = 62/212 (29%), Positives = 110/212 (51%), Gaps = 17/212 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M+ + H +LV+ LG C P + +VT+L+P L Y+ + N + + LN+ + IA+
Sbjct: 62 IMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAK 120
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAR-EETVTEMMTAETGTY--RWM 116
M L ++HRDL N+L+ +P+ +K+ DFGLAR E + A+ G +WM
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 175
A E + + ++ DV+S+G+ +WEL+T P++G+ + K R
Sbjct: 179 ALECI--------HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE-KGER 229
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
P + D+ ++ CW+ D + RP F ++
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 6e-21
Identities = 51/149 (34%), Positives = 80/149 (53%), Gaps = 11/149 (7%)
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYR 114
+I A+D LH GII+RD+K +N+LL + + L DFGL++E E A + GT
Sbjct: 113 EIVLALDHLHQLGIIYRDIKLENILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIE 171
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFK 172
+MAPE+ +R G H + VD +S G++ +ELLT PF +G N Q+ +
Sbjct: 172 YMAPEV-----IRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL 225
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLR 201
++P P+ +S + +Q +DP R
Sbjct: 226 KSKPPFPKTMSAEARDFIQKLLEKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 6e-21
Identities = 61/212 (28%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M+ V + ++ + LG C + ++T+L+P L Y+ + N ++ LN+ + IA+
Sbjct: 62 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQIAK 120
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTY--RWMA 117
M+ L ++HRDL N+L+ Q +K+ DFGLA+ E AE G +WMA
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIKWMA 179
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 176
L + Y ++ DV+S+G+ +WEL+T P++G+ + + + K R
Sbjct: 180 --------LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERL 230
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
P + D+ I+ CW+ D + RP F ++I
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 8e-21
Identities = 63/234 (26%), Positives = 112/234 (47%), Gaps = 30/234 (12%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP---------------N 44
+M+ + H N+V LG ++ + ++ E L L ++L+ P +
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 45 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 104
LD L+ A+ IA M+ L ++ +H+DL N+L+ +Q +K++D GL+RE +
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG-EQLHVKISDLGLSREIYSAD 178
Query: 105 MMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEGM 160
+ + RWM PE + G+ +++ D++SFG+VLWE+ + L P+ G
Sbjct: 179 YYRVQPKSLLPIRWMPPE-----AIMYGK---FSSDSDIWSFGVVLWEIFSFGLQPYYGF 230
Query: 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
SN + + P ED P + ++ CW E P+ RP F I L ++
Sbjct: 231 SNQEVIEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 9e-21
Identities = 64/240 (26%), Positives = 101/240 (42%), Gaps = 46/240 (19%)
Query: 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-------VSLRPNKLDLHVA-- 51
+SR+ N+ + LG C DP + ++ E + L ++L L N L +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 111
L A IA M L + +HRDL N L+ + +K+ADFG++R +
Sbjct: 133 LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT-IKIADFGMSRN--------LYSS 183
Query: 112 TY-----------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NRLPFE 158
Y RWMA E ++ G+ + K DV++FG+ LWE+LT P+E
Sbjct: 184 DYYRVQGRAPLPIRWMAWE-----SVLLGK---FTTKSDVWAFGVTLWEILTLCREQPYE 235
Query: 159 GMSNLQAAYAAAFKHARPGLPE-----DISP-DLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
+++ Q A G P D+ ++ CW D RP+F +I L
Sbjct: 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 1e-20
Identities = 74/231 (32%), Positives = 111/231 (48%), Gaps = 21/231 (9%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M KH N+V +L + D L V V E L G SL + +D +
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWV-VMEYLAGGSLTDVVTE---TCMDEGQIAAVCREC 124
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMA 117
+A++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMA
Sbjct: 125 LQALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ VT +K Y KVD++S GI+ E++ P+ + L+A Y A + P
Sbjct: 184 PEV---VT-----RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPE 234
Query: 178 L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
L PE +S + C D R S ++++ + FL +P S P
Sbjct: 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-20
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 21/217 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
++ + H+ +V++ G +DP+ + I E +PG S++ L S L +V +
Sbjct: 57 LLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQ 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETV----TEMMTAETGT 112
I + LH+N I+HRD+K N+L ++KL DFG ++ +T+ T M + TGT
Sbjct: 115 ILEGVSYLHSNMIVHRDIKGANIL-RDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGT 172
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 172
WM+PE+ S GE Y K D++S G + E+LT + P+ + A + A +
Sbjct: 173 PYWMSPEVIS------GEG--YGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 224
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P LP +S ++ +VE LRPS +++R
Sbjct: 225 PTNPVLPPHVSDHCRDFLKRIFVE-AKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 2e-20
Identities = 70/232 (30%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 1 MMSRVKHDNLVKFLGACKD----PLMVIVTELLPGM---SLRKYLVSLR--PNKLDLHVA 51
+M H N++ LG C PL+V LP M LR ++ S P DL
Sbjct: 49 IMKDFSHPNVLSLLGICLPSEGSPLVV-----LPYMKHGDLRNFIRSETHNPTVKDL--- 100
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAET 110
+ F L +A+ M+ L + +HRDL N +L D+ ++K+ADFGLAR+ E +
Sbjct: 101 IGFGLQVAKGMEYLASKKFVHRDLAARNCML--DESFTVKVADFGLARDIYDKEYYSVHN 158
Query: 111 GT-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 165
T +WMA E T + K DV+SFG++LWEL+T P +
Sbjct: 159 HTGAKLPVKWMALESLQTQK--------FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD 210
Query: 166 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217
+ R PE L ++ SCW P +RP+FS+++ + T
Sbjct: 211 ITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-20
Identities = 72/227 (31%), Positives = 108/227 (47%), Gaps = 30/227 (13%)
Query: 7 HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA-------------- 51
H N++ LGAC+ + + E P +L +L R + D A
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 111
L+FA D+AR MD L IHRDL N+L+ + + K+ADFGL+R + V T
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA-KIADFGLSRGQEVYVKKTMGRL 173
Query: 112 TYRWMAPEL--YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYA 168
RWMA E YS Y DV+S+G++LWE+++ P+ GM+ + Y
Sbjct: 174 PVRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-LYE 222
Query: 169 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ R P + ++ +++ CW E P RPSF+QI+ LN L
Sbjct: 223 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-20
Identities = 61/216 (28%), Positives = 108/216 (50%), Gaps = 19/216 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
++ ++HD +V++ G +DP + I E +PG S++ L + L +V +
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQ 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTY 113
I + + LH+N I+HRD+K N+L ++KL DFG ++ M + + TGT
Sbjct: 115 ILQGVSYLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTP 173
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
WM+PE+ S GE Y K DV+S + E+LT + P+ + A + A +
Sbjct: 174 YWMSPEVIS------GEG--YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQP 225
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+P LP+ +S ++ +VE+ RP+ ++R
Sbjct: 226 TKPMLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-20
Identities = 57/163 (34%), Positives = 78/163 (47%), Gaps = 17/163 (10%)
Query: 2 MSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFAL 56
K +VK+ GA D + I E G SL V R ++ V A
Sbjct: 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAE 112
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 116
+ + + LH+ IIHRD+KP N+LLT + +KL DFG++ E V + TGT +M
Sbjct: 113 SVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVS-GELVNSLAGTFTGTSFYM 170
Query: 117 APELYSTVTLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158
APE R QG K Y+ DV+S G+ L E+ NR PF
Sbjct: 171 APE-------RIQG--KPYSITSDVWSLGLTLLEVAQNRFPFP 204
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-20
Identities = 62/212 (29%), Positives = 108/212 (50%), Gaps = 14/212 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++S +KH N+V++ + ++ + IV + G L K + + R L++ + I
Sbjct: 52 VLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMA 117
A+ +H I+HRD+K N+ LT D ++KL DFG+AR TV E+ GT +++
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKD-GTIKLGDFGIARVLNSTV-ELARTCIGTPYYLS 169
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ E + YNNK D+++ G VL+E+ T + FE N++ + + P
Sbjct: 170 PEIC--------ENRPYNNKSDIWALGCVLYEMCTLKHAFEA-GNMKNLVLKIIRGSYPP 220
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ S DL +V + +P RPS + I+
Sbjct: 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 4e-20
Identities = 60/224 (26%), Positives = 97/224 (43%), Gaps = 30/224 (13%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+MS++ H +LVK G C ++V E + L +L N + LH L+ A +A
Sbjct: 54 LMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFL-HREKNNVSLHWKLDVAKQLAS 112
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPD------QKSLKLADFGLAREETVTEMMTAETGTYR 114
A+ L ++H ++ N+L+ +KL+D G+ +T + R
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP--------ITVLSREER 164
Query: 115 -----WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA 168
W+APE + + D +SFG L E+ +N P +S L ++
Sbjct: 165 VERIPWIAPECI------RNGQASLTIAADKWSFGTTLLEICSNGEEP---LSTLSSSEK 215
Query: 169 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
F + LP +LA ++ CW DP RPSF I+R LN
Sbjct: 216 ERFYQDQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 5e-20
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 30/217 (13%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDI 58
M+ +H N+V + G+ + + IV E G SL+ Y V+ P I
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ---------I 103
Query: 59 A-------RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET- 110
A + + LH G IHRD+K N+LLT + +KLADFG++ + T T + ++
Sbjct: 104 AYVCRETLKGLAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTAT-IAKRKSF 161
Query: 111 -GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 169
GT WMAPE+ + V + G Y+ K D+++ GI EL + P + ++A +
Sbjct: 162 IGTPYWMAPEVAA-VERKGG----YDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI 216
Query: 170 AFKHARPGLPED---ISPDLAFIVQSCWVEDPNLRPS 203
+ + P +D SP ++ C +DP RP+
Sbjct: 217 SKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 5e-20
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 19/216 (8%)
Query: 1 MMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
++ ++H+ +V++ G +D + I E +PG S++ L + L V +
Sbjct: 57 LLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQ 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTY 113
I M LH+N I+HRD+K N+L ++KL DFG ++ M + + TGT
Sbjct: 115 ILEGMSYLHSNMIVHRDIKGANIL-RDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
WM+PE+ S GE Y K DV+S G + E+LT + P+ + A + A +
Sbjct: 174 YWMSPEVIS------GEG--YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP 225
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P LP IS + +VE + RPS +++R
Sbjct: 226 TNPQLPSHISEHARDFLGCIFVEARH-RPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 6e-20
Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 28/197 (14%)
Query: 30 PGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK 87
P + R L++ P + +DL + F+ +A M+ L + +HRDL N+L+ + K
Sbjct: 221 PERTRRDTLINESPALSYMDL---VGFSYQVANGMEFLASKNCVHRDLAARNVLIC-EGK 276
Query: 88 SLKLADFGLAREETVTEMMTAETGTY---RWMAPE-----LYSTVTLRQGEKKHYNNKVD 139
+K+ DFGLAR+ ++ T+ +WMAPE LY+T++ D
Sbjct: 277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLS-------------D 323
Query: 140 VYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 198
V+SFGI+LWE+ T P+ + + Y A + R P S ++ I+Q CW E
Sbjct: 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKF 383
Query: 199 NLRPSFSQIIRMLNAFL 215
+RP FSQ++ ++ L
Sbjct: 384 EIRPDFSQLVHLVGDLL 400
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 8e-20
Identities = 61/230 (26%), Positives = 102/230 (44%), Gaps = 27/230 (11%)
Query: 2 MSRVKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLR----PNKLDLHV 50
M H N++K +G + P+ +++ + L +L+ R P L L
Sbjct: 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQT 114
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---T 107
+ F +DIA M+ L + IHRDL N +L + ++ +ADFGL+++ +
Sbjct: 115 LVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGC 173
Query: 108 AETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 165
A +W+A E L V Y DV++FG+ +WE++T + P+ G+ N +
Sbjct: 174 ASKLPVKWLALESLADNV---------YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE- 223
Query: 166 AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
Y K R P D D+ ++ CW +P RPSF + L
Sbjct: 224 IYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 9e-20
Identities = 65/241 (26%), Positives = 104/241 (43%), Gaps = 43/241 (17%)
Query: 2 MSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ +H +VK L V+V E +P L + L L ++ + +
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRD-EERPLPEAQVKSYMRMLLK 110
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAP 118
+ +HANGI+HRDLKP NLL++ D LK+ADFGLAR E + + + T + AP
Sbjct: 111 GVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPRLYSHQVATRWYRAP 169
Query: 119 E-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG------------------ 159
E LY + Y+ VD+++ G + ELL F G
Sbjct: 170 ELLYG--------ARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPN 221
Query: 160 ------MSNLQAAYAAAFKHARPGLPEDISPDL---AF-IVQSCWVEDPNLRPSFSQIIR 209
+++L F ++P E+I PD A +++ V DP+ R S ++ +R
Sbjct: 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281
Query: 210 M 210
Sbjct: 282 H 282
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-19
Identities = 57/177 (32%), Positives = 84/177 (47%), Gaps = 27/177 (15%)
Query: 1 MMSRVKHDNLVKFLGACKDPL------MVIVTELLPGMSLRKYLVSLRPNKL-DLHVALN 53
++ ++H+N++ L + P + IVTEL+ L K + S P L D H+
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQY- 107
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAE 109
F I R + LH+ +IHRDLKP N+L+ + LK+ DFGLAR +E +T
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 110 TGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
T YR APEL Y +D++S G + ELLT + F G +
Sbjct: 167 VVTRWYR--APELL-------LSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-19
Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 17/214 (7%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALD 57
++ ++ H N++K+L + ++ + IV EL L + + + K + + +
Sbjct: 55 LLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
+ A++ +H+ I+HRD+KP N+ +T +KL D GL R + ++ A + GT +
Sbjct: 115 LCSALEHMHSKRIMHRDIKPANVFITAT-GVVKLGDLGLGRFFS-SKTTAAHSLVGTPYY 172
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHA 174
M+PE + YN K D++S G +L+E+ + PF G NL + K
Sbjct: 173 MSPERI--------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCD 224
Query: 175 RPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQI 207
P LP D S +L +V C DP RP S +
Sbjct: 225 YPPLPADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 3e-19
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 27/224 (12%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALD 57
+M + +V F GA + + + E + SL + P +++ +A+
Sbjct: 56 IMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEG 115
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
+ + I+HRD+KP N+L+ + +KL DFG++ E + + GT +M+
Sbjct: 116 LTYLYNVHR---IMHRDIKPSNILVN-SRGQIKLCDFGVS-GELINSIADTFVGTSTYMS 170
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF---EGMSNLQAAYAAAF--- 171
PE QG K Y K DV+S GI + EL + PF + Q
Sbjct: 171 PERI------QGGK--YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLL 222
Query: 172 ----KHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
+ P LP D DL V +C ++DP RP+ Q+ M
Sbjct: 223 QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-19
Identities = 54/169 (31%), Positives = 89/169 (52%), Gaps = 19/169 (11%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
++ +AR M+ L + IHRDL N+LL+ + +K+ DFGLAR+ + G+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD-IYKDPDYVRKGSA 236
Query: 114 R----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 167
R WMAPE ++ V Y + DV+SFG++LWE+ + P+ G+ + +
Sbjct: 237 RLPLKWMAPESIFDKV---------YTTQSDVWSFGVLLWEIFSLGASPYPGV-QINEEF 286
Query: 168 AAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
K R PE+ +P++ I+ +CW DP RP+FS ++ +L L
Sbjct: 287 CQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-19
Identities = 66/230 (28%), Positives = 106/230 (46%), Gaps = 31/230 (13%)
Query: 7 HDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 63
H+N+VK+ G C + + ++ E LP SL++YL NK++L L +A+ I + MD
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQICKGMD 123
Query: 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET---GTYRWMAPE 119
L + +HRDL N+L+ + + +K+ DFGL + ET E T + W APE
Sbjct: 124 YLGSRQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE 182
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------NRLPFEGMSNLQAAYAA 169
+ K Y DV+SFG+ L+ELLT L G ++ Q
Sbjct: 183 CLI-------QSKFYIAS-DVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTR 234
Query: 170 AFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ G P + ++ +++ CW P+ R +F +I A L
Sbjct: 235 LVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAIL 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 6e-19
Identities = 67/226 (29%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 1 MMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFAL 56
+M + H N++ G P+M I+TE + +L +L R N V +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSRPVM-IITEFMENGALDSFL---RQNDGQFTVIQLVGMLR 113
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETG-- 111
IA M L +HRDL N+L+ + K++DFGL+R ++T T+ G
Sbjct: 114 GIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172
Query: 112 -TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 169
RW APE + R+ + + DV+S+GIV+WE+++ P+ MSN Q A
Sbjct: 173 IPIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINA 223
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ R P D L ++ CW +D N RP F QI+ L+ +
Sbjct: 224 IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 8e-19
Identities = 75/262 (28%), Positives = 110/262 (41%), Gaps = 58/262 (22%)
Query: 2 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDI 58
+ +KH N++ L + +V E + L K + + + L A ++ L
Sbjct: 56 LQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVI---KDKSIVLTPADIKSYMLMT 111
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWM- 116
R ++ LH+N I+HRDLKP+NLL+ D LKLADFGLAR + MT + T RW
Sbjct: 112 LRGLEYLHSNWILHRDLKPNNLLIASDGV-LKLADFGLARSFGSPNRKMTHQVVT-RWYR 169
Query: 117 APEL-YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF------------------ 157
APEL + +HY VD++S G + ELL R+PF
Sbjct: 170 APELLFGA--------RHYGVGVDMWSVGCIFAELL-LRVPFLPGDSDIDQLGKIFEALG 220
Query: 158 -------EGMSNLQAAYAAAFKHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPSFS 205
G+++L FK P P S D ++Q +PN R +
Sbjct: 221 TPTEENWPGVTSLP--DYVEFKP-FPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITAR 277
Query: 206 QIIRMLNAFLFTLRPPSPSVPE 227
Q L F+ P P+ P
Sbjct: 278 Q---ALEHPYFSNDPA-PTPPS 295
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 8e-19
Identities = 75/243 (30%), Positives = 117/243 (48%), Gaps = 21/243 (8%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M +K+ N+V FL + D L V++ E L G SL + ++ + L
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVM-EYLAGGSLTDVVTETCMDEAQIAAVCRECL-- 125
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMA 117
+A++ LHAN +IHRD+K DN+LL S+KL DFG + T + + GT WMA
Sbjct: 126 -QALEFLHANQVIHRDIKSDNVLLGM-DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A + P
Sbjct: 184 PEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPE 234
Query: 178 L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAA 235
L PE +SP + C D R S ++++ + FL +P S P + A
Sbjct: 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAKPLSSLTPLILAAKEAM 292
Query: 236 TSN 238
SN
Sbjct: 293 KSN 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-18
Identities = 58/159 (36%), Positives = 83/159 (52%), Gaps = 13/159 (8%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 124
LH++ IHRD+K N+LLT + ++KLADFG A ++ + GT WMAPE V
Sbjct: 131 LHSHERIHRDIKAGNILLT-EPGTVKLADFGSA---SLVSPANSFVGTPYWMAPE----V 182
Query: 125 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL-PEDIS 183
L E Y+ KVDV+S GI EL + P M+ + A Y A ++ P L D S
Sbjct: 183 ILAMDEG-QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNDSPTLSSNDWS 240
Query: 184 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 222
V SC + P RPS ++++ + F+ RPP+
Sbjct: 241 DYFRNFVDSCLQKIPQDRPSSEELLK--HRFVLRERPPT 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 1e-18
Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 46/238 (19%)
Query: 6 KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 63
+H N+VK D L V E + G +L + + + V + I + +
Sbjct: 56 EHPNIVKLKEVFRENDELY-FVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLA 113
Query: 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWM-APEL 120
+H +G HRDLKP+NLL++ + +K+ADFGLARE + T T RW APE
Sbjct: 114 HIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLARE--IRSRPPYTDYVST-RWYRAPE- 168
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL--------------QAA 166
+ LR Y++ VD+++ G ++ EL T R F G S + +
Sbjct: 169 ---ILLRST---SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQD 222
Query: 167 YAAAFKHAR---------PGLPED-----ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
+ +K A SP+ +++ DP RP+ SQ ++
Sbjct: 223 WPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-18
Identities = 51/149 (34%), Positives = 83/149 (55%), Gaps = 11/149 (7%)
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYR 114
+I A++ LH GII+RD+K +N+LL + + L DFGL++E E E + GT
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIE 171
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFK 172
+MAP++ +R G+ H + VD +S G++++ELLT PF +G N QA +
Sbjct: 172 YMAPDI-----VRGGDGGH-DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL 225
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ P P+++S I+Q ++DP R
Sbjct: 226 KSEPPYPQEMSALAKDIIQRLLMKDPKKR 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-18
Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 29/235 (12%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M H+N+V + D L V V E L G +L + R N+ + L +
Sbjct: 72 IMRDYHHENVVDMYNSYLVGDELWV-VMEFLEGGALTDIVTHTRMNEEQIATV---CLSV 127
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMA 117
RA+ LH G+IHRD+K D++LLT D + +KL+DFG A+ + GT WMA
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ S + Y +VD++S GI++ E++ P+ LQ A + R
Sbjct: 187 PEVISRLP--------YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-----AMRRIRDN 233
Query: 178 LP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
LP +S L + V +P+ R + ++++ + FL PPS VP
Sbjct: 234 LPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPPSCIVP 286
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-18
Identities = 62/211 (29%), Positives = 106/211 (50%), Gaps = 15/211 (7%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++S+ + K+ G+ KD + I+ E L G S L L P LD +I
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---LDLLEPGPLDETQIATILREIL 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAP 118
+ +D LH+ IHRD+K N+LL+ + +KLADFG+A + T T++ GT WMAP
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ ++ Y++K D++S GI EL P + ++ + K+ P L
Sbjct: 171 EVI--------KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP-KNNPPTL 221
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ S L V++C ++P+ RP+ ++++
Sbjct: 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-18
Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 17/220 (7%)
Query: 5 VKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIA 59
+ H N+++ LG C + P + +V E P L+ YL S R V A ++A
Sbjct: 52 LNHPNVLQCLGQCIESIPYL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVA 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTY--RWM 116
+ LH IH DL N LT D S+K+ D+GLA E+ + +T + RW+
Sbjct: 111 SGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVPLRWL 169
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQA-AYAAA---F 171
APEL K K +++S G+ +WEL T P+ +S+ Q
Sbjct: 170 APELVEIRGQDLLPKDQ-TKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDI 228
Query: 172 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
K +P L S ++Q CW+ DP RP+ ++ +L
Sbjct: 229 KLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 3e-18
Identities = 53/173 (30%), Positives = 85/173 (49%), Gaps = 23/173 (13%)
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 111
L+F +AR M+ L + +HRDL N+LL K +K+ DFGLAR+ ++
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGS 298
Query: 112 TY---RWMAPE-----LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 162
T+ +WMAPE LY+T++ DV+S+GI+LWE+ + P+ GM
Sbjct: 299 TFLPVKWMAPESIFDNLYTTLS-------------DVWSYGILLWEIFSLGGTPYPGMIV 345
Query: 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
Y R P+ + ++ I+ CW +P RPSF + ++ + L
Sbjct: 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 4e-18
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+++++KH N+V F + + D + IV E G L + + R L + + +
Sbjct: 51 LLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMC 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 117
+ +H ++HRD+K N+ LT + K +KL DFG AR T + A T GT ++
Sbjct: 111 LGVQHIHEKRVLHRDIKSKNIFLTQNGK-VKLGDFGSARLLT-SPGAYACTYVGTPYYVP 168
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NL-----QAAYAAA 170
PE++ E YNNK D++S G +L+EL T + PF+ S NL Q +Y
Sbjct: 169 PEIW--------ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP- 219
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
LP S +L +++ + +P RPS + I+
Sbjct: 220 -------LPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 5e-18
Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 17/170 (10%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+++ K + LVK L A +D + + E +PG R L +L L A + ++
Sbjct: 54 ILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMF 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
A+D LH G IHRDLKP+N L+ D +KL DFGL++ + + G+ +MAP
Sbjct: 112 EAVDALHELGYIHRDLKPENFLI--DASGHIKLTDFGLSKG--IVTYANSVVGSPDYMAP 167
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 168
E+ +G+ Y+ VD +S G +L+E L PF G S +
Sbjct: 168 EVL------RGKG--YDFTVDYWSLGCMLYEFLCGFPPFSG-STPNETWE 208
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 5e-18
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 15/211 (7%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++S+ + K+ G+ K + I+ E L G S L LR D +I
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA---LDLLRAGPFDEFQIATMLKEIL 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAP 118
+ +D LH+ IHRD+K N+LL+ +Q +KLADFG+A + T T++ GT WMAP
Sbjct: 112 KGLDYLHSEKKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ ++ Y++K D++S GI EL P M ++ + K+ P L
Sbjct: 171 EVI--------QQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP-KNNPPTL 221
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ S + +C +DP+ RP+ ++++
Sbjct: 222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-18
Identities = 58/208 (27%), Positives = 85/208 (40%), Gaps = 25/208 (12%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
MM + + + K + KD L +V E L G + +L L A + ++
Sbjct: 50 MMIQGESPYVAKLYYSFQSKDYLY-LVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEV 106
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMA 117
++ LH GIIHRD+KP+NLL+ DQ LKL DFGL+R GT ++A
Sbjct: 107 VLGVEDLHQRGIIHRDIKPENLLI--DQTGHLKLTDFGLSR---NGLENKKFVGTPDYLA 161
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE + D +S G V++E L PF + A R
Sbjct: 162 PETI--------LGVGDDKMSDWWSLGCVIFEFLFGYPPFH--AETPDAVFDNILSRRIN 211
Query: 178 LPED----ISPDLAFIVQSCWVEDPNLR 201
PE+ SP+ ++ DP R
Sbjct: 212 WPEEVKEFCSPEAVDLINRLLCMDPAKR 239
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 6e-18
Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 15/211 (7%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++S+ + ++ G+ K + I+ E L G S L L+P L+ +I
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA---LDLLKPGPLEETYIATILREIL 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAP 118
+ +D LH+ IHRD+K N+LL+ +Q +KLADFG+A + T T++ GT WMAP
Sbjct: 112 KGLDYLHSERKIHRDIKAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ ++ Y+ K D++S GI EL P + ++ + K++ P L
Sbjct: 171 EVI--------KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-KNSPPTL 221
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
S V++C +DP RP+ ++++
Sbjct: 222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-18
Identities = 63/223 (28%), Positives = 99/223 (44%), Gaps = 21/223 (9%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHV--ALNFALD 57
+M + H N+++ G K +I+TE + +L KYL R + + +
Sbjct: 59 IMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRG 115
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTY-- 113
IA M L +HRDL N+L+ K++DFGL+R E+ T G
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILVN-SNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 172
RW APE + + + + DV+SFGIV+WE+++ P+ MSN A
Sbjct: 175 RWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-HEVMKAIND 225
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
R P D + ++ CW +D RP F I+ +L+ L
Sbjct: 226 GFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-18
Identities = 52/146 (35%), Positives = 87/146 (59%), Gaps = 12/146 (8%)
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRW 115
++A A+D LH+ GII+RDLKP+N+LL ++ +KL DFGL++E E GT +
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 164
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE V R+G + D +SFG++++E+LT LPF+G + + K A+
Sbjct: 165 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGSLPFQG-KDRKETMTMILK-AK 214
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLR 201
G+P+ +SP+ ++++ + +P R
Sbjct: 215 LGMPQFLSPEAQSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 9e-18
Identities = 63/235 (26%), Positives = 103/235 (43%), Gaps = 37/235 (15%)
Query: 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLR----PNKLDLHV 50
M H N+++ +G C P V++ + L +L+ R P L +
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM 113
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---------REET 101
+ F DIA M+ L + IHRDL N +L + ++ +ADFGL+ R+
Sbjct: 114 LVKFMTDIASGMEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGR 172
Query: 102 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 160
+ +M +W+A E + + Y K DV+SFG+ +WE+ T + P+ G+
Sbjct: 173 IAKM------PVKWIAIESLA--------DRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218
Query: 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
N + Y + R P D L ++ SCW+ +P RPSF + L L
Sbjct: 219 ENSE-IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-18
Identities = 70/246 (28%), Positives = 109/246 (44%), Gaps = 53/246 (21%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGM---SLRKYLVSLRPNKLDLHVALNFAL 56
M+ +++H+NLV + + + +V E + L KY PN LD +
Sbjct: 53 MLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLF 107
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTY 113
I R ++ H++ IIHRD+KP+N+L++ +KL DFG AR T+ E+ T T
Sbjct: 108 QILRGIEFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFAR--TLAAPGEVYTDYVAT- 163
Query: 114 RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS----------- 161
RW APEL G+ K Y VD+++ G ++ E+LT F G S
Sbjct: 164 RWYRAPELLV------GDTK-YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC 216
Query: 162 --NLQAAYAAAFKHARPG----LPE------------DISPDLAFIVQSCWVEDPNLRPS 203
NL + F+ LPE +S + + + C DP+ RPS
Sbjct: 217 LGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
Query: 204 FSQIIR 209
SQ++
Sbjct: 277 SSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 1e-17
Identities = 70/225 (31%), Positives = 106/225 (47%), Gaps = 25/225 (11%)
Query: 1 MMSRVKHDNLVKFLGA---CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFA 55
+M + H N++ G K P+M IVTE + SL +L R + V +
Sbjct: 58 IMGQFDHPNIIHLEGVVTKSK-PVM-IVTEYMENGSLDAFL---RKHDGQFTVIQLVGML 112
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT- 112
IA M L G +HRDL N+L+ + K++DFGL+R E+ T G
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKI 171
Query: 113 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAA 170
RW APE + R+ + + DV+S+GIV+WE+++ P+ MSN Q A
Sbjct: 172 PIRWTAPE---AIAYRK-----FTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVIKAI 222
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ R P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 223 EEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-17
Identities = 63/232 (27%), Positives = 106/232 (45%), Gaps = 30/232 (12%)
Query: 1 MMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPN-------------KL 46
+++ ++H ++V+F G C + +++V E + L ++L S P+ +L
Sbjct: 60 LLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQL 119
Query: 47 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM 106
L L A IA M L + +HRDL N L+ +K+ DFG++R+ T+
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYY 178
Query: 107 TAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 162
T RWM PE ++ R+ + + D++SFG+VLWE+ T + P+ +SN
Sbjct: 179 RVGGRTMLPIRWMPPE---SILYRK-----FTTESDIWSFGVVLWEIFTYGKQPWYQLSN 230
Query: 163 LQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
+A R P P++ I+Q CW +P R I L A
Sbjct: 231 TEA--IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-17
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M+ V + + LG C + +VT+L+P L Y V +++ LN+ + IA+
Sbjct: 62 VMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDY-VRENKDRIGSQDLLNWCVQIAK 120
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETG---TYRWM 116
M L ++HRDL N+L+ +P+ +K+ DFGLAR + E G +WM
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADGGKVPIKWM 178
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 175
A L + + ++ DV+S+G+ +WEL+T P++G+ + K R
Sbjct: 179 A--------LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE-KGER 229
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
P + D+ I+ CW+ D RP F +++
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.8 bits (196), Expect = 2e-17
Identities = 72/243 (29%), Positives = 116/243 (47%), Gaps = 21/243 (8%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M K+ N+V +L + D L V++ E L G SL + ++ + L
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECL-- 126
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMA 117
+A++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMA
Sbjct: 127 -QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 184
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A + P
Sbjct: 185 PEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTPE 235
Query: 178 L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAA 235
L PE +S + C D R S ++++ + FL +P S P + A
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTPLIAAAKEAT 293
Query: 236 TSN 238
+N
Sbjct: 294 KNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 2e-17
Identities = 60/189 (31%), Positives = 96/189 (50%), Gaps = 14/189 (7%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
+ V E L G L ++ S +K DL A +A +I + LH+ GI++RDLK DN+L
Sbjct: 71 LFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNIL 128
Query: 82 LTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140
L D +K+ADFG+ +E + + T GT ++APE+ G+K YN VD
Sbjct: 129 LDTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEIL------LGQK--YNTSVDW 179
Query: 141 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNL 200
+SFG++L+E+L + PF G + + + P P ++ + I+ +V +P
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHD--EEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237
Query: 201 RPSFSQIIR 209
R IR
Sbjct: 238 RLGVKGDIR 246
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-17
Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 17/172 (9%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +++H+N+V A + + +V E + L L+ P L ++ +
Sbjct: 53 VLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLL 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWM 116
+A+ H++ IIHRD+KP+N+L++ LKL DFG AR + + Y RW
Sbjct: 111 QAIAYCHSHNIIHRDIKPENILVSESGV-LKLCDFGFAR--ALRARPASPLTDYVATRWY 167
Query: 117 -APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 167
APEL T +Y VDV++ G ++ ELL F G S++ Y
Sbjct: 168 RAPELLVGDT-------NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 2e-17
Identities = 56/167 (33%), Positives = 79/167 (47%), Gaps = 22/167 (13%)
Query: 7 HDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
H N+V+ L C P + +V E + L YL L + + R
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAP 118
+D LH++ I+HRDLKP N+L+T D + +K+ADFGLAR + +T+ T YR AP
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIYSFEMALTSVVVTLWYR--AP 175
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 164
E V L+ Y VD++S G + EL R P F G S
Sbjct: 176 E----VLLQS----SYATPVDMWSVGCIFAELF-RRRPLFRGTSEAD 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-17
Identities = 45/160 (28%), Positives = 82/160 (51%), Gaps = 14/160 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ V H +++ D + ++ E +PG L YL + + L +A +I
Sbjct: 54 VLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIV 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A++ LH+ I++RDLKP+N+LL + +KL DFG A++ + + GT ++APE
Sbjct: 112 CALEYLHSKEIVYRDLKPENILLDKE-GHIKLTDFGFAKK--LRDRTWTLCGTPEYLAPE 168
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
+ + K +N VD ++ GI+++E+L PF
Sbjct: 169 VI--------QSKGHNKAVDWWALGILIYEMLVGYPPFFD 200
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 49/212 (23%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M ++ + +V+ +G C+ ++V EL L K+L + + ++
Sbjct: 49 VMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNK--HVTEKNITELVHQVSM 106
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YRWM 116
M L +HRDL N+LL Q K++DFGL++ E +W
Sbjct: 107 GMKYLEETNFVHRDLAARNVLLV-TQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWY 165
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 175
APE + +++K DV+SFG+++WE + + P++GM + R
Sbjct: 166 APECMNYYK--------FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT-QMIESGER 216
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
P+ P++ +++ CW + RP F+ +
Sbjct: 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-17
Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 19/182 (10%)
Query: 41 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100
L L L + ++ +A+ M+ L + IHRDL N+LL+ + +K+ DFGLAR+
Sbjct: 171 LYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-ENNVVKICDFGLARD- 228
Query: 101 TVTEMMTAETGTYR----WMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 154
+ G R WMAPE ++ V Y + DV+SFG++LWE+ +
Sbjct: 229 IYKDPDYVRKGDARLPLKWMAPETIFDRV---------YTIQSDVWSFGVLLWEIFSLGA 279
Query: 155 LPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
P+ G+ + + K R P+ +P++ + CW +P+ RP+FS+++ L
Sbjct: 280 SPYPGV-KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 338
Query: 214 FL 215
L
Sbjct: 339 LL 340
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-17
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 23/219 (10%)
Query: 6 KHDNLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFAL 56
H N+ F GA D + +V EL G S+ + LR +L
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRW 115
+ R + LH N +IHRD+K N+LLT +KL DFG++ + T GT W
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYW 179
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE+ + + Y+ + DV+S GI EL + P M ++ A FK R
Sbjct: 180 MAPEV---IACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR----ALFKIPR 232
Query: 176 ---PGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P L PE+ S + C +++ RP +++
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-17
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 15/213 (7%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPN--KLDLHVALNFALD 57
++S++ H +VKF + + I+TE G L L L+ L + + +
Sbjct: 55 LLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWM 116
+ + +H I+HRDLK N+ L LK+ DFG++R + ++ T TGT +M
Sbjct: 115 LLLGVHYMHQRRILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYM 172
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
+PE QG Y++K D++S G +L+E+ FEG N + + P
Sbjct: 173 SPEALK----HQG----YDSKSDIWSLGCILYEMCCLAHAFEG-QNFLSVVLRIVEGPTP 223
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
LPE S L I+QS +DP+LRPS ++I+R
Sbjct: 224 SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-17
Identities = 46/149 (30%), Positives = 72/149 (48%), Gaps = 12/149 (8%)
Query: 20 PLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76
P + +V E L L+K++ S L +F + + + H +G++HRDLK
Sbjct: 79 PSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK 137
Query: 77 PDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135
P NLL+ + LK+AD GL R ++ + T E T + APE+ T HY+
Sbjct: 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGST-------HYS 190
Query: 136 NKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
VD++S G + E+ + F G S LQ
Sbjct: 191 TPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 4e-17
Identities = 71/231 (30%), Positives = 113/231 (48%), Gaps = 21/231 (9%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M K+ N+V +L + D L V++ E L G SL + ++ + L
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVM-EYLAGGSLTDVVTETCMDEGQIAAVCRECL-- 125
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMA 117
+A+D LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMA
Sbjct: 126 -QALDFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMA 183
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A + P
Sbjct: 184 PEVVT--------RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-TNGTPE 234
Query: 178 L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
L PE +S + C D + R S ++++ + FL +P S P
Sbjct: 235 LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKPLSSLTP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-17
Identities = 52/159 (32%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMA 117
A+ +H+ +IHRD+K N+LL + +KL DFG ++ T ++ GT ++A
Sbjct: 155 AVHHVHSKHMIHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE++ +K Y+ K D++S G++L+ELLT + PF+G N++
Sbjct: 214 PEIW--------RRKPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLAGRYDP 264
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216
LP ISP++ IV + DP RPS S+++ M LF
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303
|
Length = 496 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 47/154 (30%), Positives = 85/154 (55%), Gaps = 13/154 (8%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYR 114
I A+D +H+ ++HRDLK N+ L P +KL DFG +++ + + ++ ++ GT
Sbjct: 178 IVLALDEVHSRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 174
++APEL+ E+K Y+ K D++S G++L+ELLT PF+G S + +
Sbjct: 237 YLAPELW--------ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKY 288
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
P P +S + ++ ++P LRP+ Q++
Sbjct: 289 DP-FPCPVSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 7e-17
Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 14/159 (8%)
Query: 45 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 104
+ D A +A +I + LH GII+RDLK DN+LL + +K+ADFG+ + E +
Sbjct: 92 RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-GHIKIADFGMCK-EGILG 149
Query: 105 MMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162
+T T GT ++APE+ + Y VD ++ G++L+E+L + PFEG
Sbjct: 150 GVTTSTFCGTPDYIAPEIL------SYQP--YGPAVDWWALGVLLYEMLAGQSPFEGDDE 201
Query: 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ + R P +S + I++S ++P R
Sbjct: 202 DELFQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 9e-17
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 10/212 (4%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+++ H +VK LGA D + I+ E PG ++ ++ L + + + +
Sbjct: 62 ILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-ICRQML 120
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAP 118
A+ LH+ IIHRDLK N+LLT D +KLADFG++ + T + + GT WMAP
Sbjct: 121 EALQYLHSMKIIHRDLKAGNVLLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ T++ Y+ K D++S GI L E+ P ++ ++ A K P L
Sbjct: 180 EVVMCETMKDTP---YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPPTL 235
Query: 179 --PEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
P S + +++ + P RPS +Q++
Sbjct: 236 SQPSKWSMEFRDFLKTALDKHPETRPSAAQLL 267
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-16
Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 11/159 (6%)
Query: 5 VKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 63
+ H N+V+ L + + +V E L + L+KY+ S LD + ++ + + +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYS 122
H++ ++HRDLKP NLL+ + +LKLADFGLAR V T E T + APE
Sbjct: 114 YCHSHRVLHRDLKPQNLLID-REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE--- 169
Query: 123 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161
+ L + Y+ VD++S G + E++ R F G S
Sbjct: 170 -ILLGS---RQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-16
Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 33/235 (14%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------------- 44
+++ ++H+++VKF G C DPL ++V E + L K+L + P+
Sbjct: 60 LLTNLQHEHIVKFYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 118
Query: 45 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 104
+L L L+ A IA M L + +HRDL N L+ +K+ DFG++R+ T+
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTD 177
Query: 105 MMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 160
T RWM PE ++ R+ + + DV+SFG++LWE+ T + P+ +
Sbjct: 178 YYRVGGHTMLPIRWMPPE---SIMYRK-----FTTESDVWSFGVILWEIFTYGKQPWFQL 229
Query: 161 SNLQAAYAAAFKHARPGLPEDISPDLAF-IVQSCWVEDPNLRPSFSQIIRMLNAF 214
SN + R + P + I+ CW +P R + +I ++L+A
Sbjct: 230 SNTEV--IECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-16
Identities = 44/103 (42%), Positives = 58/103 (56%), Gaps = 12/103 (11%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-M 116
I R + +H+ GIIHRDLKP N+ + D + LK+ DFGLAR + MT T RW
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCE-LKILDFGLARH--TDDEMTGYVAT-RWYR 182
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
APE + L HYN VD++S G ++ ELLT + F G
Sbjct: 183 APE----IML---NWMHYNQTVDIWSVGCIMAELLTGKTLFPG 218
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 1e-16
Identities = 40/106 (37%), Positives = 55/106 (51%), Gaps = 14/106 (13%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGT--Y 113
+ + LH+NGI+HRD+K N+L+ + LKLADFGLAR T T T Y
Sbjct: 109 LLEGLQYLHSNGILHRDIKGSNILIN-NDGVLKLADFGLARPYTKRNSADYTNRVITLWY 167
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
R PEL G + Y +VD++S G +L EL + F+G
Sbjct: 168 R--PPELL------LGATR-YGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-16
Identities = 62/228 (27%), Positives = 106/228 (46%), Gaps = 33/228 (14%)
Query: 1 MMSRVKHDNLVKFLG-ACKDPLMVIVTELLPGMSLRKYLVSLRPN------------KLD 47
M SR++H N+V LG K+ + ++ L ++LV P+ K
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 48 LHVA--LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE- 104
L A ++ IA M+ L ++ ++H+DL N+L+ D+ ++K++D GL RE +
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF-DKLNVKISDLGLFREVYAADY 179
Query: 105 --MMTAETGTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL-PFEG 159
+M RWM+PE +Y ++ D++S+G+VLWE+ + L P+ G
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDS----------DIWSYGVVLWEVFSYGLQPYCG 229
Query: 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
SN + P P+D + ++ CW E P+ RP F I
Sbjct: 230 YSNQDVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-16
Identities = 63/223 (28%), Positives = 100/223 (44%), Gaps = 27/223 (12%)
Query: 1 MMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
MMS++ H +LV G C + +MV E + SL YL N +++ L A
Sbjct: 52 MMSQLSHKHLVLNYGVCVCGDESIMV--QEYVKFGSLDTYL-KKNKNLINISWKLEVAKQ 108
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLT--PDQKS-----LKLADFGLAREETVTEMMTAET 110
+A A+ L G+ H ++ N+LL D+K+ +KL+D G++ E++
Sbjct: 109 LAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI 168
Query: 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAA 169
W+ PE ++ + D +SFG LWE+ + P +S L +
Sbjct: 169 ---PWVPPECIE-------NPQNLSLAADKWSFGTTLWEIFSGGDKP---LSALDSQKKL 215
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
F R LP +LA ++ C +P+ RPSF IIR LN
Sbjct: 216 QFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-16
Identities = 54/165 (32%), Positives = 87/165 (52%), Gaps = 14/165 (8%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDI 58
++ ++H N+V ++ + ++ E L M L+KYL SL + +D + ++ I
Sbjct: 52 LLKELQHPNIVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQI 110
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-KLADFGLAREETV-TEMMTAETGTYRWM 116
+ + H+ ++HRDLKP NLL+ D K + KLADFGLAR + + T E T +
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLI--DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR 168
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161
APE V L G + Y+ VD++S G + E+ T + F G S
Sbjct: 169 APE----VLL--GSPR-YSTPVDIWSIGTIFAEMATKKPLFHGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-16
Identities = 49/165 (29%), Positives = 85/165 (51%), Gaps = 11/165 (6%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ + H N+VK L + + +V E L L+K++ + + + L + ++ +
Sbjct: 52 LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 118
+ + H++ ++HRDLKP NLL+ + +KLADFGLAR V T E T + AP
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAP 169
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
E+ K+Y+ VD++S G + E++T R F G S +
Sbjct: 170 EILLGC-------KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 4e-16
Identities = 51/158 (32%), Positives = 84/158 (53%), Gaps = 12/158 (7%)
Query: 45 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 104
+ DL+ A +A +I + LH+ GII+RDLK DN++L D +K+ADFG+ +E +
Sbjct: 92 RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGD 150
Query: 105 -MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
+ GT ++APE+ QG K Y VD +SFG++L+E+L + PF G +
Sbjct: 151 NRASTFCGTPDYIAPEIL------QGLK--YTFSVDWWSFGVLLYEMLIGQSPFHG--DD 200
Query: 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ + + P P I+ + I++ + DP R
Sbjct: 201 EDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRR 238
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-16
Identities = 45/141 (31%), Positives = 69/141 (48%), Gaps = 6/141 (4%)
Query: 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 129
IIHRD+KP N+L+ +KL DFG++ V + G +MAPE + Q
Sbjct: 124 IIHRDVKPTNVLVN-GNGQVKLCDFGVS-GNLVASLAKTNIGCQSYMAPERIKSGGPNQ- 180
Query: 130 EKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISPDLA 187
Y + DV+S G+ + E+ R P+ E +N+ A +A P LP S D
Sbjct: 181 -NPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239
Query: 188 FIVQSCWVEDPNLRPSFSQII 208
V C + PN RP+++Q++
Sbjct: 240 DFVAKCLNKIPNRRPTYAQLL 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-16
Identities = 61/213 (28%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 7 HDNLVKFLGA------CKDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDI 58
H N+VKF G + +V EL G S+ + + L +LD +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMA 117
+ LH N IIHRD+K +N+LLT + +KL DFG++ + T T + GT WMA
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTT-EGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + Q Y+ + DV+S GI EL P M ++ + ++ P
Sbjct: 197 PEV---IACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP-RNPPPT 252
Query: 178 L--PEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
L PE + C ++D RPS + ++
Sbjct: 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-16
Identities = 64/223 (28%), Positives = 111/223 (49%), Gaps = 18/223 (8%)
Query: 2 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 59
+ ++KH N +++ G K+ +V E G + V +P ++++ + AL
Sbjct: 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 131
Query: 60 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ + LH++ +IHRD+K N+LLT P Q +KLADFG A + + + GT WMAP
Sbjct: 132 QGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSA---SKSSPANSFVGTPYWMAP 186
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A +
Sbjct: 187 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQ 241
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221
+ + V C + P RP+ ++++R + F+ RP
Sbjct: 242 SNEWTDSFRGFVDYCLQKIPQERPASAELLR--HDFVRRDRPA 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-16
Identities = 47/165 (28%), Positives = 82/165 (49%), Gaps = 10/165 (6%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++H N+V+ + + +V E L + L+K++ S + + + I
Sbjct: 54 LLKEMQHGNIVRLQDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 118
R + H++ ++HRDLKP NLL+ +LKLADFGLAR + T E T + AP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
E+ +HY+ VD++S G + E++ + F G S +
Sbjct: 173 EILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 7e-16
Identities = 45/113 (39%), Positives = 60/113 (53%), Gaps = 20/113 (17%)
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVTEMMTAETGTY 113
+A+ +H+ +IHRDLKP N+LL D + +KLADFGLAR E ++T T
Sbjct: 118 KALKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVAT- 175
Query: 114 RWM-APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
RW APE L ST Y VD++S G +L E+L + F G S L
Sbjct: 176 RWYRAPEILLGST---------RYTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (187), Expect = 7e-16
Identities = 44/113 (38%), Positives = 58/113 (51%), Gaps = 18/113 (15%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLAR----EETVTEMMT 107
F I R + +H+ ++HRDLKP NLLL D LK+ DFGLAR E T +T
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167
Query: 108 AETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
T RW APE+ K Y +D++S G +L E+L+NR F G
Sbjct: 168 EYVAT-RWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEMLSNRPLFPG 212
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-16
Identities = 55/168 (32%), Positives = 85/168 (50%), Gaps = 14/168 (8%)
Query: 19 DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
D + +V E +PG L + + P K A + ++ A+D +H+ G+IHRD+KP
Sbjct: 115 DKYLYMVMEYMPGGDLVNLMSNYDVPEKW----AKFYTAEVVLALDAIHSMGLIHRDVKP 170
Query: 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYN 135
DN+LL LKLADFG + T M+ +T GT +++PE+ + QG +Y
Sbjct: 171 DNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS----QGGDGYYG 225
Query: 136 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDI 182
+ D +S G+ L+E+L PF S L Y+ H PED+
Sbjct: 226 RECDWWSVGVFLFEMLVGDTPFYADS-LVGTYSKIMDHKNSLNFPEDV 272
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 8e-16
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 12/149 (8%)
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYR 114
+I A++ LH GI++RD+K +N+LL + + L DFGL++E E + GT
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIE 171
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFK 172
+MAPE+ +G+ H VD +S GI+++ELLT PF EG N Q+ +
Sbjct: 172 YMAPEII------RGKGGH-GKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLR 201
P P I P+ ++ +DP R
Sbjct: 225 KCDPPFPSFIGPEAQDLLHKLLRKDPKKR 253
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-15
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 11/161 (6%)
Query: 55 ALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
A+ +A++ L IIHRD+KP N+LL ++KL DFG++ + + T + G
Sbjct: 113 AVATVKALNYLKEELKIIHRDVKPSNILLD-RNGNIKLCDFGISGQLVDSIAKTRDAGCR 171
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
+MAPE R G Y+ + DV+S GI L+E+ T + P+ +++ K
Sbjct: 172 PYMAPERIDPSA-RDG----YDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKG 226
Query: 174 ARPGLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
P L SP + C ++D + RP + +++
Sbjct: 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-15
Identities = 65/224 (29%), Positives = 112/224 (50%), Gaps = 18/224 (8%)
Query: 2 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 59
+ R+KH N +++ G ++ +V E G + V +P ++++ + AL
Sbjct: 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGAL--- 135
Query: 60 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ + LH++ +IHRD+K N+LLT P Q +KLADFG A ++ + GT WMAP
Sbjct: 136 QGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSA---SIASPANSFVGTPYWMAP 190
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A +
Sbjct: 191 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ 245
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 222
+ S V SC + P RP+ ++++ + F+ RP +
Sbjct: 246 SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM--FVLRERPET 287
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-15
Identities = 64/215 (29%), Positives = 108/215 (50%), Gaps = 14/215 (6%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL-RP-NKLDLHVALNFALD 57
+++ H N+VK L A + + I+ E G ++ ++ L RP + + V L+
Sbjct: 55 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLE 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWM 116
A++ LH N IIHRDLK N+L T D +KLADFG++ + T T + + GT WM
Sbjct: 115 ---ALNYLHENKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWM 170
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE+ V + + Y+ K DV+S GI L E+ P ++ ++ A K P
Sbjct: 171 APEV---VMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSEPP 226
Query: 177 GL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
L P S + ++ C ++ + R + +Q+++
Sbjct: 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-15
Identities = 54/161 (33%), Positives = 83/161 (51%), Gaps = 16/161 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVI--VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
++ ++H+N++ PL I VTELL G L + L S RP L+ F I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS-RP--LEKQFIQYFLYQI 117
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
R + +H+ G++HRDLKP N+L+ + LK+ DFGLAR + MT T + AP
Sbjct: 118 LRGLKYVHSAGVVHRDLKPSNILIN-ENCDLKICDFGLARIQ--DPQMTGYVSTRYYRAP 174
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
E+ T + Y+ +VD++S G + E+L + F G
Sbjct: 175 EIMLTW-------QKYDVEVDIWSAGCIFAEMLEGKPLFPG 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-15
Identities = 45/115 (39%), Positives = 62/115 (53%), Gaps = 25/115 (21%)
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EETVTEM 105
A++ LH GI+HRDLKPDNLL+T +KL DFGL++ E+ E
Sbjct: 113 ALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREF 171
Query: 106 MTAET-GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
+ + GT ++APE V LRQG Y VD ++ GI+L+E L +PF G
Sbjct: 172 LDKQVCGTPEYIAPE----VILRQG----YGKPVDWWAMGIILYEFLVGCVPFFG 218
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-15
Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 124
LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T + APE V
Sbjct: 134 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE----V 188
Query: 125 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
L G Y VD++S G ++ E++ + F G
Sbjct: 189 ILGMG----YKENVDIWSVGCIMGEMIRGTVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 2e-15
Identities = 43/107 (40%), Positives = 58/107 (54%), Gaps = 13/107 (12%)
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--YRWM 116
+ LH N I+HRDLK NLLL ++ LK+ DFGLARE + + T T YR
Sbjct: 117 SGVAHLHDNWILHRDLKTSNLLLN-NRGILKICDFGLAREYGSPLKPYTQLVVTLWYR-- 173
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
APEL G K+ Y+ +D++S G + ELLT + F G S +
Sbjct: 174 APELL------LGAKE-YSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-15
Identities = 42/140 (30%), Positives = 76/140 (54%), Gaps = 10/140 (7%)
Query: 18 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
KD L +++T L+ G L+ ++ ++ A+ +A I ++ LH I++RDLKP
Sbjct: 65 KDDLCLVMT-LMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKP 123
Query: 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 137
+N+LL D +++++D GLA E + + GT +MAPE+ + + Y+
Sbjct: 124 ENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVL--------QGEVYDFS 174
Query: 138 VDVYSFGIVLWELLTNRLPF 157
VD ++ G L+E++ R PF
Sbjct: 175 VDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-15
Identities = 46/150 (30%), Positives = 78/150 (52%), Gaps = 14/150 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 111
+ +I A+D LH+ I++RDLK +NL+L D +K+ DFGL + E +T+ T +T G
Sbjct: 100 YGAEIVSALDYLHSGKIVYRDLKLENLMLDKD-GHIKITDFGLCK-EGITDAATMKTFCG 157
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 171
T ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 172 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ + P +S D ++ ++DPN R
Sbjct: 210 EDIK--FPRTLSADAKSLLSGLLIKDPNKR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-15
Identities = 64/241 (26%), Positives = 114/241 (47%), Gaps = 34/241 (14%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----------KLD 47
+++ ++H+++VKF G C DPL ++V E + L K+L + P+ +L
Sbjct: 60 LLTNLQHEHIVKFYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELT 118
Query: 48 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 107
L+ A IA M L + +HRDL N L+ + +K+ DFG++R+ T+
Sbjct: 119 QSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG-ENLLVKIGDFGMSRDVYSTDYYR 177
Query: 108 AETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNL 163
T RWM PE ++ R+ + + DV+S G+VLWE+ T + P+ +SN
Sbjct: 178 VGGHTMLPIRWMPPE---SIMYRK-----FTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229
Query: 164 QAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 222
+ R P ++ ++ CW +P++R + I+ +++ L L S
Sbjct: 230 EV--IECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLN----IKEIHSLLQNLAKAS 283
Query: 223 P 223
P
Sbjct: 284 P 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-15
Identities = 48/221 (21%), Positives = 112/221 (50%), Gaps = 16/221 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M ++ + +V+ +G C+ +++V E+ G L K+L + +++ + + ++
Sbjct: 48 IMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKK-DEITVSNVVELMHQVSM 106
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWM 116
M L +HRDL N+LL +Q K++DFGL++ +++ + +A +W
Sbjct: 107 GMKYLEGKNFVHRDLAARNVLLV-NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY 165
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 175
APE + R+ ++++ DV+S+GI +WE + + P++ M + + + R
Sbjct: 166 APE---CINFRK-----FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-SFIEQGKR 216
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216
P + P++ +++ CW+ RP+F+++ + + +
Sbjct: 217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-15
Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 5 VKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKL---DLHVALNFALDIAR 60
++H NL++ LG C + ++V E P L+ YL S R +L D A +IA
Sbjct: 52 LQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL 111
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMA 117
+ LH N IH DL N LLT D ++K+ D+GL+ + + + RW+A
Sbjct: 112 GLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIA 170
Query: 118 PELYSTV---TLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA-AYAA--- 169
PEL V L + K N V+S G+ +WEL P+ +S+ Q Y
Sbjct: 171 PELVDEVHGNLLVVDQTKESN----VWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
K +P L +S ++Q CW++ P RPS ++
Sbjct: 227 QLKLPKPRLKLPLSDRWYEVMQFCWLQ-PEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 4e-15
Identities = 62/244 (25%), Positives = 91/244 (37%), Gaps = 55/244 (22%)
Query: 24 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83
+V E +PG L L+ R + A + ++ A+D +H G IHRD+KPDN+L+
Sbjct: 78 LVMEYMPGGDLMNLLI--RKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135
Query: 84 PDQKSLKLADFGLA-------------REETVTEMMTAET-----------------GTY 113
D +KLADFGL + GT
Sbjct: 136 AD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTP 194
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
++APE V Y + D +S G++L+E+L PF LQ Y
Sbjct: 195 DYIAPE----VLRGTP----YGLECDWWSLGVILYEMLYGFPPFYS-DTLQETYNKIINW 245
Query: 174 ARP-GLPED--ISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFT------LRPPSP 223
P D +SP+ ++ + DP R SF +I + F P
Sbjct: 246 KESLRFPPDPPVSPEAIDLICRL-LCDPEDRLGSFEEIKS--HPFFKGIDWENLRETKPP 302
Query: 224 SVPE 227
VPE
Sbjct: 303 FVPE 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 4e-15
Identities = 64/234 (27%), Positives = 107/234 (45%), Gaps = 27/234 (11%)
Query: 1 MMSRVKHDNLVK-FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M +H N+V+ + + ++ E L G +L + R N+ + L
Sbjct: 71 IMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVL--- 127
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL-AREETVTEMMTAETGTYRWMAP 118
+A+ LH+ G+IHRD+K D++LLT D + +KL+DFG A+ + GT WMAP
Sbjct: 128 QALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWMAP 186
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ S + Y +VD++S GI++ E++ P+ S +Q A K R
Sbjct: 187 EVIS--------RTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AMKRLRDSP 233
Query: 179 P------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
P ISP L ++ +P R + +++ + FL P VP
Sbjct: 234 PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD--HPFLLQTGLPECLVP 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-15
Identities = 52/167 (31%), Positives = 86/167 (51%), Gaps = 16/167 (9%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVALNFALD 57
+M +KH+N+V+ ++ LM +V E + L+KY+ LD + +F
Sbjct: 51 LMKELKHENIVRLHDVIHTENKLM-LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQ 108
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWM 116
+ + + H N ++HRDLKP NLL+ + LKLADFGLAR + + E T +
Sbjct: 109 LLKGIAFCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYR 167
Query: 117 APE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162
AP+ L + T Y+ +D++S G ++ E++T R F G +N
Sbjct: 168 APDVLLGSRT--------YSTSIDIWSVGCIMAEMITGRPLFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 5e-15
Identities = 55/164 (33%), Positives = 81/164 (49%), Gaps = 14/164 (8%)
Query: 24 IVTELLPGMSLRKYLVSLRPN-KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
+V E +PG L V+L N + A + ++ A+D +H+ G IHRD+KPDN+LL
Sbjct: 120 MVMEYMPGGDL----VNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175
Query: 83 TPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140
LKLADFG + M+ +T GT +++PE V QG +Y + D
Sbjct: 176 D-KSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPE----VLKSQGGDGYYGRECDW 230
Query: 141 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPEDIS 183
+S G+ L+E+L PF S L Y+ H P+DI
Sbjct: 231 WSVGVFLYEMLVGDTPFYADS-LVGTYSKIMDHKNSLTFPDDIE 273
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 47/154 (30%), Positives = 71/154 (46%), Gaps = 8/154 (5%)
Query: 58 IARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 116
I +A+ L G+IHRD+KP N+LL ++KL DFG++ ++ T G +M
Sbjct: 123 IVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM 181
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE Y+ + DV+S GI L EL T + P++ + P
Sbjct: 182 APERIDP----PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPP 237
Query: 177 GLP--EDISPDLAFIVQSCWVEDPNLRPSFSQII 208
LP E SPD V C +D RP + +++
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELL 271
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-15
Identities = 39/137 (28%), Positives = 78/137 (56%), Gaps = 9/137 (6%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
+ +V L+ G L+ ++ ++ L++ ++++ I + LH+ I++RD+KP+N+L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 82 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 141
L DQ + +L+D GLA E + +T GT +MAPE+ +++ Y+ VD +
Sbjct: 128 LD-DQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEIL--------KEEPYSYPVDWF 178
Query: 142 SFGIVLWELLTNRLPFE 158
+ G ++E++ R PF+
Sbjct: 179 AMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-15
Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 30/221 (13%)
Query: 7 HDNLVKFLG-------ACKDPLMVI--------VTELLPGMSLRKYLVSLRPNKLDLHVA 51
H N+VKF G D L ++ VT+L+ G R + LH A
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAET 110
L + LH N IHRD+K +N+LLT + +KL DFG++ + T T +
Sbjct: 134 L-------MGLQHLHVNKTIHRDVKGNNILLT-TEGGVKLVDFGVSAQLTSTRLRRNTSV 185
Query: 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 170
GT WMAPE+ + Q Y+ + DV+S GI EL P + ++A +
Sbjct: 186 GTPFWMAPEV---IACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP 242
Query: 171 FKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
++ P L PE S + ++ C +D RP+ S +++
Sbjct: 243 -RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 42/106 (39%), Positives = 57/106 (53%), Gaps = 10/106 (9%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR + MT T + A
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLARH--TDDEMTGYVATRWYRA 185
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
PE+ HYN VD++S G ++ ELLT R F G ++
Sbjct: 186 PEIMLNWM-------HYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-14
Identities = 44/112 (39%), Positives = 60/112 (53%), Gaps = 9/112 (8%)
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTY 113
L + R + LH N IIHRDLK NLLLT D+ LK+ADFGLAR + MT + T
Sbjct: 114 MLQLLRGLQYLHENFIIHRDLKVSNLLLT-DKGCLKIADFGLARTYGLPAKPMTPKVVTL 172
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 165
+ APEL T Y +D+++ G +L ELL ++ G S ++
Sbjct: 173 WYRAPELLLGCT-------TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 64/241 (26%), Positives = 104/241 (43%), Gaps = 40/241 (16%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK------------- 45
++SR+K N+++ LG C +DPL ++TE + L ++L S +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPL-CMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 46 ----LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 101
+ L+ AL IA M L + +HRDL N L+ + ++K+ADFG++R
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG-ENLTIKIADFGMSRNLY 189
Query: 102 VTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NRLP 156
+ + RWMA E + G+ + DV++FG+ LWE+L P
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWE-----CILMGK---FTTASDVWAFGVTLWEILMLCKEQP 241
Query: 157 FEGMSNLQAAYAAA--FKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
+ +++ Q A F+ P L ++ CW D RPSFS I
Sbjct: 242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAF 301
Query: 211 L 211
L
Sbjct: 302 L 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-14
Identities = 54/173 (31%), Positives = 83/173 (47%), Gaps = 14/173 (8%)
Query: 13 FLGACKDPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGII 71
F D + +V E +PG L + + P K A + ++ A+D +H+ G I
Sbjct: 109 FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----ARFYTAEVVLALDAIHSMGFI 164
Query: 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQG 129
HRD+KPDN+LL LKLADFG + M+ +T GT +++PE+ + QG
Sbjct: 165 HRDVKPDNMLLD-KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS----QG 219
Query: 130 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-GLPED 181
+Y + D +S G+ L+E+L PF S L Y+ H P+D
Sbjct: 220 GDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMNHKNSLTFPDD 271
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-14
Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 19/220 (8%)
Query: 2 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA--LNFALDI 58
+ + H N+V+ G + M+IVTE + +L +L R ++ L + +
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGL 116
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG--TYRWM 116
A M L G +H+ L +L+ D K++ F +E+ + T +G W
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR 175
APE ++ H+++ DV+SFGIV+WE+++ P+ MS Q A R
Sbjct: 176 APE-----AIQYH---HFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIKAVEDGFR 226
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
P + L ++ CW ++ RP FSQI +L+ +
Sbjct: 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 2e-14
Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 11/108 (10%)
Query: 53 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 112
++ + +++D +H NGI HRD+KP+N+L+ LKLADFG R T T
Sbjct: 104 SYMYQLLKSLDHMHRNGIFHRDIKPENILI--KDDILKLADFGSCRGIYSKPPYTEYIST 161
Query: 113 YRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
RW APE L G +Y K+D+++ G V +E+L+ F G
Sbjct: 162 -RWYRAPE----CLLTDG---YYGPKMDIWAVGCVFFEILSLFPLFPG 201
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 40/112 (35%), Positives = 67/112 (59%), Gaps = 12/112 (10%)
Query: 50 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 109
A+ +A +IA + LH+ GII+RDLK DN++L + +K+ADFG+ +E + T
Sbjct: 102 HAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-GHIKIADFGMCKEN-IFGGKTTR 159
Query: 110 T--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
T GT ++APE+ + + Y VD ++FG++L+E+L + PF+G
Sbjct: 160 TFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-14
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMS--LRKYLVSLRPNKLDLHVALNFALD 57
++ V H ++++ + +V LP S L YL + R L + AL
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYL-TKRSRPLPIDQALIIEKQ 165
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
I + LHA IIHRD+K +N+ + D + + D G A+ V GT A
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNA 224
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151
PE+ + + YN+K D++S GIVL+E+L
Sbjct: 225 PEVLA--------RDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-14
Identities = 51/169 (30%), Positives = 78/169 (46%), Gaps = 12/169 (7%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M+ ++KH NLV + + + +V E L + + P + H+
Sbjct: 53 MLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNE--LEKNPRGVPEHLIKKIIWQTL 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-AP 118
+A++ H + IHRD+KP+N+L+T Q +KL DFG AR T + RW AP
Sbjct: 111 QAVNFCHKHNCIHRDVKPENILIT-KQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAP 169
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 167
EL T Y VDV++ G V ELLT + + G S++ Y
Sbjct: 170 ELLVGDT-------QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-14
Identities = 40/104 (38%), Positives = 59/104 (56%), Gaps = 10/104 (9%)
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRW 115
+I+ A++ LH GII+RDLKP+N+LL Q +KL DFGL +E +T GT +
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEY 166
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
MAPE+ R G + VD +S G +++++LT PF
Sbjct: 167 MAPEILM----RSG----HGKAVDWWSLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 53/177 (29%), Positives = 83/177 (46%), Gaps = 22/177 (12%)
Query: 3 SRVKHDNLVKFL--GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+R+ H N+V L G L+ V E +PG +LR+ L + L L +
Sbjct: 33 ARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL--MLQVLD 90
Query: 61 AMDCLHANGIIHRDLKPDNLLLTP--DQKSLKLADFGLAR-----EETVTEMMTAET--- 110
A+ C H GI+HRDLKP N++++ + K+ DFG+ + +T T
Sbjct: 91 ALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVL 150
Query: 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 167
GT + APE LR GE N+ D+Y++G++ E LT + +G S + Y
Sbjct: 151 GTPTYCAPE-----QLR-GEPVTPNS--DLYAWGLIFLECLTGQRVVQGASVAEILY 199
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 5e-14
Identities = 51/222 (22%), Positives = 98/222 (44%), Gaps = 17/222 (7%)
Query: 1 MMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
+ R+ +N++K G D P + ++ E LR+ L + L L+ A
Sbjct: 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEK--DLSFKTKLDMA 128
Query: 56 LDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 114
+D + + L+ +++L + L+T + K LK+ GL + + Y
Sbjct: 129 IDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK-LKIICHGLEKILSSPPFKNVNFMVYF 187
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 174
+ ++ + + Y K D+YS G+VLWE+ T ++PFE ++ + K+
Sbjct: 188 --SYKMLNDIF------SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNN 239
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216
LP D ++ IV++C D RP+ +I+ L+ + F
Sbjct: 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281
|
Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-14
Identities = 38/107 (35%), Positives = 54/107 (50%), Gaps = 9/107 (8%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGT 112
F + R + +H+ ++HRDLKP NLLL + LK+ DFGLAR + + MT T
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVT 171
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
+ APEL + Y +DV+S G + ELL + F G
Sbjct: 172 RWYRAPELLLNCS-------EYTTAIDVWSVGCIFAELLGRKPLFPG 211
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-14
Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 10/100 (10%)
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPE 119
+ LH N I++RDLK DNLLL + +K+ADFGL +E T+ GT ++APE
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
+ + + Y VD + G++++E+L PF G
Sbjct: 172 VLT--------ETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-14
Identities = 41/111 (36%), Positives = 70/111 (63%), Gaps = 12/111 (10%)
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110
A+ +A +IA + LH+ GII+RDLK DN++L + +K+ADFG+ + E + + +T +T
Sbjct: 103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD-SEGHIKIADFGMCK-ENMWDGVTTKT 160
Query: 111 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
GT ++APE+ + + Y VD ++FG++L+E+L + PFEG
Sbjct: 161 FCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-14
Identities = 43/138 (31%), Positives = 77/138 (55%), Gaps = 8/138 (5%)
Query: 24 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83
+V E PG L L++ ++ D +A + ++ A+ +H G +HRD+KP+N+L+
Sbjct: 78 LVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI- 135
Query: 84 PDQKS-LKLADFGLAREETVTEMMTAE--TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140
D+ +KLADFG A T +M+ ++ GT ++APE+ + T+ K Y + D
Sbjct: 136 -DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLT--TMNGDGKGTYGVECDW 192
Query: 141 YSFGIVLWELLTNRLPFE 158
+S G++ +E++ R PF
Sbjct: 193 WSLGVIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 36/106 (33%), Positives = 61/106 (57%), Gaps = 12/106 (11%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 111
+ +I A+ LH+ +++RDLK +NL+L D +K+ DFGL +E +++ T +T G
Sbjct: 100 YGAEIVSALGYLHSCDVVYRDLKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCG 157
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
T ++APE+ E Y VD + G+V++E++ RLPF
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-14
Identities = 66/245 (26%), Positives = 107/245 (43%), Gaps = 56/245 (22%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNK---------LDLH 49
+MSR+K N+++ L C DPL +I TE + L ++L P + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMI-TEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 50 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 109
+ A IA M L + +HRDL N L+ + ++K+ADFG++R
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY-TIKIADFGMSR--------NLY 181
Query: 110 TGTY-----------RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NRLP 156
+G Y RWM+ E ++ L + + DV++FG+ LWE+LT P
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWE---SILLGK-----FTTASDVWAFGVTLWEILTLCKEQP 233
Query: 157 FEGMSNLQAAYAAA--FKHA-------RPGLPEDISPDLAF-IVQSCWVEDPNLRPSFSQ 206
+ +S+ Q F+ +P L PD + ++ SCW + RPSF +
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPAL----CPDSLYKLMLSCWRRNAKERPSFQE 289
Query: 207 IIRML 211
I L
Sbjct: 290 IHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-13
Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALD 57
++ ++ H N++K+ + +D + IV EL L + + + K + + +
Sbjct: 55 LLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQ 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWM 116
+ A++ +H+ ++HRD+KP N+ +T +KL D GL R + T + GT +M
Sbjct: 115 LCSALEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHAR 175
+PE + + YN K D++S G +L+E+ + PF G NL + +
Sbjct: 174 SPE--------RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY 225
Query: 176 PGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
P LP D S +L +V C DP RP + + +
Sbjct: 226 PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-13
Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 12/139 (8%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79
+ +V ++ G LR ++ ++ A + I ++ LH II+RDLKP+N
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPEN 127
Query: 80 LLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKV 138
+LL + +++++D GLA E + T GT +MAPEL QGE+ Y+ V
Sbjct: 128 VLLD-NDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELL------QGEE--YDFSV 178
Query: 139 DVYSFGIVLWELLTNRLPF 157
D ++ G+ L+E++ R PF
Sbjct: 179 DYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 2e-13
Identities = 42/105 (40%), Positives = 60/105 (57%), Gaps = 10/105 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 112
+A +IA A+ LH+ II+RDLKP+N+LL Q + L DFGL +E T+ GT
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
++APE+ LR K+ Y+ VD + G VL+E+L PF
Sbjct: 160 PEYLAPEV-----LR---KQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-13
Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 12/161 (7%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +KH N+V + + +V E L L++YL + N + +H F +
Sbjct: 56 LLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLL 113
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 118
R + H I+HRDLKP NLL+ ++ LKLADFGLAR ++V T+ + E T + P
Sbjct: 114 RGLSYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
++ T Y+ +D++ G +L+E+ T R F G
Sbjct: 173 DVLLGST-------EYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-13
Identities = 39/111 (35%), Positives = 68/111 (61%), Gaps = 12/111 (10%)
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110
A+ +A +I+ + LH GII+RDLK DN++L + +K+ADFG+ +E V + +T T
Sbjct: 103 AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD-SEGHIKIADFGMCKEHMV-DGVTTRT 160
Query: 111 --GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
GT ++APE+ + + Y VD +++G++L+E+L + PF+G
Sbjct: 161 FCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-13
Identities = 39/106 (36%), Positives = 59/106 (55%), Gaps = 10/106 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 112
+A +I A+ LH GII+RDLK DN+LL + KLADFG+ +E T+ GT
Sbjct: 101 YAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHC-KLADFGMCKEGIFNGKTTSTFCGT 159
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158
++APE+ ++ Y VD ++ G++L+E+L PFE
Sbjct: 160 PDYIAPEIL--------QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-13
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +KH N+V+ D + +V E L+KY S +D + +F +
Sbjct: 52 LLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCN-GDIDPEIVKSFMFQLL 109
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 118
+ + H++ ++HRDLKP NLL+ LKLADFGLAR + +AE T + P
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPP 168
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150
++ L Y+ +D++S G + EL
Sbjct: 169 DVLFGAKL-------YSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-13
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 24/223 (10%)
Query: 5 VKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVAL--NFALDIARA 61
++H N+++ LG C + + ++V E L+ YL + ++ + + L A +IA
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 62 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY---RWMAP 118
+ +H + +H DL N LT D ++K+ D+G+ + + E RW+AP
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 119 ELYSTVTLRQG-----EKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNL----QAAYA 168
EL V G E+ +N V++ G+ LWEL N P+ +S+
Sbjct: 171 EL---VGEFHGGLITAEQTKPSN---VWALGVTLWELFENAAQPYSHLSDREVLNHVIKD 224
Query: 169 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
K +P L S ++Q CW+ P R + ++ R+L
Sbjct: 225 QQVKLFKPQLELPYSERWYEVLQFCWLS-PEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 38/118 (32%), Positives = 66/118 (55%), Gaps = 10/118 (8%)
Query: 42 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 101
R K D + +A ++ A+ LH +G+I+RDLK DN+LL + KLADFG+ +E
Sbjct: 89 RSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE-GHCKLADFGMCKEGI 147
Query: 102 VTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158
+ + T GT ++APE+ ++ Y VD ++ G++++E++ + PFE
Sbjct: 148 LNGVTTTTFCGTPDYIAPEIL--------QELEYGPSVDWWALGVLMYEMMAGQPPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-13
Identities = 57/216 (26%), Positives = 103/216 (47%), Gaps = 15/216 (6%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALD 57
++ ++ H N++K+L + +D + IV EL L + + + K + + +
Sbjct: 55 LLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQ 114
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWM 116
+ A++ +H+ ++HRD+KP N+ +T +KL D GL R + T + GT +M
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYM 173
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHAR 175
+PE + + YN K D++S G +L+E+ + PF G NL + +
Sbjct: 174 SPE--------RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY 225
Query: 176 PGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
P LP E S L +V C DP+ RP + ++
Sbjct: 226 PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 16/161 (9%)
Query: 7 HDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
H N+V+ + C ++ + +V E + LR YL + P L + R
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
+D LHAN I+HRDLKP+N+L+T +KLADFGLAR + +T T + APE+
Sbjct: 120 GLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEV 178
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161
T Y VD++S G + E+ + F G S
Sbjct: 179 LLQST--------YATPVDMWSVGCIFAEMFRRKPLFCGNS 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 3e-13
Identities = 38/100 (38%), Positives = 55/100 (55%), Gaps = 10/100 (10%)
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
R + +H+ GIIHRDLKP N+ + D + L++ DFGLAR+ + MT T + APE
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNVAVNEDCE-LRILDFGLARQ--ADDEMTGYVATRWYRAPE 185
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
+ HYN VD++S G ++ ELL + F G
Sbjct: 186 IMLNWM-------HYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 39/95 (41%), Positives = 54/95 (56%), Gaps = 9/95 (9%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 124
LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T + APE V
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE----V 196
Query: 125 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
L G Y VD++S G ++ E++ + F G
Sbjct: 197 ILGMG----YKENVDIWSVGCIMGEMIKGGVLFPG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-13
Identities = 41/95 (43%), Positives = 54/95 (56%), Gaps = 10/95 (10%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 124
+H+ GIIHRDLKP NL + D + LK+ DFGLAR MT T + APE V
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCE-LKILDFGLARHADAE--MTGYVVTRWYRAPE----V 185
Query: 125 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
L HYN VD++S G ++ E+LT + F+G
Sbjct: 186 ILNW---MHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 4e-13
Identities = 41/134 (30%), Positives = 71/134 (52%), Gaps = 14/134 (10%)
Query: 34 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 93
L++Y+ L +H F + R + H ++HRDLKP NLL++ ++ LKLAD
Sbjct: 89 LKQYMDD-CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLAD 146
Query: 94 FGLAREETV-TEMMTAETGTYRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150
FGLAR ++V ++ + E T + P+ L ST Y+ +D++ G + +E+
Sbjct: 147 FGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST---------EYSTSLDMWGVGCIFYEM 197
Query: 151 LTNRLPFEGMSNLQ 164
T R F G ++++
Sbjct: 198 ATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-13
Identities = 40/99 (40%), Positives = 56/99 (56%), Gaps = 9/99 (9%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 124
LH+ GIIHRDLKP N+++ D +LK+ DFGLAR MMT T + APE V
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPE----V 193
Query: 125 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
L G Y VD++S G ++ EL+ + F+G ++
Sbjct: 194 ILGMG----YKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-13
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 7 HDNLVKFLGAC--KDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
H N+ + GA K+P + +V E S+ + + + N L +I
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMA 117
R + LH + +IHRD+K N+LLT + +KL DFG++ + TV T GT WMA
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMA 179
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + + Y+ K D++S GI E+ P M ++A + A
Sbjct: 180 PEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ S ++SC V++ + RP+ Q+++
Sbjct: 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 5e-13
Identities = 42/150 (28%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 111
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL + E +++ T +T G
Sbjct: 100 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCK-EGISDGATMKTFCG 157
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 171
T ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 TPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209
Query: 172 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ R P +SP+ ++ +DP R
Sbjct: 210 EEIR--FPRTLSPEAKSLLAGLLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-13
Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 20/223 (8%)
Query: 2 MSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIA 59
+ +++H N +++ G ++ +V E G + V +P ++++ + AL
Sbjct: 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGAL--- 125
Query: 60 RAMDCLHANGIIHRDLKPDNLLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ + LH++ +IHRD+K N+LL+ P +KL DFG A ++ GT WMAP
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSA---SIMAPANXFVGTPYWMAP 180
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ + + +G+ Y+ KVDV+S GI EL + P M+ + A Y A ++ P L
Sbjct: 181 EV--ILAMDEGQ---YDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESPAL 234
Query: 179 PED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220
S V SC + P RP+ +++ + F+ RP
Sbjct: 235 QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERP 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-13
Identities = 37/109 (33%), Positives = 60/109 (55%), Gaps = 13/109 (11%)
Query: 50 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTA 108
VA + ++ A + LH+ II+RDLKP+NLLL D K +K+ DFG A++ V +
Sbjct: 119 VAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL--DNKGHVKVTDFGFAKK--VPDRTFT 174
Query: 109 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
GT ++APE+ + K + VD ++ G++L+E + PF
Sbjct: 175 LCGTPEYLAPEVI--------QSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-13
Identities = 46/150 (30%), Positives = 73/150 (48%), Gaps = 11/150 (7%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELY 121
LH I+HRD+KP NLL+ K++K+ADFG++R + + M + GT +M+PE
Sbjct: 184 LHRRHIVHRDIKPSNLLIN-SAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERI 240
Query: 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE-GMSNLQAAYAAAFKHAR-PGLP 179
+T L G Y D++S G+ + E R PF G A+ A ++ P P
Sbjct: 241 NT-DLNHGAYDGYAG--DIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAP 297
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
S + + C +P R S Q+++
Sbjct: 298 ATASREFRHFISCCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.5 bits (163), Expect = 8e-13
Identities = 35/104 (33%), Positives = 52/104 (50%), Gaps = 18/104 (17%)
Query: 65 LHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR------EETVTEMMTAETGTYRW 115
LH+N ++HRDLKP N+L+ P++ +K+ D GLAR + T YR
Sbjct: 124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYR- 182
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
APEL +HY +D+++ G + ELLT F+G
Sbjct: 183 -APELLLGA-------RHYTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-13
Identities = 41/142 (28%), Positives = 75/142 (52%), Gaps = 10/142 (7%)
Query: 18 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
KD L +++T L+ G L+ ++ ++ D A+ +A +I ++ LH I++RDLKP
Sbjct: 72 KDALCLVLT-LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 137
+N+LL D ++++D GLA E E + GT +MAPE+ + + Y
Sbjct: 131 ENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV--------KNERYTFS 181
Query: 138 VDVYSFGIVLWELLTNRLPFEG 159
D + G +++E++ + PF
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-13
Identities = 44/106 (41%), Positives = 62/106 (58%), Gaps = 10/106 (9%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
+ + + +HA GIIHRDLKP NL + D + LK+ DFGLAR +T +E MT T + A
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR-QTDSE-MTGYVVTRWYRA 183
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
PE V L HY VD++S G ++ E+LT + F+G +L
Sbjct: 184 PE----VILNW---MHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 9e-13
Identities = 40/112 (35%), Positives = 56/112 (50%), Gaps = 15/112 (13%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTA 108
F I + +H+ ++HRDLKP NLL+ D + LK+ DFGLAR MT
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE-LKICDFGLARGFSENPGENAGFMTE 168
Query: 109 ETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
T RW APE+ + + Y +DV+S G +L ELL + F+G
Sbjct: 169 YVAT-RWYRAPEIMLSF-------QSYTKAIDVWSVGCILAELLGRKPVFKG 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-12
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 17/215 (7%)
Query: 1 MMSRVKHDNLVKFLGA--CKDPLMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALD 57
M+ KH N+V + G+ ++ L I E G SL+ Y V+ ++L + L
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLW-ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL- 116
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWM 116
+ + LH+ G +HRD+K N+LLT D +KLADFG+A + T T + GT WM
Sbjct: 117 --QGLAYLHSKGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWM 173
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE+ + V G YN D+++ GI EL + P + ++A + + + +P
Sbjct: 174 APEV-AAVEKNGG----YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP 228
Query: 177 GLPED---ISPDLAFIVQSCWVEDPNLRPSFSQII 208
+D S V+ ++P RP+ +++
Sbjct: 229 PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 49/144 (34%), Positives = 80/144 (55%), Gaps = 14/144 (9%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
+ V E + G L ++ R KL A ++ +I+ A++ LH GII+RDLK DN+L
Sbjct: 71 LFFVIEFVSGGDLMFHM--QRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL 128
Query: 82 LTPDQKSLKLADFGLAREETVTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140
L + +KL D+G+ +E T+ GT ++APE+ LR GE Y VD
Sbjct: 129 LDAE-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI-----LR-GED--YGFSVDW 179
Query: 141 YSFGIVLWELLTNRLPFE--GMSN 162
++ G++++E++ R PF+ GMS+
Sbjct: 180 WALGVLMFEMMAGRSPFDIVGMSD 203
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 38/112 (33%), Positives = 54/112 (48%), Gaps = 15/112 (13%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-----ETVTEMMTA 108
F + R + +H+ +IHRDLKP NLL+ D L++ DFG+AR MT
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTE 170
Query: 109 ETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
T RW APEL ++ Y +D++S G + E+L R F G
Sbjct: 171 YVAT-RWYRAPELLLSL-------PEYTTAIDMWSVGCIFAEMLGRRQLFPG 214
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-12
Identities = 47/161 (29%), Positives = 83/161 (51%), Gaps = 12/161 (7%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +KH N+V + + +V E L L++YL N +++H F +
Sbjct: 57 LLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLFLFQLL 114
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 118
R ++ H ++HRDLKP NLL+ ++ LKLADFGLAR +++ T+ + E T + P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
++ T Y+ ++D++ G + +E+ T R F G
Sbjct: 174 DILLGST-------DYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-12
Identities = 39/95 (41%), Positives = 56/95 (58%), Gaps = 9/95 (9%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTV 124
LH+ GIIHRDLKP N+++ D +LK+ DFGLAR + MMT T + APE V
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPE----V 189
Query: 125 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
L G Y VD++S G ++ E++ +++ F G
Sbjct: 190 ILGMG----YKENVDIWSVGCIMGEMVRHKILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 39/142 (27%), Positives = 75/142 (52%), Gaps = 10/142 (7%)
Query: 18 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
KD L +++T ++ G L+ ++ ++ + AL +A +I ++ LH ++RDLKP
Sbjct: 72 KDALCLVLT-IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKP 130
Query: 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 137
+N+LL D ++++D GLA + E + GT +MAPE+ + + Y
Sbjct: 131 ENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRYTLS 181
Query: 138 VDVYSFGIVLWELLTNRLPFEG 159
D + G +++E++ + PF G
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 64/239 (26%), Positives = 107/239 (44%), Gaps = 43/239 (17%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------- 51
+MSR+K+ N+++ LG C DPL ++TE + L ++L S R + A
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPL-CMITEYMENGDLNQFL-SQREIESTFTHANNIPSVS 127
Query: 52 ----LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 107
L A+ IA M L + +HRDL N L+ + ++K+ADFG++R +
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG-NHYTIKIADFGMSRNLYSGDYYR 186
Query: 108 AETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL--LTNRLPFEGMSN 162
+ RWMA + ++ L + + DV++FG+ LWE+ L P+ +S+
Sbjct: 187 IQGRAVLPIRWMA---WESILLGK-----FTTASDVWAFGVTLWEMFTLCKEQPYSLLSD 238
Query: 163 LQAAYAAA----------FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
Q + P P SP +++ CW D RP+F++I L
Sbjct: 239 EQVIENTGEFFRNQGRQIYLSQTPLCP---SPVFKLMMR-CWSRDIKDRPTFNKIHHFL 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-12
Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 10/105 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 112
+A ++A A+ LH+ II+RDLKP+N+LL Q + L DFGL +E E T+ GT
Sbjct: 101 YAAEVASAIGYLHSLNIIYRDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGT 159
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
++APE+ LR K+ Y+ VD + G VL+E+L PF
Sbjct: 160 PEYLAPEV-----LR---KEPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-12
Identities = 61/228 (26%), Positives = 93/228 (40%), Gaps = 40/228 (17%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF--ALD 57
+MS+V H +L G C + ++V E + L V LR K + VA A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD---VCLRKEKGRVPVAWKITVAQQ 125
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLT------PDQKSLKLADFG-----LAREETVTEMM 106
+A A+ L ++H ++ N+LL +KL+D G L+REE V +
Sbjct: 126 LASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI- 184
Query: 107 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA 166
W+APE + D +SFG L E+ F+G L+
Sbjct: 185 -------PWIAPECVPGGN-------SLSTAADKWSFGTTLLEIC-----FDGEVPLKER 225
Query: 167 YAAA---FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
+ F + LPE +LA ++ C +P RPSF I+R L
Sbjct: 226 TPSEKERFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-12
Identities = 40/105 (38%), Positives = 60/105 (57%), Gaps = 10/105 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-TVTEMMTAETGT 112
+A +IA A+ LH+ I++RDLKP+N+LL Q + L DFGL +E ++ T GT
Sbjct: 101 YAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
++APE+ K+ Y+N VD + G VL+E+L PF
Sbjct: 160 PEYLAPEVI--------RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 4e-12
Identities = 60/215 (27%), Positives = 101/215 (46%), Gaps = 15/215 (6%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
MM KH N+V + G+ +D L I E G SL+ P + +A + +
Sbjct: 59 MMKDCKHSNIVAYFGSYLRRDKLW-ICMEFCGGGSLQDIYHVTGPLS-ESQIAY-VSRET 115
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMA 117
+ + LH+ G +HRD+K N+LLT D +KLADFG++ + T T + GT WMA
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMA 174
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + K YN D+++ GI EL + P + ++A + + +P
Sbjct: 175 PEVAAV-----ERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229
Query: 178 LPED---ISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+D S V+ ++P RP+ ++++
Sbjct: 230 KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-12
Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 18 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN--FALDIARAMDCLHANGIIHRDL 75
K+ + +V E +P ++ KY+ N L + L ++ + RA+ +H+ I HRDL
Sbjct: 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDL 196
Query: 76 KPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135
KP NLL+ P+ +LKL DFG A+ + + + + APEL T +Y
Sbjct: 197 KPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT-------NYT 249
Query: 136 NKVDVYSFGIVLWELLTNRLPFEGMSNL 163
+D++S G ++ E++ F G S++
Sbjct: 250 THIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 5e-12
Identities = 54/187 (28%), Positives = 80/187 (42%), Gaps = 23/187 (12%)
Query: 24 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83
I TE + G SL Y K+ HV A+ + + + L + I+HRD+KP N+L+
Sbjct: 76 ICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN 129
Query: 84 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143
+ +KL DFG++ + V + GT +MAPE S GE+ Y DV+S
Sbjct: 130 -TRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERIS------GEQ--YGIHSDVWSL 179
Query: 144 GIVLWELLTNRLPFEGMSNLQAAYA------AAFKHARPGLPE-DISPDLAFIVQSCWVE 196
GI EL R P+ + Q + P LP S + C +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRK 239
Query: 197 DPNLRPS 203
P RP+
Sbjct: 240 QPKERPA 246
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 7e-12
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 54/166 (32%)
Query: 47 DLHVALN------FALDIAR--------AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLA 92
+L L + ++AR A++ LH GI++RDLKP+N+LL + L+
Sbjct: 87 ELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES-GHIMLS 145
Query: 93 DFGLA----------------------REETVTEMMTAET--------GTYRWMAPELYS 122
DF L+ +E + E GT ++APE+ S
Sbjct: 146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVIS 205
Query: 123 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 168
+ + VD ++ GI+L+E+L PF+G SN ++
Sbjct: 206 --------GDGHGSAVDWWTLGILLYEMLYGTTPFKG-SNRDETFS 242
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 7e-12
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 15/151 (9%)
Query: 54 FALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 110
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +E + + T +T
Sbjct: 100 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKE-GIKDGATMKTFC 157
Query: 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 170
GT ++APE+ E Y VD + G+V++E++ RLPF + +
Sbjct: 158 GTPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 209
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ R P +SP+ ++ +DP R
Sbjct: 210 MEEIR--FPRTLSPEAKSLLSGLLKKDPKQR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 8e-12
Identities = 39/111 (35%), Positives = 54/111 (48%), Gaps = 20/111 (18%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT---Y------ 113
LH N I+HRD+K N+L+ +Q LK+ADFGLAR + G Y
Sbjct: 131 LHENHILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVT 189
Query: 114 RWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
RW PEL GE++ Y VD++ G V E+ T R +G S++
Sbjct: 190 RWYRPPELLL------GERR-YTTAVDIWGIGCVFAEMFTRRPILQGKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-12
Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 10/118 (8%)
Query: 42 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 101
R KL A +A +I A++ LH GII+RDLK DN+LL D +KL D+G+ +E
Sbjct: 89 RQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD-GHIKLTDYGMCKEGL 147
Query: 102 VTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158
T+ GT ++APE+ +GE+ Y VD ++ G++++E++ R PF+
Sbjct: 148 GPGDTTSTFCGTPNYIAPEIL------RGEE--YGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-11
Identities = 50/161 (31%), Positives = 82/161 (50%), Gaps = 12/161 (7%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +KH N+V D + +V E L L++Y+ N + +H F I
Sbjct: 57 LLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIFLYQIL 114
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 118
R + H ++HRDLKP NLL+ ++ LKLADFGLAR ++V T+ + E T + P
Sbjct: 115 RGLAYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 173
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
+ V L E Y+ ++D++ G + +E+ + R F G
Sbjct: 174 D----VLLGSSE---YSTQIDMWGVGCIFFEMASGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 1e-11
Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 27/175 (15%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M+ +KH+N++ + + + +V +++ L+K +V + + V L I
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKK-VVDRKIRLTESQVKC-ILLQIL 129
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---------------EETVTE 104
++ LH +HRDL P N+ + + K+ADFGLAR E
Sbjct: 130 NGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 105 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
MT++ T + APEL L EK Y+ VD++S G + ELLT + F G
Sbjct: 189 EMTSKVVTLWYRAPEL-----LMGAEK--YHFAVDMWSVGCIFAELLTGKPLFPG 236
|
Length = 335 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 39/141 (27%), Positives = 75/141 (53%), Gaps = 10/141 (7%)
Query: 18 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
KD L +++T L+ G L+ ++ + + A+ +A +I ++ LH I++RDLKP
Sbjct: 72 KDALCLVLT-LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKP 130
Query: 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 137
+N+LL D ++++D GLA + + GT +MAPE+ + + Y
Sbjct: 131 ENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV--------KNERYTFS 181
Query: 138 VDVYSFGIVLWELLTNRLPFE 158
D ++ G +L+E++ + PF+
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-11
Identities = 47/181 (25%), Positives = 72/181 (39%), Gaps = 32/181 (17%)
Query: 4 RVKHDNLVKF---LGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN------- 53
R+ HDN+VK LG L V L L + + DL L
Sbjct: 58 RLDHDNIVKVYEVLGPSGSDLTEDVGSL---TELNSVYIVQEYMETDLANVLEQGPLSEE 114
Query: 54 ----FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVT 103
F + R + +H+ ++HRDLKP N+ + + LK+ DFGLAR
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 104 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
T YR +P L + +Y +D+++ G + E+LT + F G L
Sbjct: 175 LSEGLVTKWYR--SPRLLLSPN-------NYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
Query: 164 Q 164
+
Sbjct: 226 E 226
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 16/213 (7%)
Query: 7 HDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
H N+ + GA D + +V E S+ + + + N L +I
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMA 117
R + LHA+ +IHRD+K N+LLT + +KL DFG++ + TV T GT WMA
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPYWMA 189
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + + Y+ + D++S GI E+ P M ++A + ++ P
Sbjct: 190 PEV---IACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPPPK 245
Query: 178 L-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
L + S ++ C V++ RPS Q+++
Sbjct: 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 39/110 (35%), Positives = 56/110 (50%), Gaps = 11/110 (10%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAET 110
F + RA+ +H + HRDLKP N+L D K LK+ DFGLAR +T T + +
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANADCK-LKICDFGLARVAFNDTPTAIFWTDY 166
Query: 111 GTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
RW APEL + + Y +D++S G + E+LT + F G
Sbjct: 167 VATRWYRAPELCGSFFSK------YTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 38/108 (35%), Positives = 60/108 (55%), Gaps = 9/108 (8%)
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 115
+ R +D LH++ ++HRDLKP N+L+T + +KLADFGLAR + +T+ T +
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTSVVVTLWY 175
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
APE+ L Q Y VD++S G + E+ + F G S++
Sbjct: 176 RAPEV-----LLQSS---YATPVDLWSVGCIFAEMFRRKPLFRGSSDV 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-11
Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 10/140 (7%)
Query: 18 KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
KD L +++T ++ G L+ ++ ++ D A+ +A ++ ++ L I++RDLKP
Sbjct: 72 KDALCLVLT-IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKP 130
Query: 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 137
+N+LL D+ ++++D GLA + E + GT +MAPE+ EK Y
Sbjct: 131 ENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI------NNEK--YTFS 181
Query: 138 VDVYSFGIVLWELLTNRLPF 157
D + G +++E++ + PF
Sbjct: 182 PDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 42/131 (32%), Positives = 63/131 (48%), Gaps = 12/131 (9%)
Query: 34 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 93
+ K+ L P + L F + R + +H I+HRDLKP NLL++ D LKLAD
Sbjct: 93 MDKHPGGLHPENVKL-----FLFQLLRGLSYIHQRYILHRDLKPQNLLIS-DTGELKLAD 146
Query: 94 FGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153
FGLAR ++V + W P V L E Y+ +D++ G + E++
Sbjct: 147 FGLARAKSVPSHTYSNEVVTLWYRP---PDVLLGSTE---YSTCLDMWGVGCIFVEMIQG 200
Query: 154 RLPFEGMSNLQ 164
F GM ++Q
Sbjct: 201 VAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-11
Identities = 39/105 (37%), Positives = 58/105 (55%), Gaps = 10/105 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE-TGT 112
+A +IA A+ LH+ I++RDLKP+N+LL Q + L DFGL +E T+ GT
Sbjct: 101 YAAEIASALGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGT 159
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
++APE+ K+ Y+ VD + G VL+E+L PF
Sbjct: 160 PEYLAPEVL--------HKQPYDRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 3e-11
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 17/168 (10%)
Query: 42 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 101
R KL A ++ +I+ A++ LH GII+RDLK DN+LL + +KL D+G+ +E
Sbjct: 89 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD-SEGHIKLTDYGMCKEGL 147
Query: 102 VTEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE-- 158
T+ GT ++APE+ +GE Y VD ++ G++++E++ R PF+
Sbjct: 148 RPGDTTSTFCGTPNYIAPEIL------RGED--YGFSVDWWALGVLMFEMMAGRSPFDIV 199
Query: 159 GMS-----NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
G S N + + +P +S A +++S +DP R
Sbjct: 200 GSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 5e-11
Identities = 39/131 (29%), Positives = 70/131 (53%), Gaps = 10/131 (7%)
Query: 34 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 93
L +Y++ P L + F + R + +H I+HRDLKP NLL++ LKLAD
Sbjct: 89 LAQYMIQ-HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLIS-YLGELKLAD 146
Query: 94 FGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152
FGLAR +++ ++ ++E T + P++ T Y++ +D++ G + E+L
Sbjct: 147 FGLARAKSIPSQTYSSEVVTLWYRPPDVLLGAT-------DYSSALDIWGAGCIFIEMLQ 199
Query: 153 NRLPFEGMSNL 163
+ F G+S++
Sbjct: 200 GQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 7e-11
Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 10/117 (8%)
Query: 42 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EE 100
R + DL A + ++ A++ LH +I+RDLKP+N+LL Q + L DFGL +
Sbjct: 86 REGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNM 144
Query: 101 TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
+ GT ++APEL Y VD ++ G++L+E+LT PF
Sbjct: 145 KDDDKTNTFCGTPEYLAPELLLGHG--------YTKAVDWWTLGVLLYEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 36/99 (36%), Positives = 57/99 (57%), Gaps = 11/99 (11%)
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 118
A++ LH I++RDLKP+N+LL + L DFGL++ +T+ T T GT ++AP
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDAT-GHIALCDFGLSKAN-LTDNKTTNTFCGTTEYLAP 165
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
E V L ++K Y VD +S G++++E+ PF
Sbjct: 166 E----VLL---DEKGYTKHVDFWSLGVLVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-10
Identities = 61/232 (26%), Positives = 96/232 (41%), Gaps = 46/232 (19%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSL-----RKYLVSLRPNKLDLHVALNF 54
MM +V H ++V G C +D ++V E + L RK V P K
Sbjct: 57 MMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF------KV 110
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS------LKLADFG-----LAREETVT 103
A +A A+ L ++H ++ N+LL + +KL+D G L+R+E V
Sbjct: 111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE 170
Query: 104 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEG--M 160
+ W+APE + K+ + D +SFG LWE+ N +P + +
Sbjct: 171 RI--------PWIAPECVE-------DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL 215
Query: 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
+ + Y P E LA ++ C DPN RP F I+R +N
Sbjct: 216 AEKERFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQRPFFRAIMRDIN 262
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG--LAREETVTEMMTAETGTYRWMAP 118
A+D +H G +HRD+KPDN+LL ++LADFG L T GT +++P
Sbjct: 114 AIDSVHQLGYVHRDIKPDNVLLDK-NGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP 172
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
E+ + + K Y + D +S G+ ++E+L PF
Sbjct: 173 EILQAM---EDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-10
Identities = 55/224 (24%), Positives = 83/224 (37%), Gaps = 69/224 (30%)
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPD--------QKSLKLADFGLAREETVTEMMTAETG 111
R ++ LH NG IHR++K ++L++ D L G + + V + T
Sbjct: 112 RGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG-QKAKVVYDFPQFSTS 170
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAA----- 166
W++PEL LRQ + YN K D+YS GI EL T R+PF+ M Q
Sbjct: 171 VLPWLSPEL-----LRQ-DLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLK 224
Query: 167 -------YAAAF-------KHARPGL--------------------------PEDISPDL 186
F K+++ G+ + SP
Sbjct: 225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAF 284
Query: 187 AFIVQSCWVEDPNLRPS---------FSQIIRMLNAFLFTLRPP 221
+V+ C +DP RPS F Q+ + +L PP
Sbjct: 285 QNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQGSILSLLPP 328
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-10
Identities = 33/93 (35%), Positives = 48/93 (51%), Gaps = 13/93 (13%)
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTYRWMAPE 119
+H N I+HRD+K N+L+T D LKLADFGLAR + + T T + PE
Sbjct: 135 IHRNKILHRDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPE 193
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152
L GE + Y +D++ G ++ E+ T
Sbjct: 194 LL------LGE-RDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 25/52 (48%), Positives = 40/52 (76%), Gaps = 1/52 (1%)
Query: 47 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98
D +A+ + ++A A+D LH +GIIHRDLKPDN+L++ ++ +KL DFGL++
Sbjct: 102 DEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS-NEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 43/160 (26%), Positives = 76/160 (47%), Gaps = 11/160 (6%)
Query: 38 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG-- 95
L+S ++L +A + ++ A+ +H +HRD+KPDN+LL + ++LADFG
Sbjct: 91 LLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN-GHIRLADFGSC 149
Query: 96 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155
L + T + GT +++PE+ + G+ Y + D +S G+ ++E+L
Sbjct: 150 LKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGK---YGPECDWWSLGVCMYEMLYGET 206
Query: 156 PFEGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQ 191
PF S L Y H P D+S + ++Q
Sbjct: 207 PFYAES-LVETYGKIMNHEERFQFPSHITDVSEEAKDLIQ 245
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 56/238 (23%), Positives = 104/238 (43%), Gaps = 39/238 (16%)
Query: 1 MMSRVKHDNLVK----FLGACKDPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNF 54
+M +KH N+V+ FL L +++ E L + + K++ H ++
Sbjct: 65 VMRELKHKNIVRYIDRFLNKANQKLYILM-EFCDAGDLSRNIQKCYKMFGKIEEHAIVDI 123
Query: 55 ALDIARAMDCLH-----ANG--IIHRDLKPDNLLLTPDQKSL----------------KL 91
+ A+ H NG ++HRDLKP N+ L+ + + K+
Sbjct: 124 TRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKI 183
Query: 92 ADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151
DFGL++ + M + GT + +PEL E K Y++K D+++ G +++EL
Sbjct: 184 GDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKSYDDKSDMWALGCIIYELC 237
Query: 152 TNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQII 208
+ + PF +N + + K P LP + S +L ++++ RPS Q +
Sbjct: 238 SGKTPFHKANNF-SQLISELKRG-PDLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293
|
Length = 1021 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 1e-09
Identities = 40/138 (28%), Positives = 69/138 (50%), Gaps = 7/138 (5%)
Query: 38 LVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG-- 95
L+S ++L +A + ++ A+D +H +HRD+KPDN+L+ + ++LADFG
Sbjct: 91 LLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN-GHIRLADFGSC 149
Query: 96 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155
L E T + GT +++PE+ + + K Y + D +S G+ ++E+L
Sbjct: 150 LKLMEDGTVQSSVAVGTPDYISPEILQAM---EDGKGKYGPECDWWSLGVCMYEMLYGET 206
Query: 156 PFEGMSNLQAAYAAAFKH 173
PF S L Y H
Sbjct: 207 PFYAES-LVETYGKIMNH 223
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 55/177 (31%)
Query: 25 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84
V + +PG + L+ L + DL A + ++ A++ +H G IHRD+KPDN+L+
Sbjct: 79 VMDYIPGGDMMSLLIRLGIFEEDL--ARFYIAELTCAIESVHKMGFIHRDIKPDNILIDR 136
Query: 85 DQKSLKLADFGL------------------ARE------ETVTEMMTAE----------- 109
D +KL DFGL R+ E +E+
Sbjct: 137 D-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQ 195
Query: 110 ---------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
GT ++APE V LR G Y D +S G++L+E+L + PF
Sbjct: 196 HQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWWSVGVILYEMLVGQPPF 244
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-09
Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 16/179 (8%)
Query: 10 LVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HA 67
+V F GA D + I E + G SL + L + ++ + ++ + R + L
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK 122
Query: 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLR 127
+ I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE
Sbjct: 123 HQIMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------ 174
Query: 128 QGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISP 184
QG HY+ + D++S G+ L EL R P L+A + G P ISP
Sbjct: 175 QG--THYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 41/149 (27%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
+A +I ++ +H +++RDLKP N+LL + ++++D GLA + + + A GT+
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM-SNLQAAYAAAFK 172
+MAPE+ L++G Y++ D +S G +L++LL PF + +
Sbjct: 160 GYMAPEV-----LQKGVA--YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLR 201
LP+ SP+L +++ D N R
Sbjct: 213 TMAVELPDSFSPELRSLLEGLLQRDVNRR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-09
Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 10/164 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M+ +K +N+V+ A + + +V E + L L+ PN + ++ +
Sbjct: 53 MLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
+A+ H N I+HRD+KP+NLL++ + LKL DFG AR ++E A Y +A
Sbjct: 111 KAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFAR--NLSEGSNANYTEY--VATR 165
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
Y + L G Y VD++S G +L EL + F G S +
Sbjct: 166 WYRSPELLLGAP--YGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-09
Identities = 56/192 (29%), Positives = 88/192 (45%), Gaps = 50/192 (26%)
Query: 5 VKHDNL--VKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARA 61
V+ D+L VK + +D L + ++ E LPG + L ++ + L + + A
Sbjct: 56 VEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL--MKKDTLTEEETQFYIAETVLA 113
Query: 62 MDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-------REE-------------T 101
+D +H G IHRD+KPDNLLL + +KL+DFGL R E T
Sbjct: 114 IDSIHQLGFIHRDIKPDNLLLD-SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 102 VTEMMT---AET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145
M + AET GT ++APE++ ++ G YN D +S G+
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGV 224
Query: 146 VLWELLTNRLPF 157
+++E+L PF
Sbjct: 225 IMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 33/115 (28%), Positives = 51/115 (44%), Gaps = 12/115 (10%)
Query: 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 129
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 121 IMHRDVKPSNILVNSRGE-IKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG 172
Query: 130 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISP 184
HY + D++S G+ L E+ R P A F S
Sbjct: 173 T--HYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESH 223
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 51/213 (23%), Positives = 79/213 (37%), Gaps = 55/213 (25%)
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA--------REETVTEMMTA 108
D+ A+D +H+ G IHR +K ++LL+ D K L+ + R+ V + +
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKV-VLSGLRYSVSMIKHGKRQRVVHDFPKS 167
Query: 109 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ---- 164
W++PE+ L+Q + YN K D+YS GI EL +PF+ M Q
Sbjct: 168 SVKNLPWLSPEV-----LQQ-NLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221
Query: 165 ----------------------AAYAAAFKHARPGLPEDI------SPDLAFIVQSCWVE 196
+ ++ +H D S V+ C
Sbjct: 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQR 281
Query: 197 DPNLRPSFSQI--------IRMLNAFLFTLRPP 221
DP RPS SQ+ + N L L P
Sbjct: 282 DPESRPSASQLLNHSFFKQCKRRNTSLLDLLKP 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 6e-09
Identities = 41/137 (29%), Positives = 60/137 (43%), Gaps = 50/137 (36%)
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGL----------------------- 96
A+D +H G IHRD+KPDNLLL D K +KL+DFGL
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLL--DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 97 AREETVTEMMT---AET-------------GTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140
+ M + AET GT ++APE++ + YN + D
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL--------QTGYNKECDW 222
Query: 141 YSFGIVLWELLTNRLPF 157
+S G++++E+L PF
Sbjct: 223 WSLGVIMYEMLVGYPPF 239
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 1 MMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDI 58
+++ + H V G+ KD + +V E + G ++ LR NK V +A I
Sbjct: 84 ILNYINHPFCVNLYGSFKDESYLYLVLEFVIG---GEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMA 117
+ L + I++RDLKP+NLLL D +K+ DFG A+ +T T + GT ++A
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKD-GFIKMTDFGFAKVVDTRTYTL---CGTPEYIA 196
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
PE+ V + D ++ GI ++E+L PF
Sbjct: 197 PEILLNVG--------HGKAADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-08
Identities = 37/123 (30%), Positives = 60/123 (48%), Gaps = 14/123 (11%)
Query: 42 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR 98
+P +L + + I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR
Sbjct: 101 KPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
Query: 99 EETVTEMMTAETG----TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154
A+ T+ + APEL +HY +D+++ G + ELLT+
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSE 213
Query: 155 LPF 157
F
Sbjct: 214 PIF 216
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-08
Identities = 38/138 (27%), Positives = 63/138 (45%), Gaps = 17/138 (12%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
+A ++ A+D LH GI+ RDL P+N+LL D+ ++L F E V + E
Sbjct: 90 WAAEMVVALDALHREGIVCRDLNPNNILLD-DRGHIQLTYFSRWSE--VEDSCDGEAVEN 146
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
+ APE+ G D +S G +L+ELLT G + ++ + H
Sbjct: 147 MYCAPEV--------GGISEETEACDWWSLGAILFELLT------GKTLVECHPSGINTH 192
Query: 174 ARPGLPEDISPDLAFIVQ 191
+PE +S + ++Q
Sbjct: 193 TTLNIPEWVSEEARSLLQ 210
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 49/173 (28%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
+ ++ E LPG + L ++ + L + + A+D +H G IHRD+KPDNLL
Sbjct: 76 LYLIMEFLPGGDMMTLL--MKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133
Query: 82 LTPDQKS-LKLADFGLA-------REE----------------TVTEMMTAET------- 110
L D K +KL+DFGL R E + AET
Sbjct: 134 L--DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191
Query: 111 ------GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
GT ++APE++ ++ G YN D +S G++++E+L PF
Sbjct: 192 LAYSTVGTPDYIAPEVF----MQTG----YNKLCDWWSLGVIMYEMLIGYPPF 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-08
Identities = 29/114 (25%), Positives = 53/114 (46%), Gaps = 11/114 (9%)
Query: 45 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 104
KL + A++ LH + IIH D+K +N+L + + L D+GL +
Sbjct: 105 KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS 164
Query: 105 MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158
GT + +PE + + +Y+ D ++ G++ +ELLT + PF+
Sbjct: 165 CY---DGTLDYFSPE--------KIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207
|
Length = 267 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-08
Identities = 37/123 (30%), Positives = 60/123 (48%), Gaps = 14/123 (11%)
Query: 42 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLAR 98
+P +L + + I + LHAN ++HRDLKP N+L+ P++ +K+AD G AR
Sbjct: 101 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160
Query: 99 EETVTEMMTAETG----TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154
A+ T+ + APEL +HY +D+++ G + ELLT+
Sbjct: 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA-------RHYTKAIDIWAIGCIFAELLTSE 213
Query: 155 LPF 157
F
Sbjct: 214 PIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 33/104 (31%), Positives = 61/104 (58%), Gaps = 9/104 (8%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
+A +I ++ +H +++RDLKP N+LL + ++++D GLA + + + A GT+
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFS-KKKPHASVGTH 159
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
+MAPE+ L++G Y++ D +S G +L++LL PF
Sbjct: 160 GYMAPEV-----LQKGTA--YDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 2e-08
Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 17/139 (12%)
Query: 32 MSLRKYLVSL-----RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 86
M + KY L R L L A+ + A+ LH GIIHRD+K +N+ L +
Sbjct: 163 MVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE 222
Query: 87 KSLKLADFGLA---REETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143
++ L DFG A T +GT +PEL + Y K D++S
Sbjct: 223 NAV-LGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP--------YCAKTDIWSA 273
Query: 144 GIVLWELLTNRLPFEGMSN 162
G+VL+E+ + G
Sbjct: 274 GLVLFEMSVKNVTLFGKQV 292
|
Length = 392 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-08
Identities = 34/96 (35%), Positives = 50/96 (52%), Gaps = 10/96 (10%)
Query: 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAPELYST 123
H +HRD+K N+LL ++ +KLADFGLAR + T + T + PEL
Sbjct: 133 HKKNFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELL-- 189
Query: 124 VTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
GE++ Y +DV+S G +L EL T + F+
Sbjct: 190 ----LGEER-YGPAIDVWSCGCILGELFTKKPIFQA 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 1e-07
Identities = 46/184 (25%), Positives = 76/184 (41%), Gaps = 59/184 (32%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
+ V + +PG + L+ R +A + ++ A++ +H G IHRD+KPDN+L
Sbjct: 76 LYFVMDYIPGGDMMSLLI--RMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133
Query: 82 LTPDQKSLKLADFGLA------------------REETVT---------------EMMTA 108
+ D +KL DFGL R++++ + T
Sbjct: 134 IDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTL 192
Query: 109 E---------------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153
E GT ++APE V LR+G Y D +S G++L+E+L
Sbjct: 193 EQRATKQHQRCLAHSLVGTPNYIAPE----VLLRKG----YTQLCDWWSVGVILFEMLVG 244
Query: 154 RLPF 157
+ PF
Sbjct: 245 QPPF 248
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-07
Identities = 30/87 (34%), Positives = 49/87 (56%), Gaps = 10/87 (11%)
Query: 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQG 129
I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+PE QG
Sbjct: 125 IMHRDVKPSNILVN-SRGEIKLCDFGVS-GQLIDSMANSFVGTRSYMSPERL------QG 176
Query: 130 EKKHYNNKVDVYSFGIVLWELLTNRLP 156
HY+ + D++S G+ L E+ R P
Sbjct: 177 --THYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 26/110 (23%)
Query: 66 HANGIIHRDLKPDNLLL---------------TPDQKSLKLADFGLAREETVTEMMTAE- 109
H+ G++HRDLKPDN+LL + L D + MT
Sbjct: 130 HSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPG 189
Query: 110 --TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157
GT +MAPE L + D+Y+ G++L+++LT P+
Sbjct: 190 KIVGTPDYMAPE-----RLLGVPA---SESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 4e-07
Identities = 28/81 (34%), Positives = 43/81 (53%), Gaps = 9/81 (11%)
Query: 19 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
DP +IV E + G L+ + S +L+L + +I R + LH+ GIIH DL
Sbjct: 70 DPENFIIVMEYIEGEPLKDLINSNGMEELEL------SREIGRLVGKLHSAGIIHGDLTT 123
Query: 78 DNLLLTPDQKSLKLADFGLAR 98
N++L+ + + L DFGLA
Sbjct: 124 SNMILSGGK--IYLIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 7e-07
Identities = 18/40 (45%), Positives = 26/40 (65%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 97
I A+D LH+ GI+HRD+KP N++ + S K+ D G A
Sbjct: 264 ILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 30/83 (36%), Positives = 45/83 (54%), Gaps = 21/83 (25%)
Query: 24 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR--------AMDCLHANGIIHRDL 75
++ E LPG L L+ K D F+ D+ R A++ +H G IHRD+
Sbjct: 78 LIMEFLPGGDLMTMLI-----KYDT-----FSEDVTRFYMAECVLAIEAVHKLGFIHRDI 127
Query: 76 KPDNLLLTPDQKS-LKLADFGLA 97
KPDN+L+ D+ +KL+DFGL+
Sbjct: 128 KPDNILI--DRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-06
Identities = 22/81 (27%), Positives = 36/81 (44%), Gaps = 12/81 (14%)
Query: 19 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
DP IV E + G L+ + + + + + + LH GI+H DL
Sbjct: 68 DPDNKTIVMEYIEGKPLKDVI-----EEGNDELLREIGRLVGK----LHKAGIVHGDLTT 118
Query: 78 DNLLLTPDQKSLKLADFGLAR 98
N+++ D+ L L DFGL +
Sbjct: 119 SNIIVRDDK--LYLIDFGLGK 137
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 2e-06
Identities = 40/120 (33%), Positives = 57/120 (47%), Gaps = 15/120 (12%)
Query: 34 LRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLA 92
L YL R L L A + A+D +H GIIHRD+K +N+L+ P+ + L
Sbjct: 246 LYTYL-GARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE--DICLG 302
Query: 93 DFG---LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149
DFG AR T GT APE+ + G+ Y VD++S G+V++E
Sbjct: 303 DFGAACFARGSWSTPFHYGIAGTVDTNAPEVLA------GDP--YTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 62/248 (25%), Positives = 110/248 (44%), Gaps = 49/248 (19%)
Query: 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL---RPNKLDLHVALNFALD 57
M +++H N+VK +G C+ + ++ E + G +L + L +L R K+ A+
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKI--------AIG 788
Query: 58 IARAMDCLHAN---GIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTY 113
IA+A+ LH ++ +L P+ +++ D+ L+L+ GL +T + +A
Sbjct: 789 IAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSA----- 843
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ------AAY 167
++APE E K K D+Y FG++L ELLT + P + + A Y
Sbjct: 844 -YVAPETR--------ETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARY 894
Query: 168 AAAFKH----ARPGLPEDISPDLAFIVQS------CWVEDPNLRPSFSQIIRMLNAFLFT 217
+ H P + D+S + IV+ C DP RP + +++ L +
Sbjct: 895 CYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES---A 951
Query: 218 LRPPSPSV 225
R S V
Sbjct: 952 SRSSSSCV 959
|
Length = 968 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 46/191 (24%), Positives = 76/191 (39%), Gaps = 59/191 (30%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
+ V + +PG + L+ + DL A + ++ A++ +H G IHRD+KPDN+L
Sbjct: 76 LYFVMDYIPGGDMMSLLIRMGIFPEDL--ARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133
Query: 82 LTPDQKSLKLADFGLA------------------REETVTEMMTAE-------------- 109
+ D +KL DFGL R++++
Sbjct: 134 IDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 110 ----------------TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153
GT ++APE V LR G Y D +S G++L+E+L
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPE----VLLRTG----YTQLCDWWSVGVILYEMLVG 244
Query: 154 RLPFEGMSNLQ 164
+ PF + L+
Sbjct: 245 QPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 6e-06
Identities = 24/81 (29%), Positives = 37/81 (45%), Gaps = 12/81 (14%)
Query: 19 DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77
DP +IV E + G L+ L RP+ ++ R + LH GI+H DL
Sbjct: 70 DPDNGLIVMEYIEGELLKDALEEARPD---------LLREVGRLVGKLHKAGIVHGDLTT 120
Query: 78 DNLLLTPDQKSLKLADFGLAR 98
N++L+ + + DFGL
Sbjct: 121 SNIILSGGR--IYFIDFGLGE 139
|
Length = 204 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 33/97 (34%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA--REETVTEMMTAETGTYRW 115
+ RA+ LH N IIHRD+K +N+ + + L DFG A + GT
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFIN-HPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152
APEL + + Y VD++S GIVL+E+ T
Sbjct: 250 NAPELLA--------RDPYGPAVDIWSAGIVLFEMAT 278
|
Length = 391 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 50/226 (22%), Positives = 79/226 (34%), Gaps = 64/226 (28%)
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQK--------SLKLADFGLAREETVTEMMT 107
+ +A+D +H G +HR +K ++L++ D K +L + + G R V +
Sbjct: 108 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG-QRLRVVHDFPK 166
Query: 108 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA-- 165
W++PE+ Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 167 YSVKVLPWLSPEVL------QQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220
Query: 166 ----------------------------------AYAAAFKHARPGLPED--------IS 183
+ RP E S
Sbjct: 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFS 280
Query: 184 PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL--RPPSPSVPE 227
P V+ C +P+ RPS S +LN F R S ++PE
Sbjct: 281 PHFHHFVEQCLQRNPDARPSAST---LLNHSFFKQIKRRASEALPE 323
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-05
Identities = 24/66 (36%), Positives = 40/66 (60%), Gaps = 1/66 (1%)
Query: 32 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 91
M+ +K ++ +K D++V + + LH GI+HRD+KP+NLL+T D + +K+
Sbjct: 292 MAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQ-VKI 350
Query: 92 ADFGLA 97
DFG A
Sbjct: 351 IDFGAA 356
|
Length = 507 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 1e-04
Identities = 21/77 (27%), Positives = 30/77 (38%), Gaps = 12/77 (15%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
IV E + G L+ L + + LH GI+H DL N +
Sbjct: 411 KTIVMEYIGGKDLKDVL----------EGNPELVRKVGEIVAKLHKAGIVHGDLTTSNFI 460
Query: 82 LTPDQKSLKLADFGLAR 98
+ D+ L L DFGL +
Sbjct: 461 VRDDR--LYLIDFGLGK 475
|
Length = 535 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 2e-04
Identities = 32/114 (28%), Positives = 42/114 (36%), Gaps = 15/114 (13%)
Query: 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEK 131
HR K N+LLT D LKL + + Y +MAPE+ + +
Sbjct: 34 HRQAKSGNILLTWD-GLLKLDGSVAFKTPE-----QSRPDPY-FMAPEVIQGQSYTE--- 83
Query: 132 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPD 185
K D+YS GI L+E L LP+ L A P D S
Sbjct: 84 -----KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNL 132
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 6e-04
Identities = 19/74 (25%), Positives = 27/74 (36%), Gaps = 10/74 (13%)
Query: 35 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN----------GIIHRDLKPDNLLLTP 84
R L+ L VA +A + L A ++H DL P NLL+ P
Sbjct: 122 RLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPALPLVLVHGDLHPGNLLVDP 181
Query: 85 DQKSLKLADFGLAR 98
+ + DF A
Sbjct: 182 GGRVTGVIDFEDAG 195
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.96 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.84 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.67 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.64 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.63 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.58 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.49 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.48 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.47 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.45 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.45 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.42 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.36 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.21 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.16 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.07 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.03 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.0 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.97 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.9 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.79 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.47 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.19 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.19 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.9 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.83 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.8 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.43 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.28 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.27 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.23 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.2 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.11 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.44 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.34 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.54 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.35 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 95.24 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 95.21 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.19 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 95.19 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.99 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 94.93 | |
| PLN02236 | 344 | choline kinase | 94.48 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.44 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.33 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.3 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 94.29 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.13 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 94.06 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.01 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 93.95 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 93.79 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.41 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.18 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 93.07 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.39 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.37 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 92.09 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 91.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 91.56 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 91.47 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 91.2 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 91.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 90.57 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 90.46 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=308.37 Aligned_cols=204 Identities=30% Similarity=0.513 Sum_probs=178.3
Q ss_pred CCCCCCCCcccceeeeee-cC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKP 77 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~ 77 (268)
+|+.++|||||.+||+|. ++ ...++||||+||+|++++... +.+++....+|+.+++.||.|||+ ++|+||||||
T Consensus 130 il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKP 207 (364)
T KOG0581|consen 130 ILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKP 207 (364)
T ss_pred HHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCH
Confidence 367889999999999984 44 489999999999999999874 679999999999999999999996 8999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+|||++.. +.|||||||.+...... ...+..||..|||||.+.+ ..|+.++||||||++++|+..|+.||
T Consensus 208 sNlLvNsk-GeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g--------~~Ys~~sDIWSLGLsllE~a~GrfP~ 277 (364)
T KOG0581|consen 208 SNLLVNSK-GEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISG--------ESYSVKSDIWSLGLSLLELAIGRFPY 277 (364)
T ss_pred HHeeeccC-CCEEeccccccHHhhhh-hcccccccccccChhhhcC--------CcCCcccceecccHHHHHHhhCCCCC
Confidence 99999954 67999999999876554 5678899999999999965 78999999999999999999999999
Q ss_pred CCC----CcHHHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 158 EGM----SNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 158 ~~~----~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
... ...-+....+..+..+..|.. +++++++++..||++||.+|||+.++++ +.++...
T Consensus 278 ~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~--Hpfi~~~ 341 (364)
T KOG0581|consen 278 PPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ--HPFIKKF 341 (364)
T ss_pred CCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc--CHHHhhc
Confidence 763 344555666667788888887 9999999999999999999999999998 5555443
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=308.89 Aligned_cols=214 Identities=49% Similarity=0.868 Sum_probs=190.4
Q ss_pred CCCCCCCCcccceeeeeecC--CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCC
Q 024401 1 MMSRVKHDNLVKFLGACKDP--LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG-IIHRDLKP 77 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-i~H~dlk~ 77 (268)
+|++++|||||+++|+|.+. .+++||||+++|+|.+++.......+++..++.++.+|+.|++|||+++ |||||||+
T Consensus 92 il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~ 171 (362)
T KOG0192|consen 92 LLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKS 171 (362)
T ss_pred HHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccCh
Confidence 36789999999999999665 4899999999999999998744678999999999999999999999999 99999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
.|||++.+...+||+|||+++..... .......||..|||||++.+. ...++.++||||||+++|||++|+.|
T Consensus 172 ~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~------~~~~~~K~DvySFgIvlWEl~t~~~P 245 (362)
T KOG0192|consen 172 DNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE------KSPYTEKSDVYSFGIVLWELLTGEIP 245 (362)
T ss_pred hhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC------CCcCCccchhhhHHHHHHHHHHCCCC
Confidence 99999966447999999999876554 333446899999999999631 36799999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|.+....+..........++.++..+++.+..++.+||..+|.+||++.+++..|+.+......
T Consensus 246 f~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 246 FEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 9999987777777788999999999999999999999999999999999999999998765544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=310.00 Aligned_cols=209 Identities=27% Similarity=0.390 Sum_probs=175.0
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++|+|||||++++++. .+..|+||||++||.|.+.+.. ++.+.+.....+++|++.|+.|||++||+||||||+|
T Consensus 229 ILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeN 306 (475)
T KOG0615|consen 229 ILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPEN 306 (475)
T ss_pred HHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcce
Confidence 478999999999999995 4467999999999999999986 4668888899999999999999999999999999999
Q ss_pred EEEcCC--CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 80 LLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 80 il~~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||++.+ ...+||+|||+++..+....+.+.+||+.|.|||++.... ...+..+.|+|||||++|-+++|.+||
T Consensus 307 ILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg-----~~~~~~kVDiWSlGcvLfvcLsG~pPF 381 (475)
T KOG0615|consen 307 ILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKG-----VEYYPSKVDIWSLGCVLFVCLSGYPPF 381 (475)
T ss_pred EEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCC-----eecccchheeeeccceEEEEeccCCCc
Confidence 999754 2358999999999998888899999999999999997521 123335889999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 158 EGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.+.............+..... -..++++..+||.+||..||++|||++++++ +.|+...
T Consensus 382 S~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~--hpW~~~~ 443 (475)
T KOG0615|consen 382 SEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN--HPWFKDA 443 (475)
T ss_pred ccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc--Chhhhcc
Confidence 876654433333333333322 2468999999999999999999999999998 6666543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=288.71 Aligned_cols=203 Identities=28% Similarity=0.484 Sum_probs=174.2
Q ss_pred CCCCCCCCcccceeee-e-ecCC-ceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHh--CC--Ce
Q 024401 1 MMSRVKHDNLVKFLGA-C-KDPL-MVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHA--NG--II 71 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~-~-~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~--~~--i~ 71 (268)
+|++|+|||||++++. + .+.. ++||||+|.+|+|...|+..+ .+.+++.++|+++.|++.||..+|. .. |+
T Consensus 71 lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm 150 (375)
T KOG0591|consen 71 LLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM 150 (375)
T ss_pred HHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence 5789999999999994 4 4445 899999999999999998743 3569999999999999999999999 45 99
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
||||||.||+++.+ +.|||+|||+++...... .....+||+.||+||.+.+ ..|++++||||+||++|||
T Consensus 151 HRDIKPaNIFl~~~-gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~--------~~Y~~kSDiWslGCllyEM 221 (375)
T KOG0591|consen 151 HRDIKPANIFLTAN-GVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHE--------SGYNFKSDIWSLGCLLYEM 221 (375)
T ss_pred eccCcchheEEcCC-CceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhc--------CCCCcchhHHHHHHHHHHH
Confidence 99999999999955 579999999999765543 3456789999999999964 7899999999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 151 LTNRLPFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
+.-..||.+. +.......+..+..+++| ..+|.++.++|..|+..||..||+...+++.+..
T Consensus 222 caL~~PF~g~-n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 222 CALQSPFYGD-NLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred HhcCCCcccc-cHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 9999999986 566666667777777788 6789999999999999999999986666655554
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-45 Score=307.01 Aligned_cols=199 Identities=31% Similarity=0.484 Sum_probs=175.4
Q ss_pred CCCCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
-++|+|||||+++++|+|+ ..|+|.|+|..++|..+++. .+.++|.++..++.||+.||.|||+++|+|||||..|+
T Consensus 72 Hr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNl 149 (592)
T KOG0575|consen 72 HRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNL 149 (592)
T ss_pred HHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhe
Confidence 4689999999999999766 79999999999999999985 57799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ ..|||+|||+|..... .....+.+||+.|+|||++.. ...+..+||||+||++|.||.|++||+.
T Consensus 150 fL~~~-~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k--------~gHsfEvDiWSlGcvmYtLL~G~PPFet 220 (592)
T KOG0575|consen 150 FLNEN-MNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNK--------SGHSFEVDIWSLGCVMYTLLVGRPPFET 220 (592)
T ss_pred eecCc-CcEEecccceeeeecCcccccceecCCCcccChhHhcc--------CCCCCchhhhhhhhHHHhhhhCCCCccc
Confidence 99955 4699999999987664 466788899999999999974 6678899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.+- .+.+ ..+......+|..++.+..+||..+|+.+|.+|||+++++. +.++
T Consensus 221 k~v-kety-~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~--h~Ff 272 (592)
T KOG0575|consen 221 KTV-KETY-NKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD--HPFF 272 (592)
T ss_pred chH-HHHH-HHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc--CHhh
Confidence 443 3333 34455667788899999999999999999999999999998 6665
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-45 Score=294.94 Aligned_cols=202 Identities=28% Similarity=0.534 Sum_probs=171.6
Q ss_pred CCCCCCCCcccceeeee--ecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC--KDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~--~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
+|++++|||||+++|.. .++ .+++.|||++||+|.+++.+... ++++..+.+++.|++.||+|||++||+||||||
T Consensus 67 iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~ 145 (313)
T KOG0198|consen 67 ILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKP 145 (313)
T ss_pred HHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCccc
Confidence 47789999999999974 333 58999999999999999998655 799999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcc----cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETV----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
+|||++..++.+||.|||++..... ........||+.|+|||++.. +.....++|||||||++.||+||
T Consensus 146 ~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~-------g~~~~~~sDiWSlGCtVvEM~Tg 218 (313)
T KOG0198|consen 146 ANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN-------GEVARRESDIWSLGCTVVEMLTG 218 (313)
T ss_pred ceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC-------CCcCCccchhhhcCCEEEeccCC
Confidence 9999997456799999999876552 222345689999999999862 12334699999999999999999
Q ss_pred CCCCCC-CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 154 RLPFEG-MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 154 ~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
+.||.. ................|.+|..++.+.++++..|+..+|..||||++++++
T Consensus 219 ~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h 276 (313)
T KOG0198|consen 219 KPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH 276 (313)
T ss_pred CCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence 999987 444455555555556778999999999999999999999999999999983
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-43 Score=291.81 Aligned_cols=207 Identities=37% Similarity=0.642 Sum_probs=181.2
Q ss_pred CCCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++|+|+|||+++++|.. +.++|||||++.|+|.+|++......+...+.+.++.|||+|++||+++++|||||.+.|
T Consensus 254 iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARN 333 (468)
T KOG0197|consen 254 IMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARN 333 (468)
T ss_pred HHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhh
Confidence 4789999999999999965 459999999999999999997556779999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
||++.+ ..+||+|||+++....... .....-...|.|||.+.. ..++.+|||||||+++|||+| |+.|
T Consensus 334 iLV~~~-~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~--------~~FS~kSDVWSFGVlL~E~fT~G~~p 404 (468)
T KOG0197|consen 334 ILVDED-LVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY--------GKFSSKSDVWSFGVLLWELFTYGRVP 404 (468)
T ss_pred eeeccC-ceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh--------CCcccccceeehhhhHHHHhccCCCC
Confidence 999955 5799999999995443332 222344678999999964 789999999999999999999 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
|++.++.+. ......+.+.+.|..+|.++.+++..||..+|++|||++.+...|+.+...
T Consensus 405 y~~msn~ev-~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 405 YPGMSNEEV-LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCHHHH-HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 998887554 455678889999999999999999999999999999999999988887653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=282.58 Aligned_cols=199 Identities=32% Similarity=0.523 Sum_probs=171.3
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|+.++|||||++++++ .++++|+|||||.||+|.+|+.. .+.+++.++..++.||+.||++||+++|+||||||.|
T Consensus 62 iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~--~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQN 139 (429)
T KOG0595|consen 62 ILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRR--RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQN 139 (429)
T ss_pred HHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcce
Confidence 47889999999999998 46689999999999999999987 3479999999999999999999999999999999999
Q ss_pred EEEcCC--C---CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 80 LLLTPD--Q---KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 80 il~~~~--~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||++.. + -.+||.|||+++.........+.+|++.|||||++.. .+|+.|+|+||+|+++|+|++|+
T Consensus 140 iLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~--------~~YdAKADLWSiG~Ilyq~l~g~ 211 (429)
T KOG0595|consen 140 ILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMS--------QQYDAKADLWSIGTILYQCLTGK 211 (429)
T ss_pred EEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHh--------ccccchhhHHHHHHHHHHHHhCC
Confidence 999854 2 3589999999999888877888899999999999953 88999999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 155 LPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.||+..+..+........ ...+..+..++.++++++...+..++.+|-+..+...
T Consensus 212 ~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 212 PPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred CCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 999977765544433322 2334455667888889999999999999988777654
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=286.86 Aligned_cols=198 Identities=27% Similarity=0.449 Sum_probs=173.8
Q ss_pred CCCCC-CCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVK-HDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++|+ ||||+++.+++. +..+|+||||++ .+|+++++.+ ++.|++..+..|+.||++||+|+|++|+.|||+||+
T Consensus 62 L~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPE 139 (538)
T KOG0661|consen 62 LRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPE 139 (538)
T ss_pred HHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChh
Confidence 56788 999999999984 337999999995 5999999984 788999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|||+.. ...+||.|||+++...........+.|.||.|||++. +...|+.+.|+||+|||++|+.+-+..|+
T Consensus 140 NiLi~~-~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLL-------rs~~Ys~pvD~wA~GcI~aEl~sLrPLFP 211 (538)
T KOG0661|consen 140 NILISG-NDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLL-------RSGYYSSPVDMWAVGCIMAELYSLRPLFP 211 (538)
T ss_pred heEecc-cceeEecccccccccccCCCcchhhhcccccchHHhh-------hccccCCchHHHHHHHHHHHHHHhcccCC
Confidence 999984 3569999999999988887778889999999999987 46889999999999999999999999999
Q ss_pred CCCcHHHHHHHHHhhcCCC-----------------C-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPG-----------------L-----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~-----------------~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.++.++.++.+..-..+. + ....+.+..+++.+||++||.+||||+++++
T Consensus 212 G~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 212 GASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred CCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 9999888887654332221 1 1236788999999999999999999999998
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=292.83 Aligned_cols=201 Identities=33% Similarity=0.555 Sum_probs=175.7
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|+..+|+|||++++.| -++.+|.||||++||+|.|.+.. -.+++.++..|+.+++.||+|||.+||+|||||.+|
T Consensus 323 Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~---~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDn 399 (550)
T KOG0578|consen 323 VMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK---TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDN 399 (550)
T ss_pred HHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhc---ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccce
Confidence 46788999999999987 46679999999999999999986 349999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.++ .+||+|||++....... ...+..||+.|||||++.. ..|+++.||||||++++||+.|.+||-
T Consensus 400 ILL~~~g-~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtr--------k~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 400 ILLTMDG-SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTR--------KPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred eEeccCC-cEEEeeeeeeeccccccCccccccCCCCccchhhhhh--------cccCccccchhhhhHHHHHhcCCCCcc
Confidence 9999765 49999999998766544 4566799999999999963 789999999999999999999999999
Q ss_pred CCCcHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 159 GMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
..++....+.....+ .....++.+++.+++|+.+||..|+.+|+++.++|+ +.++
T Consensus 471 nE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~--HpFl 526 (550)
T KOG0578|consen 471 NENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE--HPFL 526 (550)
T ss_pred CCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc--Chhh
Confidence 877777776655433 233456789999999999999999999999999998 4444
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=287.36 Aligned_cols=204 Identities=28% Similarity=0.521 Sum_probs=175.4
Q ss_pred CCCCC-CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++ ||||+++++++. ....++||||+.||+|.+++.+ .+++.+.++..++.|+++|++|+|++||+||||||+|
T Consensus 73 ~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~EN 150 (370)
T KOG0583|consen 73 LRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPEN 150 (370)
T ss_pred HHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHH
Confidence 56777 999999999984 4569999999999999999987 4679999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccC-cccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++.+.+.+||+|||++... .......+..|++.|+|||++.+. ...-..++||||+|+++|.|++|..||.
T Consensus 151 illd~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~------~~Y~g~~aDvWS~GViLy~ml~G~~PF~ 224 (370)
T KOG0583|consen 151 ILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGK------GTYSGKAADVWSLGVILYVLLCGRLPFD 224 (370)
T ss_pred EEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCC------CCcCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 999976467999999999987 466677888999999999999751 1133589999999999999999999999
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCC-cHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+... ...... +......+|..+ +.+++.++.+||..+|.+|+++.+++. +.|+..
T Consensus 225 d~~~-~~l~~k-i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~--h~w~~~ 280 (370)
T KOG0583|consen 225 DSNV-PNLYRK-IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE--HPWFQK 280 (370)
T ss_pred CccH-HHHHHH-HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh--Chhhcc
Confidence 8443 333333 556667788888 999999999999999999999999994 676664
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=285.12 Aligned_cols=195 Identities=28% Similarity=0.475 Sum_probs=167.4
Q ss_pred CCCC-CCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRV-KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|.+| .||.|++|+-.|+|. .+|+|+||+++|+|-++|+.. +.|++..+..++.+|+.||+|||++|||||||||+|
T Consensus 127 l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 127 LTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred HHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 3455 899999999999776 699999999999999999874 679999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc--------------ccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM--------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~--------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
||++.++ .++|+|||.++....... ....+||..|.+||++.. ...++.+|+|+|||
T Consensus 205 ILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--------~~~~~~sDiWAlGC 275 (604)
T KOG0592|consen 205 ILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--------SPAGPSSDLWALGC 275 (604)
T ss_pred eeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC--------CCCCcccchHHHHH
Confidence 9999775 499999999974322111 134689999999999975 77889999999999
Q ss_pred HHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 146 VLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 146 i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|+|+|+.|.+||.+..+-- ..+. +.....+++..+++.+++||++.|..||.+|+++.+|.+
T Consensus 276 ilyQmlaG~PPFra~Neyl-iFqk-I~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 276 ILYQMLAGQPPFRAANEYL-IFQK-IQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHHhcCCCCCccccHHH-HHHH-HHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 9999999999998765422 2222 334567788999999999999999999999999999987
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=274.46 Aligned_cols=197 Identities=31% Similarity=0.488 Sum_probs=169.3
Q ss_pred CCCCCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
||.+++||.||+++-.|++. .+|+|+||+.||.|...+++ .+.|++..+..++..|+.||.|||+.||+||||||+|
T Consensus 78 IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPEN 155 (357)
T KOG0598|consen 78 ILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPEN 155 (357)
T ss_pred HHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 46789999999999999755 79999999999999999985 5779999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++..+ .++|+|||+++..... ....+.+||+.|||||.+.. ..++.++|.||||+++|+|++|..||.
T Consensus 156 ILLd~~G-Hi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~--------~gy~~~vDWWsLGillYeML~G~pPF~ 226 (357)
T KOG0598|consen 156 ILLDEQG-HIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLG--------KGYDKAVDWWSLGILLYEMLTGKPPFY 226 (357)
T ss_pred eeecCCC-cEEEeccccchhcccCCCccccccCCccccChHHHhc--------CCCCcccchHhHHHHHHHHhhCCCCCc
Confidence 9999665 5999999999965543 45566799999999999964 688999999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC----CHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP----SFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp----s~~~~l~ 209 (268)
+.+. ............+..+.-++.+.+++++.+|..+|++|. ++.++.+
T Consensus 227 ~~~~-~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~ 280 (357)
T KOG0598|consen 227 AEDV-KKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKR 280 (357)
T ss_pred CccH-HHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhc
Confidence 7654 333444444445666667999999999999999999995 5666554
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=286.16 Aligned_cols=200 Identities=30% Similarity=0.466 Sum_probs=179.6
Q ss_pred CCCCCCCCcccceeeee-ecCC-ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++++++|||||.+.+.| .++. ++|+|+||+||+|.+.|...+..-|+++.++.|+.|++.|++|||+.+|+|||||+.
T Consensus 56 lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~ 135 (426)
T KOG0589|consen 56 LLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCA 135 (426)
T ss_pred HHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhh
Confidence 46789999999999998 4555 899999999999999999866677999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|||+++++. |+|+|||+++...... ...+..||+.|++||.+.+ ..|..++|||||||++|||++-+.+|
T Consensus 136 Nifltk~~~-VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d--------~pYn~KSDiWsLGC~~yEm~~lk~aF 206 (426)
T KOG0589|consen 136 NIFLTKDKK-VKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSD--------IPYNEKSDIWSLGCCLYEMCTLKPAF 206 (426)
T ss_pred hhhccccCc-eeecchhhhhhcCCchhhhheecCCCcccCHHHhCC--------CCCCccCcchhhcchHHHHHhccccc
Confidence 999998876 7999999999877765 6678899999999999965 78999999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
...+. .............+.+..++.+++.+|..|++.+|..||++.+++..
T Consensus 207 ~a~~m-~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 207 KASNM-SELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Cccch-HHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 87654 44444555566788899999999999999999999999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=284.95 Aligned_cols=203 Identities=30% Similarity=0.510 Sum_probs=178.2
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
||+-|.||||+++|++|. ..++|+|.||++||-|.+|+.. .+++++.++.+++.||+.|+.|+|..+|+|||+||+|
T Consensus 65 iMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpEN 142 (786)
T KOG0588|consen 65 IMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPEN 142 (786)
T ss_pred HHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchh
Confidence 477889999999999995 4579999999999999999986 4679999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+|++..+. +||.|||++.....+....+.+|.+.|.+||.+.+ ....+.++||||-|+|+|.|++|+.||++
T Consensus 143 lLLd~~~n-IKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G-------~pYdG~~sDVWSCGVILfALLtG~LPFdD 214 (786)
T KOG0588|consen 143 LLLDVKNN-IKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSG-------RPYDGRPSDVWSCGVILFALLTGKLPFDD 214 (786)
T ss_pred hhhhcccC-EeeeccceeecccCCccccccCCCcccCCchhhcC-------CCCCCCccccchhHHHHHHHHhCCCCCCC
Confidence 99997665 99999999998877777888899999999999975 24456899999999999999999999984
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
++....... .......+|..++.++++|+.+|+..||..|.|.++|++ +.++..
T Consensus 215 -dNir~LLlK-V~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k--HP~l~g 268 (786)
T KOG0588|consen 215 -DNIRVLLLK-VQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILK--HPFLSG 268 (786)
T ss_pred -ccHHHHHHH-HHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhh--Cchhhc
Confidence 454544443 345566788999999999999999999999999999999 555433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=272.61 Aligned_cols=201 Identities=29% Similarity=0.494 Sum_probs=169.1
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||++++..| -+..+|+||.|+.+|++.++++..-..++++..+..|+++++.||.|||.+|.+|||||+.||
T Consensus 78 msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnI 157 (516)
T KOG0582|consen 78 MSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNI 157 (516)
T ss_pred hhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccE
Confidence 6789999999999998 566899999999999999999987777899999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-ccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
|++.+ +.|+|+|||.+..... +.. .....|+++|+|||++.. ....|+.|+||||||++..||.+|..
T Consensus 158 Li~~d-G~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q------~~~GYdfKaDIwSfGITA~ELA~G~a 230 (516)
T KOG0582|consen 158 LIDSD-GTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQ------QLHGYDFKADIWSFGITACELAHGHA 230 (516)
T ss_pred EEcCC-CcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhh------cccCccchhhhhhhhHHHHHHhcCCC
Confidence 99965 5699999998753322 111 145689999999999532 34778999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCC--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 156 PFEGMSNLQAAYAAAFKHARP--------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
||....+.+............ .....++..+++++..||.+||.+|||++++++
T Consensus 231 Pf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 231 PFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 999888777665544332211 111236778999999999999999999999998
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=277.96 Aligned_cols=206 Identities=31% Similarity=0.599 Sum_probs=167.3
Q ss_pred CCCC-CCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhC------------------------------------
Q 024401 2 MSRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR------------------------------------ 42 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------ 42 (268)
|+.+ +||||+++++++. ++..+++|||+++|+|.+++....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (338)
T cd05102 64 LIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQAS 143 (338)
T ss_pred HHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCC
Confidence 3456 8999999999884 345889999999999999997521
Q ss_pred ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 43 ------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 43 ------------------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
...+++.++..++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||+++
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~-~~~kl~DfG~a~ 222 (338)
T cd05102 144 VLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLAR 222 (338)
T ss_pred ccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCC-CcEEEeeccccc
Confidence 1347888999999999999999999999999999999999955 569999999997
Q ss_pred cCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhc
Q 024401 99 EETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHA 174 (268)
Q Consensus 99 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~ 174 (268)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+...............
T Consensus 223 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~ 294 (338)
T cd05102 223 DIYKDPDYVRKGSARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGT 294 (338)
T ss_pred ccccCcchhcccCCCCCccccCcHHhhc--------CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCC
Confidence 543221 1122345678999998853 567889999999999999997 9999987654444444444445
Q ss_pred CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 175 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
....+..++..+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 295 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 295 RMRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 555667889999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=283.78 Aligned_cols=203 Identities=30% Similarity=0.597 Sum_probs=178.9
Q ss_pred CCCCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++|+||||+.|.|+|... -+|||||||..|-|...++. ...++......|..+|+.|++|||.+.|+|||||.-||
T Consensus 166 LRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNi 243 (904)
T KOG4721|consen 166 LRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNI 243 (904)
T ss_pred HHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCce
Confidence 6789999999999999654 57899999999999999987 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
||+.+ ..|||+|||-++..........+.||..|||||++. +...++|.||||||+++|||+||..||.+.
T Consensus 244 LIs~~-d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIr--------nePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 244 LISYD-DVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIR--------NEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred Eeecc-ceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhh--------cCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 99965 569999999999877777777789999999999995 478899999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
+.....+..-......+.|..+++.+.-|+++||+-.|..|||+.+++.+|.-+-
T Consensus 315 dssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 315 DSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred chheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 6544444333344556788899999999999999999999999999999997654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=269.30 Aligned_cols=204 Identities=24% Similarity=0.388 Sum_probs=169.6
Q ss_pred CCCCCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecC
Q 024401 1 MMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRD 74 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~d 74 (268)
+|++++||||+++++++.+ ...++||||++||+|.+++.. ...+++...+.++.+++.||+|||+. +++|||
T Consensus 71 ~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrd 148 (283)
T PHA02988 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKN 148 (283)
T ss_pred HHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCc
Confidence 3678999999999998744 357899999999999999976 35689999999999999999999984 999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ....++.++||||||+++|+|++|.
T Consensus 149 lkp~nill~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~k~Di~SlGvil~el~~g~ 219 (283)
T PHA02988 149 LTSVSFLVTEN-YKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLND------IFSEYTIKDDIYSLGVVLWEIFTGK 219 (283)
T ss_pred CChhhEEECCC-CcEEEcccchHhhhccc--cccccCcccccCHHHhhh------ccccccchhhhhHHHHHHHHHHHCC
Confidence 99999999965 56999999998754322 123467889999998853 1246789999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.||.+.+..+...........+..+..++..+.+++.+||+.+|++|||+.++++.|+.+.
T Consensus 220 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 220 IPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 9998766544333333344555666678999999999999999999999999999998864
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=262.37 Aligned_cols=199 Identities=29% Similarity=0.462 Sum_probs=165.8
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
||++++|||+|.++++|. ...+++|+|||+. ++-+-+... +.+++.+.+..+++|++.|+.|+|+++++||||||+|
T Consensus 54 mLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPEN 131 (396)
T KOG0593|consen 54 MLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERY-PNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPEN 131 (396)
T ss_pred HHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhc-cCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhh
Confidence 578999999999999994 5579999999977 555555543 4679999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.+ +.+||||||.++... .+........|.||.|||.+.+ ...|+...||||+||++.||++|..-|+
T Consensus 132 ILit~~-gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvG-------DtqYG~pVDiWAiGCv~aEl~~G~pL~P 203 (396)
T KOG0593|consen 132 ILITQN-GVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVG-------DTQYGKPVDIWAIGCVFAELLTGEPLWP 203 (396)
T ss_pred eEEecC-CcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcc-------cCcCCCcccchhhhHHHHHHhcCCcCCC
Confidence 999966 569999999999766 4444555678999999999974 4678899999999999999999999999
Q ss_pred CCCcHHHHHHHHHhhcC-------------------CCCC----------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHAR-------------------PGLP----------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~-------------------~~~~----------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.++.+..+.+...-.. .+.+ ..++..+.++++.||..||.+|++-++++.
T Consensus 204 G~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 204 GRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 99988877665432111 0111 135567899999999999999999999986
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=264.71 Aligned_cols=212 Identities=27% Similarity=0.422 Sum_probs=178.1
Q ss_pred CCCCCCCCcccceeeeee---cC---CceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 1 MMSRVKHDNLVKFLGACK---DP---LMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~---~~---~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
+|+.++|||||++..+|. ++ ...+||||++. +|.++++.. .+..++.-.+.-+.+||+.||+|||+.||+|
T Consensus 70 im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcH 148 (364)
T KOG0658|consen 70 IMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICH 148 (364)
T ss_pred HHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCccc
Confidence 367889999999999872 22 35699999955 999999842 2466899999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|||||.|+|+|.+.+.+||||||.++....+........+..|.|||.+.+ ...|+.+.||||.||++.||+.
T Consensus 149 RDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifg-------a~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 149 RDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred CCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcC-------ccccCceeEEhhhhHHHHHHhc
Confidence 999999999999999999999999998877777778889999999999985 4789999999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCC---------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHARPG---------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
|+.-|.+.+..+........-..+. +....++++.+|+.++|.++|.+|.++.
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 9999998777665554432211110 2345688999999999999999999999
Q ss_pred HHHHHHHhhhhhcCCCC
Q 024401 206 QIIRMLNAFLFTLRPPS 222 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~~~ 222 (268)
+++. +.++..++.+.
T Consensus 302 ~~l~--h~fFdelr~~~ 316 (364)
T KOG0658|consen 302 EALA--HPFFDELRDPN 316 (364)
T ss_pred HHhc--chhhHHhhCcC
Confidence 9998 77777777663
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=253.60 Aligned_cols=186 Identities=31% Similarity=0.485 Sum_probs=164.7
Q ss_pred CCCCCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|+.+.||.++++++.+.|. .+|+||||++||-|..+++. .++|++..+..++.||+.||+|||..+|++||+||+|
T Consensus 97 vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk--~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPEN 174 (355)
T KOG0616|consen 97 VLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRK--SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPEN 174 (355)
T ss_pred HHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHh--cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHH
Confidence 47888999999999999655 79999999999999999986 4679999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
||+|+++ .+||+|||.++..... .-+.+||+.|+|||.+.. ..+..++|-||||+++|||+.|..||.+
T Consensus 175 iLlD~~G-~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~s--------k~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 175 LLLDQNG-HIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQS--------KGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred eeeccCC-cEEEEeccceEEecCc--EEEecCCccccChHHhhc--------CCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 9999775 5999999999876544 567799999999999965 7788899999999999999999999998
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 201 (268)
....+.... +-.....+|.-++.++++|+..+|+.|-.+|
T Consensus 244 ~~~~~iY~K--I~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 244 DNPIQIYEK--ILEGKVKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CChHHHHHH--HHhCcccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 776444333 3345567788999999999999999999999
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=265.69 Aligned_cols=199 Identities=22% Similarity=0.377 Sum_probs=164.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++||||+++|+|.+++.......+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 54 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05631 54 LEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENI 133 (285)
T ss_pred HHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence 56789999999999884 55789999999999999988764556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 134 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~pf~~~ 204 (285)
T cd05631 134 LLDDR-GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINN--------EKYTFSPDWWGLGCLIYEMIQGQSPFRKR 204 (285)
T ss_pred EECCC-CCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcC--------CCCCcccCchhHHHHHHHHHhCCCCCCCC
Confidence 99855 4699999999876543333345578999999999854 56788999999999999999999999865
Q ss_pred CcHH--HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 161 SNLQ--AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 161 ~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
.... .............++..++.++.+|+.+||..+|.+||+ ++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 205 KERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 4322 122222233444566789999999999999999999997 788887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=268.25 Aligned_cols=203 Identities=24% Similarity=0.370 Sum_probs=169.3
Q ss_pred CCCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 1 MMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
||++|.||||+++.+...+ +.+|+|+||+++ +|.-++.+ ..-.|++.++..++.||+.||+|+|.+||+|||||.
T Consensus 169 ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~ 246 (560)
T KOG0600|consen 169 ILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKG 246 (560)
T ss_pred HHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccc
Confidence 5789999999999998632 479999999977 99988875 456799999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
+||||| +++.+||.|||+++.+.... .....+.|.||.|||++.+ ...|+.+.|+||.|||+.||+.|++
T Consensus 247 SNiLid-n~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG-------~t~Yg~aVDlWS~GCIl~El~~gkP 318 (560)
T KOG0600|consen 247 SNILID-NNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLG-------ATSYGTAVDLWSVGCILAELFLGKP 318 (560)
T ss_pred cceEEc-CCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcC-------CcccccceeehhhhHHHHHHHcCCC
Confidence 999999 55679999999999655433 3455678999999999985 4789999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCC--------CC-------------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 024401 156 PFEGMSNLQAAYAAAFKHARP--------GL-------------------PEDISPDLAFIVQSCWVEDPNLRPSFSQII 208 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~--------~~-------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l 208 (268)
.|.+.++.+....+.....-+ .+ ...++....+|+..+|..||.+|.||.+++
T Consensus 319 I~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL 398 (560)
T KOG0600|consen 319 ILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSAL 398 (560)
T ss_pred CcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHh
Confidence 999988776655443221111 01 134678899999999999999999999998
Q ss_pred HHHHhhh
Q 024401 209 RMLNAFL 215 (268)
Q Consensus 209 ~~l~~~~ 215 (268)
+ ..++
T Consensus 399 ~--seyF 403 (560)
T KOG0600|consen 399 Q--SEYF 403 (560)
T ss_pred c--Cccc
Confidence 7 5555
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=271.86 Aligned_cols=195 Identities=25% Similarity=0.409 Sum_probs=163.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++||||++|++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NI 126 (323)
T cd05571 49 LQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENL 126 (323)
T ss_pred HHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHE
Confidence 56789999999999884 5578999999999999999875 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 127 ll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~ 197 (323)
T cd05571 127 MLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred EECCC-CCEEEeeCCCCcccccCCCcccceecCccccChhhhcC--------CCCCccccCcccchhhhhhhcCCCCCCC
Confidence 99965 4599999999875322 222334568999999999853 5678899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.+...... ........++..++.++.+++.+||..||++|| ++.++++
T Consensus 198 ~~~~~~~~--~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 198 QDHEKLFE--LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCHHHHHH--HHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 55433222 233344567788999999999999999999999 7999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=266.82 Aligned_cols=202 Identities=26% Similarity=0.412 Sum_probs=161.2
Q ss_pred CCCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 1 MMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
+|++|.|||||+++++.. .+.+|+|+|||..|.+...- .++. +++.++++|+..++.||+|||.+||+|||||
T Consensus 161 ilKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIK 237 (576)
T KOG0585|consen 161 ILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIK 237 (576)
T ss_pred HHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccc
Confidence 478999999999999984 34799999999888876532 2344 9999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCc------ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREET------VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
|+|+|++.+ +.|||+|||.+.... .........||+.|+|||++.+.. .....+.+.||||+|+++|.|
T Consensus 238 PsNLLl~~~-g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~----~~~~~g~a~DiWalGVTLYCl 312 (576)
T KOG0585|consen 238 PSNLLLSSD-GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGN----SFSYSGFALDIWALGVTLYCL 312 (576)
T ss_pred hhheEEcCC-CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCC----CccccchhhhhhhhhhhHHHh
Confidence 999999966 569999999987442 222223358999999999886511 124456789999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 151 LTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
+.|+.||-+.........+ ......+| ..+...+++||.+||.+||++|.+..+|..+..
T Consensus 313 lfG~~PF~~~~~~~l~~KI--vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 313 LFGQLPFFDDFELELFDKI--VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred hhccCCcccchHHHHHHHH--hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 9999999865443333332 23334444 357899999999999999999999999987443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=272.28 Aligned_cols=199 Identities=32% Similarity=0.506 Sum_probs=170.6
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|++.++||||++++++|+ ..++|+|+||+.| +|..++.. ++.++++.+..++.++++||.|||+.+|+|+|+||.|
T Consensus 54 i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqn 130 (808)
T KOG0597|consen 54 ILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQN 130 (808)
T ss_pred HHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcce
Confidence 467899999999999995 6689999999966 99999975 6789999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccc-cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||+.+. +.+|+||||+++........ ....||+.|||||++.+ +.|+..+|+|||||++||++.|++||.
T Consensus 131 iLl~~~-~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e--------~pyd~~sDlWslGcilYE~~~G~PPF~ 201 (808)
T KOG0597|consen 131 ILLEKG-GTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE--------QPYDHTSDLWSLGCILYELYVGQPPFY 201 (808)
T ss_pred eeecCC-CceeechhhhhhhcccCceeeeeccCcccccCHHHHcC--------CCccchhhHHHHHHHHHHHhcCCCCch
Confidence 999955 56999999999987765443 44579999999999954 889999999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
..+-.+. . ..+.......|...+..+..++...|.+||.+|.++.+++. +.++
T Consensus 202 a~si~~L-v-~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~--HpF~ 254 (808)
T KOG0597|consen 202 ARSITQL-V-KSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG--HPFW 254 (808)
T ss_pred HHHHHHH-H-HHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc--ChHH
Confidence 6443222 2 23344455566789999999999999999999999999988 4444
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=255.79 Aligned_cols=203 Identities=33% Similarity=0.593 Sum_probs=168.7
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++ .++..+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~ni 135 (263)
T cd05052 56 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 135 (263)
T ss_pred HHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceE
Confidence 5678999999999998 466789999999999999999765556689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccccc--CccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+.......... ....+..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 136 l~~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~ 206 (263)
T cd05052 136 LVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPY 206 (263)
T ss_pred EEcCC-CcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 99855 569999999987654332211 2233567999998753 567889999999999999998 89999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.+.+. ...............+..++.++.+++.+||..+|++||++.++++.|+.+
T Consensus 207 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 207 PGIDL-SQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 76543 344444444455667788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=259.52 Aligned_cols=199 Identities=24% Similarity=0.408 Sum_probs=170.2
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|+.|+||||+.++++|+ .+..+|||||..+|.|+||+... +.+++.++..++.||++|+.|+|.++++|||||.+|
T Consensus 106 IMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLEN 183 (668)
T KOG0611|consen 106 IMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLEN 183 (668)
T ss_pred HHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhh
Confidence 478899999999999995 55789999999999999999873 569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
||++.++ .+||.|||++..+.......+++|++-|.+||.+++ ...-.+..|.||||+++|.|+.|..||++
T Consensus 184 ILLD~N~-NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG-------~PY~GPEVDsWsLGvLLYtLVyGtMPFDG 255 (668)
T KOG0611|consen 184 ILLDQNN-NIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNG-------TPYKGPEVDSWSLGVLLYTLVYGTMPFDG 255 (668)
T ss_pred eeecCCC-CeeeeccchhhhhccccHHHHhcCCcccCCccccCC-------CCCCCCccchhhHHHHHHHHhhcccccCC
Confidence 9999665 599999999998888888888999999999999986 23446789999999999999999999998
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
.+......++.....+. ..-+.+..-||++||..||++|.|+++|..+.+
T Consensus 256 ~Dhk~lvrQIs~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 256 RDHKRLVRQISRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred chHHHHHHHhhcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 77544333332222221 235667888999999999999999999987544
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=243.63 Aligned_cols=210 Identities=27% Similarity=0.407 Sum_probs=174.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+.++++|. .+.+.+|+||++. +|...++. ....++...+..++.+++.||+|||++.|+||||||.|+
T Consensus 55 Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL 132 (318)
T KOG0659|consen 55 LQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL 132 (318)
T ss_pred HHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence 67889999999999994 5578899999955 99999987 567799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc-cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ +.+||.|||+++........ .....|.+|.|||.+.+ ...|+...|+||.|||+.||+.|.+-|.+
T Consensus 133 Lis~~-g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfG-------sr~Yg~~VDmWavGCI~AELllr~P~fpG 204 (318)
T KOG0659|consen 133 LISSD-GQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFG-------SRQYGTGVDMWAVGCIFAELLLRVPFFPG 204 (318)
T ss_pred EEcCC-CcEEeecccchhccCCCCcccccceeeeeccChHHhcc-------chhcCCcchhhhHHHHHHHHHccCCCCCC
Confidence 99965 56999999999977654433 23378999999999985 57889999999999999999999999998
Q ss_pred CCcHHHHHHHHHhhcCC------C--------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 160 MSNLQAAYAAAFKHARP------G--------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~------~--------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
.++.+........-.-+ . .....+.++.+|+..|+..||.+|.++.++++ +.
T Consensus 205 ~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~--~~ 282 (318)
T KOG0659|consen 205 DSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK--HP 282 (318)
T ss_pred CchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc--ch
Confidence 88877665543221111 0 11234677899999999999999999999998 77
Q ss_pred hhhhcCCCCC
Q 024401 214 FLFTLRPPSP 223 (268)
Q Consensus 214 ~~~~~~~~~~ 223 (268)
++.+.+.+.+
T Consensus 283 yf~~~P~pt~ 292 (318)
T KOG0659|consen 283 YFKSLPLPTP 292 (318)
T ss_pred hhhcCCCCCC
Confidence 7777555444
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=266.93 Aligned_cols=195 Identities=25% Similarity=0.392 Sum_probs=161.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 47 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Ni 124 (312)
T cd05585 47 LAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENI 124 (312)
T ss_pred HHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHe
Confidence 56789999999999884 5578999999999999999975 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+
T Consensus 125 li~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~tg~~pf~~ 195 (312)
T cd05585 125 LLDYQ-GHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLG--------HGYTKAVDWWTLGVLLYEMLTGLPPFYD 195 (312)
T ss_pred EECCC-CcEEEEECcccccCccCCCccccccCCcccCCHHHHcC--------CCCCCccceechhHHHHHHHhCCCCcCC
Confidence 99855 4699999999875322 222334568999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC---HHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS---FSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~~l~ 209 (268)
.+.... ... .......++..++.++.+++.+||..+|.+||+ +.++++
T Consensus 196 ~~~~~~-~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 196 ENVNEM-YRK-ILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHH-HHH-HHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 554332 222 233455677889999999999999999999986 455554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=255.18 Aligned_cols=202 Identities=25% Similarity=0.491 Sum_probs=167.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
++.+.||||+++++++.+...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||||.||+
T Consensus 50 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nil 127 (257)
T cd05116 50 MQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVL 127 (257)
T ss_pred HHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEE
Confidence 567899999999999987788999999999999999975 356999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ ..++|+|||++........ .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..|
T Consensus 128 l~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p 198 (257)
T cd05116 128 LVTQ-HYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY--------YKFSSKSDVWSFGVLMWEAFSYGQKP 198 (257)
T ss_pred EcCC-CeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCC
Confidence 9965 5699999999875433221 112233578999998753 567789999999999999998 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
|....... ..........+..+..++.++.+++.+||+.+|++||++.+|.+.|++++
T Consensus 199 ~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05116 199 YKGMKGNE-VTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNYY 256 (257)
T ss_pred CCCCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhccc
Confidence 98765433 33333344456677889999999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=279.14 Aligned_cols=208 Identities=29% Similarity=0.569 Sum_probs=178.6
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCC--------C----CCCHHHHHHHHHHHHHHHHHHHh
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP--------N----KLDLHVALNFALDIARAMDCLHA 67 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~--------~----~~~~~~~~~i~~ql~~~l~~lH~ 67 (268)
+|..++|||||+++|+| .++..++|+||+..|+|.+|+....+ . +++..+.+.|+.||+.|+.||-+
T Consensus 542 Lla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~ 621 (774)
T KOG1026|consen 542 LLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS 621 (774)
T ss_pred HHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 35689999999999999 45679999999999999999976332 2 27889999999999999999999
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccccc---CccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT---AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
+.+|||||-..|+||+ ++..|||+|||+++..-...... ...-..+||+||.+.- ++|+.++||||+|
T Consensus 622 ~~FVHRDLATRNCLVg-e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly--------~kFTteSDVWs~G 692 (774)
T KOG1026|consen 622 HHFVHRDLATRNCLVG-ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY--------GKFTTESDVWSFG 692 (774)
T ss_pred Ccccccchhhhhceec-cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc--------Ccccchhhhhhhh
Confidence 9999999999999999 55679999999998644332221 2244678999999964 8999999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 145 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 145 ~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+++||+++ |+.||.+.++.+......... ..+.|+++|.++.+|+..||..+|.+||++++|-..|+.+....
T Consensus 693 VvLWEIFsyG~QPy~glSn~EVIe~i~~g~-lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 693 VVLWEIFSYGKQPYYGLSNQEVIECIRAGQ-LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred hhhhhhhccccCcccccchHHHHHHHHcCC-cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 99999999 999999999877766555444 48889999999999999999999999999999999999877543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=277.81 Aligned_cols=198 Identities=27% Similarity=0.460 Sum_probs=164.3
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|+.++||||+++++.+ .++..|+||||++||+|.+++... ....+++.++..++.|++.||+|||+.||+||||||+
T Consensus 119 l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~ 198 (478)
T PTZ00267 119 LAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSA 198 (478)
T ss_pred HHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHH
Confidence 5789999999999998 456799999999999999988642 2346899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
||+++.+ +.++|+|||++....... ......|++.|+|||.+.. ..++.++|||||||++|+|++|..
T Consensus 199 NIll~~~-~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~el~tg~~ 269 (478)
T PTZ00267 199 NIFLMPT-GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER--------KRYSKKADMWSLGVILYELLTLHR 269 (478)
T ss_pred hEEECCC-CcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC--------CCCCcHHhHHHHHHHHHHHHhCCC
Confidence 9999965 569999999997543321 1234468999999998853 567889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
||...+.... ..........+.+..++.++.+++.+||..+|++||++++++.
T Consensus 270 Pf~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 270 PFKGPSQREI-MQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCCHHHH-HHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 9986554333 2333334444566778999999999999999999999999875
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=249.51 Aligned_cols=198 Identities=25% Similarity=0.403 Sum_probs=168.0
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
..||||+.+.++++ +.++++|+|.++.|-|.||+.+ .-.+++.+..+|+.|+++|+.|||..+||||||||+|||++
T Consensus 80 ~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILld 157 (411)
T KOG0599|consen 80 MGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLD 157 (411)
T ss_pred cCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeec
Confidence 36999999999995 6689999999999999999987 45699999999999999999999999999999999999999
Q ss_pred CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 84 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
++..++|+|||.+.....+......+||++|+|||.+.+.- ......|+...|+|+.|+|+|.|+.|..||......
T Consensus 158 -dn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m--~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm 234 (411)
T KOG0599|consen 158 -DNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSM--YENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM 234 (411)
T ss_pred -cccceEEeccceeeccCCchhHHHhcCCCcccChhheeeec--ccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH
Confidence 55679999999999888888778889999999999886532 223467788999999999999999999999854432
Q ss_pred HHHHHHHHhhcCCC----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 164 QAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 164 ~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
-. ...+...... .-.+++.+..+||.+||+.||.+|.|+++++.
T Consensus 235 lM--LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 235 LM--LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HH--HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 22 2233222222 23578999999999999999999999999998
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=270.90 Aligned_cols=211 Identities=32% Similarity=0.572 Sum_probs=182.7
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++|||||+++|++ .+..+++|||+|.||+|.+|++..+ ..++..+..+++.+.+.||+|||+.+++||||-..|
T Consensus 214 vMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN 292 (474)
T KOG0194|consen 214 VMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN 292 (474)
T ss_pred HHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence 46789999999999998 4557999999999999999999743 369999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccccc-CccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMT-AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+|++.+ ..+||+|||+++......... ...-...|+|||.+.. ..++.++||||||+++||+++ |..||
T Consensus 293 cL~~~~-~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~--------~~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 293 CLYSKK-GVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT--------GIFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred heecCC-CeEEeCccccccCCcceeeccccccCcceecChhhhcc--------CccccccchhheeeeEEeeeccCCCCC
Confidence 999955 448999999998654322222 2235678999999964 689999999999999999999 88899
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
.+....+..........+...+...+.++..++.+||..+|++||++.++.+.|+.+.......
T Consensus 364 ~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred CCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 9988877666666778888888999999999999999999999999999999999988766543
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=254.71 Aligned_cols=203 Identities=23% Similarity=0.553 Sum_probs=168.0
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++.+.....++||||+++++|.+++.. ....+++..+++++.|++.||+|||++|++|+||||+||+
T Consensus 49 l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil 127 (257)
T cd05115 49 MHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVL 127 (257)
T ss_pred HHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEE
Confidence 567899999999999977788999999999999999875 2356999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ ..++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|++++ |..|
T Consensus 128 ~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p 198 (257)
T cd05115 128 LVNQ-HYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGITMWEAFSYGQKP 198 (257)
T ss_pred EcCC-CcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHcc--------CCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 9855 5699999999874432211 111223567999998753 557889999999999999996 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
|....... .............+...+.++.+++.+||..+|++||++.++.+.|+.++
T Consensus 199 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~ 256 (257)
T cd05115 199 YKKMKGPE-VMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY 256 (257)
T ss_pred cCcCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence 98765433 33334445556677788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=266.50 Aligned_cols=195 Identities=25% Similarity=0.415 Sum_probs=161.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++||||+++++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 49 l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI 126 (323)
T cd05595 49 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 126 (323)
T ss_pred HHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 56789999999999884 5578999999999999998875 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 127 ll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~g~~Pf~~ 197 (323)
T cd05595 127 MLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (323)
T ss_pred EEcCC-CCEEecccHHhccccCCCCccccccCCcCcCCcccccC--------CCCCchhchhhhHHHHHHHHhCCCCCCC
Confidence 99955 5699999998875322 222234568999999999853 5678899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.+....... .......++..+++++.+++.+||..+|.+|+ ++.++++
T Consensus 198 ~~~~~~~~~--~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 198 QDHERLFEL--ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCHHHHHHH--HhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 654332222 22234456778999999999999999999998 8888887
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=269.59 Aligned_cols=205 Identities=32% Similarity=0.560 Sum_probs=165.3
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-------------------------------------
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------------------------------- 42 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------- 42 (268)
++.+ +||||+++++++. .+..++||||+++|+|.+++....
T Consensus 95 l~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (374)
T cd05106 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS 174 (374)
T ss_pred HHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence 4566 8999999999984 457899999999999999985421
Q ss_pred -------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEE
Q 024401 43 -------------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL 91 (268)
Q Consensus 43 -------------------------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l 91 (268)
...+++.++++++.|++.||+|||+.|++||||||+||+++.+ ..++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~-~~~kL 253 (374)
T cd05106 175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDG-RVAKI 253 (374)
T ss_pred ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCC-CeEEE
Confidence 1247888999999999999999999999999999999999954 56999
Q ss_pred eccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 024401 92 ADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 167 (268)
Q Consensus 92 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~ 167 (268)
+|||++........ .....++..|+|||.+.. ..++.++||||||+++|+|++ |+.||..........
T Consensus 254 ~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~ 325 (374)
T cd05106 254 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFY 325 (374)
T ss_pred eeceeeeeccCCcceeeccCCCCccceeCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHH
Confidence 99999875432211 112234567999998853 567889999999999999997 999998765544443
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 168 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
...........+..++.++.+++.+||+.+|.+|||+.++++.|+.++
T Consensus 326 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 326 KMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 443344455566678899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=266.43 Aligned_cols=196 Identities=27% Similarity=0.434 Sum_probs=162.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++.+. ++..++||||+++++|.+++.. ...+++.++..++.||+.||+|||+.||+||||||+||
T Consensus 49 l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI 126 (328)
T cd05593 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENL 126 (328)
T ss_pred HHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHe
Confidence 56789999999999885 5578999999999999998875 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 127 ll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~Pf~~ 197 (328)
T cd05593 127 MLDKD-GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYN 197 (328)
T ss_pred EECCC-CcEEEecCcCCccCCCcccccccccCCcCccChhhhcC--------CCCCccCCccccchHHHHHhhCCCCCCC
Confidence 99955 5699999999875322 222334568999999999853 5678899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 210 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~~ 210 (268)
.+...... ........++..++.++.+++.+||..+|.+|+ ++.+++++
T Consensus 198 ~~~~~~~~--~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 198 QDHEKLFE--LILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCHHHHHH--HhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 55433222 222344566788999999999999999999997 89999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=258.01 Aligned_cols=203 Identities=31% Similarity=0.569 Sum_probs=167.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
+++++||||+++++++. ++..+++|||+++++|.+++..... ..+++.+++.++.|++.||+|||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH 141 (283)
T cd05048 62 MSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS 141 (283)
T ss_pred HHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999984 4578999999999999999975321 45889999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
+.|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++|||||
T Consensus 142 ~~~i~H~dlkp~Nil~~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDv~sl 212 (283)
T cd05048 142 SHHFVHRDLAARNCLVGEG-LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY--------GKFTTESDIWSF 212 (283)
T ss_pred hCCeeccccccceEEEcCC-CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc--------CcCchhhhHHHH
Confidence 9999999999999999955 569999999987543221 1223355778999998753 567889999999
Q ss_pred HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 144 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 144 G~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
||++|+|++ |..||.+....+ .............+..++.++.+++.+||+.+|.+||++.++++.|+++
T Consensus 213 G~il~el~~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 213 GVVLWEIFSYGLQPYYGFSNQE-VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHHH-HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 999999998 999998765533 3333444455566778999999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=263.19 Aligned_cols=193 Identities=25% Similarity=0.425 Sum_probs=161.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NI 132 (291)
T cd05612 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI 132 (291)
T ss_pred HHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 57889999999999874 4578999999999999999976 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 133 li~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~~l~~g~~pf~~~ 201 (291)
T cd05612 133 LLDKE-GHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQS--------KGHNKAVDWWALGILIYEMLVGYPPFFDD 201 (291)
T ss_pred EECCC-CCEEEEecCcchhccCC--cccccCChhhcCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99855 46999999998754322 223468899999998853 55688999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
...... . ........++..++..+++++.+||+.||.+|++ ++++++
T Consensus 202 ~~~~~~-~-~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 202 NPFGIY-E-KILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CHHHHH-H-HHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 543322 2 2233445667788999999999999999999995 888887
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=268.14 Aligned_cols=204 Identities=33% Similarity=0.539 Sum_probs=164.7
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-------------------------------------
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------------------------------- 42 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------- 42 (268)
|+.+ +||||+++++++. .+..++||||++||+|.+++....
T Consensus 92 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (375)
T cd05104 92 LSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM 171 (375)
T ss_pred HHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence 3456 7999999999984 557899999999999999986421
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCC
Q 024401 43 ------------------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ 86 (268)
Q Consensus 43 ------------------------------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~ 86 (268)
...+++..+..++.|++.||+|||+.|++||||||+||+++.+
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~- 250 (375)
T cd05104 172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG- 250 (375)
T ss_pred CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECC-
Confidence 1247888999999999999999999999999999999999954
Q ss_pred CceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCCCc
Q 024401 87 KSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSN 162 (268)
Q Consensus 87 ~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~ 162 (268)
..++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.....
T Consensus 251 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~ 322 (375)
T cd05104 251 RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSSPYPGMPV 322 (375)
T ss_pred CcEEEecCccceeccCcccccccCCCCCCcceeChhHhcC--------CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc
Confidence 5699999999875433221 112234567999998854 567889999999999999998 8899987655
Q ss_pred HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
................+...+.++.+++.+||..+|++|||+.++++.|+..
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 323 DSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred hHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 4444444444444555667789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=254.64 Aligned_cols=202 Identities=26% Similarity=0.474 Sum_probs=165.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 60 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~ni 138 (266)
T cd05064 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKV 138 (266)
T ss_pred HhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhE
Confidence 56789999999999974 55799999999999999999763 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++++|||.+........ .....++..|+|||.+.. ..++.++|||||||++|++++ |..||
T Consensus 139 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~p~ 209 (266)
T cd05064 139 LVNSD-LVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY--------HHFSSASDVWSFGIVMWEVMSYGERPY 209 (266)
T ss_pred EEcCC-CcEEECCCcccccccccchhcccCCCCceeecCHHHHhh--------CCccchhHHHHHHHHHHHHhcCCCCCc
Confidence 99855 5699999998764322211 112234568999998753 667889999999999999875 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
....... ...........+.+..++..+.+++.+||+.+|.+||+++++++.|+..
T Consensus 210 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 210 WDMSGQD-VIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CcCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 8765433 2333344445566778999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=266.65 Aligned_cols=193 Identities=23% Similarity=0.370 Sum_probs=161.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++||||+.|++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 72 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NI 149 (329)
T PTZ00263 72 LMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149 (329)
T ss_pred HHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence 56789999999999984 5578999999999999999976 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... .....|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.
T Consensus 150 ll~~~-~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 150 LLDNK-GHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQS--------KGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred EECCC-CCEEEeeccCceEcCCC--cceecCChhhcCHHHHcC--------CCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 99955 46999999998754332 223468999999999854 55688999999999999999999999865
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
...... .. .......++..++..+.+++.+||..||.+|++ ++++++
T Consensus 219 ~~~~~~-~~-i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 219 TPFRIY-EK-ILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CHHHHH-HH-HhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 543322 22 233455667779999999999999999999986 688876
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=259.30 Aligned_cols=197 Identities=26% Similarity=0.423 Sum_probs=158.5
Q ss_pred CCCCCCcccceeeeee------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 3 SRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
+.++||||+++++++. +...++||||+. ++|.+++.......+++.++..++.|++.||+|||+.|++|+|||
T Consensus 59 ~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred cccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 4568999999999873 235899999995 699999987555679999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|+||+++.+ +.++|+|||++.............++..|+|||.+.. ..++.++|||||||++|+|++|..|
T Consensus 138 p~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~~ 208 (290)
T cd07862 138 PQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPL 208 (290)
T ss_pred HHHEEEcCC-CCEEEccccceEeccCCcccccccccccccChHHHhC--------CCCCCccchHHHHHHHHHHHcCCCC
Confidence 999999965 4699999999876544433445578999999998853 5678899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCC-------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARP-------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|.+....+...........+ .....++..+.+++.+||+.+|++|||+.++++
T Consensus 209 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 209 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred cCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 98766544333222110000 011346778899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=242.17 Aligned_cols=197 Identities=26% Similarity=0.415 Sum_probs=166.6
Q ss_pred CCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 3 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+.|+|||||++.+.+ .+++.|+|+|++.|++|-.-|... .-+++..+-.++.||+++|+|+|.+||||||+||+|++
T Consensus 65 ~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nll 142 (355)
T KOG0033|consen 65 RKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLL 142 (355)
T ss_pred HhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence 468999999999987 567899999999999998877653 55899999999999999999999999999999999999
Q ss_pred EcC--CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 82 LTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 82 ~~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+-. ++-.+||+|||++.....+.......|++.|+|||++. +..++..+|||+-|+++|-|+.|..||.+
T Consensus 143 LASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr--------kdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 143 LASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK--------KDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred eeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhh--------cCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 942 33469999999999888666677889999999999984 47889999999999999999999999997
Q ss_pred CCcHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+......++..... .++.-..++++.++|+++||..||.+|.|+.|.++
T Consensus 215 ~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 215 EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 654333333322222 22233578999999999999999999999999987
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=249.25 Aligned_cols=211 Identities=27% Similarity=0.353 Sum_probs=174.0
Q ss_pred CCCCCCCCcccceeeee---ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~---~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
+|.+++|||||.+.++. .-+..|+|||||+. +|..++.+.+ .+|...++..++.|++.|++|||...|+|||||+
T Consensus 128 iLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~ 205 (419)
T KOG0663|consen 128 ILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKT 205 (419)
T ss_pred HHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccch
Confidence 36688999999999986 22358999999966 9999998754 6799999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
+|+|++.. +.+||+|||+++.++.... ....+.|.||.|||.+.+ ...|+.+.|+||+|||+.||+.+++.
T Consensus 206 SNLLm~~~-G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG-------~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 206 SNLLLSHK-GILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLG-------AKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred hheeeccC-CcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcC-------CcccCcchhhhhHHHHHHHHHhcCCC
Confidence 99999955 5699999999998776543 344578999999999985 47889999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCC-----------------------------CCCCC-CcHHHHHHHHHhhhhCCCCCCCHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARP-----------------------------GLPED-ISPDLAFIVQSCWVEDPNLRPSFSQ 206 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~ 206 (268)
|.+.+..+....+...-..+ .++.. +++...+|+..+|.+||.+|.|+++
T Consensus 278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 99888777665543221111 01111 4578899999999999999999999
Q ss_pred HHHHHHhhhhhcCCCCC
Q 024401 207 IIRMLNAFLFTLRPPSP 223 (268)
Q Consensus 207 ~l~~l~~~~~~~~~~~~ 223 (268)
.++ +.++.+.+.+.+
T Consensus 358 ~L~--h~~F~e~P~p~~ 372 (419)
T KOG0663|consen 358 GLK--HEYFRETPLPID 372 (419)
T ss_pred hhc--ccccccCCCCCC
Confidence 999 788877655444
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=258.20 Aligned_cols=199 Identities=22% Similarity=0.360 Sum_probs=160.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +...++||||++|++|.+++.......+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 47 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Ni 126 (277)
T cd05607 47 LEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENV 126 (277)
T ss_pred HHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhE
Confidence 56789999999999884 55789999999999999998765556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............++..|+|||.+.. ..++.++|+|||||++|+|++|..||...
T Consensus 127 li~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 127 LLDDQ-GNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKE--------EPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred EEcCC-CCEEEeeceeeeecCCCceeeccCCCCCccCHHHHcc--------CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 99955 5699999999876544333344568899999998854 45888999999999999999999999764
Q ss_pred CcHH---HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQ---AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.... .................++.++.+++..||+.+|.+||++.++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~ 249 (277)
T cd05607 198 KEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKND 249 (277)
T ss_pred cchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence 3321 111111211112222468999999999999999999999966553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=272.48 Aligned_cols=210 Identities=24% Similarity=0.398 Sum_probs=164.2
Q ss_pred CCCCCCCCcccceeeeeec---------CCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 024401 1 MMSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANG 69 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~ 69 (268)
+|+.++||||+++++++.. ..+++||||++ ++|.+++... ....+++..+..++.|++.||+|||+.|
T Consensus 112 il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~ 190 (440)
T PTZ00036 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF 190 (440)
T ss_pred HHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3678899999999887521 13679999995 5888877542 3456999999999999999999999999
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
|+||||||+||+++.++..++|+|||+++............+++.|+|||.+.+ ...++.++|||||||++|+
T Consensus 191 IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~e 263 (440)
T PTZ00036 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLG-------ATNYTTHIDLWSLGCIIAE 263 (440)
T ss_pred EecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcC-------CCCCCcHHHHHHHHHHHHH
Confidence 999999999999987766799999999986554444445578899999998753 2457889999999999999
Q ss_pred HHhCCCCCCCCCcHHHHHHHHHhhc---------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 150 LLTNRLPFEGMSNLQAAYAAAFKHA---------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 150 ll~g~~p~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
|++|..||.+............... ...++...+.++.+|+.+||..+|.+||
T Consensus 264 lltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ 343 (440)
T PTZ00036 264 MILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL 343 (440)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc
Confidence 9999999987665443332211100 0112345678999999999999999999
Q ss_pred CHHHHHHHHHhhhhhcCC
Q 024401 203 SFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~~~ 220 (268)
|+.++++ +.++..+..
T Consensus 344 ta~e~l~--hp~f~~~~~ 359 (440)
T PTZ00036 344 NPIEALA--DPFFDDLRD 359 (440)
T ss_pred CHHHHhC--ChhHHhhhc
Confidence 9999998 566665544
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=263.31 Aligned_cols=195 Identities=27% Similarity=0.425 Sum_probs=162.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++.+. ++..|+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 54 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 131 (323)
T cd05584 54 LEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI 131 (323)
T ss_pred HHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 57889999999999884 5578999999999999999975 35688999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|+..|+|||.+.. ..++.++||||||+++|+|++|+.||..
T Consensus 132 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~pf~~ 202 (323)
T cd05584 132 LLDAQ-GHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMR--------SGHGKAVDWWSLGALMYDMLTGAPPFTA 202 (323)
T ss_pred EECCC-CCEEEeeCcCCeecccCCCcccccCCCccccChhhccC--------CCCCCcceecccHHHHHHHhcCCCCCCC
Confidence 99955 5699999999874322 222234568999999998853 5567899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.+....... .......++..++..+.+++.+||+.+|++|| ++.++++
T Consensus 203 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 203 ENRKKTIDK--ILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 654332222 22334566778899999999999999999999 7888877
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=255.38 Aligned_cols=206 Identities=28% Similarity=0.517 Sum_probs=168.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
+++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 140 (291)
T cd05094 61 LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA 140 (291)
T ss_pred HhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 56889999999999984 557899999999999999997532 134899999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
++|++|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|||||
T Consensus 141 ~~~i~H~dlkp~Nil~~~~-~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~sl 211 (291)
T cd05094 141 SQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSF 211 (291)
T ss_pred hCCeeecccCcceEEEccC-CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc--------CCCCchhhHHHH
Confidence 9999999999999999955 569999999987543321 1223456788999998753 567889999999
Q ss_pred HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 144 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 144 G~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
|+++|+|++ |..||...+... .............+..++..+.+++.+||..+|.+||++.++++.|..+...
T Consensus 212 G~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 212 GVILWEIFTYGKQPWFQLSNTE-VIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHHHhCCCCCCCCCCHHH-HHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 999999998 999987655433 2333344444455667889999999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=265.45 Aligned_cols=193 Identities=23% Similarity=0.357 Sum_probs=162.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..++||||+.||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 85 l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 162 (340)
T PTZ00426 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162 (340)
T ss_pred HHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 56789999999999985 4578999999999999999976 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
|++.+ +.++|+|||++...... .....|++.|+|||.+.+ ..++.++|+|||||++|+|++|..||...
T Consensus 163 Ll~~~-~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 163 LLDKD-GFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLN--------VGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred EECCC-CCEEEecCCCCeecCCC--cceecCChhhcCHHHHhC--------CCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 99855 56999999998754322 234568999999999853 55688999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
+...... . .......++..++..+.+++++||+.+|.+|+ +++++++
T Consensus 232 ~~~~~~~-~-i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 232 EPLLIYQ-K-ILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CHHHHHH-H-HhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 5433222 2 22334456778899999999999999999995 8999887
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=254.29 Aligned_cols=200 Identities=26% Similarity=0.396 Sum_probs=169.9
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
||+.+.||.++++|+.++ +.+.|++||||+||+|..+.+....+.|++..+..++..++.||+|||..|||+|||||+|
T Consensus 130 IL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 130 ILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred HHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 477899999999999995 6689999999999999999998777889999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCc----------------------------------c-c---------------------
Q 024401 80 LLLTPDQKSLKLADFGLAREET----------------------------------V-T--------------------- 103 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~----------------------------------~-~--------------------- 103 (268)
||+..+++ ++|+||.++.... . .
T Consensus 210 ILvredGH-IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~ 288 (459)
T KOG0610|consen 210 ILVREDGH-IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPT 288 (459)
T ss_pred eEEecCCc-EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCC
Confidence 99997765 9999999874110 0 0
Q ss_pred -ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCC
Q 024401 104 -EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 182 (268)
Q Consensus 104 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (268)
......+||-.|+|||++.+ ...+.+.|.|+||+++|||+.|..||.+.++.+............+-...+
T Consensus 289 ~~RSnSFVGThEYlAPEvI~G--------~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~v 360 (459)
T KOG0610|consen 289 GARSNSFVGTHEYLAPEVIRG--------EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEV 360 (459)
T ss_pred Cccccccccccccccceeeec--------CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcc
Confidence 00112368889999999965 555779999999999999999999999998888777766555444444578
Q ss_pred cHHHHHHHHHhhhhCCCCCCC----HHHHHH
Q 024401 183 SPDLAFIVQSCWVEDPNLRPS----FSQIIR 209 (268)
Q Consensus 183 ~~~l~~li~~~l~~~p~~Rps----~~~~l~ 209 (268)
+..+++||+++|.+||.+|.- +.+|-+
T Consensus 361 s~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 361 SSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 899999999999999999987 888876
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=256.89 Aligned_cols=200 Identities=36% Similarity=0.677 Sum_probs=161.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..++|+||+++|+|.+++.......+++.+++.|+.|++.||+|||+.+++|+||++.||
T Consensus 55 l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~ni 134 (259)
T PF07714_consen 55 LRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNI 134 (259)
T ss_dssp HHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 45789999999999986 45689999999999999999985456799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
+++.+ +.+||+|||++...... ...........|+|||.+.. ..++.++||||||+++||+++ |+.|
T Consensus 135 ll~~~-~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~ksDVysfG~~l~ei~~~~~~p 205 (259)
T PF07714_consen 135 LLDSN-GQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKD--------GEYTKKSDVYSFGMLLYEILTLGKFP 205 (259)
T ss_dssp EEETT-TEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHH--------SEESHHHHHHHHHHHHHHHHTTSSGT
T ss_pred ccccc-cccccccccccccccccccccccccccccccccccccccc--------cccccccccccccccccccccccccc
Confidence 99955 57999999999765221 22233456778999999854 457899999999999999999 7899
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
|.+... ...............+..++..+.+++.+||..+|.+|||+.++++.|
T Consensus 206 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 206 FSDYDN-EEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp TTTSCH-HHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cccccc-ccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 987754 443444466666777788999999999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=256.04 Aligned_cols=209 Identities=33% Similarity=0.560 Sum_probs=167.4
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
++++ +||||+++++++. ++..++++||+++++|.+++.... ...+++..++.++.|++.||+||
T Consensus 56 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l 135 (297)
T cd05089 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL 135 (297)
T ss_pred HHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456 7999999999984 457899999999999999996532 13488999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
|+.|++|+||||+||+++.+ ..++|+|||++..............+..|+|||.+.. ..++.++||||||+
T Consensus 136 H~~~ivH~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~ 206 (297)
T cd05089 136 SEKQFIHRDLAARNVLVGEN-LASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY--------SVYTTKSDVWSFGV 206 (297)
T ss_pred HHCCcccCcCCcceEEECCC-CeEEECCcCCCccccceeccCCCCcCccccCchhhcc--------CCCCchhhHHHHHH
Confidence 99999999999999999855 5699999999864332211122233457999998753 56788999999999
Q ss_pred HHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 146 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 146 i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
++|+|++ |..||....... .............+..++..+.+++.+||+.+|.+||+++++++.|..+....+.
T Consensus 207 il~el~t~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~~ 281 (297)
T cd05089 207 LLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARKA 281 (297)
T ss_pred HHHHHHcCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 9999997 999998765433 3333344445556677999999999999999999999999999999988765533
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.25 Aligned_cols=194 Identities=25% Similarity=0.397 Sum_probs=160.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..|+||||++|++|..++.. ..+++..++.++.|++.||+|||+.|++||||||+||
T Consensus 56 ~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Ni 132 (324)
T cd05589 56 ANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNL 132 (324)
T ss_pred ccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 45788999999999985 4578999999999999988864 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+
T Consensus 133 ll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~G~~pf~~ 203 (324)
T cd05589 133 LLDTE-GFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTE--------TSYTRAVDWWGLGVLIYEMLVGESPFPG 203 (324)
T ss_pred EECCC-CcEEeCcccCCccCCCCCCcccccccCccccCHhHhcC--------CCCCcccchhhHHHHHHHHHhCCCCCCC
Confidence 99965 4699999999874322 222334568999999998854 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.+....... ........+..++..+.+++.+||..+|.+|| ++.++++
T Consensus 204 ~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 204 DDEEEVFDS--IVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCHHHHHHH--HHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 654333222 22334556778999999999999999999999 5777766
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=267.73 Aligned_cols=197 Identities=31% Similarity=0.495 Sum_probs=169.9
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|.+++||||.++|+.+ .+..++++||||.||++.+.++. ...+++..+..++.+++.||.|||.++.+|+|||+.|
T Consensus 64 ~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaan 141 (467)
T KOG0201|consen 64 VLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAAN 141 (467)
T ss_pred HHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccc
Confidence 36789999999999988 56679999999999999999986 3345899999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|++..+ +.|+|+|||.+....... ...+..||+.|||||++.. ..|+.++||||||++.+||.+|.+|+.
T Consensus 142 il~s~~-g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~--------~~Y~~KADIWSLGITaiEla~GePP~s 212 (467)
T KOG0201|consen 142 ILLSES-GDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQ--------SGYDTKADIWSLGITAIELAKGEPPHS 212 (467)
T ss_pred eeEecc-CcEEEEecceeeeeechhhccccccccccccchhhhcc--------ccccchhhhhhhhHHHHHHhcCCCCCc
Confidence 999977 669999999998655533 3377899999999999964 688999999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+..+.... ..+.....|.....+++.+++|+..||.++|+.||||+++++
T Consensus 213 ~~hPmrvl-flIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 213 KLHPMRVL-FLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccCcceEE-EeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 87763322 223445556666789999999999999999999999999998
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=252.43 Aligned_cols=204 Identities=28% Similarity=0.523 Sum_probs=167.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
++++.||||+++++++.+...++++||+++|+|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nil 141 (279)
T cd05111 63 MGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNIL 141 (279)
T ss_pred HhcCCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEE
Confidence 4678999999999998777789999999999999999752 356899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.++|+|||+++...... ......++..|++||.+.. ..++.++||||||+++|++++ |..||
T Consensus 142 i~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~el~t~g~~p~ 212 (279)
T cd05111 142 LKSD-SIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF--------GRYTHQSDVWSYGVTVWEMMSYGAEPY 212 (279)
T ss_pred EcCC-CcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc--------CCcCchhhHHHHHHHHHHHHcCCCCCC
Confidence 9854 569999999997543221 1223346678999998853 567889999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+.... ..............+..++.++.+++.+||..+|.+|||+.++++.|.....
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 213 AGMRPH-EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCHH-HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 765432 2223333344455556678899999999999999999999999999888664
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=251.54 Aligned_cols=208 Identities=28% Similarity=0.445 Sum_probs=168.2
Q ss_pred CCCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 1 MMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+|+.++|+||+.+++.+.. ..+|+|+|++ +-+|...++. +..++...+..+++|++.||.|+|+.|++|||
T Consensus 74 lLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRD 150 (359)
T KOG0660|consen 74 LLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRD 150 (359)
T ss_pred HHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccc
Confidence 3678899999999998722 2589999999 6699999986 34499999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcc---cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
|||.|++++.++. +||+|||+++.... .........|.||.|||.+.. ...|+.+.||||+|||+.||+
T Consensus 151 LKPsNll~n~~c~-lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~-------~~~Yt~aiDiWSvGCI~AEmL 222 (359)
T KOG0660|consen 151 LKPSNLLLNADCD-LKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLN-------SSEYTKAIDIWSVGCILAEML 222 (359)
T ss_pred cchhheeeccCCC-EEeccccceeeccccCcccchhcceeeeeecCHHHHhc-------cccccchhhhhhhhHHHHHHH
Confidence 9999999997754 89999999997653 334455678999999998864 478999999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhh---------------------cCCCC--------CCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKH---------------------ARPGL--------PEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~---------------------~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|+.-|.+.+...........- ..+.. ....++...+|+.+||..||.+|+
T Consensus 223 ~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi 302 (359)
T KOG0660|consen 223 TGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI 302 (359)
T ss_pred cCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC
Confidence 9999998766544333222111 11111 135678899999999999999999
Q ss_pred CHHHHHHHHHhhhhhcCCC
Q 024401 203 SFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~~~~ 221 (268)
|++++++ +.++.....+
T Consensus 303 ta~eAL~--hPYl~~~hdp 319 (359)
T KOG0660|consen 303 TAEEALA--HPYLAPYHDP 319 (359)
T ss_pred CHHHHhc--ChhhhhhcCC
Confidence 9999998 6666555443
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=250.87 Aligned_cols=202 Identities=33% Similarity=0.512 Sum_probs=167.0
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..+++|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nil 134 (260)
T cd05069 55 MKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANIL 134 (260)
T ss_pred HHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 56789999999999987778899999999999999997654556899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||.+........ .....++..|++||.... ...+.++|+||||+++|+|++ |..||.
T Consensus 135 l~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 135 VGDN-LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred EcCC-CeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc--------CCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9954 5699999999875433221 112245667999998753 567889999999999999999 899998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
+..... .............+..++..+.+++.+||..+|.+||+++++++.|+.
T Consensus 206 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 206 GMVNRE-VLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCHHH-HHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 755433 333333444555667789999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=263.58 Aligned_cols=196 Identities=29% Similarity=0.427 Sum_probs=160.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..|+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 132 (333)
T cd05600 55 LTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF 132 (333)
T ss_pred HHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 56788999999999985 4578999999999999999975 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++..... ......|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...
T Consensus 133 l~~~~-~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~~ 201 (333)
T cd05600 133 LIDAS-GHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRG--------KGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201 (333)
T ss_pred EECCC-CCEEEEeCcCCccccc--ccCCcccCccccChhHhcC--------CCCCCccceecchHHHhhhhhCCCCCCCC
Confidence 99965 4699999999875443 2344578999999999854 57788999999999999999999999876
Q ss_pred CcHHHHHHHHHhh---cCCCCC---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 161 SNLQAAYAAAFKH---ARPGLP---EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 161 ~~~~~~~~~~~~~---~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
+..+......... ..+... ..++.++.+++.+||..+|.+||++++++++
T Consensus 202 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 202 TPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 5433322221111 111111 2568999999999999999999999999983
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=238.44 Aligned_cols=196 Identities=27% Similarity=0.450 Sum_probs=172.6
Q ss_pred CCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 3 SRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+.|+||||+++|++|.| .+.|+++||..+|.|...+...+...+++...+.++.|++.||.|+|..+++||||||+|+|
T Consensus 77 s~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlL 156 (281)
T KOG0580|consen 77 SHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLL 156 (281)
T ss_pred cccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhc
Confidence 57899999999999955 47999999999999999999777788999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
++.+ +.+++.|||.+.... .....+.+||..|.+||...+ ...+...|+|++|++.||++.|..||+...
T Consensus 157 lg~~-~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~--------~~hd~~Vd~w~lgvl~yeflvg~ppFes~~ 226 (281)
T KOG0580|consen 157 LGSA-GELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEG--------RGHDKFVDLWSLGVLCYEFLVGLPPFESQS 226 (281)
T ss_pred cCCC-CCeeccCCCceeecC-CCCceeeecccccCCHhhcCC--------CCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence 9966 459999999987655 334456789999999999864 677889999999999999999999999776
Q ss_pred cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 162 NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
. .+ ....+...+..+|..++.+..++|.+|+.++|.+|.+..+++++
T Consensus 227 ~-~e-tYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 227 H-SE-TYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred h-HH-HHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2 33 33345566677789999999999999999999999999999884
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=256.15 Aligned_cols=204 Identities=34% Similarity=0.576 Sum_probs=166.8
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++ +||||+++++.+. .+..+++|||+.+++|.+++.......+++.++..++.|++.||+|||+.|++|+||||+|
T Consensus 92 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N 171 (302)
T cd05055 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 171 (302)
T ss_pred HHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccce
Confidence 4567 7999999999984 5578999999999999999976444458999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 155 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~ 155 (268)
|+++.+ ..++|+|||++........ .....++..|+|||.+.. ..++.++||||+|+++|+|++ |..
T Consensus 172 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~t~g~~ 242 (302)
T cd05055 172 VLLTHG-KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGILLWEIFSLGSN 242 (302)
T ss_pred EEEcCC-CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhcc--------CCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 999854 5699999999875433211 122345678999998853 567889999999999999998 999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
||.....................+...+.++.+++.+||..+|++|||+.++++.|.+.
T Consensus 243 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 243 PYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 99876654444444333444455567889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=250.28 Aligned_cols=204 Identities=30% Similarity=0.495 Sum_probs=167.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++.+.+...++||||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil 134 (262)
T cd05071 55 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 134 (262)
T ss_pred HHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE
Confidence 56789999999999887778899999999999999998644556899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||.+........ .....++..|++||.... ..++.++|+||||+++|+|++ |..||.
T Consensus 135 l~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~ellt~g~~p~~ 205 (262)
T cd05071 135 VGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYP 205 (262)
T ss_pred EcCC-CcEEeccCCceeeccccccccccCCcccceecCHhHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 9955 5699999999875433221 122345667999998743 567889999999999999999 888887
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
........ ...........+..++..+.+++.+||+.+|.+||+++++++.|+.++
T Consensus 206 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~ 261 (262)
T cd05071 206 GMVNREVL-DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261 (262)
T ss_pred CCChHHHH-HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence 66543332 223333344455678999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=259.68 Aligned_cols=205 Identities=32% Similarity=0.587 Sum_probs=166.2
Q ss_pred CCC-CCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhCC------------------------------------
Q 024401 3 SRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRP------------------------------------ 43 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------ 43 (268)
.++ +||||+++++++. +..++++|||+++++|.+++.....
T Consensus 65 ~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (337)
T cd05054 65 IHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS 144 (337)
T ss_pred HhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence 456 7999999999873 4568899999999999999864221
Q ss_pred -----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccC
Q 024401 44 -----------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 44 -----------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
..+++..+..++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||++...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~-~~vkL~DfG~a~~~ 223 (337)
T cd05054 145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSEN-NVVKICDFGLARDI 223 (337)
T ss_pred cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCC-CcEEEeccccchhc
Confidence 257899999999999999999999999999999999999965 46999999999754
Q ss_pred ccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCC
Q 024401 101 TVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARP 176 (268)
Q Consensus 101 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~ 176 (268)
..... .....++..|+|||.+.. ..++.++|||||||++|+|++ |..||.+....+............
T Consensus 224 ~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 295 (337)
T cd05054 224 YKDPDYVRKGDARLPLKWMAPESIFD--------KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295 (337)
T ss_pred ccCcchhhccCCCCCccccCcHHhcC--------CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC
Confidence 32211 122345678999998854 668889999999999999998 999997655444433333344455
Q ss_pred CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 177 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..+..++.++.+++.+||+.+|++||++.+++++|+.++.
T Consensus 296 ~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 5566788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=247.03 Aligned_cols=200 Identities=24% Similarity=0.413 Sum_probs=167.5
Q ss_pred CCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 6 KHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
.|||||.++++|... .+.+|||.++||.|...|....+..|++.++..|+.||+.|++|||+.+|.||||||+|+
T Consensus 113 ~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENL 192 (400)
T KOG0604|consen 113 GHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENL 192 (400)
T ss_pred CCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhhe
Confidence 699999999987332 477999999999999999998888899999999999999999999999999999999999
Q ss_pred EEcC--CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|... .+-.+||+|||+++.........+...|+.|.|||++- ...++..+|+||+|+++|-|++|.+||+
T Consensus 193 Lyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg--------~eKydkscdmwSlgVimYIlLCGyPPFY 264 (400)
T KOG0604|consen 193 LYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGYPPFY 264 (400)
T ss_pred eeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhC--------chhcCCCCCccchhHHHHHhhcCCCccc
Confidence 9963 33468999999999877666667778999999999984 4678999999999999999999999997
Q ss_pred CCCcH--HHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 159 GMSNL--QAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 159 ~~~~~--~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
..... .-.....+......+| ..+|+..+++|+.+|..+|++|.|+.++++ +.|+
T Consensus 265 S~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~--hpwi 325 (400)
T KOG0604|consen 265 SNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD--HPWI 325 (400)
T ss_pred ccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc--Cchh
Confidence 64431 1112223333344444 358899999999999999999999999998 4444
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=264.61 Aligned_cols=196 Identities=26% Similarity=0.418 Sum_probs=162.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~N 79 (268)
++.++||||+++++.+. ++..++||||++|++|.+++.. ...+++..+..++.||+.||+|||+ .||+||||||+|
T Consensus 49 l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~N 126 (325)
T cd05594 49 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN 126 (325)
T ss_pred HHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCe
Confidence 46789999999999885 5578999999999999998875 3569999999999999999999997 799999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++.+ +.++|+|||++..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 127 Ill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tG~~Pf~ 197 (325)
T cd05594 127 LMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFY 197 (325)
T ss_pred EEECCC-CCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc--------CCCCCccccccccceeeeeccCCCCCC
Confidence 999955 4699999999874322 222334568999999998853 567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRM 210 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~~ 210 (268)
..+...... ........++..++.++.+++.+||+.||.+|+ ++.+++++
T Consensus 198 ~~~~~~~~~--~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 198 NQDHEKLFE--LILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCHHHHHH--HHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 655433222 223344556778999999999999999999996 89999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=257.64 Aligned_cols=206 Identities=27% Similarity=0.525 Sum_probs=168.9
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
++.++||||+++++++..+..++++||+.+|+|.+++... ...+++..++.++.|++.||+|||+.|++||||||+||+
T Consensus 63 l~~l~h~niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nil 141 (316)
T cd05108 63 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVL 141 (316)
T ss_pred HHhCCCCCCCeEEEEEcCCCceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheE
Confidence 5678999999999999777789999999999999999863 345889999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccc---cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.++|+|||++......... .....+..|++||.+.. ..++.++||||||+++|+|++ |..||
T Consensus 142 l~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 142 VKTP-QHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred ecCC-CcEEEccccccccccCCCcceeccCCccceeecChHHhcc--------CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 9855 46999999999865432221 22234567999998853 667889999999999999997 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.+....+ ...........+.+..++.++.+++.+||..+|.+||++.+++..|.......
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 213 DGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred CCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 7654332 23333344445556678899999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=249.46 Aligned_cols=202 Identities=31% Similarity=0.551 Sum_probs=167.2
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++.+.+...+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||+
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil 129 (257)
T cd05040 50 MHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL 129 (257)
T ss_pred HhhcCCCCccceeEEEcCCeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEE
Confidence 67899999999999986688999999999999999998743356899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..|
T Consensus 130 ~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p 200 (257)
T cd05040 130 LASD-DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT--------RTFSHASDVWMFGVTLWEMFTYGEEP 200 (257)
T ss_pred EecC-CEEEeccccccccccccccceecccCCCCCceecCHHHhcc--------cCcCchhhhHHHHHHHHHHHhCCCCC
Confidence 9966 569999999987543321 1122346778999998753 567889999999999999998 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
|......+..............+..++..+.+++.+||..+|++|||+.++++.|.
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 201 WAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 97665544333333333444455678899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=250.55 Aligned_cols=203 Identities=33% Similarity=0.541 Sum_probs=166.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 134 (261)
T cd05072 55 MKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANV 134 (261)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 56789999999999874 45689999999999999999765556789999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+........ .....++..|+|||.+.. ..++.++|+||||+++|+|++ |..||
T Consensus 135 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~ 205 (261)
T cd05072 135 LVSES-LMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLYEIVTYGKIPY 205 (261)
T ss_pred EecCC-CcEEECCCccceecCCCceeccCCCccceecCCHHHhcc--------CCCChhhhhhhhHHHHHHHHccCCCCC
Confidence 99955 5699999999976443221 122235668999998753 567889999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
........ ..........+....++.++.+++.+||..+|++||+++++.+.|+.+
T Consensus 206 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 206 PGMSNSDV-MSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 76554332 233333444455567899999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=249.96 Aligned_cols=202 Identities=32% Similarity=0.552 Sum_probs=167.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. .+..++||||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~ni 135 (261)
T cd05148 56 LKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNI 135 (261)
T ss_pred HhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceE
Confidence 57889999999999984 45789999999999999999875556789999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
+++.+ +.++|+|||.+........ .....++..|++||.+.. ..++.++|+||||+++|+|++ |..||.
T Consensus 136 lv~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 136 LVGED-LVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH--------GTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred EEcCC-ceEEEccccchhhcCCccccccCCCCceEecCHHHHcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99955 5699999999875433221 122345678999998753 567889999999999999998 899997
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
..+..... ...........+..++..+.+++.+||..+|.+|||+.++++.|+.
T Consensus 207 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 207 GMNNHEVY-DQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred cCCHHHHH-HHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 76543333 3333444556677889999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=265.51 Aligned_cols=192 Identities=29% Similarity=0.489 Sum_probs=159.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 129 (318)
T cd05582 52 LAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI 129 (318)
T ss_pred HHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHe
Confidence 57889999999999985 5578999999999999999965 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......|+..|+|||.+.. ..++.++|||||||++|+|++|+.||..
T Consensus 130 l~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~ 200 (318)
T cd05582 130 LLDEE-GHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGSLPFQG 200 (318)
T ss_pred EECCC-CcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcC--------CCCCCccceeccceEeeeeccCCCCCCC
Confidence 99955 46999999998754333 22334568999999998853 5568899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 206 (268)
.+....... .......++..++.++.+++.+||+.+|.+||++.+
T Consensus 201 ~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 201 KDRKETMTM--ILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCHHHHHHH--HHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 654333322 223345567789999999999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=249.62 Aligned_cols=201 Identities=29% Similarity=0.522 Sum_probs=166.5
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
++++.||||+++++++..+..+++|||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nil 127 (257)
T cd05060 50 MAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVL 127 (257)
T ss_pred HHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEE
Confidence 5678999999999998877889999999999999999863 36899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccc----cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.++|+|||++......... ....++..|+|||.+.. ..++.++||||||+++|++++ |..|
T Consensus 128 i~~~-~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~~~~~g~~p 198 (257)
T cd05060 128 LVNR-HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY--------GKFSSKSDVWSYGVTLWEAFSYGAKP 198 (257)
T ss_pred EcCC-CcEEeccccccceeecCCcccccccCccccccccCHHHhcC--------CCCCccchHHHHHHHHHHHHcCCCCC
Confidence 9855 56999999998754332211 11123457999998853 567889999999999999998 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
|...+..+ .............+..++..+.+++.+||..+|++||++.++++.|+..
T Consensus 199 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 199 YGEMKGAE-VIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred cccCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 98765433 3333334444566778899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=262.51 Aligned_cols=193 Identities=26% Similarity=0.452 Sum_probs=158.1
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++++. ++..|+||||++|++|.+++.. .+.+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 54 ~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~ 131 (329)
T cd05588 54 NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDA 131 (329)
T ss_pred CCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECC
Confidence 7999999999985 5578999999999999998865 357999999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC--
Q 024401 85 DQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-- 161 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~-- 161 (268)
+ +.++|+|||++.... .........|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....
T Consensus 132 ~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 202 (329)
T cd05588 132 E-GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMS 202 (329)
T ss_pred C-CCEEECcCccccccccCCCccccccCCccccCHHHHcC--------CCCCCccceechHHHHHHHHHCCCCccccccc
Confidence 5 469999999987422 2223344578999999999854 567889999999999999999999996321
Q ss_pred -----cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC------HHHHHH
Q 024401 162 -----NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS------FSQIIR 209 (268)
Q Consensus 162 -----~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~~l~ 209 (268)
................++..++.++.+++.+||..+|.+|++ ++++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 203 DNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 111222223344455677889999999999999999999987 677765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=293.27 Aligned_cols=201 Identities=28% Similarity=0.436 Sum_probs=173.8
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|..|+|||+|+++|+- .+...+|.||||+||+|.+.+.. .+..++.....+..|++.|++|||++|||||||||.|
T Consensus 1287 vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aN 1364 (1509)
T KOG4645|consen 1287 VLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPAN 1364 (1509)
T ss_pred HHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccc
Confidence 36789999999999985 66678999999999999999975 3447788888899999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|+++.+ +.+|++|||.+...... .......||+.|||||++.+.. .....-++|||||||++.||+||+
T Consensus 1365 I~Ld~~-g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~-----~kG~~~A~DiWslGCVVlEM~tGk 1438 (1509)
T KOG4645|consen 1365 ILLDFN-GLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTK-----GKGHGGAADIWSLGCVVLEMATGK 1438 (1509)
T ss_pred eeeecC-CcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccc-----cCCCCcchhhhcccceEEEeecCC
Confidence 999955 57999999999754332 2223457999999999997632 123345899999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.||...++.......+..+..|.+|..++++.++++.+||..||++|.++.++++
T Consensus 1439 rPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1439 RPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred CchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 9999998888888888888899999999999999999999999999999998887
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=249.50 Aligned_cols=202 Identities=32% Similarity=0.516 Sum_probs=167.4
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++.+.+...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nil 134 (260)
T cd05070 55 MKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL 134 (260)
T ss_pred HHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence 57889999999999987778899999999999999997655566899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccc--cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||.+......... ....++..|+|||.... ..++.++|+||||+++|+|++ |..||.
T Consensus 135 i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~~ 205 (260)
T cd05070 135 VGDG-LVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred EeCC-ceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc--------CCCcchhhhHHHHHHHHHHHhcCCCCCC
Confidence 9954 56999999998754332211 12234567999998753 567889999999999999999 889997
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
+.+... ...........+.+...+..+.+++.+||..+|++|||+.++.+.|+.
T Consensus 206 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 206 GMNNRE-VLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 655433 333334444556677889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=251.46 Aligned_cols=204 Identities=34% Similarity=0.595 Sum_probs=163.5
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
++++ +||||+++++.+. ++..+++|||+++++|.+++.... ...+++.++..++.|++.||+||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3456 7999999999984 557899999999999999997532 12478999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
|+.|++|+||||+||+++.+ +.++|+|||++..............+..|+|||.+.. ..++.++|+||||+
T Consensus 129 H~~~i~H~dikp~nili~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~ 199 (270)
T cd05047 129 SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGV 199 (270)
T ss_pred HHCCEeecccccceEEEcCC-CeEEECCCCCccccchhhhccCCCCccccCChHHHcc--------CCCCchhhHHHHHH
Confidence 99999999999999999955 5699999999864332222222233567999998743 56788999999999
Q ss_pred HHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 146 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 146 i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
++|+|++ |..||.+.+.. ..............+..++.++.+++.+||..+|.+|||+.++++.|+.++
T Consensus 200 il~el~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 200 LLWEIVSLGGTPYCGMTCA-ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred HHHHHHcCCCCCccccCHH-HHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 9999997 99999765433 233333333444556678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=252.85 Aligned_cols=206 Identities=27% Similarity=0.510 Sum_probs=167.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-----------PNKLDLHVALNFALDIARAMDCLHANG 69 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~~~i~~ql~~~l~~lH~~~ 69 (268)
+++++||||+++++++. ++..+++|||+++++|.+++.... ...+++.+++.++.|++.||+|||+.|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~ 140 (288)
T cd05093 61 LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH 140 (288)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 56789999999999984 567999999999999999997532 134899999999999999999999999
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHH
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 146 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 146 (268)
++||||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||++
T Consensus 141 i~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDiwslG~i 211 (288)
T cd05093 141 FVHRDLATRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGVV 211 (288)
T ss_pred eeecccCcceEEEccC-CcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc--------CCCCchhhHHHHHHH
Confidence 9999999999999855 5699999999875432211 122345678999998853 567889999999999
Q ss_pred HHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 147 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 147 ~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+|+|++ |..||....... .............+..++.++.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 212 l~~l~t~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 212 LWEIFTYGKQPWYQLSNNE-VIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHHHhCCCCCCCCCCHHH-HHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 999998 899987665433 2233333444455667889999999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=261.35 Aligned_cols=191 Identities=28% Similarity=0.393 Sum_probs=157.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||++|++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 50 ~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NI 127 (323)
T cd05575 50 LKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENI 127 (323)
T ss_pred HhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence 46789999999999884 5578999999999999999875 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 128 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~g~~pf~~ 198 (323)
T cd05575 128 LLDSQ-GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (323)
T ss_pred EECCC-CcEEEeccCCCcccccCCCccccccCChhhcChhhhcC--------CCCCccccccccchhhhhhhcCCCCCCC
Confidence 99965 4699999999875322 222334568999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.+..+ ...... ......+..++..+.+++.+||+.+|.+||++.
T Consensus 199 ~~~~~-~~~~i~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 199 RDTAE-MYDNIL-NKPLRLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCHHH-HHHHHH-cCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 55433 222222 233445667899999999999999999999874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=264.26 Aligned_cols=206 Identities=32% Similarity=0.543 Sum_probs=167.1
Q ss_pred CCCCC-CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-------------------------------------
Q 024401 2 MSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------------------------------- 42 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------- 42 (268)
|+++. ||||+++++++. .+..++||||+++|+|.+++....
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (400)
T cd05105 94 MTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFEN 173 (400)
T ss_pred HHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcc
Confidence 45675 999999999985 457999999999999999986421
Q ss_pred ---------------------------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 43 ---------------------------------------------------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 43 ---------------------------------------------------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
...+++.+++.++.|++.||+||
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 253 (400)
T cd05105 174 KGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL 253 (400)
T ss_pred cccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 12478888999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.|++|+||||+||+++.+ ..++|+|||++....... ......++..|+|||.+.+ ..++.++||||
T Consensus 254 H~~~ivH~dikp~Nill~~~-~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwS 324 (400)
T cd05105 254 ASKNCVHRDLAARNVLLAQG-KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD--------NLYTTLSDVWS 324 (400)
T ss_pred HhCCeeCCCCChHhEEEeCC-CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC--------CCCCchhhHHH
Confidence 99999999999999999955 569999999987543221 1122345678999998853 56788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
||+++|+|++ |..||.....................+..++.++.+++.+||..+|++||++.++.+.|..++.
T Consensus 325 lGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 325 YGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 9999999997 9999986554444444444445556667889999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=250.69 Aligned_cols=198 Identities=30% Similarity=0.550 Sum_probs=165.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. +...++++||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 58 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni 135 (263)
T cd06625 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI 135 (263)
T ss_pred HHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 56889999999999984 4579999999999999999976 34589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc----cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
+++.+ +.++|+|||.+......... ....++..|+|||.+.+ ..++.++||||||+++|+|++|+.|
T Consensus 136 lv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p 206 (263)
T cd06625 136 LRDSA-GNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADVWSVGCTVVEMLTEKPP 206 (263)
T ss_pred EEcCC-CCEEEeecccceeccccccccccccCCCcCccccCcceecc--------CCCCchhhhHHHHHHHHHHHhCCCC
Confidence 99954 56999999998654322111 23456788999999864 4578899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
|...+.................+..++..+.+++.+||..+|.+|||+.+++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 207 WAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 987665554444444445566777899999999999999999999999999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=248.16 Aligned_cols=204 Identities=29% Similarity=0.534 Sum_probs=163.0
Q ss_pred CCCCCCCcccceeeee--ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++.++||||+++++.+ .++..+++|||+.+++|.+++... ....++..+..++.|++.||+|||+.|++|+||||+|
T Consensus 50 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~n 128 (262)
T cd05058 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN 128 (262)
T ss_pred HccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcce
Confidence 5788999999999976 345689999999999999999752 3446788889999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC-
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN- 153 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g- 153 (268)
|+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++|
T Consensus 129 ili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~ 199 (262)
T cd05058 129 CMLDES-FTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRG 199 (262)
T ss_pred EEEcCC-CcEEECCccccccccCCcceeecccccCcCCccccChhHhcc--------CccchHHHHHHHHHHHHHHHcCC
Confidence 999965 469999999987432211 1112245668999998753 5678899999999999999995
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..||.... ................+..++..+.+++.+||..+|++||++.++++.|+.++.
T Consensus 200 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 200 APPYPDVD-SFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCCC-HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 55665543 333334444444555566788999999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=255.86 Aligned_cols=199 Identities=24% Similarity=0.391 Sum_probs=163.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (285)
T cd05605 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENI 133 (285)
T ss_pred HHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHE
Confidence 56789999999999884 45799999999999999988764446799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............++..|+|||.+.. ..++.++||||+|+++|+|++|..||.+.
T Consensus 134 l~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diws~G~~l~el~~g~~pf~~~ 204 (285)
T cd05605 134 LLDDY-GHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN--------ERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204 (285)
T ss_pred EECCC-CCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC--------CCCCccccchhHHHHHHHHHHCCCCCCCC
Confidence 99955 5699999999876543333344578899999998853 56788999999999999999999999865
Q ss_pred CcHHHH--HHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 161 SNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 161 ~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
...... ............+..++..+.+++.+||..||.+|| +++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 205 KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred chhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 432211 112223334455667899999999999999999999 8889877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=253.25 Aligned_cols=206 Identities=29% Similarity=0.585 Sum_probs=167.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC----------------------CCCCCHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR----------------------PNKLDLHVALNFALDI 58 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~i~~ql 58 (268)
++.++||||+++++.+. ++..++++||+.+++|.+++.... ...+++..++.++.|+
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i 136 (290)
T cd05045 57 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQI 136 (290)
T ss_pred HhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHH
Confidence 56789999999999884 557899999999999999986521 1347899999999999
Q ss_pred HHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCC
Q 024401 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYN 135 (268)
Q Consensus 59 ~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 135 (268)
+.||+|||+.|++||||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++
T Consensus 137 ~~~l~~LH~~~ivH~dikp~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~ 207 (290)
T cd05045 137 SRGMQYLAEMKLVHRDLAARNVLVAEG-RKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--------HIYT 207 (290)
T ss_pred HHHHHHHHHCCeehhhhhhheEEEcCC-CcEEeccccccccccCccchhcccCCCCCccccCHHHHcc--------CCcc
Confidence 999999999999999999999999854 5699999999875322211 122345668999998753 5678
Q ss_pred cccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 136 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 136 ~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.++||||||+++|+|++ |..||.+... +..............+..++.++.+++.+||+.+|.+||+++++++.|+++
T Consensus 208 ~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 208 TQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred hHhHHHHHHHHHHHHHhcCCCCCCCCCH-HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 89999999999999998 9999976543 333344444445556778899999999999999999999999999999987
Q ss_pred hhh
Q 024401 215 LFT 217 (268)
Q Consensus 215 ~~~ 217 (268)
+.+
T Consensus 287 ~~~ 289 (290)
T cd05045 287 MVK 289 (290)
T ss_pred Hhc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=264.98 Aligned_cols=201 Identities=25% Similarity=0.408 Sum_probs=161.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..++||||++||+|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 97 l~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 173 (370)
T cd05596 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173 (370)
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 56789999999999885 4568999999999999999875 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|++.+ +.++|+|||++....... ......|++.|+|||.+... .....++.++|||||||++|+|++|..||.
T Consensus 174 Ll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 248 (370)
T cd05596 174 LLDKS-GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (370)
T ss_pred EEcCC-CCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccC----CCCCCCCCceeeeehhHHHHHHHhCCCCcC
Confidence 99965 569999999987543322 22345789999999988531 112457889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 210 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~--Rps~~~~l~~ 210 (268)
+.+................++. .++.++.+++.+||..+|.+ |+++++++++
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 249 ADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred CCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 7665433333222222233343 57999999999999999987 9999999883
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=248.94 Aligned_cols=200 Identities=35% Similarity=0.597 Sum_probs=163.9
Q ss_pred CCCCCCCcccceeeee--ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++++++ .++..+++|||+++++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n 132 (256)
T cd05082 53 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARN 132 (256)
T ss_pred HHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchhe
Confidence 5788999999999975 34568999999999999999987554568999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
|+++.+ +.++|+|||++....... .....+..|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 133 il~~~~-~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~~g~~p~~ 201 (256)
T cd05082 133 VLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYP 201 (256)
T ss_pred EEEcCC-CcEEecCCccceeccccC--CCCccceeecCHHHHcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 999955 569999999987543222 22334567999998753 567889999999999999997 999987
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
..... ..............+..++..+.+++.+||..+|++|||+.++++.|+.
T Consensus 202 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 202 RIPLK-DVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 65432 2223333344455667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=255.92 Aligned_cols=207 Identities=33% Similarity=0.579 Sum_probs=165.5
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
+.++ +||||+++++++. ++..+++|||+++++|.+++.... ...+++.+++.++.|++.||+||
T Consensus 61 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 140 (303)
T cd05088 61 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 140 (303)
T ss_pred HHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence 3456 8999999999984 557999999999999999997532 13588999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
|+.|++||||||+||+++.+ +.++|+|||++..............+..|+|||.+.. ..++.++||||||+
T Consensus 141 H~~gi~H~dlkp~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 211 (303)
T cd05088 141 SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGV 211 (303)
T ss_pred HhCCccccccchheEEecCC-CcEEeCccccCcccchhhhcccCCCcccccCHHHHhc--------cCCcccccchhhhh
Confidence 99999999999999999955 4699999999864332222222234567999998743 55788999999999
Q ss_pred HHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 146 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 146 i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
++|+|++ |..||...+..+ .............+..++.++.+++.+||+.+|++||+++++++.|...+...
T Consensus 212 il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 212 LLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHHHHHhcCCCCcccCChHH-HHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 9999998 999997655432 22333333344455668899999999999999999999999999998876554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=255.22 Aligned_cols=202 Identities=30% Similarity=0.529 Sum_probs=158.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-----------------CCCCCHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-----------------PNKLDLHVALNFALDIARAMD 63 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-----------------~~~~~~~~~~~i~~ql~~~l~ 63 (268)
|++++||||+++++++. ++..++||||+++++|.+++.... ...+++.+++.++.|++.||+
T Consensus 73 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~ 152 (304)
T cd05096 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMK 152 (304)
T ss_pred HhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 56789999999999984 557899999999999999986521 123678899999999999999
Q ss_pred HHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccch
Q 024401 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140 (268)
Q Consensus 64 ~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 140 (268)
|||+.||+|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++||
T Consensus 153 ~lH~~~ivH~dlkp~Nill~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv 223 (304)
T cd05096 153 YLSSLNFVHRDLATRNCLVGEN-LTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--------GKFTTASDV 223 (304)
T ss_pred HHHHCCccccCcchhheEEcCC-ccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--------CCCCchhhh
Confidence 9999999999999999999955 5699999999875433221 122345678999998753 567889999
Q ss_pred HHHHHHHHHHHh--CCCCCCCCCcHHHHHHHH--Hh----hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 141 YSFGIVLWELLT--NRLPFEGMSNLQAAYAAA--FK----HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 141 ~slG~i~~~ll~--g~~p~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
||||+++|+|++ +..||...+..+...... .. ......+..++..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 224 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 224 WAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred HHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 999999999986 567887655433221111 11 1112234567899999999999999999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=248.81 Aligned_cols=198 Identities=27% Similarity=0.437 Sum_probs=165.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++||||++|++|.+++.......+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~ni 132 (256)
T cd08529 53 LAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNL 132 (256)
T ss_pred HHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 56789999999999984 55789999999999999999875556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++........ .....++..|+|||.... ..++.++|+||||+++|+|++|..||..
T Consensus 133 li~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~ 203 (256)
T cd08529 133 FLDAY-DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCED--------KPYNEKSDVWALGVVLYECCTGKHPFDA 203 (256)
T ss_pred EEeCC-CCEEEcccccceeccCccchhhccccCccccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 99965 4599999998875443222 233467889999998853 5577899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+. ............+..+..++..+.+++.+||+.+|++||++.++++
T Consensus 204 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 204 NNQ-GALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred CCH-HHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 653 3333333444555666688999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=260.01 Aligned_cols=192 Identities=29% Similarity=0.422 Sum_probs=159.0
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.+||||+++++++. .+..|+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++
T Consensus 53 ~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~ 130 (320)
T cd05590 53 RNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLD 130 (320)
T ss_pred cCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEEC
Confidence 47999999999985 4578999999999999999875 35699999999999999999999999999999999999999
Q ss_pred CCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 84 PDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||...+.
T Consensus 131 ~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 131 HE-GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE--------MLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred CC-CcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC--------CCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 55 4699999999875322 222334568999999998853 5678899999999999999999999987654
Q ss_pred HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 024401 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIR 209 (268)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~l~ 209 (268)
..... .........+..++.++.+++.+||..||.+|+++ +++++
T Consensus 202 ~~~~~--~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~ 252 (320)
T cd05590 202 DDLFE--AILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR 252 (320)
T ss_pred HHHHH--HHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence 33322 22334455667789999999999999999999998 66665
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=247.67 Aligned_cols=200 Identities=32% Similarity=0.566 Sum_probs=162.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.|++|+||+|+||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~ni 125 (252)
T cd05084 47 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNC 125 (252)
T ss_pred HHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence 56789999999999984 55789999999999999999752 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc---cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
+++.+ +.++|+|||++......... .....+..|+|||.+.. ..++.++|+||||+++|+|++ |..|
T Consensus 126 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~e~~~~~~~p 196 (252)
T cd05084 126 LVTEK-NVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY--------GRYSSESDVWSFGILLWEAFSLGAVP 196 (252)
T ss_pred EEcCC-CcEEECccccCcccccccccccCCCCCCceeecCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 99855 45999999998753322111 11123456999998854 557889999999999999997 8888
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
|....... .............+..++..+.+++.+||..+|++|||+.++++.|.
T Consensus 197 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 197 YANLSNQQ-TREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccccCHHH-HHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 87655432 23333344455667778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=261.33 Aligned_cols=193 Identities=26% Similarity=0.350 Sum_probs=158.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||++|++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 50 l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Ni 127 (325)
T cd05602 50 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 127 (325)
T ss_pred HHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 46789999999999884 5578999999999999999975 35688999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+
T Consensus 128 li~~~-~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (325)
T cd05602 128 LLDSQ-GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (325)
T ss_pred EECCC-CCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC--------CCCCCccccccccHHHHHHhcCCCCCCC
Confidence 99965 4699999999875322 222344568999999998854 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 207 (268)
.+..... ... .......+..++..+.+++.+||+.+|.+|+++.+.
T Consensus 199 ~~~~~~~-~~i-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (325)
T cd05602 199 RNTAEMY-DNI-LNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDD 244 (325)
T ss_pred CCHHHHH-HHH-HhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCC
Confidence 6543322 222 223344556789999999999999999999987643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=258.57 Aligned_cols=193 Identities=28% Similarity=0.453 Sum_probs=159.4
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.++||||+++++++. ++..|+||||+.|++|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+||++
T Consensus 52 ~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~ 129 (316)
T cd05620 52 AWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129 (316)
T ss_pred ccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 358999999999984 5578999999999999999875 3568999999999999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 83 TPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
+.+ +.++|+|||++..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 130 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 130 DRD-GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG--------LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred CCC-CCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 965 4699999999864322 222334568999999999854 567889999999999999999999998665
Q ss_pred cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-HHHHH
Q 024401 162 NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-SQIIR 209 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-~~~l~ 209 (268)
..... . ......+..+..++.++.+++.+||..||++|+++ +++++
T Consensus 201 ~~~~~-~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 201 EDELF-E-SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred HHHHH-H-HHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 43322 2 22334556677789999999999999999999997 46654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=277.63 Aligned_cols=205 Identities=23% Similarity=0.360 Sum_probs=165.6
Q ss_pred CCCCC-CCcccceeeee-----ecC---CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--C
Q 024401 2 MSRVK-HDNLVKFLGAC-----KDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--I 70 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~-----~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i 70 (268)
|++|+ |||||.+++.. .++ +++|.||||.||+|-|++..+....|++.++++|+.+++.|+++||... |
T Consensus 88 MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPi 167 (738)
T KOG1989|consen 88 MKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPI 167 (738)
T ss_pred HHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCcc
Confidence 56777 99999999942 111 4789999999999999998766777999999999999999999999997 9
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcccc-c---------ccCccCccceeccccccccccccccccCCCcccch
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-M---------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-~---------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 140 (268)
+|||||-+|||++.++ .+||||||.+....... . ......|+.|.|||+++-. .+...++|+||
T Consensus 168 IHRDLKiENvLls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly-----sg~pI~eKsDI 241 (738)
T KOG1989|consen 168 IHRDLKIENVLLSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY-----SGLPIGEKSDI 241 (738)
T ss_pred chhhhhhhheEEcCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh-----cCCCCcchhHH
Confidence 9999999999999554 69999999987433221 1 1122578999999998642 35778999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 141 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 141 ~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|+|||++|-||....||++...... .-.....+-...++..+.+||+.||+.+|++||++.+++..+..+..
T Consensus 242 WALGclLYkLCy~t~PFe~sg~laI----lng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 242 WALGCLLYKLCYFTTPFEESGKLAI----LNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred HHHHHHHHHHHHhCCCcCcCcceeE----EeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 9999999999999999987543221 11112222224789999999999999999999999999998887753
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=247.81 Aligned_cols=200 Identities=29% Similarity=0.543 Sum_probs=163.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..+++|||+.+++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||+|.||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05113 53 MMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNC 131 (256)
T ss_pred HhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceE
Confidence 57889999999999984 456899999999999999997633 3689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+........ .....++..|++||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 132 li~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~~l~~~g~~p~ 202 (256)
T cd05113 132 LVDDQ-GCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLY--------SKFSSKSDVWAFGVLMWEVYSLGKMPY 202 (256)
T ss_pred EEcCC-CCEEECCCccceecCCCceeecCCCccChhhCCHHHHhc--------CcccchhHHHHHHHHHHHHhcCCCCCc
Confidence 99955 5699999998875433221 112245577999998853 567889999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
....... .........+...+...+..+.+++.+||..+|.+||++.++++.|+
T Consensus 203 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 203 ERFNNSE-TVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CcCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 7655433 33333444455556678899999999999999999999999998663
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=256.43 Aligned_cols=205 Identities=25% Similarity=0.400 Sum_probs=159.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. +...++||||+ +++|.+++.. ....+++..+..++.|++.||+|||+.||+|+||||+||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni 134 (303)
T cd07869 57 LKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDK-HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL 134 (303)
T ss_pred HhhCCCCCcCeEEEEEecCCeEEEEEECC-CcCHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 56789999999999985 45689999999 5688888865 235689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+.+ ...++.++|||||||++|+|++|..||.+
T Consensus 135 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 135 LISDT-GELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLG-------STEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred EECCC-CCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99955 56999999998643322 22234567889999998753 24567889999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCC-----------------C-----CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 024401 160 MSNLQAAYAAAFKHARP-----------------G-----LP---------EDISPDLAFIVQSCWVEDPNLRPSFSQII 208 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~-----------------~-----~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~l 208 (268)
..+.............. . .+ ..++..+.+++.+||+.||.+|||+.+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 207 MKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred CccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 66544333222110000 0 00 12456789999999999999999999999
Q ss_pred HHHHhhhhhc
Q 024401 209 RMLNAFLFTL 218 (268)
Q Consensus 209 ~~l~~~~~~~ 218 (268)
+ +.++...
T Consensus 287 ~--h~~f~~~ 294 (303)
T cd07869 287 S--HEYFSDL 294 (303)
T ss_pred c--CcccccC
Confidence 8 6665544
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=251.44 Aligned_cols=203 Identities=30% Similarity=0.548 Sum_probs=165.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC---------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
+++++||||+++++++. +...+++|||+++++|.+++.... ...+++.++..++.|++.||+||
T Consensus 61 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 140 (283)
T cd05090 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYL 140 (283)
T ss_pred HhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 57889999999999874 557899999999999999985321 13478899999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.|++|+||||+||+++.+ ..++|+|||++....... ......++..|+|||.+.+ ..++.++|+||
T Consensus 141 H~~~i~H~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s 211 (283)
T cd05090 141 SSHFFVHKDLAARNILIGEQ-LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY--------GKFSSDSDIWS 211 (283)
T ss_pred HhcCeehhccccceEEEcCC-CcEEeccccccccccCCcceecccCCCccceecChHHhcc--------CCCCchhhhHH
Confidence 99999999999999999955 569999999997543221 1223345677999998753 55788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
||+++|+|++ |..||.+... ...............+..++..+.+++.+||..+|.+||++.++++.|..|
T Consensus 212 lG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 212 FGVVLWEIFSFGLQPYYGFSN-QEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 9999999998 8899976543 333333344445566778999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=251.15 Aligned_cols=201 Identities=31% Similarity=0.540 Sum_probs=164.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------PNKLDLHVALNFALDIARAMDCLHAN 68 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~lH~~ 68 (268)
|++++||||+++++.+. +...+++|||+++++|.+++.... ...+++..+..++.|++.||++||+.
T Consensus 62 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~ 141 (280)
T cd05049 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ 141 (280)
T ss_pred HHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC
Confidence 56789999999999984 557999999999999999997532 23478999999999999999999999
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
|++|+||||+||+++.+ +.++|+|||.+....... ......++..|+|||.+.. ..++.++||||||+
T Consensus 142 ~i~h~dlkp~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 212 (280)
T cd05049 142 HFVHRDLATRNCLVGYD-LVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSFGV 212 (280)
T ss_pred CeeccccccceEEEcCC-CeEEECCcccceecccCcceecCCCCcccceecChhhhcc--------CCcchhhhHHHHHH
Confidence 99999999999999965 569999999987432211 1122345678999998854 66788999999999
Q ss_pred HHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 146 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 146 i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
++|+|++ |..||...+.... ............+..++..+.+++.+||..+|.+||++.++++.|+
T Consensus 213 il~e~~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 213 VLWEIFTYGKQPWYGLSNEEV-IECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHHHhcCCCCCCCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 9999998 9999976654332 2333344444556678999999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=258.02 Aligned_cols=201 Identities=26% Similarity=0.473 Sum_probs=159.3
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~N 79 (268)
|++++||||+++++++ .++..++||||++|++|.+++.. ...+++..+..++.|++.||.|||+. +|+|+||||+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~N 134 (331)
T cd06649 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSN 134 (331)
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhh
Confidence 5678999999999987 45678999999999999999976 34689999999999999999999986 69999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..
T Consensus 135 il~~~~-~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 135 ILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred EEEcCC-CcEEEccCccccccccc-ccccCCCCcCcCCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999955 46999999998754322 2234468899999998853 5678899999999999999999999965
Q ss_pred CCcHHHHH---------------------------------------------HHHHhhcCCCCC-CCCcHHHHHHHHHh
Q 024401 160 MSNLQAAY---------------------------------------------AAAFKHARPGLP-EDISPDLAFIVQSC 193 (268)
Q Consensus 160 ~~~~~~~~---------------------------------------------~~~~~~~~~~~~-~~~~~~l~~li~~~ 193 (268)
.+...... ........+..+ ..++.++.+|+.+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 284 (331)
T cd06649 205 PDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKC 284 (331)
T ss_pred CCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHH
Confidence 43221110 000111112221 24788999999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhh
Q 024401 194 WVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 194 l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|+.||++|||+.++++ +.++.
T Consensus 285 L~~~P~~Rpt~~ell~--h~~~~ 305 (331)
T cd06649 285 LIKNPAERADLKMLMN--HTFIK 305 (331)
T ss_pred ccCCcccCCCHHHHhc--ChHHh
Confidence 9999999999999998 44444
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=257.41 Aligned_cols=193 Identities=31% Similarity=0.467 Sum_probs=160.1
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
..+||||+++++.+. ++..++||||++|++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||++
T Consensus 52 ~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill 129 (316)
T cd05592 52 AWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129 (316)
T ss_pred ccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE
Confidence 358999999999884 5578999999999999999976 3569999999999999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 83 TPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
+.+ +.++|+|||++..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 130 ~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 130 DKD-GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG--------QKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred CCC-CCEEEccCcCCeECCCCCCccccccCCccccCHHHHcC--------CCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 965 4699999999875322 222334568999999998853 567889999999999999999999998765
Q ss_pred cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 024401 162 NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 209 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~l~ 209 (268)
..+... ......+.++..++.++.+++.+||..+|.+||++. ++++
T Consensus 201 ~~~~~~--~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 201 EDELFD--SILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred HHHHHH--HHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 433222 233445667778999999999999999999999865 5554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=251.22 Aligned_cols=201 Identities=30% Similarity=0.530 Sum_probs=160.4
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++.+ ...+++|||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~ 136 (283)
T cd05080 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAAR 136 (283)
T ss_pred HHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChh
Confidence 568899999999998742 357899999999999999975 45999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++........ .....++..|++||.+.. ..++.++||||||+++|+|++|.
T Consensus 137 Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 137 NVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE--------NKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred eEEEcCC-CcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc--------cCCCcccccHHHHHHHHHHHhCC
Confidence 9999855 5699999999875433221 122245667999998753 56788999999999999999999
Q ss_pred CCCCCCCcHH--------------HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQ--------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 155 ~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.||....... ............+.+..++..+.+++.+||+.+|++|||++++++.|+.+
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 9986433211 01111112223344567889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=247.61 Aligned_cols=203 Identities=33% Similarity=0.540 Sum_probs=165.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..+++|||+++++|.+++.......+++..+..++.|++.||.+||+.|++|+||||+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 134 (261)
T cd05068 55 MKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNV 134 (261)
T ss_pred HHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceE
Confidence 56789999999999884 55789999999999999999764445699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc--cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||++......... .....+..|+|||.... ..++.++|+||||+++|+|++ |..||
T Consensus 135 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~ 205 (261)
T cd05068 135 LVGEN-NICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY--------NRFSIKSDVWSFGILLTEIVTYGRMPY 205 (261)
T ss_pred EEcCC-CCEEECCcceEEEccCCcccccCCCcCceeccCcccccc--------CCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 99965 45999999998765422111 11123457999998753 567889999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.+...... ............+..++..+.+++.+||..+|.+||++.++++.|+.+
T Consensus 206 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 206 PGMTNAEV-LQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCHHHH-HHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 76554332 233333444455677899999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=246.76 Aligned_cols=199 Identities=32% Similarity=0.599 Sum_probs=162.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05114 53 MMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNC 131 (256)
T ss_pred HHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceE
Confidence 56789999999999984 557899999999999999987532 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+........ .....++..|+|||.+.. ..++.++|+||||+++|+|++ |+.||
T Consensus 132 ~i~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s~G~~l~el~~~g~~p~ 202 (256)
T cd05114 132 LVSST-GVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF--------SKYSSKSDVWSFGVLMWEVFTEGKMPF 202 (256)
T ss_pred EEcCC-CeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc--------CccchhhhhHHHHHHHHHHHcCCCCCC
Confidence 99854 5699999998875432221 122234567999998853 567889999999999999999 89999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
...+.... ............+...+..+.+++.+||..+|++|||++++++.|
T Consensus 203 ~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 203 EKKSNYEV-VEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCHHHH-HHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 76654333 333344445555667889999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=247.75 Aligned_cols=202 Identities=31% Similarity=0.525 Sum_probs=168.0
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++.+.++..+++|||+.+++|.+++.......+++.++..++.|++.||+|||+.|++|+||+|+||+
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~ 134 (260)
T cd05067 55 MKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134 (260)
T ss_pred HHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEE
Confidence 56889999999999987778999999999999999997655567999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|++++ |..||.
T Consensus 135 i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~ 205 (260)
T cd05067 135 VSET-LCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTYGRIPYP 205 (260)
T ss_pred EcCC-CCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc--------CCcCcccchHHHHHHHHHHHhCCCCCCC
Confidence 9955 5699999999875442211 122345678999998853 557889999999999999998 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
+.+... ...........+.+...+.++.+++.+||..+|++||+++++++.|+.
T Consensus 206 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 206 GMTNPE-VIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCChHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 765433 333334444556667788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=248.18 Aligned_cols=204 Identities=29% Similarity=0.560 Sum_probs=168.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+
T Consensus 61 l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil 139 (270)
T cd05056 61 MRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139 (270)
T ss_pred HHhCCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE
Confidence 5678999999999999888889999999999999999763 345899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccc--cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||++......... ....++..|+|||.+.. ..++.++||||||+++|++++ |..||.
T Consensus 140 i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~pf~ 210 (270)
T cd05056 140 VSSP-DCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMLGVKPFQ 210 (270)
T ss_pred EecC-CCeEEccCceeeecccccceecCCCCccccccChhhhcc--------CCCCchhhhHHHHHHHHHHHHcCCCCCC
Confidence 9955 56999999998754332211 12233467999998753 567889999999999999986 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
........ ...........+..++..+.+++.+|+..+|.+|||+.++++.|..+..
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 211 GVKNNDVI-GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred CCCHHHHH-HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 76654333 3334445556677889999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=252.52 Aligned_cols=199 Identities=25% Similarity=0.402 Sum_probs=159.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++.++||||+++.+++. +...++||||++|++|.+++... ....+++..++.++.|++.||+|||+.||+|+||||+
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 126 (280)
T cd05608 47 LAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPE 126 (280)
T ss_pred HHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 56789999999999874 55789999999999999888542 2356999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||
T Consensus 127 Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~pf 197 (280)
T cd05608 127 NVLLDND-GNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG--------EEYDFSVDYFALGVTLYEMIAARGPF 197 (280)
T ss_pred HEEECCC-CCEEEeeCccceecCCCCccccccCCCcCccCHHHhcC--------CCCCccccHHHHHHHHHHHHhCCCCC
Confidence 9999854 569999999987543322 2233468899999999864 56788999999999999999999999
Q ss_pred CCCCcHHHH--HHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 158 EGMSNLQAA--YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
......... ...........++..++..+.+++.+||+.+|++|| +++++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 198 RARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 764432111 111122233445667899999999999999999999 6788877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=259.05 Aligned_cols=191 Identities=28% Similarity=0.365 Sum_probs=157.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. .+..++||||++|++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 50 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NI 127 (321)
T cd05603 50 LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENI 127 (321)
T ss_pred HHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 46789999999999884 4578999999999999998875 45689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|++.|+|||.+.. ..++.++|||||||++|+|++|..||..
T Consensus 128 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~ 198 (321)
T cd05603 128 LLDSQ-GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK--------EPYDRTVDWWCLGAVLYEMLYGLPPFYS 198 (321)
T ss_pred EECCC-CCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC--------CCCCCcCcccccchhhhhhhcCCCCCCC
Confidence 99965 4699999999875322 222334568999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.+... .... .......++...+..+.+++.+||+.+|.+|+++.
T Consensus 199 ~~~~~-~~~~-i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 199 RDVSQ-MYDN-ILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCHHH-HHHH-HhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 65332 2222 22334566778899999999999999999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=247.12 Aligned_cols=202 Identities=31% Similarity=0.535 Sum_probs=165.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. .+..+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.||+|+||+|.||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred HHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 56789999999999874 55789999999999999999763 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..|
T Consensus 138 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Dv~slG~~l~~l~~~g~~p 208 (266)
T cd05033 138 LVNSN-LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSYGERP 208 (266)
T ss_pred EEcCC-CCEEECccchhhcccccccceeccCCCCCccccChhhhcc--------CCCccccchHHHHHHHHHHHccCCCC
Confidence 99955 569999999998654211 1112234567999998853 567889999999999999998 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
|........ ..........+.+..++..+.+++.+||+.+|++||++.++++.|..+
T Consensus 209 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 209 YWDMSNQDV-IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 976554332 233333344455677899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=257.22 Aligned_cols=201 Identities=25% Similarity=0.410 Sum_probs=161.7
Q ss_pred CCCCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|..-.+|.||+++-+|+|. ++||||||++||++-.++.. ...+++..+..++.+++.|++.||+.|++||||||+|+
T Consensus 195 L~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNl 272 (550)
T KOG0605|consen 195 LAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNL 272 (550)
T ss_pred hhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhe
Confidence 3446789999999999765 79999999999999999986 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc----------------------cccc--------------------------cCccCc
Q 024401 81 LLTPDQKSLKLADFGLAREETV----------------------TEMM--------------------------TAETGT 112 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~----------------------~~~~--------------------------~~~~~~ 112 (268)
|||..|+ +||+|||++..... .... ...+||
T Consensus 273 LiD~~GH-iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGT 351 (550)
T KOG0605|consen 273 LIDAKGH-IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGT 351 (550)
T ss_pred eecCCCC-EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCC
Confidence 9997765 99999999852100 0000 023699
Q ss_pred cceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhh--cCCCCCCCCcHHHHHHH
Q 024401 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIV 190 (268)
Q Consensus 113 ~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li 190 (268)
|.|+|||++.+ ..|+..+|.||||||+||||.|.+||.+.+..........-. ...+....++++..+||
T Consensus 352 PDYiAPEVll~--------kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI 423 (550)
T KOG0605|consen 352 PDYIAPEVLLG--------KGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLI 423 (550)
T ss_pred ccccchHHHhc--------CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHH
Confidence 99999999975 668999999999999999999999999877655444333222 22223345789999999
Q ss_pred HHhhhhCCCCCC---CHHHHHHHHHhhhh
Q 024401 191 QSCWVEDPNLRP---SFSQIIRMLNAFLF 216 (268)
Q Consensus 191 ~~~l~~~p~~Rp---s~~~~l~~l~~~~~ 216 (268)
.+||. ||.+|. .++||.+ +.++.
T Consensus 424 ~rll~-d~~~RLG~~G~~EIK~--HPfF~ 449 (550)
T KOG0605|consen 424 TRLLC-DPENRLGSKGAEEIKK--HPFFK 449 (550)
T ss_pred HHHhc-CHHHhcCcccHHHHhc--CCccc
Confidence 99999 999996 5777776 44543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=259.67 Aligned_cols=198 Identities=27% Similarity=0.401 Sum_probs=160.0
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|+.+ +||||+++++++. ++..++||||++||+|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~N 135 (332)
T cd05614 58 LEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLEN 135 (332)
T ss_pred HHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHH
Confidence 3456 5899999999884 5578999999999999999975 3569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||++.+ +.++|+|||++....... ......|+..|+|||.+.+ ...++.++|||||||++|+|++|..||
T Consensus 136 ili~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~elltg~~pf 207 (332)
T cd05614 136 ILLDSE-GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRG-------KGGHGKAVDWWSLGILIFELLTGASPF 207 (332)
T ss_pred eEECCC-CCEEEeeCcCCccccccCCCccccccCCccccCHHHhcC-------CCCCCCccccccchhhhhhhhcCCCCC
Confidence 999965 469999999987543221 2234568999999998853 234678999999999999999999999
Q ss_pred CCCC--cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 158 EGMS--NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 158 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.... ..............+.++..++..+.+++.+||..+|++|| +++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 208 TLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 6432 22222223333455667778999999999999999999999 6778876
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=253.51 Aligned_cols=198 Identities=27% Similarity=0.430 Sum_probs=155.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++ +|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni 134 (288)
T cd07871 57 LKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL 134 (288)
T ss_pred HHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 56789999999999985 4468999999965 999988752 34589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+.+ ...++.++||||+||++|+|++|+.||.+
T Consensus 135 l~~~~-~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 135 LINEK-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG-------STEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred EECCC-CCEEECcCcceeeccCCCccccCceecccccChHHhcC-------CcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99965 46999999998754322 22234467889999998753 24578899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhc--------------------CCC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHA--------------------RPG--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~--------------------~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+..+.......... .+. ....++.++.+++.+||..||.+|||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 554333221111000 000 01246788999999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=257.25 Aligned_cols=205 Identities=25% Similarity=0.438 Sum_probs=179.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+-.+|||||++|++.. ...+|+|.|.-++|+|.|||-.+ ..++.+..+.+++.||+.|+.|+|+..+|||||||+||
T Consensus 71 MKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKH-e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENV 149 (864)
T KOG4717|consen 71 MKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKH-EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENV 149 (864)
T ss_pred HHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhh-hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCccee
Confidence 35579999999999984 55799999999999999999874 47899999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
.+...-+.|||+|||++..+..+....+.+|+..|.|||.+.+ .....++.||||||+|+|-|++|+.||+..
T Consensus 150 VFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLG-------DsYDAPAVDiWSLGVILyMLVCGq~PFqeA 222 (864)
T KOG4717|consen 150 VFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLG-------DSYDAPAVDIWSLGVILYMLVCGQPPFQEA 222 (864)
T ss_pred EEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhc-------CccCCcchhhhHHHHHHHHHHhCCCccccc
Confidence 9987778899999999998888888888999999999999975 233346899999999999999999999987
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.+.+... ++.......|..++.++++||..||..||.+|.+.++|.. ..|+...
T Consensus 223 NDSETLT--mImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s--~~Wlq~~ 276 (864)
T KOG4717|consen 223 NDSETLT--MIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS--TSWLQAG 276 (864)
T ss_pred cchhhhh--hhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc--cccccCC
Confidence 7666544 3445566778899999999999999999999999999987 5555433
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=251.64 Aligned_cols=204 Identities=33% Similarity=0.626 Sum_probs=165.7
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh--------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
++++ +||||+++++++. ++..+++|||+++++|.+++... ....+++..++.++.|++.||+||
T Consensus 69 l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L 148 (293)
T cd05053 69 MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL 148 (293)
T ss_pred HHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence 3456 7999999999984 55789999999999999999642 234589999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.||+|+||||.||+++.+ +.++|+|||.+........ .....++..|+|||.+.. ..++.++||||
T Consensus 149 H~~~ivH~dlkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s 219 (293)
T cd05053 149 ASKKCIHRDLAARNVLVTED-HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWS 219 (293)
T ss_pred HHCCccccccceeeEEEcCC-CeEEeCccccccccccccceeccCCCCCCccccCHHHhcc--------CCcCcccceee
Confidence 99999999999999999855 5699999999875433221 112234567999998753 56788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
|||++|++++ |..||...... ..............+...+..+.+++.+||..+|++|||+.++++.|+.++
T Consensus 220 lG~il~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 220 FGVLLWEIFTLGGSPYPGIPVE-ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred hhhHHHHHhcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 9999999997 89998765543 333344444455666778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=263.90 Aligned_cols=197 Identities=26% Similarity=0.438 Sum_probs=161.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+..++||||+++++.+. ++..++||||++|++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI 132 (350)
T cd05573 55 LADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI 132 (350)
T ss_pred HHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 56789999999999885 55799999999999999999863 5799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc------------------------------cccCccCccceecccccccccccccc
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE------------------------------MMTAETGTYRWMAPELYSTVTLRQGE 130 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 130 (268)
+++.+ +.++|+|||++....... ......|++.|+|||.+.+
T Consensus 133 ll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------- 204 (350)
T cd05573 133 LIDAD-GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG------- 204 (350)
T ss_pred EECCC-CCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcC-------
Confidence 99965 469999999987543322 2234468999999999864
Q ss_pred ccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCC-HHHH
Q 024401 131 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPS-FSQI 207 (268)
Q Consensus 131 ~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps-~~~~ 207 (268)
..++.++|||||||++|+|++|+.||.....................+ ..+++++.+++.+|+. +|.+|++ ++++
T Consensus 205 -~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~l 282 (350)
T cd05573 205 -TPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEI 282 (350)
T ss_pred -CCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHH
Confidence 577899999999999999999999998766444333322211122222 3469999999999997 9999999 9999
Q ss_pred HHH
Q 024401 208 IRM 210 (268)
Q Consensus 208 l~~ 210 (268)
+++
T Consensus 283 l~h 285 (350)
T cd05573 283 KSH 285 (350)
T ss_pred hcC
Confidence 983
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=248.61 Aligned_cols=205 Identities=27% Similarity=0.522 Sum_probs=166.7
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
++.++||||+++++.+.....+++++|+++|+|.+++... ...+++.+++.++.|++.||+|||+.|++|+||||+||+
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil 141 (279)
T cd05109 63 MAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVL 141 (279)
T ss_pred HHhcCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence 4578999999999999777789999999999999999752 346899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.++|+|||+++....... .....++..|++||.... ..++.++|||||||++|||++ |..||
T Consensus 142 ~~~~-~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~t~g~~p~ 212 (279)
T cd05109 142 VKSP-NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH--------RRFTHQSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred EcCC-CcEEECCCCceeecccccceeecCCCccchhhCCHHHhcc--------CCCCchhHHHHHHHHHHHHHcCCCCCC
Confidence 9854 4599999999875433221 112234567999998853 567889999999999999998 89998
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
....... ...........+.+..++..+.+++.+||..+|++||++.++++.|......
T Consensus 213 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 213 DGIPARE-IPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCCCHHH-HHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 7654432 2233333444555667899999999999999999999999999988776543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=247.00 Aligned_cols=199 Identities=30% Similarity=0.482 Sum_probs=167.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++||||+++++|.+++.......+++..+..++.+++.+|+|||+.|++|+||+|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni 132 (256)
T cd08220 53 LKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNI 132 (256)
T ss_pred HhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 57889999999999874 56789999999999999999875555689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.++..++|+|||.+.............++..|+|||.+.. ..++.++|+||||+++|+|++|..||...
T Consensus 133 l~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 133 LLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEG--------KPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred EEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccC--------CCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 9987766789999999986654444444567889999998853 55678999999999999999999999765
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.. ..............+..++.++.+++.+||..+|.+|||+.++++
T Consensus 205 ~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 205 NLP-ALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred chH-HHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 543 333333344445566778999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=248.99 Aligned_cols=201 Identities=32% Similarity=0.579 Sum_probs=162.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
++.++||||+++++++. ++..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.|++|
T Consensus 63 l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH 142 (277)
T cd05062 63 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVH 142 (277)
T ss_pred HHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 46789999999999984 4578999999999999999975321 23577889999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|+
T Consensus 143 ~dlkp~Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~e 213 (277)
T cd05062 143 RDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWE 213 (277)
T ss_pred CCcchheEEEcCC-CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc--------CCcCchhHHHHHHHHHHH
Confidence 9999999999955 5699999999874332211 112345678999998853 567889999999999999
Q ss_pred HHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 150 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 150 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
|++ |..||.+... ...............+..++..+.+++.+||+.+|++|||+.++++.|+
T Consensus 214 l~~~~~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 214 IATLAEQPYQGMSN-EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCCCCCCCCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 998 7888876554 3333333344445666778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=257.93 Aligned_cols=206 Identities=37% Similarity=0.575 Sum_probs=159.7
Q ss_pred CCCCCCCCcccceeeeee-cC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CeecCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---IIHRDL 75 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dl 75 (268)
+|++++|||+|+++|+|. ++ ..+||+||+++|+|.+++.......++|.++++|+.+++.||+|||+.. |+||||
T Consensus 124 ~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDi 203 (361)
T KOG1187|consen 124 ILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDI 203 (361)
T ss_pred HHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCC
Confidence 367899999999999995 44 3899999999999999998733227999999999999999999999964 999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcc-cccccCc-cCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
|++|||+|.+ ...||+|||+++.... ....... .||.+|++||++.. +..+.++||||||+++.|+++|
T Consensus 204 KssNILLD~~-~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~--------g~lt~KsDVySFGVvllElitg 274 (361)
T KOG1187|consen 204 KSSNILLDED-FNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST--------GKLTEKSDVYSFGVVLLELITG 274 (361)
T ss_pred CHHHeeECCC-CCEEccCccCcccCCccccceeeecCCCCccCChhhhcc--------CCcCcccccccchHHHHHHHhC
Confidence 9999999955 6699999999975544 3332333 79999999999853 7789999999999999999999
Q ss_pred CCCCCCCC-----cHHHHHHHHHh------hcCCCCC-CCCc-----HHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 154 RLPFEGMS-----NLQAAYAAAFK------HARPGLP-EDIS-----PDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 154 ~~p~~~~~-----~~~~~~~~~~~------~~~~~~~-~~~~-----~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
+.+.+... ........... ...+.+. ..++ ..+..+..+|++.+|..||++.++++.|+...
T Consensus 275 r~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 275 RKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred CcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 98776432 11111111111 1122222 2333 23667889999999999999999999885544
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=246.50 Aligned_cols=201 Identities=36% Similarity=0.633 Sum_probs=168.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
++.++||||+++++++. +...+++|||+++++|.+++.... ...+++.+++.++.|++.||+|||+.|++|+
T Consensus 50 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~ 129 (262)
T cd00192 50 MKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHR 129 (262)
T ss_pred HhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence 56788999999999984 457899999999999999998632 3669999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
||+|+||+++.+ +.++|+|||.+...... .......++..|+|||.+.. ..++.++||||||+++|+|
T Consensus 130 di~p~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 200 (262)
T cd00192 130 DLAARNCLVGED-LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKD--------GIFTSKSDVWSFGVLLWEI 200 (262)
T ss_pred ccCcceEEECCC-CcEEEcccccccccccccccccccCCCcCccccCHHHhcc--------CCcchhhccHHHHHHHHHH
Confidence 999999999965 56999999999765443 22233456788999998753 4678899999999999999
Q ss_pred Hh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 151 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 151 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
++ |..||...+. ...............+..++.++.+++.+||..+|++|||+.++++.|+
T Consensus 201 ~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 201 FTLGATPYPGLSN-EEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred HhcCCCCCCCCCH-HHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 99 6999987654 3333444445566677888999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=249.13 Aligned_cols=202 Identities=31% Similarity=0.566 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
+++++||||+++++++ .....+++|||++|++|.+++...+. ..+++..+..++.|++.||+|||+.|++|+||
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 142 (277)
T cd05036 63 MSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDI 142 (277)
T ss_pred HHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccc
Confidence 5678999999999987 45578999999999999999976432 25899999999999999999999999999999
Q ss_pred CCCCEEEcCCC--CceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 76 KPDNLLLTPDQ--KSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 76 k~~Nil~~~~~--~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
||+||+++.++ ..++|+|||++........ ......+..|+|||.+.+ ..++.++|||||||++|+|
T Consensus 143 kp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~el 214 (277)
T cd05036 143 AARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD--------GIFTSKTDVWSFGVLLWEI 214 (277)
T ss_pred chheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhc--------CCcCchhHHHHHHHHHHHH
Confidence 99999998543 3589999999875432211 112233567999998853 5688999999999999999
Q ss_pred Hh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 151 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 151 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
++ |..||...+.. ..............+..++..+.+++.+||+.+|++|||+.+++++|.
T Consensus 215 ~~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 215 FSLGYMPYPGRTNQ-EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 97 99999865543 333333444455667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=253.65 Aligned_cols=197 Identities=26% Similarity=0.354 Sum_probs=155.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..++||||++++.+..+... ...+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 131 (287)
T cd07848 54 LRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL 131 (287)
T ss_pred HHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 56789999999999884 5678999999988777655443 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.
T Consensus 132 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslGvil~el~~g~~pf~ 202 (287)
T cd07848 132 LISHN-DVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG--------APYGKAVDMWSVGCILGELSDGQPLFP 202 (287)
T ss_pred EEcCC-CcEEEeeccCcccccccccccccccccccccCCcHHHcC--------CCCCCchhHHhHHHHHHHHHhCCCCCC
Confidence 99855 569999999987643322 1233468899999998853 557889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhh-------------------c-CC----------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 024401 159 GMSNLQAAYAAAFKH-------------------A-RP----------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~-------------------~-~~----------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l 208 (268)
..+............ . .+ .....++.++.+++.+||+.||.+|||+++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l 282 (287)
T cd07848 203 GESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCL 282 (287)
T ss_pred CCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 765443322211100 0 00 00123678899999999999999999999998
Q ss_pred H
Q 024401 209 R 209 (268)
Q Consensus 209 ~ 209 (268)
+
T Consensus 283 ~ 283 (287)
T cd07848 283 N 283 (287)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=257.98 Aligned_cols=207 Identities=24% Similarity=0.366 Sum_probs=158.3
Q ss_pred CCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
++.++||||+++++++.. ...|+||||+ +++|.+++.. ...+++..+..++.|++.||+|||+.||+||||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 129 (338)
T cd07859 53 LRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDL 129 (338)
T ss_pred HHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 567899999999998622 2479999999 5699999875 346999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ....++.++|||||||++|+|+
T Consensus 130 kp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~~~~~~~DvwSlGvvl~el~ 202 (338)
T cd07859 130 KPKNILANAD-CKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS------FFSKYTPAIDIWSIGCIFAEVL 202 (338)
T ss_pred CHHHeEECCC-CcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc------cccccCchhHHHHHHHHHHHHH
Confidence 9999999955 569999999987532211 1133468999999998742 1246788999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHH----------------------HHhhcCCC-------CCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAA----------------------AFKHARPG-------LPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~----------------------~~~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|+.||.+.+........ ........ ....++..+.+++.+||..+|++||
T Consensus 203 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 282 (338)
T cd07859 203 TGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282 (338)
T ss_pred cCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC
Confidence 999999765432211100 00000000 0124677899999999999999999
Q ss_pred CHHHHHHHHHhhhhhcCC
Q 024401 203 SFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~~~ 220 (268)
|++++++ +.++.....
T Consensus 283 t~~e~l~--hp~f~~~~~ 298 (338)
T cd07859 283 TAEEALA--DPYFKGLAK 298 (338)
T ss_pred CHHHHhc--CchhhhcCc
Confidence 9999998 666655444
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=258.43 Aligned_cols=194 Identities=27% Similarity=0.448 Sum_probs=158.1
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.+||||+++++++. ++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus 53 ~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~ 130 (329)
T cd05618 53 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 130 (329)
T ss_pred CCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC
Confidence 48999999999884 5578999999999999998865 35699999999999999999999999999999999999999
Q ss_pred CCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC-
Q 024401 84 PDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS- 161 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~- 161 (268)
.+ +.++|+|||++..... ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||....
T Consensus 131 ~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (329)
T cd05618 131 SE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 201 (329)
T ss_pred CC-CCEEEeeCCccccccCCCCccccccCCccccCHHHHcC--------CCCCCccceecccHHHHHHhhCCCCCccCCC
Confidence 65 4599999999875322 222334578999999998854 567889999999999999999999995211
Q ss_pred ------cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC------HHHHHH
Q 024401 162 ------NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS------FSQIIR 209 (268)
Q Consensus 162 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps------~~~~l~ 209 (268)
................+|..++..+.+++.+||..+|.+|++ +.++++
T Consensus 202 ~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05618 202 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 261 (329)
T ss_pred cCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence 111222223334455677889999999999999999999998 467765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=255.08 Aligned_cols=193 Identities=30% Similarity=0.480 Sum_probs=158.9
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.++||||+++++++. ++..++||||++||+|.+++.. ...+++.++..++.|++.||+|||+.|++||||||+||++
T Consensus 52 ~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~ 129 (316)
T cd05619 52 AWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129 (316)
T ss_pred ccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE
Confidence 358999999999984 5578999999999999999975 3568999999999999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 83 TPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
+.+ +.++|+|||++..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...+
T Consensus 130 ~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 130 DTD-GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG--------QKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred CCC-CCEEEccCCcceECCCCCCceeeecCCccccCHHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 965 4699999999874322 122234568999999998853 567889999999999999999999998765
Q ss_pred cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 024401 162 NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 209 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~l~ 209 (268)
....... .....+.++..++.++.+++.+||..+|.+|+++. ++++
T Consensus 201 ~~~~~~~--i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 201 EEELFQS--IRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred HHHHHHH--HHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 4332222 22334556677899999999999999999999996 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=249.34 Aligned_cols=203 Identities=27% Similarity=0.480 Sum_probs=165.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh--------------CCCCCCHHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
++.++||||+++++++. .+..++++||+.+++|.+++... ....+++..++.++.|++.||+|||
T Consensus 62 ~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH 141 (283)
T cd05091 62 RSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS 141 (283)
T ss_pred HhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 46789999999999984 45789999999999999998531 1234888999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
+.|++||||||.||+++.+ ..++|+|||+++....... .....+++.|+|||.+.. ..++.++|||||
T Consensus 142 ~~gi~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~sl 212 (283)
T cd05091 142 SHHVVHKDLATRNVLVFDK-LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY--------GKFSIDSDIWSY 212 (283)
T ss_pred HcCccccccchhheEecCC-CceEecccccccccccchheeeccCccCCccccCHHHHhc--------CCCCcchhHHHH
Confidence 9999999999999999855 4599999999875433221 123345678999998753 557889999999
Q ss_pred HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 144 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 144 G~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
|+++|+|++ |..||.+.... ..............+..++..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 213 G~~l~el~~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 283 (283)
T cd05091 213 GVVLWEVFSYGLQPYCGYSNQ-DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283 (283)
T ss_pred HHHHHHHHcCCCCCCCCCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence 999999998 88888765543 33444444555566788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=249.33 Aligned_cols=201 Identities=32% Similarity=0.591 Sum_probs=164.4
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
|+.++||||+++++++ .+...+++|||+++++|.+++..... ..+++..++.++.|++.||+|||+.|++|
T Consensus 63 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 142 (277)
T cd05032 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVH 142 (277)
T ss_pred HHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 5678999999999997 45579999999999999999975221 23688899999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
+||+|+||+++.+ +.++|+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|+
T Consensus 143 ~di~p~nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e 213 (277)
T cd05032 143 RDLAARNCMVAED-LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTKSDVWSFGVVLWE 213 (277)
T ss_pred cccChheEEEcCC-CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhc--------CCCCcccchHHHHHHHHH
Confidence 9999999999965 569999999987543221 1123345678999998753 567889999999999999
Q ss_pred HHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 150 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 150 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
+++ |..||...+.... ............+..++..+.+++.+||..+|++|||+.++++.|+
T Consensus 214 l~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 214 MATLAEQPYQGLSNEEV-LKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hhccCCCCCccCCHHHH-HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 998 8999976654333 3333344556677788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=256.27 Aligned_cols=193 Identities=27% Similarity=0.393 Sum_probs=159.4
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.+||||+++++++. ++..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus 53 ~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~ 130 (321)
T cd05591 53 AKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLD 130 (321)
T ss_pred cCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 47999999999985 4578999999999999999875 35699999999999999999999999999999999999999
Q ss_pred CCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 84 PDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
.+ +.++|+|||++..... ........|+..|+|||.+.. ..++.++|||||||++|+|++|+.||...+.
T Consensus 131 ~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~tg~~Pf~~~~~ 201 (321)
T cd05591 131 AE-GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE--------LEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201 (321)
T ss_pred CC-CCEEEeecccceecccCCccccccccCccccCHHHHcC--------CCCCCccceechhHHHHHHhcCCCCCCCCCH
Confidence 65 4699999999875322 222334568999999998853 5678899999999999999999999987654
Q ss_pred HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-------CHHHHHHH
Q 024401 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-------SFSQIIRM 210 (268)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-------s~~~~l~~ 210 (268)
..... . ........+..++.++.+++.+||..+|++|+ ++.+++++
T Consensus 202 ~~~~~-~-i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 202 DDLFE-S-ILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHH-H-HHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 33322 2 22333445667899999999999999999999 78888863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=244.67 Aligned_cols=200 Identities=35% Similarity=0.607 Sum_probs=165.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Ni 133 (256)
T cd05039 54 MTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNV 133 (256)
T ss_pred HHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceE
Confidence 56789999999999985 56789999999999999999864444699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~ 159 (268)
+++.+ +.++|+|||.+........ ....+..|+|||.+.. ..++.++|+||||+++|++++ |..||..
T Consensus 134 li~~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~~~ 202 (256)
T cd05039 134 LVSED-LVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred EEeCC-CCEEEcccccccccccccc--cCCCcccccCchhhcC--------CcCCcHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 99955 5699999999976533222 2334567999998753 567789999999999999997 9999976
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
... ...............+..++..+.+++.+||..+|++|||++++++.|+.
T Consensus 203 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 203 IPL-KDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCH-HHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 543 33333333344555667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=245.69 Aligned_cols=197 Identities=28% Similarity=0.485 Sum_probs=158.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. +...++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.||+|+||||+||
T Consensus 53 l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~ni 131 (258)
T cd05078 53 MSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNV 131 (258)
T ss_pred HHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 56789999999999984 46789999999999999999763 34689999999999999999999999999999999999
Q ss_pred EEcCCCCc-------eEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 81 LLTPDQKS-------LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 81 l~~~~~~~-------~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
+++.++.. ++++|||.+...... ....++..|+|||.+.. ...++.++||||||+++|+|++|
T Consensus 132 li~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~~l~~g 201 (258)
T cd05078 132 LLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIEN-------PQNLSLAADKWSFGTTLWEIFSG 201 (258)
T ss_pred EEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccC-------CCCCCchhhHHHHHHHHHHHHcC
Confidence 99865443 799999988654332 23456778999998853 24467899999999999999998
Q ss_pred C-CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 154 R-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 154 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
. .|+...+.... . .........+...+.++.+++.+||+.+|++|||++++++.|+
T Consensus 202 ~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 202 GDKPLSALDSQKK-L--QFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred CCCChhhccHHHH-H--HHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 5 56554433222 1 1223345566677889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=269.18 Aligned_cols=200 Identities=31% Similarity=0.537 Sum_probs=173.7
Q ss_pred CCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 3 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKL--DLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++|+|.|||+++|.+ +++++-|.||-++||+|.+++.... +++ .+.+.-.+..||++||.|||+..|||||||.+|
T Consensus 627 ~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDN 705 (1226)
T KOG4279|consen 627 STLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDN 705 (1226)
T ss_pred HHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCc
Confidence 578999999999998 5667889999999999999998743 345 788999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.-.+.+||+|||-++.... ..-..+..||.-|||||++.. +...|+.++|||||||++.||.||++||.
T Consensus 706 VLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDq------G~RGYG~aADIWS~GCT~vEMATGrPPF~ 779 (1226)
T KOG4279|consen 706 VLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQ------GPRGYGKAADIWSFGCTMVEMATGRPPFV 779 (1226)
T ss_pred EEEeeccceEEecccccchhhccCCccccccccchhhhChHhhcc------CCcCCCchhhhhhccceeEeeccCCCCee
Confidence 99998888999999999875443 344567789999999999964 45778999999999999999999999998
Q ss_pred CCCcHHHHHHH-HHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAA-AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.....+...-. ..-...|++|..++.+.+.+|.+|+.++|.+||++.++++
T Consensus 780 ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 780 ELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred ecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 77766554332 2345678899999999999999999999999999999987
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=277.05 Aligned_cols=201 Identities=24% Similarity=0.428 Sum_probs=161.9
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC-------C
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHAN-------G 69 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~-------~ 69 (268)
|++|+||||+++++++.+ ..+|+||||+++++|.+++.... ...+++..++.|+.||+.||+|||+. +
T Consensus 66 L~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~ 145 (1021)
T PTZ00266 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER 145 (1021)
T ss_pred HHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence 568899999999998732 35899999999999999997532 35699999999999999999999985 4
Q ss_pred CeecCCCCCCEEEcCC----------------CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccC
Q 024401 70 IIHRDLKPDNLLLTPD----------------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKH 133 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~----------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 133 (268)
|+|+||||+|||++.+ ...++|+|||++.............+++.|+|||++.. ....
T Consensus 146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~g------e~~~ 219 (1021)
T PTZ00266 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLH------ETKS 219 (1021)
T ss_pred ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhc------cCCC
Confidence 9999999999999632 22489999999986554444445578999999998853 2345
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 134 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 134 ~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
++.++|||||||++|+|++|..||................... .....+.++.+||..||..+|.+||++.+++.
T Consensus 220 ~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 220 YDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 7889999999999999999999998766555444333322211 12457899999999999999999999999996
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=248.61 Aligned_cols=201 Identities=29% Similarity=0.542 Sum_probs=163.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC-------------CCCCHHHHHHHHHHHHHHHHHHHh
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-------------NKLDLHVALNFALDIARAMDCLHA 67 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-------------~~~~~~~~~~i~~ql~~~l~~lH~ 67 (268)
++.++||||+++++++. .+..+++|||+++++|.+++..... ..+++..+..++.|++.||+|||+
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~ 140 (280)
T cd05092 61 LTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS 140 (280)
T ss_pred HhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999885 4568999999999999999976432 348899999999999999999999
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
.|++|+||||+||+++.+ ..++|+|||++........ .....++..|+|||.+.. ..++.++||||||
T Consensus 141 ~~i~H~dlkp~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 211 (280)
T cd05092 141 LHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDIWSFG 211 (280)
T ss_pred CCeecccccHhhEEEcCC-CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc--------CCcCchhhHHHHH
Confidence 999999999999999954 5699999999864432211 122234678999998753 5678899999999
Q ss_pred HHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 145 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 145 ~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
|++|+|++ |..||......... ...........+..++..+.+++.+||..+|.+||++.++++.|.
T Consensus 212 ~il~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 212 VVLWEIFTYGKQPWYQLSNTEAI-ECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHHHHcCCCCCCccCCHHHHH-HHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 99999998 89999765543332 223333444556778999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=245.11 Aligned_cols=199 Identities=33% Similarity=0.616 Sum_probs=162.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..++||||++|++|.+++.... ..+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni 131 (256)
T cd05059 53 MMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNC 131 (256)
T ss_pred HHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhE
Confidence 56789999999999884 457899999999999999997633 4689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc--cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.++........ ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||
T Consensus 132 ~i~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~ 202 (256)
T cd05059 132 LVGED-NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDY--------SRFSSKSDVWSFGVLMWEVFSEGKMPY 202 (256)
T ss_pred EECCC-CcEEECCcccceecccccccccCCCCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHhccCCCCC
Confidence 99955 56999999998754332211 11223457999998853 567889999999999999998 89999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
...+.... ............+..++..+.+++.+||..+|++|||+.++++.|
T Consensus 203 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 203 ERFSNSEV-VESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCHHHH-HHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 76554333 333344445566677899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=255.08 Aligned_cols=191 Identities=28% Similarity=0.435 Sum_probs=159.2
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++++. .+..++||||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||||+||+++.
T Consensus 54 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~ 131 (318)
T cd05570 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDS 131 (318)
T ss_pred CCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECC
Confidence 7999999999884 4578999999999999999876 346999999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
+ +.++|+|||++..... ........++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..
T Consensus 132 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~ 202 (318)
T cd05570 132 E-GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY--------QPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202 (318)
T ss_pred C-CcEEecccCCCeecCcCCCcccceecCccccCHHHhcC--------CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH
Confidence 5 4699999999864322 222233468899999999854 56788999999999999999999999866543
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 209 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~l~ 209 (268)
.... ........++..++.++.+++.+||..+|.+||++ .++++
T Consensus 203 ~~~~--~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 203 ELFQ--SILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred HHHH--HHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3222 22334455667899999999999999999999999 88876
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=252.09 Aligned_cols=199 Identities=23% Similarity=0.400 Sum_probs=163.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++|+||+++++.+. ++..++||||++|++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05630 54 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENI 133 (285)
T ss_pred HHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHE
Confidence 56789999999999884 55789999999999999999765556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............++..|+|||.+.. ..++.++|+||+|+++|+|++|..||...
T Consensus 134 l~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 134 LLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred EECCC-CCEEEeeccceeecCCCccccCCCCCccccChHHHcC--------CCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 99965 4599999999875443333344578999999999853 56788999999999999999999999864
Q ss_pred CcHH--HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 161 SNLQ--AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 161 ~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
.... ..............+..++.++.+++.+||+.+|.+||| ++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 205 KKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred CccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 4321 122222222333456678999999999999999999999 889988
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=246.27 Aligned_cols=203 Identities=29% Similarity=0.546 Sum_probs=162.9
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSL----RPNKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
++.++||||+++++.+.. ...+++|||+.+++|.+++... ....+++..+..++.|++.||+|||+.||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 133 (272)
T cd05075 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSF 133 (272)
T ss_pred HHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 567899999999997621 2468999999999999988532 22458999999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
+|+||||+||+++.+ ..++|+|||++........ .....++..|++||.+.. ..++.++||||||+++
T Consensus 134 ~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Di~slG~il 204 (272)
T cd05075 134 IHRDLAARNCMLNEN-MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD--------RVYTTKSDVWSFGVTM 204 (272)
T ss_pred eccccchhheEEcCC-CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC--------CCcChHHHHHHHHHHH
Confidence 999999999999855 5699999999876543221 122245667999998853 5678899999999999
Q ss_pred HHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 148 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 148 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
|+|++ |..||...... ..............+..++..+.+++.+||..+|.+|||+.++++.|+.+
T Consensus 205 ~el~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 205 WEIATRGQTPYPGVENS-EIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHcCCCCCCCCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 99999 78999765543 33333344444455677889999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=261.28 Aligned_cols=205 Identities=26% Similarity=0.418 Sum_probs=162.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NI 173 (370)
T cd05621 97 MAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM 173 (370)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 46789999999999985 4579999999999999999975 3589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|++.+ +.++|+|||++....... ......||+.|+|||.+... .....++.++|+|||||++|+|++|..||.
T Consensus 174 Ll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~----~~~~~~~~~~DiwSlG~ilyell~G~~Pf~ 248 (370)
T cd05621 174 LLDKH-GHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248 (370)
T ss_pred EECCC-CCEEEEecccceecccCCceecccCCCCcccCCHHHHhcc----CCCCCCCcccCEEeehHHHHHHHhCCCCCC
Confidence 99955 569999999987643322 22355789999999998531 112347789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~--Rps~~~~l~~l~~~~~ 216 (268)
..+................++. .++..+.+++..||..++.. |+++.++++ +.++.
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~--hp~~~ 308 (370)
T cd05621 249 ADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ--HPFFK 308 (370)
T ss_pred CCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc--CcccC
Confidence 7665444333333223334443 46899999999999855543 889999998 44443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=258.36 Aligned_cols=191 Identities=29% Similarity=0.381 Sum_probs=157.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||++|++|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 50 l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NI 127 (325)
T cd05604 50 LKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENI 127 (325)
T ss_pred HHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 45789999999999884 5678999999999999998875 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..
T Consensus 128 ll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~G~~pf~~ 198 (325)
T cd05604 128 LLDSQ-GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK--------QPYDNTVDWWCLGAVLYEMLYGLPPFYC 198 (325)
T ss_pred EECCC-CCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC--------CCCCCcCccccccceehhhhcCCCCCCC
Confidence 99965 4699999999875322 222334568999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.+.... ..... ......+...+..+.+++.+||..+|.+||++.
T Consensus 199 ~~~~~~-~~~~~-~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 199 RDVAEM-YDNIL-HKPLVLRPGASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred CCHHHH-HHHHH-cCCccCCCCCCHHHHHHHHHHhccCHHhcCCCC
Confidence 654332 22222 223344556889999999999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=243.66 Aligned_cols=200 Identities=33% Similarity=0.598 Sum_probs=164.8
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++.+.++..+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.|++||||+|+||+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nil 132 (254)
T cd05083 53 MTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNIL 132 (254)
T ss_pred HHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEE
Confidence 56789999999999987777899999999999999998654456899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 160 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~ 160 (268)
++.+ +.++|+|||.+...... ......+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||...
T Consensus 133 i~~~-~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 133 VSED-GVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKH--------KKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred EcCC-CcEEECCCccceecccc--CCCCCCCceecCHHHhcc--------CCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 9865 46999999988754322 122234567999998753 567889999999999999997 99999766
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
+... .............+..++..+.+++.+||+.+|.+||+++++++.|+.
T Consensus 202 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 202 SLKE-VKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CHHH-HHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 5433 233333334444556788999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=246.44 Aligned_cols=196 Identities=24% Similarity=0.421 Sum_probs=156.7
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++ .++..++||||+++++|..++.. ....+++..+..++.|++.||+|||+.||+||||||.||
T Consensus 70 ~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Ni 148 (274)
T cd05076 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK-EKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNI 148 (274)
T ss_pred HhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccE
Confidence 5678999999999998 45578999999999999999865 235689999999999999999999999999999999999
Q ss_pred EEcCCC------CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH-hC
Q 024401 81 LLTPDQ------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL-TN 153 (268)
Q Consensus 81 l~~~~~------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll-~g 153 (268)
+++..+ ..++++|||.+...... ....++..|+|||.+.. ...++.++||||||+++|+++ +|
T Consensus 149 ll~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~-------~~~~~~~~Dv~slG~~l~el~~~g 218 (274)
T cd05076 149 LLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPG-------GNSLSTAADKWSFGTTLLEICFDG 218 (274)
T ss_pred EEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcC-------CCCCCcHHHHHHHHHHHHHHHhCC
Confidence 997432 23799999987543221 22356778999998753 245788999999999999985 68
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
..||.......... .. ......+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 219 ~~p~~~~~~~~~~~--~~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 219 EVPLKERTPSEKER--FY-EKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred CCCccccChHHHHH--HH-HhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 99997665433221 11 122334455678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=257.44 Aligned_cols=204 Identities=26% Similarity=0.426 Sum_probs=158.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. ++..++||||+++++|.+. ...++..+..++.||+.||+|||+.||+||||||+||
T Consensus 126 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 199 (353)
T PLN00034 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL 199 (353)
T ss_pred HHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 56789999999999984 5578999999999998753 2356788899999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......|+..|+|||.+.... ..+...+.++|||||||++|+|++|+.||..
T Consensus 200 ll~~~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 200 LINSA-KNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDL---NHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred EEcCC-CCEEEcccccceecccccccccccccCccccCcccccccc---ccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99955 56999999998754332 1223457899999999874210 0123345689999999999999999999974
Q ss_pred CCc--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
... ................+..++.++.+++.+||..+|++|||+.++++ +.++..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~--hp~~~~ 333 (353)
T PLN00034 276 GRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ--HPFILR 333 (353)
T ss_pred CCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Cccccc
Confidence 322 12222222233445556778999999999999999999999999998 555544
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=260.49 Aligned_cols=197 Identities=24% Similarity=0.400 Sum_probs=156.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||++||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Ni 132 (381)
T cd05626 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNI 132 (381)
T ss_pred HHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHE
Confidence 56789999999999985 4578999999999999999976 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc------------------------------------------------ccccCccCc
Q 024401 81 LLTPDQKSLKLADFGLAREETVT------------------------------------------------EMMTAETGT 112 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~------------------------------------------------~~~~~~~~~ 112 (268)
+++.+ +.++|+|||++...... .......||
T Consensus 133 li~~~-~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (381)
T cd05626 133 LIDLD-GHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGT 211 (381)
T ss_pred EECCC-CCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCC
Confidence 99955 56999999987532100 001124689
Q ss_pred cceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHH
Q 024401 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIV 190 (268)
Q Consensus 113 ~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li 190 (268)
..|+|||.+.. ..++.++|||||||++|+|++|..||...+................++ ..++.++.+++
T Consensus 212 ~~Y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli 283 (381)
T cd05626 212 PNYIAPEVLLR--------KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLI 283 (381)
T ss_pred ccccCHHHHcC--------CCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHH
Confidence 99999999853 567889999999999999999999998766544333332212222333 35889999999
Q ss_pred HHhh--hhCCCCCCCHHHHHH
Q 024401 191 QSCW--VEDPNLRPSFSQIIR 209 (268)
Q Consensus 191 ~~~l--~~~p~~Rps~~~~l~ 209 (268)
.+|+ ..++..|++++++++
T Consensus 284 ~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 284 TKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHccCcccccCCCCHHHHhc
Confidence 9854 556666999999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=243.57 Aligned_cols=207 Identities=31% Similarity=0.503 Sum_probs=167.0
Q ss_pred CCCCCCCCc-ccceeeee-ecC------CceEEEEcCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 1 MMSRVKHDN-LVKFLGAC-KDP------LMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 1 ~l~~l~Hp~-i~~~~~~~-~~~------~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
+|+.++|+| |+++++++ .++ .+++||||+ ..+|.+|+..... .+++...+..++.||+.||+|||++||
T Consensus 63 llk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~I 141 (323)
T KOG0594|consen 63 LLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGI 141 (323)
T ss_pred HHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 467899999 99999997 333 688999999 5599999987543 468889999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
+||||||.||+++.+ +.+||.|||+++.... .......++|.+|.|||++.+ ...|+...||||+|||+.|
T Consensus 142 lHRDLKPQNlLi~~~-G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlG-------s~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 142 LHRDLKPQNLLISSS-GVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLG-------STSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred ecccCCcceEEECCC-CcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcC-------CCcCCCCcchHhHHHHHHH
Confidence 999999999999964 5699999999996653 333556689999999999975 3578999999999999999
Q ss_pred HHhCCCCCCCCCcHHHHHHHHHhhcCC----------------CCC------------CCCcHHHHHHHHHhhhhCCCCC
Q 024401 150 LLTNRLPFEGMSNLQAAYAAAFKHARP----------------GLP------------EDISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 150 ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------~~~------------~~~~~~l~~li~~~l~~~p~~R 201 (268)
|++++.-|.+..+.+........-..+ .++ ...+....+++..||+.+|.+|
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 999999999888766655443221111 011 1122478899999999999999
Q ss_pred CCHHHHHHHHHhhhhhc
Q 024401 202 PSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 202 ps~~~~l~~l~~~~~~~ 218 (268)
.|++.+++ +.++...
T Consensus 294 ~Sa~~al~--h~yf~~~ 308 (323)
T KOG0594|consen 294 ISAKGALT--HPYFSEL 308 (323)
T ss_pred cCHHHHhc--Chhhccc
Confidence 99999998 4444433
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=263.99 Aligned_cols=190 Identities=28% Similarity=0.457 Sum_probs=164.8
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||.+++++..|+ .+++|+||||+.||++..++. ...|++..+..|+..++.||+|||++||+|||||.+|||+|.
T Consensus 427 ~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~ 503 (694)
T KOG0694|consen 427 RHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDT 503 (694)
T ss_pred cCCeEeecccccccCCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcc
Confidence 7999999999995 568999999999999444333 367999999999999999999999999999999999999998
Q ss_pred CCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
+++ +||.|||+++..- .+..+.+..||+.|+|||++.+ ..|+.+.|-||||+++||||.|..||++.++.
T Consensus 504 eGh-~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e--------~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 504 EGH-VKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE--------QSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred cCc-EEecccccccccCCCCCccccccCChhhcChhhhcc--------CcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 865 9999999998654 5667888999999999999965 88999999999999999999999999976643
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-C----HHHHHH
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-S----FSQIIR 209 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s----~~~~l~ 209 (268)
+. -..+....+.+|-.++.+...+++++|.++|++|. + +++|..
T Consensus 575 e~--FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~ 623 (694)
T KOG0694|consen 575 EV--FDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKK 623 (694)
T ss_pred HH--HHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhh
Confidence 33 23344556677888999999999999999999997 3 566655
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=245.82 Aligned_cols=198 Identities=28% Similarity=0.461 Sum_probs=164.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..+++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|.||
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~ni 131 (255)
T cd08219 52 LAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNI 131 (255)
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceE
Confidence 56789999999999984 55799999999999999998764556689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||..
T Consensus 132 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~p~~~ 202 (255)
T cd08219 132 FLTQN-GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN--------MPYNNKSDIWSLGCILYELCTLKHPFQA 202 (255)
T ss_pred EECCC-CcEEEcccCcceeecccccccccccCCccccCHHHHcc--------CCcCchhhhhhhchhheehhhccCCCCC
Confidence 99855 569999999987543322 2233467888999998753 5678899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+.... ..........+.+..++..+.+++.+||..+|++||++.+++.
T Consensus 203 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 203 NSWKNL-ILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred CCHHHH-HHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 554333 2333344455566778999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=254.22 Aligned_cols=201 Identities=21% Similarity=0.361 Sum_probs=154.8
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++ .++..++||||+++++|.+++.......+++..++.++.|++.||+|||+.||+|+||||+||
T Consensus 53 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Ni 132 (327)
T cd08227 53 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 132 (327)
T ss_pred HHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhE
Confidence 5678999999999998 466799999999999999999765556699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
+++.+ +.++++||+......... ......++..|+|||.+.. ....++.++|||||||++|+|++
T Consensus 133 l~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~ 205 (327)
T cd08227 133 LISVD-GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELAN 205 (327)
T ss_pred EEecC-CcEEEcccchhhccccccccccccccccccccceecccChHHhhc------ccCCCCchhhHHHHHHHHHHHHH
Confidence 99965 458999998654221110 1112345677999998853 12457889999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcC--------------------------------------------CCCCCCCcHHHHH
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHAR--------------------------------------------PGLPEDISPDLAF 188 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~l~~ 188 (268)
|..||.................. .+....+++.+.+
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (327)
T cd08227 206 GHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHH 285 (327)
T ss_pred CCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHH
Confidence 99999765433322111110000 0011235678999
Q ss_pred HHHHhhhhCCCCCCCHHHHHH
Q 024401 189 IVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 189 li~~~l~~~p~~Rps~~~~l~ 209 (268)
++.+||+.||++|||++++++
T Consensus 286 li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 286 FVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred HHHHHHhhCchhcCCHHHHhc
Confidence 999999999999999999998
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=261.17 Aligned_cols=196 Identities=24% Similarity=0.435 Sum_probs=156.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++.+. ++..++||||++||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI 132 (364)
T cd05599 55 LAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132 (364)
T ss_pred HHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 56789999999999985 4578999999999999999976 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc---------------------------------------cccCccCccceeccccc
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE---------------------------------------MMTAETGTYRWMAPELY 121 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~ 121 (268)
|++.+ +.++|+|||++....... ......||+.|+|||.+
T Consensus 133 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 211 (364)
T cd05599 133 LLDAK-GHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVF 211 (364)
T ss_pred EECCC-CCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHH
Confidence 99965 469999999886432110 00123589999999988
Q ss_pred cccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCC
Q 024401 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPN 199 (268)
Q Consensus 122 ~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~ 199 (268)
.. ..++.++|||||||++|+|++|..||...+................++. .+++++.+++.+|+. +|.
T Consensus 212 ~~--------~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~ 282 (364)
T cd05599 212 LQ--------TGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAE 282 (364)
T ss_pred cC--------CCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHh
Confidence 53 5678899999999999999999999987665443322221111222232 478999999999996 999
Q ss_pred CCCC---HHHHHH
Q 024401 200 LRPS---FSQIIR 209 (268)
Q Consensus 200 ~Rps---~~~~l~ 209 (268)
+|++ +.++++
T Consensus 283 ~R~~~~~~~~ll~ 295 (364)
T cd05599 283 RRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCHHHHhc
Confidence 9997 888887
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=258.54 Aligned_cols=206 Identities=23% Similarity=0.370 Sum_probs=157.0
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++||||+++++++. +...++++|++ +++|.+++.. ...+++.+++.++.|++.||+|||+.||+||||||+|
T Consensus 136 il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~N 212 (391)
T PHA03212 136 ILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAEN 212 (391)
T ss_pred HHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHh
Confidence 367899999999999884 55789999999 5699998875 3568999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc--ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|+++.+ +.++|+|||++...... .......||+.|+|||.+.. ..++.++|||||||++|+|++|..||
T Consensus 213 Ill~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~p~ 283 (391)
T PHA03212 213 IFINHP-GDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR--------DPYGPAVDIWSAGIVLFEMATCHDSL 283 (391)
T ss_pred EEEcCC-CCEEEEeCCcccccccccccccccccCccCCCChhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 999955 46999999998643221 22234578999999998853 56788999999999999999999876
Q ss_pred CCCCcH------HHHHHHH----------------------H---hhcCCCCC---------CCCcHHHHHHHHHhhhhC
Q 024401 158 EGMSNL------QAAYAAA----------------------F---KHARPGLP---------EDISPDLAFIVQSCWVED 197 (268)
Q Consensus 158 ~~~~~~------~~~~~~~----------------------~---~~~~~~~~---------~~~~~~l~~li~~~l~~~ 197 (268)
...... ....... . .......+ ..++.++.+++.+||..|
T Consensus 284 ~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~d 363 (391)
T PHA03212 284 FEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363 (391)
T ss_pred CCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCC
Confidence 432210 0000000 0 00000000 134668999999999999
Q ss_pred CCCCCCHHHHHHHHHhhhhhcCC
Q 024401 198 PNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 198 p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|.+|||++++++ +.++.....
T Consensus 364 P~~Rpta~elL~--hp~f~~~~~ 384 (391)
T PHA03212 364 AHHRPSAEALLD--FAAFQDIPD 384 (391)
T ss_pred hhhCCCHHHHhc--ChhhccCCC
Confidence 999999999998 666655433
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=249.35 Aligned_cols=197 Identities=28% Similarity=0.406 Sum_probs=156.1
Q ss_pred CCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 3 SRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
+.++||||+++++++.+ ...+++|||+. ++|.+++.......+++..+..++.|++.||+|||+.|++|+|||
T Consensus 57 ~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dik 135 (288)
T cd07863 57 EAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLK 135 (288)
T ss_pred hhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 35689999999998732 24789999996 599999876555569999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++|||||||++|+|++|..|
T Consensus 136 p~Nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~~ 206 (288)
T cd07863 136 PENILVTSG-GQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPL 206 (288)
T ss_pred HHHEEECCC-CCEEECccCccccccCcccCCCccccccccCchHhhC--------CCCCCcchhhhHHHHHHHHHhCCcC
Confidence 999999955 5699999999876544333344567889999998853 5678899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|.................. ......++..+.+++.+||+.||.+|||+.++++
T Consensus 207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 9765543332221110000 0111346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=261.89 Aligned_cols=196 Identities=22% Similarity=0.386 Sum_probs=155.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..|+||||++||+|.+++.. .+.+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NI 132 (377)
T cd05629 55 LAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI 132 (377)
T ss_pred HHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 56789999999999985 4579999999999999999975 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc------------------------------------------------cccCccCc
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE------------------------------------------------MMTAETGT 112 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~------------------------------------------------~~~~~~~~ 112 (268)
+++.+ +.++|+|||+++...... ......|+
T Consensus 133 ll~~~-~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (377)
T cd05629 133 LIDRG-GHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211 (377)
T ss_pred EECCC-CCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCC
Confidence 99855 569999999985321100 00023589
Q ss_pred cceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCC--CCcHHHHHHH
Q 024401 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIV 190 (268)
Q Consensus 113 ~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li 190 (268)
+.|+|||.+.. ..++.++|||||||++|+|++|..||...+................++. .++.++.+++
T Consensus 212 ~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli 283 (377)
T cd05629 212 PDYIAPEIFLQ--------QGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLI 283 (377)
T ss_pred ccccCHHHHcc--------CCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHH
Confidence 99999998853 5678899999999999999999999987654333222221112223333 4789999999
Q ss_pred HHhhhhCCCCC---CCHHHHHH
Q 024401 191 QSCWVEDPNLR---PSFSQIIR 209 (268)
Q Consensus 191 ~~~l~~~p~~R---ps~~~~l~ 209 (268)
.+||. +|.+| +++.++++
T Consensus 284 ~~lL~-~~~~r~~r~~~~~~l~ 304 (377)
T cd05629 284 RRLIT-NAENRLGRGGAHEIKS 304 (377)
T ss_pred HHHhc-CHhhcCCCCCHHHHhc
Confidence 99997 66665 59999888
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=261.42 Aligned_cols=202 Identities=27% Similarity=0.522 Sum_probs=177.0
Q ss_pred CCCCCCCCcccceeeeeecC---CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCC
Q 024401 1 MMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDL 75 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dl 75 (268)
||+.|+||||+++|.+|.+. ...+|+|.+..|+|..|++.+ +.++...+..|+.||+.||.|||++. |+||||
T Consensus 94 lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDL 171 (632)
T KOG0584|consen 94 LLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDL 171 (632)
T ss_pred HHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCcccccc
Confidence 58899999999999998433 478999999999999999874 56889999999999999999999995 999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
|-+||||+.+-+.|||+|+|++......... ..+|||.|||||++. ..|....||||||+++.||+|+.+
T Consensus 172 KCDNIFinG~~G~VKIGDLGLAtl~r~s~ak-svIGTPEFMAPEmYE---------E~YnE~VDVYaFGMCmLEMvT~eY 241 (632)
T KOG0584|consen 172 KCDNIFVNGNLGEVKIGDLGLATLLRKSHAK-SVIGTPEFMAPEMYE---------ENYNELVDVYAFGMCMLEMVTSEY 241 (632)
T ss_pred ccceEEEcCCcCceeecchhHHHHhhccccc-eeccCccccChHHHh---------hhcchhhhhhhhhHHHHHHHhccC
Confidence 9999999999899999999999876544433 379999999999984 688999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
||....+....++.+..+..|.-. ..-.++++++|.+||.. .+.|+|+.++|+ +.++..
T Consensus 242 PYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~--d~Ff~~ 301 (632)
T KOG0584|consen 242 PYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK--DPFFDE 301 (632)
T ss_pred ChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh--Chhhcc
Confidence 999999988888888877666433 44567899999999999 899999999998 555544
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=249.50 Aligned_cols=207 Identities=31% Similarity=0.621 Sum_probs=166.4
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
++++ .||||+++++++. ++..+++|||+++++|.+++.... ...+++.++..++.|++.||+||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 150 (314)
T cd05099 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL 150 (314)
T ss_pred HHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence 3455 6999999999985 456899999999999999997632 13488999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.|++|+||||+||+++.+ +.++|+|||.++....... .....++..|+|||.+.. ..++.++||||
T Consensus 151 H~~gi~H~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Diws 221 (314)
T cd05099 151 ESRRCIHRDLAARNVLVTED-NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD--------RVYTHQSDVWS 221 (314)
T ss_pred HHCCeeeccccceeEEEcCC-CcEEEccccccccccccccccccccCCCCccccCHHHHcc--------CCcCccchhhH
Confidence 99999999999999999865 4699999999975433211 111233457999998753 56788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
||+++|+|++ |..||..... ...............+..++.++.+++.+||..+|.+|||+.++++.|.......
T Consensus 222 lG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 222 FGILMWEIFTLGGSPYPGIPV-EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 9999999999 8889876543 3333333444445566788999999999999999999999999999999876544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=244.82 Aligned_cols=197 Identities=25% Similarity=0.410 Sum_probs=155.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. +...+++|||+++++|..++.. ....+++..++.++.|++.||+|||+.|++|+||||.||
T Consensus 58 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Ni 136 (262)
T cd05077 58 MRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR-KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNI 136 (262)
T ss_pred HHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccE
Confidence 56789999999999984 4578999999999999998865 335689999999999999999999999999999999999
Q ss_pred EEcCCCC------ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH-hC
Q 024401 81 LLTPDQK------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL-TN 153 (268)
Q Consensus 81 l~~~~~~------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll-~g 153 (268)
+++.++. .++++|||++...... ....++..|+|||.+.. ...++.++||||||+++|+|+ .|
T Consensus 137 ll~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 137 LLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVED-------SKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred EEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcC-------CCCCCchhHHHHHHHHHHHHHhCC
Confidence 9975432 2899999988654322 23356778999998742 256788999999999999998 48
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
..||........ .. . ...........+.++.+++.+||..+|.+||++.++++.|+
T Consensus 207 ~~p~~~~~~~~~-~~-~-~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 207 EIPLKDKTLAEK-ER-F-YEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred CCCCCCcchhHH-HH-H-HhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 888865432221 11 1 11222233445688999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=258.37 Aligned_cols=198 Identities=25% Similarity=0.388 Sum_probs=155.5
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+..++||||+++++.+.+ ...|+||||++||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI 132 (363)
T cd05628 55 LVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132 (363)
T ss_pred HHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 567899999999999854 478999999999999999975 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc------------------------------------cccCccCccceecccccccc
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE------------------------------------MMTAETGTYRWMAPELYSTV 124 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~ 124 (268)
|++.+ +.++|+|||++....... ......||+.|+|||.+.+
T Consensus 133 Li~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~- 210 (363)
T cd05628 133 LLDSK-GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ- 210 (363)
T ss_pred EECCC-CCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-
Confidence 99965 569999999986432110 0123468999999999853
Q ss_pred ccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhh--hCCCC
Q 024401 125 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWV--EDPNL 200 (268)
Q Consensus 125 ~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~--~~p~~ 200 (268)
..++.++|||||||++|+|++|..||.+.+................++. .++.++.+++.+|+. .++..
T Consensus 211 -------~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~ 283 (363)
T cd05628 211 -------TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIG 283 (363)
T ss_pred -------CCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCC
Confidence 5678899999999999999999999987665443332222112222332 478899999998664 23345
Q ss_pred CCCHHHHHHH
Q 024401 201 RPSFSQIIRM 210 (268)
Q Consensus 201 Rps~~~~l~~ 210 (268)
||++++++++
T Consensus 284 r~~~~ei~~h 293 (363)
T cd05628 284 APGVEEIKTN 293 (363)
T ss_pred CCCHHHHhCC
Confidence 6899999883
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=249.14 Aligned_cols=206 Identities=33% Similarity=0.653 Sum_probs=166.7
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~ql~~~l~~l 65 (268)
++.+ +||||+++++++. ++..++||||+++++|.+++...+. ..+++.+++.++.|++.||+||
T Consensus 77 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l 156 (307)
T cd05098 77 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL 156 (307)
T ss_pred HHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 3455 7999999999984 5578999999999999999976322 3488999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.|++|+||||+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||
T Consensus 157 H~~gi~H~dlkp~Nill~~~-~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dvws 227 (307)
T cd05098 157 ASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWS 227 (307)
T ss_pred HHCCcccccccHHheEEcCC-CcEEECCCcccccccccchhhccccCCCccceeChHHhcc--------CCCCcHHHHHH
Confidence 99999999999999999966 5699999999875432211 111234467999998853 56788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
||+++|+|++ |..||.... ................+..++.++.+++.+||..+|.+|||+.++++.|..++..
T Consensus 228 lG~~l~el~~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 228 FGVLLWEIFTLGGSPYPGVP-VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHHcCCCCCCCcCC-HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 9999999998 888887644 3333334444445566778899999999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=244.77 Aligned_cols=203 Identities=31% Similarity=0.593 Sum_probs=165.0
Q ss_pred CCCCCCCcccceeeeeec-C------CceEEEEcCCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 2 MSRVKHDNLVKFLGACKD-P------LMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~------~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
++.++||||+++++.+.+ + ..++++||+++++|..++...+ ...+++..+..++.|++.||+|||+.|+
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i 134 (273)
T cd05035 55 MKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNF 134 (273)
T ss_pred HHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 467899999999998632 2 3789999999999999985522 2468999999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
+|+||||+||+++.+ +.++|+|||+++....... ......+..|++||.+.. ..++.++||||||+++
T Consensus 135 ~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~SlG~il 205 (273)
T cd05035 135 IHRDLAARNCMLRED-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTM 205 (273)
T ss_pred eccccchheEEECCC-CeEEECCccceeeccccccccccccccCCccccCHhhccc--------CCCCcccchHHHHHHH
Confidence 999999999999955 5699999999875432211 112234567999998743 5678899999999999
Q ss_pred HHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 148 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 148 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
|+|++ |..||.+..+.+ .............+..++..+.+++.+||+.+|.+|||+.++++.|..+
T Consensus 206 ~el~~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 206 WEIATRGQTPYPGVENHE-IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999 889997765433 3344444556667788999999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=260.06 Aligned_cols=204 Identities=28% Similarity=0.463 Sum_probs=173.6
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
||..|.||+||+++++| .++.+|++.|||.||.++..+... ...+++.++.-+++|++.||.|||+.+|+|||||..|
T Consensus 82 ILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGN 160 (1187)
T KOG0579|consen 82 ILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGN 160 (1187)
T ss_pred hhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccc
Confidence 57889999999999975 788999999999999999998873 5779999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.++. ++|.|||.+...... .....++||+.|||||++.+-... ..+|++++||||||+++.+|.-+.+|-.
T Consensus 161 iL~TldGd-irLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~K---D~PYDykaDiWSlGITLIEMAqiEPPHh 236 (1187)
T KOG0579|consen 161 ILLTLDGD-IRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFK---DQPYDYKADIWSLGITLIEMAQIEPPHH 236 (1187)
T ss_pred eEEEecCc-EeeecccccccchhHHhhhccccCCcccccchheeecccc---CCCchhhhhHHhhhhHHHHHhccCCCcc
Confidence 99997765 999999988654443 334677999999999998775433 3688999999999999999999999987
Q ss_pred CCCcHHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
................+ ...|..|+..+.+++.+||.+||..||+++++++
T Consensus 237 elnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 237 ELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 77666655544432221 2245679999999999999999999999999998
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=255.28 Aligned_cols=203 Identities=30% Similarity=0.443 Sum_probs=173.2
Q ss_pred CCCCCC-CCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 1 MMSRVK-HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 1 ~l~~l~-Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+|++++ ||||+.+++++.+ ...++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.|++|+||||+
T Consensus 88 il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpE 164 (382)
T KOG0032|consen 88 ILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPE 164 (382)
T ss_pred HHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHH
Confidence 367787 9999999999964 4689999999999999999874 3999999999999999999999999999999999
Q ss_pred CEEEcCCC---CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 79 NLLLTPDQ---KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 79 Nil~~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
|+|+.... ..++++|||++.............||+.|+|||++.. ..++..+||||+|+++|.|++|..
T Consensus 165 N~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~--------~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 165 NLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGG--------RPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred HeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcC--------CCCCcccchhHHHHHHHHHhhCCC
Confidence 99996432 3699999999998777667788899999999999853 688999999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 156 PFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
||.+.+............. ..+....++..+.++++.|+..||..|+|+.++++ +.|+.
T Consensus 237 PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~--HpWi~ 297 (382)
T KOG0032|consen 237 PFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ--HPWIK 297 (382)
T ss_pred CCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc--Ccccc
Confidence 9998876555554333222 22233568999999999999999999999999999 35543
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=250.86 Aligned_cols=207 Identities=33% Similarity=0.630 Sum_probs=166.9
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
++++ +||||+++++.+. ++..++++||+++++|.+++.... ...+++.++..++.|++.||+||
T Consensus 71 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L 150 (334)
T cd05100 71 MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL 150 (334)
T ss_pred HHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence 4566 7999999999984 557899999999999999997532 23478889999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.|++|+||||+||+++.+ +.++|+|||+++....... .....++..|+|||.+.. ..++.++||||
T Consensus 151 H~~givH~dlkp~Nill~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s 221 (334)
T cd05100 151 ASQKCIHRDLAARNVLVTED-NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWS 221 (334)
T ss_pred HHCCeeccccccceEEEcCC-CcEEECCcccceecccccccccccCCCcCceEcCHHHhcc--------CCcCchhhhHH
Confidence 99999999999999999855 5699999999875433221 122234567999998853 56788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
||+++|+|++ |..||.+.+. ...............+..++.++.+++.+||..+|.+|||+.++++.|.......
T Consensus 222 lG~il~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 222 FGVLLWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHHhcCCCCCCCCCH-HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 9999999998 8888876543 3333333444455666778899999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=245.41 Aligned_cols=196 Identities=29% Similarity=0.572 Sum_probs=162.7
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++ .++..+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~ni 137 (267)
T cd06628 60 LKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANI 137 (267)
T ss_pred HHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHE
Confidence 5678999999999987 45578999999999999999976 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.. ..++.++|+||||+++|+|++|
T Consensus 138 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g 208 (267)
T cd06628 138 LVDNK-GGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ--------TSYTRKADIWSLGCLVVEMLTG 208 (267)
T ss_pred EEcCC-CCEEecccCCCcccccccccCCccccccccCCCcCccChhHhcc--------CCCCchhhhHHHHHHHHHHhhC
Confidence 99855 569999999987543211 1112347788999998853 5567899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..||.......... .......+..+..++..+.+++.+||+.+|.+||++.++++
T Consensus 209 ~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 209 KHPFPDCTQLQAIF-KIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCCCCCccHHHHHH-HHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 99998765544332 22334456677789999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=241.27 Aligned_cols=200 Identities=34% Similarity=0.602 Sum_probs=162.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. .+..++||||+++++|.+++... ...+++..+..++.|++.+|.|||+.|++|+||+|+||
T Consensus 46 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~ni 124 (250)
T cd05085 46 LKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNC 124 (250)
T ss_pred HHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheE
Confidence 46789999999999984 45789999999999999998753 34589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc--cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||++......... ....++..|+|||.+.. ..++.++|+||||+++|++++ |..||
T Consensus 125 li~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ll~~~~~~g~~p~ 195 (250)
T cd05085 125 LVGEN-NVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY--------GRYSSESDVWSYGILLWETFSLGVCPY 195 (250)
T ss_pred EEcCC-CeEEECCCccceeccccccccCCCCCCcccccCHHHhcc--------CCCCchhHHHHHHHHHHHHhcCCCCCC
Confidence 99855 56999999998653322211 11234567999998853 567889999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
......... ...........+..++..+.+++.+||..+|++||++.++++.|.
T Consensus 196 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 196 PGMTNQQAR-EQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHH-HHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 876543332 333344455566778999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=259.06 Aligned_cols=202 Identities=27% Similarity=0.415 Sum_probs=158.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||++||+|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 97 ~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 173 (371)
T cd05622 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 173 (371)
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence 45689999999999985 4578999999999999999975 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++....... ......||+.|+|||.+... .....++.++|||||||++|+|++|..||.
T Consensus 174 ll~~~-~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 248 (371)
T cd05622 174 LLDKS-GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248 (371)
T ss_pred EECCC-CCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhcc----CCCccCCCccceeehhHHHHHHHhCCCCCC
Confidence 99965 569999999987543322 22345789999999998531 112347889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRML 211 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~--Rps~~~~l~~l 211 (268)
..+................++ ..++..+.+++..||..++.+ |+++++++++.
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 249 ADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 765543333322222222333 368999999999999844433 67999998843
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=243.50 Aligned_cols=199 Identities=28% Similarity=0.447 Sum_probs=165.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..+++|||+++++|.+++.......+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni 132 (256)
T cd08221 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNI 132 (256)
T ss_pred HHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhE
Confidence 56789999999999984 55789999999999999999875456689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 133 ~~~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08221 133 FLTKA-GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQG--------VKYNFKSDIWALGCVLYELLTLKRTFDA 203 (256)
T ss_pred EEeCC-CCEEECcCcceEEcccccccccccCCCccccCHhhcCC--------CCCCCcchhHHHHHHHHHHHHCCCCCCC
Confidence 99955 569999999987543322 2334568899999998853 4567899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
..... .............+..++.++.+++.+||..+|.+||+++++++.
T Consensus 204 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 204 TNPLN-LVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCHHH-HHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 54433 333334444455556789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=254.70 Aligned_cols=194 Identities=28% Similarity=0.441 Sum_probs=151.8
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
++.++||||+++++++... ..|+||||+.+ +|.+.+. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 74 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrD 148 (359)
T cd07876 74 LKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 148 (359)
T ss_pred HHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 5678999999999987321 36899999955 6777664 3488999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++|||||||++|+|++|.
T Consensus 149 lkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~tg~ 219 (359)
T cd07876 149 LKPSNIVVKSD-CTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELVKGS 219 (359)
T ss_pred CCHHHEEECCC-CCEEEecCCCccccccCccCCCCcccCCCCCchhccC--------CCCCcchhhHHHHHHHHHHHhCC
Confidence 99999999965 5699999999976544333344578899999999854 56788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHH--------------------HhhcCCC--------------------CCCCCcHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQAAYAAA--------------------FKHARPG--------------------LPEDISPDLAFIVQSCW 194 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~--------------------~~~~~~~--------------------~~~~~~~~l~~li~~~l 194 (268)
.||.+.+......... .....+. .....++.+++++.+||
T Consensus 220 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 299 (359)
T cd07876 220 VIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299 (359)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHh
Confidence 9998665432211100 0000110 11124577999999999
Q ss_pred hhCCCCCCCHHHHHH
Q 024401 195 VEDPNLRPSFSQIIR 209 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~ 209 (268)
..||++|||+.++++
T Consensus 300 ~~dP~~R~t~~e~l~ 314 (359)
T cd07876 300 VIDPDKRISVDEALR 314 (359)
T ss_pred ccCcccCCCHHHHhc
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=247.48 Aligned_cols=206 Identities=31% Similarity=0.624 Sum_probs=166.7
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
++.+ +||||+++++.+. +...+++|||+++++|.+++.... ...+++.++..++.|++.||+||
T Consensus 74 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L 153 (304)
T cd05101 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL 153 (304)
T ss_pred HHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence 3456 7999999999984 457899999999999999997632 13478889999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.|++|+||||+||+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++||||
T Consensus 154 H~~givH~dlkp~Nili~~~-~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~s 224 (304)
T cd05101 154 ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWS 224 (304)
T ss_pred HHCCeeecccccceEEEcCC-CcEEECCCccceecccccccccccCCCCCceeeCchhhcc--------CCCCchhhHHH
Confidence 99999999999999999855 5699999999875533221 122345678999998853 56788999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
||+++|+|++ |..||.+.+. ...............+..++..+.+++.+||..+|.+|||+.++++.|+.+..-
T Consensus 225 lG~~l~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 225 FGVLMWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHcCCCCCcccCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 9999999998 7888876543 333333444445556678899999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=248.19 Aligned_cols=199 Identities=22% Similarity=0.378 Sum_probs=163.2
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++|+||+++.+.+ .++..+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.||+|+||||+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Ni 133 (285)
T cd05632 54 LEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133 (285)
T ss_pred HHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHE
Confidence 5678999999999887 455789999999999999998765556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ ..++|+|||++.............++..|+|||.+.+ ..++.++|+||||+++|+|++|..||...
T Consensus 134 li~~~-~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 134 LLDDY-GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN--------QRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred EECCC-CCEEEecCCcceecCCCCcccCCCCCcCccChHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 99855 4699999998865443333344578999999999853 56788999999999999999999999876
Q ss_pred CcHHHHHH--HHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 161 SNLQAAYA--AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
........ ..........+..++.++.+++..||+.+|.+||+ ++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 205 KEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred CHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 54322211 11222234455678899999999999999999999 777776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=243.48 Aligned_cols=202 Identities=28% Similarity=0.497 Sum_probs=163.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..++||||+++++|.+++.. ....+++.++..++.|++.||+|||+.|++|+||||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred HhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 56889999999999984 5578999999999999999976 335689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc----cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 155 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~ 155 (268)
+++.+ ..++|+|||++......... .....+..|++||.+.. ..++.++|+||||+++|++++ |..
T Consensus 139 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~il~ell~~g~~ 209 (268)
T cd05063 139 LVNSN-LECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY--------RKFTSASDVWSFGIVMWEVMSFGER 209 (268)
T ss_pred EEcCC-CcEEECCCccceecccccccceeccCCCcCceecCHHHhhc--------CCcChHhHHHHHHHHHHHHHhCCCC
Confidence 99955 56999999998754322111 11123457999998753 567889999999999999997 999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
||....... ...........+.+..++..+.+++.+||..+|++||++.++++.|+.+
T Consensus 210 p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 210 PYWDMSNHE-VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCcCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 997655433 3333333344455567899999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=244.85 Aligned_cols=202 Identities=34% Similarity=0.622 Sum_probs=163.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-----PNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
++.++||||+++++++. ++..+++|||+++++|.+++.... ...+++.++..++.|++.||+|||+.+++|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl 132 (269)
T cd05044 53 MSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDL 132 (269)
T ss_pred HHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 56789999999999884 457899999999999999997532 234789999999999999999999999999999
Q ss_pred CCCCEEEcCCC----CceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 76 KPDNLLLTPDQ----KSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 76 k~~Nil~~~~~----~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
+|+||+++.++ ..++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|
T Consensus 133 ~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~ 204 (269)
T cd05044 133 AARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD--------GKFTTQSDVWSFGVLMW 204 (269)
T ss_pred ChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc--------CCcccchhHHHHHHHHH
Confidence 99999998654 269999999987543221 1122345678999998853 56788999999999999
Q ss_pred HHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 149 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 149 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
+|++ |..||........ ............+..++..+.+++.+||..+|.+||+++++++.|+
T Consensus 205 ellt~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 205 EILTLGQQPYPALNNQEV-LQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred HHHHcCCCCCcccCHHHH-HHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9998 9999976554332 2233333444556778999999999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=235.20 Aligned_cols=207 Identities=25% Similarity=0.396 Sum_probs=160.8
Q ss_pred CCCCCCcccceeeee----ecC--CceEEEEcCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC--Cee
Q 024401 3 SRVKHDNLVKFLGAC----KDP--LMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHANG--IIH 72 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~----~~~--~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H 72 (268)
++++||||++++++. .|. ..|++++|+..|+|.+.+....- ..+++.+++.|+.++++||.+||+.. +.|
T Consensus 73 rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH 152 (302)
T KOG2345|consen 73 RKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAH 152 (302)
T ss_pred HhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccc
Confidence 578999999999986 222 58999999999999999987443 35999999999999999999999998 999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCccccc----------ccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
+||||.||+++.+ +.+++.|||.+......-. ......|..|.|||.+... .....+.++||||
T Consensus 153 ~DiKP~NILls~~-~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk-----~~~ti~ertDIWS 226 (302)
T KOG2345|consen 153 RDIKPANILLSDS-GLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVK-----SHCTITERTDIWS 226 (302)
T ss_pred cCCCcceeEecCC-CceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecc-----cCcccccccchhh
Confidence 9999999999954 5689999999875432111 1123578899999998642 3456788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 143 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 143 lG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
|||++|+|+.|..||+...................+| ..+++.+.++++.|++.||.+||++.+++..++.+.
T Consensus 227 LGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 227 LGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred hhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 9999999999999996322111111111111122222 348999999999999999999999999999887653
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-36 Score=243.27 Aligned_cols=202 Identities=30% Similarity=0.522 Sum_probs=164.1
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++ .++..++||||+++++|.+++... ...+++.++..++.|++.||++||+.|++|+||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 59 MGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 5678999999999998 455789999999999999999763 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc----cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 155 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~ 155 (268)
+++.+ +.++|+|||++......... ....++..|++||.+.. ..++.++|+||||+++|++++ |..
T Consensus 138 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~l~ell~~g~~ 208 (267)
T cd05066 138 LVNSN-LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGER 208 (267)
T ss_pred EECCC-CeEEeCCCCcccccccccceeeecCCCccceeecCHhHhcc--------CccCchhhhHHHHHHHHHHhcCCCC
Confidence 99855 56999999998754332211 11223467999998853 567889999999999999886 999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
||......+ ...........+.+..++..+.+++.+||+.+|.+||++.++++.|...
T Consensus 209 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 209 PYWEMSNQD-VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcccCCHHH-HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 997665433 2233333344455567889999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=253.38 Aligned_cols=193 Identities=27% Similarity=0.424 Sum_probs=157.7
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++++. .+..++||||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.
T Consensus 54 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~ 131 (327)
T cd05617 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDA 131 (327)
T ss_pred CCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeC
Confidence 6999999999884 5578999999999999998875 356999999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC--
Q 024401 85 DQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS-- 161 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~-- 161 (268)
+ +.++|+|||++.... .........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||....
T Consensus 132 ~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~ell~g~~pf~~~~~~ 202 (327)
T cd05617 132 D-GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202 (327)
T ss_pred C-CCEEEeccccceeccCCCCceecccCCcccCCHHHHCC--------CCCCchheeehhHHHHHHHHhCCCCCCccCCC
Confidence 5 459999999987432 2223344578999999998853 667889999999999999999999996322
Q ss_pred ---cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 024401 162 ---NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIR 209 (268)
Q Consensus 162 ---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~l~ 209 (268)
................++..++..+.+++.+||..+|.+|+++ +++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 259 (327)
T cd05617 203 PDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKS 259 (327)
T ss_pred cccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHc
Confidence 1122222333344556778899999999999999999999974 56665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=243.05 Aligned_cols=198 Identities=31% Similarity=0.506 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++++.+. +...+++|||+++++|.+++.......+++.+++.++.+++.||++||+.|++|+||+|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~n 132 (257)
T cd08223 53 LSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQN 132 (257)
T ss_pred HHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchh
Confidence 56789999999999874 3457899999999999999987555669999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++.+ +.++|+|||++...... .......++..|+|||.+.. ..++.++|+||||+++++|++|..||.
T Consensus 133 il~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~~~~ 203 (257)
T cd08223 133 VFLTRT-NIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN--------KPYNYKSDVWALGCCVYEMATLKHAFN 203 (257)
T ss_pred EEEecC-CcEEEecccceEEecccCCccccccCCcCccChhHhcC--------CCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 999855 56999999998754322 22233467889999998853 567789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..+... ..........+..+..+++.+.+++.+||+.+|.+||++.++++
T Consensus 204 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 204 AKDMNS-LVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCHHH-HHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 655433 22333444455566788999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=253.15 Aligned_cols=202 Identities=25% Similarity=0.457 Sum_probs=158.6
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~N 79 (268)
|++++||||+++++++ .++..++||||+.+++|.+++.. ...+++..+..++.|++.||+|||+. +++|+||||+|
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~N 134 (333)
T cd06650 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 134 (333)
T ss_pred HHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhh
Confidence 5678999999999998 45679999999999999999976 34589999999999999999999985 79999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 135 ili~~~-~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 135 ILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred EEEcCC-CCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999855 45999999998654322 1233468889999998853 5678899999999999999999999875
Q ss_pred CCcHHHHH-------------------------------------------HHHHhhcCCCCC-CCCcHHHHHHHHHhhh
Q 024401 160 MSNLQAAY-------------------------------------------AAAFKHARPGLP-EDISPDLAFIVQSCWV 195 (268)
Q Consensus 160 ~~~~~~~~-------------------------------------------~~~~~~~~~~~~-~~~~~~l~~li~~~l~ 195 (268)
........ ........+..+ ..++.++.+++.+||.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 284 (333)
T cd06650 205 PDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLI 284 (333)
T ss_pred cchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhcc
Confidence 43211110 001111111222 2367889999999999
Q ss_pred hCCCCCCCHHHHHHHHHhhhhh
Q 024401 196 EDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 196 ~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.||++|||++++++ +.++..
T Consensus 285 ~~P~~Rpt~~ell~--h~~~~~ 304 (333)
T cd06650 285 KNPAERADLKQLMV--HAFIKR 304 (333)
T ss_pred CCcccCcCHHHHhh--CHHHhc
Confidence 99999999999987 555543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=246.08 Aligned_cols=203 Identities=26% Similarity=0.412 Sum_probs=161.0
Q ss_pred CCC-CCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 3 SRV-KHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+++ +||||+++++.+.+ ...+++|||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+|
T Consensus 57 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~d 136 (272)
T cd06637 57 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 136 (272)
T ss_pred HHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 445 69999999998732 3578999999999999999875556799999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
|+|+||+++.+ +.++|+|||++...... .......++..|+|||.+.... .....++.++|+||+|+++|+|++|
T Consensus 137 l~~~nili~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 137 IKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred CCHHHEEECCC-CCEEEccCCCceecccccccCCcccccccccCHhHhcccc---CcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999955 46999999998754322 2223456788999999875311 0124577899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..||........................++..+.+++.+||..+|.+|||+.++++
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 213 APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 99997655444333322222223333567899999999999999999999999986
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=255.59 Aligned_cols=205 Identities=33% Similarity=0.554 Sum_probs=167.0
Q ss_pred CCCCC-CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC------------------------------------
Q 024401 2 MSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP------------------------------------ 43 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------ 43 (268)
|.++. ||||+++++++. .+..++||||+++|+|.+++...+.
T Consensus 94 l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (401)
T cd05107 94 MSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSE 173 (401)
T ss_pred HHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhc
Confidence 45676 999999999985 4578999999999999999964321
Q ss_pred ------------------------------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 024401 44 ------------------------------------------------------------NKLDLHVALNFALDIARAMD 63 (268)
Q Consensus 44 ------------------------------------------------------------~~~~~~~~~~i~~ql~~~l~ 63 (268)
..+++..++.++.|++.||+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 253 (401)
T cd05107 174 SDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGME 253 (401)
T ss_pred cCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 23677888999999999999
Q ss_pred HHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccch
Q 024401 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140 (268)
Q Consensus 64 ~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 140 (268)
|||+.|++|+||||.||+++. ...++|+|||+++...... ......++..|++||.+.. ..++.++|+
T Consensus 254 ~LH~~~ivHrdlkp~NiLl~~-~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv 324 (401)
T cd05107 254 FLASKNCVHRDLAARNVLICE-GKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN--------NLYTTLSDV 324 (401)
T ss_pred HHhcCCcCcccCCcceEEEeC-CCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC--------CCCCcHhHH
Confidence 999999999999999999995 4569999999987532211 1122345778999998853 557889999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 141 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 141 ~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
||||+++|+|++ |..||......+...........+..+..++.++.+++.+||..+|.+||+++++++.|+.++
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 999999999998 889997766555444444555556677788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=259.92 Aligned_cols=196 Identities=23% Similarity=0.414 Sum_probs=156.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++||||++||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NI 132 (382)
T cd05625 55 LAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132 (382)
T ss_pred HHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 56789999999999985 5579999999999999999975 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc------------------------------------------------ccccCccCc
Q 024401 81 LLTPDQKSLKLADFGLAREETVT------------------------------------------------EMMTAETGT 112 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~------------------------------------------------~~~~~~~~~ 112 (268)
|++.+ +.++|+|||++...... .......||
T Consensus 133 Ll~~~-g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt 211 (382)
T cd05625 133 LIDRD-GHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211 (382)
T ss_pred EECCC-CCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccC
Confidence 99965 46999999987421100 001123688
Q ss_pred cceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCC--CCCCcHHHHHHH
Q 024401 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIV 190 (268)
Q Consensus 113 ~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li 190 (268)
+.|+|||.+.+ ..++.++|||||||++|+|++|..||...+................. ...+++++.+++
T Consensus 212 ~~Y~aPE~~~~--------~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li 283 (382)
T cd05625 212 PNYIAPEVLLR--------TGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLI 283 (382)
T ss_pred cccCCHHHhcC--------CCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHH
Confidence 99999998853 56788999999999999999999999876654443333221222222 245889999999
Q ss_pred HHhhhhCCCCCCC---HHHHHH
Q 024401 191 QSCWVEDPNLRPS---FSQIIR 209 (268)
Q Consensus 191 ~~~l~~~p~~Rps---~~~~l~ 209 (268)
.+|+ .+|.+|++ ++++++
T Consensus 284 ~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 284 IKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHc-cCHhHcCCCCCHHHHhc
Confidence 9986 59999987 888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=272.22 Aligned_cols=209 Identities=33% Similarity=0.593 Sum_probs=177.4
Q ss_pred CCCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 1 MMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLR-----PNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+|+.++|||||+++|.+.+ ...++++||++||+|..|+++.+ ...++..+.+.++.+|+.|..||+++++||||
T Consensus 748 ~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRD 827 (1025)
T KOG1095|consen 748 LMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRD 827 (1025)
T ss_pred HHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcc
Confidence 4788999999999999854 46899999999999999998842 35589999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccc--cccCc-cCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAE-TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~-~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
|...|+|++.. ..|||.|||+++...... ..... .-...|||||.+.. +.++.++||||||+++||++
T Consensus 828 LAaRNCLL~~~-r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d--------~iFtskSDvWsFGVllWEif 898 (1025)
T KOG1095|consen 828 LAARNCLLDER-RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD--------GIFTSKSDVWSFGVLLWEIF 898 (1025)
T ss_pred hhhhheeeccc-CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh--------cccccccchhhhHHHHHHHH
Confidence 99999999965 679999999999332221 11111 33578999999864 88999999999999999999
Q ss_pred h-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 152 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
+ |..||.+.++.+.... ...+.+.+.|..++..+.+++.+||+.+|++||++..+++.+..+.....
T Consensus 899 slG~~PY~~~~n~~v~~~-~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 899 SLGATPYPSRSNFEVLLD-VLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred hCCCCCCCCcchHHHHHH-HHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 9 9999998887665543 34455888899999999999999999999999999999998888775543
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=257.71 Aligned_cols=203 Identities=24% Similarity=0.365 Sum_probs=161.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||++|++|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NI 133 (330)
T cd05601 55 LSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133 (330)
T ss_pred HHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHhe
Confidence 45679999999999885 45789999999999999999863 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++....... ......+++.|+|||.+...... ....++.++|||||||++|+|++|..||.
T Consensus 134 ll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~el~~g~~Pf~ 210 (330)
T cd05601 134 LIDRT-GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD--GKGTYGVECDWWSLGVIAYEMIYGRSPFH 210 (330)
T ss_pred EECCC-CCEEeccCCCCeECCCCCceeeecccCCccccCHHHhcccccc--ccCCCCCcceeecccceeeeeccCCCCCC
Confidence 99955 469999999997543322 12234688999999988532111 13567789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...................++ ..++.++.+++..||. +|.+||+++++++
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 211 EGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred CCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 766544333222212222223 3578999999999998 9999999999987
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=243.31 Aligned_cols=202 Identities=28% Similarity=0.499 Sum_probs=162.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.|++|+||+|+||
T Consensus 59 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 59 MGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred HHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 56789999999999984 55789999999999999999763 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccC----c--cCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-C
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTA----E--TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 153 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~----~--~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g 153 (268)
+++.+ ..++|+|||.+........... . ..+..|++||.+.. ..++.++||||||+++||+++ |
T Consensus 138 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DvwslG~~l~e~l~~g 208 (269)
T cd05065 138 LVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYG 208 (269)
T ss_pred EEcCC-CcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc--------CcccchhhhhhhHHHHHHHhcCC
Confidence 99854 5699999998864432211111 1 12357999998753 567889999999999999886 9
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
..||........ ..........+.+..++..+.+++.+||..+|.+||++.++++.|+.+
T Consensus 209 ~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 209 ERPYWDMSNQDV-INAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred CCCCCCCCHHHH-HHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 999977654332 222333334455567889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=243.32 Aligned_cols=205 Identities=29% Similarity=0.558 Sum_probs=168.2
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.+...+++|||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+||+
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil 141 (279)
T cd05057 63 MASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVL 141 (279)
T ss_pred HHhCCCCCcceEEEEEecCceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEE
Confidence 5678999999999999778899999999999999999763 345899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccc---cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.++|+|||.+......... ....++..|++||.+.. ..++.++|+||||+++|++++ |..||
T Consensus 142 ~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~ 212 (279)
T cd05057 142 VKTP-QHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH--------RIYTHKSDVWSYGVTVWELMTFGAKPY 212 (279)
T ss_pred EcCC-CeEEECCCcccccccCcccceecCCCcccccccCHHHhhc--------CCcCchhhHHHHHHHHHHHhcCCCCCC
Confidence 9855 46999999998754332211 11223567999998743 567889999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.+.... ..............+...+..+.+++.+||..+|..||++.++++.|..+...
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 213 EGIPAV-EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 876543 33333334444555667889999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=245.21 Aligned_cols=203 Identities=28% Similarity=0.505 Sum_probs=159.7
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++++.+ ...+++|||++|++|.+++... ...+++.+++.++.|++.||+|||+.|++|+||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~ 138 (284)
T cd05079 60 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 138 (284)
T ss_pred HHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchh
Confidence 567899999999998843 4588999999999999999653 345899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|+++.
T Consensus 139 Nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~ellt~~ 209 (284)
T cd05079 139 NVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ--------SKFYIASDVWSFGVTLYELLTYC 209 (284)
T ss_pred eEEEcCC-CCEEECCCccccccccCccceeecCCCCCCccccCHHHhcc--------CCCCccccchhhhhhhhhhhcCC
Confidence 9999855 5699999999875433211 123345677999998753 56788999999999999999976
Q ss_pred CCCCCCC--------------cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 155 LPFEGMS--------------NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 155 ~p~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.|+.... ...............+.+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 210 DSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred CCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 6542110 11111111222333445667899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=241.40 Aligned_cols=202 Identities=34% Similarity=0.543 Sum_probs=165.7
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++|+||+++++.+.+...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||+
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~ 134 (260)
T cd05073 55 MKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134 (260)
T ss_pred HHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE
Confidence 56789999999999987788899999999999999998655566899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ ..++|+|||.+........ .....++..|++||.+.. ..++.++|+||||+++|++++ |..||.
T Consensus 135 i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~t~g~~p~~ 205 (260)
T cd05073 135 VSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYP 205 (260)
T ss_pred EcCC-CcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc--------CCcCccccchHHHHHHHHHHhcCCCCCC
Confidence 9855 5699999998865432211 112234567999998853 567889999999999999998 899998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
..+..... .........+.+...+.++.+++.+||..+|++||++.++.+.|+.
T Consensus 206 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 206 GMSNPEVI-RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCHHHHH-HHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 75543322 2333333445556788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=252.47 Aligned_cols=194 Identities=26% Similarity=0.408 Sum_probs=157.3
Q ss_pred CCCCC-Ccccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRVKH-DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l~H-p~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
..+.| ++|+.+++++. .+..|+||||++|++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 ~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni 132 (324)
T cd05587 55 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (324)
T ss_pred HhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 44555 55888888874 4578999999999999999975 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+
T Consensus 133 ll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~ 203 (324)
T cd05587 133 MLDAE-GHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDG 203 (324)
T ss_pred EEcCC-CCEEEeecCcceecCCCCCceeeecCCccccChhhhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCC
Confidence 99965 4699999999864322 222334568999999999854 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~l~ 209 (268)
.+...... ........++..++.++.+++.+||..+|.+|++. .++++
T Consensus 204 ~~~~~~~~--~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 256 (324)
T cd05587 204 EDEDELFQ--SIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE 256 (324)
T ss_pred CCHHHHHH--HHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 65433322 23344556678899999999999999999999976 56654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=243.76 Aligned_cols=205 Identities=28% Similarity=0.501 Sum_probs=166.1
Q ss_pred CCCCCCCcccceeeeeec--CCceEEEEcCCCCCHHHHHhhhCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 2 MSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP------NKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
+++++||||+++++++.+ ...+++++|+.+++|.+++..... ..+++.+++.++.|++.||+|||+.|++|+
T Consensus 62 l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~ 141 (280)
T cd05043 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHK 141 (280)
T ss_pred HHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 567899999999998743 568999999999999999976332 458999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
||+|+||+++.+ ..++|+|||+++....... .....++..|+|||.+.. ..++.++||||||+++|++
T Consensus 142 di~p~nil~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~~l~el 212 (280)
T cd05043 142 DIAARNCVIDEE-LQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN--------KEYSSASDVWSFGVLLWEL 212 (280)
T ss_pred ccCHhhEEEcCC-CcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc--------CCCCchhhHHHhHHHHHHH
Confidence 999999999855 5699999999975432211 122345677999998853 5678899999999999999
Q ss_pred Hh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 151 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 151 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
++ |..||..... ...............+..++..+.+++.+||..+|++|||+.++++.|..+..
T Consensus 213 ~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 213 MTLGQTPYVEIDP-FEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred hcCCCCCcCcCCH-HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 98 9999976543 33333333344444556678999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=260.82 Aligned_cols=197 Identities=22% Similarity=0.364 Sum_probs=156.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++||||++||+|.+++.. ...+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni 132 (376)
T cd05598 55 LAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132 (376)
T ss_pred HHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence 56789999999999985 5579999999999999999976 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc--------------------------------------------ccccCccCcccee
Q 024401 81 LLTPDQKSLKLADFGLAREETVT--------------------------------------------EMMTAETGTYRWM 116 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~--------------------------------------------~~~~~~~~~~~y~ 116 (268)
+++.+ +.++|+|||++...... .......|++.|+
T Consensus 133 ll~~~-~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 211 (376)
T cd05598 133 LIDRD-GHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYI 211 (376)
T ss_pred EECCC-CCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCcccc
Confidence 99965 46999999987421100 0011236899999
Q ss_pred ccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhh
Q 024401 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCW 194 (268)
Q Consensus 117 aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l 194 (268)
|||.+.. ..++.++|||||||++|+|++|..||.+................. +....++.++.+++.+|+
T Consensus 212 aPE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~ 283 (376)
T cd05598 212 APEVLLR--------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC 283 (376)
T ss_pred CHHHHcC--------CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh
Confidence 9999853 567889999999999999999999998766544333222111111 222468899999999976
Q ss_pred hhCCCCCC---CHHHHHHH
Q 024401 195 VEDPNLRP---SFSQIIRM 210 (268)
Q Consensus 195 ~~~p~~Rp---s~~~~l~~ 210 (268)
.+|.+|+ ++.+++++
T Consensus 284 -~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 284 -CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred -cCHhhcCCCCCHHHHhCC
Confidence 5999999 89999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=242.01 Aligned_cols=202 Identities=34% Similarity=0.546 Sum_probs=166.3
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+.+ ...+++|||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~ni 134 (261)
T cd05034 55 MKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNI 134 (261)
T ss_pred HhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheE
Confidence 567899999999999854 6789999999999999999875556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+........ ......+..|+|||.+.+ ..++.++|+||||+++|++++ |+.||
T Consensus 135 li~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~ 205 (261)
T cd05034 135 LVGEN-LVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY--------GRFTIKSDVWSFGILLTEIVTYGRVPY 205 (261)
T ss_pred EEcCC-CCEEECccccceeccchhhhhhhccCCCccccCHHHhcc--------CCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99965 5699999999875432211 112234567999998753 567889999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
.+.+.. ..............+...+.++.+++.+||..+|.+||+++++.+.|+.
T Consensus 206 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 206 PGMTNR-EVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHH-HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 765543 3333334444555667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=245.73 Aligned_cols=203 Identities=28% Similarity=0.423 Sum_probs=161.6
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+ .++..++|+||+++++|..++.. ....+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 56 l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~ni 134 (282)
T cd06643 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNI 134 (282)
T ss_pred HHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence 4578999999999987 45678999999999999998765 345699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+.... .....++.++|+||+|+++|+|++|..||..
T Consensus 135 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvil~el~~g~~p~~~ 210 (282)
T cd06643 135 LFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET---SKDRPYDYKADVWSLGITLIEMAQIEPPHHE 210 (282)
T ss_pred EEccC-CCEEEccccccccccccccccccccccccccCHhhccccC---CCCCCCCccchhhhHHHHHHHHccCCCCccc
Confidence 99855 56999999998654322 2223446788999999874211 1234567899999999999999999999987
Q ss_pred CCcHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+........... ......+..++.++.+++.+||..+|.+||+++++++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 211 LNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 6544333322211 1122345668899999999999999999999999987
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=251.75 Aligned_cols=191 Identities=27% Similarity=0.420 Sum_probs=158.0
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||+|+.+++++. ++..++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+||+++.
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~ 136 (323)
T cd05616 59 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDS 136 (323)
T ss_pred CCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECC
Confidence 6899999999885 4578999999999999999875 356999999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
+ +.++|+|||++..... ........|++.|+|||.+.. ..++.++|+|||||++|+|++|+.||.+.+..
T Consensus 137 ~-~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 137 E-GHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred C-CcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC--------CCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 5 4699999999875332 222334578999999999853 56789999999999999999999999876543
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 209 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~l~ 209 (268)
..... .......++..++.++.+++.+||+.+|.+|++. .++++
T Consensus 208 ~~~~~--i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 208 ELFQS--IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred HHHHH--HHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 33222 2234456677899999999999999999999974 56654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=247.86 Aligned_cols=201 Identities=31% Similarity=0.477 Sum_probs=161.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. +.+.++||||++|++|.+++.. ..+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 71 l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Ni 147 (296)
T cd06654 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (296)
T ss_pred HHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 46789999999999874 5579999999999999999865 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||..
T Consensus 148 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~~l~~g~~pf~~ 218 (296)
T cd06654 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (296)
T ss_pred EEcCC-CCEEECccccchhccccccccCcccCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99855 569999999887543322 1223467889999998753 5567899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
............... ....+..++..+.+++.+||..+|.+||++.++++ ..++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~--~~~~~ 274 (296)
T cd06654 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLK 274 (296)
T ss_pred CCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh--Chhhh
Confidence 654333322222111 12334568899999999999999999999999998 44443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=243.54 Aligned_cols=204 Identities=25% Similarity=0.431 Sum_probs=163.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++.+. .+..++++||+++++|.+++... ....+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ 135 (267)
T cd08228 56 LKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPA 135 (267)
T ss_pred HHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHH
Confidence 57789999999999874 55789999999999999988642 2345899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..||
T Consensus 136 nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~el~~g~~p~ 206 (267)
T cd08228 136 NVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred HEEEcCC-CCEEECccccceeccchhHHHhcCCCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHhcCCCCC
Confidence 9999865 459999999887544322 1233467888999998853 55678999999999999999999998
Q ss_pred CCCCcH-HHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 158 EGMSNL-QAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
...... ............++. ...++..+.+++.+||..+|++||++.++++.++.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 207 YGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred ccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 654322 222222222222332 346788999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=251.04 Aligned_cols=206 Identities=30% Similarity=0.567 Sum_probs=164.2
Q ss_pred CCCC-CCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhC------------------------------------
Q 024401 2 MSRV-KHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR------------------------------------ 42 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~------------------------------------ 42 (268)
|.++ +||||+++++++. +...+++|||+++|+|.+++....
T Consensus 64 l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (343)
T cd05103 64 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITS 143 (343)
T ss_pred HHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhcccccc
Confidence 3456 6899999999873 346789999999999999986421
Q ss_pred -----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEec
Q 024401 43 -----------------------------PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLAD 93 (268)
Q Consensus 43 -----------------------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~D 93 (268)
...+++..+..++.|++.||+|||+.||+|+||||.||+++.+ +.++|+|
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~-~~~kl~d 222 (343)
T cd05103 144 SQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEN-NVVKICD 222 (343)
T ss_pred ccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCC-CcEEEEe
Confidence 1236788899999999999999999999999999999999955 5699999
Q ss_pred cCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 024401 94 FGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAA 169 (268)
Q Consensus 94 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~ 169 (268)
||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||............
T Consensus 223 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 294 (343)
T cd05103 223 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294 (343)
T ss_pred cccccccccCcchhhcCCCCCCcceECcHHhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence 99987542221 1122344567999998753 567889999999999999997 89999765544444444
Q ss_pred HHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 170 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.........+...++++.+++.+||..+|.+|||+.++++.|+.++.
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 295 LKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 44444555566678899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=245.57 Aligned_cols=202 Identities=29% Similarity=0.539 Sum_probs=160.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---------PNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
+++++||||+++++++. ++..+++|||+.+++|.+++.... ...+++..++.++.|++.||+|||+.|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~ 152 (296)
T cd05051 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV 152 (296)
T ss_pred HHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 56789999999999985 468999999999999999997633 12589999999999999999999999999
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|
T Consensus 153 H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~ 223 (296)
T cd05051 153 HRDLATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--------GKFTTKSDVWAFGVTLW 223 (296)
T ss_pred ccccchhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHHHhhc--------CCCCccchhhhhHHHHH
Confidence 99999999999955 569999999987533221 1223345678999998753 56788999999999999
Q ss_pred HHHh--CCCCCCCCCcHHHHHHHHHh------hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 149 ELLT--NRLPFEGMSNLQAAYAAAFK------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 149 ~ll~--g~~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
+|++ +..||...+..+........ ......+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 224 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 224 EILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 9998 67788765543322221111 1112234457789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=235.93 Aligned_cols=198 Identities=28% Similarity=0.503 Sum_probs=167.9
Q ss_pred CCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCEE
Q 024401 4 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLL 81 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~Nil 81 (268)
.-.+|+||+.+|+| .+...++.||.+ +..++.+++.. .+++++..+-++...++.||.||.++ ||+|||+||+|||
T Consensus 147 s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNIL 224 (391)
T KOG0983|consen 147 SHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNIL 224 (391)
T ss_pred ccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceE
Confidence 34579999999998 677789999999 66888888763 46799999999999999999999975 8999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
+|. .+.+||||||++.............|.+.|||||.+... ....|+.++||||||++++||.||+.||.+..
T Consensus 225 lDe-~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~-----~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 225 LDE-RGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPP-----DKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred Ecc-CCCEEeecccccceeecccccccccCCccccCccccCCC-----CCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 994 466999999999876655555556789999999999742 35788999999999999999999999999877
Q ss_pred cHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 162 NLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...+..........+.++. .+++++++++..||.+|+.+||.+.++++
T Consensus 299 tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 299 TDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 6666666666655555553 48999999999999999999999999988
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=245.98 Aligned_cols=205 Identities=28% Similarity=0.559 Sum_probs=166.1
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
++.++||||+++++.+.+...++++||+++|+|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus 63 ~~~l~h~niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nil 141 (303)
T cd05110 63 MASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVL 141 (303)
T ss_pred HHhCCCCCcccEEEEEcCCCceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceee
Confidence 4678999999999998766778999999999999998763 346899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.++|+|||++........ .....++..|++||.+.+ ..++.++||||||+++|++++ |..||
T Consensus 142 l~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~DiwslG~~l~el~t~g~~p~ 212 (303)
T cd05110 142 VKSP-NHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY--------RKFTHQSDVWSYGVTIWELMTFGGKPY 212 (303)
T ss_pred ecCC-CceEEccccccccccCcccccccCCCccccccCCHHHhcc--------CCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence 9855 4599999999975433221 122334668999998753 567889999999999999997 88999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.+... ...............+...+..+.+++..||..+|++||+++++++.|+.+...
T Consensus 213 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 213 DGIPT-REIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCH-HHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 76543 222223333344445566888999999999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=248.26 Aligned_cols=205 Identities=25% Similarity=0.412 Sum_probs=158.9
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++ .++..++||||+++ +|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni 135 (309)
T cd07872 58 LKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL 135 (309)
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 5678999999999998 45678999999964 898888653 34589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||.+
T Consensus 136 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~tg~~pf~~ 207 (309)
T cd07872 136 LINER-GELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLG-------SSEYSTQIDMWGVGCIFFEMASGRPLFPG 207 (309)
T ss_pred EECCC-CCEEECccccceecCCCccccccccccccccCCHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99955 569999999987543222 2233467889999998753 24578899999999999999999999976
Q ss_pred CCcHHHHHHHHHh--------------------hcCC--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 160 MSNLQAAYAAAFK--------------------HARP--------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 160 ~~~~~~~~~~~~~--------------------~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
.+........... ...+ .....++.++.+++.+||..||.+|||++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~-- 285 (309)
T cd07872 208 STVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK-- 285 (309)
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc--
Confidence 5543222111100 0000 011246788999999999999999999999998
Q ss_pred Hhhhhhc
Q 024401 212 NAFLFTL 218 (268)
Q Consensus 212 ~~~~~~~ 218 (268)
+.++...
T Consensus 286 h~~~~~~ 292 (309)
T cd07872 286 HAYFRSL 292 (309)
T ss_pred Chhhhhc
Confidence 5555544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=242.46 Aligned_cols=201 Identities=29% Similarity=0.454 Sum_probs=160.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +...+++|||+.+++|.+++... ...+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 132 (262)
T cd06613 54 LKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANI 132 (262)
T ss_pred HHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhE
Confidence 57889999999999874 55789999999999999998763 25699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|++||.+... ....++.++|+||||+++|+|++|..||..
T Consensus 133 ~i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-----~~~~~~~~~Di~slG~~l~~~~tg~~p~~~ 206 (262)
T cd06613 133 LLTED-GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYDGKCDIWALGITAIELAELQPPMFD 206 (262)
T ss_pred EECCC-CCEEECccccchhhhhhhhccccccCCccccCchhhccc-----ccCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99955 569999999987544322 22344678889999987531 113677899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+..............+ .....++.++.+++.+||..+|.+|||+.+++.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 207 LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred CCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 66544433322221111 122346788999999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=240.72 Aligned_cols=197 Identities=27% Similarity=0.440 Sum_probs=156.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.....++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nil 133 (259)
T cd05037 55 MSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNIL 133 (259)
T ss_pred HHcCCCcchhheeeEEecCCcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEE
Confidence 57889999999999886577899999999999999998632 36899999999999999999999999999999999999
Q ss_pred EcCCCC------ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CC
Q 024401 82 LTPDQK------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 154 (268)
Q Consensus 82 ~~~~~~------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~ 154 (268)
++.++. .++|+|||++..... .....++..|+|||.+.. ....++.++|+||||+++|+|++ |.
T Consensus 134 l~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 134 VARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRN------GQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred EecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcC------CCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 986542 499999999876443 223345677999998854 11367889999999999999999 57
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
.||........ ..... .....+......+.+++.+||..+|.+|||+.++++.|
T Consensus 205 ~p~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 205 EPLSTLSSSEK-ERFYQ--DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred CCcccCCchhH-HHHHh--cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 77766542221 11111 12222233347899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=264.68 Aligned_cols=210 Identities=28% Similarity=0.482 Sum_probs=180.7
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
||.++.||||+++.|+.. .....||+||+++|+|+.|++.+ ++.|+..+...+++.|++|+.||-++|+|||||...|
T Consensus 683 IMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~-DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARN 761 (996)
T KOG0196|consen 683 IMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN-DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARN 761 (996)
T ss_pred hcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc-CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhh
Confidence 577999999999999985 45688999999999999999984 4669999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-cc-cCcc--CccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-MM-TAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 154 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-~~-~~~~--~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~ 154 (268)
||++ .+..+|++|||+++...... .. .+.. -..+|.|||.+.. .+++.++||||+|+++||.++ |.
T Consensus 762 ILVN-snLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~--------RKFTsASDVWSyGIVmWEVmSyGE 832 (996)
T KOG0196|consen 762 ILVN-SNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAY--------RKFTSASDVWSYGIVMWEVMSYGE 832 (996)
T ss_pred eeec-cceEEEeccccceeecccCCCccccccCCccceeecChhHhhh--------cccCchhhccccceEEEEecccCC
Confidence 9999 55789999999998543322 11 1112 2468999999964 789999999999999999888 99
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
.||.+.++-+ ....+..+.+.+-|.++|..|.+|+..||++|...||.+.+|+..|+++..+....
T Consensus 833 RPYWdmSNQd-VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL 898 (996)
T KOG0196|consen 833 RPYWDMSNQD-VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL 898 (996)
T ss_pred CcccccchHH-HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence 9999988744 44556677788889999999999999999999999999999999999998765443
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=241.33 Aligned_cols=198 Identities=28% Similarity=0.537 Sum_probs=165.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. +...++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni 133 (258)
T cd06632 56 LSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANI 133 (258)
T ss_pred HHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 56789999999999885 4578999999999999999976 34589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+.............++..|++||.+.. ...++.++|+||||+++|+|++|..||...
T Consensus 134 ~~~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-------~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 134 LVDTN-GVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ-------QGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred EECCC-CCEEEccCccceeccccccccccCCCcceeCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 99865 4699999998876444333345568889999998753 123788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...............+.++..++..+.+++.+||..+|.+||++.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 206 EGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 6444443333324455667788999999999999999999999999986
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=262.47 Aligned_cols=199 Identities=30% Similarity=0.489 Sum_probs=163.2
Q ss_pred CCCCCCCcccceeeeee--cC-------CceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 2 MSRVKHDNLVKFLGACK--DP-------LMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~--~~-------~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
|..++|+||+++.+.+. +. ..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.||
T Consensus 85 l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~I 164 (496)
T PTZ00283 85 LLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHM 164 (496)
T ss_pred HhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 45789999999887652 11 367999999999999999752 23569999999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
+||||||+||+++.+ +.++|+|||+++..... .......|++.|+|||.+.. ..++.++|||||||++
T Consensus 165 iHrDLKP~NILl~~~-~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~s~k~DVwSlGvil 235 (496)
T PTZ00283 165 IHRDIKSANILLCSN-GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR--------KPYSKKADMFSLGVLL 235 (496)
T ss_pred ecCCCCHHHEEEeCC-CCEEEEecccCeeccccccccccccccCCcceeCHHHhCC--------CCCCcHHHHHHHHHHH
Confidence 999999999999965 46999999998754321 12234578999999999853 5678999999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 148 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 148 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
|+|++|+.||...+. .............+.+..+++++.+++.+||..+|.+||++.+++++
T Consensus 236 yeLltG~~Pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 236 YELLTLKRPFDGENM-EEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHHHCCCCCCCCCH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 999999999986543 33333444445556778899999999999999999999999999874
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=243.61 Aligned_cols=204 Identities=30% Similarity=0.571 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
++.++||||+++++.+. .+..++||||+++|+|.+++..... ...+...+..++.|++.||+|||+.|++|
T Consensus 63 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H 142 (288)
T cd05061 63 MKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVH 142 (288)
T ss_pred HHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcC
Confidence 56789999999999874 4578999999999999999975321 23567789999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
+||||+||+++.+ +.++|+|||+++....... .....++..|+|||.+.+ ..++.++|+|||||++|+
T Consensus 143 ~dikp~nili~~~-~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~DvwslG~~l~e 213 (288)
T cd05061 143 RDLAARNCMVAHD-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD--------GVFTTSSDMWSFGVVLWE 213 (288)
T ss_pred CCCChheEEEcCC-CcEEECcCCccccccccccccccCCCcccccccCHHHhcc--------CCCChHhHHHHHHHHHHH
Confidence 9999999999955 5699999999875432211 122234667999998753 567889999999999999
Q ss_pred HHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 150 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 150 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
|++ |..||.+....+ .............+..++..+.+++.+||+.+|++|||+.++++.|....
T Consensus 214 l~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 214 ITSLAEQPYQGLSNEQ-VLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHhCCCCCCCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 998 788987655433 33333344455566778899999999999999999999999999888754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=241.01 Aligned_cols=204 Identities=27% Similarity=0.468 Sum_probs=164.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++|+||+++++.+. ++..+++|||+++++|.+++.... ...+++..++.++.+++.||+|||+.|++|+||+|+
T Consensus 56 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ 135 (267)
T cd08224 56 LKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPA 135 (267)
T ss_pred HHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChh
Confidence 56789999999999884 557899999999999999986532 345899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||++....... ......++..|.|||.+.+ ..++.++|+||||+++|+|++|..||
T Consensus 136 nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~ 206 (267)
T cd08224 136 NVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred hEEECCC-CcEEEeccceeeeccCCCcccceecCCccccCHHHhcc--------CCCCchhcHHHHHHHHHHHHHCCCCc
Confidence 9999965 459999999886543221 1223457888999998753 56788999999999999999999998
Q ss_pred CCCCc-HHHHHHHHHhhcCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 158 EGMSN-LQAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 158 ~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
..... .............++.+. .++..+.+++.+||..+|++|||+.++++.|..+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 207 YGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred ccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 65432 222222223333444444 6888999999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=246.42 Aligned_cols=200 Identities=27% Similarity=0.411 Sum_probs=158.6
Q ss_pred CCCcccceeeeee-------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 6 KHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+||||+++++.+. +...+++|||+++++|.+++...+...+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus 71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ 150 (282)
T cd06636 71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ 150 (282)
T ss_pred CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 6999999999872 346899999999999999998766667899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||++...... .......++..|+|||.+... ......++.++|+||||+++|+|++|..||
T Consensus 151 nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~---~~~~~~~~~~~DvwslG~~l~el~~g~~p~ 226 (282)
T cd06636 151 NVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD---ENPDATYDYRSDIWSLGITAIEMAEGAPPL 226 (282)
T ss_pred HEEECCC-CCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcc---cCcCcCCCcccchhHHHHHHHHHHhCCCCc
Confidence 9999955 45999999998754322 222345678899999987421 011345678999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
........................++.++.+++.+||..+|.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 227 CDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred cccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 7655433333222222222233468899999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=244.69 Aligned_cols=204 Identities=32% Similarity=0.498 Sum_probs=165.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++|+||+++++|.+++.. ..+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Ni 146 (296)
T cd06655 70 MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNV 146 (296)
T ss_pred HHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 56789999999999884 5579999999999999999875 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 147 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~~lltg~~pf~~ 217 (296)
T cd06655 147 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (296)
T ss_pred EECCC-CCEEEccCccchhcccccccCCCcCCCccccCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99855 5699999998875433221 223467889999998853 5578899999999999999999999987
Q ss_pred CCcHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 160 MSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 160 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
.+............ .....+..++..+.+++.+||..+|.+||++.++++ +.++....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~--~~~~~~~~ 276 (296)
T cd06655 218 ENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKLAK 276 (296)
T ss_pred CCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh--ChHhhhcc
Confidence 66544433222211 122345678899999999999999999999999998 66665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=242.53 Aligned_cols=204 Identities=25% Similarity=0.438 Sum_probs=162.8
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++.++||||+++++.+ .++..+++|||+++++|.+++... ....+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ 135 (267)
T cd08229 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPA 135 (267)
T ss_pred HHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 5678999999999987 456789999999999999998642 2345899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++|+||||+++|+|++|..||
T Consensus 136 nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~ 206 (267)
T cd08229 136 NVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPF 206 (267)
T ss_pred HEEEcCC-CCEEECcchhhhccccCCcccccccCCcCccCHHHhcC--------CCccchhhHHHHHHHHHHHHhCCCCc
Confidence 9999855 5699999998875433221 223467889999998853 55778999999999999999999999
Q ss_pred CCCCcH-HHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 158 EGMSNL-QAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.+.... ............++. +..++..+.+++.+||..+|++|||+.++++.+...
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 207 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 754432 222222222222222 345888999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=256.65 Aligned_cols=205 Identities=31% Similarity=0.581 Sum_probs=178.3
Q ss_pred CCCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+|+++.||||++++|.|.+...|+|||.++-|-|..|++.+ ...++..+...++.||+.+|+|||+..+|||||...||
T Consensus 444 iMrnfdHphIikLIGv~~e~P~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNi 522 (974)
T KOG4257|consen 444 IMRNFDHPHIIKLIGVCVEQPMWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNI 522 (974)
T ss_pred HHHhCCCcchhheeeeeeccceeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhe
Confidence 47889999999999999999999999999999999999874 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccC--ccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTA--ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
|+... .-|||+|||+++.......... ..-...|||||.++- ..++.++|||.||+++||++. |..||
T Consensus 523 LVsSp-~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINf--------RrFTtASDVWMFgVCmWEIl~lGvkPf 593 (974)
T KOG4257|consen 523 LVSSP-QCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINF--------RRFTTASDVWMFGVCMWEILSLGVKPF 593 (974)
T ss_pred eecCc-ceeeecccchhhhccccchhhccccccceeecCccccch--------hcccchhhHHHHHHHHHHHHHhcCCcc
Confidence 99854 4599999999997655433322 234568999999964 789999999999999999987 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+..+.+... ....+.+.+.|..+++.+..++.+||+++|.+||++.++...|...+.
T Consensus 594 qgvkNsDVI~-~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 594 QGVKNSDVIG-HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ccccccceEE-EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 8877655432 345678899999999999999999999999999999999998887654
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=241.60 Aligned_cols=207 Identities=29% Similarity=0.480 Sum_probs=157.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---NKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
++.++||||+++++.+. ....++||||+++|+|.+++...+. ...++..+..++.|++.||+|||+.||+|+||||
T Consensus 49 ~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 128 (269)
T cd05042 49 YRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLAL 128 (269)
T ss_pred HHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccH
Confidence 45689999999999884 5578999999999999999976432 2356788899999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-C
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 153 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g 153 (268)
+||+++.+ +.++|+|||++....... ......++..|+|||.+...... .....++.++||||||+++|+|++ |
T Consensus 129 ~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~~ 206 (269)
T cd05042 129 RNCQLTAD-LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQD-LLPKDQTKKSNIWSLGVTMWELFTAA 206 (269)
T ss_pred hheEecCC-CcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcccc-ccccccchhhHHHHHHHHHHHHHhCC
Confidence 99999955 569999999986532221 11223456679999987531110 012456789999999999999999 7
Q ss_pred CCCCCCCCcHHHHHHHHHhh----cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKH----ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
..||....+........... ..+..+..++..+.+++..|| .+|++|||++++++.|
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 207 DQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 88887665544333222211 122334568888999999998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=257.88 Aligned_cols=211 Identities=34% Similarity=0.626 Sum_probs=172.5
Q ss_pred CCCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+|++-+|.||+=+.|+|....+.||+-+|+|.+|+.++.- ...+|+..+.+.|+.|++.|+.|||.++|+|+|||..||
T Consensus 441 ~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv-~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNI 519 (678)
T KOG0193|consen 441 VLKKTRHENILLFMGACMNPPLAIITQWCEGSSLYTHLHV-QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNI 519 (678)
T ss_pred HHhhcchhhheeeehhhcCCceeeeehhccCchhhhhccc-hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccce
Confidence 3677899999999999976666999999999999999976 346799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc---cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
++..+ +.|+|+|||++..... ........+...|+|||++.. .....|++.+||||||+++|||++|..||
T Consensus 520 Fl~~~-~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRm-----qd~nPfS~qSDVYaFGiV~YELltg~lPy 593 (678)
T KOG0193|consen 520 FLHED-LKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRM-----QDDNPFSFQSDVYAFGIVWYELLTGELPY 593 (678)
T ss_pred EEccC-CcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhh-----cccCCCCcccchhhhhHHHHHHHhCcCCc
Confidence 99955 6799999999974332 233344568889999999862 23578999999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 158 EGMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
......+..+........+ ....+.++++.+|+..||.+++++||.+.+|+..|..+..++
T Consensus 594 si~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 594 SIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred CCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 8443333333222221122 233567889999999999999999999999999998877654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=244.16 Aligned_cols=208 Identities=30% Similarity=0.473 Sum_probs=162.5
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+ .++..++||||++|++|..++... ...+++..+..++.|++.+|+|||+.|++|+||+|+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Ni 141 (292)
T cd06644 63 LATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNV 141 (292)
T ss_pred HHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceE
Confidence 5678999999999987 466799999999999999988652 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+..... ....++.++|+||||+++|+|++|..||..
T Consensus 142 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 217 (292)
T cd06644 142 LLTLD-GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM---KDTPYDYKADIWSLGITLIEMAQIEPPHHE 217 (292)
T ss_pred EEcCC-CCEEEccCccceeccccccccceecCCccccCceeeccccc---cCCCCCchhhhHhHHHHHHHHhcCCCCCcc
Confidence 99854 56999999988653222 12233457788999998753110 124467899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.+....... ......+ ..+..++.++.+++.+||..+|++||+++++++ +.++..
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 274 (292)
T cd06644 218 LNPMRVLLK-IAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE--HPFVSS 274 (292)
T ss_pred ccHHHHHHH-HhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc--Cccccc
Confidence 554332222 2222222 234568889999999999999999999999987 444443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=244.33 Aligned_cols=202 Identities=27% Similarity=0.395 Sum_probs=158.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||+|+||
T Consensus 60 l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 137 (267)
T cd06646 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI 137 (267)
T ss_pred HHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 56789999999999884 5578999999999999999865 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+... ....++.++|+||+|+++|+|++|..||..
T Consensus 138 ll~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-----~~~~~~~~~Dvws~G~il~el~~g~~p~~~ 211 (267)
T cd06646 138 LLTDN-GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVE-----KNGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred EECCC-CCEEECcCccceeecccccccCccccCccccCHhHcccc-----cCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 99855 459999999987543221 12334678899999987421 124467799999999999999999999865
Q ss_pred CCcHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
................+ .....++..+.+++.+||..+|++|||++++++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 212 LHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred cchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 54332221111111111 11235788999999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=241.71 Aligned_cols=202 Identities=27% Similarity=0.542 Sum_probs=161.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-------NKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
|++++||||+++++++. ++..++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.|++|+
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~ 141 (275)
T cd05046 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHR 141 (275)
T ss_pred HHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccC
Confidence 56789999999999985 4578999999999999999976431 258999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||||+||+++.+ +.++++|||++....... ......++..|++||.+.. ...+.++||||||+++|+++
T Consensus 142 dlkp~Nili~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~ 212 (275)
T cd05046 142 DLAARNCLVSSQ-REVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE--------DDFSTKSDVWSFGVLMWEVF 212 (275)
T ss_pred cCccceEEEeCC-CcEEEcccccccccCcccccccCCceeEEeecChhhhcc--------CCCCchhhHHHHHHHHHHHH
Confidence 999999999865 459999999886432211 1223345677999998753 45678999999999999999
Q ss_pred h-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 152 T-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
+ |..||.....................+..++..+.+++.+||..+|.+|||+.++++.|.
T Consensus 213 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred hCCCCCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 8 788987655433333222222233445678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=253.32 Aligned_cols=198 Identities=26% Similarity=0.415 Sum_probs=151.1
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++++||||+++++++. +...++|||++ .++|.+++.. ....+++.++..|+.|++.||+|||+.||+||||||+|
T Consensus 110 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 187 (357)
T PHA03209 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTK-RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTEN 187 (357)
T ss_pred HHHhCCCCCCcChhheEEeCCeeEEEEEcc-CCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 367899999999999984 55689999999 5689998865 34679999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC-C
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF-E 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~-~ 158 (268)
|+++.+ +.++|+|||.+.............|+..|+|||.+.. ..++.++|||||||++|+|+++..++ .
T Consensus 188 ill~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 188 IFINDV-DQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR--------DKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred EEECCC-CCEEEecCccccccccCcccccccccccccCCeecCC--------CCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 999955 4599999999875433333344568999999999853 56788999999999999999855443 3
Q ss_pred CCCcHHH--------HHHHHHh---hcCCCCC------------------------------CCCcHHHHHHHHHhhhhC
Q 024401 159 GMSNLQA--------AYAAAFK---HARPGLP------------------------------EDISPDLAFIVQSCWVED 197 (268)
Q Consensus 159 ~~~~~~~--------~~~~~~~---~~~~~~~------------------------------~~~~~~l~~li~~~l~~~ 197 (268)
....... ....... .....++ ..++.++.++|.+||..|
T Consensus 259 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~d 338 (357)
T PHA03209 259 DPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFD 338 (357)
T ss_pred CCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCC
Confidence 2211100 0000000 0000010 135667788999999999
Q ss_pred CCCCCCHHHHHH
Q 024401 198 PNLRPSFSQIIR 209 (268)
Q Consensus 198 p~~Rps~~~~l~ 209 (268)
|.+|||+.++++
T Consensus 339 P~~Rpta~e~l~ 350 (357)
T PHA03209 339 AAMRPSAEEILN 350 (357)
T ss_pred cccCcCHHHHhc
Confidence 999999999998
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=252.80 Aligned_cols=194 Identities=28% Similarity=0.409 Sum_probs=153.2
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
++.++||||+++++.+.. ...|+||||++ ++|.+++.. .+++..+..++.|++.||+|||+.||+|||
T Consensus 77 l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 151 (364)
T cd07875 77 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151 (364)
T ss_pred HHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCC
Confidence 567899999999998632 24799999995 488887753 488999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||+++............++..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 152 lkp~NIll~~~-~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~ 222 (364)
T cd07875 152 LKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGG 222 (364)
T ss_pred CCHHHEEECCC-CcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhC--------CCCCchhhHHhHHHHHHHHHhCC
Confidence 99999999955 5699999999986554433445578999999999854 56788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHh--------------------hcCCC--------------------CCCCCcHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQAAYAAAFK--------------------HARPG--------------------LPEDISPDLAFIVQSCW 194 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~--------------------~~~~~--------------------~~~~~~~~l~~li~~~l 194 (268)
.||.+.+........... ...+. .....+..+++++.+||
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 302 (364)
T cd07875 223 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302 (364)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhc
Confidence 999876543332221110 00010 01123467899999999
Q ss_pred hhCCCCCCCHHHHHH
Q 024401 195 VEDPNLRPSFSQIIR 209 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~ 209 (268)
..||.+|||+.++++
T Consensus 303 ~~dP~~R~t~~e~L~ 317 (364)
T cd07875 303 VIDASKRISVDEALQ 317 (364)
T ss_pred CcCcccCCCHHHHhc
Confidence 999999999999998
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=253.82 Aligned_cols=192 Identities=24% Similarity=0.379 Sum_probs=155.4
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
.||||+++++.+. ++..|+||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||+++.
T Consensus 54 ~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~ 131 (330)
T cd05586 54 ESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDA 131 (330)
T ss_pred CCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECC
Confidence 7999999999885 5578999999999999999875 456999999999999999999999999999999999999995
Q ss_pred CCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
+ +.++|+|||++..... ........|+..|+|||.+.+ ...++.++|||||||++|+|++|..||...+..
T Consensus 132 ~-~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~ 203 (330)
T cd05586 132 T-GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD-------EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ 203 (330)
T ss_pred C-CCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcC-------CCCCCCccceeccccEEEEeccCCCCCCCCCHH
Confidence 5 4699999999875322 222344578999999998753 234688999999999999999999999875543
Q ss_pred HHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCC----CHHHHHH
Q 024401 164 QAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRP----SFSQIIR 209 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp----s~~~~l~ 209 (268)
+. ....... ...++ ..++.++.+++.+||..+|.+|| ++.++++
T Consensus 204 ~~-~~~i~~~-~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 204 QM-YRNIAFG-KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HH-HHHHHcC-CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 32 2222222 22333 35789999999999999999998 5677666
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=243.92 Aligned_cols=204 Identities=24% Similarity=0.389 Sum_probs=163.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..|+||||+++++|.+++.......+++.++..++.|++.||.|||+.|++|+||+|+||
T Consensus 47 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Ni 126 (277)
T cd05577 47 LEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENV 126 (277)
T ss_pred HHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 56789999999999884 55789999999999999999875545799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+.............++..|++||.+.+ ..++.++|+||||+++|+|++|+.||...
T Consensus 127 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~ 197 (277)
T cd05577 127 LLDDH-GNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG--------EVYDFSVDWFALGCTLYEMIAGRSPFRQR 197 (277)
T ss_pred EECCC-CCEEEccCcchhhhccCCccccccCCCCcCCHHHhcC--------CCCCchhhhHHHHHHHHHHhhCCCCCCCC
Confidence 99955 4699999998875443333334567788999998753 44788999999999999999999999765
Q ss_pred CcH--HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhh
Q 024401 161 SNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~ 216 (268)
... ...............+..+++.+.+++.+||+.+|.+|| ++.++++ +.++.
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~--h~~~~ 258 (277)
T cd05577 198 KEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE--HPLFK 258 (277)
T ss_pred cccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh--Chhhh
Confidence 431 111111222334456677899999999999999999999 7777776 44443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=241.13 Aligned_cols=197 Identities=34% Similarity=0.576 Sum_probs=162.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++++||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 56 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 133 (265)
T cd06631 56 LKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV 133 (265)
T ss_pred HHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhE
Confidence 56789999999999984 5578999999999999999975 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-------cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
+++.+ +.++|+|||.+..... ........++..|+|||.+.. ..++.++|+||||+++|+|++|
T Consensus 134 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 134 MLMPN-GIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE--------SGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred EECCC-CeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcC--------CCCcchhhHHHHHHHHHHHHhC
Confidence 99955 5699999998864321 111223457889999998853 5567899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..||...+........... ...+..+..++.++.+++.+||..+|.+||++.++++
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 9999876554433322222 3345567789999999999999999999999999986
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=258.29 Aligned_cols=197 Identities=27% Similarity=0.409 Sum_probs=169.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|.+++|||++.+.|+|. +...|+||||| -|+-.|++.-+ .+++.+.++..|+.+.+.||+|||+.+.+|||||..||
T Consensus 80 L~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNI 157 (948)
T KOG0577|consen 80 LRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNI 157 (948)
T ss_pred HHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccce
Confidence 67899999999999994 55789999999 56989988653 47799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
|++ +.+.|||.|||.+..... ...++||+.|||||++..- ..+.|+-+.||||||+++.||...++|+..+
T Consensus 158 LLs-e~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAM-----DEGqYdgkvDvWSLGITCIELAERkPPlFnM 228 (948)
T KOG0577|consen 158 LLS-EPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNM 228 (948)
T ss_pred Eec-CCCeeeeccccchhhcCc---hhcccCCccccchhHheec-----cccccCCccceeeccchhhhhhhcCCCccCc
Confidence 999 556799999999876544 3567899999999998752 4578899999999999999999999999888
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.....+-+.....+.-....|+..++.|+..||++-|.+|||.++++.
T Consensus 229 NAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 229 NAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred hHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 7766666555444333334579999999999999999999999999887
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=243.30 Aligned_cols=201 Identities=30% Similarity=0.538 Sum_probs=161.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------------CCCCCHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------------PNKLDLHVALNFALDIAR 60 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------------~~~~~~~~~~~i~~ql~~ 60 (268)
++++.||||+++++++. +...+++|||+++++|.+++.... ...+++.+++.++.|++.
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 141 (288)
T cd05050 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAA 141 (288)
T ss_pred HHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHH
Confidence 56789999999999985 457899999999999999997421 124788899999999999
Q ss_pred HHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcc
Q 024401 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 137 (268)
Q Consensus 61 ~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 137 (268)
||+|||+.|++|+||+|+||+++.+ +.++|+|||.+........ ......+..|+|||.+.. ..++.+
T Consensus 142 aL~~lH~~~i~H~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~ 212 (288)
T cd05050 142 GMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY--------NRYTTE 212 (288)
T ss_pred HHHHHHhCCeecccccHhheEecCC-CceEECccccceecccCccccccCCCccChhhcCHHHHhc--------CCCCch
Confidence 9999999999999999999999855 4699999999875432211 122234567999998753 567889
Q ss_pred cchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 138 VDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 138 ~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
+||||||+++|+|++ |..||.+..... .............+..++.++.+++.+||+.+|.+|||+.++++.|+
T Consensus 213 ~Dv~slG~il~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEE-VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 999999999999997 888887655433 33333334444556778999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=247.54 Aligned_cols=199 Identities=26% Similarity=0.400 Sum_probs=159.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++.+. +...++||||+.|++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 134 (316)
T cd05574 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134 (316)
T ss_pred HHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHe
Confidence 56789999999999984 55789999999999999999865556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc------------------------------cccCccCccceecccccccccccccc
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE------------------------------MMTAETGTYRWMAPELYSTVTLRQGE 130 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 130 (268)
+++.+ +.++|+|||++....... ......|+..|+|||.+.+
T Consensus 135 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------- 206 (316)
T cd05574 135 LLHES-GHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG------- 206 (316)
T ss_pred EEcCC-CCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-------
Confidence 99965 469999999886432211 0112357788999998853
Q ss_pred ccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC----HHH
Q 024401 131 KKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS----FSQ 206 (268)
Q Consensus 131 ~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~ 206 (268)
..++.++||||||+++|+|++|..||.+.+.....................+..+.+++.+||..+|++||+ +++
T Consensus 207 -~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ 285 (316)
T cd05574 207 -DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285 (316)
T ss_pred -CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHH
Confidence 556889999999999999999999998766544333322222222222237899999999999999999999 888
Q ss_pred HHH
Q 024401 207 IIR 209 (268)
Q Consensus 207 ~l~ 209 (268)
+++
T Consensus 286 ll~ 288 (316)
T cd05574 286 IKQ 288 (316)
T ss_pred HHc
Confidence 877
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=241.77 Aligned_cols=203 Identities=30% Similarity=0.512 Sum_probs=157.4
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++. +...++||||+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ 137 (284)
T cd05081 59 LKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137 (284)
T ss_pred HHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence 56789999999999862 23588999999999999999753 245899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccc----cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMM----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++......... ....++..|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 138 nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~~ 208 (284)
T cd05081 138 NILVESE-NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYS 208 (284)
T ss_pred hEEECCC-CeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc--------CCcChHHHHHHHHHHHHHHhhcC
Confidence 9999855 45999999998754332211 11223456999998753 56788999999999999999987
Q ss_pred CCCCCCCcHH---------------HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQ---------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 155 ~p~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.++....... ............+.+..++.++.+++.+||..+|++|||+.++++.|+.+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 209 DKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred CcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 6653221110 01111122233344567889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=241.94 Aligned_cols=200 Identities=28% Similarity=0.436 Sum_probs=157.9
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+ .++..+++|||+++++|.+++.. ...+++.+++.++.|++.||+|||+.|++|+||||+||
T Consensus 60 ~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 137 (267)
T cd06645 60 MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANI 137 (267)
T ss_pred HHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 4578999999999987 45678999999999999999875 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+... ....++.++|+||||+++|+|++|..||..
T Consensus 138 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 138 LLTDN-GHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVE-----RKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred EECCC-CCEEECcceeeeEccCcccccccccCcccccChhhhccc-----cCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 99855 45999999998644322 122344688899999987420 124567899999999999999999999876
Q ss_pred CCcHHHHHHHHHhhcCCC-C--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPG-L--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~-~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
................+. . ...++..+.+++.+||..+|++||+++++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 212 LHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 554333222222111111 1 1247788999999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=242.90 Aligned_cols=202 Identities=28% Similarity=0.504 Sum_probs=158.4
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP----------NKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~----------~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
+++++||||+++++++ .++..++||||+.+++|.+++..... ..+++..++.++.|++.||+|||+.|+
T Consensus 71 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 150 (295)
T cd05097 71 MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF 150 (295)
T ss_pred HHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 5689999999999998 45678999999999999999864211 236888999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
+|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++|+||||+++
T Consensus 151 ~H~dlkp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~~l 221 (295)
T cd05097 151 VHRDLATRNCLVGNH-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTL 221 (295)
T ss_pred eccccChhhEEEcCC-CcEEecccccccccccCcceeccCcCcCceeecChhhhcc--------CCcCchhhHHHHHHHH
Confidence 999999999999954 5699999999875432211 122244678999998753 5678899999999999
Q ss_pred HHHHh--CCCCCCCCCcHHHHHHHH--H----hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 148 WELLT--NRLPFEGMSNLQAAYAAA--F----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 148 ~~ll~--g~~p~~~~~~~~~~~~~~--~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
|+|++ +..||............. . .......+..++..+.+++.+||+.+|.+|||++++++.|.
T Consensus 222 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 222 WEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 99988 667887655433222111 1 11122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=241.44 Aligned_cols=201 Identities=29% Similarity=0.516 Sum_probs=161.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKL--DLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~--~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++++. ++..++++||+++++|.+++.... ..+ ++..+..++.|++.||+|||+.||+|+||||+
T Consensus 59 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~ 137 (268)
T cd06624 59 HSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137 (268)
T ss_pred HHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 56789999999999984 457899999999999999997632 334 88889999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+.+.++|+|||.+....... ......++..|+|||.+.. ....++.++|+||||+++|+|++|..||
T Consensus 138 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~------~~~~~~~~~Dv~slGvvl~~l~~g~~p~ 211 (268)
T cd06624 138 NVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK------GPRGYGAPADIWSLGCTIVEMATGKPPF 211 (268)
T ss_pred HEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhcc------ccccCCchhhhHHHHHHHHHHHhCCCCC
Confidence 99998656679999999886543221 1223357889999998743 1234678999999999999999999999
Q ss_pred CCCCcHHHH-HHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAA-YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
......... .........+.++..+++++.+++.+||..+|.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 212 IELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 765433222 2222233445667788999999999999999999999999987
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=253.43 Aligned_cols=195 Identities=27% Similarity=0.406 Sum_probs=153.1
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
++.++||||+++++++.. ...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+.||+|||
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrD 144 (355)
T cd07874 70 MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144 (355)
T ss_pred HHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 467899999999998732 246899999955 77777653 488999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||+++............++..|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 145 ikp~Nill~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~ 215 (355)
T cd07874 145 LKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_pred CChHHEEECCC-CCEEEeeCcccccCCCccccCCccccCCccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999955 5699999999986554444445678999999998854 56788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHh--------------------hcC--------------------CCCCCCCcHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQAAYAAAFK--------------------HAR--------------------PGLPEDISPDLAFIVQSCW 194 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~--------------------~~~--------------------~~~~~~~~~~l~~li~~~l 194 (268)
.||.+.+........... ... ...+...+.++.+++.+||
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 295 (355)
T cd07874 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295 (355)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHh
Confidence 999876543322111100 000 0011224567899999999
Q ss_pred hhCCCCCCCHHHHHHH
Q 024401 195 VEDPNLRPSFSQIIRM 210 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~~ 210 (268)
..||++|||+.+++++
T Consensus 296 ~~dP~~Rps~~ell~h 311 (355)
T cd07874 296 VIDPAKRISVDEALQH 311 (355)
T ss_pred cCCchhcCCHHHHhcC
Confidence 9999999999999983
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=240.44 Aligned_cols=202 Identities=28% Similarity=0.425 Sum_probs=165.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|.||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~ni 124 (262)
T cd05572 47 LEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENL 124 (262)
T ss_pred HHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHE
Confidence 56789999999999874 5578999999999999999976 34589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+.............++..|++||.+.. ..++.++|+||+|+++|+|++|..||...
T Consensus 125 lv~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~ 195 (262)
T cd05572 125 LLDSN-GYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN--------KGYDFSVDYWSLGILLYELLTGRPPFGED 195 (262)
T ss_pred EEcCC-CCEEEeeCCcccccCcccccccccCCcCccChhHhcC--------CCCCChhhhhhhHHHHHHHHhCCCCcCCC
Confidence 99965 4699999999986554333334467889999998753 55788999999999999999999999766
Q ss_pred Cc-HHHHHHHHH-hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhhh
Q 024401 161 SN-LQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~ 216 (268)
.. ......... .......+...+.++.+++.+||..+|.+||+ ++++++ +.++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~--~~~~~ 256 (262)
T cd05572 196 DEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK--HKWFN 256 (262)
T ss_pred CCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc--Chhhh
Confidence 52 222222222 24455666677899999999999999999999 888887 44443
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=242.22 Aligned_cols=196 Identities=30% Similarity=0.541 Sum_probs=160.5
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++.+.+ ...++++||+++++|.+++.. ...+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ 135 (266)
T cd06651 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGA 135 (266)
T ss_pred HHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHH
Confidence 567899999999998743 457899999999999999976 345899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccc----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+
T Consensus 136 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~i~~el~~g~ 206 (266)
T cd06651 136 NILRDSA-GNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG--------EGYGRKADVWSLGCTVVEMLTEK 206 (266)
T ss_pred HEEECCC-CCEEEccCCCccccccccccCCccccCCccccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHHCC
Confidence 9999855 46999999998743221 11122357888999998853 56788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.||..................+.++..+++.+.+++ +||..+|++||+++++++
T Consensus 207 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 207 PPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 999876655554444444445666677888999998 688899999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=238.64 Aligned_cols=200 Identities=39% Similarity=0.715 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..+++|||+++++|.+++.......+++..+..++.|++.||++||+.|++|+||+|+||
T Consensus 55 l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~ni 134 (258)
T smart00219 55 MRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNC 134 (258)
T ss_pred HHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceE
Confidence 45789999999999984 46789999999999999999764333399999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccccc--CccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+.......... ...++..|++||.+.. ..++.++|+||||+++++|++ |..||
T Consensus 135 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~--------~~~~~~~Di~slG~i~~~l~~~g~~p~ 205 (258)
T smart00219 135 LVGEN-LVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKD--------GKFTSKSDVWSFGVLLWEIFTLGESPY 205 (258)
T ss_pred EEccC-CeEEEcccCCceecccccccccccCCCcccccChHHhcc--------CCCCcchhHHHHHHHHHHHHhCCCCCC
Confidence 99955 469999999987554332111 1235678999998743 667889999999999999998 78888
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
...+. ...............+..++.++.+++.+||..+|++|||+.++++.|
T Consensus 206 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 206 PGMSN-EEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCH-HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 76443 333444445555666677899999999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=239.31 Aligned_cols=208 Identities=29% Similarity=0.461 Sum_probs=157.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
+++++||||+++++.+. ....++||||+++++|.+++.... ....++..+..++.|++.||+|||+.|++|+||||
T Consensus 49 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp 128 (269)
T cd05087 49 YRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLAL 128 (269)
T ss_pred HHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCc
Confidence 56789999999999985 456899999999999999997532 23467778889999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-C
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 153 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g 153 (268)
+||+++.+ ..++|+|||.+........ .....++..|+|||.+...... .....++.++|+||||+++|+|++ |
T Consensus 129 ~nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~~~~~~~DiwslG~~l~el~~~g 206 (269)
T cd05087 129 RNCLLTAD-LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN-LLVVDQTKESNVWSLGVTIWELFELG 206 (269)
T ss_pred ceEEEcCC-CcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccccc-ccccCCCccchhHHHHHHHHHHHhCC
Confidence 99999965 5699999999864332221 1223567789999988531100 001245789999999999999996 9
Q ss_pred CCCCCCCCcHHHHHHHHHhh----cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKH----ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
..||......+......... ..+......++.+.+++.+|| .+|++|||+++++..|.
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 207 SQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 99998766544332222111 112222357788999999998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=241.64 Aligned_cols=200 Identities=29% Similarity=0.469 Sum_probs=163.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. +...++|+||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 129 (274)
T cd06609 53 LSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP---GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANI 129 (274)
T ss_pred HHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 46789999999999874 5578999999999999999975 3789999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|++||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 130 ~i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~sDv~slG~il~~l~tg~~p~~~ 200 (274)
T cd06609 130 LLSEE-GDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ--------SGYDEKADIWSLGITAIELAKGEPPLSD 200 (274)
T ss_pred EECCC-CCEEEcccccceeecccccccccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 99965 56999999998765433 22334467788999999864 4588999999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+..... ........+..+.. ++.++.+++.+||..+|++|||++++++ +.++.
T Consensus 201 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~--~~~~~ 255 (274)
T cd06609 201 LHPMRVL-FLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK--HKFIK 255 (274)
T ss_pred CchHHHH-HHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh--Chhhc
Confidence 5533322 22233334444444 8899999999999999999999999988 45543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=236.13 Aligned_cols=200 Identities=35% Similarity=0.607 Sum_probs=161.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. +...++||||+.+++|.+++... ...+++..+..++.+++.+|+|||+.|++|+||+|+||
T Consensus 46 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~ni 124 (251)
T cd05041 46 LKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNC 124 (251)
T ss_pred HHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceE
Confidence 56789999999999874 55789999999999999999753 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc---cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
+++.+ +.++|+|||.+......... .....+..|+|||.+.+ ..++.++|+||||+++|+|++ |..|
T Consensus 125 li~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~i~~~l~t~~~~p 195 (251)
T cd05041 125 LVGEN-NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY--------GRYTSESDVWSYGILLWETFSLGDTP 195 (251)
T ss_pred EEcCC-CcEEEeeccccccccCCcceeccccCcceeccCChHhhcc--------CCCCcchhHHHHHHHHHHHHhccCCC
Confidence 99855 46999999998754321111 11223566999998753 567889999999999999998 8888
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
|....... .............+..++.++.+++.+||..+|.+||++.++++.|+
T Consensus 196 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 196 YPGMSNQQ-TRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHH-HHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 87655433 22223333344556778999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=242.14 Aligned_cols=202 Identities=28% Similarity=0.503 Sum_probs=157.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---------NKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~---------~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
|+.++||||+++++++. ++..+++|||+++++|.+++..... ..+++.++..++.|++.||+|||+.|++
T Consensus 73 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~ 152 (296)
T cd05095 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFV 152 (296)
T ss_pred HHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 56789999999999984 5578999999999999999976321 2377889999999999999999999999
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
|+||||+||+++.+ +.++|+|||++........ ......+..|++||.... ..++.++|+|||||++|
T Consensus 153 H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~DiwSlG~~l~ 223 (296)
T cd05095 153 HRDLATRNCLVGKN-YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--------GKFTTASDVWAFGVTLW 223 (296)
T ss_pred cccCChheEEEcCC-CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc--------CCccchhhhhHHHHHHH
Confidence 99999999999854 5699999999875432211 112233567999997643 56788999999999999
Q ss_pred HHHh--CCCCCCCCCcHHHHHHH--HH----hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 149 ELLT--NRLPFEGMSNLQAAYAA--AF----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 149 ~ll~--g~~p~~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
+|++ |..||...+..+..... .. .....+.+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 224 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 9998 77888765543322111 11 11122334567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=255.73 Aligned_cols=196 Identities=25% Similarity=0.407 Sum_probs=155.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+.+++||||+++++.+. ++..++||||++||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NI 132 (360)
T cd05627 55 LVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL 132 (360)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 46789999999999985 4578999999999999999975 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc------------------------------------cccCccCccceecccccccc
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE------------------------------------MMTAETGTYRWMAPELYSTV 124 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~ 124 (268)
+++.+ +.++|+|||++....... ......||+.|+|||.+.+
T Consensus 133 li~~~-~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~- 210 (360)
T cd05627 133 LLDAK-GHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ- 210 (360)
T ss_pred EECCC-CCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-
Confidence 99855 569999999986432110 0113468999999999854
Q ss_pred ccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCC--CCcHHHHHHHHHhhhhCCCCCC
Q 024401 125 TLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE--DISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 125 ~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p~~Rp 202 (268)
..++.++|+|||||++|+|++|..||...+................++. .++.++.+++.+|+. +|.+|+
T Consensus 211 -------~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~ 282 (360)
T cd05627 211 -------TGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRI 282 (360)
T ss_pred -------CCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcC
Confidence 5678899999999999999999999987665443332221112222332 378899999999874 999998
Q ss_pred C---HHHHHH
Q 024401 203 S---FSQIIR 209 (268)
Q Consensus 203 s---~~~~l~ 209 (268)
+ +.++++
T Consensus 283 ~~~~~~ei~~ 292 (360)
T cd05627 283 GSNGVEEIKS 292 (360)
T ss_pred CCCCHHHHhc
Confidence 5 667766
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=236.58 Aligned_cols=208 Identities=24% Similarity=0.416 Sum_probs=156.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++.++||||+++++.+. ....++||||+++++|.+++.... ....++..+..++.|++.||+|||+.+++|+||||+
T Consensus 49 ~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ 128 (268)
T cd05086 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALR 128 (268)
T ss_pred HhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccc
Confidence 46789999999999985 457899999999999999997632 234677788999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~ 154 (268)
||+++.+ +.++|+|||++...... .......++..|+|||.+..... ......++.++||||||+++|+|++ |.
T Consensus 129 nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~~~~~~~DiwslG~~l~el~~~~~ 206 (268)
T cd05086 129 NCFLTSD-LTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHG-GLITAEQTKPSNVWALGVTLWELFENAA 206 (268)
T ss_pred eEEEcCC-ccEEecccccccccCcchhhhcccCCcCcccccCchhcccccC-ccccCCCCCcchhHHHHHHHHHHHhCCC
Confidence 9999855 56999999987542211 11223457788999998743110 0012345789999999999999997 56
Q ss_pred CCCCCCCcHHHHHHHHHhh----cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 155 LPFEGMSNLQAAYAAAFKH----ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
.||................ ..+..+..++..+.+++..|| .+|.+||+++++++.|.
T Consensus 207 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 207 QPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 7887655433222221111 223444568889999999999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=238.72 Aligned_cols=198 Identities=29% Similarity=0.463 Sum_probs=165.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++||||+.+++|.+++.......+++.+++.++.|++.||+|||+.|++|+||+|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~ni 132 (256)
T cd08218 53 LSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 132 (256)
T ss_pred HHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 57889999999999984 55789999999999999999764445689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ ..++|+|||.+........ .....++..|+|||.+.+ ...+.++|+||||+++++|++|..||..
T Consensus 133 l~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~i~~~l~~g~~~~~~ 203 (256)
T cd08218 133 FLTKD-GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICEN--------RPYNNKSDIWALGCVLYEMCTLKHAFEA 203 (256)
T ss_pred EEcCC-CCEEEeeccceeecCcchhhhhhccCCccccCHHHhCC--------CCCCCccchhHHHHHHHHHHcCCCCccC
Confidence 99855 4699999999875433221 223457888999998754 5677899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..... ..........+..+..++.++.+++.+||+.+|.+||++.++++
T Consensus 204 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 204 GNMKN-LVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCHHH-HHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 54433 33333445555667788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=243.04 Aligned_cols=193 Identities=30% Similarity=0.477 Sum_probs=161.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|.||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni 132 (290)
T cd05580 55 LQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL 132 (290)
T ss_pred HHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 56789999999999985 45789999999999999999763 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... .....++..|++||.+.+ ...+.++|+||||+++|+|++|..||...
T Consensus 133 li~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~ 201 (290)
T cd05580 133 LLDSD-GYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILS--------KGYGKAVDWWALGILIYEMLAGYPPFFDD 201 (290)
T ss_pred EECCC-CCEEEeeCCCccccCCC--CCCCCCCccccChhhhcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99965 46999999998765433 334467889999998753 45678999999999999999999999866
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
+.... ... .......++..++..+.+++.+||..+|.+|+ +++++++
T Consensus 202 ~~~~~-~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 202 NPIQI-YEK-ILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred CHHHH-HHH-HhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 53222 222 22445567778899999999999999999998 7788876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=239.46 Aligned_cols=198 Identities=25% Similarity=0.417 Sum_probs=165.0
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCCe
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLH-----ANGII 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH-----~~~i~ 71 (268)
+++++||||+++++.+. +...+++|||+++++|.+++.... ...+++..++.++.|++.||+||| +.+++
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~ 132 (265)
T cd08217 53 LRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL 132 (265)
T ss_pred HHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce
Confidence 56789999999999763 335789999999999999997632 356899999999999999999999 88999
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
|+||+|+||+++.+ +.++|+|||++........ .....++..|++||.+.. ..++.++|+||||+++|+|
T Consensus 133 h~dl~p~nili~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Dv~slG~il~~l 203 (265)
T cd08217 133 HRDLKPANIFLDAN-NNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNH--------MSYDEKSDIWSLGCLIYEL 203 (265)
T ss_pred ecCCCHHHEEEecC-CCEEEecccccccccCCcccccccccCCCccChhhhcC--------CCCCchhHHHHHHHHHHHH
Confidence 99999999999955 5699999999886544332 334467889999998854 5578899999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 151 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
++|..||...+ .............+..+..++..+.+++.+||..+|.+||++.++++
T Consensus 204 ~~g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 204 CALSPPFTARN-QLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred HHCCCcccCcC-HHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 99999998765 33333444444555667788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=249.55 Aligned_cols=201 Identities=28% Similarity=0.438 Sum_probs=156.4
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
|++++||||+++++++.. ...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrd 143 (343)
T cd07878 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRD 143 (343)
T ss_pred HHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 578899999999987632 2468999998 8899998864 5699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++|||||||++|+|++|.
T Consensus 144 ikp~Nil~~~~-~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~ 213 (343)
T cd07878 144 LKPSNVAVNED-CELRILDFGLARQADDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLKGK 213 (343)
T ss_pred CChhhEEECCC-CCEEEcCCccceecCCC--cCCccccccccCchHhcC-------CccCCchhhhHhHHHHHHHHHHCC
Confidence 99999999955 56999999998764332 233468899999998753 245788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHh---------------------hcCCCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFK---------------------HARPGL--------PEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~---------------------~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+.+........... ...+.. ....++.+.+++.+||..||.+|||+.
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ 293 (343)
T cd07878 214 ALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293 (343)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHH
Confidence 999765433222111100 000111 123566789999999999999999999
Q ss_pred HHHHHHHhhhhhc
Q 024401 206 QIIRMLNAFLFTL 218 (268)
Q Consensus 206 ~~l~~l~~~~~~~ 218 (268)
++++ +.++...
T Consensus 294 ell~--hp~~~~~ 304 (343)
T cd07878 294 EALA--HPYFSQY 304 (343)
T ss_pred HHhc--Ccchhcc
Confidence 9998 5565543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=244.39 Aligned_cols=205 Identities=29% Similarity=0.492 Sum_probs=162.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 73 l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni 149 (292)
T cd06658 73 MRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI 149 (292)
T ss_pred HHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence 46789999999999874 5678999999999999998864 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++|+||||+++|+|++|..||..
T Consensus 150 ll~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGvil~el~~g~~p~~~ 220 (292)
T cd06658 150 LLTSD-GRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMIDGEPPYFN 220 (292)
T ss_pred EEcCC-CCEEEccCcchhhcccccccCceeecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99955 569999999886432221 1233467889999998753 5578899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 160 MSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
.+....... ........ ....++..+.+++.+||..+|.+|||++++++ +.++....++
T Consensus 221 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~--~~~~~~~~~~ 281 (292)
T cd06658 221 EPPLQAMRR-IRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQ--HPFLKLAGPP 281 (292)
T ss_pred CCHHHHHHH-HHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhh--ChhhhccCCc
Confidence 654433222 22222222 22357889999999999999999999999998 5555544443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=238.50 Aligned_cols=198 Identities=30% Similarity=0.469 Sum_probs=160.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +...++++||+++++|.+++.. ....+++..+..++.|++.||.|||+.|++|+||+|.||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~-~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni 130 (256)
T cd06612 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNI 130 (256)
T ss_pred HHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHh-CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 56789999999999884 5578999999999999999975 235689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|++||.+.+ ..++.++||||||+++|+|++|+.||..
T Consensus 131 ~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~s~G~il~~l~~g~~p~~~ 201 (256)
T cd06612 131 LLNEE-GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNNKADIWSLGITAIEMAEGKPPYSD 201 (256)
T ss_pred EECCC-CcEEEcccccchhcccCccccccccCCccccCHHHHhc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99965 469999999987654332 2233457888999998854 5678899999999999999999999986
Q ss_pred CCcHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
............. ......+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 202 IHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 5543332221111 1111233457789999999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=238.28 Aligned_cols=200 Identities=28% Similarity=0.523 Sum_probs=161.8
Q ss_pred CCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCC
Q 024401 3 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPD 78 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~ 78 (268)
+.++||||+++++.+ .++..+++|||++|++|.+++... ....+++..++.++.|++.||.|||+ .|++|+||+|.
T Consensus 64 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ 143 (269)
T cd08528 64 EQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143 (269)
T ss_pred hcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHH
Confidence 357899999999987 456799999999999999998542 33568999999999999999999996 78999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||+++.+ +.++|+|||.+.............++..|++||.+.+ ..++.++|+||||+++|+|++|..||.
T Consensus 144 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 144 NIMLGED-DKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN--------EPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred HEEECCC-CcEEEecccceeecccccccccccCcccCcChhhhcC--------CCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 9999965 4699999999976554433344567889999998853 557889999999999999999999997
Q ss_pred CCCcHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
......... ........+.+ ..++..+.+++.+||+.+|++||++.++...+.
T Consensus 215 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 215 STNMLSLAT-KIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCHHHHHH-HHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 654433222 22222222222 367899999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=245.42 Aligned_cols=205 Identities=32% Similarity=0.486 Sum_probs=163.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||+++++|.+++.. ..+++.++..++.|++.||+|||+.|++|+||||+||
T Consensus 70 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Ni 146 (297)
T cd06656 70 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNI 146 (297)
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 46789999999999984 5578999999999999999865 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+........ .....++..|++||.+.+ ..++.++|+||||+++|++++|..||..
T Consensus 147 li~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 147 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred EECCC-CCEEECcCccceEccCCccCcCcccCCccccCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99855 5699999998875433221 223467888999998853 5667899999999999999999999976
Q ss_pred CCcHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 160 MSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 160 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
.+............ .....+..++..+.+++.+||..+|++||+++++++ +.++...++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~~ 277 (297)
T cd06656 218 ENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ--HPFLKLAKP 277 (297)
T ss_pred CCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhccccc
Confidence 55433322211111 112244568889999999999999999999999998 566554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=252.06 Aligned_cols=202 Identities=34% Similarity=0.524 Sum_probs=157.0
Q ss_pred CCCCCCCcccceeeeeecC------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
|+.++||||+++++++.+. ..|+||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++||||
T Consensus 53 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dl 129 (372)
T cd07853 53 LCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDI 129 (372)
T ss_pred HHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 5678999999999988432 5799999995 688888864 456999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|||||||++|+|++|
T Consensus 130 kp~Nili~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g 201 (372)
T cd07853 130 KPGNLLVNSN-CVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG-------SRHYTSAVDIWSVGCIFAELLGR 201 (372)
T ss_pred ChHHEEECCC-CCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcC-------CCCCCcHHHHHhHHHHHHHHHcC
Confidence 9999999955 569999999987543221 2223457889999998753 24568899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHH----------------------h-hcCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 024401 154 RLPFEGMSNLQAAYAAAF----------------------K-HARP-------GLPEDISPDLAFIVQSCWVEDPNLRPS 203 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~----------------------~-~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps 203 (268)
+.||.+.+.......... . ...+ ......+.++.+++.+||..||.+|||
T Consensus 202 ~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t 281 (372)
T cd07853 202 RILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS 281 (372)
T ss_pred CCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC
Confidence 999987654332211110 0 0000 123446788999999999999999999
Q ss_pred HHHHHHHHHhhhh
Q 024401 204 FSQIIRMLNAFLF 216 (268)
Q Consensus 204 ~~~~l~~l~~~~~ 216 (268)
+.++++ +.++.
T Consensus 282 ~~e~l~--hp~~~ 292 (372)
T cd07853 282 AADALA--HPYLD 292 (372)
T ss_pred HHHHhc--CHhhC
Confidence 999988 44443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=253.43 Aligned_cols=196 Identities=29% Similarity=0.373 Sum_probs=160.0
Q ss_pred Ccccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc-CC
Q 024401 8 DNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT-PD 85 (268)
Q Consensus 8 p~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~-~~ 85 (268)
-|||+++++| ..+++|||+|.+ ..+|+++++.++..+++...+..++.||+.||.+||+.||||+||||+|||+. .+
T Consensus 248 ~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~ 326 (586)
T KOG0667|consen 248 YNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPK 326 (586)
T ss_pred eeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCC
Confidence 4799999998 567999999999 66999999998889999999999999999999999999999999999999995 34
Q ss_pred CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHH
Q 024401 86 QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 165 (268)
Q Consensus 86 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~ 165 (268)
...|||+|||.+........ +.+.+..|.|||++.+ ..|+.+.||||||||++||++|.+.|.+.+..+.
T Consensus 327 r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILG--------lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 327 RSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILG--------LPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred cCceeEEecccccccCCcce--eeeeccccccchhhcc--------CCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 44799999999987665433 6678889999999986 7899999999999999999999888877665444
Q ss_pred HHHHHHhhcCCC--------------------------------------------------CC-----------CCCcH
Q 024401 166 AYAAAFKHARPG--------------------------------------------------LP-----------EDISP 184 (268)
Q Consensus 166 ~~~~~~~~~~~~--------------------------------------------------~~-----------~~~~~ 184 (268)
..........++ .| ..-..
T Consensus 397 l~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~ 476 (586)
T KOG0667|consen 397 LARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDK 476 (586)
T ss_pred HHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHH
Confidence 333221111000 01 01124
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 185 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 185 ~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+.+++++||..||..|+|+.++++ +.++.
T Consensus 477 ~F~dflk~~L~~dP~~R~tp~qal~--Hpfl~ 506 (586)
T KOG0667|consen 477 LFIDFLKRCLEWDPAERITPAQALN--HPFLT 506 (586)
T ss_pred HHHHHHHHHhccCchhcCCHHHHhc--Ccccc
Confidence 5789999999999999999999998 55543
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=245.41 Aligned_cols=186 Identities=26% Similarity=0.426 Sum_probs=153.1
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||+|+++++++. ++..|+||||++|++|.+++.. ...+++.++..++.|++.||+|||+.|++||||||+||+++.
T Consensus 59 ~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~ 136 (323)
T cd05615 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDS 136 (323)
T ss_pred CCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECC
Confidence 4678888998874 4578999999999999999875 356999999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
+ +.++|+|||++...... .......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.+....
T Consensus 137 ~-~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~elltG~~pf~~~~~~ 207 (323)
T cd05615 137 E-GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY--------QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207 (323)
T ss_pred C-CCEEEeccccccccCCCCccccCccCCccccCHHHHcC--------CCCCCccchhhhHHHHHHHHhCCCCCCCCCHH
Confidence 5 46999999998753322 22234468999999998853 56788999999999999999999999876543
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 204 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 204 (268)
..... ........+..++.++.+++.+||..+|.+|++.
T Consensus 208 ~~~~~--i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 208 ELFQS--IMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHHHH--HHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 33222 2233445677899999999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=240.86 Aligned_cols=207 Identities=30% Similarity=0.496 Sum_probs=163.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +...++||||+++++|.+++... ...+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni 134 (280)
T cd06611 56 LSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNI 134 (280)
T ss_pred HHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence 56789999999999984 55789999999999999998763 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+...... .......++..|++||.+.... .....++.++|+||||+++|+|++|..||..
T Consensus 135 li~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~~~~sDi~slG~il~~l~~g~~p~~~ 210 (280)
T cd06611 135 LLTLD-GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET---FKDNPYDYKADIWSLGITLIELAQMEPPHHE 210 (280)
T ss_pred EECCC-CCEEEccCccchhhcccccccceeecchhhcCHHHHhhcc---cCCCCCCccccHHHHHHHHHHHHhCCCCccc
Confidence 99855 56999999987654322 1223346788899999874211 1124567899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+...... .......+ ..+..++.++.+++.+||..+|.+||++.++++ +.++.
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~ 266 (280)
T cd06611 211 LNPMRVLL-KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK--HPFVS 266 (280)
T ss_pred CCHHHHHH-HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhc--Chhhc
Confidence 65443322 22222222 234568899999999999999999999999988 45543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=235.76 Aligned_cols=199 Identities=31% Similarity=0.569 Sum_probs=160.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ....+++|||+.+++|.+++... ...+++..+..++.|++.||++||+.|++|+||+|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni 131 (256)
T cd05112 53 MMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNC 131 (256)
T ss_pred HHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceE
Confidence 56789999999999984 45789999999999999999752 34589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||
T Consensus 132 ~i~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~--------~~~~~~~Dv~slG~~l~el~~~g~~p~ 202 (256)
T cd05112 132 LVGEN-QVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF--------SKYSSKSDVWSFGVLMWEVFSEGKTPY 202 (256)
T ss_pred EEcCC-CeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc--------CCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence 99854 5699999998875432211 112234568999998753 567889999999999999998 89999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
...... ..............+...+..+.+++.+||..+|++|||+.++++.|
T Consensus 203 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 203 ENRSNS-EVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CcCCHH-HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 765432 22223333334444566789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=240.91 Aligned_cols=195 Identities=29% Similarity=0.471 Sum_probs=160.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++||||+++++|.+++.. ..+++..+..++.|++.|++|||+.|++|+||+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni 132 (277)
T cd06642 56 LSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANV 132 (277)
T ss_pred HHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheE
Confidence 56789999999999884 5578999999999999999864 4689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 133 ~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06642 133 LLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDFKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred EEeCC-CCEEEccccccccccCcchhhhcccCcccccCHHHhCc--------CCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence 99855 5699999999875443221 223457888999998854 5678899999999999999999999876
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
....... ........+.....++.++.+++.+||..+|++||++.++++
T Consensus 204 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 204 LHPMRVL-FLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred cchhhHH-hhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 5433322 222233344455678899999999999999999999999998
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=240.37 Aligned_cols=196 Identities=29% Similarity=0.486 Sum_probs=161.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++++.||||+++++.+. +...++||||++|++|.+++.. .++++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Ni 132 (277)
T cd06640 56 LSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhE
Confidence 56789999999999984 5579999999999999999865 4689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 133 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~--------~~~~~~~Dv~slG~il~el~tg~~p~~~ 203 (277)
T cd06640 133 LLSEQ-GDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQ--------SAYDSKADIWSLGITAIELAKGEPPNSD 203 (277)
T ss_pred EEcCC-CCEEEcccccceeccCCccccccccCcccccCHhHhcc--------CCCccHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99955 569999999987543322 1223357788999998853 5578899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
........ .......+..+..++..+.+++.+||..+|++||++++++++
T Consensus 204 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 204 MHPMRVLF-LIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred cChHhHhh-hhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 55433222 222333455556788899999999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=240.53 Aligned_cols=197 Identities=29% Similarity=0.531 Sum_probs=161.5
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~N 79 (268)
+++++||||+++++.+ .++..++++||+.+++|.+++.... ..+++..+..++.|++.||+|||+ .|++|+||+|+|
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~n 131 (265)
T cd06605 53 LHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131 (265)
T ss_pred HHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHH
Confidence 4678899999999987 4567899999999999999998643 679999999999999999999999 999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.++|+|||.+......... ...++..|++||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 132 i~~~~~-~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 201 (265)
T cd06605 132 ILVNSR-GQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG--------NDYSVKSDIWSLGLSLIELATGRFPYPP 201 (265)
T ss_pred EEECCC-CCEEEeecccchhhHHHHhh-cccCChhccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCc
Confidence 999965 56999999988654332221 2567889999998854 5678899999999999999999999975
Q ss_pred CC----cHHHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MS----NLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~----~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.. ..............+..+.. ++.++.++|.+||..+|.+|||+.+++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 202 ENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred cccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 52 22222233333344444444 8899999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=252.45 Aligned_cols=203 Identities=24% Similarity=0.396 Sum_probs=156.9
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++||||+++++.+. +...+++||++ +++|.+++.. ...+++.+++.++.||+.||+|||+.||+||||||+|
T Consensus 139 il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~N 215 (392)
T PHA03207 139 ILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTEN 215 (392)
T ss_pred HHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHH
Confidence 367899999999999884 55789999999 5689998853 4569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|+++.+ +.++|+|||++....... ......|+..|+|||.+.. ..++.++|||||||++|+|++|..|
T Consensus 216 ill~~~-~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DvwslGvil~el~~g~~p 286 (392)
T PHA03207 216 IFLDEP-ENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL--------DPYCAKTDIWSAGLVLFEMSVKNVT 286 (392)
T ss_pred EEEcCC-CCEEEccCccccccCcccccccccccccccCccCHhHhcC--------CCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999955 469999999987543322 1223468999999998853 5678899999999999999999999
Q ss_pred CCCCCcH---HHHHHHH-------------------------HhhcCCC--CC-----CCCcHHHHHHHHHhhhhCCCCC
Q 024401 157 FEGMSNL---QAAYAAA-------------------------FKHARPG--LP-----EDISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 157 ~~~~~~~---~~~~~~~-------------------------~~~~~~~--~~-----~~~~~~l~~li~~~l~~~p~~R 201 (268)
|.+.... ....... ....++. .+ ..++.++.++|.+||..+|++|
T Consensus 287 f~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 366 (392)
T PHA03207 287 LFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFR 366 (392)
T ss_pred CCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhC
Confidence 9654321 1110000 0000110 11 2356788999999999999999
Q ss_pred CCHHHHHHHHHhhhhh
Q 024401 202 PSFSQIIRMLNAFLFT 217 (268)
Q Consensus 202 ps~~~~l~~l~~~~~~ 217 (268)
||+.+++. +.++..
T Consensus 367 psa~e~l~--~p~f~~ 380 (392)
T PHA03207 367 PSAQDILS--LPLFTK 380 (392)
T ss_pred CCHHHHhh--Cchhhc
Confidence 99999998 455543
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=241.13 Aligned_cols=199 Identities=27% Similarity=0.425 Sum_probs=155.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++++++. ++..++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~n 131 (285)
T cd07861 53 LKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQN 131 (285)
T ss_pred HHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHH
Confidence 56789999999999984 567999999996 58999886533 2568999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||.
T Consensus 132 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~~~~ 203 (285)
T cd07861 132 LLIDNK-GVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLG-------SPRYSTPVDIWSIGTIFAEMATKKPLFH 203 (285)
T ss_pred EEEcCC-CcEEECcccceeecCCCcccccCCcccccccChHHhcC-------CCCcCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999955 569999999987543221 1223356788999998753 2346789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhh-------------------c--------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKH-------------------A--------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~-------------------~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.............. . .......+++++.+++.+||..||.+|||+.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 204 GDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 655433222111000 0 00112347889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=239.93 Aligned_cols=203 Identities=28% Similarity=0.472 Sum_probs=158.9
Q ss_pred CCCC-CCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 2 MSRV-KHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
++++ .||||+++++.+.+. ..+++|||+++++|.+++.... +..+++..+..++.|++.||+|||+.|++
T Consensus 56 l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~ 135 (275)
T cd06608 56 LRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVI 135 (275)
T ss_pred HHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 3455 699999999998432 3799999999999999987643 46799999999999999999999999999
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
|+||+|+||+++.+ +.++|+|||.+...... .......++..|+|||.+..... ....++.++||||||+++|+|
T Consensus 136 H~~l~p~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~---~~~~~~~~~Dv~slG~il~~l 211 (275)
T cd06608 136 HRDIKGQNILLTKN-AEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQ---PDASYDARSDVWSLGITAIEL 211 (275)
T ss_pred cCCCCHHHEEEccC-CeEEECCCccceecccchhhhcCccccccccCHhHhccccc---ccCCccccccHHHhHHHHHHH
Confidence 99999999999965 56999999988654322 22234467889999998753211 134567899999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 151 LTNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
++|..||............ .....+. .+..+++++.+++.+||..+|++|||+.++++
T Consensus 212 ~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 212 ADGKPPLCDMHPMRALFKI-PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HhCCCCccccchHHHHHHh-hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999999765543333322 2222222 22347889999999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=238.77 Aligned_cols=196 Identities=30% Similarity=0.537 Sum_probs=159.3
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++.+.+ ..++++|||++|++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 135 (265)
T cd06652 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGA 135 (265)
T ss_pred HHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 567899999999998754 3578999999999999999753 45899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccc----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 136 nil~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~ 206 (265)
T cd06652 136 NILRDSV-GNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG--------EGYGRKADIWSVGCTVVEMLTEK 206 (265)
T ss_pred HEEecCC-CCEEECcCccccccccccccccccccCCCCccccChhhhcC--------CCCCcchhHHHHHHHHHHHhhCC
Confidence 9999955 56999999988753221 11223457889999998853 55688999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.||..................+..+..++..+.+++.+|+. +|++||+++++++
T Consensus 207 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 207 PPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred CCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 99987655444433333333455666788889999999995 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=239.47 Aligned_cols=198 Identities=29% Similarity=0.520 Sum_probs=161.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. .+..++|+||+.|++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|.||
T Consensus 57 l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ni 134 (268)
T cd06630 57 MARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANL 134 (268)
T ss_pred HHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 56789999999999985 4578999999999999999975 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
+++.++..++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~ 206 (268)
T cd06630 135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG--------EQYGRSCDVWSVGCVIIEMATAKP 206 (268)
T ss_pred EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc--------CCCCcccchHHHHHHHHHHHhCCC
Confidence 998766679999999987543321 1123457889999998753 556789999999999999999999
Q ss_pred CCCCCCcHH---HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 156 PFEGMSNLQ---AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 156 p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
||....... ...........+..+..++.++.+++.+||..+|.+||++.++++
T Consensus 207 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 207 PWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 996543211 111111223345566778899999999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=236.90 Aligned_cols=201 Identities=30% Similarity=0.507 Sum_probs=167.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~N 79 (268)
+++++||||+++++.+. ++..+++|||+++++|.+++... ..+++..++.++.|++.||+|||+ .|++|+||+|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~n 130 (264)
T cd06623 53 LRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN 130 (264)
T ss_pred HHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHH
Confidence 45688999999999984 56789999999999999999863 669999999999999999999999 999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccc-cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++.+ +.++|+|||.+......... ....++..|+|||.+.. ..++.++|+||||+++|+|++|..||.
T Consensus 131 i~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~tg~~p~~ 201 (264)
T cd06623 131 LLINSK-GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQG--------ESYSYAADIWSLGLTLLECALGKFPFL 201 (264)
T ss_pred EEECCC-CCEEEccCccceecccCCCcccceeecccccCHhhhCC--------CCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 999955 56999999998765433222 24467788999998754 567889999999999999999999997
Q ss_pred CCC--cHHHHHHHHHhhcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 159 GMS--NLQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 159 ~~~--~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
... ..............+..+.. ++..+.+++.+||..+|++||++.++++ ..++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~--~~~~ 259 (264)
T cd06623 202 PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ--HPFI 259 (264)
T ss_pred cccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh--CHHH
Confidence 765 43444444444555556666 8999999999999999999999999998 4444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=243.14 Aligned_cols=201 Identities=25% Similarity=0.455 Sum_probs=157.6
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~N 79 (268)
+++++||||+++++.+ .++..+++|||++|++|.+++... ..+++..+..++.|++.||+|||+ .+++|+||+|+|
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n 130 (308)
T cd06615 53 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN 130 (308)
T ss_pred HHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence 5678999999999988 466899999999999999999763 568999999999999999999997 599999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 131 il~~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 131 ILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred EEEecC-CcEEEccCCCccccccc-ccccCCCCcCccChhHhcC--------CCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 999855 56999999988654322 1234467889999998743 5578899999999999999999999864
Q ss_pred CCcHHHHHH-----------------------------------HHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCC
Q 024401 160 MSNLQAAYA-----------------------------------AAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPS 203 (268)
Q Consensus 160 ~~~~~~~~~-----------------------------------~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps 203 (268)
.+....... .......+..+ ..++.++.+++.+||..+|++||+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 280 (308)
T cd06615 201 PDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD 280 (308)
T ss_pred cchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC
Confidence 332111100 00011111222 136788999999999999999999
Q ss_pred HHHHHHHHHhhhh
Q 024401 204 FSQIIRMLNAFLF 216 (268)
Q Consensus 204 ~~~~l~~l~~~~~ 216 (268)
++++++ +.++.
T Consensus 281 ~~~ll~--~~~~~ 291 (308)
T cd06615 281 LKELTK--HPFIK 291 (308)
T ss_pred HHHHhc--Chhhh
Confidence 999998 44443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=245.63 Aligned_cols=200 Identities=25% Similarity=0.362 Sum_probs=149.6
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
|++++||||+++++.+. +...+++|||+ +++|.+++.... ...+++..+..++.|++.||+|||+.||+
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 130 (317)
T cd07868 52 LRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 56789999999999873 34588999999 569998876421 23589999999999999999999999999
Q ss_pred ecCCCCCCEEEc---CCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 72 HRDLKPDNLLLT---PDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 72 H~dlk~~Nil~~---~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
||||||+||++. ...+.++|+|||++....... ......++..|+|||.+.+ ...++.++||||+|
T Consensus 131 HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG 203 (317)
T cd07868 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIG 203 (317)
T ss_pred cCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcC-------CCCcCchhhHHHHH
Confidence 999999999994 233569999999997543221 1234567899999998853 24578899999999
Q ss_pred HHHHHHHhCCCCCCCCCcHH--------HHHHHHHhhc-------------CC------------------------CCC
Q 024401 145 IVLWELLTNRLPFEGMSNLQ--------AAYAAAFKHA-------------RP------------------------GLP 179 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~~--------~~~~~~~~~~-------------~~------------------------~~~ 179 (268)
|++|+|++|..||....... .......... .+ ...
T Consensus 204 ~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (317)
T cd07868 204 CIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 283 (317)
T ss_pred HHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcC
Confidence 99999999999996433210 0000000000 00 000
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 180 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...+..+.+++.+||..||.+|||++++++
T Consensus 284 ~~~~~~~~dli~~mL~~dP~~R~t~~e~l~ 313 (317)
T cd07868 284 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 313 (317)
T ss_pred CCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence 123456889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=242.10 Aligned_cols=202 Identities=25% Similarity=0.383 Sum_probs=158.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++||||++|++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|.||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI 132 (305)
T cd05609 55 LTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL 132 (305)
T ss_pred HHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence 56789999999999884 55689999999999999999763 5689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc----------------cccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE----------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
+++.+ +.++|+|||+++...... ......++..|+|||.+.. ..++.++|+||||
T Consensus 133 ll~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 203 (305)
T cd05609 133 LITSM-GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--------QGYGKPVDWWAMG 203 (305)
T ss_pred EECCC-CCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccC--------CCCCchhhHHHHH
Confidence 99854 569999999886311100 0112346778999998753 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 145 IVLWELLTNRLPFEGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
+++|+|++|..||.+....+......... ..+.....++.++.+++.+||+.+|++||+..++.+.|...
T Consensus 204 ~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~ 274 (305)
T cd05609 204 IILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR 274 (305)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence 99999999999998655433222222111 12222235789999999999999999999976666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=244.12 Aligned_cols=208 Identities=24% Similarity=0.402 Sum_probs=160.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..+++|||+++++|.+++.......+++..+..++.|++.||+|||+.||+|+||||+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Ni 132 (314)
T cd08216 53 SRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHI 132 (314)
T ss_pred HHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceE
Confidence 56789999999999884 55789999999999999999875556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.. ....++.++|+||+|+++|+|++
T Consensus 133 li~~~-~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Diws~G~il~el~~ 205 (314)
T cd08216 133 LLSGD-GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ------NLQGYNEKSDIYSVGITACELAN 205 (314)
T ss_pred EEecC-CceEEecCccceeeccccccccccccccccccccccccCHHHhcC------CCCCCCcchhHHHHHHHHHHHHh
Confidence 99955 569999999886432211 1123356678999998753 12346789999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhc--------------------------------CCCCCCCCcHHHHHHHHHhhhhCCCC
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHA--------------------------------RPGLPEDISPDLAFIVQSCWVEDPNL 200 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~ 200 (268)
|..||................. .......++.++.+++.+||..+|++
T Consensus 206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 285 (314)
T cd08216 206 GHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPES 285 (314)
T ss_pred CCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCc
Confidence 9999987654433322211000 00011224567889999999999999
Q ss_pred CCCHHHHHHHHHhhhhhc
Q 024401 201 RPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 201 Rps~~~~l~~l~~~~~~~ 218 (268)
|||++++++ +.++...
T Consensus 286 Rpt~~~ll~--~p~~~~~ 301 (314)
T cd08216 286 RPSASQLLN--HSFFKQC 301 (314)
T ss_pred CcCHHHHhc--CchHhhh
Confidence 999999998 5555443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=237.11 Aligned_cols=199 Identities=29% Similarity=0.482 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..++|+||+++++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|.||
T Consensus 53 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni 132 (257)
T cd08225 53 LAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNI 132 (257)
T ss_pred HHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 56789999999999884 55789999999999999999764445689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.++..++|+|||.+....... ......++..|+|||.... ..++.++|+||||++++++++|..||..
T Consensus 133 l~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~ 204 (257)
T cd08225 133 FLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN--------RPYNNKTDIWSLGCVLYELCTLKHPFEG 204 (257)
T ss_pred EEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999776667999999887543322 1223457888999998753 5577899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
....... ..............++.++.+++.+||..+|++|||+.++++
T Consensus 205 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 205 NNLHQLV-LKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ccHHHHH-HHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 5443332 233334444555678899999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=239.24 Aligned_cols=203 Identities=30% Similarity=0.502 Sum_probs=162.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +++.++++||+.|++|.+++.. ..+++.++..++.|++.||+|||+.|++||||+|+||
T Consensus 70 l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Ni 146 (285)
T cd06648 70 MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSI 146 (285)
T ss_pred HHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhE
Confidence 46789999999999874 5678999999999999999876 4689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 147 l~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slGv~l~ell~g~~p~~~ 217 (285)
T cd06648 147 LLTSD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR--------LPYGTEVDIWSLGIMVIEMVDGEPPYFN 217 (285)
T ss_pred EEcCC-CcEEEcccccchhhccCCcccccccCCccccCHHHhcC--------CCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence 99955 569999999876433221 2233467889999998753 5578899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 160 MSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
.+........ .....+.. +..++..+.+++.+||..+|++||++.++++ +.++...+
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~~~ 276 (285)
T cd06648 218 EPPLQAMKRI-RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN--HPFLAKAG 276 (285)
T ss_pred CCHHHHHHHH-HhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc--CcccccCC
Confidence 5543333222 22222222 2347889999999999999999999999997 55554433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=249.96 Aligned_cols=206 Identities=33% Similarity=0.564 Sum_probs=177.2
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|+.++|||+|+++|+|. +..+|||+||+..|+|-+|+++.....++.-..+.++.||.+|++||..++++||||...|
T Consensus 316 vMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARN 395 (1157)
T KOG4278|consen 316 VMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARN 395 (1157)
T ss_pred HHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 478899999999999995 5579999999999999999998655668888889999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccc--cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMM--TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
+|+.. ++.||+.|||+++.+...... ....-.+.|.|||.+.- ..++.++|||+||+++||+.+ |..|
T Consensus 396 CLVgE-nhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAy--------NtFSiKSDVWAFGVLLWEIATYGMsP 466 (1157)
T KOG4278|consen 396 CLVGE-NHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NTFSIKSDVWAFGVLLWEIATYGMSP 466 (1157)
T ss_pred ccccc-cceEEeeccchhhhhcCCceecccCccCcccccCcccccc--------cccccchhhHHHHHHHHHHHhcCCCC
Confidence 99994 467999999999976543221 11234567999998853 678889999999999999999 8999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|++.+. ...+.....+.+..-|+.+++.+.+|++.||++.|.+||+++++-+.|+..+.
T Consensus 467 YPGidl-SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 467 YPGIDL-SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred CCCccH-HHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 998764 44455667788889999999999999999999999999999999999988763
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=246.03 Aligned_cols=204 Identities=21% Similarity=0.332 Sum_probs=156.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..|+||||++|++|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni 133 (331)
T cd05597 55 LVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNV 133 (331)
T ss_pred HHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHE
Confidence 45679999999999985 55799999999999999999752 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++........ .....|++.|+|||.+.... .....++.++|||||||++|+|++|+.||.
T Consensus 134 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DiwslG~~l~el~~g~~Pf~ 209 (331)
T cd05597 134 LLDKN-GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME---DGKGRYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EECCC-CCEEEEECCceeecCCCCCccccceeccccccCHHHHhhcc---ccccCCCCcceeehhhhHHHHHhhCCCCCC
Confidence 99855 4699999999865433221 22346899999999885311 012456789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCC--CCCCHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPN--LRPSFSQIIRM 210 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~--~Rps~~~~l~~ 210 (268)
.....+.............+ ...++..+++++.+|+..++. .|+++.+++++
T Consensus 210 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 210 AESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred CCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 76544433332222222222 234789999999998865443 37899999883
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=238.84 Aligned_cols=195 Identities=23% Similarity=0.344 Sum_probs=158.1
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
...||||+.+++.+. ++..++||||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus 53 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~ 130 (279)
T cd05633 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130 (279)
T ss_pred hCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE
Confidence 457999999999884 5678999999999999999875 3569999999999999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 83 TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
+.+ +.++|+|||++....... .....++..|+|||.+.. +..++.++|+||+|+++|+|++|..||.....
T Consensus 131 ~~~-~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 201 (279)
T cd05633 131 DEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 201 (279)
T ss_pred CCC-CCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcC-------CCCCCchhhhHHHHHHHHHHHhCCCCcCCCCC
Confidence 855 569999999986543222 223468899999998742 24567899999999999999999999975432
Q ss_pred H-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 163 L-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 163 ~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
. ...............+..++.++.+++.+||..+|.+|+ |+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 202 KDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred cCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 1 122222222344556678999999999999999999999 5999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=264.45 Aligned_cols=207 Identities=24% Similarity=0.387 Sum_probs=160.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---------PNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
+++++||||+++++++. ++..+++|||++|++|.+++.... ....++..++.++.|++.||+|||+.||+
T Consensus 56 Ls~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GII 135 (932)
T PRK13184 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVL 135 (932)
T ss_pred HHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 56789999999999985 457899999999999999986421 13356778899999999999999999999
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCccc-------------------ccccCccCccceecccccccccccccccc
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-------------------EMMTAETGTYRWMAPELYSTVTLRQGEKK 132 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 132 (268)
||||||+||+++.+ +.++|+|||++...... .......||+.|+|||.+.+ .
T Consensus 136 HRDLKPeNILLd~d-g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--------~ 206 (932)
T PRK13184 136 HRDLKPDNILLGLF-GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--------V 206 (932)
T ss_pred ccCCchheEEEcCC-CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC--------C
Confidence 99999999999965 45999999998754110 01112468999999998853 5
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHH
Q 024401 133 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRM 210 (268)
Q Consensus 133 ~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~l~~ 210 (268)
.++.++|||||||++|+|++|..||................. .......++..+.+++.+||..+|++|+ +++++++.
T Consensus 207 ~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~ 286 (932)
T PRK13184 207 PASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQD 286 (932)
T ss_pred CCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 678899999999999999999999976443222221111110 0111236788999999999999999996 68888888
Q ss_pred HHhhhhh
Q 024401 211 LNAFLFT 217 (268)
Q Consensus 211 l~~~~~~ 217 (268)
|..+...
T Consensus 287 Le~~lq~ 293 (932)
T PRK13184 287 LEPHLQG 293 (932)
T ss_pred HHHHHhc
Confidence 8887654
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=253.49 Aligned_cols=198 Identities=26% Similarity=0.375 Sum_probs=150.9
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++||||+++++++ .++..++|||++ .++|.+++.. ....+++.+++.|+.|++.||+|||+.||+||||||+|
T Consensus 213 iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~N 290 (461)
T PHA03211 213 LLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGA-RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTEN 290 (461)
T ss_pred HHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHH
Confidence 36789999999999987 456789999999 5699998875 23469999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
||++.+ +.++|+|||++....... ......||..|+|||.+.+ ..++.++|||||||++|||++|..+
T Consensus 291 ILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~sDvwSlGviL~El~~g~~~ 361 (461)
T PHA03211 291 VLVNGP-EDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG--------DPYTPSVDIWSAGLVIFEAAVHTAS 361 (461)
T ss_pred EEECCC-CCEEEcccCCceecccccccccccccCCCcCCcCHHHHcC--------CCCCchHHHHHHHHHHHHHHHcCCC
Confidence 999955 459999999987543221 1123468999999999854 5678899999999999999987755
Q ss_pred CCCCCc-------HHHHHHHHHhh--------------------------cCCCCC-------CCCcHHHHHHHHHhhhh
Q 024401 157 FEGMSN-------LQAAYAAAFKH--------------------------ARPGLP-------EDISPDLAFIVQSCWVE 196 (268)
Q Consensus 157 ~~~~~~-------~~~~~~~~~~~--------------------------~~~~~~-------~~~~~~l~~li~~~l~~ 196 (268)
+..... ........... ..+... ..++.++.+||.+||+.
T Consensus 362 lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~ 441 (461)
T PHA03211 362 LFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTF 441 (461)
T ss_pred cccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHccc
Confidence 422110 11111111000 000000 13456799999999999
Q ss_pred CCCCCCCHHHHHH
Q 024401 197 DPNLRPSFSQIIR 209 (268)
Q Consensus 197 ~p~~Rps~~~~l~ 209 (268)
||.+|||+.++++
T Consensus 442 DP~~RPsa~elL~ 454 (461)
T PHA03211 442 DGARRPSAAELLR 454 (461)
T ss_pred ChhhCcCHHHHhh
Confidence 9999999999998
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=244.02 Aligned_cols=204 Identities=21% Similarity=0.344 Sum_probs=158.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+..++||||+++++.+. ++..++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Ni 133 (332)
T cd05623 55 LVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133 (332)
T ss_pred HhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence 45679999999999985 45789999999999999999752 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++....... ......|++.|+|||.+.... .....++.++|||||||++|+|++|+.||.
T Consensus 134 li~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~~~~~DvwSlGvil~ell~g~~Pf~ 209 (332)
T cd05623 134 LMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---DGKGKYGPECDWWSLGVCMYEMLYGETPFY 209 (332)
T ss_pred EECCC-CCEEEeecchheecccCCcceecccccCccccCHHHHhccc---cCCCCCCCcCCEEeeHHHHHHHhcCCCCCC
Confidence 99955 469999999986533221 122346899999999885311 112457889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLP---EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 210 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~~~l~~ 210 (268)
..+................++ ..++.++.+++.+|+..++.. |+++++++++
T Consensus 210 ~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 210 AESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 766544443332222222233 467999999999999654444 6789999884
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=236.59 Aligned_cols=199 Identities=28% Similarity=0.562 Sum_probs=159.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..++||||+++++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~ni 139 (272)
T cd06629 62 LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL 139 (272)
T ss_pred HHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhE
Confidence 56789999999999984 45789999999999999999763 5689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.. ....++.++|+||||+++|++++|..||
T Consensus 140 l~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~------~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 212 (272)
T cd06629 140 LVDAD-GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS------YSQGYSAKVDIWSLGCVVLEMFAGRRPW 212 (272)
T ss_pred EEcCC-CeEEEeeccccccccccccccccccccCCccccCHHHhcc------ccCCCCccchhHHHHHHHHHHHhCCCCC
Confidence 99955 569999999987543221 1223357889999998753 1134688999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
....................++ ..++.++.+++.+||..+|.+|||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 213 SDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 7655544333322222223222 346889999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=238.54 Aligned_cols=198 Identities=28% Similarity=0.420 Sum_probs=156.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +...++||||+++++|..++.. ...+++..+..++.|++.||+|||+.|++|+||+|.||
T Consensus 54 l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni 131 (286)
T cd07847 54 LKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI 131 (286)
T ss_pred HHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence 56789999999999985 4578999999999888887754 34699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||.+
T Consensus 132 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~i~~~l~~g~~p~~~ 203 (286)
T cd07847 132 LITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG-------DTQYGPPVDVWAIGCVFAELLTGQPLWPG 203 (286)
T ss_pred EEcCC-CcEEECccccceecCCCcccccCcccccccCCHHHHhC-------CCCcCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 99965 469999999987654332 2223456788999998742 24567899999999999999999999987
Q ss_pred CCcHHHHHHHHHhh----------------------cCC-------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKH----------------------ARP-------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~----------------------~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
....+......... ..+ .....++..+.+++.+||..+|++||++.+++.
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 204 KSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred CChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 66544332211100 000 001246788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=234.93 Aligned_cols=197 Identities=24% Similarity=0.310 Sum_probs=157.0
Q ss_pred CCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 3 SRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
...+||||+++++.+. ++..++|+||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|.||+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil 129 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL 129 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence 4568999999999985 5579999999999999999976 346899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
++.+ +.++|+|||++..... .....++..|++||.+.+ ..++.++|+||||+++|+|++|..||...+
T Consensus 130 ~~~~-~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 130 IDQT-GHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILG--------VGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred ECCC-CcEEEeecccceeccc---cccCCCCcCccChhhhcC--------CCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 9965 5699999998875433 223457788999998753 447889999999999999999999998665
Q ss_pred cHHHHHHHHHhh--cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 162 NLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 162 ~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
............ ........+++++.+++.+||..+|++||++.++.+.|..
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~ 251 (260)
T cd05611 198 PDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH 251 (260)
T ss_pred HHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence 433222221111 1122334578999999999999999999977655554444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=242.09 Aligned_cols=198 Identities=34% Similarity=0.575 Sum_probs=158.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. +...+++||++.+++|.+++.. ...+++.+++.++.|++.||++||+.|++|+||||+||
T Consensus 52 ~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NI 129 (260)
T PF00069_consen 52 LRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENI 129 (260)
T ss_dssp HHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGE
T ss_pred cccccccccccccccccccccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccc
Confidence 35678999999999984 5678999999999999999983 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccC-cccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++ +++.++|+|||.+... ..........++..|.|||.+. .....+.++|+||||+++|+|++|..||..
T Consensus 130 l~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~~Di~slG~il~~l~~~~~p~~~ 201 (260)
T PF00069_consen 130 LLD-ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQ-------QGKKYTRKSDIWSLGIILYELLTGKLPFEE 201 (260)
T ss_dssp EES-TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHT-------TTSSBSTHHHHHHHHHHHHHHHHSSSSSTT
T ss_pred ccc-ccccccccccccccccccccccccccccccccccccccc-------cccccccccccccccccccccccccccccc
Confidence 999 4456999999998752 2333445567889999999975 136788999999999999999999999987
Q ss_pred CCcHHHHH---HHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAY---AAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~---~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
........ .......... .....+..+.+++.+||..+|++|||+.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 202 SNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp SSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 63222111 1111111111 11223489999999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=238.27 Aligned_cols=196 Identities=29% Similarity=0.425 Sum_probs=163.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +...++|+||+.|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|.||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni 131 (258)
T cd05578 54 LQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNI 131 (258)
T ss_pred HHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence 56889999999999884 45799999999999999999763 5799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+.............++..|++||.+.. ..++.++|+||||+++|+|++|..||...
T Consensus 132 l~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 202 (258)
T cd05578 132 LLDEQ-GHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR--------QGYSVAVDWWSLGVTAYECLRGKRPYRGH 202 (258)
T ss_pred EEcCC-CCEEEeecccccccCCCccccccCCChhhcCHHHHcc--------cCCCCcccchhhHHHHHHHHhCCCCCCCC
Confidence 99955 5699999999876554434445568889999998853 44788999999999999999999999876
Q ss_pred Cc--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH--HHHHH
Q 024401 161 SN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF--SQIIR 209 (268)
Q Consensus 161 ~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~~~l~ 209 (268)
+. ..... ..........+..++..+.+++.+||..+|.+||++ .++++
T Consensus 203 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 203 SRTIRDQIR-AKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred CccHHHHHH-HHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 54 22222 222225566677889999999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=240.56 Aligned_cols=198 Identities=26% Similarity=0.437 Sum_probs=153.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..++++||+. ++|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~ni 130 (284)
T cd07839 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL 130 (284)
T ss_pred HHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 46789999999999984 557899999995 5888887653 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|..|+..
T Consensus 131 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 131 LINKN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred EEcCC-CcEEECccchhhccCCCCCCcCCCccccCCcChHHHhC-------CcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 99965 569999999987543322 2233456789999998753 24467899999999999999999888654
Q ss_pred CCcHHHHHHHHHhhc-------------------CC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHA-------------------RP---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~-------------------~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
............... .+ .....++.++.+++.+||..+|.+|||++++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 203 GNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred CCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 443332222111100 00 111246788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=238.44 Aligned_cols=212 Identities=24% Similarity=0.433 Sum_probs=166.0
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~ 78 (268)
+++++||||+++++.+ .++..++||||++|++|..++.... ...+++..+..++.|++.||.|||+ .|++|+||+|+
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~ 132 (286)
T cd06622 53 LHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPT 132 (286)
T ss_pred HHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHH
Confidence 5678999999999987 4667999999999999999987521 2369999999999999999999997 59999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||+++.+ +.++|+|||.+...... ......++..|+|||.+.+.... ....++.++|+||||+++|+|++|..||.
T Consensus 133 nil~~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~ 208 (286)
T cd06622 133 NVLVNGN-GQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPN--QNPTYTVQSDVWSLGLSILEMALGRYPYP 208 (286)
T ss_pred HEEECCC-CCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCC--ccCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 9999964 56999999998754322 22334577889999987542110 12345789999999999999999999997
Q ss_pred CCCcHHH--HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 159 GMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 159 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
....... ..........+..+..++.++.+++.+||..+|++||+++++++ +.++...+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~--~~~~~~~~ 269 (286)
T cd06622 209 PETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE--HPWLVKYK 269 (286)
T ss_pred CcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc--Chhhhhcc
Confidence 5443221 11222334455667779999999999999999999999999998 55554433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=234.82 Aligned_cols=191 Identities=22% Similarity=0.354 Sum_probs=156.3
Q ss_pred CCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++.+ .++..++||||+++++|.+++... ..+++.++..++.|++.||+|||+.|++|+||+|+||+++.
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC
Confidence 699999999998 455799999999999999999763 47999999999999999999999999999999999999997
Q ss_pred CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHH
Q 024401 85 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~ 164 (268)
++..++|+|||.+...... ....++..|+|||.+.. ..++.++|+||+|+++|+|++|..||.......
T Consensus 145 ~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKG--------HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred CCCeEEEecCccceecCCC---ccCCCCCcccChhhhcC--------CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 7647999999988754322 23357889999999853 567889999999999999999999997544322
Q ss_pred HHHHHH--HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 024401 165 AAYAAA--FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-FSQIIR 209 (268)
Q Consensus 165 ~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~~l~ 209 (268)
...... ........+..++..+.+++.+||+.+|.+|++ ++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 214 LDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 111111 112333445578999999999999999999995 699986
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=240.72 Aligned_cols=203 Identities=25% Similarity=0.421 Sum_probs=157.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 58 l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni 135 (301)
T cd07873 58 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL 135 (301)
T ss_pred HHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence 56789999999999984 557899999996 5999988753 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|+.||..
T Consensus 136 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 136 LINER-GELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred EECCC-CcEEECcCcchhccCCCCCcccccceeecccCcHHHhC-------CCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99955 569999999987543222 2233456889999998753 24567899999999999999999999986
Q ss_pred CCcHHHHHHHHHhh--------------------cCCC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 160 MSNLQAAYAAAFKH--------------------ARPG--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 160 ~~~~~~~~~~~~~~--------------------~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
.+............ ..+. ....+++.+.+++.+||..+|.+|||++++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~-- 285 (301)
T cd07873 208 STVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK-- 285 (301)
T ss_pred CCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc--
Confidence 55432211110000 0000 11346888999999999999999999999998
Q ss_pred Hhhhh
Q 024401 212 NAFLF 216 (268)
Q Consensus 212 ~~~~~ 216 (268)
+.++.
T Consensus 286 h~~f~ 290 (301)
T cd07873 286 HPYFH 290 (301)
T ss_pred Ccccc
Confidence 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=234.27 Aligned_cols=200 Identities=30% Similarity=0.491 Sum_probs=160.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. .+..++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 53 ~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~ni 130 (264)
T cd06626 53 LELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANI 130 (264)
T ss_pred HHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 56789999999999874 5578999999999999999976 34588999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc-----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
+++. ++.++|+|||.+........ .....++..|++||.+... .....+.++||||||+++|++++|..
T Consensus 131 l~~~-~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-----~~~~~~~~~Dv~s~G~il~~l~~g~~ 204 (264)
T cd06626 131 FLDH-NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG-----KGKGHGRAADIWSLGCVVLEMATGKR 204 (264)
T ss_pred EECC-CCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCC-----CCCCCCcccchHHHHHHHHHHHhCCC
Confidence 9996 45699999999875433222 1124567899999998641 11347889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
||...+..............+.++.. ++..+.+++.+||+.+|.+||++.+++.
T Consensus 205 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 205 PWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 99766543333333333344444444 4899999999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=237.61 Aligned_cols=192 Identities=28% Similarity=0.484 Sum_probs=153.5
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+ .++..++||||+++++|..+. .+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 126 (279)
T cd06619 53 LYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM 126 (279)
T ss_pred HHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence 5678999999999988 456789999999999997642 378899999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... ......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||...
T Consensus 127 ll~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 127 LVNTR-GQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISG--------EQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred EECCC-CCEEEeeCCcceecccc-cccCCCCChhhcCceeecC--------CCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 99965 56999999998754332 2234468889999998853 56788999999999999999999999653
Q ss_pred CcHH------HHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQ------AAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~------~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.... ...........+.. ...++.++.+++.+||..+|.+||+++++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 197 QKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred cccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 3211 11111111222222 2357889999999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=239.81 Aligned_cols=202 Identities=27% Similarity=0.450 Sum_probs=161.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.+.||||+++++.+. ++..++++||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus 72 l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Ni 148 (297)
T cd06659 72 MRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSI 148 (297)
T ss_pred HHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHe
Confidence 46789999999999874 5678999999999999998864 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 149 ll~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~p~~~ 219 (297)
T cd06659 149 LLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--------TPYGTEVDIWSLGIMVIEMVDGEPPYFS 219 (297)
T ss_pred EEccC-CcEEEeechhHhhcccccccccceecCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99965 469999999886433221 1233467889999998853 5578899999999999999999999986
Q ss_pred CCcHHHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.+........... .........++..+.+++.+||..+|.+||+++++++ +.++..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~--~~~~~~ 276 (297)
T cd06659 220 DSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLD--HPFLLQ 276 (297)
T ss_pred CCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh--Chhhcc
Confidence 5544333221111 1111223457889999999999999999999999998 444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=239.47 Aligned_cols=198 Identities=29% Similarity=0.469 Sum_probs=167.8
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++.+|+.|++|++||.| ....+|+|||||..|++.|.++. +++++++.++..++...+.||+|||...-+|||||..|
T Consensus 81 IMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGN 159 (502)
T KOG0574|consen 81 IMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGN 159 (502)
T ss_pred HHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhccccc
Confidence 46789999999999976 67789999999999999999986 67889999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.++ ..||.|||.+...... ...++.+||+.|+|||++.. ..|..++||||||++..||..|++||.
T Consensus 160 ILLNT~G-~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~E--------IGY~~~ADIWSLGITaIEMAEG~PPYs 230 (502)
T KOG0574|consen 160 ILLNTDG-IAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEE--------IGYDTKADIWSLGITAIEMAEGRPPYS 230 (502)
T ss_pred EEEcccc-hhhhhhccccchhhhhHHhhCccccCcccccHHHHHH--------hccchhhhHhhhcchhhhhhcCCCCcc
Confidence 9999775 5999999999765443 23467799999999999964 667889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+..+.....-.. ....+. -|+.++.++-++++.||.++|++|.|+.++++
T Consensus 231 DIHPMRAIFMIP-T~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 231 DIHPMRAIFMIP-TKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred cccccceeEecc-CCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 766544332211 112222 24568999999999999999999999999887
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=233.87 Aligned_cols=203 Identities=29% Similarity=0.571 Sum_probs=160.5
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
|++++||||+++++++... ..+++++|+.+++|.+++.... ...+++..++.++.|++.||+|||+.||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i 134 (273)
T cd05074 55 MKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNF 134 (273)
T ss_pred HhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 5788999999999986321 2478999999999999875422 1247899999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
+|+||||+||+++.+ ..++|+|||.+....... ......++..|++||.+.. ..++.++||||||+++
T Consensus 135 ~H~dikp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~sDi~slG~il 205 (273)
T cd05074 135 IHRDLAARNCMLNEN-MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD--------NVYTTHSDVWAFGVTM 205 (273)
T ss_pred eecccchhhEEEcCC-CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc--------CccchhhhhHHHHHHH
Confidence 999999999999854 569999999987543221 1122334567999998753 5677899999999999
Q ss_pred HHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 148 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 148 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
|+|++ |..||...+. ...............+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 206 ~el~~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 206 WEIMTRGQTPYAGVEN-SEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHhhCCCCCCCCCCH-HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 99999 8888876544 333333333344445567889999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=237.76 Aligned_cols=207 Identities=29% Similarity=0.378 Sum_probs=160.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 56 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~ni 133 (298)
T cd07841 56 LQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL 133 (298)
T ss_pred HhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhE
Confidence 56789999999999985 45789999999 889999997632 3699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+|||||++|+|++|..+|.+
T Consensus 134 ll~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~e~~~g~~~~~~ 205 (298)
T cd07841 134 LIASD-GVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG-------ARHYGVGVDMWSVGCIFAELLLRVPFLPG 205 (298)
T ss_pred EEcCC-CCEEEccceeeeeccCCCccccccccceeeeCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHcCCccccC
Confidence 99965 569999999987554322 2223356778999998742 24567899999999999999999888876
Q ss_pred CCcHHHHHHHHHhhcC---------------------C-----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 160 MSNLQAAYAAAFKHAR---------------------P-----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~---------------------~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
.++............. + ......+..+.+++.+||..+|++|||+.++++ +.
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~--~~ 283 (298)
T cd07841 206 DSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE--HP 283 (298)
T ss_pred CccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh--Cc
Confidence 5543322211110000 0 011335778999999999999999999999998 66
Q ss_pred hhhhcCC
Q 024401 214 FLFTLRP 220 (268)
Q Consensus 214 ~~~~~~~ 220 (268)
++.+...
T Consensus 284 ~~~~~~~ 290 (298)
T cd07841 284 YFSNDPA 290 (298)
T ss_pred cccCCCC
Confidence 6665443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=237.50 Aligned_cols=198 Identities=29% Similarity=0.432 Sum_probs=156.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. +...++|+||+ +++|.+++... ...+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 53 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 130 (286)
T cd07832 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL 130 (286)
T ss_pred HHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHE
Confidence 56789999999999985 55789999999 99999998763 36699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ...++.++||||+|+++|+|++|..+|.
T Consensus 131 ~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~ 202 (286)
T cd07832 131 LISAD-GVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG-------ARKYDPGVDLWAVGCIFAELLNGSPLFP 202 (286)
T ss_pred EEcCC-CcEEEeeeeecccccCCCCCccccccCcccccCceeeec-------cccCCchhHHHHHHHHHHHHHcCCcCcC
Confidence 99965 569999999987554332 1233467889999998753 2456789999999999999999988887
Q ss_pred CCCcHHHHHHHHHhhcC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHAR----------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+..+............. .......+..+.+++.+||..+|.+||+++++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 203 GENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 65543322221110000 0011345788999999999999999999999987
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=235.68 Aligned_cols=196 Identities=27% Similarity=0.388 Sum_probs=153.5
Q ss_pred CCC-CCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 3 SRV-KHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
.++ +||||+++++++.+ +..++||||+. ++|.+++... ...+++.++..++.|++.||+|||+.|++|+||+|.
T Consensus 52 ~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ 129 (282)
T cd07831 52 RRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPE 129 (282)
T ss_pred hhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHH
Confidence 445 49999999998743 57899999996 5888888752 356899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||+++. +.++|+|||++.............++..|+|||.+.. ...++.++|+|||||++|+|++|..||.
T Consensus 130 ni~l~~--~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~el~~~~~p~~ 200 (282)
T cd07831 130 NILIKD--DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT-------DGYYGPKMDIWAVGCVFFEILSLFPLFP 200 (282)
T ss_pred HEEEcC--CCeEEEecccccccccCCCcCCCCCCcccCChhHhhc-------CCCCCcchhHHHHHHHHHHHHcCCcCCC
Confidence 999996 6799999999976544333334467889999997642 2456789999999999999999999997
Q ss_pred CCCcHHHHHHHHHhh----------------cCCCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKH----------------ARPGL-----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~----------------~~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.+..+......... ....+ ...++..+.+++.+||..+|++||+++++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 201 GTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred CCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 755433211111000 00001 1246789999999999999999999999987
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=238.26 Aligned_cols=204 Identities=27% Similarity=0.454 Sum_probs=157.9
Q ss_pred CCCC-CCCcccceeeeee------cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRV-KHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
++++ +||||+++++++. ++..++||||++|++|.+++... ....+++..+..++.|++.||.|||+.+++|
T Consensus 68 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H 147 (286)
T cd06638 68 LKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIH 147 (286)
T ss_pred HHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 3455 6999999999862 24589999999999999988642 2356899999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
+||||+||+++.+ +.++|+|||.+....... ......++..|+|||.+.... .....++.++|+||+|+++|+|+
T Consensus 148 ~dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Dv~slGvi~~el~ 223 (286)
T cd06638 148 RDVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QLDSTYDARCDVWSLGITAIELG 223 (286)
T ss_pred cCCCHHhEEECCC-CCEEEccCCceeecccCCCccccccCCCcccChhhhchhh---hccccccchhhhhhHHHHHHHHh
Confidence 9999999999965 459999999987543322 223446888999999874311 01245688999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
+|+.||............ .... ....+..++..+.+++.+||+.+|++|||+.+++++
T Consensus 224 ~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 224 DGDPPLADLHPMRALFKI-PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cCCCCCCCCchhHHHhhc-cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 999999766543332221 1111 112344578899999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=236.27 Aligned_cols=198 Identities=30% Similarity=0.436 Sum_probs=155.3
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
+++++||||+++++++. .+..++||||++|++|.+++... ....+++..+..++.|++.||+|||+.|++|+||+
T Consensus 53 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~ 132 (287)
T cd06621 53 NKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK 132 (287)
T ss_pred HHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 56889999999999873 23589999999999999987642 23558999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|.||+++.+ +.++|+|||++........ ....++..|++||.+.+ ..++.++|+||||+++|+|++|..|
T Consensus 133 ~~nil~~~~-~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p 202 (287)
T cd06621 133 PSNILLTRK-GQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQG--------KPYSITSDVWSLGLTLLEVAQNRFP 202 (287)
T ss_pred HHHEEEecC-CeEEEeecccccccccccc-ccccCCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999855 5699999999865432221 23356788999998753 5678899999999999999999999
Q ss_pred CCCCC----cHHHHHHHHHhhcCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMS----NLQAAYAAAFKHARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~----~~~~~~~~~~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|.... ..............+..+ ..+++.+.+++.+||..+|.+|||+.++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 203 FPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 97652 111222211221222211 235678999999999999999999999998
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=236.42 Aligned_cols=203 Identities=29% Similarity=0.532 Sum_probs=160.8
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++.++||||+++++++.+ ...+++|||+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus 60 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ 138 (284)
T cd05038 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAAR 138 (284)
T ss_pred HHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhC-ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 567899999999998743 3689999999999999999763 235999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||.+........ .....++..|++||.+.. ..++.++|+||||+++|+|++|.
T Consensus 139 nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Di~slG~~l~el~tg~ 209 (284)
T cd05038 139 NILVESE-DLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT--------SKFSSASDVWSFGVTLYELFTYG 209 (284)
T ss_pred hEEEcCC-CCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc--------CCCCcccchHHHhhhhheeeccC
Confidence 9999965 5699999999976542211 112234556999998753 56788999999999999999999
Q ss_pred CCCCCCCcHH--------------HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQ--------------AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 155 ~p~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.|+....... ..............+..++.++.+++.+||..+|.+|||+.++++.|+.+
T Consensus 210 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 210 DPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred CCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 8875432211 11122222333344566788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=237.32 Aligned_cols=208 Identities=28% Similarity=0.491 Sum_probs=161.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~ 77 (268)
++.++||||+++++++. ++..+++|||++ ++|.+++... ....+++..++.++.|++.||+|||++ +++|+||||
T Consensus 54 ~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp 132 (283)
T cd06617 54 MRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKP 132 (283)
T ss_pred HHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence 34578999999999984 567899999995 6998888652 234689999999999999999999997 999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+||+++.+ +.++|+|||.+.............++..|+|||.+.+. .....++.++|+||||+++|+|++|+.||
T Consensus 133 ~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (283)
T cd06617 133 SNVLINRN-GQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPE----LNQKGYDVKSDVWSLGITMIELATGRFPY 207 (283)
T ss_pred HHEEECCC-CCEEEeecccccccccccccccccCCccccChhhcCCc----ccccccCccccchhhHHHHHHHHhCCCCC
Confidence 99999965 46999999998765433222334678889999987531 01145678999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCC-CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
..................+..+ ..++.++.+++.+||..+|.+||++.++++ +.++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--~~~~~~ 266 (283)
T cd06617 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ--HPFFEL 266 (283)
T ss_pred CccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--Cchhhh
Confidence 7543322333333333344443 357899999999999999999999999988 444443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=247.88 Aligned_cols=194 Identities=29% Similarity=0.413 Sum_probs=161.7
Q ss_pred CCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.-+||||+++.+.+.++ +.|+|||.+.|+-+.+-+.. .+....++..|+.+|+.++.|||++|+|||||||+|||+
T Consensus 372 ~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~---~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~ 448 (612)
T KOG0603|consen 372 VRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRS---KPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILL 448 (612)
T ss_pred hcCCCcceeecceecCCceeeeeehhccccHHHHHHHh---cchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheee
Confidence 44799999999999654 79999999999888887765 223337888899999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 83 TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
+.+.+.++|+|||.+...... ......|..|.|||++. ...+++++|+||||+++|+|++|+.||.....
T Consensus 449 ~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~--------~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~ 518 (612)
T KOG0603|consen 449 DGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA--------IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA 518 (612)
T ss_pred cCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc--------cCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence 534556999999999876544 34446788899999985 37899999999999999999999999987666
Q ss_pred HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
..+. ......+.+...+|.+.++|+.+||+.+|.+|+++.++.. +.|+
T Consensus 519 ~~ei---~~~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~--h~w~ 566 (612)
T KOG0603|consen 519 GIEI---HTRIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA--HPWF 566 (612)
T ss_pred hHHH---HHhhcCCccccccCHHHHHHHHHhccCChhhCcChhhhcc--Ccch
Confidence 5222 2333455566889999999999999999999999999988 5555
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=232.23 Aligned_cols=198 Identities=31% Similarity=0.535 Sum_probs=165.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++.++|||++++.+.+. ++..++++||+++++|.+++.... ...+++.++..++.+++.||++||+.|++|+||+|+
T Consensus 53 l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~ 132 (258)
T cd08215 53 LKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQ 132 (258)
T ss_pred HHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChH
Confidence 46789999999999874 457899999999999999998743 367999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||.+....... ......++..|++||.... ..++.++|+||+|+++++|++|..||
T Consensus 133 nil~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~g~~p~ 203 (258)
T cd08215 133 NIFLTSN-GLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQN--------KPYNYKSDIWSLGCVLYELCTLKHPF 203 (258)
T ss_pred HeEEcCC-CcEEECCccceeecccCcceecceeeeecccChhHhcc--------CCCCccccHHHHHHHHHHHHcCCCCC
Confidence 9999954 569999999987554432 2233467888999998753 55788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...+. ...............+..++..+.+++.+||..+|++|||+.++++
T Consensus 204 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 204 EGENL-LELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCcH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 76653 3333344455566677789999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=235.25 Aligned_cols=196 Identities=23% Similarity=0.335 Sum_probs=159.7
Q ss_pred CCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 3 SRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+...||||+++++.+. ++..++||||+.|++|.+++.. ...+++..+..++.|++.||+|||+.+++|+||+|+||+
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nil 129 (278)
T cd05606 52 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANIL 129 (278)
T ss_pred HhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEE
Confidence 3457999999999885 4578999999999999999875 356999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
++.+ +.++|+|||++...... ......++..|+|||.+.. +..++.++||||+|+++|+|++|..||....
T Consensus 130 i~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~ 200 (278)
T cd05606 130 LDEH-GHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (278)
T ss_pred ECCC-CCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcC-------CCCCCcccchHhHHHHHHHHHhCCCCCCCCC
Confidence 9955 56999999998654322 2234468899999998752 2357889999999999999999999997653
Q ss_pred cH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 162 NL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 162 ~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.. ...............+..++.++.+++.+||..+|.+|| ++.++++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 201 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 21 111222233345566777899999999999999999999 9999987
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=244.93 Aligned_cols=204 Identities=20% Similarity=0.330 Sum_probs=157.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+..++||||+++++++. ++..|+||||+.||+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Ni 133 (331)
T cd05624 55 LVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133 (331)
T ss_pred HHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHE
Confidence 45679999999999985 55789999999999999999763 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++........ .....|+..|+|||.+.+... ....++.++|+||||+++|+|++|+.||.
T Consensus 134 ll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwSlGvil~ell~g~~Pf~ 209 (331)
T cd05624 134 LLDMN-GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED---GMGKYGPECDWWSLGVCMYEMLYGETPFY 209 (331)
T ss_pred EEcCC-CCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhcccc---CCCCCCCcccEEeeehhhhhhhhCCCCcc
Confidence 99955 4699999999875433221 223468999999998753110 11356789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCC---CCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLP---EDISPDLAFIVQSCWVEDPNL--RPSFSQIIRM 210 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~--Rps~~~~l~~ 210 (268)
..+................++ ..++.++.+++.+|+..++.+ |+++++++++
T Consensus 210 ~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 210 AESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred CCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 765444333332222222333 357899999999999866544 4578888763
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=235.71 Aligned_cols=203 Identities=32% Similarity=0.551 Sum_probs=162.7
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+ .++..++++||++|++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 69 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni 147 (286)
T cd06614 69 MKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNI 147 (286)
T ss_pred HHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhE
Confidence 5678999999999987 4567999999999999999998743 3799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 148 ~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slGvil~~l~~g~~p~~~ 218 (286)
T cd06614 148 LLSKD-GSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR--------KDYGPKVDIWSLGIMCIEMAEGEPPYLR 218 (286)
T ss_pred EEcCC-CCEEECccchhhhhccchhhhccccCCcccCCHhHhcC--------CCCCCccccHHHHHHHHHHHhCCCCCCC
Confidence 99955 469999999876433221 2233457788999998753 5578899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
........... ....+.. +..++..+.+++.+||+.+|.+||++.++++ +.++..
T Consensus 219 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~--~~~~~~ 275 (286)
T cd06614 219 EPPLRALFLIT-TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ--HPFLKK 275 (286)
T ss_pred CCHHHHHHHHH-hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh--ChHhhc
Confidence 65543333322 2222222 2337899999999999999999999999987 444443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=236.59 Aligned_cols=206 Identities=25% Similarity=0.421 Sum_probs=160.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. +...++||||++ ++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 55 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~ni 133 (294)
T PLN00009 55 LKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNL 133 (294)
T ss_pred HHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceE
Confidence 56789999999999984 557999999995 5898888764445578899999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.++..++|+|||++....... ......++..|++||.+.+ ...++.++|+||||+++|+|++|..||..
T Consensus 134 ll~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 134 LIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG-------SRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred EEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 998666679999999987543221 1223356788999998743 24567899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcC-------------------CC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHAR-------------------PG--------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~-------------------~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
.+.............. +. ....++..+.+++.+||..+|++||++.++++ +
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~--~ 284 (294)
T PLN00009 207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE--H 284 (294)
T ss_pred CCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc--C
Confidence 6554433322110000 00 11346788999999999999999999999998 4
Q ss_pred hhhhh
Q 024401 213 AFLFT 217 (268)
Q Consensus 213 ~~~~~ 217 (268)
.++..
T Consensus 285 ~~~~~ 289 (294)
T PLN00009 285 EYFKD 289 (294)
T ss_pred chHhH
Confidence 55443
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=234.48 Aligned_cols=199 Identities=30% Similarity=0.509 Sum_probs=160.4
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|+.++||||+++++.+ .+...++++|++++++|.+++..... ..+++..+..++.|++.||++||+.|++|+||+|+|
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~n 132 (267)
T cd06610 53 MSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGN 132 (267)
T ss_pred HHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence 5678999999999987 45678999999999999999976433 568999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc-----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|+++.+ +.++|+|||++........ .....++..|++||.+.. ...++.++|+||||+++|+|++|.
T Consensus 133 i~~~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-------~~~~~~~~Dv~slG~i~~~l~~g~ 204 (267)
T cd06610 133 ILLGED-GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ-------VHGYDFKADIWSFGITAIELATGA 204 (267)
T ss_pred EEEcCC-CCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc-------ccCcCcccchHhHhHHHHHHHhCC
Confidence 999965 5699999998865433221 133457889999998753 136788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCC-----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLP-----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.||...+........ .....+... ..++..+.+++.+||..+|++||++.++++
T Consensus 205 ~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 205 APYSKYPPMKVLMLT-LQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccChhhhHHHH-hcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 999876554332222 222222222 257789999999999999999999999987
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=236.81 Aligned_cols=202 Identities=29% Similarity=0.463 Sum_probs=157.5
Q ss_pred CCC-CCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 3 SRV-KHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
.++ +||||+++++++.. +..++||||++|++|.+++... ....+++..++.++.|++.||+|||+.|++|+
T Consensus 73 ~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~ 152 (291)
T cd06639 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHR 152 (291)
T ss_pred HHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 345 79999999998732 3589999999999999998642 24568999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
||||+||+++.+ +.++|+|||.+....... ......++..|+|||.+.... .....++.++|+||||+++|+|++
T Consensus 153 dlkp~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slGvi~~el~~ 228 (291)
T cd06639 153 DVKGNNILLTTE-GGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQ---QYDYSYDARCDVWSLGITAIELGD 228 (291)
T ss_pred CCCHHHEEEcCC-CCEEEeecccchhcccccccccCccCCccccChhhhcCCC---CcccccCCccchHHHHHHHHHHhh
Confidence 999999999865 459999999987543322 223346788899999875311 011246789999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|+.||........... ......+ ..+..++..+.+++.+||+.+|++||++.++++
T Consensus 229 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 229 GDPPLFDMHPVKTLFK-IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred CCCCCCCCcHHHHHHH-HhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999987654433322 2222222 224467788999999999999999999999987
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=236.32 Aligned_cols=197 Identities=27% Similarity=0.459 Sum_probs=158.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~N 79 (268)
++.++||||+++++.+. .+..++||||+++++|.+++.. .+.+++..+..++.+++.||.|||+ .|++|+||+|+|
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~n 134 (284)
T cd06620 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSN 134 (284)
T ss_pred HHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHH
Confidence 46789999999999984 4578999999999999999875 3568999999999999999999997 699999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.++|+|||++...... ......++..|+|||.+.. ..++.++|+|||||++|++++|..||..
T Consensus 135 il~~~~-~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~slG~~l~~l~tg~~p~~~ 204 (284)
T cd06620 135 ILVNSR-GQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQG--------GKYTVKSDVWSLGISIIELALGKFPFAF 204 (284)
T ss_pred EEECCC-CcEEEccCCcccchhhh-ccCccccCcccCCHHHHcc--------CCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 999855 56999999988643221 1233468889999998753 5678899999999999999999999975
Q ss_pred CCcH----------HHHHHHHHhhcCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 160 MSNL----------QAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 160 ~~~~----------~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
.... ............+.++. .++.++.+++.+||..+|.+|||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 205 SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred cchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 4432 11112222222333333 378899999999999999999999999984
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=231.22 Aligned_cols=197 Identities=33% Similarity=0.576 Sum_probs=161.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +...++++||+++++|.+++... ...+++..+..++.|++.+|++||+.|++||||+|+||
T Consensus 51 l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni 129 (253)
T cd05122 51 LKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST-NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANI 129 (253)
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHE
Confidence 56788999999999884 56789999999999999999763 25799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+.............++..|++||.+.+ ...+.++|+||||+++|+|++|..||...
T Consensus 130 ~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 130 LLTSD-GEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING--------KPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred EEccC-CeEEEeeccccccccccccccceecCCcccCHHHHcC--------CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 99955 5699999999876554432344567889999998854 44788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.......... ...+..+.. ++..+.+++.+||..+|++|||+.++++
T Consensus 201 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 201 PPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred chHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 54443333222 333333333 4889999999999999999999999986
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=242.50 Aligned_cols=200 Identities=24% Similarity=0.362 Sum_probs=148.7
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhh-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSL-------RPNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~-------~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
|+.++||||+++++++. +...+++|||+. ++|.+++... ....+++..+..++.|++.||+|||+.|++
T Consensus 52 l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv 130 (317)
T cd07867 52 LRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 56789999999999872 346899999995 5888887532 123588999999999999999999999999
Q ss_pred ecCCCCCCEEEc---CCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 72 HRDLKPDNLLLT---PDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 72 H~dlk~~Nil~~---~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
|+||||+||++. .+.+.++|+|||+++...... ......++..|+|||.+.+ ...++.++||||||
T Consensus 131 H~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG 203 (317)
T cd07867 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIG 203 (317)
T ss_pred cCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcC-------CCccCcHHHHHhHH
Confidence 999999999994 234569999999997543321 1223467889999998753 24568899999999
Q ss_pred HHHHHHHhCCCCCCCCCcHHH--------HHHHHHhh---------------------------c----------CCCCC
Q 024401 145 IVLWELLTNRLPFEGMSNLQA--------AYAAAFKH---------------------------A----------RPGLP 179 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~~~--------~~~~~~~~---------------------------~----------~~~~~ 179 (268)
|++|+|++|..||........ ........ . .....
T Consensus 204 ~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (317)
T cd07867 204 CIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHK 283 (317)
T ss_pred HHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhccc
Confidence 999999999999864332100 00000000 0 00001
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 180 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...+..+.+++.+||..||.+|||++++++
T Consensus 284 ~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~ 313 (317)
T cd07867 284 VKPDSKVFLLLQKLLTMDPTKRITSEQALQ 313 (317)
T ss_pred CCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence 123456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=236.64 Aligned_cols=199 Identities=28% Similarity=0.445 Sum_probs=156.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+. ++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 53 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~ni 131 (284)
T cd07860 53 LKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNL 131 (284)
T ss_pred HHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 56789999999999974 557899999995 6899998765556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||..
T Consensus 132 ll~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~tg~~p~~~ 203 (284)
T cd07860 132 LINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFPG 203 (284)
T ss_pred EECCC-CCEEEeeccchhhcccCccccccccccccccCCeEEec-------CCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99955 569999999987543321 1223356788999998753 23457789999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+..............+ .....++.++.++|.+||+.||.+||+++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 204 DSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred CCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 55433322211110000 011346788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=234.67 Aligned_cols=198 Identities=28% Similarity=0.476 Sum_probs=158.5
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
.||||+++++.+. +...+++|||++|++|.+++.. ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.
T Consensus 60 ~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~ 136 (277)
T cd06917 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN 136 (277)
T ss_pred CCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcC
Confidence 4999999999884 5578999999999999999865 36899999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
+ +.++|+|||.+....... ......++..|+|||.+.. +..++.++|+||||+++|+|++|..||......
T Consensus 137 ~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 208 (277)
T cd06917 137 T-GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITE-------GKYYDTKADIWSLGITIYEMATGNPPYSDVDAF 208 (277)
T ss_pred C-CCEEEccCCceeecCCCccccccccCCcceeCHHHhcc-------CCccccchhHHHHHHHHHHHHhCCCCCCCCChh
Confidence 4 569999999887544322 2233467888999998742 245678999999999999999999999765543
Q ss_pred HHHHHHHHhhcCCCCCC-CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 164 QAAYAAAFKHARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~-~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.... .......+.++. .++.++.+++.+||..+|++||++.++++ ..++..
T Consensus 209 ~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~--~~~~~~ 260 (277)
T cd06917 209 RAMM-LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK--SKWIKA 260 (277)
T ss_pred hhhh-ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh--ChHhhc
Confidence 3221 111222233333 37889999999999999999999999988 455543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=231.65 Aligned_cols=197 Identities=31% Similarity=0.543 Sum_probs=164.6
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++.+.+ ...++++||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ 130 (260)
T cd06606 53 LSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF--GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGA 130 (260)
T ss_pred HHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHH
Confidence 467899999999999854 4689999999999999999863 37999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
||+++.+ +.++|+|||.+........ .....++..|++||.... ...+.++|+||||+++++|++|..
T Consensus 131 ni~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~ 201 (260)
T cd06606 131 NILVDSD-GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG--------EEYGRAADIWSLGCTVIEMATGKP 201 (260)
T ss_pred HEEEcCC-CCEEEcccccEEecccccccccccCCCCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999964 5699999999876555432 344578889999998854 447889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHH-hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 156 PFEGMSNLQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
||....+......... ....+..+..++..+.+++.+|+..+|.+||++.++++
T Consensus 202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 202 PWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 9987663332222221 23455667788999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=237.08 Aligned_cols=197 Identities=29% Similarity=0.417 Sum_probs=156.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..++|+||+. |+|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|.||
T Consensus 69 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nI 146 (307)
T cd06607 69 LQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI 146 (307)
T ss_pred HHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence 56789999999999984 557899999995 5888877642 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... ....++..|+|||.+... ....++.++||||||+++|+|++|..||...
T Consensus 147 l~~~~-~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~s~G~il~el~tg~~p~~~~ 217 (307)
T cd06607 147 LLTEP-GTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (307)
T ss_pred EECCC-CCEEEeecCcceecCCC---CCccCCccccCceeeecc-----CCCCCCcccchHHHHHHHHHHHcCCCCCCCc
Confidence 99955 56999999988654322 234577889999987421 1255788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.................+..++..+.+++.+||..+|.+||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 218 NAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred cHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 5444333222222222223457889999999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=240.70 Aligned_cols=207 Identities=25% Similarity=0.398 Sum_probs=156.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..++|+||+.+++|.+++.......+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 53 ~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Ni 132 (328)
T cd08226 53 SHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHI 132 (328)
T ss_pred HHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 35689999999999985 45789999999999999999875556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--------ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
+++.+ +.++++||+.+........ .....++..|++||.+.. ....++.++|||||||++|+|++
T Consensus 133 ll~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~DiwslG~~l~el~~ 205 (328)
T cd08226 133 LISGD-GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQ------DLYGYNVKSDIYSVGITACELAT 205 (328)
T ss_pred EEeCC-CcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHh
Confidence 99965 4699999975432211100 011234567999998853 22446789999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhc---------------------------------------------CCCCCCCCcHHHH
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHA---------------------------------------------RPGLPEDISPDLA 187 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~---------------------------------------------~~~~~~~~~~~l~ 187 (268)
|..||................. ..+....++..+.
T Consensus 206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (328)
T cd08226 206 GRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQ 285 (328)
T ss_pred CCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHH
Confidence 9999976654333222111000 0111223567899
Q ss_pred HHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 188 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 188 ~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+++.+||..+|++|||++++++ +.++..
T Consensus 286 ~li~~~l~~dP~~Rpta~e~l~--~~~~~~ 313 (328)
T cd08226 286 NLVELCLQQDPEKRPSASSLLS--HAFFKQ 313 (328)
T ss_pred HHHHHHccCCcccCCCHHHHhh--CHHHHH
Confidence 9999999999999999999998 455443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=240.47 Aligned_cols=200 Identities=23% Similarity=0.374 Sum_probs=171.8
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
||++++.|.||.+--+|+ .+.+++|+..+.||+|.-+|.+..+.+|++..++.++.+|+.||++||+++||+||+||+|
T Consensus 238 iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN 317 (591)
T KOG0986|consen 238 ILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN 317 (591)
T ss_pred HHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence 467788999999887774 5679999999999999999998888899999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
||+| +.+.|+|+|+|++.....+.......||.+|||||++.. ..|+.+.|-|||||++|+|+.|..||..
T Consensus 318 ILLD-d~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n--------e~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 318 ILLD-DHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN--------EVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred eeec-cCCCeEeeccceEEecCCCCccccccCcccccCHHHHcC--------CcccCCccHHHHHhHHHHHHcccCchhh
Confidence 9999 455699999999999888888777899999999999964 6699999999999999999999999964
Q ss_pred CCcHH--HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 160 MSNLQ--AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 160 ~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
..... +............+++.++++++++.+..|.+||.+|. .+.++.+
T Consensus 389 ~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~ 445 (591)
T KOG0986|consen 389 RKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKE 445 (591)
T ss_pred hhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhh
Confidence 33211 11223344455667789999999999999999999995 4666665
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=233.36 Aligned_cols=195 Identities=30% Similarity=0.485 Sum_probs=160.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. +...++||||+++++|.+++.. ..+++..+..++.|++.++++||+.|++|+||+|.||
T Consensus 56 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni 132 (277)
T cd06641 56 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 132 (277)
T ss_pred HHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhE
Confidence 46789999999999984 5578999999999999999864 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|++||.+.+ ..++.++|+||||+++|+|++|..||..
T Consensus 133 ~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 203 (277)
T cd06641 133 LLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELAKGEPPHSE 203 (277)
T ss_pred EECCC-CCEEEeecccceecccchhhhccccCCccccChhhhcc--------CCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence 99855 569999999886543322 1223457888999998753 5567899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...... .........+..+..++.++.+++.+||..+|.+||++.++++
T Consensus 204 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 204 LHPMKV-LFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cchHHH-HHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 543222 2223334445566678999999999999999999999999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=232.13 Aligned_cols=196 Identities=29% Similarity=0.522 Sum_probs=161.7
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++.+.+ +..++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ 135 (264)
T cd06653 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGA 135 (264)
T ss_pred HHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence 567899999999998743 357899999999999999975 245899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccc----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|.
T Consensus 136 ni~i~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~ 206 (264)
T cd06653 136 NILRDSA-GNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG--------EGYGRKADVWSVACTVVEMLTEK 206 (264)
T ss_pred HEEEcCC-CCEEECccccccccccccccCccccccCCcccccCHhhhcC--------CCCCccccHHHHHHHHHHHHhCC
Confidence 9999855 46999999998754321 11123457888999998853 55678999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.||..................+.++..+++.+.+++.+||. +|..||++.++++
T Consensus 207 ~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 207 PPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 99987665555444444445566788899999999999999 5799999998876
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=241.73 Aligned_cols=200 Identities=26% Similarity=0.411 Sum_probs=154.5
Q ss_pred CCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
.|.+|++++++- .|+++|+|||+- ..+|..+++.... ..+.-.+..+..|++.++.++|++||||.||||.|+|+-.
T Consensus 418 g~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~-~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk 495 (677)
T KOG0596|consen 418 GHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKS-IDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK 495 (677)
T ss_pred CCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccC-CCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe
Confidence 489999999995 788999999998 4599999987433 2333378889999999999999999999999999999973
Q ss_pred CCCceEEeccCCcccCccccc---ccCccCccceeccccccccccc-cc--cccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 85 DQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLR-QG--EKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~-~~--~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+.+||+|||++........ ....+||+.||+||.+..-... ++ ..-..++++||||||||+|+|+.|+.||.
T Consensus 496 --G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~ 573 (677)
T KOG0596|consen 496 --GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG 573 (677)
T ss_pred --eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH
Confidence 4599999999986554332 3456899999999988653221 11 13346789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhh-cCCCCCCCCc-HHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKH-ARPGLPEDIS-PDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~-~~~~~~~~~~-~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...+........... ...++|..-+ .++.++++.||+.||.+||++.++|+
T Consensus 574 ~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 574 QIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 655444433333222 1224443322 23999999999999999999999998
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=234.58 Aligned_cols=199 Identities=32% Similarity=0.489 Sum_probs=158.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++++||+.+++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 47 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~ni 124 (265)
T cd05579 47 LSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNI 124 (265)
T ss_pred HHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHe
Confidence 46788999999999874 55789999999999999999763 3699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc---------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE---------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
+++.+ +.++|+|||++....... ......++..|++||.... ...+.++|+||||+++|+++
T Consensus 125 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~Dv~slG~~~~~l~ 195 (265)
T cd05579 125 LIDSN-GHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG--------QGHSKTVDWWSLGCILYEFL 195 (265)
T ss_pred EEcCC-CCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcC--------CCCCcchhhHHHHHHHHHHH
Confidence 99965 469999999887533221 1223456788999998753 44788999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
+|..||............ .. .....+.. ++..+.+++.+||+.+|.+|||+..+.+.|+.
T Consensus 196 ~g~~p~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 196 VGIPPFHGETPEEIFQNI-LN-GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred hCCCCCCCCCHHHHHHHH-hc-CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 999999866543332222 21 22333333 48999999999999999999999555555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=235.76 Aligned_cols=198 Identities=27% Similarity=0.364 Sum_probs=155.7
Q ss_pred CCCCCCCcccceeeeee-c--CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-D--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++++. + +..++||||+. ++|.+++... ...+++.++..++.|++.||+|||+.|++|+||+|+
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ 135 (293)
T cd07843 58 LLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETM-KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTS 135 (293)
T ss_pred HHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence 45789999999999873 3 57999999996 5999998763 346999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||++...... .......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||
T Consensus 136 nili~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~~f 207 (293)
T cd07843 136 NLLLNNR-GILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLG-------AKEYSTAIDMWSVGCIFAELLTKKPLF 207 (293)
T ss_pred HEEECCC-CcEEEeecCceeeccCCccccccccccccccCchhhcC-------CccccchhhHHHHHHHHHHHHhCCCCC
Confidence 9999955 56999999988765443 22233456788999998753 234678999999999999999999999
Q ss_pred CCCCcHHHHHHHHHh-----------------------------hcCCCCCCC-CcHHHHHHHHHhhhhCCCCCCCHHHH
Q 024401 158 EGMSNLQAAYAAAFK-----------------------------HARPGLPED-ISPDLAFIVQSCWVEDPNLRPSFSQI 207 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~-~~~~l~~li~~~l~~~p~~Rps~~~~ 207 (268)
...+........... .....++.. +++.+.+++.+||+.+|++|||++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~el 287 (293)
T cd07843 208 PGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDA 287 (293)
T ss_pred CCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHH
Confidence 866543332211100 001112222 58889999999999999999999999
Q ss_pred HH
Q 024401 208 IR 209 (268)
Q Consensus 208 l~ 209 (268)
++
T Consensus 288 l~ 289 (293)
T cd07843 288 LK 289 (293)
T ss_pred hc
Confidence 86
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=236.71 Aligned_cols=203 Identities=32% Similarity=0.496 Sum_probs=161.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..++|+||+++++|.+++.. ..+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 70 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Ni 146 (293)
T cd06647 70 MRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 146 (293)
T ss_pred HhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHE
Confidence 56789999999999984 5578999999999999999975 4588999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|++||.+.. ..++.++|+||||+++|++++|..||..
T Consensus 147 li~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~--------~~~~~~~Dv~slG~ll~~ll~g~~pf~~ 217 (293)
T cd06647 147 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (293)
T ss_pred EEcCC-CCEEEccCcceecccccccccccccCChhhcCchhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99955 469999999876443322 2233457888999998853 5568899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 160 MSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
.+........ .....+ ..+..++..+.+++.+||..+|++||++.+++. +.++....
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~--h~~~~~~~ 276 (293)
T cd06647 218 ENPLRALYLI-ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HPFLKIAK 276 (293)
T ss_pred CChhhheeeh-hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHhcCc
Confidence 5543322211 111112 223457788999999999999999999999998 55554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=231.04 Aligned_cols=197 Identities=28% Similarity=0.463 Sum_probs=164.3
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++.+ .+...++||||+++++|.+++... ....+++..++.++.|++.||+|||+.|++|+||+|.
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ 132 (256)
T cd08530 53 LASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSA 132 (256)
T ss_pred HHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcc
Confidence 5678999999999987 456789999999999999998652 2356899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||+++.+ +.++|+|||++...... ......++..|++||.+.+ ..++.++|+||||+++|+|++|+.||.
T Consensus 133 ni~~~~~-~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~ 202 (256)
T cd08530 133 NILLVAN-DLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG--------RPYSYKSDIWSLGCLLYEMATFAPPFE 202 (256)
T ss_pred eEEEecC-CcEEEeeccchhhhccC-CcccccCCccccCHHHHCC--------CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999964 56999999998765443 2334567889999998853 567789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..+.. ...........+..+..++.++.+++.+||..+|.+||++.++++
T Consensus 203 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 203 ARSMQ-DLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCHH-HHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 76543 333333444555566678999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=234.63 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=160.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++|||++++++++. +...++||||+. |+|.+++... ...+++.++..++.|++.||.|||+.|++|+||+|+||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni 156 (317)
T cd06635 79 LQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 156 (317)
T ss_pred HHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence 56789999999999984 556899999996 4888877642 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++..... .....++..|+|||.+... ....++.++|+||||+++|+|++|..||...
T Consensus 157 l~~~~-~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 157 LLTEP-GQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred EECCC-CCEEEecCCCccccCC---cccccCCccccChhhhhcC-----CCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99855 5699999998865432 2234678889999987421 1245788999999999999999999998776
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
.....................+++.+.+++.+||+.+|.+||++.++++++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 228 NAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred cHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 54444333333333333345688899999999999999999999999985544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=243.40 Aligned_cols=205 Identities=27% Similarity=0.487 Sum_probs=168.9
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|.+|+||||++++++| .|+.+++|+||+++|+|.+|+..+......-....+|+.||++|++||.+.++|||||.+.|
T Consensus 588 iLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rN 667 (807)
T KOG1094|consen 588 ILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRN 667 (807)
T ss_pred HHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccc
Confidence 37899999999999999 68889999999999999999988644445666778899999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccc---cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh--CC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--NR 154 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~--g~ 154 (268)
+|++.+ ..+||+|||+++..-.+... ....-...|+|+|.+.. ++++.++|+|+||+++||+++ ..
T Consensus 668 cLv~~e-~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsill--------gkFttaSDvWafgvTlwE~~~~C~e 738 (807)
T KOG1094|consen 668 CLVDGE-FTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILL--------GKFTTASDVWAFGVTLWEVFMLCRE 738 (807)
T ss_pred eeecCc-ccEEecCcccccccccCCceeeecceeeeeeehhHHHHHh--------ccccchhhhhhhHHHHHHHHHHHhh
Confidence 999965 56999999999854332221 22345678999998864 889999999999999999865 78
Q ss_pred CCCCCCCcHHHHHHHHHh------hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQAAYAAAFK------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.||...++.+........ ...+..|..++..+.+++.+||..+..+||+++++...|...
T Consensus 739 ~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 739 QPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred CchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 899887765554433221 122345677999999999999999999999999999888764
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=239.12 Aligned_cols=194 Identities=28% Similarity=0.411 Sum_probs=152.4
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+++++||||+++++++.. ...|+||||+. ++|.+++.. .++...+..++.|++.||+|||+.|++|+|
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (353)
T cd07850 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLHSAGIIHRD 143 (353)
T ss_pred HHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 567899999999998732 24699999995 589888864 289999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++||||||+++|+|++|+
T Consensus 144 lkp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~~l~~g~ 214 (353)
T cd07850 144 LKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIRGT 214 (353)
T ss_pred CCHHHEEECCC-CCEEEccCccceeCCCCCCCCCCcccccccCHHHHhC--------CCCCCchhhHhHHHHHHHHHHCC
Confidence 99999999965 4699999999986544433344567889999998853 56788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHH--------------------hhcCCC---------------------CCCCCcHHHHHHHHHh
Q 024401 155 LPFEGMSNLQAAYAAAF--------------------KHARPG---------------------LPEDISPDLAFIVQSC 193 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~--------------------~~~~~~---------------------~~~~~~~~l~~li~~~ 193 (268)
.||...+.......... ....+. .+...+..+++++.+|
T Consensus 215 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 294 (353)
T cd07850 215 VLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294 (353)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHH
Confidence 99976553322111100 000000 0113466789999999
Q ss_pred hhhCCCCCCCHHHHHH
Q 024401 194 WVEDPNLRPSFSQIIR 209 (268)
Q Consensus 194 l~~~p~~Rps~~~~l~ 209 (268)
|..||.+|||+.++++
T Consensus 295 L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 295 LVIDPEKRISVDDALQ 310 (353)
T ss_pred cCCChhhCcCHHHHhc
Confidence 9999999999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=233.28 Aligned_cols=203 Identities=29% Similarity=0.492 Sum_probs=161.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++.+. ++..+++|||+++++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Ni 147 (292)
T cd06657 71 MRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI 147 (292)
T ss_pred HHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 46789999999999884 5678999999999999998764 4589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|++||.+.. ..++.++|+||+|+++|+|++|..||..
T Consensus 148 lv~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~--------~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 148 LLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred EECCC-CCEEEcccccceecccccccccccccCccccCHHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99965 459999999876543221 1233457888999998743 5567899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 160 MSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
......... ........ ....++..+.+++.+||..+|.+||++.++++ +.++....
T Consensus 219 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~--~~~~~~~~ 277 (292)
T cd06657 219 EPPLKAMKM-IRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKAG 277 (292)
T ss_pred CCHHHHHHH-HHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc--ChHHhccC
Confidence 554333221 11122221 23457889999999999999999999999998 66665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=248.92 Aligned_cols=197 Identities=20% Similarity=0.294 Sum_probs=150.1
Q ss_pred CCCCcccceeeeeec--CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCEE
Q 024401 5 VKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLL 81 (268)
Q Consensus 5 l~Hp~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~Nil 81 (268)
..|++|+.+++++.. ++.++|||++ |++|.+++.. ...+++..+..|+.||+.||+|||. .||+||||||+|||
T Consensus 188 ~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NIL 264 (467)
T PTZ00284 188 ADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL 264 (467)
T ss_pred ccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence 346678999988743 4688999998 7899998875 3569999999999999999999998 59999999999999
Q ss_pred EcCCCC---------------ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHH
Q 024401 82 LTPDQK---------------SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 146 (268)
Q Consensus 82 ~~~~~~---------------~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 146 (268)
++.++. .+||+|||.+..... ......||..|+|||.+.+ ..++.++|||||||+
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~--------~~~~~~~DiwSlGvi 334 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLG--------LGWMYSTDMWSMGCI 334 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhc--------CCCCcHHHHHHHHHH
Confidence 985432 489999998754322 2234578999999999864 568889999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHHhhc-------------------------CCCC--------------C-CCCcHHH
Q 024401 147 LWELLTNRLPFEGMSNLQAAYAAAFKHA-------------------------RPGL--------------P-EDISPDL 186 (268)
Q Consensus 147 ~~~ll~g~~p~~~~~~~~~~~~~~~~~~-------------------------~~~~--------------~-~~~~~~l 186 (268)
+|||++|+.||.+.+..+.......... .+.. . ......+
T Consensus 335 l~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (467)
T PTZ00284 335 IYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLL 414 (467)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHH
Confidence 9999999999987665332221110000 0000 0 0113457
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 187 AFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 187 ~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+||.+||.+||.+|||++++++ +.++.
T Consensus 415 ~dli~~mL~~dP~~R~ta~e~L~--Hp~~~ 442 (467)
T PTZ00284 415 CDLIYGLLHYDRQKRLNARQMTT--HPYVL 442 (467)
T ss_pred HHHHHHhCCcChhhCCCHHHHhc--Ccccc
Confidence 79999999999999999999998 44443
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=232.93 Aligned_cols=198 Identities=27% Similarity=0.440 Sum_probs=155.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..+++|||++++.+..+... ...+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 54 l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 131 (288)
T cd07833 54 LRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI 131 (288)
T ss_pred HHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 56789999999999984 5578999999988777665543 35599999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.
T Consensus 132 ~~~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 203 (288)
T cd07833 132 LVSES-GVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVG-------DTNYGKPVDVWAIGCIMAELLDGEPLFP 203 (288)
T ss_pred EECCC-CCEEEEeeecccccCCCccccccCcccccCCcCCchhcC-------CCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99954 569999999987654432 2234467788999999854 1267889999999999999999999997
Q ss_pred CCCcHHHHHHHHHhhc--------------------C----------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 024401 159 GMSNLQAAYAAAFKHA--------------------R----------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~--------------------~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l 208 (268)
+............... . ...+..++.++.+++.+||..+|++||++++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 283 (288)
T cd07833 204 GDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELL 283 (288)
T ss_pred CCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHh
Confidence 6554333222111000 0 011233588899999999999999999999998
Q ss_pred H
Q 024401 209 R 209 (268)
Q Consensus 209 ~ 209 (268)
+
T Consensus 284 ~ 284 (288)
T cd07833 284 Q 284 (288)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=226.98 Aligned_cols=196 Identities=32% Similarity=0.581 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..+++|||+++++|.+++... ..+++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni 130 (254)
T cd06627 53 LKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANI 130 (254)
T ss_pred HHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHE
Confidence 56789999999999874 55789999999999999999763 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+........ .....++..|++||.+.. ...+.++|+|++|+++|+|++|..||..
T Consensus 131 ~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--------~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 131 LTTKD-GVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM--------SGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred EECCC-CCEEEeccccceecCCCcccccccccchhhcCHhhhcC--------CCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 99964 5699999999876544322 233467888999998753 3467899999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
......... .........+..++..+.+++.+||..+|++|||+.+++.
T Consensus 202 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 202 LNPMAALFR-IVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred ccHHHHHHH-HhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 664333333 2334555667788999999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=246.17 Aligned_cols=198 Identities=31% Similarity=0.555 Sum_probs=174.7
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|.+|+|||++++||...+....+|||.+++|+|.+.+.......|.......++.||+.|++||..+++|||||-..|++
T Consensus 165 M~~L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNll 244 (1039)
T KOG0199|consen 165 MLKLQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLL 244 (1039)
T ss_pred HHhccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhe
Confidence 56899999999999998888999999999999999998866677999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccccc----CccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEMMT----AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~~~----~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
+-. ...|||+|||+.+......... ...-...|+|||.+.. ..++.++|+|++|+++|||++ |..|
T Consensus 245 las-prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh--------~kFShaSDvWmyGVTiWEMFtyGEeP 315 (1039)
T KOG0199|consen 245 LAS-PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRH--------RKFSHASDVWMYGVTIWEMFTYGEEP 315 (1039)
T ss_pred ecc-cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcc--------ccccccchhhhhhhhHHhhhccCCCC
Confidence 985 4569999999998655443322 2234567999999965 788999999999999999999 8999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|.+....+...... ...+.+.|+.+++++.++++.||..+|.+||++..|.+
T Consensus 316 W~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 316 WVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 99988766655544 78888899999999999999999999999999999975
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=235.42 Aligned_cols=205 Identities=27% Similarity=0.505 Sum_probs=155.3
Q ss_pred CCCC-CCcccceeeee-ecCCceEEEEcCCCCCHHHHHh---hhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCC
Q 024401 3 SRVK-HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLV---SLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLK 76 (268)
Q Consensus 3 ~~l~-Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~---~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk 76 (268)
.++. ||||+++++++ .++..+++|||+. ++|.++.. ......+++..+..++.|++.||+|||+. |++|||||
T Consensus 57 ~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk 135 (288)
T cd06616 57 MRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVK 135 (288)
T ss_pred HHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCC
Confidence 3454 99999999987 4557899999984 57666543 22346799999999999999999999975 99999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|+||+++.+ +.++|+|||++.............++..|+|||.+... ....++.++||||||+++|+|++|+.|
T Consensus 136 p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p 209 (288)
T cd06616 136 PSNILLDRN-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS-----ARDGYDVRSDVWSLGITLYEVATGKFP 209 (288)
T ss_pred HHHEEEccC-CcEEEeecchhHHhccCCccccccCccCccCHHHhccc-----cccCCcchhhhhHHHHHHHHHHhCCCC
Confidence 999999855 56999999998754433333344678889999988531 013678899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|..................+.. +..++.++.+++.+||..+|++|||++++++ +.++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~--~~~~~ 271 (288)
T cd06616 210 YPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE--HPFIK 271 (288)
T ss_pred chhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhh
Confidence 9765432222222222222222 2347889999999999999999999999998 44443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=233.24 Aligned_cols=199 Identities=28% Similarity=0.450 Sum_probs=156.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..+++|||+ +++|.+++.......+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 52 l~~l~~~~iv~~~~~~~~~~~~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~ni 130 (283)
T cd07835 52 LKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNL 130 (283)
T ss_pred HHhcCCCCccCHhheeccCCeEEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHE
Confidence 46789999999999984 56789999999 56999999764445699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++. ++.++|+|||.+....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|+.||..
T Consensus 131 l~~~-~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 202 (283)
T cd07835 131 LIDR-EGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------SRQYSTPVDIWSIGCIFAEMVNRRPLFPG 202 (283)
T ss_pred EEcC-CCcEEEeecccccccCCCccccCccccccCCCCCceeec-------CcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9996 4569999999987543221 1222356788999998743 23467899999999999999999999976
Q ss_pred CCcHHHHHHHHHhh---------------------------cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKH---------------------------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+............ ........++..+.+++.+||+.+|.+||+++++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 203 DSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 65433322211100 001112457788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=232.93 Aligned_cols=198 Identities=25% Similarity=0.456 Sum_probs=152.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. +...++||||+.+ +|.+++... ...+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~ni 134 (291)
T cd07844 57 LKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNL 134 (291)
T ss_pred HhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHE
Confidence 56889999999999985 4578999999965 999988753 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||+|+++|+|++|..||..
T Consensus 135 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 135 LISER-GELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG-------STEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred EEcCC-CCEEECccccccccCCCCccccccccccccCCcHHhhc-------CcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99955 469999999986533211 1122346788999998753 24467899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCC-----------------------------CCCCCCc--HHHHHHHHHhhhhCCCCCCCHHHHH
Q 024401 160 MSNLQAAYAAAFKHARP-----------------------------GLPEDIS--PDLAFIVQSCWVEDPNLRPSFSQII 208 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~--~~l~~li~~~l~~~p~~Rps~~~~l 208 (268)
................. .....++ .++.+++.+||..+|++|||+.+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred CccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 55322222211110000 0001233 7888999999999999999999988
Q ss_pred H
Q 024401 209 R 209 (268)
Q Consensus 209 ~ 209 (268)
+
T Consensus 287 ~ 287 (291)
T cd07844 287 K 287 (291)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=246.51 Aligned_cols=198 Identities=29% Similarity=0.463 Sum_probs=169.7
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|+.++|||||+++.+.. ...+|+||||+.+|.+.+|+.+ .....+.++..++.|++++++|+|+++|+|||||++|
T Consensus 108 imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~--~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eN 185 (596)
T KOG0586|consen 108 IMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVK--HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAEN 185 (596)
T ss_pred HHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHh--cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhh
Confidence 367899999999999984 6689999999999999999987 4557779999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+. .++|+|||++..........+.+|++.|.|||+..+ .....+.+|+|++|+++|.|++|..||++
T Consensus 186 ilL~~~m-nikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g-------~~y~gpe~D~Wslgvvly~LV~GsLPFDG 257 (596)
T KOG0586|consen 186 ILLDENM-NIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNG-------KKYDGPEVDIWSLGVVLYALVEGSLPFDG 257 (596)
T ss_pred ccccccc-ceeeeccccceeecccccccccCCCCCccChHhhcC-------cccCCcceehhhhhhhheeeeecccccCC
Confidence 9999664 499999999998887777788899999999999975 34667899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
..-.. ..... ......++.-++.++.++|+++|.++|.+|++.+++.+.
T Consensus 258 ~~lk~-Lr~rv-l~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 258 QNLKE-LRPRV-LRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccccc-ccchh-eeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 54322 22111 123344566788999999999999999999999999883
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=230.05 Aligned_cols=197 Identities=32% Similarity=0.508 Sum_probs=161.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++.+. .+..++++||+++++|.+++... ....+++.+++.++.|++.||+|||+.|++|+||+|+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~ 135 (260)
T cd08222 56 LSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAK 135 (260)
T ss_pred HHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChh
Confidence 46789999999999874 45689999999999999998642 2356999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++. +.++|+|||.+...... .......++..|++||.... ..++.++|+||||+++|+|++|..||
T Consensus 136 nili~~--~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~Dv~slG~~~~~l~~~~~~~ 205 (260)
T cd08222 136 NIFLKN--NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH--------QGYDSKSDIWSLGCILYEMCCLAHAF 205 (260)
T ss_pred heEeec--CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 999973 34999999988654332 22233457888999998743 45677899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
....... ..........+..+..++.++.+++.+||..+|++||++.++++
T Consensus 206 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 206 EGQNFLS-VVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCccHHH-HHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 7654333 22333345556667788999999999999999999999999987
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=233.31 Aligned_cols=197 Identities=28% Similarity=0.436 Sum_probs=157.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. +...|+||||+. ++|.+++.. ....+++.++..++.|++.+|+|||+.|++|+||+|+||
T Consensus 75 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ni 152 (313)
T cd06633 75 LQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI 152 (313)
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhE
Confidence 56789999999999985 456899999995 588888765 335689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+..... .....++..|+|||.+... ....++.++|+||||+++|+|++|..||...
T Consensus 153 li~~~-~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~-----~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 153 LLTEP-GQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred EECCC-CCEEEeecCCCcccCC---CCCccccccccChhhcccc-----CCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99855 4599999998864322 2344678889999987421 1245778999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+....................++..+.+++.+||+.+|.+||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 224 NAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 5544444333222222233457888999999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=241.05 Aligned_cols=197 Identities=27% Similarity=0.415 Sum_probs=178.7
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|..+..|.||++|..|.| .++|++||-|-||.|+..+.. .+.|+..++..++.-+++|++|||++||++|||||+|.
T Consensus 474 m~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 474 MMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred HHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 456789999999999954 589999999999999999986 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.+||.|||.++....+..+-+.+||+.|.|||.+.. ...+.+.|.||||+++|||++|.+||.+.
T Consensus 552 lLd~~-Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILn--------KGHD~avDyWaLGIli~ELL~G~pPFs~~ 622 (732)
T KOG0614|consen 552 LLDNR-GYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILN--------KGHDRAVDYWALGILIYELLTGSPPFSGV 622 (732)
T ss_pred eeccC-CceEEeehhhHHHhccCCceeeecCCcccccchhhhc--------cCcchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence 99955 5699999999999988888889999999999999975 55678999999999999999999999999
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
++......+...-....+|..+++...+++++++..+|..|.- +.+|-+
T Consensus 623 dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk 676 (732)
T KOG0614|consen 623 DPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK 676 (732)
T ss_pred chHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence 9888888777777778899999999999999999999999964 777776
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=229.30 Aligned_cols=196 Identities=26% Similarity=0.442 Sum_probs=168.9
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|+.++||.+..+.-.|+ .+++|+||||..||.|.-.+.. .+.|++.....+...|++||.|||+++||+||||.+|
T Consensus 221 VL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLEN 298 (516)
T KOG0690|consen 221 VLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLEN 298 (516)
T ss_pred HHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhh
Confidence 467899999999988874 6689999999999999988875 5679999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
.+++++++ +||.|||+++... .+....+.+||+.|+|||++.. ..|..+.|-|.+|+++|||++|+.||.
T Consensus 299 LlLDkDGH-IKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleD--------nDYgraVDWWG~GVVMYEMmCGRLPFy 369 (516)
T KOG0690|consen 299 LLLDKDGH-IKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLED--------NDYGRAVDWWGVGVVMYEMMCGRLPFY 369 (516)
T ss_pred heeccCCc-eEeeecccchhcccccceeccccCChhhcCchhhcc--------ccccceeehhhhhHHHHHHHhccCccc
Confidence 99998865 9999999998543 4556788899999999999964 788999999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
..+.... . ..+......+|..++++.+.|+..+|.++|.+|. ++.+|.+
T Consensus 370 n~dh~kL-F-eLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~ 423 (516)
T KOG0690|consen 370 NKDHEKL-F-ELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR 423 (516)
T ss_pred ccchhHH-H-HHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence 7664332 2 2333445678899999999999999999999994 4666665
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=232.77 Aligned_cols=198 Identities=29% Similarity=0.465 Sum_probs=154.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..++|+||+++++|.++... ...+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus 54 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni 131 (286)
T cd07846 54 LKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI 131 (286)
T ss_pred HHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 46789999999999984 5578999999999999887754 34589999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|..||..
T Consensus 132 ~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 132 LVSQS-GVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG-------DTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred EECCC-CcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcc-------ccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 99865 569999999987543322 2223457889999998753 24467789999999999999999999876
Q ss_pred CCcHHHHHHHHHhh--------------------cCC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKH--------------------ARP---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~--------------------~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.............. ..+ .....++..+.+++.+||..+|++||++.++++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 204 DSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred CchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 55332211111000 000 012356788999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=231.90 Aligned_cols=204 Identities=27% Similarity=0.363 Sum_probs=157.7
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++++.+ +..++||||+. ++|.+++... ...+++.++..++.|++.||+|||+.|++|+||+|+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 137 (309)
T cd07845 60 LLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS 137 (309)
T ss_pred HHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 567899999999998743 35799999995 5899988753 356999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||
T Consensus 138 nil~~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~~~f 209 (309)
T cd07845 138 NLLLTDK-GCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG-------CTTYTTAIDMWAVGCILAELLAHKPLL 209 (309)
T ss_pred HEEECCC-CCEEECccceeeecCCccCCCCcccccccccChhhhcC-------CCCcCchHHHHHHHHHHHHHHhCCCCC
Confidence 9999955 569999999987654321 1222345778999998753 245678999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhc-----------------CCCC-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHA-----------------RPGL-----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~-----------------~~~~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...+............. .... ...+++.+.+++.+||..||++|||++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 210 PGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 87665443322211100 0000 0125788999999999999999999999997
Q ss_pred HHHhhhhh
Q 024401 210 MLNAFLFT 217 (268)
Q Consensus 210 ~l~~~~~~ 217 (268)
+.++..
T Consensus 290 --h~~f~~ 295 (309)
T cd07845 290 --SSYFKE 295 (309)
T ss_pred --Chhhcc
Confidence 566543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=230.47 Aligned_cols=198 Identities=25% Similarity=0.425 Sum_probs=151.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++|+||+++++++. ++..++||||+. ++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 57 l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 134 (291)
T cd07870 57 LKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134 (291)
T ss_pred HHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 56789999999999985 447899999995 6888777542 35688889999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||||+++|+|++|..||..
T Consensus 135 l~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 135 LISYL-GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLG-------ATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred EEcCC-CcEEEeccccccccCCCCCCCCCccccccccCCceeec-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99855 469999999887533221 2233456889999998753 23467789999999999999999999986
Q ss_pred CCcHHHHHHHHHhhcC-------------C----C-----CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 024401 160 MSNLQAAYAAAFKHAR-------------P----G-----LP---------EDISPDLAFIVQSCWVEDPNLRPSFSQII 208 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~-------------~----~-----~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~l 208 (268)
................ + . .+ ...+..+.+++.+|+..+|.+|||+.+++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 207 VSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred chhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 6543332222111000 0 0 00 01356789999999999999999999997
Q ss_pred H
Q 024401 209 R 209 (268)
Q Consensus 209 ~ 209 (268)
.
T Consensus 287 ~ 287 (291)
T cd07870 287 L 287 (291)
T ss_pred c
Confidence 6
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=232.18 Aligned_cols=198 Identities=27% Similarity=0.397 Sum_probs=156.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++|||++++.+++. +...++||||+. ++|.+++.. ....+++.++..++.|++.||.|||+.|++|+||+|.||
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni 146 (308)
T cd06634 69 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (308)
T ss_pred HHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence 56789999999999874 456899999995 588887754 235689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... ....++..|+|||.+... .....+.++||||||+++|+|++|..||...
T Consensus 147 l~~~~-~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 217 (308)
T cd06634 147 LLSEP-GLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNM 217 (308)
T ss_pred EECCC-CcEEECCcccceeecCc---ccccCCccccCHHHHhhc-----ccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence 99865 56999999988654322 234577889999987421 1245678999999999999999999998765
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
.....................++..+.+++.+||..+|.+||++.++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 218 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred cHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 54333332222222222344688899999999999999999999999984
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=226.85 Aligned_cols=195 Identities=33% Similarity=0.498 Sum_probs=160.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++.+. ++..+++|||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|.||
T Consensus 47 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni 124 (250)
T cd05123 47 LSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENI 124 (250)
T ss_pred HHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceE
Confidence 46789999999999884 55789999999999999999763 4689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+...... .......++..|++||...+ ...+.++|+||||+++|++++|..||..
T Consensus 125 ~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~D~~slG~~~~~l~~g~~p~~~ 195 (250)
T cd05123 125 LLDAD-GHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG--------KGYGKAVDWWSLGVLLYEMLTGKPPFYA 195 (250)
T ss_pred EEcCC-CcEEEeecCcceecccCCCcccCCcCCccccChHHhCC--------CCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99955 56999999998765433 22344567889999998853 4467899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH---HHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF---SQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~---~~~l~ 209 (268)
.+.. ....... .....++..++..+.+++.+||..+|++||++ +++++
T Consensus 196 ~~~~-~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~ 246 (250)
T cd05123 196 EDRK-EIYEKIL-KDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA 246 (250)
T ss_pred CCHH-HHHHHHh-cCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence 6542 2222222 24566777889999999999999999999999 55543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=231.62 Aligned_cols=199 Identities=29% Similarity=0.506 Sum_probs=155.9
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCEEE
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLL 82 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~Nil~ 82 (268)
..||||+++++++. +...+++|||+ +++|.+++... ...+++..+..++.|++.||+|||+ .|++|+||+|+||++
T Consensus 71 ~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill 148 (296)
T cd06618 71 HDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL 148 (296)
T ss_pred cCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE
Confidence 35999999999984 55799999999 55888887653 3579999999999999999999997 599999999999999
Q ss_pred cCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 83 TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
+.+ +.++|+|||++.............++..|+|||.+.... ....++.++|+||||+++|+|++|+.||.....
T Consensus 149 ~~~-~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 223 (296)
T cd06618 149 DAS-GNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD----PNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223 (296)
T ss_pred cCC-CCEEECccccchhccCCCcccCCCCCccccCHhhcCCCC----CccccccchhHHHHHHHHHHHHhCCCCCCcchh
Confidence 854 569999999987554333333345778899999885311 124477899999999999999999999976443
Q ss_pred HHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 163 LQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 163 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
.............+..+ ..++.++.+++.+||..+|.+||++++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 224 EFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 33333333333333333 2478999999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=224.42 Aligned_cols=199 Identities=27% Similarity=0.479 Sum_probs=161.6
Q ss_pred CCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
.|+||++++++|+| ..+|+|||-+.||+|-..|.. .+-|++.++.+++..|+.||.|||.+||.|||+||+|||...
T Consensus 134 gh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~--~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 134 GHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQK--RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCES 211 (463)
T ss_pred CCccHHHHHHHhcccceEEEEEecccCchHHHHHHH--hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecC
Confidence 59999999999964 579999999999999999986 356999999999999999999999999999999999999964
Q ss_pred CCC--ceEEeccCCcccCcccc--------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 85 DQK--SLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 85 ~~~--~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
.+. .||||||.+........ ...+..|+..|||||++.... ++...|+.++|.||||+|+|-|++|.
T Consensus 212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv---~qA~~YDKrCDlwSLGvIlYImLsGY 288 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFV---DQATFYDKRCDLWSLGVILYIMLSGY 288 (463)
T ss_pred CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhc---cccccccccccHHHHHHHHHHHHhCC
Confidence 333 58999999986432221 123447888999999875432 23467889999999999999999999
Q ss_pred CCCCCCCc-------------HHHHHHHHHhhcCCCCCC----CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 155 LPFEGMSN-------------LQAAYAAAFKHARPGLPE----DISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 155 ~p~~~~~~-------------~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.||.+.-. .+...-..+.....++|+ .++.+..+++..+|..++.+|.++.++++
T Consensus 289 pPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 289 PPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 99954221 233333344556667775 48899999999999999999999999987
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=229.22 Aligned_cols=197 Identities=28% Similarity=0.417 Sum_probs=154.4
Q ss_pred CCCCCCcccceeeeeecC-C-----ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 3 SRVKHDNLVKFLGACKDP-L-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~~~-~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
++++||||+++++.+.+. . .+++|||+. ++|.+++.......+++..++.++.|++.||+|||+.|++|+||+
T Consensus 56 ~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~ 134 (287)
T cd07838 56 ESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLK 134 (287)
T ss_pred hccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCC
Confidence 456799999999998432 3 889999996 589999876444569999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|+||+++.+ +.++|+|||.+.............++..|+|||.+.. ..++.++|+||||+++|+|++|..|
T Consensus 135 ~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Di~s~G~~l~~l~~~~~~ 205 (287)
T cd07838 135 PQNILVTSD-GQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQ--------SSYATPVDMWSVGCIFAELFRRRPL 205 (287)
T ss_pred hhhEEEccC-CCEEEeccCcceeccCCcccccccccccccChHHhcc--------CCCCCcchhhhHHHHHHHHHhCCCc
Confidence 999999966 5699999999876544433334457888999998853 5578899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|.................. ......++..+.+++.+||..+|.+||++.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 206 FRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 8765543322211110000 0001234677899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=230.63 Aligned_cols=197 Identities=16% Similarity=0.264 Sum_probs=151.0
Q ss_pred CCCCCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 3 SRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
..+.|+||+++++.+... ..+++++++ ..++.+++... ...++..+..++.|++.||+|||+.|++||||||
T Consensus 78 ~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp 154 (294)
T PHA02882 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKP 154 (294)
T ss_pred ccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 467899999999976322 346888888 55888877652 3467888999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCccc--------ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
+||+++.+ +.++|+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|+
T Consensus 155 ~Nill~~~-~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~--------~~~~~~~DiwSlG~~l~e 225 (294)
T PHA02882 155 ENIMVDGN-NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG--------ACVTRRGDLESLGYCMLK 225 (294)
T ss_pred HHEEEcCC-CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC--------CCCCcHHHHHHHHHHHHH
Confidence 99999855 45999999998754221 11123468999999998754 667899999999999999
Q ss_pred HHhCCCCCCCCCcHHHHHH----HHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 150 LLTNRLPFEGMSNLQAAYA----AAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 150 ll~g~~p~~~~~~~~~~~~----~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
|++|..||.+......... ....... .......++.+.+++..|+..+|++||++.++++.|
T Consensus 226 l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 226 WAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 9999999987643221111 0111100 111245688999999999999999999999999865
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=237.36 Aligned_cols=204 Identities=24% Similarity=0.391 Sum_probs=157.0
Q ss_pred CCCCCCCcccceeeeeec---------------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACKD---------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
+++++||||+++++.+.+ ...+++|||++ ++|.+++.. ..+++..+..++.|++.||+|||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH 131 (342)
T cd07854 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH 131 (342)
T ss_pred HHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH
Confidence 567899999999987632 24689999996 599988864 46899999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
+.|++|+||||+||+++.++..++|+|||.+....... ......++..|+|||.+.. ...++.++||||
T Consensus 132 ~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwS 204 (342)
T cd07854 132 SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWA 204 (342)
T ss_pred hCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhC-------ccccCchhhHHH
Confidence 99999999999999998776778999999987542211 1122356788999997642 245678999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHh-----------------------hcCC-----CCCCCCcHHHHHHHHHhh
Q 024401 143 FGIVLWELLTNRLPFEGMSNLQAAYAAAFK-----------------------HARP-----GLPEDISPDLAFIVQSCW 194 (268)
Q Consensus 143 lG~i~~~ll~g~~p~~~~~~~~~~~~~~~~-----------------------~~~~-----~~~~~~~~~l~~li~~~l 194 (268)
|||++|+|++|+.||............... .... .....++.++.+++.+||
T Consensus 205 lGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 284 (342)
T cd07854 205 AGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL 284 (342)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHh
Confidence 999999999999999766543332221110 0000 012357788999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 195 VEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
..+|.+|||+.++++ +.++...
T Consensus 285 ~~dP~~R~t~~ell~--h~~~~~~ 306 (342)
T cd07854 285 TFNPMDRLTAEEALM--HPYMSCY 306 (342)
T ss_pred CCCchhccCHHHHhC--CCccccc
Confidence 999999999999987 6666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=247.40 Aligned_cols=198 Identities=19% Similarity=0.312 Sum_probs=146.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
|++++||||+++++++. ++..|++++++ +++|.+++.... ........+..|+.|++.||+|||+.||+||||||
T Consensus 217 l~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP 295 (501)
T PHA03210 217 LGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKL 295 (501)
T ss_pred HHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 56789999999999984 55789999999 568888875421 12244667889999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
+|||++.+ +.++|+|||++....... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..
T Consensus 296 ~NILl~~~-~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvil~ell~~~~ 366 (501)
T PHA03210 296 ENIFLNCD-GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--------DGYCEITDIWSCGLILLDMLSHDF 366 (501)
T ss_pred HHEEECCC-CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC--------CCCCcHHHHHHHHHHHHHHHHCCC
Confidence 99999965 469999999997654322 1223568999999999854 567889999999999999999875
Q ss_pred C-CCCCC-cHHHHHHHHHhhc---CCC-------------------C---------CCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 156 P-FEGMS-NLQAAYAAAFKHA---RPG-------------------L---------PEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 156 p-~~~~~-~~~~~~~~~~~~~---~~~-------------------~---------~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+ +.... ............. ... . ...++.++.+++.+||..||.+||
T Consensus 367 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp 446 (501)
T PHA03210 367 CPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP 446 (501)
T ss_pred CCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc
Confidence 4 43222 1111111111000 000 0 012456678889999999999999
Q ss_pred CHHHHHH
Q 024401 203 SFSQIIR 209 (268)
Q Consensus 203 s~~~~l~ 209 (268)
|+.++++
T Consensus 447 sa~elL~ 453 (501)
T PHA03210 447 GAAELLA 453 (501)
T ss_pred CHHHHhh
Confidence 9999987
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=229.51 Aligned_cols=199 Identities=28% Similarity=0.454 Sum_probs=154.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++++.+. ++..++||||+++ +|.+++.... ...+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus 52 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~n 130 (284)
T cd07836 52 MKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQN 130 (284)
T ss_pred HHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence 56789999999999984 5578999999965 8999887533 2458999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++.+ +.++|+|||++....... ......++..|++||.+.+ ...++.++|+||||+++|+|++|+.||.
T Consensus 131 i~~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~~l~~g~~~~~ 202 (284)
T cd07836 131 LLINKR-GELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLG-------SRTYSTSIDIWSVGCIMAEMITGRPLFP 202 (284)
T ss_pred EEECCC-CcEEEeecchhhhhcCCccccccccccccccChHHhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999955 569999999987543321 1223456788999998753 2456789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhh------------c----CCC-----------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKH------------A----RPG-----------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~------------~----~~~-----------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.+..+......... . ... +....+..+.+++.+||+.+|.+||+++++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 203 GTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 766443322211100 0 000 11235778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=225.88 Aligned_cols=182 Identities=23% Similarity=0.285 Sum_probs=147.2
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
...||||+++++.+. ....+++|||++|++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||++
T Consensus 41 ~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~ 118 (237)
T cd05576 41 PHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL 118 (237)
T ss_pred hcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE
Confidence 346999999999874 45789999999999999999763 459999999999999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 83 TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
+.++ .++++|||.+...... .....++..|+|||.+.. ..++.++|+||+|+++|+|++|..|+.....
T Consensus 119 ~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~~g~~~~~~~~~ 187 (237)
T cd05576 119 DDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI--------SEETEACDWWSLGAILFELLTGKTLVECHPS 187 (237)
T ss_pred cCCC-CEEEecccchhccccc--cccCCcCccccCCcccCC--------CCCCchhhHHHHHHHHHHHHHCcchhhcCch
Confidence 9664 5999999987654332 223345677999998743 5567899999999999999999988753321
Q ss_pred HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH
Q 024401 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF 204 (268)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~ 204 (268)
. ........++..++..+.+++.+||+.||++|+++
T Consensus 188 ~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 188 G------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred h------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence 1 11112234566788999999999999999999986
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-33 Score=233.25 Aligned_cols=203 Identities=26% Similarity=0.384 Sum_probs=157.2
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++ .++..+++|||+. ++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~ni 150 (335)
T PTZ00024 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANI 150 (335)
T ss_pred HHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHe
Confidence 5678999999999987 4567899999995 599999875 34699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc---------------cccccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 81 LLTPDQKSLKLADFGLAREETV---------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
+++.+ +.++|+|||.+..... ........++..|+|||.+.+ ...++.++|+||||+
T Consensus 151 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~ 222 (335)
T PTZ00024 151 FINSK-GICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-------AEKYHFAVDMWSVGC 222 (335)
T ss_pred EECCC-CCEEECCccceeecccccccccccccccccccccccccccccCCCCChhccc-------CCCCCcHHHHHHHHH
Confidence 99955 5699999998875431 011112345778999998753 234678999999999
Q ss_pred HHHHHHhCCCCCCCCCcHHHHHHHHHhhcCC--------------------------CCCCCCcHHHHHHHHHhhhhCCC
Q 024401 146 VLWELLTNRLPFEGMSNLQAAYAAAFKHARP--------------------------GLPEDISPDLAFIVQSCWVEDPN 199 (268)
Q Consensus 146 i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~~p~ 199 (268)
++|+|++|..||.+.+..............+ ......+..+.+++.+||+.+|+
T Consensus 223 ~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 302 (335)
T PTZ00024 223 IFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPL 302 (335)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCch
Confidence 9999999999998766543322211100000 01124578899999999999999
Q ss_pred CCCCHHHHHHHHHhhhhh
Q 024401 200 LRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 200 ~Rps~~~~l~~l~~~~~~ 217 (268)
+|||+++++. +.++..
T Consensus 303 ~R~s~~~~l~--~~~~~~ 318 (335)
T PTZ00024 303 ERISAKEALK--HEYFKS 318 (335)
T ss_pred hccCHHHHhc--CcccCC
Confidence 9999999998 555543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=235.42 Aligned_cols=207 Identities=26% Similarity=0.416 Sum_probs=158.4
Q ss_pred CCCCCCCcccceeeeee-----cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 2 MSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
|++++||||+++++++. ....++||||+ +++|.+++.. ...+++..+..++.|++.||+|||+.|++|+|||
T Consensus 58 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlk 134 (334)
T cd07855 58 LRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLK 134 (334)
T ss_pred HHhcCCCCccCHHHhccccCCCCceEEEEEehh-hhhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 56789999999998763 23589999999 4699998865 3559999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCccccc-----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
|+||+++.+ +.++|+|||++........ .....++..|++||.+.. ...++.++||||||+++|+|+
T Consensus 135 p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 135 PSNLLVNED-CELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS-------LPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred HHHEEEcCC-CcEEecccccceeecccCcCCCcccccccccccccChHHhcC-------CcccccccchHHHHHHHHHHH
Confidence 999999965 5699999999875432211 123467889999998743 245788999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHH----------------------hhc--CCC-----CCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAAAF----------------------KHA--RPG-----LPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~----------------------~~~--~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|+.||.+.+.......... ... ... .....+.++.+++.+||+.+|.+||
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 286 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc
Confidence 99999976553322111000 000 011 1134688999999999999999999
Q ss_pred CHHHHHHHHHhhhhhcCCC
Q 024401 203 SFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~~~~ 221 (268)
++++++. +.++.....+
T Consensus 287 t~~~~l~--~~~~~~~~~~ 303 (334)
T cd07855 287 TVEQALQ--HPFLAQYHDP 303 (334)
T ss_pred CHHHHHh--ChhhhhccCC
Confidence 9999998 5565544443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=235.39 Aligned_cols=204 Identities=27% Similarity=0.430 Sum_probs=157.0
Q ss_pred CCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
++.++||||+++++++.. ...++++||+ +++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||
T Consensus 58 l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl 134 (337)
T cd07858 58 LRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDL 134 (337)
T ss_pred HHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 567899999999998732 2479999999 5699999875 356999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
+|+||+++.+ +.++|+|||++...... .......++..|+|||.+.. ...++.++|+||||+++|+|++|.
T Consensus 135 kp~Nil~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~ 206 (337)
T cd07858 135 KPSNLLLNAN-CDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLN-------CSEYTTAIDVWSVGCIFAELLGRK 206 (337)
T ss_pred CHHHEEEcCC-CCEEECcCccccccCCCcccccccccccCccChHHHhc-------CCCCCCcccHHHHHHHHHHHHcCC
Confidence 9999999865 56999999998755432 22234467889999998752 234788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHH----------------------hh----cC---CCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAF----------------------KH----AR---PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~----------------------~~----~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+.+.......... .. .. ......++.++.+++.+||..+|.+|||++
T Consensus 207 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ 286 (337)
T cd07858 207 PLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVE 286 (337)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHH
Confidence 99976543211110000 00 00 011235788999999999999999999999
Q ss_pred HHHHHHHhhhhhc
Q 024401 206 QIIRMLNAFLFTL 218 (268)
Q Consensus 206 ~~l~~l~~~~~~~ 218 (268)
++++ +.++...
T Consensus 287 ell~--h~~~~~~ 297 (337)
T cd07858 287 EALA--HPYLASL 297 (337)
T ss_pred HHHc--Ccchhhh
Confidence 9998 4444443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=227.69 Aligned_cols=198 Identities=28% Similarity=0.429 Sum_probs=156.1
Q ss_pred CCCC-CCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRVK-HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l~-Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++++ ||||+++++.+ .++..++||||+ +++|.+++.......+++..+..++.|++.+|.|||+.|++|+||+|.||
T Consensus 52 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni 130 (283)
T cd07830 52 RKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENL 130 (283)
T ss_pred HhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhE
Confidence 4567 99999999987 455789999999 88999998764445789999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+.............++..|+|||.+.. ...++.++|+||||+++++|++|..||...
T Consensus 131 ~i~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 131 LVSGP-EVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLR-------STSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred EEcCC-CCEEEeecccceeccCCCCcCCCCCcccccCceeeec-------CcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 99954 5699999999876554433344567888999998742 245688999999999999999999999765
Q ss_pred CcHHHHHHHHHhhcC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHAR----------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
............... .......+..+.+++.+||..+|++||++++++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 203 SEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 543332211110000 0001123678999999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=229.69 Aligned_cols=199 Identities=28% Similarity=0.387 Sum_probs=153.2
Q ss_pred CCC-CCCcccceeeeeec-CC-----ceEEEEcCCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 3 SRV-KHDNLVKFLGACKD-PL-----MVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~~-~~-----~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
+.+ +||||+++++.+.. .. .|++|||+++ +|.+++.... ...+++..++.++.|++.||+|||+.|++|
T Consensus 55 ~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H 133 (295)
T cd07837 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMH 133 (295)
T ss_pred HHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 455 46999999998743 22 7999999975 8999886532 245899999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
+||+|+||+++.+++.++|+|||++...... .......+++.|+|||.+.+ ...++.++|+||||+++|+|+
T Consensus 134 ~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~ 206 (295)
T cd07837 134 RDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLG-------STHYSTPVDIWSVGCIFAEMS 206 (295)
T ss_pred cCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhC-------CCCCCchHHHHHHHHHHHHHH
Confidence 9999999999974677999999998754322 11222356788999998742 245688999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhcC------------------C--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHAR------------------P--------GLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
+|..||.+.+.............. + .....++.++.++|.+||..+|.+||+++
T Consensus 207 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ 286 (295)
T cd07837 207 RKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286 (295)
T ss_pred cCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHH
Confidence 999999876554433221110000 0 01134788899999999999999999999
Q ss_pred HHHH
Q 024401 206 QIIR 209 (268)
Q Consensus 206 ~~l~ 209 (268)
+++.
T Consensus 287 eil~ 290 (295)
T cd07837 287 AALT 290 (295)
T ss_pred HHhc
Confidence 9986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=232.90 Aligned_cols=203 Identities=29% Similarity=0.410 Sum_probs=156.2
Q ss_pred CCCC-CCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRV-KHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
++++ +||||+++++++.. ...++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+.||+|+||+|
T Consensus 60 l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p 135 (337)
T cd07852 60 LQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKP 135 (337)
T ss_pred HHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 4567 99999999998742 25799999996 599999875 2688999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccc------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ...++.++|+||||+++|+|+
T Consensus 136 ~nill~~~-~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~~l~el~ 207 (337)
T cd07852 136 SNILLNSD-CRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLG-------STRYTKGVDMWSVGCILGEML 207 (337)
T ss_pred HHEEEcCC-CcEEEeeccchhccccccccccCcchhcccccccccCceeeec-------cccccccchHHHHHHHHHHHH
Confidence 99999965 469999999987543221 1223457889999998742 245678999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhc-----------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHA-----------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|+.||.+............... .......++.++.+++.+||+.+|++||
T Consensus 208 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp 287 (337)
T cd07852 208 LGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL 287 (337)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc
Confidence 99999976554332211111000 0011123688999999999999999999
Q ss_pred CHHHHHHHHHhhhhhc
Q 024401 203 SFSQIIRMLNAFLFTL 218 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~ 218 (268)
|+.++++ ..++...
T Consensus 288 s~~~il~--~~~~~~~ 301 (337)
T cd07852 288 TAEEALE--HPYVAQF 301 (337)
T ss_pred CHHHHhh--Chhhhhh
Confidence 9999998 4555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=233.93 Aligned_cols=206 Identities=30% Similarity=0.471 Sum_probs=160.7
Q ss_pred CCCCCCCcccceeeeeecC------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
++.++||||+++++++.+. ..|++|||+. ++|.+++.. ...+++..++.++.|++.||++||+.|++|+||
T Consensus 53 l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dl 129 (330)
T cd07834 53 LRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDL 129 (330)
T ss_pred HHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 4678999999999987432 6899999996 589998875 347999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||.||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ...++.++|+||||+++|+|+
T Consensus 130 kp~nili~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~sDi~slG~il~~l~ 201 (330)
T cd07834 130 KPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS-------SSRYTKAIDIWSVGCIFAELL 201 (330)
T ss_pred CHHHEEEcCC-CCEEEcccCceEeecccccccccccccccccCcCCceeeec-------ccCCCcchhHHHHHHHHHHHH
Confidence 9999999966 569999999998654432 1233467888999998864 126788999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhcC-----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHAR-----------------------------PGLPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|..||...+.............. ......++.++.+++.+||+.+|.+||
T Consensus 202 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 281 (330)
T cd07834 202 TRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI 281 (330)
T ss_pred cCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC
Confidence 999999766543322211110000 001133678899999999999999999
Q ss_pred CHHHHHHHHHhhhhhcCC
Q 024401 203 SFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~~~ 220 (268)
+++++++ +.++.....
T Consensus 282 t~~~ll~--~~~~~~~~~ 297 (330)
T cd07834 282 TADEALA--HPYLAQLHD 297 (330)
T ss_pred CHHHHHh--CccHHhhcc
Confidence 9999998 556555444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=229.93 Aligned_cols=198 Identities=29% Similarity=0.434 Sum_probs=156.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++.+. ++..++++||+++ +|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni 129 (283)
T cd05118 52 LKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL 129 (283)
T ss_pred HHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhh-cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHE
Confidence 56789999999999874 5578999999965 888888762 35799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|++||.+.+ ...++.++|+||||+++|+|++|+.||..
T Consensus 130 li~~~-~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-------~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 201 (283)
T cd05118 130 LINTE-GVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG-------DKGYSTPVDIWSVGCIFAELLSRRPLFPG 201 (283)
T ss_pred EECCC-CcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhc-------CCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99955 569999999887554432 2223457788999998753 23678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHAR----------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+.............. ......++.++.+++.+||..+|.+||++.+++.
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 202 KSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred CCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 6654432222111000 0011246788999999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=224.56 Aligned_cols=200 Identities=28% Similarity=0.471 Sum_probs=164.1
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS---LRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk 76 (268)
++.-+.||||++||++ .++..|++||.+ ..||+.+.+. .+...+++...-.|..-.+.||.||.+. .|+|||+|
T Consensus 117 mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK 195 (361)
T KOG1006|consen 117 MKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK 195 (361)
T ss_pred HhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence 3445789999999985 788899999999 6688887654 3456799999999999999999999975 89999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|+|||++..+ .|||||||++......-......|...|+|||.+.. ....++.++|+||||+++||+.+|..|
T Consensus 196 PSNILldr~G-~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p------~~~gyDiRSDvWSLGITL~EvAtG~fP 268 (361)
T KOG1006|consen 196 PSNILLDRHG-DVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDP------SDKGYDIRSDVWSLGITLYEVATGNFP 268 (361)
T ss_pred hhheEEecCC-CEeeecccchHhHHHHHHhhhccCCccccChhccCC------ccCCcchhhhhhhhcceEeeeecCCCC
Confidence 9999999665 599999999976554444455678899999999975 224589999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCC--C---CCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLP--E---DISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~--~---~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|.+-+..-+.......+..+.+. . .++..+..+|..||.+|.+.||.+.++.+
T Consensus 269 yr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 269 YRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 98877665555555544444322 2 37889999999999999999999999987
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=228.00 Aligned_cols=199 Identities=27% Similarity=0.403 Sum_probs=156.7
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|+++ +||||+++++.+. +...++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~n 135 (290)
T cd05613 58 LEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLEN 135 (290)
T ss_pred HHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 4456 5899999999885 4568899999999999999976 3568999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|+++.+ +.++|+|||++....... ......++..|++||.+.. .....+.++||||||+++|+|++|..||
T Consensus 136 il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~~l~~ll~g~~p~ 208 (290)
T cd05613 136 ILLDSN-GHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG------GDGGHDKAVDWWSMGVLMYELLTGASPF 208 (290)
T ss_pred eEECCC-CCEEEeeCccceecccccccccccccCCcccCChhhccC------CCCCCCccccHHHHHHHHHHHhcCCCCC
Confidence 999965 569999999987543321 1223457889999998753 1234577899999999999999999998
Q ss_pred CCCCcH--HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 158 EGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 158 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
...... ............++.+..++..+.+++.+||..+|.+|| +++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 209 TVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 643221 111122222334556677899999999999999999997 6777766
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=228.53 Aligned_cols=206 Identities=27% Similarity=0.376 Sum_probs=161.3
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++ +||||+++++.+. +...++||||+++++|.+++.. ...+++..+..++.|++.+|+|||+.|++|+||+|.|
T Consensus 58 l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~n 135 (288)
T cd05583 58 LEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLEN 135 (288)
T ss_pred HHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 4456 5999999999874 4568899999999999999875 3568999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|+++.+ +.++|+|||++........ .....++..|++||.+.+ .....+.++|+||||+++|+|++|..||
T Consensus 136 il~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Dv~slG~il~el~tg~~p~ 208 (288)
T cd05583 136 ILLDSE-GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG------GSGGHDKAVDWWSLGVLTFELLTGASPF 208 (288)
T ss_pred eEECCC-CCEEEEECccccccccccccccccccCCccccCHHHhcC------CCCCCcchhhhHHHHHHHHHHHhCCCCc
Confidence 999965 4699999999875433221 123357889999998753 1223678999999999999999999998
Q ss_pred CCCCc--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..... ................+..++..+.+++.+||+.+|++|||+.++.+.|+..+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~ 269 (288)
T cd05583 209 TVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269 (288)
T ss_pred ccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccc
Confidence 64321 111111222233455667789999999999999999999998888777766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=231.51 Aligned_cols=200 Identities=22% Similarity=0.345 Sum_probs=151.1
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
++.++||||+++++++.+ ...++||||++ ++|.+++.... ...+++..++.++.|++.||+|||+.|++|+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dl 134 (316)
T cd07842 56 LRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDL 134 (316)
T ss_pred HHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCC
Confidence 567899999999999843 46899999995 47877775422 236899999999999999999999999999999
Q ss_pred CCCCEEEcC---CCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 76 KPDNLLLTP---DQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 76 k~~Nil~~~---~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
||+||+++. ..+.++|+|||++........ .....++..|+|||.+.+ ...++.++|+||||+++|
T Consensus 135 kp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~~l~ 207 (316)
T cd07842 135 KPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLG-------ARHYTKAIDIWAIGCIFA 207 (316)
T ss_pred CHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhC-------CCCCCcHHHHHHHHHHHH
Confidence 999999986 135699999999875433211 223456888999998753 245678999999999999
Q ss_pred HHHhCCCCCCCCCcHH--------HHHHHHH-------------------------hhcCCCCC-----------CCCcH
Q 024401 149 ELLTNRLPFEGMSNLQ--------AAYAAAF-------------------------KHARPGLP-----------EDISP 184 (268)
Q Consensus 149 ~ll~g~~p~~~~~~~~--------~~~~~~~-------------------------~~~~~~~~-----------~~~~~ 184 (268)
+|++|..||....... ....... ......++ ...+.
T Consensus 208 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (316)
T cd07842 208 ELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDS 287 (316)
T ss_pred HHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCH
Confidence 9999999997544321 0000000 00001111 14667
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 185 DLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 185 ~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
++.+++.+||+.+|++|||+.++++
T Consensus 288 ~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 288 QGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHhc
Confidence 8999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=228.78 Aligned_cols=198 Identities=26% Similarity=0.387 Sum_probs=149.7
Q ss_pred CCCCCCCcccceeeeeec---------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
+++++||||+++++++.+ ...++||||+. ++|.+++.. ....+++.+++.++.|++.||+|||+.|++|
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H 142 (310)
T cd07865 65 LQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSN-KNVKFTLSEIKKVMKMLLNGLYYIHRNKILH 142 (310)
T ss_pred HHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 568899999999998732 23589999995 588888865 3346899999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCccccc-----ccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ...++.++|+||||+++
T Consensus 143 ~dl~p~nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l 214 (310)
T cd07865 143 RDMKAANILITKD-GILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDMWGAGCIM 214 (310)
T ss_pred cCCCHHHEEECCC-CcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcC-------CcccCchhhhHHHHHHH
Confidence 9999999999955 5699999999875432211 123356788999998753 23467799999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHhh--cCC---------------CCC-------------CCCcHHHHHHHHHhhhhC
Q 024401 148 WELLTNRLPFEGMSNLQAAYAAAFKH--ARP---------------GLP-------------EDISPDLAFIVQSCWVED 197 (268)
Q Consensus 148 ~~ll~g~~p~~~~~~~~~~~~~~~~~--~~~---------------~~~-------------~~~~~~l~~li~~~l~~~ 197 (268)
|+|++|..||...+............ ..+ ..+ ...+..+.+++.+||..+
T Consensus 215 ~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~ 294 (310)
T cd07865 215 AEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD 294 (310)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCC
Confidence 99999999997655432211111000 000 000 113466789999999999
Q ss_pred CCCCCCHHHHHH
Q 024401 198 PNLRPSFSQIIR 209 (268)
Q Consensus 198 p~~Rps~~~~l~ 209 (268)
|.+|||++++++
T Consensus 295 P~~R~t~~e~l~ 306 (310)
T cd07865 295 PAKRIDADTALN 306 (310)
T ss_pred hhhccCHHHHhc
Confidence 999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=232.70 Aligned_cols=197 Identities=29% Similarity=0.475 Sum_probs=151.0
Q ss_pred CCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
+++++||||+++++++.. ...++++||+. ++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||
T Consensus 57 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dl 132 (336)
T cd07849 57 LRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDL 132 (336)
T ss_pred HHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 567899999999998632 24789999995 588888764 56999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ...++.++||||||+++|+|+
T Consensus 133 kp~Nill~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGvil~el~ 204 (336)
T cd07849 133 KPSNLLLNTN-CDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKAIDIWSVGCILAEML 204 (336)
T ss_pred CHHHEEECCC-CCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC-------CCCCCcHHHHHHHHHHHHHHH
Confidence 9999999955 569999999987543221 1123467889999997642 245688999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHH----------------------Hhhc--CCC-----CCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAAA----------------------FKHA--RPG-----LPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~----------------------~~~~--~~~-----~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|+.||.+.+......... .... ... ....++.++.+++.+||+.+|.+||
T Consensus 205 ~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 284 (336)
T cd07849 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI 284 (336)
T ss_pred hCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc
Confidence 9999997654322111000 0000 000 1124577899999999999999999
Q ss_pred CHHHHHHH
Q 024401 203 SFSQIIRM 210 (268)
Q Consensus 203 s~~~~l~~ 210 (268)
|+.+++++
T Consensus 285 t~~e~l~h 292 (336)
T cd07849 285 TVEEALAH 292 (336)
T ss_pred CHHHHhcC
Confidence 99999983
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=228.67 Aligned_cols=198 Identities=25% Similarity=0.319 Sum_probs=152.5
Q ss_pred CCCCCCCcccceeeeeecC-----------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 2 MSRVKHDNLVKFLGACKDP-----------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-----------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
+++++||||+++++++.+. ..++++||+++ ++.+++... ...+++..+..++.|++.||+|||+.||
T Consensus 60 ~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i 137 (302)
T cd07864 60 LRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNF 137 (302)
T ss_pred HHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5678999999999987332 58999999965 787777652 3569999999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
+|+||+|+||+++.+ +.++|+|||.+....... ......++..|++||.+.+ ...++.++||||||+++|
T Consensus 138 ~H~dl~p~nili~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Di~slG~~~~ 209 (302)
T cd07864 138 LHRDIKCSNILLNNK-GQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLG-------EERYGPAIDVWSCGCILG 209 (302)
T ss_pred ecCCCCHHHEEECCC-CcEEeCcccccccccCCcccccccceeccCccChHHhcC-------CCCCCchhHHHHHHHHHH
Confidence 999999999999954 569999999987543322 1122345678999998742 234678999999999999
Q ss_pred HHHhCCCCCCCCCcHHHHHHHHHhhcCC----------------------------CCCCCCcHHHHHHHHHhhhhCCCC
Q 024401 149 ELLTNRLPFEGMSNLQAAYAAAFKHARP----------------------------GLPEDISPDLAFIVQSCWVEDPNL 200 (268)
Q Consensus 149 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~ 200 (268)
+|++|+.||...+..............+ .....++..+.+++.+||..+|.+
T Consensus 210 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 289 (302)
T cd07864 210 ELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSK 289 (302)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhh
Confidence 9999999997655433222211110000 011246889999999999999999
Q ss_pred CCCHHHHHH
Q 024401 201 RPSFSQIIR 209 (268)
Q Consensus 201 Rps~~~~l~ 209 (268)
||+++++++
T Consensus 290 Rp~~~~il~ 298 (302)
T cd07864 290 RCTAEEALN 298 (302)
T ss_pred CCCHHHHhc
Confidence 999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=228.12 Aligned_cols=195 Identities=27% Similarity=0.499 Sum_probs=159.5
Q ss_pred CCCCC-CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVK-HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++. ||||+++++.+. ++..+++||++++++|.+++... ..+++..++.++.|++.||++||+.|++|+||+|+|
T Consensus 55 ~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~n 132 (280)
T cd05581 55 LTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPEN 132 (280)
T ss_pred HHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 34667 999999999874 55789999999999999999863 469999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc---------------------cccCccCccceeccccccccccccccccCCCccc
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE---------------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 138 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~---------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~ 138 (268)
|+++.++ .++|+|||++....... ......++..|++||.... ...+.++
T Consensus 133 i~i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--------~~~~~~~ 203 (280)
T cd05581 133 ILLDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--------KPAGKSS 203 (280)
T ss_pred eEECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC--------CCCChhh
Confidence 9999654 59999999887443221 1122356788999998753 4578899
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH----HHHHH
Q 024401 139 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF----SQIIR 209 (268)
Q Consensus 139 Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~----~~~l~ 209 (268)
|+||||++++++++|..||...+....... ........+..+++.+.+++.+||..+|.+||++ +++++
T Consensus 204 Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 204 DLWALGCIIYQMLTGKPPFRGSNEYLTFQK--ILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred hHHHHHHHHHHHHhCCCCCCCccHHHHHHH--HHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 999999999999999999987654332222 2234455667889999999999999999999999 78775
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=251.00 Aligned_cols=201 Identities=26% Similarity=0.431 Sum_probs=169.0
Q ss_pred CCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
..+=|+.++-+|+|. ++|+||||++||+|-.++.... .+++..+..++..++.||.-||+.|+|||||||+|||++.
T Consensus 133 ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 133 NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecc
Confidence 456688888888655 7999999999999999998743 7999999999999999999999999999999999999997
Q ss_pred CCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 85 DQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
.|+ ++|.|||.+-.....+ .....+|||.|++||++..... ..+.|+..+|.||+|+++|||+.|..||+..+-
T Consensus 211 ~GH-ikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~---~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl 286 (1317)
T KOG0612|consen 211 SGH-IKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGD---GKGEYGRECDWWSLGVFMYEMLYGETPFYADSL 286 (1317)
T ss_pred cCc-EeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcC---CccccCCccchhhhHHHHHHHHcCCCcchHHHH
Confidence 765 9999999987665433 3455689999999999976321 237899999999999999999999999998777
Q ss_pred HHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCC---HHHHHHHHHhhh
Q 024401 163 LQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPS---FSQIIRMLNAFL 215 (268)
Q Consensus 163 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~~l~~l~~~~ 215 (268)
......++.+.....+| ..+|.+.++||.+.+ .+|+.|.. ++++.. +.++
T Consensus 287 veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~--HpFF 341 (1317)
T KOG0612|consen 287 VETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKN--HPFF 341 (1317)
T ss_pred HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHh--Cccc
Confidence 77777777777777777 569999999998876 46678876 999887 4444
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=229.92 Aligned_cols=206 Identities=25% Similarity=0.379 Sum_probs=154.8
Q ss_pred CCC-CCCcccceeeeee---c--CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 3 SRV-KHDNLVKFLGACK---D--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~---~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
+++ +||||+++++.+. + ...+++++++ +++|.+++.. ...+++..+..++.|++.||+|||+.|++|+|||
T Consensus 56 ~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlk 132 (332)
T cd07857 56 RHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLK 132 (332)
T ss_pred HHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 345 5999999998641 2 3478899998 5699999865 4569999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
|+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++|+||+|+++|+|+
T Consensus 133 p~Nili~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~~Di~slGv~l~~l~ 204 (332)
T cd07857 133 PGNLLVNAD-CELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLS-------FQSYTKAIDVWSVGCILAELL 204 (332)
T ss_pred HHHeEEcCC-CCEEeCcCCCceecccccccccccccCcccCccccCcHHHhC-------CCCCCcHHHHHHHHHHHHHHH
Confidence 999999965 469999999987543211 1123467889999998642 245678999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHH----------------------h----hcCC---CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAAAF----------------------K----HARP---GLPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~----------------------~----~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|..||...+.......... . .... ......+..+.+++.+||..+|.+||
T Consensus 205 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 284 (332)
T cd07857 205 GRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI 284 (332)
T ss_pred hCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC
Confidence 99999976542211110000 0 0000 11123578899999999999999999
Q ss_pred CHHHHHHHHHhhhhhcCCC
Q 024401 203 SFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~~~~ 221 (268)
|+.+++. +.++.+.+.+
T Consensus 285 t~~~ll~--~~~~~~~~~~ 301 (332)
T cd07857 285 SVEEALE--HPYLAIWHDP 301 (332)
T ss_pred CHHHHhc--ChhhhhhcCc
Confidence 9999987 6666655443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=225.78 Aligned_cols=198 Identities=28% Similarity=0.387 Sum_probs=153.8
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++.++||||+++++++.+ +..++|+||+++ +|.+++... ...+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus 52 l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~ 129 (287)
T cd07840 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGS 129 (287)
T ss_pred HHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHH
Confidence 467899999999999843 579999999964 999988752 257999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ...++.++||||||+++|+|++|..|
T Consensus 130 nil~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-------~~~~~~~~Dv~slG~~l~el~t~~~p 201 (287)
T cd07840 130 NILINND-GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG-------ATRYGPEVDMWSVGCILAELFLGKPI 201 (287)
T ss_pred HeEEcCC-CCEEEccccceeeccCCCcccccccccccccCCceeeEc-------cccCChHHHHHHHHHHHHHHHhCCCC
Confidence 9999954 569999999987554432 1223456778999997753 24567899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcC------C-----------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHAR------P-----------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~------~-----------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 207 (268)
|...+.............. + .+...++..+.+++.+||..+|.+||+++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 281 (287)
T cd07840 202 FQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281 (287)
T ss_pred CCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9765543222111110000 0 0011137889999999999999999999999
Q ss_pred HH
Q 024401 208 IR 209 (268)
Q Consensus 208 l~ 209 (268)
++
T Consensus 282 l~ 283 (287)
T cd07840 282 LQ 283 (287)
T ss_pred hh
Confidence 86
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=233.99 Aligned_cols=201 Identities=29% Similarity=0.455 Sum_probs=156.5
Q ss_pred CCCCCCCcccceeeeee-cC------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACK-DP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+++++||||+++.+++. ++ ..++|+||+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++|+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (343)
T cd07851 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRD 143 (343)
T ss_pred HHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 56789999999998763 22 379999999 7799999875 5699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|+|+||+++.+ +.++|+|||.+...... .....++..|+|||.+.. ...++.++||||||+++|+|++|+
T Consensus 144 lkp~Nill~~~-~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslGv~l~elltg~ 213 (343)
T cd07851 144 LKPSNIAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGK 213 (343)
T ss_pred CCHHHeEECCC-CCEEEcccccccccccc--ccCCcccccccCHHHHhC-------CCCCCchHhHHHHHHHHHHHHhCC
Confidence 99999999955 56999999998765432 233456788999998742 135678999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcC---------------------C--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHAR---------------------P--------GLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+................ + .....++..+.+++.+||..+|.+|||+.
T Consensus 214 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ 293 (343)
T cd07851 214 TLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAA 293 (343)
T ss_pred CCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHH
Confidence 999765543322211110000 0 01123588899999999999999999999
Q ss_pred HHHHHHHhhhhhc
Q 024401 206 QIIRMLNAFLFTL 218 (268)
Q Consensus 206 ~~l~~l~~~~~~~ 218 (268)
++++ +.++...
T Consensus 294 ell~--h~~~~~~ 304 (343)
T cd07851 294 EALA--HPYLAEY 304 (343)
T ss_pred HHhc--CCCcccc
Confidence 9987 5555443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-32 Score=228.02 Aligned_cols=202 Identities=27% Similarity=0.430 Sum_probs=156.6
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
|++++||||+++++++..+ ..++||||+ |++|.+++.. ..+++..+..++.|++.||+|||+.||+|+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~d 143 (343)
T cd07880 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRD 143 (343)
T ss_pred HHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 5678999999999987422 358999999 7899998864 5699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|+|+||+++.+ +.++|+|||++...... .....++..|++||.+.+ ...++.++|+||||+++|++++|.
T Consensus 144 lkp~Nill~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~ll~~l~~g~ 213 (343)
T cd07880 144 LKPGNLAVNED-CELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILN-------WMHYTQTVDIWSVGCIMAEMLTGK 213 (343)
T ss_pred CCHHHEEEcCC-CCEEEeecccccccccC--ccccccCCcccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999955 56999999998754322 223356788999998752 134678999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhc---------------------C--------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHA---------------------R--------PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||...+............. . ......++..+.+++.+|+..+|.+|||+.
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~ 293 (343)
T cd07880 214 PLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAA 293 (343)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHH
Confidence 99986554322211110000 0 011235778899999999999999999999
Q ss_pred HHHHHHHhhhhhcC
Q 024401 206 QIIRMLNAFLFTLR 219 (268)
Q Consensus 206 ~~l~~l~~~~~~~~ 219 (268)
+++. +.++....
T Consensus 294 ~~l~--~~~~~~~~ 305 (343)
T cd07880 294 EALA--HPYFEEFH 305 (343)
T ss_pred HHhc--CccHhhhc
Confidence 9996 55555443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=222.50 Aligned_cols=198 Identities=30% Similarity=0.462 Sum_probs=154.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..++|+||++ ++|.+++.... ..+++..+..++.|++.||++||+.|++||||+|+||
T Consensus 52 l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni 129 (282)
T cd07829 52 LKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI 129 (282)
T ss_pred HHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheE
Confidence 46778999999999874 457999999996 59999998632 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... .......+..|+|||.+.. ...++.++|+||||+++|++++|..||..
T Consensus 130 ~~~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-------~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 201 (282)
T cd07829 130 LINRD-GVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG-------SKHYSTAVDIWSVGCIFAEMITGKPLFPG 201 (282)
T ss_pred EEcCC-CCEEEecCCcccccCCCccccCccccCcCcCChHHhcC-------CcCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99954 569999999987654322 2223345678999998753 23678899999999999999999999976
Q ss_pred CCcHHHHHHHHHh-------------------hcCC--------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFK-------------------HARP--------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~-------------------~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
............. ...+ .....++..+.+++.+||..+|++||++.++++
T Consensus 202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 202 DSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 5543322211100 0000 001234778999999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=226.11 Aligned_cols=203 Identities=28% Similarity=0.460 Sum_probs=155.6
Q ss_pred CCCCCCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++.+++. +...++++||+ +++|.+++.. ..+++..+..++.|++.||+|||+.|++|+||+|.|
T Consensus 63 l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~N 138 (328)
T cd07856 63 LKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSN 138 (328)
T ss_pred HHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 56789999999999874 34689999999 6799998864 458899999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.++|+|||.+...... .....++..|++||.+.+ ...++.++|+||||+++|+|++|..||..
T Consensus 139 ili~~~-~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slG~il~el~tg~~~f~~ 208 (328)
T cd07856 139 ILINEN-CDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLT-------WQKYDVEVDIWSAGCIFAEMLEGKPLFPG 208 (328)
T ss_pred EeECCC-CCEEeCccccccccCCC--cCCCcccccccCceeeec-------cCCcCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999954 56999999998754322 123356778999998642 24578899999999999999999999976
Q ss_pred CCcHHHHHHHH----------------------Hhhc--CCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 160 MSNLQAAYAAA----------------------FKHA--RPG-----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 160 ~~~~~~~~~~~----------------------~~~~--~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
........... .... ... ....++..+.+++.+||+.+|++||++++++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~- 287 (328)
T cd07856 209 KDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA- 287 (328)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc-
Confidence 54321111000 0000 000 11346789999999999999999999999987
Q ss_pred HHhhhhhcCC
Q 024401 211 LNAFLFTLRP 220 (268)
Q Consensus 211 l~~~~~~~~~ 220 (268)
+.++.....
T Consensus 288 -~~~~~~~~~ 296 (328)
T cd07856 288 -HPYLAPYHD 296 (328)
T ss_pred -CCccccccC
Confidence 555544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=216.79 Aligned_cols=197 Identities=37% Similarity=0.580 Sum_probs=162.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++|+||+++++.+. +...++++||+.+++|.+++... ..++...++.++.+++.++++||+.|++|+||+|.||
T Consensus 41 ~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni 118 (244)
T smart00220 41 LKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR--GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENI 118 (244)
T ss_pred HHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHe
Confidence 45779999999999884 56789999999999999999763 2389999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+.............++..|++||.... ..++.++|+|+||++++++++|..||...
T Consensus 119 ~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~--------~~~~~~~Di~slG~~l~~l~~~~~p~~~~ 189 (244)
T smart00220 119 LLDED-GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG--------KGYGKAVDVWSLGVILYELLTGKPPFPGD 189 (244)
T ss_pred EECCC-CcEEEccccceeeeccccccccccCCcCCCCHHHHcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99965 5699999999987655444455567889999998753 56678999999999999999999999874
Q ss_pred CcHHHHHHHHHhhcCCCCCCC--CcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..................... ++.++.+++.+||..+|++||++.++++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 190 DQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred CcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 444444443333333222222 8899999999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=226.51 Aligned_cols=203 Identities=29% Similarity=0.417 Sum_probs=155.5
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+++++||||+++++++.. ...+++++++ |++|.+++.. ..+++..+..++.|++.||+|||+.|++|+|
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~d 145 (345)
T cd07877 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRD 145 (345)
T ss_pred HHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 567899999999998732 2367888887 8899998864 4599999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++||||||+++|+|++|+
T Consensus 146 lkp~NIll~~~-~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~il~el~~g~ 215 (345)
T cd07877 146 LKPSNLAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGR 215 (345)
T ss_pred CChHHEEEcCC-CCEEEeccccccccccc--ccccccCCCccCHHHHhC-------ccCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999965 46999999998754322 233467888999998742 235678999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhh---------------------cCCC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKH---------------------ARPG--------LPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~---------------------~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||...+............ ..+. .....+.++.+++.+||..+|.+||++.
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ 295 (345)
T cd07877 216 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 295 (345)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHH
Confidence 9997655433221110000 0000 0123577899999999999999999999
Q ss_pred HHHHHHHhhhhhcCC
Q 024401 206 QIIRMLNAFLFTLRP 220 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~ 220 (268)
++++ +.++.....
T Consensus 296 e~l~--h~~f~~~~~ 308 (345)
T cd07877 296 QALA--HAYFAQYHD 308 (345)
T ss_pred HHhc--ChhhhhcCC
Confidence 9998 566654433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=241.76 Aligned_cols=201 Identities=27% Similarity=0.463 Sum_probs=169.8
Q ss_pred CCCCCcccceeeee------ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 4 RVKHDNLVKFLGAC------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
...|||++.+++++ .++.+|||||||.|||..|++++..+..+.|..+..|++.++.|+++||+..++|||||-
T Consensus 72 ~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG 151 (953)
T KOG0587|consen 72 YSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKG 151 (953)
T ss_pred ccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccC
Confidence 45799999999986 355899999999999999999998888899999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
.|||++.++ .|||+|||.+..... .....+.+||+.|||||++.+- +.....|+.++|+||||++..||-.|.+|
T Consensus 152 ~NiLLT~e~-~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~---e~~d~tyd~R~D~WsLGITaIEladG~PP 227 (953)
T KOG0587|consen 152 QNVLLTENA-EVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACD---ESPDATYDYRSDLWSLGITAIEMAEGAPP 227 (953)
T ss_pred ceEEEeccC-cEEEeeeeeeeeeecccccccCcCCCcccccceeeecc---cCCCCCcccccchhhccceeehhcCCCCC
Confidence 999999665 599999999986554 3445778999999999999763 22346778899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+-++.+......+. ...++. .+..+++++.++|..||.+|-.+||+..++++
T Consensus 228 l~DmHPmraLF~Ip-RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 228 LCDMHPMRALFLIP-RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ccCcchhhhhccCC-CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 98776655444322 122221 24679999999999999999999999999886
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=228.01 Aligned_cols=202 Identities=26% Similarity=0.413 Sum_probs=154.2
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
++.++||||+++++++... ..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+.|++|||
T Consensus 68 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~d 142 (342)
T cd07879 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRD 142 (342)
T ss_pred HHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 5678999999999987422 3589999995 48877653 3589999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|+|+||+++.+ +.++|+|||++...... .....++..|+|||.+.. ...++.++|+||||+++|+|++|+
T Consensus 143 lkp~NIll~~~-~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 143 LKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILN-------WMHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred CCHHHEEECCC-CCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcC-------ccccCchHHHHHHHHHHHHHHhCC
Confidence 99999999965 56999999998754322 123356788999998742 234678999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhh---------------------cCCCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKH---------------------ARPGL--------PEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~---------------------~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+.+............ ..+.. ....+..+.+++.+||..+|.+||+++
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 292 (342)
T cd07879 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292 (342)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 9998755433222111100 00111 124677899999999999999999999
Q ss_pred HHHHHHHhhhhhcCC
Q 024401 206 QIIRMLNAFLFTLRP 220 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~ 220 (268)
+++. +.++...+.
T Consensus 293 e~l~--h~~f~~~~~ 305 (342)
T cd07879 293 EALE--HPYFDSFRD 305 (342)
T ss_pred HHhc--Ccchhhccc
Confidence 9997 555555543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=239.10 Aligned_cols=202 Identities=34% Similarity=0.610 Sum_probs=173.1
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC------------C--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------P--NKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~------------~--~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
+||||+.++|+|. ++..++|+||+..|+|.+|++..+ . ..++..+.+.++.||+.|++||++..+
T Consensus 360 ~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~ 439 (609)
T KOG0200|consen 360 KHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPC 439 (609)
T ss_pred CCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 6999999999995 567999999999999999998754 0 138899999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcccccc--cCcc--CccceeccccccccccccccccCCCcccchHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM--TAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 146 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~--~~~~--~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 146 (268)
+||||-..|||+..+ ..+|++|||+++........ .... -...|+|||.+.. ..++.++||||+|++
T Consensus 440 vHRDLAaRNVLi~~~-~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--------~~ft~kSDVWSfGI~ 510 (609)
T KOG0200|consen 440 VHRDLAARNVLITKN-KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--------RVFTSKSDVWSFGIL 510 (609)
T ss_pred cchhhhhhhEEecCC-CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc--------CcccccchhhHHHHH
Confidence 999999999999955 57999999999854332221 1112 2456999999964 789999999999999
Q ss_pred HHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 147 LWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 147 ~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
+||+++ |..||++.............+.+.+.|..++.++.++++.||..+|++||++.++.+.|...+.
T Consensus 511 L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 511 LWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 999999 8999998665566666677888889999999999999999999999999999999999999544
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.2e-32 Score=224.55 Aligned_cols=198 Identities=26% Similarity=0.370 Sum_probs=149.5
Q ss_pred CCCCCCCcccceeeeeec---------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
++.++||||+++++.+.+ ...++|+||+. ++|...+.. ....+++.++..++.|++.||+|||+.|++|
T Consensus 61 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H 138 (311)
T cd07866 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLEN-PSVKLTESQIKCYMLQLLEGINYLHENHILH 138 (311)
T ss_pred HHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 567899999999987621 24689999995 477777764 2356999999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCccccc------------ccCccCccceeccccccccccccccccCCCcccch
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 140 (268)
+||+|+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ...++.++||
T Consensus 139 ~dl~p~nil~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Dv 210 (311)
T cd07866 139 RDIKAANILIDNQ-GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-------ERRYTTAVDI 210 (311)
T ss_pred CCCCHHHEEECCC-CCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhC-------CCccCchhHh
Confidence 9999999999955 5699999999874332111 112245778999998753 2456789999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcC------------C---------CC-------CCCCcHHHHHHHHH
Q 024401 141 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------------P---------GL-------PEDISPDLAFIVQS 192 (268)
Q Consensus 141 ~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------~---------~~-------~~~~~~~l~~li~~ 192 (268)
||||+++|+|++|+.||.+.+.............. + .. ...+++.+.+++.+
T Consensus 211 ~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 290 (311)
T cd07866 211 WGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK 290 (311)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHH
Confidence 99999999999999999765543322221110000 0 00 02345678999999
Q ss_pred hhhhCCCCCCCHHHHHH
Q 024401 193 CWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 193 ~l~~~p~~Rps~~~~l~ 209 (268)
||..+|.+|||+.+++.
T Consensus 291 ~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 291 LLSLDPYKRLTASDALE 307 (311)
T ss_pred HcccCcccCcCHHHHhc
Confidence 99999999999999986
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=255.02 Aligned_cols=197 Identities=23% Similarity=0.424 Sum_probs=148.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH---ANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dlk~ 77 (268)
+++++||||+++++++. ++..++||||+++|+|.+++.. +++..+.+++.|++.|++||| +.+++||||||
T Consensus 737 l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp 811 (968)
T PLN00113 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP 811 (968)
T ss_pred HhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence 56889999999999984 5578999999999999999963 889999999999999999999 66999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+||+++.+. ..++. |+....... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||
T Consensus 812 ~Nil~~~~~-~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~--------~~~~~~sDv~S~Gvvl~el~tg~~p~ 878 (968)
T PLN00113 812 EKIIIDGKD-EPHLR-LSLPGLLCT---DTKCFISSAYVAPETRET--------KDITEKSDIYGFGLILIELLTGKSPA 878 (968)
T ss_pred HhEEECCCC-ceEEE-ecccccccc---CCCccccccccCcccccC--------CCCCcccchhhHHHHHHHHHhCCCCC
Confidence 999998553 35543 554433221 122357889999998853 66889999999999999999999998
Q ss_pred CCCCc----HHHHHHHHHhh------cCCCC------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSN----LQAAYAAAFKH------ARPGL------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~----~~~~~~~~~~~------~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..... ........... ..+.. ......++.+++.+||+.+|++|||+.++++.|+....
T Consensus 879 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 879 DAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 53221 11111110000 01111 11122357789999999999999999999999988654
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=233.37 Aligned_cols=154 Identities=38% Similarity=0.603 Sum_probs=134.4
Q ss_pred CCCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 1 MMSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
+|++++|||||++++.-++ ....++||||.||+|...+....+ .++++.+++.++..+..|+.|||++||+|
T Consensus 64 ilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvH 143 (732)
T KOG4250|consen 64 ILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVH 143 (732)
T ss_pred HHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCcee
Confidence 4789999999999998532 247899999999999999987333 56999999999999999999999999999
Q ss_pred cCCCCCCEEEcCCC---CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQ---KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 73 ~dlk~~Nil~~~~~---~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
|||||.||++.... ...||+|||.++....+.......||..|.+||++.. .+.++..+|.|||||++|+
T Consensus 144 RDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~-------q~~y~~tVDLWS~GvtlY~ 216 (732)
T KOG4250|consen 144 RDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYER-------QKKYTATVDLWSFGVTLYE 216 (732)
T ss_pred ccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhh-------ccCcCceeehhhhhhHHHH
Confidence 99999999995322 2579999999999888888888899999999999842 3788999999999999999
Q ss_pred HHhCCCCCCCCC
Q 024401 150 LLTNRLPFEGMS 161 (268)
Q Consensus 150 ll~g~~p~~~~~ 161 (268)
+.||..||....
T Consensus 217 caTG~lPF~p~~ 228 (732)
T KOG4250|consen 217 CATGELPFIPFG 228 (732)
T ss_pred HhccCCCCCcCC
Confidence 999999995433
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=219.59 Aligned_cols=201 Identities=27% Similarity=0.419 Sum_probs=160.9
Q ss_pred CCCCCCcccceeeeee-c-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--CCeecCCCCC
Q 024401 3 SRVKHDNLVKFLGACK-D-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GIIHRDLKPD 78 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~-~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--~i~H~dlk~~ 78 (268)
+.|.||.||++|+++. | ..+|-|.|||+|.+|+-|++. .+-+++.++..|+.||+.||.||.+. .|+|-||||.
T Consensus 522 KeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ--hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPg 599 (775)
T KOG1151|consen 522 KELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ--HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPG 599 (775)
T ss_pred hccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh--hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCc
Confidence 5689999999999983 3 358999999999999999986 46699999999999999999999987 5999999999
Q ss_pred CEEEc--CCCCceEEeccCCcccCccc--------ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 79 NLLLT--PDQKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 79 Nil~~--~~~~~~~l~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
|||+. ...+.+||+|||+++.+... .......||.||++||++.-. ......+.+.||||+|+|+|
T Consensus 600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVg----kePPKIsnKVDVWSvGVIFy 675 (775)
T KOG1151|consen 600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVG----KEPPKISNKVDVWSVGVIFY 675 (775)
T ss_pred cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecC----CCCCccccceeeEeeehhhh
Confidence 99995 23457999999999865432 123445799999999988642 24577899999999999999
Q ss_pred HHHhCCCCCCCCCcHHHHHHH--HHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 149 ELLTNRLPFEGMSNLQAAYAA--AFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 149 ~ll~g~~p~~~~~~~~~~~~~--~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.++.|+.||.....-+..... +.......+| ..++.+..++|++||++.-++|.+..++..
T Consensus 676 QClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 676 QCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred hhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 999999999764433333221 1111122233 468999999999999999999999888865
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=229.93 Aligned_cols=200 Identities=24% Similarity=0.383 Sum_probs=170.5
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|.++.||.||.+.-.|+ .++.+.|||-+ .|+.-+.|-....+.+++.....++.||+.||.|||-.||+|+||||+|
T Consensus 616 ILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPEN 694 (888)
T KOG4236|consen 616 ILQNLHHPGIVNLECMFETPERVFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPEN 694 (888)
T ss_pred HHHhcCCCCeeEEEEeecCCceEEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchh
Confidence 477899999999999885 45789999999 4566666655566789999999999999999999999999999999999
Q ss_pred EEEcCCC--CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 80 LLLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 80 il~~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+.... ..+||||||.++..+.........||+.|+|||++.. ..|..+-|+||+|+|+|--++|..||
T Consensus 695 VLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrn--------kGyNrSLDMWSVGVIiYVsLSGTFPF 766 (888)
T KOG4236|consen 695 VLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRN--------KGYNRSLDMWSVGVIIYVSLSGTFPF 766 (888)
T ss_pred eeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhh--------ccccccccceeeeEEEEEEecccccC
Confidence 9997432 3699999999999988888888899999999999964 77888999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
....++.+..+.......+.--..++.+..+||..+|+.+=.+|.|.+..+.
T Consensus 767 NEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 767 NEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred CCccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 8777666555544433444444678999999999999999999999988776
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=209.89 Aligned_cols=208 Identities=25% Similarity=0.363 Sum_probs=157.2
Q ss_pred CCCCCCCCcccceeeee--ecCCceEEEEcCCCCCHHHHHhhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
+++.++||||+.+..++ .|..+++++||.+. +|+..|+-++ .+.++...+..|++||+.|++|||+.=|+||||
T Consensus 80 L~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDL 158 (438)
T KOG0666|consen 80 LLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDL 158 (438)
T ss_pred HHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccC
Confidence 35678999999999987 37789999999976 9999886432 356999999999999999999999999999999
Q ss_pred CCCCEEEcCC---CCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 76 KPDNLLLTPD---QKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 76 k~~Nil~~~~---~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
||.|||+..+ .+.|||.|+|+++.....- .....+.|.+|.|||.+.+ ...|+.+.|+|++|||+.
T Consensus 159 KPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLG-------a~hYT~AiDvWAiGCIfa 231 (438)
T KOG0666|consen 159 KPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLG-------ARHYTKAIDVWAIGCIFA 231 (438)
T ss_pred CcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcc-------cccccchhhhHHHHHHHH
Confidence 9999999754 3579999999998654422 2334578999999999985 478999999999999999
Q ss_pred HHHhCCCCCCCCCcHH--------HHHHHHHhh-c------------CCCC-----------------------CCCCcH
Q 024401 149 ELLTNRLPFEGMSNLQ--------AAYAAAFKH-A------------RPGL-----------------------PEDISP 184 (268)
Q Consensus 149 ~ll~g~~p~~~~~~~~--------~~~~~~~~~-~------------~~~~-----------------------~~~~~~ 184 (268)
||++..+.|.+..... +....++.- . .++. ...-++
T Consensus 232 ElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~ 311 (438)
T KOG0666|consen 232 ELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDP 311 (438)
T ss_pred HHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCc
Confidence 9999877664322100 000000000 0 0000 011233
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 185 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 185 ~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
...+|+..||..||.+|.|+++.++ +.++...
T Consensus 312 ~a~~LL~klL~yDP~kRIta~qAle--h~yF~~d 343 (438)
T KOG0666|consen 312 SALDLLQKLLTYDPIKRITAEQALE--HPYFTED 343 (438)
T ss_pred hHHHHHHHHhccCchhhccHHHHhc--ccccccC
Confidence 4778999999999999999999998 5555443
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=204.57 Aligned_cols=205 Identities=24% Similarity=0.385 Sum_probs=159.9
Q ss_pred CCCCCCCCcccceeeeee-----cC----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 1 MMSRVKHDNLVKFLGACK-----DP----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-----~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
+|..++|+|++.+++.|. .. .+|+||++|+. +|.-++.+ ....++..++.+++.+++.||.|+|+..|+
T Consensus 69 iL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kil 146 (376)
T KOG0669|consen 69 ILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIHRNKIL 146 (376)
T ss_pred HHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHHHhhHH
Confidence 356789999999999872 11 38999999966 99998876 446799999999999999999999999999
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCccc-----ccccCccCccceeccccccccccccccccCCCcccchHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 146 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 146 (268)
|||+|+.|+||+.++ .++|.|||+++..... ........|.+|.+||.+.+ ...++++.|||+-|||
T Consensus 147 HRDmKaaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG-------~r~yg~~iDiWgAgCi 218 (376)
T KOG0669|consen 147 HRDMKAANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-------DREYGPPIDIWGAGCI 218 (376)
T ss_pred hhcccHhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCHHHhhc-------ccccCCcchhHhHHHH
Confidence 999999999999764 5999999999743321 12233467999999999975 4788999999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHHhh------cC--------------CCCCC-------------CCcHHHHHHHHHh
Q 024401 147 LWELLTNRLPFEGMSNLQAAYAAAFKH------AR--------------PGLPE-------------DISPDLAFIVQSC 193 (268)
Q Consensus 147 ~~~ll~g~~p~~~~~~~~~~~~~~~~~------~~--------------~~~~~-------------~~~~~l~~li~~~ 193 (268)
+.+|+++.+.+.+.++.+....+..-. .+ ++.++ .-.++..+|+..+
T Consensus 219 maeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~l 298 (376)
T KOG0669|consen 219 MAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKL 298 (376)
T ss_pred HHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHH
Confidence 999999999887766544432221100 00 11111 1234788999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 194 WVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 194 l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+..||.+|++++++++ +.++..
T Consensus 299 l~~DP~kR~~ad~aln--h~~F~k 320 (376)
T KOG0669|consen 299 LKLDPTKRIDADQALN--HDFFWK 320 (376)
T ss_pred hccCcccCcchHhhhc--hhhhhc
Confidence 9999999999999998 555544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-31 Score=196.76 Aligned_cols=171 Identities=29% Similarity=0.463 Sum_probs=138.8
Q ss_pred CCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCC
Q 024401 3 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPD 78 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~ 78 (268)
+...+|.+|++||.. .++..|+.||.+ ..||+.+.+. .++..+++..+-+|+..++.||.|||++ .++|||+||+
T Consensus 100 r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPs 178 (282)
T KOG0984|consen 100 RTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPS 178 (282)
T ss_pred cCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcc
Confidence 445789999999985 567899999999 6699998865 3456799999999999999999999987 8999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|||++.++ .||+||||++......-......|...|+|||.++.. .....|+.++||||||+++.||.+++.||+
T Consensus 179 NiLIn~~G-qVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e----~n~~gY~vksDvWSLGItmiElA~lr~PY~ 253 (282)
T KOG0984|consen 179 NILINYDG-QVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPE----LNQKGYSVKSDVWSLGITMIEMAILRFPYE 253 (282)
T ss_pred eEEEccCC-cEEEcccccceeehhhhHHHHhcCCCccCChhhcCcc----cCcccceeehhhhhhhhhhhhhhhcccccc
Confidence 99999775 5999999999765444433445788899999998752 233578999999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCC
Q 024401 159 GMSNLQAAYAAAFKHARPGLP 179 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~ 179 (268)
.-....+..........+.+|
T Consensus 254 ~w~tpF~qLkqvVeep~P~Lp 274 (282)
T KOG0984|consen 254 SWGTPFQQLKQVVEEPSPQLP 274 (282)
T ss_pred ccCCHHHHHHHHhcCCCCCCc
Confidence 765555555555555555544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=208.55 Aligned_cols=208 Identities=28% Similarity=0.486 Sum_probs=174.6
Q ss_pred CCCCCCCCcccceeeee-e-cCCceEEEEcCCCCCHHHHHhhhC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 1 MMSRVKHDNLVKFLGAC-K-DPLMVIVTELLPGMSLRKYLVSLR------PNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~-~~~~~lv~e~~~~~~L~~~~~~~~------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
+|..+.|||+..+.+.+ + ....+.++.+..-|+|..|+..-+ ...++..+...++.|++.|++|||++|++|
T Consensus 340 lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViH 419 (563)
T KOG1024|consen 340 LLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIH 419 (563)
T ss_pred HHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 35678999999999987 3 346889999998899999998422 234777888999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
.||...|++|+ +...|||+|=.+++....... .........||+||.+.. ..|+.++|+||||+++||
T Consensus 420 kDiAaRNCvId-d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n--------~~yssasDvWsfGVllWE 490 (563)
T KOG1024|consen 420 KDIAARNCVID-DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN--------SHYSSASDVWSFGVLLWE 490 (563)
T ss_pred chhhhhcceeh-hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhh--------hhhcchhhhHHHHHHHHH
Confidence 99999999999 557899999999985443221 223345678999999964 889999999999999999
Q ss_pred HHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 150 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 150 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|++ |+.||-+.++.+ ...-..++.+...|.++|+++..++..||+..|++||+++++...|..+-..+
T Consensus 491 Lmtlg~~PyaeIDPfE-m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 491 LMTLGKLPYAEIDPFE-MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred HHhcCCCCccccCHHH-HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 999 999998776644 34445678888899999999999999999999999999999999998876543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=213.72 Aligned_cols=196 Identities=24% Similarity=0.327 Sum_probs=154.8
Q ss_pred ccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC----
Q 024401 10 LVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---- 84 (268)
Q Consensus 10 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~---- 84 (268)
++.+.+++ ..++.+||+|.+ |-|+.+++.++...+++...+..+++|++.++++||+.+++|-||||+|||+..
T Consensus 153 cv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 153 CVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred EEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 56666666 467899999999 889999999988889999999999999999999999999999999999999832
Q ss_pred ------C---------CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 85 ------D---------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 85 ------~---------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
. +..|+|+|||.++...... ...+.|..|.|||++.+ -.++..+||||+|||++|
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg--------LGwS~pCDvWSiGCIL~E 301 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG--------LGWSQPCDVWSIGCILVE 301 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec--------cCcCCccCceeeeeEEEE
Confidence 1 2248999999998765554 45678999999999986 567889999999999999
Q ss_pred HHhCCCCCCCCCcHHHHH--HHHHh-----------------hcCCCCCC-------------------------CCcHH
Q 024401 150 LLTNRLPFEGMSNLQAAY--AAAFK-----------------HARPGLPE-------------------------DISPD 185 (268)
Q Consensus 150 ll~g~~p~~~~~~~~~~~--~~~~~-----------------~~~~~~~~-------------------------~~~~~ 185 (268)
+++|...|+..++.+... +.+.. ......++ .-..+
T Consensus 302 lytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~ 381 (415)
T KOG0671|consen 302 LYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQ 381 (415)
T ss_pred eeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhH
Confidence 999999998777654321 00000 00111110 01235
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 186 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 186 l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+.+|+++||..||.+|+|+.|+++ +.++..+
T Consensus 382 LfDLl~~mL~fDP~~RiTl~EAL~--HpFF~~~ 412 (415)
T KOG0671|consen 382 LFDLLRRMLEFDPARRITLREALS--HPFFARL 412 (415)
T ss_pred HHHHHHHHHccCccccccHHHHhc--CHHhhcC
Confidence 899999999999999999999998 5555543
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=213.33 Aligned_cols=183 Identities=28% Similarity=0.450 Sum_probs=157.3
Q ss_pred CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCC
Q 024401 7 HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 85 (268)
Q Consensus 7 Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~ 85 (268)
-|.++++...++ -+++|+||||+.||+|--.|+. -+.+.+..+..++..|+.||-+||++||++||||.+||+++.+
T Consensus 409 ppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ--~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~e 486 (683)
T KOG0696|consen 409 PPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE 486 (683)
T ss_pred CchHHHHHHHhhhhhheeeEEEEecCchhhhHHHH--hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccC
Confidence 466777777764 4689999999999999988876 4669999999999999999999999999999999999999977
Q ss_pred CCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHH
Q 024401 86 QKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164 (268)
Q Consensus 86 ~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~ 164 (268)
++ +||.|||+++..-. .....+..||+.|+|||.+.- ..|+.+.|-||+|+++|||+.|+.||++.+..+
T Consensus 487 GH-iKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y--------qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 487 GH-IKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred Cc-eEeeecccccccccCCcceeeecCCCcccccceEEe--------cccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 65 99999999986543 445677899999999998853 788999999999999999999999999876544
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 165 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
.-. .+......+|..+|.+..++.+..|.+.|.+|.
T Consensus 558 lF~--aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 558 LFQ--AIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred HHH--HHHHccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 333 344556678899999999999999999999994
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=193.29 Aligned_cols=199 Identities=28% Similarity=0.426 Sum_probs=160.8
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|+.++|.|||++++.. .++.+.+|+||| ..+|..|..+ -++.++.+.+..++.|++.||.|+|+++++|||+||.|
T Consensus 54 llkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfds-lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqn 131 (292)
T KOG0662|consen 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDS-LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQN 131 (292)
T ss_pred HHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHh-cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcce
Confidence 46789999999999986 677899999999 5699999986 46789999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
.+++.+ +.+||.|||+++..+..- -......|.+|.+|.++.+ ...|+.+.|+||-|||+.|+.. |.+.|
T Consensus 132 llin~n-gelkladfglarafgipvrcysaevvtlwyrppdvlfg-------akly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 132 LLINRN-GELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred EEeccC-CcEEecccchhhhcCCceEeeeceeeeeeccCcceeee-------eehhccchHhhhcchHHHHHhhcCCCCC
Confidence 999966 569999999999766544 3355678999999999986 3678899999999999999998 66667
Q ss_pred CCCCcHHHHHHHHHhhc------CCC------------CC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHA------RPG------------LP---------EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~------~~~------------~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
++.+-.+........-. ++. ++ ..++..-++++...+.-+|.+|.++++.++
T Consensus 204 pg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 204 PGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 76554444433322111 111 11 123345789999999999999999999987
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=243.36 Aligned_cols=194 Identities=21% Similarity=0.298 Sum_probs=141.8
Q ss_pred CCCCC-Ccccceeeee--------ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 3 SRVKH-DNLVKFLGAC--------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 3 ~~l~H-p~i~~~~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
+.++| +||+++++++ .+..+++++|++ +++|.+++.. ....+++.+++.++.||+.||+|||++||+||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-PDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-ccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 56778 7899999876 123577889988 6699999975 34569999999999999999999999999999
Q ss_pred CCCCCCEEEcCC------------------CCceEEeccCCcccCcccc-----------------cccCccCccceecc
Q 024401 74 DLKPDNLLLTPD------------------QKSLKLADFGLAREETVTE-----------------MMTAETGTYRWMAP 118 (268)
Q Consensus 74 dlk~~Nil~~~~------------------~~~~~l~Dfg~~~~~~~~~-----------------~~~~~~~~~~y~aP 118 (268)
||||+|||++.. ...++++|||+++...... ......+|+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999532 2346677777765321100 00113578889999
Q ss_pred ccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCC
Q 024401 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 198 (268)
Q Consensus 119 E~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 198 (268)
|.+.+ ..++.++|||||||++|||++|..|+....... ........++...........++.+||.++|
T Consensus 185 E~~~~--------~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P 253 (793)
T PLN00181 185 EEDNG--------SSSNCASDVYRLGVLLFELFCPVSSREEKSRTM---SSLRHRVLPPQILLNWPKEASFCLWLLHPEP 253 (793)
T ss_pred hhhcc--------CCCCchhhhhhHHHHHHHHhhCCCchhhHHHHH---HHHHHhhcChhhhhcCHHHHHHHHHhCCCCh
Confidence 99854 567899999999999999999888865322111 1111111121111223456788999999999
Q ss_pred CCCCCHHHHHH
Q 024401 199 NLRPSFSQIIR 209 (268)
Q Consensus 199 ~~Rps~~~~l~ 209 (268)
.+||++.++++
T Consensus 254 ~~Rps~~eil~ 264 (793)
T PLN00181 254 SCRPSMSELLQ 264 (793)
T ss_pred hhCcChHHHhh
Confidence 99999999987
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=229.02 Aligned_cols=206 Identities=29% Similarity=0.551 Sum_probs=176.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|.++.|||+++++++|..+.+-||++|+++|+|.||++.++ ..+-....+.|..||++|+.|||++++|||||-..|||
T Consensus 752 masldHpnl~RLLgvc~~s~~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVL 830 (1177)
T KOG1025|consen 752 MASLDHPNLLRLLGVCMLSTLQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVL 830 (1177)
T ss_pred HhcCCCchHHHHhhhcccchHHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhee
Confidence 67899999999999998888999999999999999999854 56888899999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+..- ..+|+.|||+++....... .......+.|+|-|.+. ...++.++||||+|+++||++| |..||
T Consensus 831 VksP-~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~--------~~~~thqSDVWsfGVtiWElmTFGa~Py 901 (1177)
T KOG1025|consen 831 VKSP-NHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR--------IRKYTHQSDVWSFGVTIWELMTFGAKPY 901 (1177)
T ss_pred ecCC-CeEEEEecchhhccCcccccccccccccCcHHHHHHHhh--------ccCCCchhhhhhhhhhHHHHHhcCCCcc
Confidence 9855 4599999999986544322 22334467789999874 4889999999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.+..- .+.......+.+.+.|..++.++..++.+||..|+..||+++++...+.......
T Consensus 902 ~gi~~-~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 902 DGIPA-EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred CCCCH-HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 87654 4445556677778889999999999999999999999999999999888765443
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=207.36 Aligned_cols=194 Identities=30% Similarity=0.447 Sum_probs=155.7
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+..++|+||++++.++.. ...|+|||++ ..+|...+. ..++-.++..|+.|++.|+.|||+.||+|||
T Consensus 69 ~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~IihRd 143 (369)
T KOG0665|consen 69 MKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAGIIHRD 143 (369)
T ss_pred hhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcceeecc
Confidence 457899999999999822 1589999999 559998886 3488889999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||++..++ .+||+|||+++.....-.......+..|.|||++.+ ..+.+..||||+||++.||++|.
T Consensus 144 LkPsnivv~~~~-~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~--------~~~ke~vdiwSvGci~gEli~~~ 214 (369)
T KOG0665|consen 144 LKPSNIVVNSDC-TLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGELILGT 214 (369)
T ss_pred cCcccceecchh-heeeccchhhcccCcccccCchhheeeccCchheec--------cCCcccchhhhhhhHHHHHhhce
Confidence 999999999664 599999999987766544455678999999999975 44889999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhh--------------------cCCC---------CCC-----------CCcHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQAAYAAAFKH--------------------ARPG---------LPE-----------DISPDLAFIVQSCW 194 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~--------------------~~~~---------~~~-----------~~~~~l~~li~~~l 194 (268)
.-|.+.+..+...+....- .++. +|+ .-+..+++++.+||
T Consensus 215 Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~ML 294 (369)
T KOG0665|consen 215 VLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKML 294 (369)
T ss_pred EEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhh
Confidence 9888766544433221111 0100 110 12345899999999
Q ss_pred hhCCCCCCCHHHHHH
Q 024401 195 VEDPNLRPSFSQIIR 209 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~ 209 (268)
..+|++|.|+.++++
T Consensus 295 vi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 295 VIDPEKRISVDDALR 309 (369)
T ss_pred ccChhhcccHHHHhc
Confidence 999999999999998
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-30 Score=231.68 Aligned_cols=94 Identities=34% Similarity=0.557 Sum_probs=84.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+..++||||+++++.+. +...|+||||+.|++|.+++.. ...+++..++.|+.||+.||+|||..||+|+||||+||
T Consensus 58 l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NI 135 (669)
T cd05610 58 LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM 135 (669)
T ss_pred HHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHE
Confidence 45689999999999874 5679999999999999999975 34689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcc
Q 024401 81 LLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~ 98 (268)
|++.+ +.++|+|||+++
T Consensus 136 Ll~~~-g~vkL~DFGls~ 152 (669)
T cd05610 136 LISNE-GHIKLTDFGLSK 152 (669)
T ss_pred EEcCC-CCEEEEeCCCCc
Confidence 99865 469999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=196.60 Aligned_cols=202 Identities=21% Similarity=0.355 Sum_probs=161.7
Q ss_pred CCCCC-CCcccceeeeeecC---CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVK-HDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
|..|. ||||+++++...|. ...+|+||+.+.+...+... ++..++..++.+++.||.|+|++||.|||+||
T Consensus 86 L~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKP 160 (338)
T KOG0668|consen 86 LQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKP 160 (338)
T ss_pred HHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCc
Confidence 44555 99999999998543 57799999999888877644 88888999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
.|++++.....++|+|+|++.....+...+....+..|.-||.+.. -..++.+-|+|||||++..|+..+.||
T Consensus 161 hNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVd-------y~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 161 HNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred ceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheee-------chhccccHHHHHHHHHHHHHHhccCcc
Confidence 9999998888899999999998887777777788889999999975 367889999999999999999998887
Q ss_pred CC-CCcHHHHHHHHHhh---------------cCC--------------------CCCCCCcHHHHHHHHHhhhhCCCCC
Q 024401 158 EG-MSNLQAAYAAAFKH---------------ARP--------------------GLPEDISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 158 ~~-~~~~~~~~~~~~~~---------------~~~--------------------~~~~~~~~~l~~li~~~l~~~p~~R 201 (268)
.. .++-+........- ..+ .-..-++++..+++..+|..|-.+|
T Consensus 234 FhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeR 313 (338)
T KOG0668|consen 234 FHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQER 313 (338)
T ss_pred cCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccc
Confidence 53 33433332221100 000 0111256889999999999999999
Q ss_pred CCHHHHHHHHHhhhhh
Q 024401 202 PSFSQIIRMLNAFLFT 217 (268)
Q Consensus 202 ps~~~~l~~l~~~~~~ 217 (268)
+|+.|.+. +.++..
T Consensus 314 lTakEam~--HpyF~~ 327 (338)
T KOG0668|consen 314 LTAKEAMA--HPYFAP 327 (338)
T ss_pred cchHHHhc--CchHHH
Confidence 99999987 444433
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=230.59 Aligned_cols=192 Identities=26% Similarity=0.404 Sum_probs=145.4
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh-CCCC-CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL-RPNK-LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-~~~~-~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.||||+++++.-+ +.+.||..|.|.. +|++++... .... ......+.++.|+++||++||+.+||||||||.||||
T Consensus 561 ~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI 639 (903)
T KOG1027|consen 561 EHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILI 639 (903)
T ss_pred CCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEE
Confidence 7999999999875 4579999999955 999999863 1111 1114568889999999999999999999999999999
Q ss_pred cC----CCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-C
Q 024401 83 TP----DQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 153 (268)
Q Consensus 83 ~~----~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g 153 (268)
+. ....++|+|||+++....+.. .....||.+|+|||.+.. ...+.+.|||||||++|+.++ |
T Consensus 640 ~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~--------~~~~~avDiFslGCvfyYvltgG 711 (903)
T KOG1027|consen 640 SVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLRE--------DRKTQAVDIFSLGCVFYYVLTGG 711 (903)
T ss_pred EccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhc--------cccCcccchhhcCceEEEEecCC
Confidence 85 224689999999986554332 345679999999999964 444669999999999999988 5
Q ss_pred CCCCCCCCcHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..||.+.-..+. .+..... ..+......+..+||.+|+.++|..||+|.+++.
T Consensus 712 ~HpFGd~~~R~~---NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 712 SHPFGDSLERQA---NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ccCCCchHHhhh---hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence 899975432221 1111111 1111112228999999999999999999999986
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=192.66 Aligned_cols=163 Identities=28% Similarity=0.356 Sum_probs=126.8
Q ss_pred CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccC
Q 024401 32 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETG 111 (268)
Q Consensus 32 ~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 111 (268)
|+|.+++.. ....+++.+++.|+.|++.||+|||+.+ ||+||+++.+ +.+++ ||.+...... ...+
T Consensus 1 GsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~-~~~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEV-RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWD-GLLKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCc-cceee--ccceEeeccc----cCCC
Confidence 689999975 2456999999999999999999999998 9999999855 45777 9988754332 2257
Q ss_pred ccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCC------CCCCCcH-
Q 024401 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG------LPEDISP- 184 (268)
Q Consensus 112 ~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~- 184 (268)
++.|+|||.+.+ ..++.++|||||||++|+|++|..||.................... .+..++.
T Consensus 67 ~~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 67 DPYFMAPEVIQG--------QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred cccccChHHhcC--------CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhh
Confidence 899999999854 5678899999999999999999999976554333333333222222 1122334
Q ss_pred -HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 185 -DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 185 -~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+.+++.+||..+|.+||++.++++++.....
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 69999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-30 Score=209.89 Aligned_cols=204 Identities=29% Similarity=0.535 Sum_probs=158.6
Q ss_pred CCCCcccceeeeee-----cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CCe
Q 024401 5 VKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--------GII 71 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~i~ 71 (268)
|+|+||+.++++-. ...+|||++|++.|||.||+.. ..++.+..++++..+++||++||.. +|.
T Consensus 262 LRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIA 338 (513)
T KOG2052|consen 262 LRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIA 338 (513)
T ss_pred hccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhh
Confidence 68999999999851 2369999999999999999986 5699999999999999999999964 599
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCccc-----ccccCccCccceeccccccccccccccccCC--CcccchHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHY--NNKVDVYSFG 144 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~--~~~~Di~slG 144 (268)
|||||..|||+.++ +.+.|.|+|++...... ...+...||.+|||||++...- ....+ -..+||||||
T Consensus 339 HRDlKSKNILVKkn-~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdeti----n~~~Fesyk~ADIYafg 413 (513)
T KOG2052|consen 339 HRDLKSKNILVKKN-GTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETI----NMKHFESYKRADIYAFG 413 (513)
T ss_pred ccccccccEEEccC-CcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhc----ChhhhhhhhHHHHHHHH
Confidence 99999999999955 56999999999743332 2235568999999999996521 11111 1368999999
Q ss_pred HHHHHHHhC----------CCCCCCCCcHHHHH-----HHHHhhcCCCCCCCCc-----HHHHHHHHHhhhhCCCCCCCH
Q 024401 145 IVLWELLTN----------RLPFEGMSNLQAAY-----AAAFKHARPGLPEDIS-----PDLAFIVQSCWVEDPNLRPSF 204 (268)
Q Consensus 145 ~i~~~ll~g----------~~p~~~~~~~~~~~-----~~~~~~~~~~~~~~~~-----~~l~~li~~~l~~~p~~Rps~ 204 (268)
.++||+... +.||.+..+.+... ..+.+..+|.+|..+. ..+.++++.||..+|..|.|+
T Consensus 414 LVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 414 LVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 999999752 46776433322222 2234566777776544 347789999999999999999
Q ss_pred HHHHHHHHhhhh
Q 024401 205 SQIIRMLNAFLF 216 (268)
Q Consensus 205 ~~~l~~l~~~~~ 216 (268)
--+-+.|.++..
T Consensus 494 LriKKtl~~l~~ 505 (513)
T KOG2052|consen 494 LRIKKTLAKLSN 505 (513)
T ss_pred HHHHHHHHHHhc
Confidence 999999888764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=203.07 Aligned_cols=187 Identities=26% Similarity=0.434 Sum_probs=159.5
Q ss_pred CCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
-+||.+|-+..+| .++++++|.||++||+|--.++. +++++++.+..+...|+.||.|||++||++||||.+|+|++
T Consensus 308 sn~pflvglhscfqtesrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlld 385 (593)
T KOG0695|consen 308 SNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLD 385 (593)
T ss_pred cCCCeEEehhhhhcccceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEc
Confidence 3689999999988 47789999999999999888875 67799999999999999999999999999999999999999
Q ss_pred CCCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC--C
Q 024401 84 PDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG--M 160 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~--~ 160 (268)
..+ .+||+|+|+++... .+....+..||+.|+|||.+.+ ..|..+.|.|+||++++||+.|+.||+- .
T Consensus 386 aeg-hikltdygmcke~l~~gd~tstfcgtpnyiapeilrg--------eeygfsvdwwalgvlmfemmagrspfdivgm 456 (593)
T KOG0695|consen 386 AEG-HIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG--------EEYGFSVDWWALGVLMFEMMAGRSPFDIVGM 456 (593)
T ss_pred cCC-ceeecccchhhcCCCCCcccccccCCCcccchhhhcc--------cccCceehHHHHHHHHHHHHcCCCCcceecC
Confidence 765 49999999998643 4566788899999999999954 8899999999999999999999999952 1
Q ss_pred ----CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 161 ----SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 161 ----~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
.+.++.....+-.....+|..++-....+++..|.+||..|.
T Consensus 457 ~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 457 DNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred CCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhc
Confidence 233344444445555667778888888999999999999994
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=206.24 Aligned_cols=208 Identities=32% Similarity=0.518 Sum_probs=158.5
Q ss_pred CCCCCcccceeeeee-----cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---------C
Q 024401 4 RVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---------G 69 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---------~ 69 (268)
.++|+||++++++-. ...++||++|++.|+|.+|++. ..+++.+..+++..++.||+|||+. .
T Consensus 260 ~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~ 336 (534)
T KOG3653|consen 260 GMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPP 336 (534)
T ss_pred CccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCc
Confidence 579999999999852 2268999999999999999987 5699999999999999999999974 5
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHH
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 146 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 146 (268)
|+|||||..|||+..| ....|+|||++.....+.. .....||.+|||||++.+.-.-+. ...-.+.||||+|.+
T Consensus 337 IaHRDlkSkNVLvK~D-lTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d--~~Afkr~DvYamgLV 413 (534)
T KOG3653|consen 337 IAHRDLKSKNVLVKND-LTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQD--RDAFKRIDVYAMGLV 413 (534)
T ss_pred cccccccccceEEccC-CcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhccccc--HHHHHHHHHHHHHHH
Confidence 9999999999999955 5699999999976543322 233689999999999975321110 112236899999999
Q ss_pred HHHHHhCCC------------CCC---C-CCcHHHH-HHHHHhhcCCCCCCCC-----cHHHHHHHHHhhhhCCCCCCCH
Q 024401 147 LWELLTNRL------------PFE---G-MSNLQAA-YAAAFKHARPGLPEDI-----SPDLAFIVQSCWVEDPNLRPSF 204 (268)
Q Consensus 147 ~~~ll~g~~------------p~~---~-~~~~~~~-~~~~~~~~~~~~~~~~-----~~~l~~li~~~l~~~p~~Rps~ 204 (268)
+|||+++.. ||+ + ....++. .....+..+|.++..+ ..-+++.+..||..|++.|.|+
T Consensus 414 LWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 414 LWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 999998533 332 1 1112222 2233455667666543 4568999999999999999999
Q ss_pred HHHHHHHHhhhhh
Q 024401 205 SQIIRMLNAFLFT 217 (268)
Q Consensus 205 ~~~l~~l~~~~~~ 217 (268)
.=+.+.+..+...
T Consensus 494 ~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 494 GCVEERMAELMML 506 (534)
T ss_pred HHHHHHHHHHhcc
Confidence 9998888876543
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=226.27 Aligned_cols=179 Identities=31% Similarity=0.489 Sum_probs=130.9
Q ss_pred CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccC
Q 024401 21 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
.+||=||||+..+|.+++..+... -.....|+++.+|++||+|+|++||+||||||.||+++.+ +.|||+|||++...
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~-~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~-~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFN-SQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSR-NSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccc-hhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCC-CCeeecccccchhh
Confidence 478999999888888888752211 1578899999999999999999999999999999999955 55999999999751
Q ss_pred c-------------------ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 101 T-------------------VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 101 ~-------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
. ........+||.-|+|||.+.+- ....|+.|.|+||||+|++||+. ||...-
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~-----~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM 819 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT-----SSNKYNSKIDMYSLGIVLFEMLY---PFGTSM 819 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc-----ccccccchhhhHHHHHHHHHHhc---cCCchH
Confidence 1 01112334799999999998641 12478999999999999999984 454222
Q ss_pred cHHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 162 NLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.-...........+.. ...-.+.-..+|++|++.||.+||||.++++
T Consensus 820 ERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 820 ERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 11111111111211211 1223345678999999999999999999987
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-29 Score=211.84 Aligned_cols=187 Identities=24% Similarity=0.418 Sum_probs=146.4
Q ss_pred CCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.-..+-||+||-.|+|+ .+|+||+|++||++-.++-. -+-|++..+..++..+..|+++.|..|+|||||||+||||
T Consensus 685 EADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI 762 (1034)
T KOG0608|consen 685 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI 762 (1034)
T ss_pred hcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE
Confidence 34567799999999765 69999999999999998875 3569999999999999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCc---------cc-----------------c-----------------cccCccCccceeccc
Q 024401 83 TPDQKSLKLADFGLAREET---------VT-----------------E-----------------MMTAETGTYRWMAPE 119 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~---------~~-----------------~-----------------~~~~~~~~~~y~aPE 119 (268)
|.+++ +||+|||++.... .+ . .....+||+.|+|||
T Consensus 763 DrdGH-IKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiape 841 (1034)
T KOG0608|consen 763 DRDGH-IKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPE 841 (1034)
T ss_pred ccCCc-eeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChH
Confidence 98865 9999999996210 00 0 001226899999999
Q ss_pred cccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHH--HHHhhcCCCCCCCCcHHHHHHHHHhhhhC
Q 024401 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARPGLPEDISPDLAFIVQSCWVED 197 (268)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 197 (268)
++.. ..++..+|.||.|+|+|||+.|+.||-..+..+.... .+..........+++++..++|.+++. .
T Consensus 842 vl~r--------~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-s 912 (1034)
T KOG0608|consen 842 VLAR--------TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-S 912 (1034)
T ss_pred Hhcc--------cCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-C
Confidence 9963 6678899999999999999999999977665444332 233344445557799999998866542 3
Q ss_pred CCCCC
Q 024401 198 PNLRP 202 (268)
Q Consensus 198 p~~Rp 202 (268)
++.|.
T Consensus 913 ad~RL 917 (1034)
T KOG0608|consen 913 ADSRL 917 (1034)
T ss_pred hhhhh
Confidence 44554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=218.68 Aligned_cols=195 Identities=20% Similarity=0.215 Sum_probs=133.2
Q ss_pred cCCceEEEEcCCCCCHHHHHhhhCC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 19 DPLMVIVTELLPGMSLRKYLVSLRP------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 19 ~~~~~lv~e~~~~~~L~~~~~~~~~------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+...++|+||+.+++|.+++..... .......+..++.|++.||+|||+.||+||||||+||
T Consensus 207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI 286 (566)
T PLN03225 207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI 286 (566)
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence 4468999999999999999875211 0112344678999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc--cccccCccCccceeccccccccccccc--------------cccCCCcccchHHHH
Q 024401 81 LLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQG--------------EKKHYNNKVDVYSFG 144 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~--------------~~~~~~~~~Di~slG 144 (268)
|++.+.+.++|+|||++..... ........+++.|+|||.+........ ....++.++||||||
T Consensus 287 Ll~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 287 IFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred EEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 9986666799999999975432 222345578899999996532111000 011345577999999
Q ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHh----------hcCCCC----------CCCCcHHHHHHHHHhhhhCCCCCCCH
Q 024401 145 IVLWELLTNRLPFEGMSNLQAAYAAAFK----------HARPGL----------PEDISPDLAFIVQSCWVEDPNLRPSF 204 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~~~~~~~~~~----------~~~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~ 204 (268)
|++|+|+++..++.. ........... ...... .........+|+.+||.+||.+|||+
T Consensus 367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 999999987665432 11111111000 000000 11123345689999999999999999
Q ss_pred HHHHHHHHhhhhh
Q 024401 205 SQIIRMLNAFLFT 217 (268)
Q Consensus 205 ~~~l~~l~~~~~~ 217 (268)
.++++ +.++..
T Consensus 445 ~e~L~--Hpff~~ 455 (566)
T PLN03225 445 KAALA--HPYFDR 455 (566)
T ss_pred HHHhC--CcCcCC
Confidence 99998 566544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-29 Score=192.11 Aligned_cols=196 Identities=24% Similarity=0.362 Sum_probs=150.4
Q ss_pred CCCcccceeee-e-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 6 KHDNLVKFLGA-C-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 6 ~Hp~i~~~~~~-~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.|.||+.-|+. | .-+.+++++||++.|+|..-+.. .++-+....+++.|+++||.|||+.++||||||.+||||-
T Consensus 79 ~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif 155 (378)
T KOG1345|consen 79 PHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIF 155 (378)
T ss_pred cchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEe
Confidence 48899998875 4 34578899999999999987764 6688999999999999999999999999999999999994
Q ss_pred -CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 84 -PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 84 -~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
.+...|||||||..+..+..- ...-.+..|.+||....+. .+.....+.+|+|.||++++.+++|..||.....
T Consensus 156 ~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~---ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~ 230 (378)
T KOG1345|consen 156 DADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVV---NEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI 230 (378)
T ss_pred cCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhcc---ccceEecccccchheeeeeeeeecCCCcchhhhc
Confidence 455589999999997654432 2223456799999876542 2345567789999999999999999999974332
Q ss_pred ---HHHHHHHHHhhcCCCCC---CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 163 ---LQAAYAAAFKHARPGLP---EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 163 ---~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
....+..+.....+..| ..+++.+..++++-|..++++|.-.-++.+
T Consensus 231 ~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk 283 (378)
T KOG1345|consen 231 MDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK 283 (378)
T ss_pred cCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence 22233333444444444 457889999999999999999954444443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=193.76 Aligned_cols=200 Identities=31% Similarity=0.468 Sum_probs=156.3
Q ss_pred CCCCCCCCcccceeeeeecC------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 1 MMSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
||..++|.|++..++..+-. ..|.++|.+ ..+|.+.|.+ +..++...+.-+++||+.||.|||+.||+|||
T Consensus 105 mLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRD 181 (449)
T KOG0664|consen 105 MLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRD 181 (449)
T ss_pred HHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhcc
Confidence 45678999999999876322 478999999 5599999876 56689999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|||.|.|++.+ ..+||||||+++....... +.....|..|.|||.+.+ ...|+.+.||||+|||+.|++.
T Consensus 182 IKPGNLLVNSN-CvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMG-------aRhYs~AvDiWSVGCIFaELLg 253 (449)
T KOG0664|consen 182 IKPGNLLVNSN-CILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMG-------ARRYTGAVDIWSVGCIFAELLQ 253 (449)
T ss_pred CCCccEEeccC-ceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhc-------chhhcCccceehhhHHHHHHHh
Confidence 99999999955 5699999999997655443 334467889999999975 4789999999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcC------------------------CCCC--------CCCcHHHHHHHHHhhhhCCCC
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHAR------------------------PGLP--------EDISPDLAFIVQSCWVEDPNL 200 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~------------------------~~~~--------~~~~~~l~~li~~~l~~~p~~ 200 (268)
.+..|....+.+....+..--.- +.++ ..-..+...++..++..+|+.
T Consensus 254 RrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dk 333 (449)
T KOG0664|consen 254 RKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDK 333 (449)
T ss_pred hhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcc
Confidence 88888776665544332211100 1111 122345677888999999999
Q ss_pred CCCHHHHHHHH
Q 024401 201 RPSFSQIIRML 211 (268)
Q Consensus 201 Rps~~~~l~~l 211 (268)
|.+.++.+.++
T Consensus 334 ris~~~A~~~~ 344 (449)
T KOG0664|consen 334 RISVEEALQHR 344 (449)
T ss_pred cccHhhhcccc
Confidence 99999888744
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=206.17 Aligned_cols=192 Identities=26% Similarity=0.401 Sum_probs=155.9
Q ss_pred Ccccceeeee-ecCCceEEEEcCCCCCHHHHHhhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCC
Q 024401 8 DNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 85 (268)
Q Consensus 8 p~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~ 85 (268)
-|+++++..| ..+++|+|||.+ ..+|.+.++.. ++-++....+..++.|++.||..|...||+|.||||.|||++..
T Consensus 494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNES 572 (752)
T ss_pred hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccC
Confidence 3678888776 567899999999 77999999873 45679999999999999999999999999999999999999988
Q ss_pred CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHH
Q 024401 86 QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA 165 (268)
Q Consensus 86 ~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~ 165 (268)
...+||||||.+........++ ...+..|.|||.+.+ ..|+...|+||+||++|||.||+..|++.++.+.
T Consensus 573 k~iLKLCDfGSA~~~~eneitP-YLVSRFYRaPEIiLG--------~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M 643 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENEITP-YLVSRFYRAPEIILG--------LPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM 643 (752)
T ss_pred cceeeeccCccccccccccccH-HHHHHhccCcceeec--------CcccCCccceeeceeeEEeeccceecCCCCcHHH
Confidence 8899999999998766544322 245678999999986 7789999999999999999999999999888766
Q ss_pred HHHHHHhhcCCC-------------------------------------------------------CCCC---CcHHHH
Q 024401 166 AYAAAFKHARPG-------------------------------------------------------LPED---ISPDLA 187 (268)
Q Consensus 166 ~~~~~~~~~~~~-------------------------------------------------------~~~~---~~~~l~ 187 (268)
....+......+ .+.+ +-..++
T Consensus 644 Lrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~r 723 (752)
T KOG0670|consen 644 LRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLR 723 (752)
T ss_pred HHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHH
Confidence 544332111100 0000 123588
Q ss_pred HHHHHhhhhCCCCCCCHHHHHH
Q 024401 188 FIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 188 ~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+|+..||.+||++|.|..++|.
T Consensus 724 dLLdkml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 724 DLLDKMLILDPEKRITVNQALK 745 (752)
T ss_pred HHHHHHhccChhhcCCHHHHhc
Confidence 9999999999999999999987
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=207.88 Aligned_cols=201 Identities=27% Similarity=0.409 Sum_probs=164.4
Q ss_pred CCCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++.++||||+.+++.+ .+..+|++||||.||+|++...- ..++++.++..+.+..+.||+|||+.|=+|||||..|
T Consensus 65 ~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGan 142 (829)
T KOG0576|consen 65 MLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGAN 142 (829)
T ss_pred eeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccc
Confidence 46789999999999998 56689999999999999998764 5779999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++.. +.+++.|||.+......- ......||+.|+|||+..- ...+.|...+|||++|++..|+-.-+.|..
T Consensus 143 illtd~-gDvklaDfgvsaqitati~KrksfiGtpywmapEvaav-----erkggynqlcdiwa~gitAiel~eLqpplf 216 (829)
T KOG0576|consen 143 ILLTDE-GDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAV-----ERKGGYNQLCDIWALGITAIELGELQPPLF 216 (829)
T ss_pred eeeccc-CceeecccCchhhhhhhhhhhhcccCCccccchhHHHH-----HhcccccccccccccccchhhhhhcCCccc
Confidence 999944 569999999987655432 3456789999999997642 245677889999999999999988788765
Q ss_pred CCCcHHHHHHHHHhhcCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+....+....-......++ -+..+++.+.+|++.++.++|.+||+++.+++
T Consensus 217 dlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 217 DLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 5554444433332222222 22458899999999999999999999998876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-27 Score=203.46 Aligned_cols=200 Identities=21% Similarity=0.226 Sum_probs=137.5
Q ss_pred cccceeeeee---------cCCceEEEEcCCCCCHHHHHhhhC----------------------CCCCCHHHHHHHHHH
Q 024401 9 NLVKFLGACK---------DPLMVIVTELLPGMSLRKYLVSLR----------------------PNKLDLHVALNFALD 57 (268)
Q Consensus 9 ~i~~~~~~~~---------~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~i~~q 57 (268)
++++++++|. ++..++|+||+++++|.+++.... ...+++..+..++.|
T Consensus 238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q 317 (507)
T PLN03224 238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ 317 (507)
T ss_pred hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence 3456666652 245799999999999999986421 112467788999999
Q ss_pred HHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccccc--CccCccceeccccccccccccc------
Q 024401 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT--AETGTYRWMAPELYSTVTLRQG------ 129 (268)
Q Consensus 58 l~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~------ 129 (268)
++.+|+|||+.+|+|+||||+||+++.+ ..++|+|||++.......... ...+++.|++||.+........
T Consensus 318 l~~aL~~lH~~~ivHrDLKp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~ 396 (507)
T PLN03224 318 VLTGLRKLHRIGIVHRDIKPENLLVTVD-GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAM 396 (507)
T ss_pred HHHHHHHHHHCCeecCCCchHhEEECCC-CcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhh
Confidence 9999999999999999999999999965 469999999986543322211 2234789999998753110000
Q ss_pred --------cccCCCcccchHHHHHHHHHHHhCCC-CCCCCCcHHHHHH---------HHHhhcC--CCCCCCCcHHHHHH
Q 024401 130 --------EKKHYNNKVDVYSFGIVLWELLTNRL-PFEGMSNLQAAYA---------AAFKHAR--PGLPEDISPDLAFI 189 (268)
Q Consensus 130 --------~~~~~~~~~Di~slG~i~~~ll~g~~-p~~~~~~~~~~~~---------~~~~~~~--~~~~~~~~~~l~~l 189 (268)
.......+.|+||+||++|+|+++.. |+........... ....... ......++....++
T Consensus 397 ~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dL 476 (507)
T PLN03224 397 AALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDL 476 (507)
T ss_pred hhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHH
Confidence 00111235799999999999999875 6643221111100 0111111 22234578899999
Q ss_pred HHHhhhhCC---CCCCCHHHHHH
Q 024401 190 VQSCWVEDP---NLRPSFSQIIR 209 (268)
Q Consensus 190 i~~~l~~~p---~~Rps~~~~l~ 209 (268)
+.+||..+| .+|+|++++++
T Consensus 477 i~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 477 ACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred HHHHhccCCCCcccCCCHHHHhC
Confidence 999999866 68999999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=180.74 Aligned_cols=168 Identities=38% Similarity=0.647 Sum_probs=142.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++|++|+++++++. ....++++|++.|++|.+++.... ..+++..++.++.+++.++++||+.|++|+||+|.||
T Consensus 45 ~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni 123 (215)
T cd00180 45 LKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENI 123 (215)
T ss_pred HHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhE
Confidence 46789999999999985 467899999999899999997632 4689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.....++|+|||.+....... ......+...|++||.... ....+.+.|+|++|++++++
T Consensus 124 ~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~D~~~lg~~~~~l--------- 187 (215)
T cd00180 124 LLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG-------KGYYSEKSDIWSLGVILYEL--------- 187 (215)
T ss_pred EEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcc-------cCCCCchhhhHHHHHHHHHH---------
Confidence 999624569999999987544332 1233456788999998753 12677899999999999999
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
..+.+++..|+..+|++||++.++++.
T Consensus 188 ------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 678899999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=196.40 Aligned_cols=147 Identities=24% Similarity=0.446 Sum_probs=123.7
Q ss_pred CCCCC---CCcccceeeeeec-CCceEEEEcCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 2 MSRVK---HDNLVKFLGACKD-PLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 2 l~~l~---Hp~i~~~~~~~~~-~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
|..++ |+||++++++|+| +++|++||-..- .+|.++|.- ...+++.++.-|+.|++.|+++||+.||||||||
T Consensus 620 la~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdik 697 (772)
T KOG1152|consen 620 LATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIK 697 (772)
T ss_pred HHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccc
Confidence 44455 9999999999965 478899998743 488888875 3569999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
-+|+.++.++ -+||+|||.+... ..++.....||..|.|||++-+ ........|||+||+++|.++...+|
T Consensus 698 denvivd~~g-~~klidfgsaa~~-ksgpfd~f~gtv~~aapevl~g-------~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 698 DENVIVDSNG-FVKLIDFGSAAYT-KSGPFDVFVGTVDYAAPEVLGG-------EKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred cccEEEecCC-eEEEeeccchhhh-cCCCcceeeeeccccchhhhCC-------CccCCCcchhhhhhheeeEEEeccCC
Confidence 9999999665 5999999988654 3445567799999999999964 34456688999999999999999999
Q ss_pred CCC
Q 024401 157 FEG 159 (268)
Q Consensus 157 ~~~ 159 (268)
|+.
T Consensus 769 yyn 771 (772)
T KOG1152|consen 769 YYN 771 (772)
T ss_pred CcC
Confidence 864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=171.88 Aligned_cols=159 Identities=36% Similarity=0.538 Sum_probs=128.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++|+|++++++.+. +...++++|++++++|.+++.... ..+++..+..++.+++.++.+||+.|++|+||+|.||
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni 129 (225)
T smart00221 51 LKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG-GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENI 129 (225)
T ss_pred HHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 35678999999999884 467899999999999999998632 1289999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ ..++|+|||.+....... ......++..|++||.+. ....++.++|+|+||+++++|++|+.||.
T Consensus 130 ~v~~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-------~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 130 LLGMD-GLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLL-------GGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred EEcCC-CCEEEeeCceeeEecCcccccccceeccCCcCCHhHhc-------CCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 99965 569999999887654432 223446677899999873 12566679999999999999999999997
Q ss_pred C-CCcHHHHHHH
Q 024401 159 G-MSNLQAAYAA 169 (268)
Q Consensus 159 ~-~~~~~~~~~~ 169 (268)
. ..+.......
T Consensus 202 ~~~~~~~~~~~~ 213 (225)
T smart00221 202 GEGEFTSLLSDV 213 (225)
T ss_pred ccchhHHHHHHH
Confidence 6 3443333333
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=175.35 Aligned_cols=204 Identities=26% Similarity=0.361 Sum_probs=155.6
Q ss_pred CCCCcccceeeeeec----------------------------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHH
Q 024401 5 VKHDNLVKFLGACKD----------------------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 56 (268)
Q Consensus 5 l~Hp~i~~~~~~~~~----------------------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ 56 (268)
-+|||||+++.+|-| ..+|+||...+. +|..|+.. ...+.....-++.
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~la 348 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVILA 348 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHHH
Confidence 379999999886522 147899999955 99999975 4577888899999
Q ss_pred HHHHHHHHHHhCCCeecCCCCCCEEEcCCC---CceEEeccCCcccCcc-------cccccCccCccceecccccccccc
Q 024401 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKLADFGLAREETV-------TEMMTAETGTYRWMAPELYSTVTL 126 (268)
Q Consensus 57 ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~---~~~~l~Dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~ 126 (268)
|+++|+.|||++|+.|||+|.+|||+.-+. ..+.|.|||.+-.... ........|....+|||.....+-
T Consensus 349 QlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG 428 (598)
T KOG4158|consen 349 QLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG 428 (598)
T ss_pred HHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence 999999999999999999999999995322 2578999998753221 111123357788999998875321
Q ss_pred ccccccC-CCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 127 RQGEKKH-YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 127 ~~~~~~~-~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.... .-.++|.|+.|.+.||++....||++....-...........+.+++.++..+++++...|+.||++|+|..
T Consensus 429 ---p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 429 ---PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred ---CceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 1111 124899999999999999999999875443333333445667889999999999999999999999999977
Q ss_pred HHHHHHHhhh
Q 024401 206 QIIRMLNAFL 215 (268)
Q Consensus 206 ~~l~~l~~~~ 215 (268)
-..+.|+-.+
T Consensus 506 iAANvl~LsL 515 (598)
T KOG4158|consen 506 IAANVLNLSL 515 (598)
T ss_pred HHHhHHHHHH
Confidence 7666665543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-24 Score=177.63 Aligned_cols=76 Identities=33% Similarity=0.484 Sum_probs=69.2
Q ss_pred CCCcccceeeeee-----cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCC
Q 024401 6 KHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDN 79 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~N 79 (268)
.-.+||++++.|. +.++++|+|++ |.+|-.+|.....++++...+.+|++|++.||.|||+. ||+|-||||+|
T Consensus 140 ~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPEN 218 (590)
T KOG1290|consen 140 GKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPEN 218 (590)
T ss_pred CCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcce
Confidence 3457999999883 34799999999 88999999988889999999999999999999999986 99999999999
Q ss_pred EEE
Q 024401 80 LLL 82 (268)
Q Consensus 80 il~ 82 (268)
||+
T Consensus 219 vLl 221 (590)
T KOG1290|consen 219 VLL 221 (590)
T ss_pred eee
Confidence 998
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.6e-23 Score=171.65 Aligned_cols=202 Identities=24% Similarity=0.327 Sum_probs=159.1
Q ss_pred Ccccceeeee--ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCC
Q 024401 8 DNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 85 (268)
Q Consensus 8 p~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~ 85 (268)
+++..+++.. .+.+.++||+.+ |.+|.++.....++.++..++++|+.|++.+|.+||+.|++||||||.|+++...
T Consensus 80 ~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~ 158 (322)
T KOG1164|consen 80 SHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQS 158 (322)
T ss_pred CCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCC
Confidence 5888888887 355789999999 9999999877666889999999999999999999999999999999999999855
Q ss_pred C----CceEEeccCCcc--cCcccc--------c-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 86 Q----KSLKLADFGLAR--EETVTE--------M-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 86 ~----~~~~l~Dfg~~~--~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
. ..+.|.|||+++ ...... . .....||..|+++..+.+ ...+.+.|+||+++++.++
T Consensus 159 ~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~--------~e~~r~DDles~~Y~l~el 230 (322)
T KOG1164|consen 159 SRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG--------IEQGRRDDLESLFYMLLEL 230 (322)
T ss_pred CCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCC--------CccCCchhhhhHHHHHHHH
Confidence 3 468999999998 321111 1 123459999999998854 7778999999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHH--HHhhcCCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 151 LTNRLPFEGMSNLQAAYAA--AFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~--~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+.|..||............ ........ .....+.++.++...+-..+...+|++..+...|.......
T Consensus 231 ~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 231 LKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 9999999766543222111 11111111 33446677888888888899999999999999988877654
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-24 Score=173.57 Aligned_cols=196 Identities=26% Similarity=0.400 Sum_probs=148.2
Q ss_pred CCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
.+.||+++.+++ ..+...+|+||++.....+++.. ++..++..+++.++.||+++|..||+||||||+|++.+.
T Consensus 93 G~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~ 167 (418)
T KOG1167|consen 93 GSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNR 167 (418)
T ss_pred cchhhhcchhhhccCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccc
Confidence 478899999987 46678999999999999999875 789999999999999999999999999999999999997
Q ss_pred CCCceEEeccCCcccCcc--------c-------c----------------c--------------ccCccCccceeccc
Q 024401 85 DQKSLKLADFGLAREETV--------T-------E----------------M--------------MTAETGTYRWMAPE 119 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~--------~-------~----------------~--------------~~~~~~~~~y~aPE 119 (268)
..+.-.|+|||++..... . . . .....||++|.|||
T Consensus 168 ~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPE 247 (418)
T KOG1167|consen 168 RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPE 247 (418)
T ss_pred ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchH
Confidence 777789999999861000 0 0 0 00125899999999
Q ss_pred cccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc-HHHHHHH-----------------------------
Q 024401 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAA----------------------------- 169 (268)
Q Consensus 120 ~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~-~~~~~~~----------------------------- 169 (268)
++.. ...-+.+.||||.|+|+..++++..||....+ .......
T Consensus 248 vL~k-------~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~ 320 (418)
T KOG1167|consen 248 VLFR-------CPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPT 320 (418)
T ss_pred HHhh-------ccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccc
Confidence 9874 35557799999999999999999999842221 0000000
Q ss_pred ------HHhhc--------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 170 ------AFKHA--------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 170 ------~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.+... .....+.++..+.+++.+|+..||.+|.|+++.|+ +.++
T Consensus 321 ~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk--HpFF 384 (418)
T KOG1167|consen 321 IPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK--HPFF 384 (418)
T ss_pred cHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc--CcCC
Confidence 00000 00111234557899999999999999999999997 4444
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-24 Score=188.88 Aligned_cols=203 Identities=25% Similarity=0.374 Sum_probs=154.7
Q ss_pred CCCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 3 SRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+.++|||++..+..+.+. ...-.||||++ +|..++.. ...+...++..++.|++.|+.|+|..||.|+|+|++|++
T Consensus 376 ~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll 452 (601)
T KOG0590|consen 376 SSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLL 452 (601)
T ss_pred ccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEE
Confidence 468999998877766332 22334999999 99999986 246899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccc-----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
+..+ +.++|+|||.+...... .......|+..|+|||.+.+ ........||||.|++++.|.+|+.|
T Consensus 453 ~~~~-g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~-------~~ydpr~vDiwS~~ii~~~m~~~~~~ 524 (601)
T KOG0590|consen 453 VTEN-GILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTG-------KEYDPRAVDVWSCGIIYICMILGRFP 524 (601)
T ss_pred EecC-CceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccc-------cccCcchhhhhhccceEEEEecCCCc
Confidence 9965 46999999988643221 33455688999999999975 23334578999999999999999999
Q ss_pred CCCCCcHHHHHHHH-H------hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 157 FEGMSNLQAAYAAA-F------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 157 ~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|......+..+... . ......+...++...+.++.+||+.+|.+|.|+++|++ ..|+.+.
T Consensus 525 Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~--d~W~~~i 591 (601)
T KOG0590|consen 525 WKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN--DEWIRSI 591 (601)
T ss_pred cccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh--ChHhhhc
Confidence 96544332221110 0 01111122357788999999999999999999999998 6666544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-22 Score=157.05 Aligned_cols=202 Identities=29% Similarity=0.487 Sum_probs=162.8
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dlk~~ 78 (268)
|+-+.||||+.++++|+. ..+.+|..|++.|+|...+.....--++..++.+++..++.|++|||+.. |.---|+..
T Consensus 241 lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~ 320 (448)
T KOG0195|consen 241 LRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSK 320 (448)
T ss_pred eeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccc
Confidence 345689999999999954 47899999999999999998754555788999999999999999999874 333457788
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++++.+ ...+|+ ++-++. .-........+.|++||.+... .......++|+|||++++|||.|...||.
T Consensus 321 hvmided-ltaris-mad~kf---sfqe~gr~y~pawmspealqrk-----ped~n~raadmwsfaillwel~trevpfa 390 (448)
T KOG0195|consen 321 HVMIDED-LTARIS-MADTKF---SFQEVGRAYSPAWMSPEALQRK-----PEDLNIRAADMWSFAILLWELNTREVPFA 390 (448)
T ss_pred eEEecch-hhhhee-ccccee---eeeccccccCcccCCHHHHhcC-----chhcchhhhhHHHHHHHHHHhhccccccc
Confidence 8999854 334432 111111 1112334567889999998642 22344568999999999999999999999
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
+.++.+-..+....+.+..+|..++..+..++.-|+..||.+||.+++++-.|+.
T Consensus 391 dlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 391 DLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred cCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHH
Confidence 9999888888899999999999999999999999999999999999999887765
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-23 Score=186.90 Aligned_cols=200 Identities=23% Similarity=0.248 Sum_probs=144.7
Q ss_pred CCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.++|||++++.-+- .+...|+|=+|+.+ +|+|.+..+ .-+...+...|+.||+.||..+|+.||+|||||.+|||+
T Consensus 77 l~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 77 LMKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred hhcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 46899999988875 56678999999955 999999763 237788899999999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCcc--------cccccCccCccceeccccccccc--cccccccC-CCcccchHHHHHHHHHHH
Q 024401 83 TPDQKSLKLADFGLAREETV--------TEMMTAETGTYRWMAPELYSTVT--LRQGEKKH-YNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~--------~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~-~~~~~Di~slG~i~~~ll 151 (268)
+.-+. +.|+||...+..-. .-...+.....+|+|||...... ........ .+++.||||+||++.||+
T Consensus 154 TSWNW-~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf 232 (1431)
T KOG1240|consen 154 TSWNW-LYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF 232 (1431)
T ss_pred eeech-hhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence 97765 89999997753211 11123334567899999876522 12222222 678999999999999999
Q ss_pred h-CCCCCCCCCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 152 T-NRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
+ |+++|.-. +...+.......++ +..--+..++.++..|++.||++|.|++++++.
T Consensus 233 ~Eg~PlF~LS---QL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 233 LEGRPLFTLS---QLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hcCCCcccHH---HHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 8 78888521 10000000000000 001123368999999999999999999999985
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=167.78 Aligned_cols=212 Identities=33% Similarity=0.512 Sum_probs=160.3
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-eecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI-IHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i-~H~dlk~~N 79 (268)
|+.+.|.|+.+++|.+ .++..+.|.+||..|+|.|.+.. ....++.--...++..++.|++|+|...| .||.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 6789999999999998 45678999999999999999987 45668888889999999999999999876 999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
++++ ....+||+|||+....... ..........-|.|||.+....... .....+.+.||||+|++++|+++...|
T Consensus 80 Clvd-~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~-~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 80 CLVD-SRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQS-LESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ceee-eeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccccccc-ccccccccCCeehHHHHHHHHHhccCc
Confidence 9999 6688999999988754321 1111122345689999986522111 112357789999999999999999999
Q ss_pred CCCCCcH---HHHHHHHHh-hc---CCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 157 FEGMSNL---QAAYAAAFK-HA---RPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 157 ~~~~~~~---~~~~~~~~~-~~---~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|...... .+....... .. +|.+. ..+.+++..++++||..+|..||+++++-..+.....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9753322 222222222 11 22222 1355579999999999999999999999887776554
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.2e-20 Score=146.58 Aligned_cols=205 Identities=20% Similarity=0.336 Sum_probs=162.3
Q ss_pred CCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc-
Q 024401 6 KHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT- 83 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~- 83 (268)
..++|...+-+.+++ +-.+|+|.+ |.+|.|++.- ..+.|+..+++.++.|++.-++++|++.+|+|||||+|+||.
T Consensus 82 g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGr 159 (449)
T KOG1165|consen 82 GTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGR 159 (449)
T ss_pred CCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecC
Confidence 357787777776544 678999999 9999998864 678899999999999999999999999999999999999995
Q ss_pred ---CCCCceEEeccCCcccCccccc--------ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 84 ---PDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 84 ---~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
++...+.++|||+++.+..... .....||..||+--...+ ..-+.+.|+-|||-++++.+.
T Consensus 160 p~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlG--------rEQSRRDDLEaLGHvFmYFLR 231 (449)
T KOG1165|consen 160 PGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLG--------REQSRRDDLEALGHVFMYFLR 231 (449)
T ss_pred CCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeecccc--------chhhhhhhHHHhhhhhhhhcc
Confidence 3444689999999986543322 234479999999887765 667889999999999999999
Q ss_pred CCCCCCCCC--cHHHHHHHHHhhcCCC----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 153 NRLPFEGMS--NLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 153 g~~p~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|..||.+.. ...+.++.+....+.. +...+|.++..-+...=..+-.+-|+++-+...+..++..+-.
T Consensus 232 GsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 232 GSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred CCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 999998644 3334444433333322 2356888888888888889999999999999999888765543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-19 Score=151.18 Aligned_cols=204 Identities=32% Similarity=0.468 Sum_probs=156.1
Q ss_pred CCCCCCC-cccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHD-NLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp-~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+..+.|+ +|+++++.+... ..+++++++.++++.+++..... ..++...+..++.|++.++.++|+.|++|||+||+
T Consensus 51 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~ 130 (384)
T COG0515 51 LASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPE 130 (384)
T ss_pred HHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHH
Confidence 3567777 799999998544 46999999999999977765221 26999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||+++..+..++++|||.+....... ......++..|++||.+.... ........|+|++|+++++++
T Consensus 131 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~-----~~~~~~~~D~~s~g~~~~~~~ 205 (384)
T COG0515 131 NILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLS-----LAYASSSSDIWSLGITLYELL 205 (384)
T ss_pred HeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCC-----CCCCCchHhHHHHHHHHHHHH
Confidence 99999665468999999987443322 235668999999999885310 146778999999999999999
Q ss_pred hCCCCCCCCCc---HHHHHHHHHhhcCC----CCCCCC----cHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 152 TNRLPFEGMSN---LQAAYAAAFKHARP----GLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 152 ~g~~p~~~~~~---~~~~~~~~~~~~~~----~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
.|..||..... .............+ ...... ...+.+++..++..+|..|.+..+....
T Consensus 206 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 206 TGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred hCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 99999876654 23333333322222 111222 2578999999999999999988877764
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.2e-21 Score=155.47 Aligned_cols=169 Identities=22% Similarity=0.341 Sum_probs=110.6
Q ss_pred ceEEEEcCCCCCHHHHHhh---hCCC--CCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCC
Q 024401 22 MVIVTELLPGMSLRKYLVS---LRPN--KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 96 (268)
Q Consensus 22 ~~lv~e~~~~~~L~~~~~~---~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~ 96 (268)
.+++|+-. .++|.+++.. .... .........+..|++..+++||..|++|+||+|+|++++.++ .+.|+||+.
T Consensus 114 ~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v~Lg~F~~ 191 (288)
T PF14531_consen 114 RFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG-GVFLGDFSS 191 (288)
T ss_dssp EEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS--EEE--GGG
T ss_pred hhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC-CEEEcChHH
Confidence 46889988 5599998653 2222 123334456678999999999999999999999999999765 599999998
Q ss_pred cccCcccccccCccCccceeccccccccc-cccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcC
Q 024401 97 AREETVTEMMTAETGTYRWMAPELYSTVT-LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175 (268)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~ 175 (268)
....+..... ...+..|.+||...... ... ....++.+.|.|+||+++|.|+++..||........... ..
T Consensus 192 ~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~-~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-----~f 263 (288)
T PF14531_consen 192 LVRAGTRYRC--SEFPVAFTPPELESCAGQFGQ-NNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-----DF 263 (288)
T ss_dssp EEETTEEEEG--GGS-TTTS-HHHHHHHTSCHH-SEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-----GG
T ss_pred HeecCceeec--cCCCcccCChhhhhhhcccCc-ccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-----cc
Confidence 7766554433 33457789999764321 011 234678899999999999999999999975543221110 22
Q ss_pred CCCCCCCcHHHHHHHHHhhhhCCCCC
Q 024401 176 PGLPEDISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 176 ~~~~~~~~~~l~~li~~~l~~~p~~R 201 (268)
..+. ++++.++.||..+|+.+|.+|
T Consensus 264 ~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 264 SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 2344 899999999999999999887
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=138.95 Aligned_cols=201 Identities=22% Similarity=0.319 Sum_probs=153.7
Q ss_pred ccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC--CC
Q 024401 10 LVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP--DQ 86 (268)
Q Consensus 10 i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~--~~ 86 (268)
|.++..+. +..+-.+||+.. |.+|.+++.= ..+.|+..+++-++-|++.-++|+|.++++||||||+|+|..- -.
T Consensus 73 iP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~ 150 (341)
T KOG1163|consen 73 IPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHC 150 (341)
T ss_pred Cchhhhhccccccceeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccccc
Confidence 44444444 344678999999 9999998763 5678999999999999999999999999999999999999863 33
Q ss_pred CceEEeccCCcccCccccc--------ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 87 KSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 87 ~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
..+.|+|||+++..-.... .....||..|.+-..+.+ ..-+.+.|+-|+|+++.++-.|..||.
T Consensus 151 ~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g--------~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 151 NKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLG--------IEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred ceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhh--------hhhhhhhhhhhhcceeeeeecCCCccc
Confidence 4688999999985432211 123368899998776654 555789999999999999999999998
Q ss_pred CCCcHHHH-HHHHHhhcCCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 159 GMSNLQAA-YAAAFKHARPG-----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 159 ~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
+....... ....+...... ..+.+|.+..-.+..|=...-++-|++..+.+.+..++..+..
T Consensus 223 glka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred ccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 76532211 11122222222 2357889999999999999999999999999999888866643
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.7e-20 Score=156.45 Aligned_cols=184 Identities=29% Similarity=0.440 Sum_probs=151.5
Q ss_pred CCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
.||.++++.-.+ .++..+++.++..||.|...+.. ...+++.....+...++-+++++|+.|++|+|+|++||+++.
T Consensus 55 ~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~ 132 (612)
T KOG0603|consen 55 NTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL 132 (612)
T ss_pred CCCceeeeeeeeccccchhHhhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc
Confidence 389999999887 57789999999999999888765 455888999999999999999999999999999999999997
Q ss_pred CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHH
Q 024401 85 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~ 164 (268)
++. +++.|||+++........ +|+.-|+|||.++ ....+.|.||+|+++++|++|..||.. +
T Consensus 133 ~Gh-i~~tdfglske~v~~~~~---cgt~eymApEI~~----------gh~~a~D~ws~gvl~felltg~~pf~~----~ 194 (612)
T KOG0603|consen 133 EGH-IKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN----------GHLSAADWWSFGVLAFELLTGTLPFGG----D 194 (612)
T ss_pred cCc-cccCCchhhhHhHhhhhc---ccchhhhhhHhhh----------ccCCcccchhhhhhHHHHhhCCCCCch----H
Confidence 754 999999999865444332 8899999999985 246689999999999999999999986 1
Q ss_pred HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH--HHHHHHH
Q 024401 165 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF--SQIIRML 211 (268)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~--~~~l~~l 211 (268)
. . ..+......+|...+..+++++.+++..+|..|.-. ..+.+..
T Consensus 195 ~-~-~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik 241 (612)
T KOG0603|consen 195 T-M-KRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIK 241 (612)
T ss_pred H-H-HHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHh
Confidence 1 1 223334556778899999999999999999999633 3444433
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=9.4e-20 Score=153.69 Aligned_cols=169 Identities=31% Similarity=0.489 Sum_probs=127.2
Q ss_pred CceEEEEcCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 21 LMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 21 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
++||.|++|.-.+|.+++...+ ...-+....+.++.|++.|+.| +|.+|+|+||.||+...+ ..++|+|||+...
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d-~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDD-DQLKIGDFGLVTS 405 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccc-hhhhhhhhhheee
Confidence 5889999999999999997533 2457788899999999999999 999999999999999855 4699999999875
Q ss_pred Ccccc-------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 024401 100 ETVTE-------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 171 (268)
Q Consensus 100 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~ 171 (268)
..... ......||.+|++||.+.+ ..|+.++||||||++++|++. -..+++. ........
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--------~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r 473 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRG--------QQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIR 473 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhh--------hhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhh
Confidence 54433 3345579999999999964 889999999999999999997 2222211 11111222
Q ss_pred hhcCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 024401 172 KHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206 (268)
Q Consensus 172 ~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 206 (268)
.+..+ .+-.+++. -..|+.+++.++|..||++.+
T Consensus 474 ~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHHH
Confidence 22222 22233333 447999999999999994443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4e-18 Score=143.13 Aligned_cols=111 Identities=26% Similarity=0.267 Sum_probs=83.1
Q ss_pred CCCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC-CCCC
Q 024401 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL-KPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl-k~~N 79 (268)
+|++++|+||++.+..+ +..|+||||++|++|.. +.. .. ...++.+++.+|+|||+.||+|||| ||+|
T Consensus 74 iL~~L~h~~iv~~l~~~--~~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~N 142 (365)
T PRK09188 74 ALKTVRGIGVVPQLLAT--GKDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQN 142 (365)
T ss_pred HHHhccCCCCCcEEEEc--CCcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcce
Confidence 36788999998633322 45799999999999973 211 11 1467899999999999999999999 9999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc---------ccCccCccceeccccccc
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM---------MTAETGTYRWMAPELYST 123 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~~ 123 (268)
||++.+ +.++|+|||+++....... .....++..|.+||.+..
T Consensus 143 ILv~~~-~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 143 WLMGPD-GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEcCC-CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999855 4699999999985433211 123356778999998865
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-17 Score=128.09 Aligned_cols=139 Identities=18% Similarity=0.164 Sum_probs=99.6
Q ss_pred CCCCC-CCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC-CCCC
Q 024401 2 MSRVK-HDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL-KPDN 79 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl-k~~N 79 (268)
|++|. |++|++++++ +..+++|||+.|.+|...+.. ....++.|++.+|.++|+.||+|+|| ||+|
T Consensus 55 L~~L~~~~~vP~ll~~---~~~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~N 122 (218)
T PRK12274 55 LRQLDGLPRTPRLLHW---DGRHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRCGVAHNDLAKEAN 122 (218)
T ss_pred HHhcCCCCCCCEEEEE---cCEEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHCcCccCCCCCcce
Confidence 56674 4889999886 345999999999999764321 11357889999999999999999999 7999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccc--------------cCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMM--------------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
|+++.+ +.++|+|||++......... .-..+++.|++|+...-+ ......+.+.++.|+
T Consensus 123 ILv~~~-g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l------~~~~~~~~~w~~~g~ 195 (218)
T PRK12274 123 WLVQED-GSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVL------KRTSWIRELWFATGK 195 (218)
T ss_pred EEEcCC-CCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhh------ccchhHHHHHHHhcc
Confidence 999865 45999999999744332210 011356667777643211 122235667889999
Q ss_pred HHHHHHhCCCCCCC
Q 024401 146 VLWELLTNRLPFEG 159 (268)
Q Consensus 146 i~~~ll~g~~p~~~ 159 (268)
-+|.++|+..+..+
T Consensus 196 ~~~~~~~~~~~~~~ 209 (218)
T PRK12274 196 PVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHhccCCccc
Confidence 99999998877543
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=7.1e-18 Score=132.26 Aligned_cols=119 Identities=17% Similarity=0.316 Sum_probs=88.7
Q ss_pred CCCCCCCcccceeeeee---------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACK---------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
+.++.||+|..+.+++. ++..+++|||++|.+|.++.. +++ ....+++.+|..+|+.|++|
T Consensus 89 l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~gi~H 158 (232)
T PRK10359 89 TDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHGMVS 158 (232)
T ss_pred HHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcCCcc
Confidence 35678999999888752 235789999999999988732 333 34569999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||++|+||+++.++ ++|+|||............. ... ...+..++|+|+||+++..+.
T Consensus 159 ~Dikp~Nili~~~g--i~liDfg~~~~~~e~~a~d~-----------~vl--------er~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 159 GDPHKGNFIVSKNG--LRIIDLSGKRCTAQRKAKDR-----------IDL--------ERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCChHHEEEeCCC--EEEEECCCcccccchhhHHH-----------HHH--------HhHhcccccccceeEeehHHH
Confidence 99999999998654 99999998865432211111 111 133456899999999987664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=146.15 Aligned_cols=177 Identities=23% Similarity=0.281 Sum_probs=134.7
Q ss_pred cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc------CCCCceEEe
Q 024401 19 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT------PDQKSLKLA 92 (268)
Q Consensus 19 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~------~~~~~~~l~ 92 (268)
.+..++|+||.+.|+|.+++.. .+.+++..+..++.|++..+.+||..+||||||||+|+++. .+...++|+
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred CCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 3456899999999999999984 57799999999999999999999999999999999999994 233458999
Q ss_pred ccCCcccCc---ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 024401 93 DFGLAREET---VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 169 (268)
Q Consensus 93 Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~ 169 (268)
|||.+..+. .+......++|-.+-.+|+..+ ..+++..|.|.|+.+++.|+.|+.--
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g--------rpWtYq~DyfGlAa~~h~mLFG~y~q------------ 903 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG--------RPWTYQIDYFGLAATVHVMLFGKYME------------ 903 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcC--------CCCchhhhhHHHHHHHHHHHHHHHHH------------
Confidence 999886432 2334566788999999999864 88999999999999999999986531
Q ss_pred HHhhcCCC----CCCCCcHH-HHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 170 AFKHARPG----LPEDISPD-LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 170 ~~~~~~~~----~~~~~~~~-l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
...+.... ++.-+-.+ +-+++..+|..+-..=|...++...|+.++..
T Consensus 904 ~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~ 956 (974)
T KOG1166|consen 904 VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE 956 (974)
T ss_pred hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence 11111111 11122222 44677888885544447888888888777654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.9e-17 Score=124.85 Aligned_cols=75 Identities=24% Similarity=0.275 Sum_probs=64.2
Q ss_pred ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccC
Q 024401 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 22 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
.++||||++|+++...... ...+++.++..++.|++.+|.++ |+.||+||||||+||+++ + +.++|+|||++...
T Consensus 92 ~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D-GKLYIIDVSQSVEH 167 (190)
T ss_pred CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C-CcEEEEEccccccC
Confidence 3899999988877655432 35689999999999999999999 799999999999999998 3 45999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=5e-16 Score=121.28 Aligned_cols=87 Identities=14% Similarity=0.275 Sum_probs=69.0
Q ss_pred CCCcccceeeeeecC----Cce-EEEEc--CCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCeecCCCC
Q 024401 6 KHDNLVKFLGACKDP----LMV-IVTEL--LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAM-DCLHANGIIHRDLKP 77 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~~----~~~-lv~e~--~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l-~~lH~~~i~H~dlk~ 77 (268)
.||||+++++++.++ ..+ +|+|| +.+++|.+++.. ..+++. ..++.+++.++ +|||+++|+|+||||
T Consensus 59 ~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp 133 (210)
T PRK10345 59 DWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKP 133 (210)
T ss_pred CCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence 689999999998544 333 78999 447999999975 236665 35678888777 999999999999999
Q ss_pred CCEEEcCC---CCceEEeccCCc
Q 024401 78 DNLLLTPD---QKSLKLADFGLA 97 (268)
Q Consensus 78 ~Nil~~~~---~~~~~l~Dfg~~ 97 (268)
+||+++.. +..++|+||+.+
T Consensus 134 ~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 134 QNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHEEEeccCCCCCcEEEEECCCC
Confidence 99999742 236999995544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.6e-16 Score=119.32 Aligned_cols=92 Identities=21% Similarity=0.144 Sum_probs=70.9
Q ss_pred CCCCCcccceeeeeecCCceEEEEcCCCCCHHHH-HhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCEE
Q 024401 4 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKY-LVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLL 81 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~-~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~Nil 81 (268)
++.|++|.....+... ..++||||++|+++... +. ...++..++..++.|++.++.++|. .||+|+||||+||+
T Consensus 75 ~l~~~~i~~p~~~~~~-~~~lVmE~~~g~~~~~~~l~---~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIl 150 (190)
T cd05145 75 RLYEAGVPVPEPILLK-KNVLVMEFIGDDGSPAPRLK---DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNIL 150 (190)
T ss_pred HHHhCCCCCceEEEec-CCEEEEEEecCCCchhhhhh---hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEE
Confidence 4556665443333222 34899999988755443 33 2457889999999999999999999 99999999999999
Q ss_pred EcCCCCceEEeccCCcccCc
Q 024401 82 LTPDQKSLKLADFGLAREET 101 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~ 101 (268)
++ + +.++|+|||++....
T Consensus 151 l~-~-~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-D-GKPYIIDVSQAVELD 168 (190)
T ss_pred EE-C-CCEEEEEcccceecC
Confidence 98 4 459999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=8.3e-16 Score=139.14 Aligned_cols=135 Identities=32% Similarity=0.507 Sum_probs=105.6
Q ss_pred HHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcc----------------cccccCccCccceecccccc
Q 024401 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV----------------TEMMTAETGTYRWMAPELYS 122 (268)
Q Consensus 59 ~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~----------------~~~~~~~~~~~~y~aPE~~~ 122 (268)
+.+++|||+.||+|+|+||+|.+|+.- +.+|++|||+++.... .-......||+.|+|||++.
T Consensus 153 vla~Eylh~ygivhrdlkpdnllIT~m-GhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVil 231 (1205)
T KOG0606|consen 153 VLAVEYLHSYGIVHRDLKPDNLLITSM-GHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVIL 231 (1205)
T ss_pred hHHhHhhccCCeecCCCCCCcceeeec-ccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhh
Confidence 889999999999999999999999955 4599999999863211 01123457999999999986
Q ss_pred ccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 024401 123 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 123 ~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 201 (268)
- ..|....|.|++|+|+|+.+-|..||.+.+..+..-..+ ....+++--..++.++++++.++|+.+|..|
T Consensus 232 r--------qgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~R 303 (1205)
T KOG0606|consen 232 R--------QGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCR 303 (1205)
T ss_pred h--------hccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhh
Confidence 4 667889999999999999999999998866533322222 1223333345688999999999999999999
Q ss_pred C
Q 024401 202 P 202 (268)
Q Consensus 202 p 202 (268)
.
T Consensus 304 l 304 (1205)
T KOG0606|consen 304 L 304 (1205)
T ss_pred c
Confidence 5
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.58 E-value=2.4e-16 Score=140.78 Aligned_cols=196 Identities=27% Similarity=0.343 Sum_probs=154.3
Q ss_pred CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCCEEEcC
Q 024401 7 HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 7 Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~dlk~~Nil~~~ 84 (268)
|+|++++++... ....+++++|..|+++.+-+........+...+..++.|+..++.|+| ..++.|+|++|+|.+++.
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~ 159 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDE 159 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhcc
Confidence 999999999985 446889999999999999884222226788889999999999999999 999999999999999996
Q ss_pred CCCceEEeccCCcccCcc----cccccCccC-ccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 85 DQKSLKLADFGLAREETV----TEMMTAETG-TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~----~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
++...++.|||++..... ........| ++.|.|||.... ........|+||.|+++..+++|..||..
T Consensus 160 s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~-------~~~~~~~~d~~S~g~~l~~~~~g~~p~~~ 232 (601)
T KOG0590|consen 160 SGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSG-------KAYRGPSVDVWSLGIVLSAMLTGELPWDF 232 (601)
T ss_pred CCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccc-------hhhcCCCcccccccccccccccCCCCccc
Confidence 653689999999985544 222344567 999999999864 14556789999999999999999999976
Q ss_pred CCcHHHHHHHHHhhc---CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHA---RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.......+..+.... .......++....+++..++..+|..|.+.+++-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 233 PSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 554443322222221 12334568888999999999999999999998865
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.7e-14 Score=111.76 Aligned_cols=89 Identities=30% Similarity=0.443 Sum_probs=73.9
Q ss_pred CCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 3 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
..+.|++|.....++ ..+..+++|||++|++|.+++... .. ++..++.+++.+|.++|+.|++|+|++|.||+
T Consensus 54 ~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil 127 (211)
T PRK14879 54 SRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMI 127 (211)
T ss_pred HHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEE
Confidence 456678877666554 455679999999999999998652 12 88999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCccc
Q 024401 82 LTPDQKSLKLADFGLARE 99 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~ 99 (268)
++ + +.++|+|||.+..
T Consensus 128 ~~-~-~~~~liDf~~a~~ 143 (211)
T PRK14879 128 LS-G-GKIYLIDFGLAEF 143 (211)
T ss_pred EE-C-CCEEEEECCcccC
Confidence 98 3 4589999998754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.9e-13 Score=117.24 Aligned_cols=134 Identities=17% Similarity=0.268 Sum_probs=104.9
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~dlk~~N 79 (268)
|+.++||||+++++.+ .++..|+|+|.+ . .|..++.+ +....+...+.||+.||.||| +.+++|++|.-..
T Consensus 63 lKtlRHP~Il~yL~t~e~~~~~ylvTErV-~-Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~S 135 (690)
T KOG1243|consen 63 LKTLRHPNILSYLDTTEEEGTLYLVTERV-R-PLETVLKE-----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDS 135 (690)
T ss_pred hhhccCchhhhhhhhhcccCceEEEeecc-c-cHHHHHHH-----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeee
Confidence 6789999999999998 567899999998 3 88888876 447778888999999999998 5689999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
|+++.++ ..+|++|.++........ .....-...|..|+.+.. ..-..|.|.|||++++++.|
T Consensus 136 VfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~----------s~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 136 VFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP----------SEWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred EEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc----------cccchhhhhHHHHHHHHhCc
Confidence 9999665 589999988864433221 122223345777776531 12457999999999999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.4e-14 Score=113.48 Aligned_cols=75 Identities=24% Similarity=0.297 Sum_probs=63.5
Q ss_pred CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 21 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
..++||||+.|++|..+... ...+...++..++.|++.++++||+.| ++|+||||+||+++ + +.++|+|||.+..
T Consensus 122 ~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~-~~i~LiDFg~a~~ 197 (237)
T smart00090 122 RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D-GKVVIIDVSQSVE 197 (237)
T ss_pred CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C-CCEEEEEChhhhc
Confidence 45899999999888776532 234667778899999999999999999 99999999999998 4 4699999998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.47 E-value=9.2e-14 Score=124.11 Aligned_cols=86 Identities=26% Similarity=0.371 Sum_probs=73.2
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++|++|+....++ .....++||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||
T Consensus 390 l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NI 459 (535)
T PRK09605 390 LSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNF 459 (535)
T ss_pred HHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHE
Confidence 4567899988876665 3446789999999999999885 3467899999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCccc
Q 024401 81 LLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~ 99 (268)
+++ + +.++|+|||+++.
T Consensus 460 Ll~-~-~~~~liDFGla~~ 476 (535)
T PRK09605 460 IVR-D-DRLYLIDFGLGKY 476 (535)
T ss_pred EEE-C-CcEEEEeCccccc
Confidence 995 3 4599999998865
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.6e-14 Score=113.88 Aligned_cols=190 Identities=21% Similarity=0.289 Sum_probs=129.5
Q ss_pred CCCCCcccceeeeeecC------CceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC--Ceec
Q 024401 4 RVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANG--IIHR 73 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~ 73 (268)
++-|.||+++..+|.|. +..+++||+..|++..++++.+ ...+....-.+|+-||++||.|||+.. |+|+
T Consensus 123 qlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihg 202 (458)
T KOG1266|consen 123 QLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHG 202 (458)
T ss_pred HHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccC
Confidence 45799999999988443 5789999999999999998743 345777788899999999999999984 9999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccC-----cccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREE-----TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
++....|++..++. +++.--.-.... ..........+.++|.+||.=. ....+-++|||++|....
T Consensus 203 nlTc~tifiq~ngL-Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~--------~tn~~~a~dIy~fgmcAl 273 (458)
T KOG1266|consen 203 NLTCDTIFIQHNGL-IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGT--------TTNTTGASDIYKFGMCAL 273 (458)
T ss_pred CcchhheeecCCce-EEecccCccccchhhhhhhHhhhhccccCCccccCCcCc--------ccccccchhhhhhhHHHH
Confidence 99999999996643 554322111110 0011122235677899998532 244566899999999999
Q ss_pred HHHhCCCCCCCC-Cc--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 149 ELLTNRLPFEGM-SN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 149 ~ll~g~~p~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+|..+...-... +. .++....... ..-...-++++..|++.+|..||++.+++-
T Consensus 274 emailEiq~tnseS~~~~ee~ia~~i~-------~len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 274 EMAILEIQSTNSESKVEVEENIANVII-------GLENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HHHHheeccCCCcceeehhhhhhhhee-------eccCccccCcCcccccCCCCCCcchhhhhc
Confidence 998765432111 11 1111111110 111122356889999999999999999876
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.8e-13 Score=109.53 Aligned_cols=90 Identities=26% Similarity=0.357 Sum_probs=69.1
Q ss_pred CCCCCCCcc--cceeeee--ecCC---ceEEEEcCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 2 MSRVKHDNL--VKFLGAC--KDPL---MVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 2 l~~l~Hp~i--~~~~~~~--~~~~---~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
+.++.|++| ++.+++. .... .++|||+++| .+|.+++.. ..+++. .+.+++.+|.+||+.||+|+
T Consensus 94 l~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~----~~~~i~~~l~~lH~~GI~Hr 166 (239)
T PRK01723 94 LAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE---APLSEE----QWQAIGQLIARFHDAGVYHA 166 (239)
T ss_pred HHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc---CCCCHH----HHHHHHHHHHHHHHCCCCCC
Confidence 345677774 5666654 2222 3599999997 699999864 345554 35789999999999999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCccc
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
||||.|||++.++ .++|+|||.+..
T Consensus 167 Dlkp~NILv~~~~-~v~LIDfg~~~~ 191 (239)
T PRK01723 167 DLNAHNILLDPDG-KFWLIDFDRGEL 191 (239)
T ss_pred CCCchhEEEcCCC-CEEEEECCCccc
Confidence 9999999998654 699999998865
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.2e-13 Score=107.72 Aligned_cols=86 Identities=28% Similarity=0.397 Sum_probs=67.7
Q ss_pred CCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 3 SRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
..+.|+++.....++ .++..+++|||++|++|.+++.... . .++.+++.+|.+||+.|++|+|++|.||+
T Consensus 52 ~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil 122 (199)
T TIGR03724 52 SRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---D------ELLREIGRLVGKLHKAGIVHGDLTTSNII 122 (199)
T ss_pred HHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH---H------HHHHHHHHHHHHHHHCCeecCCCCcceEE
Confidence 345666544433332 4456799999999999999876411 1 88999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCccc
Q 024401 82 LTPDQKSLKLADFGLARE 99 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~ 99 (268)
++ + +.++++|||.+..
T Consensus 123 ~~-~-~~~~liDfg~a~~ 138 (199)
T TIGR03724 123 VR-D-DKLYLIDFGLGKY 138 (199)
T ss_pred EE-C-CcEEEEECCCCcC
Confidence 98 4 5699999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.42 E-value=2.2e-13 Score=117.30 Aligned_cols=190 Identities=28% Similarity=0.294 Sum_probs=143.5
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCeecCCCCCCE
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR----AMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~----~l~~lH~~~i~H~dlk~~Ni 80 (268)
.|+|.++.+..+. ++..++-+|++ +.+|..+... ...-++...++.++.+... ||.++|..+++|.|++|.||
T Consensus 176 ~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i 253 (524)
T KOG0601|consen 176 SHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANI 253 (524)
T ss_pred ccccccccCcccccCCcceeeeccc-cchhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhhe
Confidence 4788888777774 55788888888 7899999876 3445888899999999999 99999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc------cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
+...+....+++|||+.......... ....+...|++||... ..++..+|+|++|.++.+..++.
T Consensus 254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~---------~l~~~~~di~sl~ev~l~~~l~~ 324 (524)
T KOG0601|consen 254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN---------GLATFASDIFSLGEVILEAILGS 324 (524)
T ss_pred ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc---------cccchHhhhcchhhhhHhhHhhc
Confidence 99977467899999999865544321 1225677899999986 56788999999999999988875
Q ss_pred CCCCCC--CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 155 LPFEGM--SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 155 ~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...... +...... ......++....+..+...+.+|++.+|..|++...+..
T Consensus 325 ~~~~~g~~~~W~~~r---~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 325 HLPSVGKNSSWSQLR---QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccccCCCCCCccccc---cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 544322 1111000 001222333456677888999999999999998877765
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=7.9e-13 Score=103.14 Aligned_cols=72 Identities=22% Similarity=0.260 Sum_probs=60.7
Q ss_pred CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 20 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
...+++|||++|++|.++... .....++.+++.++.++|+.|++|+||+|+||+++.+ +.++|+|||++..
T Consensus 104 ~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~-~~~~liDfg~~~~ 174 (198)
T cd05144 104 NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD-EKIYIIDWPQMVS 174 (198)
T ss_pred CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC-CcEEEEECCcccc
Confidence 455899999999999875431 3456788999999999999999999999999999864 5699999999865
Q ss_pred C
Q 024401 100 E 100 (268)
Q Consensus 100 ~ 100 (268)
.
T Consensus 175 ~ 175 (198)
T cd05144 175 T 175 (198)
T ss_pred C
Confidence 4
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.5e-10 Score=95.24 Aligned_cols=194 Identities=19% Similarity=0.308 Sum_probs=135.4
Q ss_pred ceEEEEcCCCC-CHHHHHhh-hC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCC
Q 024401 22 MVIVTELLPGM-SLRKYLVS-LR---PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 96 (268)
Q Consensus 22 ~~lv~e~~~~~-~L~~~~~~-~~---~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~ 96 (268)
.-+.|+.+.|. .+.+++.. .+ .....+.-.++++..++.+.+-||+.|.+-||++++|+|++.+ ..|.|+|-..
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~-~~V~LVdsDs 163 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDD-SKVVLVDSDS 163 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecC-ceEEEEcccc
Confidence 56889999874 55555432 11 1337788999999999999999999999999999999999955 5588988765
Q ss_pred cccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC-CCCCCCCCc-------HHHHHH
Q 024401 97 AREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN-------LQAAYA 168 (268)
Q Consensus 97 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g-~~p~~~~~~-------~~~~~~ 168 (268)
......+.......|...|.+||.-.-. ...+..-+...|.|.||+++++++.| +.||.+..- .+....
T Consensus 164 fqi~~ng~~~~cpVg~~eftPPElQ~~~---sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 164 FQINANGTLHLCPVGVSEFTPPELQTLP---SFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred eeeccCCceEecccCccccCCHHHhccc---cccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 5444444444556788999999976421 11234556789999999999999885 899965321 110000
Q ss_pred -------HHHhhcCCC----CC-CCCcHHHHHHHHHhhhhC--CCCCCCHHHHHHHHHhhhhhcC
Q 024401 169 -------AAFKHARPG----LP-EDISPDLAFIVQSCWVED--PNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 169 -------~~~~~~~~~----~~-~~~~~~l~~li~~~l~~~--p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
........+ +| .-+++.+..++.+|+... +.-|||++..+..|..+..++.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 000011111 11 236788999999999654 5689999999988887765543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.8e-10 Score=97.05 Aligned_cols=182 Identities=18% Similarity=0.245 Sum_probs=132.7
Q ss_pred CCCCCCCcccceeeee-----ecCCceEEEEcCCC-CCHHHHHhhhC-------------CCCCCHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGAC-----KDPLMVIVTELLPG-MSLRKYLVSLR-------------PNKLDLHVALNFALDIARAM 62 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-----~~~~~~lv~e~~~~-~~L~~~~~~~~-------------~~~~~~~~~~~i~~ql~~~l 62 (268)
++++.|+|||++.+++ .|..+++|++|.++ ++|.++..... +.+.++..+|.++.||..||
T Consensus 327 wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL 406 (655)
T KOG3741|consen 327 WKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAAL 406 (655)
T ss_pred HHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHH
Confidence 5678999999999876 35579999999998 68888764421 23478899999999999999
Q ss_pred HHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 63 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 63 ~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
.++|+.|+.-+-|.+.+|+++.+. .++|+..|+........ . +.+. -..+.|.=.
T Consensus 407 ~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~d~-----------~--~~le-----------~~Qq~D~~~ 461 (655)
T KOG3741|consen 407 YSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQEDP-----------T--EPLE-----------SQQQNDLRD 461 (655)
T ss_pred HHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecCCC-----------C--cchh-----------HHhhhhHHH
Confidence 999999999999999999999654 58888777664332221 0 1111 122679999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 143 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 143 lG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
||.++..|.+|..--...+..+...... +-..++.++++++......++++ -++.+++..+-.-+.
T Consensus 462 lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff 527 (655)
T KOG3741|consen 462 LGLLLLALATGTENSNRTDSTQSSHLTR-------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFF 527 (655)
T ss_pred HHHHHHHHhhcccccccccchHHHHHHH-------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHH
Confidence 9999999999854322222222221111 22468889999999999999887 678888877665543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.2e-11 Score=91.12 Aligned_cols=75 Identities=27% Similarity=0.294 Sum_probs=58.1
Q ss_pred CceEEEEcCCCCCHHH-HHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 21 LMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 21 ~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
..+++|||++|+++.. .+.... .. ..+..++.+++.++.++|. .|++|+||||+||+++ + +.++|+|||.+.
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~-~~~~liDfg~a~ 162 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-D-GKVYIIDVPQAV 162 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-C-CcEEEEECcccc
Confidence 4589999999854321 111100 11 6688999999999999999 9999999999999999 4 459999999986
Q ss_pred cCc
Q 024401 99 EET 101 (268)
Q Consensus 99 ~~~ 101 (268)
...
T Consensus 163 ~~~ 165 (187)
T cd05119 163 EID 165 (187)
T ss_pred ccc
Confidence 543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.9e-11 Score=87.91 Aligned_cols=82 Identities=24% Similarity=0.300 Sum_probs=67.5
Q ss_pred Ccccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCeecCCCCCCEEEc
Q 024401 8 DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN---GIIHRDLKPDNLLLT 83 (268)
Q Consensus 8 p~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dlk~~Nil~~ 83 (268)
+++++++.... .+..+++|||++|+.+..+ +......++.+++.+++.+|.. +++|+|++|.||+++
T Consensus 53 ~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~ 123 (155)
T cd05120 53 LPVPKVLASGESDGWSYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD 123 (155)
T ss_pred CCCCeEEEEcCCCCccEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEE
Confidence 57778877763 3568999999988777653 5566788899999999999985 699999999999999
Q ss_pred CCCCceEEeccCCccc
Q 024401 84 PDQKSLKLADFGLARE 99 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~ 99 (268)
. .+.++++|||.+..
T Consensus 124 ~-~~~~~l~Df~~~~~ 138 (155)
T cd05120 124 D-GKILGIIDWEYAGY 138 (155)
T ss_pred C-CcEEEEEecccccC
Confidence 6 45699999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.4e-10 Score=83.59 Aligned_cols=69 Identities=29% Similarity=0.465 Sum_probs=58.3
Q ss_pred CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 20 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
....|+|||++|..|.+++... ...++..+-.-+.-||..||+||||.++||+++.++ +.++|||++..
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~--i~~IDfGLg~~ 140 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR--IYFIDFGLGEF 140 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc--EEEEECCcccc
Confidence 3457999999999999998763 256677788888899999999999999999998443 89999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.6e-10 Score=105.55 Aligned_cols=187 Identities=26% Similarity=0.331 Sum_probs=138.8
Q ss_pred CCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCC
Q 024401 7 HDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPD 85 (268)
Q Consensus 7 Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~ 85 (268)
||-+++..-.+ .....+++++|..|++|...+.+. ...+.+-+...+..+..++++||...+.|+|++|.|.++..+
T Consensus 863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~--~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~ 940 (1205)
T KOG0606|consen 863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS--GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYD 940 (1205)
T ss_pred CCceecccCCCCCCCCcchhhHHhccCCchhhhhcC--CCcccccccchhHHHHhhhhccccchhhcccccccchhhccc
Confidence 35555544443 345689999999999999988763 346667777888899999999999999999999999999866
Q ss_pred CCceEEeccCCcccCcc--------------------------------cccccCccCccceeccccccccccccccccC
Q 024401 86 QKSLKLADFGLAREETV--------------------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKH 133 (268)
Q Consensus 86 ~~~~~l~Dfg~~~~~~~--------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 133 (268)
+. ..+.||+.....+. ........+++.|.+||...+ ..
T Consensus 941 gh-~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg--------~~ 1011 (1205)
T KOG0606|consen 941 GH-RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG--------RR 1011 (1205)
T ss_pred CC-cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc--------cc
Confidence 54 78888873321000 011223468899999999865 55
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh--hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 134 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK--HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 134 ~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
....+|.|++|+++++.++|..||......+.. ..+.. ..++.-+...+.+.++++...+..++.+|..+.
T Consensus 1012 hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f-~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1012 HGSAADWWSSGVCLFEVLTGIPPFNAETPQQIF-ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhhhhhhhhhhcCCCCCCCcchhhhh-hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 567899999999999999999999875543332 22221 223344566889999999999999999997665
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=5.2e-10 Score=86.10 Aligned_cols=76 Identities=21% Similarity=0.205 Sum_probs=58.6
Q ss_pred CceEEEEcCCCCCHHH-HHhhhCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 21 LMVIVTELLPGMSLRK-YLVSLRPNKLDLHVALNFALDIARAMDCL-HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 21 ~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~i~~ql~~~l~~l-H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.-++||||+.++.+.. .++ +..++..+...+..+++.++..| |+.|++||||++.||++.. +.+.|+|||.+.
T Consensus 98 ~~~lvME~Ig~~~~~~~~Lk---d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~~--~~v~iIDF~qav 172 (197)
T cd05146 98 KHVLVMSFIGDDQVPAPKLK---DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWHD--GKVWFIDVSQSV 172 (197)
T ss_pred CCEEEEEEcCCCCccchhhh---ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEC--CcEEEEECCCce
Confidence 4589999996643321 222 23456667788899999999998 8999999999999999973 348999999886
Q ss_pred cCc
Q 024401 99 EET 101 (268)
Q Consensus 99 ~~~ 101 (268)
...
T Consensus 173 ~~~ 175 (197)
T cd05146 173 EPT 175 (197)
T ss_pred eCC
Confidence 543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.07 E-value=8e-11 Score=101.75 Aligned_cols=191 Identities=21% Similarity=0.185 Sum_probs=136.3
Q ss_pred CCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
.|.+++.++..| +....|+--|||+++++...+.. ...+++...+++..|++.++.++|+..++|+|++|.||++..
T Consensus 324 ~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~ 401 (524)
T KOG0601|consen 324 SHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISN 401 (524)
T ss_pred cccccCCCCCCccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeecc
Confidence 578888877766 55567899999999998887744 245888899999999999999999999999999999999986
Q ss_pred CCCceEEeccCCcccCcccccccCccCcccee-ccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~-aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
++...+++|||......... ......-++. ..|.+. ....+..+.|+++||..+.+..++..--+.....
T Consensus 402 ~~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~-------e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~ 472 (524)
T KOG0601|consen 402 DGFFSKLGDFGCWTRLAFSS--GVFHHIDRLYPIAEILL-------EDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS 472 (524)
T ss_pred chhhhhccccccccccceec--ccccccccccccchhhc-------cccccccccccccccccccccccCcccCcccccc
Confidence 65668899999886422111 1112222333 244443 2356677999999999999999876543322211
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
. . ......+.......++..+.+.+...++..||.+.++..+.+
T Consensus 473 ~----~-i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 473 L----T-IRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred e----e-eecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 1 1 112222223344488888999999999999999888766444
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=8.5e-10 Score=89.47 Aligned_cols=78 Identities=28% Similarity=0.304 Sum_probs=65.9
Q ss_pred CceEEEEcCCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC------CCCceEEec
Q 024401 21 LMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP------DQKSLKLAD 93 (268)
Q Consensus 21 ~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~------~~~~~~l~D 93 (268)
..++|||++++. +|.+++........+......++.+++..+.-||..||+|+|+++.|||++. +...+.|+|
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 468999999875 8999986533345677788899999999999999999999999999999974 235689999
Q ss_pred cCCcc
Q 024401 94 FGLAR 98 (268)
Q Consensus 94 fg~~~ 98 (268)
|+.+.
T Consensus 189 l~r~~ 193 (268)
T PRK15123 189 LHRAQ 193 (268)
T ss_pred CCccc
Confidence 99774
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.04 E-value=1.7e-09 Score=80.79 Aligned_cols=80 Identities=29% Similarity=0.429 Sum_probs=64.8
Q ss_pred CceEEEEcCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCce--EEeccCCc
Q 024401 21 LMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLA 97 (268)
Q Consensus 21 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~--~l~Dfg~~ 97 (268)
.-.++|||++| .++.+++...-.......-...++..+-+.+.-||..+|+||||..+||++..++..+ .++|||++
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 34799999977 5899999774443344444478899999999999999999999999999998766655 89999998
Q ss_pred ccC
Q 024401 98 REE 100 (268)
Q Consensus 98 ~~~ 100 (268)
...
T Consensus 164 ~~s 166 (229)
T KOG3087|consen 164 SVS 166 (229)
T ss_pred hcc
Confidence 653
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=9.3e-11 Score=103.00 Aligned_cols=148 Identities=15% Similarity=0.306 Sum_probs=104.5
Q ss_pred HHHHHHHHHHHHHHhC-CCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc----------ccCccCccceeccccc
Q 024401 53 NFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM----------MTAETGTYRWMAPELY 121 (268)
Q Consensus 53 ~i~~ql~~~l~~lH~~-~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~ 121 (268)
.=+.+++.|+.|+|+. ++||++|.|++|.++.+ +.+||+.|+.+........ .........|.+||.+
T Consensus 103 ~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~-~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~ 181 (700)
T KOG2137|consen 103 ANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNAN-GDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYL 181 (700)
T ss_pred hhhhcccchhhhhccCcceeecccchhheeeccC-cceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhh
Confidence 3345666999999987 79999999999999965 4599999998764322111 1111345679999998
Q ss_pred cccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCCCcHH--HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCC
Q 024401 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQ--AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDP 198 (268)
Q Consensus 122 ~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 198 (268)
.+ ...+.++|+||+|+++|.+.. |+.-+....... ........-........+++++++=+.+++..+.
T Consensus 182 ~~--------~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 182 LG--------TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred cc--------ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCc
Confidence 64 566789999999999999984 555444332211 1111112222233446799999999999999999
Q ss_pred CCCCCHHHHHH
Q 024401 199 NLRPSFSQIIR 209 (268)
Q Consensus 199 ~~Rps~~~~l~ 209 (268)
..||++..+..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99997776654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.2e-09 Score=94.89 Aligned_cols=77 Identities=25% Similarity=0.402 Sum_probs=59.3
Q ss_pred CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHH-HHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 20 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR-AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~-~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
+..++||||++|++|.++.... ....+ ...++.+++. .+..+|..|++|+|+||.||+++.+ +.++++|||++.
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~-~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~-g~i~liDfG~~~ 305 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALD-EAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKD-GKIIALDFGIVG 305 (437)
T ss_pred CCceEEEEeECCcccccHHHHH-hcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCC-CcEEEEeCCCee
Confidence 3469999999999999887542 12233 3455666655 4788999999999999999999855 469999999987
Q ss_pred cCc
Q 024401 99 EET 101 (268)
Q Consensus 99 ~~~ 101 (268)
...
T Consensus 306 ~l~ 308 (437)
T TIGR01982 306 RLS 308 (437)
T ss_pred ECC
Confidence 654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.97 E-value=5.6e-10 Score=84.68 Aligned_cols=75 Identities=29% Similarity=0.340 Sum_probs=56.3
Q ss_pred ceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCC-----eecCCCCCCEEEcCCC
Q 024401 12 KFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI-----IHRDLKPDNLLLTPDQ 86 (268)
Q Consensus 12 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i-----~H~dlk~~Nil~~~~~ 86 (268)
+++... .+..++||||++|.++.+. . . ....++.+++.+|+.||..++ +|||++|.||+++ +
T Consensus 57 ~~~~~~-~~~~~lv~e~i~G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~- 123 (170)
T cd05151 57 KLYYFD-PETGVLITEFIEGSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-D- 123 (170)
T ss_pred ceEEEe-CCCCeEEEEecCCCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-C-
Confidence 344443 3345899999999887643 0 1 113456799999999999985 9999999999998 4
Q ss_pred CceEEeccCCccc
Q 024401 87 KSLKLADFGLARE 99 (268)
Q Consensus 87 ~~~~l~Dfg~~~~ 99 (268)
+.++++||+.+..
T Consensus 124 ~~~~liDf~~a~~ 136 (170)
T cd05151 124 GRLWLIDWEYAGM 136 (170)
T ss_pred CeEEEEecccccC
Confidence 3589999997743
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.90 E-value=7.1e-09 Score=81.27 Aligned_cols=77 Identities=35% Similarity=0.509 Sum_probs=65.3
Q ss_pred CceEEEEcCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCC--CceEEeccCCc
Q 024401 21 LMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ--KSLKLADFGLA 97 (268)
Q Consensus 21 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~--~~~~l~Dfg~~ 97 (268)
..++|+|+++| .+|.+++..... .+......++.+++..++-||+.||+|+|+++.|||++.++ ..+.++||+-+
T Consensus 91 ~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~ 168 (206)
T PF06293_consen 91 RSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRM 168 (206)
T ss_pred eEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence 35899999988 489999976322 67778889999999999999999999999999999998664 25889999876
Q ss_pred cc
Q 024401 98 RE 99 (268)
Q Consensus 98 ~~ 99 (268)
..
T Consensus 169 ~~ 170 (206)
T PF06293_consen 169 RF 170 (206)
T ss_pred ee
Confidence 54
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.3e-07 Score=82.13 Aligned_cols=75 Identities=21% Similarity=0.324 Sum_probs=52.5
Q ss_pred CCceEEEEcCCCCCHHHHHhhhCCCCCC-----HHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCC---CceEE
Q 024401 20 PLMVIVTELLPGMSLRKYLVSLRPNKLD-----LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQ---KSLKL 91 (268)
Q Consensus 20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~-----~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~---~~~~l 91 (268)
+..++||||+.|+++.++..- ...+.+ +..+..++.| +...|++|+|+||.||+++.++ +.+++
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~l 305 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIA 305 (537)
T ss_pred CCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEE
Confidence 356899999999999885321 112233 3333333334 4469999999999999998664 26999
Q ss_pred eccCCcccCcc
Q 024401 92 ADFGLAREETV 102 (268)
Q Consensus 92 ~Dfg~~~~~~~ 102 (268)
+|||++.....
T Consensus 306 lDFGivg~l~~ 316 (537)
T PRK04750 306 LDFGIVGSLNK 316 (537)
T ss_pred EecceEEECCH
Confidence 99999876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.78 E-value=6.1e-09 Score=79.83 Aligned_cols=82 Identities=27% Similarity=0.334 Sum_probs=52.6
Q ss_pred ccceeeeeecCCceEEEEcCC--CCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCeecCCCCCCEEEcCCC
Q 024401 10 LVKFLGACKDPLMVIVTELLP--GMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC-LHANGIIHRDLKPDNLLLTPDQ 86 (268)
Q Consensus 10 i~~~~~~~~~~~~~lv~e~~~--~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~-lH~~~i~H~dlk~~Nil~~~~~ 86 (268)
+.+.+++. .-++||||++ |..+..+... .++......++.+++..+.. +|..||+|||+++.||+++.+
T Consensus 72 vP~p~~~~---~~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~- 143 (188)
T PF01163_consen 72 VPKPYDYN---RNVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG- 143 (188)
T ss_dssp S--EEEEE---TTEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-
T ss_pred CCcEEEEe---CCEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-
Confidence 44444432 3389999998 6566554432 12244567778888885555 679999999999999999955
Q ss_pred CceEEeccCCcccC
Q 024401 87 KSLKLADFGLAREE 100 (268)
Q Consensus 87 ~~~~l~Dfg~~~~~ 100 (268)
.+.++|||.+...
T Consensus 144 -~~~iIDf~qav~~ 156 (188)
T PF01163_consen 144 -KVYIIDFGQAVDS 156 (188)
T ss_dssp -CEEE--GTTEEET
T ss_pred -eEEEEecCcceec
Confidence 4999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=8.5e-08 Score=74.50 Aligned_cols=67 Identities=27% Similarity=0.438 Sum_probs=52.8
Q ss_pred CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 21 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
..+++|||++|..|.++.. +++ .+...+.+++.-||+.|++|||.+|.|++++.+ + ++++||+..+.
T Consensus 117 ~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~-i~iID~~~k~~ 183 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-G-IRIIDTQGKRM 183 (229)
T ss_pred EEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-c-EEEEECccccc
Confidence 3568999999988877532 333 244667788999999999999999999999843 3 89999986643
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.3e-07 Score=69.83 Aligned_cols=79 Identities=16% Similarity=0.192 Sum_probs=65.1
Q ss_pred CceEEEEcCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCC-ceEEeccCCcc
Q 024401 21 LMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAR 98 (268)
Q Consensus 21 ~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~-~~~l~Dfg~~~ 98 (268)
+.+||+|-+.| .+|.+++.+..-.+.+......+..+++..++-||..|+.|+|+.+.||+++.++. .+.++||--++
T Consensus 99 rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 99 RALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 36799998854 69999987643345688888999999999999999999999999999999974432 48999997665
Q ss_pred c
Q 024401 99 E 99 (268)
Q Consensus 99 ~ 99 (268)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.47 E-value=5.2e-07 Score=69.43 Aligned_cols=94 Identities=22% Similarity=0.235 Sum_probs=71.3
Q ss_pred CCCCC-CcccceeeeeecCCceEEEEcCCCCCHHHHHhh-hCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCeecCCCC
Q 024401 3 SRVKH-DNLVKFLGACKDPLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHA---NGIIHRDLKP 77 (268)
Q Consensus 3 ~~l~H-p~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dlk~ 77 (268)
+.+.+ +++.+++|+|.+ ++++||...+++...... ..-...++..+.+|+.+++..+.+++. ..+.-.|+++
T Consensus 14 ~~l~~~~~~pk~lG~CG~---~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~ 90 (188)
T PF12260_consen 14 QLLQGSEPFPKLLGSCGR---FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSP 90 (188)
T ss_pred HHcCCCCCCCCeeeECCC---EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecch
Confidence 34444 599999999955 789999977655421100 001236899999999999999999998 3477799999
Q ss_pred CCEEEcCCCCceEEeccCCcccC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
+|+-++.+ +.++++|.+.+...
T Consensus 91 ~nfgv~~~-~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 91 DNFGVNDD-GRLKLIDLDDVFVE 112 (188)
T ss_pred HHeEEeCC-CcEEEEechhcchh
Confidence 99999954 56999999977543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.39 E-value=9.3e-07 Score=69.85 Aligned_cols=89 Identities=28% Similarity=0.434 Sum_probs=65.3
Q ss_pred Ccccceeeeeec----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh----------------
Q 024401 8 DNLVKFLGACKD----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA---------------- 67 (268)
Q Consensus 8 p~i~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~---------------- 67 (268)
..+.+++.+..+ +..++||||++|.++.+.+.. ..+++.....++.+++..|+.||+
T Consensus 57 ~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~ 133 (223)
T cd05154 57 VPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGG 133 (223)
T ss_pred CCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCc
Confidence 345666666543 356899999999888775531 346777777778888888888873
Q ss_pred ----------------------------------------CCCeecCCCCCCEEEcCC-CCceEEeccCCccc
Q 024401 68 ----------------------------------------NGIIHRDLKPDNLLLTPD-QKSLKLADFGLARE 99 (268)
Q Consensus 68 ----------------------------------------~~i~H~dlk~~Nil~~~~-~~~~~l~Dfg~~~~ 99 (268)
..++|||+++.||+++.+ +..+.|+||+.+..
T Consensus 134 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 134 YLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred hHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236999999999999863 34578999987754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.19 E-value=4e-06 Score=66.85 Aligned_cols=73 Identities=25% Similarity=0.284 Sum_probs=56.1
Q ss_pred cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 19 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 19 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.++-.+|||+++|..|...- ++....-.++..|+.-+..+-..|+||||+++-||+++.+++ +.++||-.+.
T Consensus 179 ~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~-~~vIDwPQ~v 250 (304)
T COG0478 179 WNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD-IVVIDWPQAV 250 (304)
T ss_pred cccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC-EEEEeCcccc
Confidence 34568999999997666522 245556667777777777777999999999999999997655 8899997654
Q ss_pred c
Q 024401 99 E 99 (268)
Q Consensus 99 ~ 99 (268)
.
T Consensus 251 ~ 251 (304)
T COG0478 251 P 251 (304)
T ss_pred c
Confidence 3
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.3e-05 Score=75.34 Aligned_cols=189 Identities=17% Similarity=0.182 Sum_probs=127.4
Q ss_pred CCCCCCCcccceeeeee----cC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 2 MSRVKHDNLVKFLGACK----DP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~----~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
+..+.|+|+..++.+.. .+ ...+..+++...++...+... ..++..+...+..++.+||.++|+....|.-+.
T Consensus 236 l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~ 313 (1351)
T KOG1035|consen 236 LSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSLSLEHVVLS 313 (1351)
T ss_pred HHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHhccceeEEe
Confidence 45679999999999862 22 345778899888998888763 458999999999999999999999965555444
Q ss_pred CC---CEEEcCCCCceEEe--ccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 77 PD---NLLLTPDQKSLKLA--DFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 77 ~~---Nil~~~~~~~~~l~--Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
.. +.-.+.+ +.+..+ ||+.+..............+..+.++|.... .........|+|.+|.....+.
T Consensus 314 ~s~~~~~~~~~e-~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~------~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 314 ASSSKESTVDGE-GVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE------NTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred cccccccccCcc-ceeecchhhhcccccCCCcccchhhcCcccccccccccc------ccchhhhhhHHHHHHHHHhhhh
Confidence 44 2222222 234444 7877766554444444445556667776543 2244455679999999999998
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
.|..+-....... .-.+......+.+....|+.-+++.|+++.+++..
T Consensus 387 ~~~~i~~~~~~~~-----------~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 387 QGEDISEKSAVPV-----------SLLDVLSTSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred hcCcccccccchh-----------hhhccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence 8765422111000 00112222378889999999999999999999873
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.5e-05 Score=68.02 Aligned_cols=89 Identities=20% Similarity=0.290 Sum_probs=59.6
Q ss_pred ccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC---CC
Q 024401 10 LVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP---DQ 86 (268)
Q Consensus 10 i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~---~~ 86 (268)
|.+++..+ .+..+|+|||++|..+.|.-.- ...+++...+..-+.+... ..|=..|++|+|-+|.||++.+ .+
T Consensus 266 VP~Vy~~~-st~RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~ 341 (538)
T KOG1235|consen 266 VPKVYWDL-STKRVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGD 341 (538)
T ss_pred CCeehhhc-CcceEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCC
Confidence 33444333 2356999999999877665332 2356777655544444332 3334568999999999999984 35
Q ss_pred CceEEeccCCcccCcc
Q 024401 87 KSLKLADFGLAREETV 102 (268)
Q Consensus 87 ~~~~l~Dfg~~~~~~~ 102 (268)
..+.+.|||+......
T Consensus 342 ~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 342 EEIVLLDHGLYAVISH 357 (538)
T ss_pred ccEEEEcccccccccH
Confidence 6789999999875443
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.84 E-value=5.7e-05 Score=66.79 Aligned_cols=78 Identities=21% Similarity=0.364 Sum_probs=56.6
Q ss_pred CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 20 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
+..+++|||++|..+.+.... +..+++...+...+.++. +..+=..|++|+|.+|.||+++.+ +.+.+.|||+...
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l-~~~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~-g~i~~lDfGi~g~ 314 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAAL-KSAGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSD-GRIVLLDFGIVGR 314 (517)
T ss_pred CCcEEEEEeeCCEecccHHHH-HhcCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecC-CcEEEEcCcceec
Confidence 456999999999999998543 225567544444333322 344556899999999999999976 4588999999875
Q ss_pred Cc
Q 024401 100 ET 101 (268)
Q Consensus 100 ~~ 101 (268)
..
T Consensus 315 l~ 316 (517)
T COG0661 315 LD 316 (517)
T ss_pred CC
Confidence 44
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.83 E-value=4.5e-05 Score=60.33 Aligned_cols=76 Identities=25% Similarity=0.264 Sum_probs=54.9
Q ss_pred ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCEEEcCCCCceEEeccCCcccC
Q 024401 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 22 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
-.+||||+.. ...- --....-++...++..+..+++..+.-|-. .|+||+||+.-|||+. + +.+.++|||.+...
T Consensus 141 nVLvMEfIg~-~g~p-AP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~-~~p~iID~~QaV~~ 216 (268)
T COG1718 141 NVLVMEFIGD-DGLP-APRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-D-GEPYIIDVSQAVTI 216 (268)
T ss_pred CeEEEEeccC-CCCC-CCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-C-CeEEEEECcccccc
Confidence 4799999944 3110 000112334444788888999999998887 8999999999999998 4 34889999988654
Q ss_pred c
Q 024401 101 T 101 (268)
Q Consensus 101 ~ 101 (268)
.
T Consensus 217 ~ 217 (268)
T COG1718 217 D 217 (268)
T ss_pred C
Confidence 3
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=3e-06 Score=74.81 Aligned_cols=142 Identities=20% Similarity=0.217 Sum_probs=104.0
Q ss_pred CCCCCCCCc-ccceeeee-ecCCceEEEEcCCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 1 MMSRVKHDN-LVKFLGAC-KDPLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 1 ~l~~l~Hp~-i~~~~~~~-~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
||.+++||| .++.++-+ .+.+.+++++++.++ +....+.. ....+...+...+...-+.+++++|+.-=+|+|
T Consensus 286 LLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d--- 361 (829)
T KOG0576|consen 286 LLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD--- 361 (829)
T ss_pred HHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc---
Confidence 467889999 67777666 466889999999877 33332221 112344555666777788899999998778888
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+... ..++..||+...............+++.+++||.... ..+..+.|.|++|.-..++.-|..|-
T Consensus 362 -~~l~s~--~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~--------~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 362 -NILGSE--EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQE--------NTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred -cccccc--cccccccccCCcccCcccccccCCCCCCCCCchhhcc--------cccccCCCccCCCcchhhcCCCCCCC
Confidence 887763 3489999999887766655667789999999998753 66777899999998777776665543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.00028 Score=61.47 Aligned_cols=39 Identities=28% Similarity=0.502 Sum_probs=32.8
Q ss_pred CCCCCCCCcccceeeeeec--CCceEEEEcCCCCCHHHHHhh
Q 024401 1 MMSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVS 40 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~ 40 (268)
+++.+.|+|.+.+++.... .+..+|+|++ +.+|.++...
T Consensus 35 ~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 35 YLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 3678899999999998743 3588999999 8899999876
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.002 Score=51.24 Aligned_cols=28 Identities=21% Similarity=0.253 Sum_probs=23.8
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.++|||++|.||+++.++ +.++||+.+.
T Consensus 154 ~~~HgD~~~~Nii~~~~~--~~iIDwe~a~ 181 (226)
T TIGR02172 154 TCLHGDFQIGNLITSGKG--TYWIDLGDFG 181 (226)
T ss_pred ceEecCCCCCcEEEcCCC--cEEEechhcC
Confidence 478999999999998554 8899998774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0014 Score=52.68 Aligned_cols=29 Identities=24% Similarity=0.324 Sum_probs=24.0
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.++|||+.|.||+++.+ ..+.|+||+.+.
T Consensus 164 ~l~HgD~~~~Nil~~~~-~~~~iIDwe~a~ 192 (244)
T cd05150 164 VVTHGDACLPNIIVDPG-KFSGFIDLGRLG 192 (244)
T ss_pred EEECCCCCCccEEEeCC-cEEEEEEccccc
Confidence 48999999999999954 446799998664
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.00095 Score=63.24 Aligned_cols=31 Identities=32% Similarity=0.680 Sum_probs=24.9
Q ss_pred CCeecCCCCCCEEEcCCCC-ceEEeccCCccc
Q 024401 69 GIIHRDLKPDNLLLTPDQK-SLKLADFGLARE 99 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~-~~~l~Dfg~~~~ 99 (268)
.++|||+++.||+++.++. ..-|.||.++..
T Consensus 226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred ceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 4999999999999985433 346999998864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.20 E-value=2.4e-05 Score=75.58 Aligned_cols=146 Identities=12% Similarity=0.022 Sum_probs=107.9
Q ss_pred CCCCCCcccceeeee---ecCCceEEEEcCCCCCHHHHHhhhCC--CCCCHHHHHHHHHHHHHHHHHHHhC-C----Cee
Q 024401 3 SRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRP--NKLDLHVALNFALDIARAMDCLHAN-G----IIH 72 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~---~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~-~----i~H 72 (268)
+..+|+++...+.-. .+...+.+++++.+|.+.+.|.+.-. .+.+..-+.....+.+....-+|.. | -+|
T Consensus 1284 ~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1284 REAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred hhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence 346788888877654 23467999999999999999866322 2344444555555557777777754 1 689
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcc-cCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAR-EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~-~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
.++++.|.++..+ ..+++.++|+.+ ............+++-|+.++..+. -.++.++|+|..|+.+|...
T Consensus 1364 ~~Lkf~lpmIVtn-y~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~--------ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTN-YNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE--------IKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred hhhhhhccceecC-CcccccccccccccCchHhhhhhhhCCHHHHHHHHHHH--------HhhhhHHHHHHHHHHHHHHh
Confidence 9999999999854 569999999998 4333444455677888899887754 56677799999999999998
Q ss_pred hCCCCC
Q 024401 152 TNRLPF 157 (268)
Q Consensus 152 ~g~~p~ 157 (268)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0065 Score=47.16 Aligned_cols=84 Identities=24% Similarity=0.351 Sum_probs=59.1
Q ss_pred CCCCCcccceeeeeecC-CceEEEEcCCC------CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 4 RVKHDNLVKFLGACKDP-LMVIVTELLPG------MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~------~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
...+.+|.+++|+.+.+ ..-+|+|.+.. .||.+++.. ..++. .+...+-.-..+|-+.+|+.+|++
T Consensus 73 ~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~ 145 (199)
T PF10707_consen 73 GVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE---GGLTE----ELRQALDEFKRYLLDHHIVIRDLN 145 (199)
T ss_pred CCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc---CCccH----HHHHHHHHHHHHHHHcCCeecCCC
Confidence 34578899999998543 56777777644 378898864 44665 334455556678889999999999
Q ss_pred CCCEEEcCCC--C-ceEEecc
Q 024401 77 PDNLLLTPDQ--K-SLKLADF 94 (268)
Q Consensus 77 ~~Nil~~~~~--~-~~~l~Df 94 (268)
|.||++.... . .+.|+|-
T Consensus 146 ~~NIv~~~~~~~~~~lvlIDG 166 (199)
T PF10707_consen 146 PHNIVVQRRDSGEFRLVLIDG 166 (199)
T ss_pred cccEEEEecCCCceEEEEEeC
Confidence 9999996332 2 4566663
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0028 Score=52.47 Aligned_cols=70 Identities=24% Similarity=0.309 Sum_probs=51.4
Q ss_pred CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 20 PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 20 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
++-++|||++.|-+|...-. -.+. -.+...++.-+--|.++|+||||.+--||+++.+ ..++++||-...
T Consensus 181 ~RH~Vvmelv~g~Pl~~v~~-----v~d~---~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd-~~i~vIDFPQmv 250 (465)
T KOG2268|consen 181 NRHCVVMELVDGYPLRQVRH-----VEDP---PTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDD-DKIVVIDFPQMV 250 (465)
T ss_pred cceeeHHHhhcccceeeeee-----cCCh---HHHHHHHHHHHHHHHHcCceecccchheeEEecC-CCEEEeechHhh
Confidence 45689999998877765321 1223 3444566666677889999999999999999955 458899997654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0067 Score=51.01 Aligned_cols=71 Identities=23% Similarity=0.316 Sum_probs=57.6
Q ss_pred CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 21 LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 21 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
+.|++|++. |++|.-. +-...+++..++++++..++-+... .+=|+|+...||+++ + +.|.|+||.+++.
T Consensus 300 y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~-GnvtLIDfklsRl 370 (488)
T COG5072 300 YLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E-GNVTLIDFKLSRL 370 (488)
T ss_pred EEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c-CceEEEEeeeeec
Confidence 577889998 7676542 2256788899999999988888876 689999999999999 4 4599999999984
Q ss_pred C
Q 024401 100 E 100 (268)
Q Consensus 100 ~ 100 (268)
.
T Consensus 371 ~ 371 (488)
T COG5072 371 S 371 (488)
T ss_pred c
Confidence 3
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.019 Score=45.72 Aligned_cols=30 Identities=27% Similarity=0.481 Sum_probs=25.1
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
+++|+|+++.||+++.++..+.|+||..+.
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 589999999999999633458999998664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.35 E-value=0.034 Score=46.36 Aligned_cols=30 Identities=43% Similarity=0.651 Sum_probs=25.0
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.+++|||+++.||+++.+ ..+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~-~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGD-SVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECC-ceEEEeeccccc
Confidence 589999999999999865 345799998763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.021 Score=45.63 Aligned_cols=29 Identities=34% Similarity=0.489 Sum_probs=23.5
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
+++|||+++.||+++. +...-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~-~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQD-GRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEEC-CCEEEEEeCcccC
Confidence 5899999999999984 3434699999764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.037 Score=45.98 Aligned_cols=30 Identities=40% Similarity=0.515 Sum_probs=25.1
Q ss_pred CCeecCCCCCCEEEcCC---CCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPD---QKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~---~~~~~l~Dfg~~~ 98 (268)
+++|+|+.+.||+++.+ .+.+.++||..+.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999854 2458999998774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.051 Score=45.28 Aligned_cols=29 Identities=28% Similarity=0.502 Sum_probs=24.2
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.+++|||+++.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence 47899999999999985 3 47899998663
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=95.19 E-value=0.012 Score=46.49 Aligned_cols=30 Identities=37% Similarity=0.641 Sum_probs=19.9
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLA 97 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~ 97 (268)
..++|||+.+.||+++.+++.+.|+||+.+
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred cEEEEeccccccceeeeccceeEEEecccc
Confidence 359999999999999944454579999866
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.058 Score=45.19 Aligned_cols=30 Identities=40% Similarity=0.575 Sum_probs=24.4
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.|++|||+++.||+++.+ ...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~-~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGD-RLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECC-ceEEEEeccccc
Confidence 389999999999999843 434799998774
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.047 Score=45.15 Aligned_cols=30 Identities=40% Similarity=0.557 Sum_probs=24.5
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.+++|||++|.||+++.+ ..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~-~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGD-ELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCC-ceEEEeehhhhc
Confidence 479999999999999854 445799998663
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.054 Score=46.00 Aligned_cols=31 Identities=23% Similarity=0.555 Sum_probs=26.0
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
.++|+|+++.||+++.++..+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999985545699999987743
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.44 E-value=0.08 Score=44.92 Aligned_cols=76 Identities=28% Similarity=0.273 Sum_probs=56.0
Q ss_pred ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCEEEcCCCCceEEeccCCcccC
Q 024401 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 22 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
-+|||+|+ |.+-+..-. .++..++...+..+-.+++.-+.-|-+ .++||.||+--|+|+- ++ .+.++|.+.+...
T Consensus 239 hVLVM~Fl-Grdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG-~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 239 HVLVMEFL-GRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG-KLYIIDVSQSVEH 314 (520)
T ss_pred ceEeeeec-cCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC-EEEEEEccccccC
Confidence 46999999 544332211 123557777888888888888777754 5899999999999997 43 4899999988654
Q ss_pred c
Q 024401 101 T 101 (268)
Q Consensus 101 ~ 101 (268)
.
T Consensus 315 D 315 (520)
T KOG2270|consen 315 D 315 (520)
T ss_pred C
Confidence 3
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.33 E-value=0.041 Score=42.17 Aligned_cols=29 Identities=28% Similarity=0.479 Sum_probs=24.3
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCcccC
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
.+|+|+.|.|++++.+ + ++|+||+.+...
T Consensus 79 p~H~D~~~~N~~~~~~-~-~~lIDwe~a~~g 107 (188)
T PRK10271 79 PLHMDVHAGNLVHSAS-G-LRLIDWEYAGDG 107 (188)
T ss_pred eecCCCCCccEEEECC-C-EEEEeCCcccCC
Confidence 6999999999999844 4 889999988543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.30 E-value=0.076 Score=44.70 Aligned_cols=29 Identities=45% Similarity=0.654 Sum_probs=24.2
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
+||+|+.|.||+++.++..+-++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999654346799998664
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=94.29 E-value=0.12 Score=40.09 Aligned_cols=32 Identities=31% Similarity=0.493 Sum_probs=25.4
Q ss_pred CCCeecCCCCCCEEEcCCCC----ceEEeccCCccc
Q 024401 68 NGIIHRDLKPDNLLLTPDQK----SLKLADFGLARE 99 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~----~~~l~Dfg~~~~ 99 (268)
..++|||+.+.||++..++. .+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 35899999999999975432 588999987743
|
subfamily of choline kinases |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.13 E-value=0.11 Score=42.57 Aligned_cols=48 Identities=31% Similarity=0.361 Sum_probs=34.4
Q ss_pred HHHHHHHHHHHHHHHHhC--CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 51 ALNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 51 ~~~i~~ql~~~l~~lH~~--~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
..+.+..+-..+.-++.. -++|+|+.|+|++.+..+ .++|+||..+..
T Consensus 134 ~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~ 183 (269)
T COG0510 134 LRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence 333455555555555554 589999999999999534 499999988754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.048 Score=44.18 Aligned_cols=29 Identities=38% Similarity=0.619 Sum_probs=24.6
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
.++|+|+.|.||+++.++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC--CEEEeccccCc
Confidence 489999999999998654 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.01 E-value=0.19 Score=42.49 Aligned_cols=30 Identities=33% Similarity=0.503 Sum_probs=25.5
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
++|+|+.+.||+++.+++.++++||..+..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999985556699999987743
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=93.95 E-value=0.031 Score=43.84 Aligned_cols=31 Identities=35% Similarity=0.553 Sum_probs=19.9
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
.++|+|+.+.||+++..++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 5899999999999933455699999998853
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=93.79 E-value=0.053 Score=44.53 Aligned_cols=31 Identities=29% Similarity=0.533 Sum_probs=24.7
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
.++|||+++.||+++.++...-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999985444356999997754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.41 E-value=0.083 Score=44.28 Aligned_cols=49 Identities=29% Similarity=0.379 Sum_probs=30.6
Q ss_pred HHHHHHHHHHHHHHHHh----CCCeecCCCCCCEEEcCCCC-----------------ceEEeccCCccc
Q 024401 51 ALNFALDIARAMDCLHA----NGIIHRDLKPDNLLLTPDQK-----------------SLKLADFGLARE 99 (268)
Q Consensus 51 ~~~i~~ql~~~l~~lH~----~~i~H~dlk~~Nil~~~~~~-----------------~~~l~Dfg~~~~ 99 (268)
+..++.|++.-.--+-+ .+++|.||||+|||+-.+.. .++|.||..+..
T Consensus 277 vkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 346 (434)
T PF05445_consen 277 VKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV 346 (434)
T ss_pred HHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence 34455566554322322 36999999999999953322 256777777654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.18 E-value=0.087 Score=41.51 Aligned_cols=38 Identities=26% Similarity=0.315 Sum_probs=31.0
Q ss_pred HHHHHHHHhC--CCeecCCCCCCEEEcCCCCceEEeccCCc
Q 024401 59 ARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLA 97 (268)
Q Consensus 59 ~~~l~~lH~~--~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~ 97 (268)
+..|.-.|+. +.+|||..|+||+-++. +.+||.|-+..
T Consensus 151 i~~L~~fH~~~~~~lHGD~np~NiM~D~~-G~lKlVDP~~L 190 (308)
T PF07387_consen 151 IKDLMDFHSENQHCLHGDCNPDNIMCDKF-GYLKLVDPVCL 190 (308)
T ss_pred HHHHHHhhccCCCeecCCCChhheeecCC-CCEEecChhhh
Confidence 5677888854 69999999999999966 45999997743
|
The function of this family is unknown. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=93.07 E-value=0.33 Score=36.88 Aligned_cols=65 Identities=28% Similarity=0.342 Sum_probs=45.6
Q ss_pred eEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC--CCEEEcCCCCceEEeccCCcc
Q 024401 23 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP--DNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 23 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~--~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
++.|||+.|.+|.+.-.. .+... +..+++.---|-..||-|+.|+- .||+++ ++ .+.|+||..++
T Consensus 88 ~i~me~i~G~~L~~~~~~-----~~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~-~~-~~~iIDFd~At 154 (201)
T COG2112 88 FIRMEYIDGRPLGKLEIG-----GDRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVN-DR-DVYIIDFDSAT 154 (201)
T ss_pred hhhhhhhcCcchhhhhhc-----ccHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEec-CC-cEEEEEccchh
Confidence 567999999899886543 13333 33455555567788999999984 466665 43 48899999886
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.39 E-value=0.23 Score=41.85 Aligned_cols=28 Identities=32% Similarity=0.395 Sum_probs=23.5
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.+++|+|+.+.||+++ + + +.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~-~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-G-PHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-C-cEEEeCCCCC
Confidence 3789999999999995 4 3 6799999774
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.37 E-value=0.24 Score=41.33 Aligned_cols=30 Identities=17% Similarity=0.205 Sum_probs=25.1
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
+++|||+.++|++++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 799999999999998554 478899987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.09 E-value=0.2 Score=48.64 Aligned_cols=31 Identities=26% Similarity=0.332 Sum_probs=24.9
Q ss_pred CCCeecCCCCCCEEEcCCC----CceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQ----KSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~----~~~~l~Dfg~~~ 98 (268)
.|+||+|+++.||+++.+. ...-|+|||.+.
T Consensus 208 ~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 208 LQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred ccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 5899999999999998553 123699999775
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=91.69 E-value=0.33 Score=40.12 Aligned_cols=30 Identities=37% Similarity=0.565 Sum_probs=24.3
Q ss_pred CeecCCCCCCEEEcCCCC----ceEEeccCCccc
Q 024401 70 IIHRDLKPDNLLLTPDQK----SLKLADFGLARE 99 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~----~~~l~Dfg~~~~ 99 (268)
++|||++..|||+..++. .++++||..++.
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeeccccccC
Confidence 899999999999975532 588999986643
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.56 E-value=0.16 Score=42.40 Aligned_cols=32 Identities=28% Similarity=0.553 Sum_probs=27.1
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcccCc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 101 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~ 101 (268)
.++|||+++.|++++.++. +-++||+++....
T Consensus 199 ~lvHGD~~~gNlii~~~~~-~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRP-TGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEEeCCCe-eEEEeccccccCC
Confidence 4899999999999996655 8899999886543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.47 E-value=0.37 Score=41.58 Aligned_cols=29 Identities=31% Similarity=0.494 Sum_probs=23.6
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCc
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 97 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~ 97 (268)
...++|||++|.|||++.++ .+++|.-.+
T Consensus 226 ~~aLlHGDlHtGSI~v~~~~--~kvIDpEFA 254 (409)
T PRK12396 226 AQALIHGDLHTGSVFVKNDS--TKVIDPEFA 254 (409)
T ss_pred chhhccCcCCCCCEEecCCc--eEEEccccc
Confidence 34699999999999999653 788887655
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.20 E-value=0.49 Score=39.70 Aligned_cols=35 Identities=31% Similarity=0.382 Sum_probs=25.0
Q ss_pred HHHHHHHHHHHHHHHHh----CCCeecCCCCCCEEEcCC
Q 024401 51 ALNFALDIARAMDCLHA----NGIIHRDLKPDNLLLTPD 85 (268)
Q Consensus 51 ~~~i~~ql~~~l~~lH~----~~i~H~dlk~~Nil~~~~ 85 (268)
+..++.|++.-.-.+-+ .+++|.||||+|||+-.+
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 45566777665545533 369999999999999644
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.13 E-value=0.81 Score=39.63 Aligned_cols=63 Identities=21% Similarity=0.296 Sum_probs=46.0
Q ss_pred ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCeecCCCCCCEEEcCCCC
Q 024401 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD-CLHANGIIHRDLKPDNLLLTPDQK 87 (268)
Q Consensus 22 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~-~lH~~~i~H~dlk~~Nil~~~~~~ 87 (268)
..++-+|..|.++..++.. +..++..+.+++.--+.++- .+--.+++|.|++|.||++..+..
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~---~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW---KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT 383 (565)
T ss_pred ceeeeeccccccHHhhhhc---ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence 4688889999999999975 44566566666665555543 444568999999999999964433
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=90.57 E-value=0.44 Score=37.06 Aligned_cols=37 Identities=38% Similarity=0.562 Sum_probs=31.6
Q ss_pred HHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCc
Q 024401 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 97 (268)
Q Consensus 55 ~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~ 97 (268)
+.++.+-+..+|..||+-+|+++.|.. + -+|+|||.+
T Consensus 170 ~~~~~~dl~~~~k~gI~~~Dv~~~ny~---~---G~lvDfs~~ 206 (207)
T PF13095_consen 170 IPQMLRDLKILHKLGIVPRDVKPRNYR---G---GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHHHHCCeeeccCcccccc---C---CEEEecccC
Confidence 567888888999999999999999988 3 279999864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=90.46 E-value=0.42 Score=46.67 Aligned_cols=32 Identities=34% Similarity=0.533 Sum_probs=25.3
Q ss_pred CCCeecCCCCCCEEEcCCCC-ceE-EeccCCccc
Q 024401 68 NGIIHRDLKPDNLLLTPDQK-SLK-LADFGLARE 99 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~-~~~-l~Dfg~~~~ 99 (268)
.++||+|+++.||+++.+.. .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 47999999999999986541 344 999998753
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 268 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 5e-30 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-28 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-26 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 5e-26 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-23 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-22 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-22 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-22 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-22 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-22 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-22 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-22 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-22 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-22 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-22 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-22 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-22 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-22 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-22 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-22 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-22 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-22 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-22 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-22 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-21 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-21 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-21 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-21 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-21 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-21 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-21 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-21 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-21 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-21 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-21 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-21 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-21 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-21 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 4e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-21 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 4e-21 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-21 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-21 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-21 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-21 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-21 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 5e-21 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-21 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 7e-21 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-21 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-21 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-21 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-21 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-20 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-20 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-20 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-20 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-20 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-20 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-20 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-20 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-20 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-20 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-20 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-20 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 6e-20 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-19 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-19 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-19 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-19 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-19 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-19 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-19 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 5e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-19 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 5e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 6e-19 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-19 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-19 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 9e-19 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-18 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-18 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-18 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-18 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-18 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-18 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-18 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-18 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-18 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-18 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-18 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-18 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-18 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-18 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-18 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-18 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-18 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-18 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-18 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 9e-18 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-18 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 9e-18 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-17 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-17 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-17 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-16 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-16 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-16 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-16 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-16 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-16 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-16 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-16 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-16 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-16 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-16 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-16 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-16 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-16 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-16 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-16 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 8e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-15 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-15 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-15 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-15 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-14 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-14 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-14 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-14 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-14 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-14 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-14 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 6e-14 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-14 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 9e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-13 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-13 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-13 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-13 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-13 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-13 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 4e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-13 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-12 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-12 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 6e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 6e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 8e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 8e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 8e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 9e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-11 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-11 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-11 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-11 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-11 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-11 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-11 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-11 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-11 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-11 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-11 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-11 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-11 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-11 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-11 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 7e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 7e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-11 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 9e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-10 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-10 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-10 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-10 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-10 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-10 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-10 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-10 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 4e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-10 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 6e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-10 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 6e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-10 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 8e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-09 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-09 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-09 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-08 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-08 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-08 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-08 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 3e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 4e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 4e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-08 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 6e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 6e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 6e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 7e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 8e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-08 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-08 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 8e-08 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 9e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 9e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-07 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 1e-07 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-07 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-07 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-07 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-07 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-07 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-07 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-07 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-07 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-07 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-07 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-07 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-07 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-07 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-07 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-07 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-07 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 7e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 7e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 7e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-07 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 8e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 8e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-07 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 8e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 8e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-06 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-06 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-06 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-06 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-06 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-06 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-06 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-06 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-06 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 307 bits (789), Expect = e-105
Identities = 83/226 (36%), Positives = 127/226 (56%), Gaps = 14/226 (6%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL-VSLRPNKLDLHVALNFALDI 58
+M R++H N+V F+GA + P + IVTE L SL + L S +LD L+ A D+
Sbjct: 87 IMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 59 ARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRW 115
A+ M+ LH I+HR+LK NLL+ + ++K+ DFGL+R + T + GT W
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKASTFLSSKSAAGTPEW 205
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE+ + N K DVYSFG++LWEL T + P+ ++ Q A FK R
Sbjct: 206 MAPEVL--------RDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR 257
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221
+P +++P +A I++ CW +P RPSF+ I+ +L + + PP
Sbjct: 258 LEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 303 bits (778), Expect = e-104
Identities = 68/222 (30%), Positives = 111/222 (50%), Gaps = 18/222 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+MS + H N+VK G +P +V E +P L L+ + + + V L LDIA
Sbjct: 76 IMSNLNHPNIVKLYGLMHNPPR-MVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIAL 133
Query: 61 AMDCLHANG--IIHRDLKPDNLLLTPDQKS----LKLADFGLAREETVTEMMTAETGTYR 114
++ + I+HRDL+ N+ L ++ K+ADFGL+++ ++ G ++
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQ 191
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA--FK 172
WMAPE E++ Y K D YSF ++L+ +LT PF+ S + + +
Sbjct: 192 WMAPETIG------AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
RP +PED P L +++ CW DP RP FS I++ L+
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = e-103
Identities = 75/250 (30%), Positives = 122/250 (48%), Gaps = 16/250 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPN-KLDLHVALNFALDIA 59
+SRV H N+VK GAC +P+ +V E G SL L P A+++ L +
Sbjct: 54 QLSRVNHPNIVKLYGACLNPVC-LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112
Query: 60 RAMDCLHA---NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 116
+ + LH+ +IHRDLKP NLLL LK+ DFG A + + MT G+ WM
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD--IQTHMTNNKGSAAWM 170
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHAR 175
APE++ E +Y+ K DV+S+GI+LWE++T R PF+ + A R
Sbjct: 171 APEVF--------EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR 222
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAA 235
P L +++ + ++ CW +DP+ RPS +I++++ + + +
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPP 282
Query: 236 TSNGAMTEFS 245
+G + +
Sbjct: 283 GEDGRVEPYV 292
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = e-102
Identities = 78/224 (34%), Positives = 114/224 (50%), Gaps = 23/224 (10%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ + +KH N++ G C K+P + +V E G L + L ++ + +N+A+ IA
Sbjct: 59 LFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQIA 115
Query: 60 RAMDCLHANG---IIHRDLKPDNLLLT-------PDQKSLKLADFGLAREETVTEMMTAE 109
R M+ LH IIHRDLK N+L+ K LK+ DFGLARE T M+A
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA- 174
Query: 110 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 169
G Y WMAPE+ ++ DV+S+G++LWELLT +PF G+ L AY
Sbjct: 175 AGAYAWMAPEVI--------RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
A +P A +++ CW DP+ RPSF+ I+ L
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = e-102
Identities = 58/231 (25%), Positives = 106/231 (45%), Gaps = 13/231 (5%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ +H+N+V F+GAC P + I+T L G +L + LD++ A +I
Sbjct: 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIV 140
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT------EMMTAETGTY 113
+ M LHA GI+H+DLK N+ D + + DFGL V + + + G
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFY--DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198
Query: 114 RWMAPELYSTVTL-RQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 172
+APE+ ++ + +K ++ DV++ G + +EL PF+ +
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMG-T 257
Query: 173 HARPGLPE-DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 222
+P L + + +++ I+ CW + RP+F++++ ML R S
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 296 bits (759), Expect = e-101
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 15/219 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDPL---MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+ H N++ LGAC+ P ++T +P SL L +D A+ FALD
Sbjct: 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 58 IARAMDCLHA--NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 115
+AR M LH I L ++++ + + +++ + W
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQ----SPGRMYAPAW 174
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
+APE L++ + D++SF ++LWEL+T +PF +SN++ A + R
Sbjct: 175 VAPEA-----LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLR 229
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
P +P ISP ++ +++ C EDP RP F I+ +L
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 288 bits (740), Expect = 2e-98
Identities = 67/222 (30%), Positives = 113/222 (50%), Gaps = 14/222 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++ A AR
Sbjct: 73 VLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTAR 131
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMA 117
MD LHA IIHRDLK +N+ L + ++K+ DFGLA E++ +G+ WMA
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMA 190
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-AFKHARP 176
PE+ +R + Y+ + DVY+FGIVL+EL+T +LP+ ++N P
Sbjct: 191 PEV-----IRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245
Query: 177 GL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
L + + ++ C + + RPSF +I+ +
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 3e-82
Identities = 71/251 (28%), Positives = 107/251 (42%), Gaps = 30/251 (11%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++H N++KF+G KD + +TE + G +LR + S ++ ++FA DIA
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIA 118
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-------------- 105
M LH+ IIHRDL N L+ + K++ +ADFGLAR +
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 106 -MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
G WMAPE+ + + Y+ KVDV+SFGIVL E++
Sbjct: 178 KRYTVVGNPYWMAPEM-----ING---RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229
Query: 165 AAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL---RP 220
+ + P + P I C DP RPSF ++ L L P
Sbjct: 230 MDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLP 289
Query: 221 PSPSVPESDTN 231
P + + D
Sbjct: 290 LGPQLEQLDRG 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 235 bits (600), Expect = 1e-76
Identities = 56/254 (22%), Positives = 95/254 (37%), Gaps = 46/254 (18%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
++H+N++ F+ A + ++T+ SL YL + LD L A
Sbjct: 84 QTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLA 140
Query: 56 LDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-----TV 102
+ LH I HRDLK N+L+ + + +AD GLA + V
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEV 199
Query: 103 TEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--------- 152
GT R+M PE L ++ + D+YSFG++LWE+
Sbjct: 200 DIPPNTRVGTKRYMPPEVLDESLNRNHFQ---SYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 153 -NRLPFEGMSNLQAAY-----AAAFKHARPGLPE-----DISPDLAFIVQSCWVEDPNLR 201
+LP+ + +Y K RP P + + ++ CW +P R
Sbjct: 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316
Query: 202 PSFSQIIRMLNAFL 215
+ ++ + L
Sbjct: 317 LTALRVKKTLAKMS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 1e-76
Identities = 59/250 (23%), Positives = 100/250 (40%), Gaps = 44/250 (17%)
Query: 1 MMSRVKHDNLVKFLGAC-----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
++H+N++ F+ + + ++T SL YL + LD L
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIV 111
Query: 56 LDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM- 106
L IA + LH I HRDLK N+L+ + +AD GLA + +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQL 170
Query: 107 ----TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------- 152
GT R+MAPE+ Q + +VD+++FG+VLWE+
Sbjct: 171 DVGNNPRVGTKRYMAPEVLDETI--QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
Query: 153 NRLPFEGMSNLQAAY-----AAAFKHARPGLPEDISPD-----LAFIVQSCWVEDPNLRP 202
+ PF + ++ RP +P D LA +++ CW ++P+ R
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL 288
Query: 203 SFSQIIRMLN 212
+ +I + L
Sbjct: 289 TALRIKKTLT 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 7e-72
Identities = 55/251 (21%), Positives = 100/251 (39%), Gaps = 46/251 (18%)
Query: 1 MMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
++H+N++ F+ A + +V++ SL YL + + + A
Sbjct: 89 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 145
Query: 56 LDIARAMDCLHAN--------GIIHRDLKPDNLLLTPDQKSLKLADFGLAREE-----TV 102
L A + LH I HRDLK N+L+ + + +AD GLA T+
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTI 204
Query: 103 TEMMTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT--------- 152
GT R+MAPE L ++ ++ E + D+Y+ G+V WE+
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFE---SFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 153 -NRLPFEGMSNLQAAY-----AAAFKHARPGLPE-----DISPDLAFIVQSCWVEDPNLR 201
+LP+ + + + RP +P + +A I++ CW + R
Sbjct: 262 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321
Query: 202 PSFSQIIRMLN 212
+ +I + L+
Sbjct: 322 LTALRIKKTLS 332
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-65
Identities = 64/280 (22%), Positives = 106/280 (37%), Gaps = 55/280 (19%)
Query: 1 MMSRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 54
+ ++HDN+ +F+ + ++V E P SL KYL + D +
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRL 116
Query: 55 ALDIARAMDCLHA---------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 105
A + R + LH I HRDL N+L+ D + ++DFGL+ T +
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRL 175
Query: 106 ---------MTAETGTYRWMAPE-LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL---T 152
+E GT R+MAPE L V LR E +VD+Y+ G++ WE+ T
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE--SALKQVDMYALGLIYWEIFMRCT 233
Query: 153 NRLPFEGMSNLQAAYAA---------------AFKHARPGLPEDISPD------LAFIVQ 191
+ P E + Q A+ + + RP PE + L ++
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 192 SCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN 231
CW +D R + + + P + +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHHH 333
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 3e-65
Identities = 63/252 (25%), Positives = 100/252 (39%), Gaps = 46/252 (18%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
+ +KH+N+++F+GA K V ++T SL +L + N + + + A
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIA 127
Query: 56 LDIARAMDCLHAN----------GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETV 102
+AR + LH + I HRD+K N+LL + + +ADFGLA
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKS 186
Query: 103 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------- 152
+ GT R+MAPE+ Q + ++D+Y+ G+VLWEL +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRD---AFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 153 -NRLPFEGM-----SNLQAAYAAAFKHARPGLPEDISPD-----LAFIVQSCWVEDPNLR 201
LPFE S K RP L + L ++ CW D R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 202 PSFSQIIRMLNA 213
S + +
Sbjct: 304 LSAGCVGERITQ 315
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-54
Identities = 71/230 (30%), Positives = 109/230 (47%), Gaps = 28/230 (12%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
++ + H N+V+ +G C K P+ IV EL+ G +L + +L + L D
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIY-IVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDA 222
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT----YR 114
A M+ L + IHRDL N L+T ++ LK++DFG++REE A G +
Sbjct: 223 AAGMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGV-YAASGGLRQVPVK 280
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKH 173
W APE L G Y+++ DV+SFGI+LWE + P+ +SN Q +
Sbjct: 281 WTAPE-----ALNYG---RYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREF 327
Query: 174 ARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219
G PE + +++ CW +P RPSFS I + L + R
Sbjct: 328 VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKRHR 377
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 7e-53
Identities = 71/224 (31%), Positives = 115/224 (51%), Gaps = 25/224 (11%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M +++H LV+ ++P+ I+TE + SL +L + KL ++ L+ A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIY-IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
M + IHRDL+ N+L++ D S K+ADFGLAR E TA G +W
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWT 177
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 175
APE + G + K DV+SFGI+L E++T+ R+P+ GM+N + ++
Sbjct: 178 APE-----AINYG---TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLE 224
Query: 176 PG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G P++ +L +++ CW E P RP+F + +L F
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-52
Identities = 67/225 (29%), Positives = 110/225 (48%), Gaps = 29/225 (12%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M++++H NLV+ LG + + IVTE + SL YL S + L L F+LD+
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRW 115
AM+ L N +HRDL N+L++ + K++DFGL +E + + + +W
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-----STQDTGKLPVKW 180
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
APE LR+ ++ K DV+SFGI+LWE+ + R+P+ +
Sbjct: 181 TAPE-----ALREK---KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRV 227
Query: 175 RPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G P+ P + ++++CW D +RPSF Q+ L
Sbjct: 228 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-52
Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 29/225 (12%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M++++H NLV+ LG + + IVTE + SL YL S + L L F+LD+
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRW 115
AM+ L N +HRDL N+L++ + K++DFGL +E + + + +W
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEAS-----STQDTGKLPVKW 352
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
APE LR+ ++ K DV+SFGI+LWE+ + R+P+ +
Sbjct: 353 TAPE-----ALREK---KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----VVPRV 399
Query: 175 RPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G P+ P + ++++CW D RP+F Q+ L
Sbjct: 400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-52
Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M +KH NLV+ LG C + P I+TE + +L YL ++ V L A I
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 120
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRW 115
+ AM+ L IHRDL N L+ + +K+ADFGL+R T + TA G +W
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKW 178
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
APE +L ++ K DV++FG++LWE+ T P+ G+ Q ++
Sbjct: 179 TAPE-----SLAYN---KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELL 225
Query: 175 RPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
PE + ++++CW +P+ RPSF++I +
Sbjct: 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-52
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 20/214 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
M+ ++H N+V+F + + + +V+VTEL+ +L+ YL R + + V ++
Sbjct: 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL--KRFKVMKIKVLRSWC 135
Query: 56 LDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
I + + LH IIHRDLK DN+ +T S+K+ D GLA + + GT
Sbjct: 136 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTP 194
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY-AAAFK 172
+MAPE+Y ++ Y+ VDVY+FG+ + E+ T+ P+ N Y
Sbjct: 195 EFMAPEMY---------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206
+ P++ I++ C ++ + R S
Sbjct: 246 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 6e-51
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 26/237 (10%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M +++H+ LV+ ++P+ IVTE + SL +L L L ++ A IA
Sbjct: 232 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMA 117
M + +HRDL+ N+L+ + K+ADFGLAR E + +W A
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 176
PE + K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 350 PEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVER 396
Query: 177 G----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 229
G P + L ++ CW ++P RP+F + L + P +
Sbjct: 397 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY---FTSTEPQYQPGE 450
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-51
Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHVALN 53
++S+ H N+V+ +G P I+ EL+ G L+ +L RP L + L+
Sbjct: 86 IISKFNHQNIVRCIGVSLQSLPRF-ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTAETG 111
A DIA L N IHRD+ N LLT K+ DFG+AR+
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 112 TY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY 167
+WM PE +G + +K D +SFG++LWE+ + +P+ SN +
Sbjct: 205 AMLPVKWMPPE-----AFMEG---IFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-- 254
Query: 168 AAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 223
+ G P++ + I+ CW P RP+F+ I+ + +
Sbjct: 255 ---LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 311
Query: 224 SVPESDTN 231
++P
Sbjct: 312 ALPIEYGP 319
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-50
Identities = 58/222 (26%), Positives = 107/222 (48%), Gaps = 21/222 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M+ V + ++ + LG C + ++T+L+P L Y+ + + LN+ + IA
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIA 127
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
+ M+ L ++HRDL N+L+ + +K+ DFGLA+ E G +WM
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 117 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 173
A E L+ Y ++ DV+S+G+ +WEL+T P++G+ + + K
Sbjct: 187 ALESILHRI----------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKG 235
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
R P + D+ I++ CW+ D + RP F ++I +
Sbjct: 236 ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 1e-50
Identities = 74/224 (33%), Positives = 109/224 (48%), Gaps = 25/224 (11%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++HD LVK K+P+ I+TE + SL +L S +K L ++F+ IA
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
M + IHRDL+ N+L++ K+ADFGLAR E TA G +W
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWT 352
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 175
APE + + K DV+SFGI+L E++T R+P+ GMSN + +
Sbjct: 353 APEAIN--------FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-----VIRALE 399
Query: 176 PG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G PE+ +L I+ CW P RP+F I +L+ F
Sbjct: 400 RGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 1e-50
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 26/225 (11%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M +KH NLV+ LG C + P I+TE + +L YL ++ V L A I
Sbjct: 269 VMKEIKHPNLVQLLGVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 327
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRW 115
+ AM+ L IHR+L N L+ + +K+ADFGL+R T + TA G +W
Sbjct: 328 SSAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKW 385
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
APE + ++ K DV++FG++LWE+ T P+ G+ Q ++
Sbjct: 386 TAPESLA--------YNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELL 432
Query: 175 RPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
PE + ++++CW +P+ RPSF++I +
Sbjct: 433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-50
Identities = 63/248 (25%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-----KLDLHVALN 53
++S+ H N+V+ +G P I+ EL+ G L+ +L RP L + L+
Sbjct: 127 IISKFNHQNIVRCIGVSLQSLPRF-ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSL--KLADFGLAREETVTEMMTAETG 111
A DIA L N IHRD+ N LLT K+ DFG+AR+
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 112 TY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAY 167
+WM PE +G + +K D +SFG++LWE+ + +P+ SN +
Sbjct: 246 AMLPVKWMPPE-----AFMEGI---FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-- 295
Query: 168 AAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 223
+ G P++ + I+ CW P RP+F+ I+ + +
Sbjct: 296 ---LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINT 352
Query: 224 SVPESDTN 231
++P
Sbjct: 353 ALPIEYGP 360
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 4e-50
Identities = 64/237 (27%), Positives = 101/237 (42%), Gaps = 26/237 (10%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M +++H+ LV+ ++P+ IVTE + SL +L L L ++ A IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMA 117
M + +HRDL+ N+L+ + K+ADFGLAR E + +W A
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 176
PE + K DV+SFGI+L EL T R+P+ GM N +
Sbjct: 433 PEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVER 479
Query: 177 G----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 229
G P + L ++ CW ++P RP+F + L + P +
Sbjct: 480 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY---FTSTEPQYQPGE 533
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-50
Identities = 58/229 (25%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 1 MMSRVKHDNLVKFLGA-----------------CKDPLMVIVTELLPGMSLRKYLVSLRP 43
++++ H N+V + G K + I E +L +++ R
Sbjct: 57 ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 44 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
KLD +AL I + +D +H+ +I+RDLKP N+ L ++ +K+ DFGL
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ-VKIGDFGLVTSLKND 175
Query: 104 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
T GT R+M+PE + Y +VD+Y+ G++L ELL S
Sbjct: 176 GKRTRSKGTLRYMSPEQI--------SSQDYGKEVDLYALGLILAELLHVCDTAFETSKF 227
Query: 164 QAAYAAAFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
F R G + + ++Q + P RP+ S+I+R L
Sbjct: 228 -------FTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-49
Identities = 65/227 (28%), Positives = 108/227 (47%), Gaps = 31/227 (13%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M ++ H LV+ G C + P+ +VTE + L YL + + L LD+
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPIC-LVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDV 113
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRW 115
M L +IHRDL N L+ + + +K++DFG+ R + T+ TGT +W
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 171
Query: 116 MAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 172
+PE +S Y++K DV+SFG+++WE+ + ++P+E SN + +
Sbjct: 172 ASPEVFSFSR----------YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VE 216
Query: 173 HARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G P S + I+ CW E P RP+FS+++R L
Sbjct: 217 DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-49
Identities = 65/227 (28%), Positives = 102/227 (44%), Gaps = 31/227 (13%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
M ++ H LVKF G C + P+ IVTE + L YL S L+ L D+
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIY-IVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDV 113
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRW 115
M L ++ IHRDL N L+ +K++DFG+ R + + GT +W
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKW 171
Query: 116 MAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 172
APE Y Y++K DV++FGI++WE+ + ++P++ +N +
Sbjct: 172 SAPEVFHYFK----------YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VL 216
Query: 173 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G P S + I+ SCW E P RP+F Q++ +
Sbjct: 217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-49
Identities = 59/230 (25%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M + H N++ +G + L ++ + L +++ S + N + ++F L +
Sbjct: 75 LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN-PTVKDLISFGLQV 133
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----- 113
AR M+ L +HRDL N +L + ++K+ADFGLAR+ E + + +
Sbjct: 134 ARGMEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 172
+W A E +L+ + K DV+SFG++LWELLT P+ +
Sbjct: 193 KWTALE-----SLQTYR---FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL-----TH 239
Query: 173 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
G PE L ++Q CW DP +RP+F ++ + + L
Sbjct: 240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 4e-49
Identities = 64/227 (28%), Positives = 111/227 (48%), Gaps = 31/227 (13%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M + H+ LV+ G C + P+ I+TE + L YL +R + L D+
Sbjct: 72 VMMNLSHEKLVQLYGVCTKQRPIF-IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDV 129
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRW 115
AM+ L + +HRDL N L+ DQ +K++DFGL+R E T+ G+ RW
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRW 187
Query: 116 MAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 172
PE +YS +++K D+++FG+++WE+ + ++P+E +N + +
Sbjct: 188 SPPEVLMYSK----------FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-----AE 232
Query: 173 HARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
H GL P S + I+ SCW E + RP+F ++ + +
Sbjct: 233 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-49
Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 27/230 (11%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M H N++ LG C + ++V + LR ++ + N + + F L +
Sbjct: 79 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 137
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----- 113
A+ M L + +HRDL N +L ++ ++K+ADFGLAR+ E + T
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 172
+WMA E +L+ + + K DV+SFG++LWEL+T P+ ++
Sbjct: 197 KWMALE-----SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TV 243
Query: 173 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
+ G PE L ++ CW +RPSFS+++ ++A T
Sbjct: 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 1e-48
Identities = 63/241 (26%), Positives = 110/241 (45%), Gaps = 43/241 (17%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------------- 44
+++ ++H+++VKF G C DPL+ +V E + L K+L + P+
Sbjct: 70 LLTNLQHEHIVKFYGVCGDGDPLI-MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 45 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 104
+L L L+ A IA M L + +HRDL N L+ +K+ DFG++R+ T+
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMSRDVYSTD 187
Query: 105 MMTAETGTY---RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158
T RWM PE +Y + + DV+SFG++LWE+ T + P+
Sbjct: 188 YYRVGGHTMLPIRWMPPESIMYRK----------FTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 159 GMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
+SN + + G P ++ ++ CW +P R + +I ++L+A
Sbjct: 238 QLSNTEV-----IECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKILHAL 292
Query: 215 L 215
Sbjct: 293 G 293
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-48
Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 33/243 (13%)
Query: 1 MMSRVKHDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLRP----NKLDLH 49
M H ++ K +G + P+ +++ + L +L++ R L L
Sbjct: 78 CMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQ 137
Query: 50 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE 109
+ F +DIA M+ L + IHRDL N +L D ++ +ADFGL+R+ +
Sbjct: 138 TLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYYRQG 196
Query: 110 TGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQA 165
+ +W+A E +L Y DV++FG+ +WE++T + P+ G+ N +
Sbjct: 197 CASKLPVKWLALE-----SLADNL---YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI 248
Query: 166 AYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221
+ + G P + ++ ++ CW DP RPSF+ + L L L
Sbjct: 249 -----YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVL 303
Query: 222 SPS 224
S S
Sbjct: 304 STS 306
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-48
Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 28/225 (12%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M + H ++VK +G ++P+ I+ EL LR +L + LDL + +A ++
Sbjct: 69 TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLS 126
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMA 117
A+ L + +HRD+ N+L++ +KL DFGL+R + A G +WMA
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 185
Query: 118 PE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
PE + + + + DV+ FG+ +WE+L + PF+G+ N
Sbjct: 186 PESINF----------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRI 230
Query: 175 RPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 231 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 3e-48
Identities = 64/253 (25%), Positives = 104/253 (41%), Gaps = 49/253 (19%)
Query: 1 MMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 56
++ + H++++K+ G C L +V E +P SLR YL + + L L FA
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQ-LVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQ 141
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--- 112
I M LHA IHRDL N+LL + + +K+ DFGLA+ E
Sbjct: 142 QICEGMAYLHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200
Query: 113 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------------NRL 155
W APE + DV+SFG+ L+ELLT +
Sbjct: 201 VFWYAPECLKEYK----------FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250
Query: 156 PFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
M+ L+ + G P+ ++ ++++CW + + RP+F +I +L
Sbjct: 251 AQGQMTVLRL-----TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
Query: 212 NAFLFTLRPPSPS 224
+ +PS
Sbjct: 306 KTVHEKYQGQAPS 318
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-48
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 38/238 (15%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------------K 45
+++ ++H ++V+F G C PL+++ E + L ++L S P+
Sbjct: 96 LLTMLQHQHIVRFFGVCTEGRPLLMV-FEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 46 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 105
L L L A +A M L +HRDL N L+ +K+ DFG++R+ T+
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDY 213
Query: 106 MTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMS 161
T RWM PE ++ + + + DV+SFG+VLWE+ T + P+ +S
Sbjct: 214 YRVGGRTMLPIRWMPPE-----SILYRK---FTTESDVWSFGVVLWEIFTYGKQPWYQLS 265
Query: 162 NLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
N +A G P P++ I++ CW +P R S + L A
Sbjct: 266 NTEA-----IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-48
Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 40/240 (16%)
Query: 1 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP-------------- 43
MM + KH N++ LGAC PL VI E +LR+YL + RP
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 44 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
++ ++ +AR M+ L + IHRDL N+L+T + +K+ADFGLAR+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNI 210
Query: 104 EMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 159
+ T +WMAPE L Y ++ DV+SFG+++WE+ T P+ G
Sbjct: 211 DYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQSDVWSFGVLMWEIFTLGGSPYPG 262
Query: 160 MSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ + FK + G P + + +L +++ CW P+ RP+F Q++ L+ L
Sbjct: 263 IPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 317
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-48
Identities = 65/236 (27%), Positives = 105/236 (44%), Gaps = 32/236 (13%)
Query: 1 MMSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRP----NKLDLHV 50
M H N+++ LG C + P +++ + L YL+ R + L
Sbjct: 89 CMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT 148
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110
L F +DIA M+ L +HRDL N +L D ++ +ADFGL+++ +
Sbjct: 149 LLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYRQGR 207
Query: 111 GT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 166
+W+A E +L Y +K DV++FG+ +WE+ T P+ G+ N +
Sbjct: 208 IAKMPVKWIAIE-----SLADRV---YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM- 258
Query: 167 YAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
+ + G PED +L I+ SCW DP RP+FS + L L +L
Sbjct: 259 ----YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-48
Identities = 72/240 (30%), Positives = 115/240 (47%), Gaps = 40/240 (16%)
Query: 1 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN------------- 44
MM + KH N++ LGAC PL VI E +LR+YL + RP
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 45 -KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
++ ++ +AR M+ L + IHRDL N+L+T + +K+ADFGLAR+
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNI 256
Query: 104 EMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 159
+ T +WMAPE L Y ++ DV+SFG+++WE+ T P+ G
Sbjct: 257 DYYKKTTNGRLPVKWMAPE-----ALFDRV---YTHQSDVWSFGVLMWEIFTLGGSPYPG 308
Query: 160 MSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ + FK + G P + + +L +++ CW P+ RP+F Q++ L+ L
Sbjct: 309 IPVEEL-----FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 5e-48
Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 41/233 (17%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
MMS++ H +LV G C D + +V E + SL YL + +++ L A +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENI-LVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQL 122
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSL-------KLADFGLAREETVTEMMTAETG 111
A AM L N +IH ++ N+LL ++ KL+D G++
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLPKD 175
Query: 112 TY----RWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 164
W+ PE K+ N D +SFG LWE+ + P + + +
Sbjct: 176 ILQERIPWVPPECIENP---------KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226
Query: 165 AAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ LP + +LA ++ +C +P+ RPSF IIR LN+
Sbjct: 227 K-----LQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 5e-48
Identities = 58/220 (26%), Positives = 103/220 (46%), Gaps = 17/220 (7%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ + H ++V+ LG C L +VT+ LP SL ++ R L + LN+ + IA
Sbjct: 68 AIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIA 125
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
+ M L +G++HR+L N+LL +++ADFG+A + + +WM
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 175
A E Y ++ DV+S+G+ +WEL+T P+ G+ + K R
Sbjct: 185 ALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-VPDLLEKGER 235
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
P+ + D+ ++ CW+ D N+RP+F ++
Sbjct: 236 LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 5e-48
Identities = 70/233 (30%), Positives = 110/233 (47%), Gaps = 33/233 (14%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN--------KLDLHV 50
+M ++V+ LG P +VI EL+ L+ YL SLRP L
Sbjct: 81 VMKEFNCHHVVRLLGVVSQGQPTLVI-MELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110
+ A +IA M L+AN +HRDL N ++ D ++K+ DFG+ R+ T+
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGG 198
Query: 111 GTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAA 166
RWM+PE +L+ G + DV+SFG+VLWE+ T P++G+SN Q
Sbjct: 199 KGLLPVRWMSPE-----SLKDGV---FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV- 249
Query: 167 YAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ G P++ L +++ CW +P +RPSF +II + +
Sbjct: 250 ----LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-47
Identities = 61/250 (24%), Positives = 111/250 (44%), Gaps = 33/250 (13%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M+ V + ++ + LG C + ++T+L+P L Y+ + + LN+ + IA
Sbjct: 70 VMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIA 127
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT---YRWM 116
+ M+ L ++HRDL N+L+ + +K+ DFGLA+ E G +WM
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 117 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKH 173
A E L+ Y ++ DV+S+G+ +WEL+T P++G+ + + K
Sbjct: 187 ALESILHRI----------YTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKG 235
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL------------FTLRPP 221
R P + D+ I+ CW+ D + RP F ++I + + P
Sbjct: 236 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLP 295
Query: 222 SPSVPESDTN 231
SP+
Sbjct: 296 SPTDSNFYRA 305
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 1e-47
Identities = 61/230 (26%), Positives = 106/230 (46%), Gaps = 27/230 (11%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M H N++ LG C + ++V + LR ++ + N + + F L +
Sbjct: 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQV 201
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY----- 113
A+ M L + +HRDL N +L ++ ++K+ADFGLAR+ E + T
Sbjct: 202 AKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 172
+WMA E +L+ + + K DV+SFG++LWEL+T P+ ++
Sbjct: 261 KWMALE-----SLQTQK---FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI-----TV 307
Query: 173 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
+ G PE L ++ CW +RPSFS+++ ++A T
Sbjct: 308 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-47
Identities = 75/240 (31%), Positives = 116/240 (48%), Gaps = 40/240 (16%)
Query: 1 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP-------------- 43
MM + KH N++ LGAC PL VI E +LR+YL + RP
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVI-VEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 44 NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
+L ++ A +AR M+ L + IHRDL N+L+T D +K+ADFGLAR+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHI 244
Query: 104 EMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG 159
+ T +WMAPE L Y ++ DV+SFG++LWE+ T P+ G
Sbjct: 245 DYYKKTTNGRLPVKWMAPE-----ALFDRI---YTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 160 MSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ + FK + G P + + +L +++ CW P+ RP+F Q++ L+ +
Sbjct: 297 VPVEEL-----FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-47
Identities = 63/247 (25%), Positives = 113/247 (45%), Gaps = 47/247 (19%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP--------------- 43
++ +V H +++K GAC PL++IV E SLR +L R
Sbjct: 79 VLKQVNHPHVIKLYGACSQDGPLLLIV-EYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 44 -------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 96
L + ++FA I++ M L ++HRDL N+L+ + +K++DFGL
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEG-RKMKISDFGL 196
Query: 97 AREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 152
+R+ + + +WMA E +L Y + DV+SFG++LWE++T
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIE-----SLFDHI---YTTQSDVWSFGVLLWEIVTL 248
Query: 153 NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
P+ G+ + F + G P++ S ++ ++ CW ++P+ RP F+ I
Sbjct: 249 GGNPYPGIPPERL-----FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADIS 303
Query: 209 RMLNAFL 215
+ L +
Sbjct: 304 KDLEKMM 310
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-47
Identities = 61/248 (24%), Positives = 98/248 (39%), Gaps = 41/248 (16%)
Query: 2 MSRVKHDNLVKFLGACKD-------------PLMVIVTELLPGMSLRKYLVSLRPNK-LD 47
+++++H +V++ A + + I +L +L+ ++ + +
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 48 LHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--------- 98
V L+ L IA A++ LH+ G++HRDLKP N+ T D +K+ DFGL
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV-VKVGDFGLVTAMDQDEEEQ 175
Query: 99 ----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154
T + GT +M+PE Y++KVD++S G++L+ELL
Sbjct: 176 TVLTPMPAYARHTGQVGTKLYMSPEQI--------HGNSYSHKVDIFSLGLILFELLY-- 225
Query: 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
PF P L P +VQ P RP II NA
Sbjct: 226 -PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NAV 282
Query: 215 LFTLRPPS 222
L P
Sbjct: 283 FEDLDFPG 290
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-47
Identities = 60/238 (25%), Positives = 105/238 (44%), Gaps = 39/238 (16%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPN-------------- 44
+ +R++H N+V LG PL ++ L ++LV P+
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 45 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE 104
L+ ++ IA M+ L ++ ++H+DL N+L+ D+ ++K++D GL RE +
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY-DKLNVKISDLGLFREVYAAD 182
Query: 105 MMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 160
+ RWMAPE + G ++ D++S+G+VLWE+ + P+ G
Sbjct: 183 YYKLLGNSLLPIRWMAPE-----AIMYG---KFSIDSDIWSYGVVLWEVFSYGLQPYCGY 234
Query: 161 SNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
SN + R P+D + ++ CW E P+ RP F I L A+
Sbjct: 235 SNQDV-----VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 287
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-47
Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M + H ++VK +G ++P+ I+ EL LR +L + LDL + +A ++
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLS 501
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMA 117
A+ L + +HRD+ N+L++ +KL DFGL+R + A G +WMA
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 560
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 176
PE ++ + + DV+ FG+ +WE+L + PF+G+ N
Sbjct: 561 PE-----SINFR---RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-----VIGRIEN 607
Query: 177 G----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G +P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 608 GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-47
Identities = 54/235 (22%), Positives = 107/235 (45%), Gaps = 22/235 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++ + +V+ +G C + LM +V E+ G L K+LV + ++ + ++
Sbjct: 63 IMHQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVS 120
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---YRW 115
M L +HRDL N+LL ++ K++DFGL++ + TA + +W
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 116 MAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 172
APE + ++++ DV+S+G+ +WE L+ + P++ M + A +
Sbjct: 180 YAPECINFRK----------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQ 228
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 227
R P + P+L ++ CW+ RP F + + + A ++L
Sbjct: 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHH 283
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-47
Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 28/225 (12%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M + H ++VK +G ++P I+ EL P L YL + L + + ++L I
Sbjct: 66 IMKNLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQIC 123
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY--RWMA 117
+AM L + +HRD+ N+L+ + +KL DFGL+R + A +WM+
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 118 PE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHA 174
PE + + DV+ F + +WE+L+ + PF + N
Sbjct: 183 PESINFRR----------FTTASDVWMFAVCMWEILSFGKQPFFWLENKD-----VIGVL 227
Query: 175 RPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G P+ P L ++ CW DP+ RP F++++ L+
Sbjct: 228 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-47
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 21/219 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M + H NL++ G P+ +VTEL P SL L L +A+ +A
Sbjct: 74 AMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVA 131
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---YRW 115
M L + IHRDL NLLL + +K+ DFGL R + + + W
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 116 MAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 172
APE T +++ D + FG+ LWE+ T + P+ G++ Q + +
Sbjct: 191 CAPESLKTRT----------FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
R PED D+ ++ CW P RP+F + L
Sbjct: 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-46
Identities = 69/238 (28%), Positives = 108/238 (45%), Gaps = 33/238 (13%)
Query: 1 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------ 51
++S + H N+V LGAC P +VI TE L +L R + + +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVI-TEYCCYGDLLNFLRRKRDSFICSKTSPAIMED 137
Query: 52 ----------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 101
L+F+ +A+ M L + IHRDL N+LLT + K+ DFGLAR+
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIK 196
Query: 102 VTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157
+ +WMAPE ++ Y + DV+S+GI LWEL + P+
Sbjct: 197 NDSNYVVKGNARLPVKWMAPE-----SIFNCV---YTFESDVWSYGIFLWELFSLGSSPY 248
Query: 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
GM Y + R PE ++ I+++CW DP RP+F QI++++ +
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-46
Identities = 59/245 (24%), Positives = 97/245 (39%), Gaps = 48/245 (19%)
Query: 1 MMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 56
++ ++HDN+VK+ G C + L ++ E LP SLR YL + ++D L +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTS 121
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--- 112
I + M+ L IHRDL N+L+ ++ +K+ DFGL + E +
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 113 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------------NR 154
W APE S ++ DV+SFG+VL+EL T
Sbjct: 181 IFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 230
Query: 155 LPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
M + + P+ ++ I+ CW + N RPSF +
Sbjct: 231 DKQGQMIVFHL-----IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
Query: 211 LNAFL 215
++
Sbjct: 286 VDQIR 290
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-46
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 27/226 (11%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M + H N+++ G M IVTE + SL +L + + + + +
Sbjct: 103 IMGQFDHPNIIRLEGVVTRGRLAM-IVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGV 160
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YR 114
M L G +HRDL N+L+ K++DFGL+R E + TG R
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKH 173
W APE + +++ DV+SFG+V+WE+L P+ M+N
Sbjct: 220 WTAPE-----AIAFR---TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV-----ISS 266
Query: 174 ARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G P L ++ CW +D RP FSQI+ +L+A +
Sbjct: 267 VEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI 312
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-46
Identities = 54/230 (23%), Positives = 98/230 (42%), Gaps = 31/230 (13%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++ + +V+ +G C + M +V E+ L KYL + + + ++
Sbjct: 71 VMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVS 127
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---YRW 115
M L + +HRDL N+LL Q K++DFGL++ E A+T +W
Sbjct: 128 MGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 116 MAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFK 172
APE Y +++K DV+SFG+++WE + + P+ GM +
Sbjct: 187 YAPECINYYK----------FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-----VTA 231
Query: 173 HARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
G P ++ ++ CW D RP F+ + L + + +
Sbjct: 232 MLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 59/245 (24%), Positives = 97/245 (39%), Gaps = 48/245 (19%)
Query: 1 MMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 56
++ ++HDN+VK+ G C + L ++ E LP SLR YL + ++D L +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLK-LIMEYLPYGSLRDYLQKHKE-RIDHIKLLQYTS 152
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--- 112
I + M+ L IHRDL N+L+ ++ +K+ DFGL + E +
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 113 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT----------------NR 154
W APE S ++ DV+SFG+VL+EL T
Sbjct: 212 IFWYAPESLTESK----------FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN 261
Query: 155 LPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
M + + P+ ++ I+ CW + N RPSF +
Sbjct: 262 DKQGQMIVFHL-----IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 316
Query: 211 LNAFL 215
++
Sbjct: 317 VDQIR 321
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 72/242 (29%), Positives = 113/242 (46%), Gaps = 47/242 (19%)
Query: 1 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------ 51
++ ++ H N++ LGAC + L + E P +L +L R + D A
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136
Query: 52 --------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
L+FA D+AR MD L IHRDL N+L+ + K+ADFGL+R +
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQ--- 192
Query: 104 EMMTAETGT---YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157
E+ +T RWMA E YS Y DV+S+G++LWE+++ P+
Sbjct: 193 EVYVKKTMGRLPVRWMAIESLNYSV----------YTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 158 EGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
GM+ + ++ G P + ++ +++ CW E P RPSF+QI+ LN
Sbjct: 243 CGMTCAEL-----YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297
Query: 214 FL 215
L
Sbjct: 298 ML 299
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-46
Identities = 64/250 (25%), Positives = 108/250 (43%), Gaps = 34/250 (13%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M + H N+++ G P+M I+TE + +L K+L + + + + I
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMM-IITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGI 156
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YR 114
A M L +HRDL N+L+ K++DFGL+R E E +G R
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 115 WMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAF 171
W APE Y + + + DV+SFGIV+WE++T P+ +SN +
Sbjct: 216 WTAPEAISY----------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----M 260
Query: 172 KHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 227
K G P D + ++ CW ++ RP F+ I+ +L+ +R P
Sbjct: 261 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL---IRAPDSLKTL 317
Query: 228 SDTNEAAATS 237
+D + +
Sbjct: 318 ADFDPRVSIR 327
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 2e-46
Identities = 59/212 (27%), Positives = 107/212 (50%), Gaps = 12/212 (5%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+++ +KH N+V++ + ++ + IV + G L K + + + L++ + I
Sbjct: 76 VLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 118
A+ +H I+HRD+K N+ LT D +++L DFG+AR + E+ A GT +++P
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSP 194
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ E K YNNK D+++ G VL+EL T + FE +++ + P +
Sbjct: 195 EIC--------ENKPYNNKSDIWALGCVLYELCTLKHAFEA-GSMKNLVLKIISGSFPPV 245
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
S DL +V + +P RPS + I+
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 3e-46
Identities = 64/247 (25%), Positives = 105/247 (42%), Gaps = 47/247 (19%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP--------------- 43
+M+ + N+VK LG C P+ ++ E + L ++L S+ P
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLL-FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 44 -------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 96
L L A +A M L +HRDL N L+ + +K+ADFGL
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGL 220
Query: 97 AREETVTEMMTAETGTY---RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 152
+R + A+ RWM PE ++ Y + DV+++G+VLWE+ +
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWMPPE-----SIFYNR---YTTESDVWAYGVVLWEIFSY 272
Query: 153 NRLPFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
P+ GM++ + + R G PE+ +L +++ CW + P RPSF I
Sbjct: 273 GLQPYYGMAHEEV-----IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 327
Query: 209 RMLNAFL 215
R+L
Sbjct: 328 RILQRMC 334
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-46
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 16/211 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+H V+ A ++ ++ + TEL G SL+++ L + D
Sbjct: 110 HEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLRDTL 167
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A+ LH+ G++H D+KP N+ L P + KL DFGL E + G R+MAPE
Sbjct: 168 LALAHLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
L L+ Y DV+S G+ + E+ N G Q + P
Sbjct: 227 L-----LQGS----YGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQ---GYLPPEFT 274
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
+S +L ++ DP LR + ++ +
Sbjct: 275 AGLSSELRSVLVMMLEPDPKLRATAEALLAL 305
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-46
Identities = 67/237 (28%), Positives = 109/237 (45%), Gaps = 32/237 (13%)
Query: 1 MMSRV-KHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRP------------- 43
++ + H N+V LGAC PLMVI E +L YL S R
Sbjct: 83 ILIHIGHHLNVVNLLGACTKPGGPLMVI-VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLY 141
Query: 44 -NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV 102
+ L L + ++ +A+ M+ L + IHRDL N+LL+ +K+ DFGLAR+
Sbjct: 142 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYK 200
Query: 103 TEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158
+ +WMAPE T+ Y + DV+SFG++LWE+ + P+
Sbjct: 201 DPDYVRKGDARLPLKWMAPE-----TIFDRV---YTIQSDVWSFGVLLWEIFSLGASPYP 252
Query: 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
G+ + + R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 6e-46
Identities = 71/243 (29%), Positives = 105/243 (43%), Gaps = 38/243 (15%)
Query: 1 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVA------ 51
MM+++ H+N+V LGAC P+ +I E L YL S R + +
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLI-FEYCCYGDLLNYLRSKREKFSEDEIEYENQKR 159
Query: 52 ---------------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGL 96
L FA +A+ M+ L +HRDL N+L+T K +K+ DFGL
Sbjct: 160 LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGL 218
Query: 97 AREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 152
AR+ +WMAPE +L +G Y K DV+S+GI+LWE+ +
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWMAPE-----SLFEGI---YTIKSDVWSYGILLWEIFSL 270
Query: 153 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
P+ G+ Y + P + ++ I+QSCW D RPSF + L
Sbjct: 271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330
Query: 213 AFL 215
L
Sbjct: 331 CQL 333
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-46
Identities = 64/244 (26%), Positives = 105/244 (43%), Gaps = 47/244 (19%)
Query: 1 MMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 56
++ + H+N+VK+ G C + + ++ E LP SL++YL NK++L L +A+
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIK-LIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAV 133
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--- 112
I + MD L + +HRDL N+L+ + +K+ DFGL + ET E T +
Sbjct: 134 QICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEYYTVKDDRDSP 192
Query: 113 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT---------------NRL 155
W APE + S + DV+SFG+ L ELLT
Sbjct: 193 VFWYAPECLMQSK----------FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242
Query: 156 PFEGMSNLQAAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
M+ + + G P + ++ +++ CW P+ R SF +I
Sbjct: 243 THGQMTVTRL-----VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297
Query: 212 NAFL 215
A L
Sbjct: 298 EALL 301
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 9e-46
Identities = 52/242 (21%), Positives = 106/242 (43%), Gaps = 17/242 (7%)
Query: 1 MMSRVKH--DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+++++ D +++ + +V E + L +L + +D ++ +
Sbjct: 107 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKN 163
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYR 114
+ A+ +H +GI+H DLKP N L+ LKL DFG+A +T + + ++ G
Sbjct: 164 MLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221
Query: 115 WMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAA 170
+M PE S+ K + K DV+S G +L+ + + PF+ + N + +A
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 281
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 230
+ P+ DL +++ C DP R S +++ + ++ P + + T
Sbjct: 282 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTT 339
Query: 231 NE 232
E
Sbjct: 340 EE 341
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-45
Identities = 53/242 (21%), Positives = 107/242 (44%), Gaps = 17/242 (7%)
Query: 1 MMSRVKH--DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+++++ D +++ + +V E + L +L + +D ++ +
Sbjct: 79 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKN 135
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYR 114
+ A+ +H +GI+H DLKP N L+ LKL DFG+A +T + + ++ GT
Sbjct: 136 MLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193
Query: 115 WMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAA 170
+M PE S+ K + K DV+S G +L+ + + PF+ + N + +A
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 230
+ P+ DL +++ C DP R S +++ + ++ P + + T
Sbjct: 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTT 311
Query: 231 NE 232
E
Sbjct: 312 EE 313
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-45
Identities = 67/239 (28%), Positives = 106/239 (44%), Gaps = 39/239 (16%)
Query: 1 MMSRV-KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRP------------NK 45
+MS + +H+N+V LGAC P++VI TE L +L +
Sbjct: 102 IMSHLGQHENIVNLLGACTHGGPVLVI-TEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 46 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 105
L+F+ +A+ M L + IHRD+ N+LLT K+ DFGLAR+
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSN 219
Query: 106 MTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEG-M 160
+ +WMAPE ++ Y + DV+S+GI+LWE+ + P+ G +
Sbjct: 220 YIVKGNARLPVKWMAPE-----SIFDCV---YTVQSDVWSYGILLWEIFSLGLNPYPGIL 271
Query: 161 SNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
N + +K + G P ++ I+Q+CW +P RP+F QI L
Sbjct: 272 VNSKF-----YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA 325
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-45
Identities = 53/242 (21%), Positives = 107/242 (44%), Gaps = 17/242 (7%)
Query: 1 MMSRVKH--DNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+++++ D +++ + +V E + L +L + +D ++ +
Sbjct: 60 YLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKN 116
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYR 114
+ A+ +H +GI+H DLKP N L+ LKL DFG+A +T + + ++ GT
Sbjct: 117 MLEAVHTIHQHGIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174
Query: 115 WMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAA 170
+M PE S+ K + K DV+S G +L+ + + PF+ + N + +A
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 230
+ P+ DL +++ C DP R S +++ + ++ P + + T
Sbjct: 235 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQIQTHPVNQMAKGTT 292
Query: 231 NE 232
E
Sbjct: 293 EE 294
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-45
Identities = 61/263 (23%), Positives = 100/263 (38%), Gaps = 49/263 (18%)
Query: 1 MMSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFAL 56
++ + D +VK+ G + L +V E LP LR +L R +LD L ++
Sbjct: 77 ILKALHSDFIVKYRGVSYGPGRQSLR-LVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSS 134
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT--- 112
I + M+ L + +HRDL N+L+ + +K+ADFGLA+ +
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 113 YRWMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAA 169
W APE + ++ + DV+SFG+VL+EL T A +
Sbjct: 194 IFWYAPESLSDNI----------FSRQSDVWSFGVVLYELFTYCDKSCSPS----AEFLR 239
Query: 170 AFKHARPGL-----------------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
R P ++ +++ CW P RPSFS + L+
Sbjct: 240 MMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLD 299
Query: 213 AFLFTLR----PPSPSVPESDTN 231
R + PE +
Sbjct: 300 MLWSGSRGCETHAFTAHPEGKHH 322
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-44
Identities = 56/241 (23%), Positives = 91/241 (37%), Gaps = 34/241 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFAL 56
++ ++ H N+VK ++ V++ E P SL L L L
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTP---DQKSLKLADFGLAREETVTEMMTAETGTY 113
D+ M+ L NGI+HR++KP N++ Q KL DFG ARE E + GT
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ--------- 164
++ P++Y LR+ +K Y VD++S G+ + T LPF +
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 165 -----AAYAAAFKHARPG-------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206
+ + + A G L + L ++ + D F Q
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 207 I 207
Sbjct: 300 F 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 56/249 (22%), Positives = 91/249 (36%), Gaps = 34/249 (13%)
Query: 1 MMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSL-RPNKLDLHVALNFAL 56
++ ++ H N+VK ++ V++ E P SL L L L
Sbjct: 60 VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFGLAREETVTEMMTAETGTY 113
D+ M+ L NGI+HR++KP N++ Q KL DFG ARE E + GT
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN----------- 162
++ P++Y LR+ +K Y VD++S G+ + T LPF
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 163 LQAAYAAAFKHARPG----------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206
+ + A + L + L ++ + D F Q
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 207 IIRMLNAFL 215
+ L
Sbjct: 300 FFAETSDIL 308
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-44
Identities = 70/264 (26%), Positives = 109/264 (41%), Gaps = 42/264 (15%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M + H N+++ G P+M IVTE + SL +L + + + I
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVM-IVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGI 156
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGT---YR 114
A M L G +HRDL N+L+ K++DFGL R E E G R
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215
Query: 115 WMAPE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAF 171
W +PE Y + + + DV+S+GIVLWE+++ P+ MSN
Sbjct: 216 WTSPEAIAY----------RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-----I 260
Query: 172 KHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL-----------F 216
K G P D L ++ CW +D N RP F QI+ +L+ +
Sbjct: 261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSA 320
Query: 217 TLRPPSPSVPESDTNEAAATSNGA 240
RP + + +S+ + + G
Sbjct: 321 AARPSNLLLDQSNVDITTFRTTGD 344
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-44
Identities = 51/241 (21%), Positives = 90/241 (37%), Gaps = 44/241 (18%)
Query: 1 MMSRVKHDNLVKFLGA--------------CKDPLMVIVTELLPGMSLRKYLVSLRPNKL 46
+++ + H +V++ A K + I E +L + S
Sbjct: 55 LLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQ 113
Query: 47 DLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-------- 98
I A+ +H+ GIIHRDLKP N+ + + +K+ DFGLA+
Sbjct: 114 QRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN-VKIGDFGLAKNVHRSLDI 172
Query: 99 -------EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151
++ +T+ GT ++A E+ HYN K+D+YS GI+ +E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLD-------GTGHYNEKIDMYSLGIIFFEMI 225
Query: 152 TNRLPFEGMSNLQAAYAAAFKHAR---PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208
PF + P ++ I++ DPN RP ++
Sbjct: 226 Y---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282
Query: 209 R 209
Sbjct: 283 N 283
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-44
Identities = 54/241 (22%), Positives = 108/241 (44%), Gaps = 23/241 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M ++ + +V+ +G C+ +++V E+ G L K+LV R ++ + ++
Sbjct: 389 IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSM 447
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMM-TAETGT---YRWM 116
M L +HR+L N+LL ++ K++DFGL++ + TA + +W
Sbjct: 448 GMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506
Query: 117 APE--LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKH 173
APE + ++++ DV+S+G+ +WE L+ + P++ M + A +
Sbjct: 507 APECINFRK----------FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQG 555
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEA 233
R P + P+L ++ CW+ RP F + + + A + V E
Sbjct: 556 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC---YYSLASKVEGGSALEV 612
Query: 234 A 234
A
Sbjct: 613 A 613
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-43
Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 21/221 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFA 55
++ +KH N+V++ D + IV E G L + + L L
Sbjct: 58 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 117
Query: 56 LDIARAMDCLH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAE 109
+ A+ H + ++HRDLKP N+ L Q ++KL DFGLAR T
Sbjct: 118 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTF 176
Query: 110 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 169
GT +M+PE + YN K D++S G +L+EL PF + +
Sbjct: 177 VGTPYYMSPEQM--------NRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGK 227
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
+ +P S +L I+ RPS +I+
Sbjct: 228 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-43
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 24 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83
+V E + G +L +Y+ S P L + A+NF I + H I+HRD+KP N+L+
Sbjct: 88 LVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID 145
Query: 84 PDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140
+ K+LK+ DFG+A+ E ++T+ GT ++ +PE Q + + + D+
Sbjct: 146 SN-KTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPE--------QAKGEATDECTDI 195
Query: 141 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR---PGLP----EDISPDLAFIVQSC 193
YS GIVL+E+L PF G + + A KH + P + +DI L+ ++
Sbjct: 196 YSIGIVLYEMLVGEPPFNGETAVSIAI----KHIQDSVPNVTTDVRKDIPQSLSNVILRA 251
Query: 194 WVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA 234
+D R + ++ L++ L R A
Sbjct: 252 TEKDKANRYKTIQEMKDDLSSVLHENRANEDVYELDKMKTIA 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-43
Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 20/235 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDI 58
+ +KH N+V++LG+ + + I E +PG SL L S P K + + I
Sbjct: 72 LHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQI 131
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMA 117
+ LH N I+HRD+K DN+L+ LK++DFG ++ + TGT ++MA
Sbjct: 132 LEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMA 191
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK----H 173
PE+ + Y D++S G + E+ T + PF L AA FK
Sbjct: 192 PEII------DKGPRGYGKAADIWSLGCTIIEMATGKPPF---YELGEPQAAMFKVGMFK 242
Query: 174 ARPGLPEDISPDL-AFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 227
P +PE +S + AFI++ C+ DP+ R + ++ + FL + P+
Sbjct: 243 VHPEIPESMSAEAKAFILK-CFEPDPDKRACANDLLV--DEFLKVSSKKKKTQPK 294
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-43
Identities = 55/246 (22%), Positives = 96/246 (39%), Gaps = 28/246 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNK--LDLHVALN 53
M H N+++ + C ++ +L + L+ L L
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW 138
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---------- 103
L I R ++ +HA G HRDLKP N+LL D+ L D G + +
Sbjct: 139 LLLGICRGLEAIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 104 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
+ A+ T + APEL +++ + + DV+S G VL+ ++ P++ +
Sbjct: 198 QDWAAQRCTISYRAPEL---FSVQSHCV--IDERTDVWSLGCVLYAMMFGEGPYDMVFQK 252
Query: 164 QAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 222
+ A A + S L ++ S DP+ RP ++ L A L+PP+
Sbjct: 253 GDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA----LQPPA 308
Query: 223 PSVPES 228
P +
Sbjct: 309 PGQHTT 314
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-43
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 2 MSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDI 58
+ ++ H N++K+ + + + IV EL L + + + K + + + +
Sbjct: 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMA 117
A++ +H+ ++HRD+KP N+ +T +KL D GL R + T + GT +M+
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFITATGV-VKLGDLGLGRFFSSKTTAAHSLVGTPYYMS 204
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-MSNLQAAYAAAFKHARP 176
PE + YN K D++S G +L+E+ + PF G NL + + P
Sbjct: 205 PERI--------HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256
Query: 177 GLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
LP D S +L +V C DP RP + + +
Sbjct: 257 PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-42
Identities = 52/211 (24%), Positives = 86/211 (40%), Gaps = 18/211 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ + +V GA ++ V I ELL G SL + + + L AL +
Sbjct: 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQAL 160
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAET--GTY 113
++ LH I+H D+K DN+LL+ D L DFG L + ++T + GT
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTE 220
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAFK 172
MAPE V + + + KVD++S ++ +L P+ A+
Sbjct: 221 THMAPE----VVMGKP----CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEP 272
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPS 203
+P +P A +Q ++P R S
Sbjct: 273 PPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 26/201 (12%)
Query: 24 IVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
I +L +L+ ++ + V L+ + IA A++ LH+ G++HRDLKP N+
Sbjct: 138 IQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF 197
Query: 83 TPDQKSLKLADFGLAR-------------EETVTEMMTAETGTYRWMAPELYSTVTLRQG 129
T D +K+ DFGL T + GT +M+PE Q
Sbjct: 198 TMDDV-VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE--------QI 248
Query: 130 EKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFI 189
+Y++KVD++S G++L+ELL F P L P +
Sbjct: 249 HGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMM 305
Query: 190 VQSCWVEDPNLRPSFSQIIRM 210
VQ P RP + II
Sbjct: 306 VQDMLSPSPTERPEATDIIEN 326
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-42
Identities = 62/231 (26%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 24 IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83
IV E + G++LR + + P + A+ D +A++ H NGIIHRD+KP N++++
Sbjct: 93 IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS 150
Query: 84 PDQKSLKLADFGLAREETVTEMMTAET----GTYRWMAPELYSTVTLRQGEKKHYNNKVD 139
+K+ DFG+AR + +T GT ++++PE Q + + D
Sbjct: 151 ATNA-VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE--------QARGDSVDARSD 201
Query: 140 VYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR------PGLPEDISPDLAFIVQSC 193
VYS G VL+E+LT PF G S + AY +H R E +S DL +V
Sbjct: 202 VYSLGCVLYEVLTGEPPFTGDSPVSVAY----QHVREDPIPPSARHEGLSADLDAVVLKA 257
Query: 194 WVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPS-VPESDTNEAAATSNGAMT 242
++P R + +++ L P +P + +++ +++ G ++
Sbjct: 258 LAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAERTSLLSSAAGNLS 308
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 8e-42
Identities = 38/230 (16%), Positives = 80/230 (34%), Gaps = 35/230 (15%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALD 57
+H ++V++ A +D M+I E G SL + + + L
Sbjct: 64 HAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQ 123
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS------------------LKLADFGLARE 99
+ R + +H+ ++H D+KP N+ ++ K+ D G
Sbjct: 124 VGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV-- 181
Query: 100 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
T E G R++A E+ E + K D+++ + +
Sbjct: 182 -TRISSPQVEEGDSRFLANEVLQ-------ENYTHLPKADIFALALTVVCAAGAEPLPRN 233
Query: 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ + P +P+ +S + +++ DP RPS +++
Sbjct: 234 GD----QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 5e-39
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 23/219 (10%)
Query: 1 MMSRVKHDNLVKFL-------GACKDPLMVIVTELLPGMSLRKYLVSL-RPNKLDLHVAL 52
+M ++ H N+V + L ++ E G LRKYL L
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 53 NFALDIARAMDCLHANGIIHRDLKPDNLLL--TPDQKSLKLADFGLAREETVTEMMTAET 110
DI+ A+ LH N IIHRDLKP+N++L P + K+ D G A+E E+ T
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFV 184
Query: 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYA 168
GT +++APEL E+K Y VD +SFG + +E +T PF
Sbjct: 185 GTLQYLAPELL--------EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKV 236
Query: 169 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
+ + +D++ + F S + PN
Sbjct: 237 REKSNEHIVVYDDLTGAVKF---SSVLPTPNHLSGILAG 272
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 5e-38
Identities = 33/219 (15%), Positives = 77/219 (35%), Gaps = 20/219 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGM-----SLRKYLVSL--RPNKLDLHVALN 53
++ + +++ +D ++ L P M + + L+S L H L
Sbjct: 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 210
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
L + R + LH G++H L+P +++L + L F + + +
Sbjct: 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG-VFLTGFEHLVRDG---ARVVSSVSR 266
Query: 114 RWMAPEL---YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 170
+ PEL +T++ + + D ++ G+V++ + LP
Sbjct: 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK-DAALGGSEWI 325
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
F+ ++I + +++ R Q +
Sbjct: 326 FRS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-38
Identities = 51/212 (24%), Positives = 99/212 (46%), Gaps = 19/212 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ S ++H N+++ G D V ++ E P ++ + L + +K D + ++A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELA 119
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 117
A+ H+ +IHRD+KP+NLLL + LK+ADFG + GT ++
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGE-LKIADFGWS---VHAPSSRRTDLCGTLDYLP 175
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ E + ++ KVD++S G++ +E L + PFE + Q Y +
Sbjct: 176 PEMI--------EGRMHDEKVDLWSLGVLCYEFLVGKPPFEA-NTYQETYKRISR-VEFT 225
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P+ ++ ++ +P+ RP +++
Sbjct: 226 FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 257
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-37
Identities = 54/214 (25%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++KH ++++ +D V +V E+ + +YL + R + A +F I
Sbjct: 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIIT 123
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPE 119
M LH++GI+HRDL NLLLT ++K+ADFGLA + + E GT +++PE
Sbjct: 124 GMLYLHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPE 182
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY----AAAFKHAR 175
+ + + + + DV+S G + + LL R PF+ ++ A ++
Sbjct: 183 IAT--------RSAHGLESDVWSLGCMFYTLLIGRPPFDT-DTVKNTLNKVVLADYE--- 230
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+P +S + ++ +P R S S ++
Sbjct: 231 --MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-37
Identities = 62/234 (26%), Positives = 99/234 (42%), Gaps = 34/234 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALD 57
+S +H +LV +G C + M+++ + + +L+++L L + L +
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAR---EETVTEMMTAETGTY 113
AR + LH IIHRD+K N+LL D+ K+ DFG+++ E T + T GT
Sbjct: 148 AARGLHYLHTRAIIHRDVKSINILL--DENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF-----EGMSNLQAAYA 168
++ PE + K DVYSFG+VL+E+L R M NL A +A
Sbjct: 206 GYIDPEYFIK--------GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL-AEWA 256
Query: 169 AAFKHAR-------PGLPEDISPDLAF----IVQSCWVEDPNLRPSFSQIIRML 211
+ P L + I P+ C RPS ++ L
Sbjct: 257 VESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-37
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ H ++V F G +D V +V EL SL + + L A + I
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVL 126
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPE 119
LH N +IHRDLK NL L + +K+ DFGLA + E E GT ++APE
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K +P
Sbjct: 186 VLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRI-KKNEYSIP 235
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ I+P A ++Q DP RP+ ++++
Sbjct: 236 KHINPVAASLIQKMLQTDPTARPTINELLN 265
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 6e-37
Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 35/219 (15%)
Query: 19 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78
D + + L+ G+ L L P L A+ I A+D HA G HRD+KP+
Sbjct: 106 DGQLYVDMRLINGVDLAAMLRRQGP--LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPE 163
Query: 79 NLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135
N+L++ D L DFG+A +E +T++ GT +MAPE + + H
Sbjct: 164 NILVSADDF-AYLVDFGIASATTDEKLTQLGNT-VGTLYYMAPE--------RFSESHAT 213
Query: 136 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH----------ARPGLPEDISPD 185
+ D+Y+ VL+E LT P++G + H RPG+P
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGDQ-----LSVMGAHINQAIPRPSTVRPGIP----VA 264
Query: 186 LAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFTLRPPSP 223
++ ++P R + + +A L T
Sbjct: 265 FDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQDRA 303
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-37
Identities = 48/210 (22%), Positives = 88/210 (41%), Gaps = 15/210 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ S ++H N+++ D + ++ E P L K L + + D + F ++A
Sbjct: 67 IQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQ--KHGRFDEQRSATFMEELA 124
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A+ H +IHRD+KP+NLL+ + LK+ADFG + T GT ++ PE
Sbjct: 125 DALHYCHERKVIHRDIKPENLLMG-YKGELKIADFGWSVHAPSLRRRTM-CGTLDYLPPE 182
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ E K ++ KVD++ G++ +E L PF+ + + P
Sbjct: 183 MI--------EGKTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVN-VDLKFP 232
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+S ++ P R ++
Sbjct: 233 PFLSDGSKDLISKLLRYHPPQRLPLKGVME 262
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 58/268 (21%), Positives = 100/268 (37%), Gaps = 41/268 (15%)
Query: 1 MMSRVKHDNLVKFLGACKDP---------LMVIVTELLPGMSLRKYLVSLRP-NKLDLHV 50
M H N+V+F A +++TEL G L ++L + L
Sbjct: 79 MKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDT 137
Query: 51 ALNFALDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----- 103
L RA+ +H IIHRDLK +NLLL+ +Q ++KL DFG A +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSW 196
Query: 104 --------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155
E T + PE+ + K D+++ G +L+ L +
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYS-----NFPIGEKQDIWALGCILYLLCFRQH 251
Query: 156 PFEGMSNLQAAYAAAFKHARPGLPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213
PFE + L + + +P ++++ +P R S ++++ L
Sbjct: 252 PFEDGAKL------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305
Query: 214 FLFTLRPPSPSVPESDTNEAAATSNGAM 241
+ R +P P ++ E A
Sbjct: 306 -IAAARNVNPKSPITELLEQNGGYGSAT 332
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 15/210 (7%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ H ++V F G +D V +V EL SL + + L A + I
Sbjct: 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVL 152
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA-REETVTEMMTAETGTYRWMAPE 119
LH N +IHRDLK NL L + +K+ DFGLA + E E GT ++APE
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ S KK ++ +VDV+S G +++ LL + PFE S L+ Y K +P
Sbjct: 212 VLS--------KKGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRI-KKNEYSIP 261
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ I+P A ++Q DP RP+ ++++
Sbjct: 262 KHINPVAASLIQKMLQTDPTARPTINELLN 291
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 63/231 (27%), Positives = 97/231 (41%), Gaps = 30/231 (12%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNK-LDLHVALNFALDI 58
+M++ +H+NLV+ LG D + +V +P SL L L L H+ A
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGA 142
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRW 115
A ++ LH N IHRD+K N+LL + K++DFGLAR + T M + GT +
Sbjct: 143 ANGINFLHENHHIHRDIKSANILLDEAFTA-KISDFGLARASEKFAQTVMTSRIVGTTAY 201
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE---GMSNLQAAYAAAFK 172
MAPE G K D+YSFG+VL E++T + L +
Sbjct: 202 MAPE-ALR-----G---EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL-LDIKEEIE 251
Query: 173 HARPGLPEDISPDL-----------AFIVQSCWVEDPNLRPSFSQIIRMLN 212
+ + I + + C E N RP ++ ++L
Sbjct: 252 DEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 53/233 (22%), Positives = 88/233 (37%), Gaps = 35/233 (15%)
Query: 2 MSRVKHDNLVK------FLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
++ V H ++V+ DP+ IV E + G SL+ + KL + A+ +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK----RSKGQKLPVAEAIAYL 188
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW 115
L+I A+ LH+ G+++ DLKP+N++LT +Q LKL D G + GT +
Sbjct: 189 LEILPALSYLHSIGLVYNDLKPENIMLTEEQ--LKLIDLGAVSRINSFGYL---YGTPGF 243
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
APE+ T D+Y+ G L L + G
Sbjct: 244 QAPEIVRT---------GPTVATDIYTVGRTLAALTLDLPTRNG---------RYVDGLP 285
Query: 176 PGLPE-DISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRPPSPSVP 226
P +++ DP R + ++ L L + VP
Sbjct: 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-36
Identities = 47/213 (22%), Positives = 84/213 (39%), Gaps = 18/213 (8%)
Query: 6 KHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64
+H N++++ KD I EL +L++Y+ + + +
Sbjct: 76 EHPNVIRYFCTEKDRQFQYIAIELCAA-TLQEYVEQ-KDFAHLGLEPITLLQQTTSGLAH 133
Query: 65 LHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAR----EETVTEMMTAETGTYRWM 116
LH+ I+HRDLKP N+L++ ++DFGL + + GT W+
Sbjct: 134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYA-AAFKHA 174
APE+ L + K++ VD++S G V + +++ PF QA A
Sbjct: 194 APEM-----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD 248
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
+ +++ DP RPS +
Sbjct: 249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-35
Identities = 44/235 (18%), Positives = 90/235 (38%), Gaps = 34/235 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVS------LRPNKLDLHVALN 53
+++ +K++ + G + V I+ E + S+ K+ + + V
Sbjct: 96 IITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKC 155
Query: 54 FALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 112
+ + +H I HRD+KP N+L+ + +KL+DFG + ++ + GT
Sbjct: 156 IIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN-GRVKLSDFGESEYMVDKKIKGSR-GT 213
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY----- 167
Y +M PE +S E + KVD++S GI L+ + N +PF +L +
Sbjct: 214 YEFMPPEFFS------NESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
Query: 168 -------------AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+S + ++ ++P R + ++
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 32/239 (13%), Positives = 74/239 (30%), Gaps = 20/239 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLP-----GMSLRKYLVSL--RPNKLDLHVALN 53
++ + +++ +D ++ L P + + L+S L H L
Sbjct: 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQ 215
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 111
L + R + LH G++H L+P +++L + L F + + +
Sbjct: 216 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGASAVSPIGRGFA 274
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 171
A + Q D ++ G+ ++ + LP F
Sbjct: 275 PPETTAERMLPF---GQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTD-DAALGGSEWIF 330
Query: 172 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDT 230
+ ++I + +++ R Q + + S ++P T
Sbjct: 331 RS-----CKNIPQPVRALLEGFLRYPKEDRLLPLQAMET-PEYEQLRTELSAALPLYQT 383
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-34
Identities = 49/185 (26%), Positives = 87/185 (47%), Gaps = 13/185 (7%)
Query: 35 RKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADF 94
+ L + L L + ++ +A+ M+ L + IHRDL N+LL+ +K+ DF
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDF 237
Query: 95 GLAREETVTEMMTAETGT---YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151
GLAR+ + +WMAPE + Y + DV+SFG++LWE+
Sbjct: 238 GLARDIYKDPDYVRKGDARLPLKWMAPE--------TIFDRVYTIQSDVWSFGVLLWEIF 289
Query: 152 TN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
+ P+ G+ + + R P+ +P++ + CW +P+ RP+FS+++
Sbjct: 290 SLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
Query: 211 LNAFL 215
L L
Sbjct: 350 LGNLL 354
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 29/91 (31%), Positives = 35/91 (38%), Gaps = 10/91 (10%)
Query: 1 MMSRVKHDNLVKFLGAC---KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
++ H N+V LGAC PLMVIV E +L YL S R +
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKT------K 131
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKS 88
AR G I DLK +T Q S
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSS 162
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++ ++ H ++K IV EL+ G L +V +L + +
Sbjct: 193 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLL 250
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAP 118
A+ LH NGIIHRDLKP+N+LL+ ++ +K+ DFG ++ T +M GT ++AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ L YN VD +S G++L+ L+ PF Q + +
Sbjct: 311 EV-----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSLKDQITSGKYNF 364
Query: 179 PE----DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 209
++S DL V+ V DP R + + +R
Sbjct: 365 IPEVWAEVSEKALDL---VKKLLVVDPKARFTTEEALR 399
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 2e-33
Identities = 23/175 (13%), Positives = 49/175 (28%), Gaps = 16/175 (9%)
Query: 42 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 101
+ + R L + G++H PDNL + PD L L D +
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALWKV- 244
Query: 102 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161
A + + E + + ++ + G+ ++ + LPF ++
Sbjct: 245 -GTRGPASSVPVTYAPRE------FLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 162 NLQAAYAAAFKHARPGLPE-------DISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
PG + + ++ D R + +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 44/228 (19%), Positives = 89/228 (39%), Gaps = 29/228 (12%)
Query: 7 HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLV-----SLRPNKLDLHVALNFALDIAR 60
H N++++ + + I EL +L+ + + ++ IA
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKS------------LKLADFGLAR-----EETVT 103
+ LH+ IIHRDLKP N+L++ + + ++DFGL + + +
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 104 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSN 162
+ +GT W APEL Q K+ +D++S G V + +L+ + PF +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQT-KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 163 LQAAYAAA---FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
++ + + + ++ DP RP+ ++
Sbjct: 246 RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-33
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALD 57
++ + H N++K +D + IV E G L + +VS + L
Sbjct: 73 VLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 58 IARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRW 115
+ A+ H+ ++H+DLKP+N+L S +K+ DFGLA E T GT +
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALY 192
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFK 172
MAPE++ K+ K D++S G+V++ LLT LPF G S Q A
Sbjct: 193 MAPEVF---------KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 173 HARPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQI 207
+A ++P DL ++ +DP RPS +Q+
Sbjct: 244 YAVE--CRPLTPQAVDL---LKQMLTKDPERRPSAAQV 276
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 6e-33
Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 21/216 (9%)
Query: 2 MSRVKHDNLVKFL----GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+ ++ H N+VK + +D L +V EL+ + + L A + D
Sbjct: 90 LKKLDHPNVVKLVEVLDDPNEDHLY-MVFELVNQGPVMEVP---TLKPLSEDQARFYFQD 145
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-GTYRWM 116
+ + ++ LH IIHRD+KP NLL+ + +K+ADFG++ E ++ + + T GT +M
Sbjct: 146 LIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFM 204
Query: 117 APELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
APE S +K ++ +DV++ G+ L+ + + PF + ++ K
Sbjct: 205 APESLS------ETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKI-KSQA 256
Query: 176 PGLPE--DISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P+ DI+ DL ++ ++P R +I
Sbjct: 257 LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-33
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ + H N++K +D +V E G L ++ K + A +
Sbjct: 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVL 146
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMA 117
+ LH + I+HRDLKP+NLLL + ++ + +K+ DFGL+ + M GT ++A
Sbjct: 147 SGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHA 174
PE+ +K Y+ K DV+S G++L+ LL PF G ++ L+ +
Sbjct: 207 PEVL---------RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
P ++S +++ D R S Q
Sbjct: 258 SPEWK-NVSEGAKDLIKQMLQFDSQRRISAQQA 289
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-33
Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 14/215 (6%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 58
+++ H +VK LGA D + I+ E PG ++ ++ L + + +
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV-VCRQM 126
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWM 116
A++ LH+ IIHRDLK N+L+T + ++LADFG++ + T + ++ GT WM
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKT-LQKRDSFIGTPYWM 184
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE+ V + Y+ K D++S GI L E+ P ++ ++ A K P
Sbjct: 185 APEV---VMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA-KSDPP 240
Query: 177 GL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
L P S + ++ ++P RPS +Q++
Sbjct: 241 TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-32
Identities = 54/211 (25%), Positives = 92/211 (43%), Gaps = 11/211 (5%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL--VSLRPNKLDLHVALNFALD 57
M V V F GA ++ + I EL+ SL K+ V + + + A+
Sbjct: 59 SMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 58 IARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 116
I +A++ LH+ +IHRD+KP N+L+ +K+ DFG++ + G +M
Sbjct: 118 IVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYM 176
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE + +K Y+ K D++S GI + EL R P++ + P
Sbjct: 177 APE----RINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232
Query: 177 GLPEDI-SPDLAFIVQSCWVEDPNLRPSFSQ 206
LP D S + C ++ RP++ +
Sbjct: 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 10/210 (4%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +V+ G + + I EL+ + + + + + I
Sbjct: 77 VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKK--RMQGPIPERILGKMTVAIV 134
Query: 60 RAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+A+ L +G+IHRD+KP N+LL ++ +KL DFG++ + G +MAP
Sbjct: 135 KALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAP 193
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E + Y+ + DV+S GI L EL T + P++ + P L
Sbjct: 194 ERIDPPDPTKP---DYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250
Query: 179 PEDI--SPDLAFIVQSCWVEDPNLRPSFSQ 206
P + S D V+ C +D RP +++
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 27/277 (9%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ ++ H N++K +D IV EL G L ++ + H A +
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFS 132
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ +H + I+HRDLKP+N+LL + ++ +K+ DFGL+ M GT ++AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHAR 175
E+ + Y+ K DV+S G++L+ LL+ PF G + L+ +
Sbjct: 193 EVL---------RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDL 243
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAAA 235
P IS D +++ P+LR + +Q + + ++ +P++ + + E+A
Sbjct: 244 PQWR-TISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYSSETPTISDLPSLESAM 300
Query: 236 TSNGAMTEFSARARGKFAFLR----QLFTAKRTKNLQ 268
T+ + +F A + A L +L T TK L
Sbjct: 301 TN---IRQFQAEKKLAQAALLYMASKLTTLDETKQLT 334
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-32
Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++ H N++K +D +V E+ G L ++S + A +
Sbjct: 79 LLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVL 136
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMA 117
+ +H N I+HRDLKP+NLLL + + + +++ DFGL+ ++ M + GT ++A
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHA 174
PE+ Y+ K DV+S G++L+ LL+ PF G + L+ +
Sbjct: 197 PEVL---------HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFE 247
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
P +S +++ P++R S
Sbjct: 248 LPQWK-KVSESAKDLIRKMLTYVPSMRISARDA 279
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-32
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ + H N++K +D +VTE G L + +++ +K D A N I
Sbjct: 99 LLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQIL 156
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMA 117
+ LH + I+HRD+KP+N+LL + +K+ DFGL+ + + GT ++A
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIA 216
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHA 174
PE+ KK YN K DV+S G++++ LL PF G ++ ++ +
Sbjct: 217 PEVL---------KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
+IS + +++ D N R + +
Sbjct: 268 FNDWK-NISDEAKELIKLMLTYDYNKRCTAEEA 299
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-32
Identities = 33/189 (17%), Positives = 66/189 (34%), Gaps = 25/189 (13%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFAL 56
+ +KF A V+V EL +L + + + + ++FA+
Sbjct: 120 RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTP----------DQKSLKLADFGLAREETV---T 103
+ ++ +H IIH D+KPDN +L L L D G + + +
Sbjct: 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 104 EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
+ TA+ T + E+ K +N ++D + ++ +L
Sbjct: 240 TIFTAKCETSGFQCVEML--------SNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 164 QAAYAAAFK 172
+ F+
Sbjct: 292 ECKPEGLFR 300
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 9e-32
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 58
++S+ + K+ G+ KD + I+ E L G S L P LD +A +I
Sbjct: 73 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIAT-ILREI 128
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWM 116
+ +D LH+ IHRD+K N+LL+ + +KLADFG+A + T T + T GT WM
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDT-QIKRNTFVGTPFWM 186
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE V + Y++K D++S GI EL P + ++ + K+ P
Sbjct: 187 APE----VIKQSA----YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-KNNPP 237
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPS 203
L + S L V++C ++P+ RP+
Sbjct: 238 TLEGNYSKPLKEFVEACLNKEPSFRPT 264
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 20/218 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++ ++ H ++K IV EL+ G L +V +L + +
Sbjct: 68 ILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLL 125
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
A+ LH NGIIHRDLKP+N+LL + ++ +K+ DFG ++ T +M GT ++AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ L YN VD +S G++L+ L+ PF Q + +
Sbjct: 186 EV-----LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE-HRTQVSLKDQITSGKYNF 239
Query: 179 PE----DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 209
++S DL V+ V DP R + + +R
Sbjct: 240 IPEVWAEVSEKALDL---VKKLLVVDPKARFTTEEALR 274
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++H LV + +D M +V +LL G LR +L + F ++
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICELV 125
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
A+D L IIHRD+KPDN+LL D+ + + DF +A +T GT +MAP
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILL--DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAP 183
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHARP 176
E+ + Y+ VD +S G+ +ELL R P+ S + + F+
Sbjct: 184 EM-----FSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV-HTFETTVV 237
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLR 201
P S ++ +++ +P+ R
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-31
Identities = 59/209 (28%), Positives = 95/209 (45%), Gaps = 19/209 (9%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 58
+M + ++VK+ G+ K+ + IV E S+ ++ LR L +A
Sbjct: 77 IMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-ILQST 134
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWM 116
+ ++ LH IHRD+K N+LL + KLADFG+A + T T M T GT WM
Sbjct: 135 LKGLEYLHFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDT-MAKRNTVIGTPFWM 192
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE+ + YN D++S GI E+ + P+ + ++A + + P
Sbjct: 193 APEVIQ--------EIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP-TNPPP 243
Query: 177 GL--PEDISPDLAFIVQSCWVEDPNLRPS 203
PE S + V+ C V+ P R +
Sbjct: 244 TFRKPELWSDNFTDFVKQCLVKSPEQRAT 272
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-31
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 26/217 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M + H N+++ +D + +V EL G L + +V A D+
Sbjct: 59 IMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVL 116
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMA 117
A+ H + HRDLKP+N L T S LKL DFGLA +MM + GT +++
Sbjct: 117 SAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVS 176
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
P++ + Y + D +S G++++ LL PF +
Sbjct: 177 PQVL---------EGLYGPECDEWSAGVMMYVLLCGYPPFSA-PTDSEVMLKI-REGTFT 225
Query: 178 LPED----ISP---DLAFIVQSCWVEDPNLRPSFSQI 207
PE +SP L ++ + P R + Q
Sbjct: 226 FPEKDWLNVSPQAESL---IRRLLTKSPKQRITSLQA 259
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 18/220 (8%)
Query: 1 MMSRVKHDNLVKFLGA-------CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVAL 52
+ H N+ + GA D + +V E S+ + + + N L +A
Sbjct: 74 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 133
Query: 53 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 110
+I R + LH + +IHRD+K N+LLT + +KL DFG++ + T + T
Sbjct: 134 -ICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRT-VGRRNTFI 190
Query: 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 170
GT WMAPE+ + + Y+ K D++S GI E+ P M ++A +
Sbjct: 191 GTPYWMAPEV---IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247
Query: 171 FKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
++ P L + S ++SC V++ + RP+ Q+++
Sbjct: 248 -RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-31
Identities = 69/232 (29%), Positives = 109/232 (46%), Gaps = 23/232 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 58
+M K+ N+V +L + + +V E L G SL + +D +A +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAA-VCREC 125
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWM 116
+A++ LH+N +IHRD+K DN+LL S+KL DFG + T T GT WM
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWM 183
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE+ + +K Y KVD++S GI+ E++ P+ + L+A Y A + P
Sbjct: 184 APEVVT--------RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA-TNGTP 234
Query: 177 GL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
L PE +S + C D R S ++++ + FL +P S P
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-31
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLR--KYLVSLRPNKLDLHVALNFALD 57
+M +V+F GA ++ I EL+ + KY+ S+ + + + L
Sbjct: 74 VMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 58 IARAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 116
+A++ L N IIHRD+KP N+LL ++KL DFG++ + + T + G +M
Sbjct: 134 TVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYM 192
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE ++ Y+ + DV+S GI L+EL T R P+ +++ K P
Sbjct: 193 APE----RIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPP 248
Query: 177 GLPEDI----SPDLAFIVQSCWVEDPNLRPSFSQ 206
L SP V C +D + RP + +
Sbjct: 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-30
Identities = 54/216 (25%), Positives = 95/216 (43%), Gaps = 26/216 (12%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ ++ H N++K +D IV EL G L ++ + H A +
Sbjct: 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFS 132
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ +H + I+HRDLKP+N+LL + ++ +K+ DFGL+ M GT ++AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ + Y+ K DV+S G++L+ LL+ PF G + + + +
Sbjct: 193 EVL---------RGTYDEKCDVWSAGVILYILLSGTPPFYGKN--EYDILKRVETGKYAF 241
Query: 179 PED----ISP---DLAFIVQSCWVEDPNLRPSFSQI 207
IS DL ++ P+LR + +Q
Sbjct: 242 DLPQWRTISDDAKDL---IRKMLTFHPSLRITATQC 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 15/210 (7%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
M + H N+VK + + ++ E G + YLV+ ++ A + I
Sbjct: 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVS 125
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
A+ H I+HRDLK +NLLL ++K+ADFG + E TV + A G + APEL
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPEL 184
Query: 121 YSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ K Y+ +VDV+S G++L+ L++ LPF+G NL+ + +P
Sbjct: 185 FQ--------GKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELR-ERVLRGKYRIP 234
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+S D +++ V +P R + QI++
Sbjct: 235 FYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 46/213 (21%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 2 MSRVKHD--NLVKFLGACKDPLM-VIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+ +V +++ L + P V++ E P L ++ L +A +F
Sbjct: 100 LKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQ 157
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
+ A+ H G++HRD+K +N+L+ ++ LKL DFG T + GT +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSP 216
Query: 118 PELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
PE Y+ V+S GI+L++++ +PFE + +
Sbjct: 217 PEWIR--------YHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQV 260
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ +S + +++ C P+ RP+F +I
Sbjct: 261 FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 62/232 (26%), Positives = 108/232 (46%), Gaps = 23/232 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 58
+M +H N+V+ + + ++ E L G +L + +L+ +A +
Sbjct: 95 IMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIAT-VCEAV 150
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWM 116
+A+ LHA G+IHRD+K D++LLT +KL+DFG + + + ++ GT WM
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKD-VPKRKSLVGTPYWM 208
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE+ S + Y +VD++S GI++ E++ P+ S +QA P
Sbjct: 209 APEVIS--------RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPPP 259
Query: 177 GL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
L +SP L ++ V DP R + +++ + FL P VP
Sbjct: 260 KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLLQTGLPECLVP 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-30
Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 31/225 (13%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN------ 53
MS+ H N+V + + + +V +LL G S+ + + L+
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG----LAREETVTEMMTAE 109
++ ++ LH NG IHRD+K N+LL + S+++ADFG LA +T +
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRK 184
Query: 110 T--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 167
T GT WMAPE+ + + Y+ K D++SFGI EL T P+ ++
Sbjct: 185 TFVGTPCWMAPEVME-------QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM 237
Query: 168 AAAFKHARPGLPEDI---------SPDLAFIVQSCWVEDPNLRPS 203
++ P L + ++ C +DP RP+
Sbjct: 238 LTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-30
Identities = 56/241 (23%), Positives = 100/241 (41%), Gaps = 22/241 (9%)
Query: 2 MSRVKHDNLVKF---LGACKDPLMVIVTELLPG--MSLRKYLVSLRPNKLDLHVALNFAL 56
+ R++H N+++ L + M +V E + + + + A +
Sbjct: 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE---KRFPVCQAHGYFC 116
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTY 113
+ ++ LH+ GI+H+D+KP NLLLT +LK++ G+A + G+
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
+ PE+ + G KVD++S G+ L+ + T PFEG N+ + K
Sbjct: 176 AFQPPEIAN------GLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGK- 227
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM--LNAFLFTLRPPSPSVPESDTN 231
+P D P L+ +++ +P R S QI + P P P DT
Sbjct: 228 GSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTK 287
Query: 232 E 232
+
Sbjct: 288 D 288
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 34/236 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDPLM-VIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFALD 57
M+S H NL++ G C P ++V + S+ L ++ LD AL
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 58 IARAMDCLH--AN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGT 112
AR + LH + IIHRD+K N+LL + ++ + DFGLA+ + T + TA GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA-VVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 172
+APE ST G + K DV+ +G++L EL+T + F+
Sbjct: 199 IGHIAPEYLST-----G---KSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 173 HARP-----GLPEDISPDL------------AFIVQSCWVEDPNLRPSFSQIIRML 211
+ L + DL + C P RP S+++RML
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 5e-30
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 34/277 (12%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+++H N+V+ + ++ +V +L+ G L + +V+ A + I
Sbjct: 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILE 139
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
++ H+NGI+HR+LKP+NLLL + + + +KLADFGLA E +E GT +++P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ L+ K Y+ VD+++ G++L+ LL PF Q A K
Sbjct: 200 EV-----LK---KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDY 249
Query: 179 PED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTN 231
P ++P L + S +P R + Q L R S
Sbjct: 250 PSPEWDTVTPEAKSL---IDSMLTVNPKKRITADQA---LKVPWICNRERVASAIHRQDT 303
Query: 232 EAAATSNGAMTEFSARARGKFAFLRQLFTAKRTKNLQ 268
+ +F+AR + K A L + + NL
Sbjct: 304 VD------CLKKFNARRKLKGAILTTMIATRNLSNLG 334
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-30
Identities = 57/228 (25%), Positives = 100/228 (43%), Gaps = 18/228 (7%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ +H +++K P +V E + G L Y+ +++ A I
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILS 122
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
A+D H + ++HRDLKP+N+LL + K+ADFGL+ + E + G+ + APE+
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181
Query: 121 YSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
S + Y +VD++S G++L+ LL LPF+ ++ + +P
Sbjct: 182 IS--------GRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRG-GVFYIP 231
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 227
E ++ +A ++ DP R + I F PS PE
Sbjct: 232 EYLNRSVATLLMHMLQVDPLKRATIKDIREHE---WFKQDLPSYLFPE 276
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-30
Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 6 KHDNLVKFLGACKDPLM-VIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 63
H +++ L + ++V E LP L Y+ L + F + A+
Sbjct: 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQ 153
Query: 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYST 123
H+ G++HRD+K +N+L+ + KL DFG + GT + PE S
Sbjct: 154 HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWIS- 211
Query: 124 VTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDI 182
+ Y+ V+S GI+L++++ +PFE + A P +
Sbjct: 212 -------RHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------LEAELHFPAHV 256
Query: 183 SPDLAFIVQSCWVEDPNLRPSFSQIIR 209
SPD +++ C P+ RPS +I+
Sbjct: 257 SPDCCALIRRCLAPKPSSRPSLEEILL 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 53/257 (20%), Positives = 93/257 (36%), Gaps = 55/257 (21%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHV--------- 50
+M ++ H N+ + +D + +V EL G L L +
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 51 -----------------------------ALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
N I A+ LH GI HRD+KP+N L
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFL 200
Query: 82 LTPDQKS-LKLADFGLAR-----EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135
+ ++ +KL DFGL++ MT + GT ++APE+ L + Y
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-----LN-TTNESYG 254
Query: 136 NKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHARPGLPEDISPDLAFIVQS 192
K D +S G++L LL +PF G+++ + P +SP ++ +
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN-VLSPLARDLLSN 313
Query: 193 CWVEDPNLRPSFSQIIR 209
+ + R + ++
Sbjct: 314 LLNRNVDERFDAMRALQ 330
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 24/219 (10%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ R+ H N++K + P + +V EL+ G L +V A + I
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQIL 158
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMA 117
A+ LH NGI+HRDLKP+NLL TP + LK+ADFGL++ +M GT + A
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCA 218
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ LR Y +VD++S GI+ + LL PF Q + +
Sbjct: 219 PEI-----LR---GCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMF-RRILNCEYY 269
Query: 178 LPE----DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 209
++S DL V+ V DP R + Q ++
Sbjct: 270 FISPWWDEVSLNAKDL---VRKLIVLDPKKRLTTFQALQ 305
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 58
+ +++H N +++ G ++ +V E G + L+ + L + +A
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAA-VTHGA 163
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWM 116
+ + LH++ +IHRD+K N+LL+ + +KL DFG A + M A + GT WM
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSA-----SIMAPANSFVGTPYWM 217
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
APE+ + ++ Y+ KVDV+S GI EL + P M+ + A Y A ++ P
Sbjct: 218 APEV-----ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-QNESP 271
Query: 177 GL-PEDISPDLAFIVQSCWVEDPNLRPS 203
L S V SC + P RP+
Sbjct: 272 ALQSGHWSEYFRNFVDSCLQKIPQDRPT 299
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-29
Identities = 58/216 (26%), Positives = 101/216 (46%), Gaps = 25/216 (11%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+++H N+V+ + ++ +V +L+ G L + +V+ A + I
Sbjct: 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILE 116
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
++ H+NGI+HR+LKP+NLLL + + + +KLADFGLA E +E GT +++P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ L+ K Y+ VD+++ G++L+ LL PF Q A K
Sbjct: 177 EV-----LK---KDPYSKPVDIWACGVILYILLVGYPPFWDED--QHRLYAQIKAGAYDY 226
Query: 179 PED----ISP---DLAFIVQSCWVEDPNLRPSFSQI 207
P ++P L + S +P R + Q
Sbjct: 227 PSPEWDTVTPEAKSL---IDSMLTVNPKKRITADQA 259
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-29
Identities = 51/211 (24%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+SRV+H N++K L ++ +V E G+ L ++ R +LD +A +
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID--RHPRLDEPLASYIFRQLV 140
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A+ L IIHRD+K +N+++ + ++KL DFG A ++ GT + APE
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199
Query: 120 LYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
+ Y +++++S G+ L+ L+ PF L+ AA
Sbjct: 200 VLM--------GNPYRGPELEMWSLGVTLYTLVFEENPFC---ELEETVEAAIH-----P 243
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P +S +L +V P R + +++
Sbjct: 244 PYLVSKELMSLVSGLLQPVPERRTTLEKLVT 274
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 58/214 (27%), Positives = 98/214 (45%), Gaps = 17/214 (7%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ H+N+VKF G ++ + + E G L + + A F +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA 116
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMA 117
+ LH GI HRD+KP+NLLL ++ +LK++DFGLA R ++ GT ++A
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 118 PELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
PEL ++ ++ VDV+S GIVL +L LP++ S+ Y+ +
Sbjct: 176 PELLK--------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227
Query: 177 GLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P + I ++ VE+P+ R + I +
Sbjct: 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-28
Identities = 54/300 (18%), Positives = 100/300 (33%), Gaps = 71/300 (23%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLD-LHVALNFALDI 58
+ H N+V + D + +VT + S + + + + ++ L +A +
Sbjct: 79 VSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY-ILQGV 137
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA--------REETVTEMMTAET 110
+A+D +H G +HR +K ++L++ + L+ R+ V +
Sbjct: 138 LKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196
Query: 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA----- 165
W++PE+ L+Q + Y+ K D+YS GI EL +PF+ M Q
Sbjct: 197 KVLPWLSPEV-----LQQ-NLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250
Query: 166 ---------------------------------------AYAAAFKHARPGLPEDISPDL 186
+ SP
Sbjct: 251 NGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHF 310
Query: 187 AFIVQSCWVEDPNLRPS---------FSQIIRMLNAFLFTLRPPSPSVPESDTNEAAATS 237
V+ C +P+ RPS F QI R + L L P + + +++ S
Sbjct: 311 HHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHS 370
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 63/233 (27%), Positives = 106/233 (45%), Gaps = 19/233 (8%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ ++H +++K P + +V E G L Y+V + ++ F I
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYAGG-ELFDYIVEKK--RMTEDEGRRFFQQIIC 119
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
A++ H + I+HRDLKP+NLLL D ++K+ADFGL+ T + G+ + APE+
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 121 YSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ K Y +VDV+S GIVL+ +L RLPF+ + + +P
Sbjct: 179 IN--------GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKV-NSCVYVMP 228
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNE 232
+ +SP +++ V DP R + +I R F + P P +
Sbjct: 229 DFLSPGAQSLIRRMIVADPMQRITIQEIRRDP---WFNVNLPDYLRPMEEVQG 278
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 65/269 (24%), Positives = 110/269 (40%), Gaps = 38/269 (14%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL--HVALNFALDI 58
+KH ++V+ L M+ +V E + G L +V VA ++ I
Sbjct: 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 59 ARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRW 115
A+ H N IIHRD+KP +LL + + + +KL FG+A + + GT +
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN--LQAAYAAAFKH 173
MAPE+ ++ ++ Y VDV+ G++L+ LL+ LPF G + +K
Sbjct: 200 MAPEV-----VK---REPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKM 251
Query: 174 ARPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPE 227
IS DL V+ + DP R + + + + + + P E
Sbjct: 252 NPRQWS-HISESAKDL---VRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE 307
Query: 228 SDTNEAAATSNGAMTEFSARARGKFAFLR 256
+ +F+AR + K A L
Sbjct: 308 Q------------LRKFNARRKLKGAVLA 324
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 9e-28
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 20/242 (8%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ H+N+VKF G ++ + + E G L + + A F +
Sbjct: 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMA 116
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA---REETVTEMMTAETGTYRWMA 117
+ LH GI HRD+KP+NLLL ++ +LK++DFGLA R ++ GT ++A
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 118 PELYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
PEL ++ ++ VDV+S GIVL +L LP++ S+ Y+ +
Sbjct: 176 PELLK--------RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 227
Query: 177 GLP-EDISPDLAFIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNE 232
P + I ++ VE+P+ R + I + + P + +
Sbjct: 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESP 287
Query: 233 AA 234
+
Sbjct: 288 SG 289
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 23/215 (10%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
MS ++H LV A +D MV++ E + G L + + NK+ A+ + +
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVC 265
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ + +H N +H DLKP+N++ T LKL DFGL + + TGT + AP
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ E K D++S G++ + LL+ PF G + K +
Sbjct: 326 EVA--------EGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--DDETLRNVKSCDWNM 375
Query: 179 PED----ISP---DLAFIVQSCWVEDPNLRPSFSQ 206
+ IS D ++ + DPN R + Q
Sbjct: 376 DDSAFSGISEDGKDF---IRKLLLADPNTRMTIHQ 407
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 23/176 (13%)
Query: 1 MMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL---HV 50
+M VKH N+V G KD + + +V E +P ++ + K + +
Sbjct: 85 IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP-ETVYRASRHYAKLKQTMPMLLI 143
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAE- 109
L + + R++ +H+ GI HRD+KP NLLL P LKL DFG A+ E +
Sbjct: 144 KL-YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYI 202
Query: 110 -TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
+ YR APEL T +Y +D++S G V+ EL+ + F G S +
Sbjct: 203 CSRYYR--APELIFGAT-------NYTTNIDIWSTGCVMAELMQGQPLFPGESGID 249
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-27
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 13/149 (8%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
I A++ LH GII+RD+K +N+LL + + L DFGL++E E A GT +
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEY 226
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK--- 172
MAP++ +G ++ VD +S G++++ELLT PF + + A +
Sbjct: 227 MAPDIV------RGGDSGHDKAVDWWSLGVLMYELLTGASPFTV-DGEKNSQAEISRRIL 279
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ P P+++S ++Q ++DP R
Sbjct: 280 KSEPPYPQEMSALAKDLIQRLLMKDPKKR 308
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-27
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 30/226 (13%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
++V L ++ I+ E + G L + A
Sbjct: 75 HWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM 134
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTY 113
DI A+ LH++ I HRD+KP+NLL + ++ + LKL DFG A+E T + T T
Sbjct: 135 RDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTP 193
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
++APE+ + Y+ D++S G++++ LL PF + QA +
Sbjct: 194 YYVAPEVL--------GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG-QAISPGMKRR 244
Query: 174 ARPGLPE-------DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 209
R G ++S L ++ DP R + +Q +
Sbjct: 245 IRLGQYGFPNPEWSEVSEDAKQL---IRLLLKTDPTERLTITQFMN 287
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-27
Identities = 55/236 (23%), Positives = 102/236 (43%), Gaps = 18/236 (7%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ +H +++K P + +V E + G L Y+ +LD + I
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILS 127
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
+D H + ++HRDLKP+N+LL + K+ADFGL+ + E + G+ + APE+
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 186
Query: 121 YSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
S + Y +VD++S G++L+ LL LPF+ ++ + P
Sbjct: 187 IS--------GRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKI-CDGIFYTP 236
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDTNE 232
+ ++P + +++ DP R + I L P PS + ++
Sbjct: 237 QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDD 292
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-27
Identities = 51/216 (23%), Positives = 83/216 (38%), Gaps = 19/216 (8%)
Query: 1 MMSRVK-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
++ +V H N+++ + +V +L+ L YL L +
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRAL 133
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ LH I+HRDLKP+N+LL D ++KL DFG + + E + GT ++AP
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ Y +VD++S G++++ LL PF Q
Sbjct: 193 EIIECSM--NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--QMLMLRMIMSGNYQF 248
Query: 179 PE----DISP---DLAFIVQSCWVEDPNLRPSFSQI 207
D S DL V V P R + +
Sbjct: 249 GSPEWDDYSDTVKDL---VSRFLVVQPQKRYTAEEA 281
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-27
Identities = 65/276 (23%), Positives = 114/276 (41%), Gaps = 35/276 (12%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ +KH N+V+ + + ++ +L+ G L + +V+ A + I
Sbjct: 63 ICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQIL 120
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRWM 116
A+ H G++HR+LKP+NLLL + + + +KLADFGLA E E + GT ++
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYL 180
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
+PE+ LR K Y VD+++ G++L+ LL PF Q K
Sbjct: 181 SPEV-----LR---KDPYGKPVDLWACGVILYILLVGYPPFWDED--QHRLYQQIKAGAY 230
Query: 177 GLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESD 229
P ++P DL + +P+ R + ++ L + R S
Sbjct: 231 DFPSPEWDTVTPEAKDL---INKMLTINPSKRITAAEA---LKHPWISHRSTVASCMHRQ 284
Query: 230 TNEAAATSNGAMTEFSARARGKFAFLRQLFTAKRTK 265
+ +F+AR + K A L + +
Sbjct: 285 ETVD------CLKKFNARRKLKGAILTVMLATRNFS 314
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-27
Identities = 51/205 (24%), Positives = 87/205 (42%), Gaps = 17/205 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+MSR+ H VK +D + L KY+ + D + +I
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIV 140
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAET--GTYRWM 116
A++ LH GIIHRDLKP+N+LL + +++ DFG A+ ++ A + GT +++
Sbjct: 141 SALEYLHGKGIIHRDLKPENILLN-EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
+PEL +K D+++ G ++++L+ PF N +
Sbjct: 200 SPELL--------TEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNEYLIF-QKIIKLEY 249
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLR 201
PE P +V+ V D R
Sbjct: 250 DFPEKFFPKARDLVEKLLVLDATKR 274
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-26
Identities = 48/214 (22%), Positives = 96/214 (44%), Gaps = 21/214 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M+++ H L+ A +D MV++ E L G L + + K+ +N+
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQAC 159
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ +H + I+H D+KP+N++ T S+K+ DFGLA + E++ T T + AP
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHAR 175
E+ +++ D+++ G++ + LL+ PF G + LQ ++
Sbjct: 220 EIV--------DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 271
Query: 176 PGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQ 206
+SP D +++ ++P R +
Sbjct: 272 DAFS-SVSPEAKDF---IKNLLQKEPRKRLTVHD 301
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 58/247 (23%), Positives = 97/247 (39%), Gaps = 22/247 (8%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++H N+V+F P + I+ E G L + + + + A F +
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLS 127
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAPE 119
+ H+ I HRDLK +N LL LK+ DFG ++ + + GT ++APE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187
Query: 120 LYSTVTLRQGEKKHYN-NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG- 177
+ ++ Y+ DV+S G+ L+ +L PFE Y +
Sbjct: 188 VLL--------RQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRILSVK 238
Query: 178 --LPED--ISPDLAFIVQSCWVEDPNLRPSFSQIIR---MLNAFLFTLRPPSPSVPESDT 230
+P+D ISP+ ++ +V DP R S +I L L S + +
Sbjct: 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE 298
Query: 231 NEAAATS 237
E S
Sbjct: 299 PEQPMQS 305
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-26
Identities = 39/214 (18%), Positives = 92/214 (42%), Gaps = 23/214 (10%)
Query: 2 MSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++ +H N++ + + +V++ E + G+ + + + + +L+ +++ +
Sbjct: 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCE 113
Query: 61 AMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A+ LH++ I H D++P+N++ T ++K+ +FG AR+ + + APE
Sbjct: 114 ALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE 173
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ + + D++S G +++ LL+ PF + +A
Sbjct: 174 V-----HQH---DVVSTATDMWSLGTLVYVLLSGINPFLAET--NQQIIENIMNAEYTFD 223
Query: 180 ED----ISP---DLAFIVQSCWVEDPNLRPSFSQ 206
E+ IS D V V++ R + S+
Sbjct: 224 EEAFKEISIEAMDF---VDRLLVKERKSRMTASE 254
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 21/216 (9%)
Query: 2 MSRVK-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ +V H +++ + + + + +V +L+ L YL L + +
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE--KVALSEKETRSIMRSLL 210
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A+ LHAN I+HRDLKP+N+LL + ++L+DFG + E + GT ++APE
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269
Query: 120 -LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
L ++ Y +VD+++ G++L+ LL PF Q +
Sbjct: 270 ILKCSMDETH---PGYGKEVDLWACGVILFTLLAGSPPFWHRR--QILMLRMIMEGQYQF 324
Query: 179 PE----DISP---DLAFIVQSCWVEDPNLRPSFSQI 207
D S DL + DP R + Q
Sbjct: 325 SSPEWDDRSSTVKDL---ISRLLQVDPEARLTAEQA 357
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-26
Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 19/213 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M+++ H NL++ A + +V+V E + G L ++ L + F I
Sbjct: 139 VMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQIC 197
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ +H I+H DLKP+N+L D K +K+ DFGLAR E + GT ++AP
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHAR 175
E+ + + D++S G++ + LL+ PF G ++ L A +
Sbjct: 258 EV-----VNY---DFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLED 309
Query: 176 PGLPEDISPDLA--FIVQSCWVEDPNLRPSFSQ 206
DIS + A FI +++ + R S S+
Sbjct: 310 EEFQ-DIS-EEAKEFI-SKLLIKEKSWRISASE 339
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 56/176 (31%), Positives = 86/176 (48%), Gaps = 23/176 (13%)
Query: 1 MMSRVKHDNLVKFL------GACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDL---HV 50
+M ++ H N+V+ G KD + + +V + +P ++ + K L +V
Sbjct: 100 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYV 158
Query: 51 ALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110
L + + R++ +H+ GI HRD+KP NLLL PD LKL DFG A++ E +
Sbjct: 159 KL-YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 111 GT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
+ YR APEL T Y + +DV+S G VL ELL + F G S +
Sbjct: 218 CSRYYR--APELIFGAT-------DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD 264
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-26
Identities = 57/268 (21%), Positives = 103/268 (38%), Gaps = 37/268 (13%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +V H N++ ++ +V++ EL+ G L +L L A +F I
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQIL 125
Query: 60 RAMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWM 116
++ LH I H DLKP+N++L +KL DFGLA E GT ++
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFV 185
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKH 173
APE+ + + + D++S G++ + LL+ PF G + L A ++
Sbjct: 186 APEI-----VNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 174 ARPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP---SPSVPE 227
S D ++ V++ R + + LR P +
Sbjct: 238 DEEFFS-QTSELAKDF---IRKLLVKETRKRLTIQEA----------LRHPWITPVDTQQ 283
Query: 228 SDTNEAAATSNGAMTEFSARARGKFAFL 255
+ + + + R R K +F
Sbjct: 284 AMVRRESVVNLENFKKQYVRRRWKLSFS 311
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 59/219 (26%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++KH+N+V + +V +L+ G L ++ A +
Sbjct: 59 VLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVL 116
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMA 117
A+ LH NGI+HRDLKP+NLL TP++ S + + DFGL++ E M TA GT ++A
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTA-CGTPGYVA 175
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ +K Y+ VD +S G++ + LL PF + ++ K
Sbjct: 176 PEVL--------AQKPYSKAVDCWSIGVITYILLCGYPPFYEET--ESKLFEKIKEGYYE 225
Query: 178 LPE----DISP---DLAFIVQSCWVEDPNLRPSFSQIIR 209
DIS D + +DPN R + + +
Sbjct: 226 FESPFWDDISESAKDF---ICHLLEKDPNERYTCEKALS 261
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-26
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 2 MSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ +V H N++ ++ +V++ EL+ G L +L L A +F I
Sbjct: 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILD 126
Query: 61 AMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
++ LH I H DLKP+N++L +KL DFGLA E GT ++A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHA 174
PE+ + + + D++S G++ + LL+ PF G + L + ++
Sbjct: 187 PEI-----VNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238
Query: 175 RPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQ 206
S D ++ V++ R + +
Sbjct: 239 EEFFS-HTSELAKDF---IRKLLVKETRKRLTIQE 269
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-26
Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 14/162 (8%)
Query: 2 MSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ ++H N++ ++ +V++ EL+ G L +L L A F I
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAE--KESLTEDEATQFLKQILD 119
Query: 61 AMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
+ LH+ I H DLKP+N++L +KL DFG+A + GT ++A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
PE+ + + + D++S G++ + LL+ PF G
Sbjct: 180 PEI-----VNY---EPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-26
Identities = 39/163 (23%), Positives = 74/163 (45%), Gaps = 18/163 (11%)
Query: 7 HDNLVKFLGACKDPLM---VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 63
N++ KDP+ +V E + ++ +L D + + +I +A+D
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT----DYDIRF-YMYEILKALD 144
Query: 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWM-APELYS 122
H+ GI+HRD+KP N+++ + + L+L D+GLA + + R+ PEL
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS-RYFKGPELLV 203
Query: 123 TVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 164
+ Y+ +D++S G +L ++ + P F G N
Sbjct: 204 DY-------QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 7e-26
Identities = 37/241 (15%), Positives = 74/241 (30%), Gaps = 48/241 (19%)
Query: 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+SR+ + + L ++V E + G SL++ + A+ +A
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAA 140
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
A D H G+ P + ++ D + LA +
Sbjct: 141 AADAAHRAGVALSIDHPSRVRVSID-GDVVLAYPATMPDANP------------------ 181
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPE 180
+ D+ G L+ LL NR P + +++ A A + E
Sbjct: 182 ----------------QDDIRGIGASLYALLVNRWPLPE-AGVRSGLAPAERDTAGQPIE 224
Query: 181 ------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA 234
DI ++ + D +R + S ++ ++ P + +A
Sbjct: 225 PADIDRDIPFQISAVAARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVSA 283
Query: 235 A 235
A
Sbjct: 284 A 284
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 2 MSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ ++H N++ ++ ++++ EL+ G L +L L A F I
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILN 125
Query: 61 AMDCLHANGIIHRDLKPDNLLL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
+ LH+ I H DLKP+N++L + +K+ DFGLA + GT ++A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHA 174
PE+ + + + D++S G++ + LL+ PF G + L A ++
Sbjct: 186 PEI-----VNY---EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237
Query: 175 RPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQ 206
+ S D ++ V+DP R +
Sbjct: 238 DEYFS-NTSALAKDF---IRRLLVKDPKKRMTIQD 268
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-25
Identities = 44/178 (24%), Positives = 80/178 (44%), Gaps = 26/178 (14%)
Query: 1 MMSRVKHDNLVKFL--------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDL---H 49
++ + H N+V+ +D + +V E +P +L + + ++
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPIL 130
Query: 50 VALNFALDIARAMDCLHAN--GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMT 107
+ + F + R++ CLH + HRD+KP N+L+ +LKL DFG A++ + +E
Sbjct: 131 IKV-FLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 108 AETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163
A + YR APEL HY VD++S G + E++ F G ++
Sbjct: 190 AYICSRYYR--APELIFGNQ-------HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 52/251 (20%), Positives = 93/251 (37%), Gaps = 58/251 (23%)
Query: 1 MMSRVKHDNLVKFLGA-CKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +V F GA D + I E + G SL + L + ++ + ++ +
Sbjct: 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAVI 141
Query: 60 RAMDCLHANG-IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ + L I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+P
Sbjct: 142 KGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSP 199
Query: 119 ELYSTVTLR-QGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-- 175
E R QG HY+ + D++S G+ L E+ R P + +
Sbjct: 200 E-------RLQGT--HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDA 250
Query: 176 ---------------------------------------PGLPEDI-SPDLAFIVQSCWV 195
P LP + S + V C +
Sbjct: 251 AETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI 310
Query: 196 EDPNLRPSFSQ 206
++P R Q
Sbjct: 311 KNPAERADLKQ 321
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-25
Identities = 51/146 (34%), Positives = 85/146 (58%), Gaps = 14/146 (9%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
+A A+D LH+ GII+RDLKP+N+LL + +KL DFGL++E + A + GT +
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEE-GHIKLTDFGLSKES-IDHEKKAYSFCGTVEY 192
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE V R+G + D +SFG++++E+LT LPF+G + + A+
Sbjct: 193 MAPE----VVNRRG----HTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETM-TMILKAK 242
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLR 201
G+P+ +SP+ +++ + +P R
Sbjct: 243 LGMPQFLSPEAQSLLRMLFKRNPANR 268
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-25
Identities = 50/265 (18%), Positives = 96/265 (36%), Gaps = 34/265 (12%)
Query: 2 MSRVKHD-NLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ K ++ ++ ++++ E G + + + + + I
Sbjct: 82 LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL 141
Query: 60 RAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMA 117
+ LH N I+H DLKP N+LL + +K+ DFG++R+ + GT ++A
Sbjct: 142 EGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLA 201
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---LQAAYAAAFKHA 174
PE+ L D+++ GI+ + LLT+ PF G N ++
Sbjct: 202 PEI-----LNY---DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYS 253
Query: 175 RPGLPEDISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP--SPSVPESD 229
+S D +QS V++P RP+ L E+
Sbjct: 254 EETFS-SVSQLATDF---IQSLLVKNPEKRPTAEIC----------LSHSWLQQWDFENL 299
Query: 230 TNEAAATSNGAMTEFSARARGKFAF 254
+ +S+ + S R+
Sbjct: 300 FHPEETSSSSQTQDHSVRSSEDKTS 324
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 61/269 (22%), Positives = 106/269 (39%), Gaps = 29/269 (10%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +H N++ D V +VTEL+ G L ++ + A I
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTIT 126
Query: 60 RAMDCLHANGIIHRDLKPDNLLLT---PDQKSLKLADFGLARE-ETVTEMMTAETGTYRW 115
+ ++ LHA G++HRDLKP N+L + +S+++ DFG A++ ++ T +
Sbjct: 127 KTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF 186
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN-LQAAYAAAFKHA 174
+APE V RQG Y+ D++S G++L+ +LT PF + A
Sbjct: 187 VAPE----VLERQG----YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238
Query: 175 RPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPE 227
+ L +S DL V DP+ R + + + L P
Sbjct: 239 KFSLSGGYWNSVSDTAKDL---VSKMLHVDPHQRLTAALV---LRHPWIVHWDQLPQYQL 292
Query: 228 SDTNEAAATSNGAMTEFSARARGKFAFLR 256
+ + +SA R + L
Sbjct: 293 NRQDAPHLVKGAMAATYSALNRNQSPVLE 321
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 46/193 (23%), Positives = 86/193 (44%), Gaps = 15/193 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ + A +D + +V + G L L+S ++L +A + ++
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL-TLLSKFEDRLPEEMARFYLAEMV 185
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET--GTYRWM 116
A+D +H +HRD+KPDN+L+ D ++LADFG + + + GT ++
Sbjct: 186 IAIDSVHQLHYVHRDIKPDNILM--DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH--- 173
+PE+ + +G K Y + D +S G+ ++E+L PF +L Y H
Sbjct: 244 SPEI---LQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKER 299
Query: 174 -ARPGLPEDISPD 185
P D+S +
Sbjct: 300 FQFPTQVTDVSEN 312
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 16/146 (10%)
Query: 24 IVTELLPGMSLRKYLVSLRPNKLDL---HVALNFALDIARAMDCLHANGIIHRDLKPDNL 80
++ E +P +L K L S + + +++ + + RA+ +H+ GI HRD+KP NL
Sbjct: 115 VIMEYVP-DTLHKVLKSFIRSGRSIPMNLISI-YIYQLFRAVGFIHSLGICHRDIKPQNL 172
Query: 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKV 138
L+ +LKL DFG A++ +E A + YR APEL T Y +
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGAT-------EYTPSI 223
Query: 139 DVYSFGIVLWELLTNRLPFEGMSNLQ 164
D++S G V EL+ + F G +++
Sbjct: 224 DLWSIGCVFGELILGKPLFSGETSID 249
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-25
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 14/146 (9%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
I+ A+ LH GII+RDLKP+N++L +KL DFGL +E + + T GT +
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQ-GHVKLTDFGLCKES-IHDGTVTHTFCGTIEY 187
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
MAPE + +R G +N VD +S G +++++LT PF G N + +
Sbjct: 188 MAPE----ILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTI-DKILKCK 237
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLR 201
LP ++ + +++ + R
Sbjct: 238 LNLPPYLTQEARDLLKKLLKRNAASR 263
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 49/223 (21%), Positives = 86/223 (38%), Gaps = 27/223 (12%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
+ ++V+ + ++ IV E L G L + A
Sbjct: 108 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 167
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTY 113
I A+ LH+ I HRD+KP+NLL + + LKL DFG A+E T +T T
Sbjct: 168 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 227
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAF 171
++APE V + Y+ D++S G++++ LL PF +
Sbjct: 228 YYVAPE----VLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279
Query: 172 KHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQI 207
+ + P +S L +++ +P R + ++
Sbjct: 280 RMGQYEFPNPEWSEVSEEVKML---IRNLLKTEPTQRMTITEF 319
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 45/146 (30%), Positives = 68/146 (46%), Gaps = 14/146 (9%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
IA A+ LH+ I++RDLKP+N+LL + L DFGL +E + T T GT +
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQ-GHIVLTDFGLCKEN-IEHNSTTSTFCGTPEY 205
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
+APE V +Q Y+ VD + G VL+E+L PF N Y +
Sbjct: 206 LAPE----VLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMY-DNILNKP 255
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLR 201
L +I+ +++ +D R
Sbjct: 256 LQLKPNITNSARHLLEGLLQKDRTKR 281
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 1e-24
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
I+ A++ LH GII+RDLK DN+LL + +KL D+G+ +E + T T GT +
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNY 176
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------- 168
+APE + + Y VD ++ G++++E++ R PF+ + +
Sbjct: 177 IAPE----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 228
Query: 169 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ +P +S A +++S +DP R
Sbjct: 229 QVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 14/146 (9%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
I A+ LH GII+RDLK DN+LL + KLADFG+ +E + +T T GT +
Sbjct: 133 IISALMFLHDKGIIYRDLKLDNVLLDHE-GHCKLADFGMCKEG-ICNGVTTATFCGTPDY 190
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
+APE + Y VD ++ G++L+E+L PFE N + A +
Sbjct: 191 IAPE----ILQEML----YGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLF-EAILNDE 240
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLR 201
P + D I++S ++P +R
Sbjct: 241 VVYPTWLHEDATGILKSFMTKNPTMR 266
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-24
Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 19/153 (12%)
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRW 115
I+ A++ LH GII+RDLK DN+LL + +KL D+G+ +E + T T GT +
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSE-GHIKLTDYGMCKEG-LRPGDTTSTFCGTPNY 219
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA------- 168
+APE + + Y VD ++ G++++E++ R PF+ + +
Sbjct: 220 IAPE----ILRGED----YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271
Query: 169 AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ +P +S A +++S +DP R
Sbjct: 272 QVILEKQIRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 1e-24
Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 18/203 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ V LVK + KD + +V E + G + +L R + A +A I
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIV 151
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ LH+ +I+RDLKP+NLL+ DQ+ +++ DFG A+ V GT +AP
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLI--DQQGYIQVTDFGFAKR--VKGRTWTLCGTPEALAP 207
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E + L +G YN VD ++ G++++E+ PF Y +
Sbjct: 208 E----IILSKG----YNKAVDWWALGVLIYEMAAGYPPFFA-DQPIQIY-EKIVSGKVRF 257
Query: 179 PEDISPDLAFIVQSCWVEDPNLR 201
P S DL ++++ D R
Sbjct: 258 PSHFSSDLKDLLRNLLQVDLTKR 280
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 52/174 (29%), Positives = 86/174 (49%), Gaps = 20/174 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPG---MSLRKYLVSLRPNKLDLHVALNFAL 56
+M+ +V+ A +D + +V E +PG ++L + + A +
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNL------MSNYDVPEKWARFYTA 175
Query: 57 DIARAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAET--GTY 113
++ A+D +H+ G IHRD+KPDN+LL D+ LKLADFG + M+ +T GT
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLL--DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 167
+++PE V QG +Y + D +S G+ L+E+L PF +L Y
Sbjct: 234 DYISPE----VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGTY 282
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 56/204 (27%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M+S V H +++ G +D + ++ + + G L L + + VA +A ++
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL--RKSQRFPNPVAKFYAAEVC 116
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMA 117
A++ LH+ II+RDLKP+N+LL + +K+ DFG A+ T GT ++A
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKYVPD----VTYTLCGTPDYIA 171
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE V + YN +D +SFGI+++E+L PF SN Y +A
Sbjct: 172 PE----VVSTKP----YNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTY-EKILNAELR 221
Query: 178 LPEDISPDLAFIVQSCWVEDPNLR 201
P + D+ ++ D + R
Sbjct: 222 FPPFFNEDVKDLLSRLITRDLSQR 245
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 41/150 (27%), Positives = 75/150 (50%), Gaps = 14/150 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 111
+ +I A++ LH+ +++RD+K +NL+L D +K+ DFGL +E +++ T +T G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEG-ISDGATMKTFCG 167
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 171
T ++APE V Y VD + G+V++E++ RLPF + + +
Sbjct: 168 TPEYLAPE----VLEDND----YGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLF-ELI 217
Query: 172 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
P +SP+ ++ +DP R
Sbjct: 218 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 2e-24
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 16/168 (9%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M+ ++KH NLV L + + +V E ++ L + H+ +
Sbjct: 55 MLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD-HTVLHELDR-YQRGVPEHLVKSITWQTL 112
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWM 116
+A++ H + IHRD+KP+N+L+T +KL DFG AR T ++ E T YR
Sbjct: 113 QAVNFCHKHNCIHRDVKPENILITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYR-- 169
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
+PEL + Y VDV++ G V ELL+ + G S++
Sbjct: 170 SPELL----VGD---TQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVD 210
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-24
Identities = 43/191 (22%), Positives = 81/191 (42%), Gaps = 11/191 (5%)
Query: 2 MSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ + + A +D + +V E G L L+S ++ +A + +I
Sbjct: 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL-TLLSKFGERIPAEMARFYLAEIVM 173
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAP 118
A+D +H G +HRD+KPDN+LL ++LADFG + + + GT +++P
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSP 232
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR--- 175
E+ V G Y + D ++ G+ +E+ + PF + Y +
Sbjct: 233 EILQAVGGGPGTGS-YGPECDWWALGVFAYEMFYGQTPFYA-DSTAETYGKIVHYKEHLS 290
Query: 176 -PGLPEDISPD 185
P + E + +
Sbjct: 291 LPLVDEGVPEE 301
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 3e-24
Identities = 54/179 (30%), Positives = 91/179 (50%), Gaps = 16/179 (8%)
Query: 25 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84
V E L G L ++ +K DL A +A +I + LH+ GI++RDLK DN+LL
Sbjct: 96 VMEYLNGGDLMYHI--QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK 153
Query: 85 DQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142
D +K+ADFG+ +E + T GT ++APE+ + YN+ VD +S
Sbjct: 154 D-GHIKIADFGMCKEN-MLGDAKTNTFCGTPDYIAPEIL--------LGQKYNHSVDWWS 203
Query: 143 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
FG++L+E+L + PF G + + + + + P P + + ++ +V +P R
Sbjct: 204 FGVLLYEMLIGQSPFHG-QDEEELF-HSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKR 260
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 6e-24
Identities = 45/150 (30%), Positives = 79/150 (52%), Gaps = 14/150 (9%)
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET--G 111
+A +IA + L + GII+RDLK DN++L + +K+ADFG+ +E + + +T +T G
Sbjct: 126 YAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN-IWDGVTTKTFCG 183
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 171
T ++APE + Q Y VD ++FG++L+E+L + PFEG + + +
Sbjct: 184 TPDYIAPE----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELF-QSI 233
Query: 172 KHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
P+ +S + I + + P R
Sbjct: 234 MEHNVAYPKSMSKEAVAICKGLMTKHPGKR 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 7e-24
Identities = 46/162 (28%), Positives = 83/162 (51%), Gaps = 14/162 (8%)
Query: 42 RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREET 101
+ + A+ +A +IA + L + GII+RDLK DN++L + +K+ADFG+ +E
Sbjct: 435 QVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSE-GHIKIADFGMCKEN- 492
Query: 102 VTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159
+ + +T +T GT ++APE + Q Y VD ++FG++L+E+L + PFEG
Sbjct: 493 IWDGVTTKTFCGTPDYIAPE----IIAYQP----YGKSVDWWAFGVLLYEMLAGQAPFEG 544
Query: 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+ + + P+ +S + I + + P R
Sbjct: 545 -EDEDELF-QSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKR 584
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-24
Identities = 62/238 (26%), Positives = 103/238 (43%), Gaps = 34/238 (14%)
Query: 1 MMSRVK-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
M+ + + H N+++ + ++ +V E + G S+ ++ R + A D+
Sbjct: 63 MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDV 120
Query: 59 ARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAR--------EETVTEMMTA 108
A A+D LH GI HRDLKP+N+L P+Q S +K+ DF L T +
Sbjct: 121 ASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 109 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAA 166
G+ +MAPE+ V E Y+ + D++S G++L+ LL+ PF S+
Sbjct: 181 PCGSAEYMAPEV---VEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWD 237
Query: 167 YAAAFKHARPGLPEDI--------SPDLAFI-------VQSCWVEDPNLRPSFSQIIR 209
A + L E I D A I + V D R S +Q+++
Sbjct: 238 RGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 9e-24
Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 30/177 (16%)
Query: 1 MMSRVKHDNLVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 54
+ +H N+V+ ++ + +V E + L YL + + +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDM 125
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT-- 112
+ R +D LH++ ++HRDLKP N+L+T +KLADFGLAR + +T+ T
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 113 YRWMAPEL-----YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
YR APE+ Y+T VD++S G + E+ + F G S++
Sbjct: 185 YR--APEVLLQSSYAT-------------PVDLWSVGCIFAEMFRRKPLFRGSSDVD 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 20/172 (11%)
Query: 1 MMSRVKHDNLVKFL------GACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 54
+ +H N+V+ + ++ + +V E + LR YL P L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDL 125
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT-- 112
R +D LHAN I+HRDLKP+N+L+T ++KLADFGLAR + +T T
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLW 184
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
YR APE+ L Y VD++S G + E+ + F G S
Sbjct: 185 YR--APEVL----L--QST--YATPVDMWSVGCIFAEMFRRKPLFCGNSEAD 226
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 45/172 (26%), Positives = 71/172 (41%), Gaps = 20/172 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKLDLHVALNF 54
+++ H N++ +VTEL+ L + + R H+ F
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQY-F 139
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT-- 112
I + LH G++HRDL P N+LL + + + DF LARE+T T
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNND-ITICDFNLAREDTADANKTHYVTHRW 198
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
YR APEL + K + VD++S G V+ E+ + F G +
Sbjct: 199 YR--APELV-------MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 1e-23
Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 16/168 (9%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +++H+NLV L CK +V E + ++ L L PN LD V + I
Sbjct: 77 LLKQLRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDL-ELFPNGLDYQVVQKYLFQII 134
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWM 116
+ H++ IIHRD+KP+N+L++ +KL DFG AR E+ E T YR
Sbjct: 135 NGIGFCHSHNIIHRDIKPENILVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYR-- 191
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
APEL G+ Y VDV++ G ++ E+ F G S++
Sbjct: 192 APELLV------GD-VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDID 232
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 43/180 (23%), Positives = 77/180 (42%), Gaps = 13/180 (7%)
Query: 25 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84
V L+ G L+ ++ + A+ +A +I ++ LH I++RDLKP+N+LL
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL-D 320
Query: 85 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144
D ++++D GLA + + GT +MAPE V + Y D ++ G
Sbjct: 321 DHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPE----VVKNER----YTFSPDWWALG 372
Query: 145 IVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+L+E++ + PF+ + + E SP + +DP R
Sbjct: 373 CLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-23
Identities = 56/226 (24%), Positives = 92/226 (40%), Gaps = 30/226 (13%)
Query: 1 MMSRVK-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+ + H N+VK D L +V ELL G L + + + A +
Sbjct: 58 ALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK--HFSETEASYIMRKL 115
Query: 59 ARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLARE-ETVTEMMTAETGTYRW 115
A+ +H G++HRDLKP+NLL + +K+ DFG AR + + T +
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY 175
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-----A 170
APEL L + Y+ D++S G++L+ +L+ ++PF+ +A
Sbjct: 176 AAPEL-----LN---QNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKK 227
Query: 171 FKHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIR 209
K + +S DL +Q DPN R S +
Sbjct: 228 IKKGDFSFEGEAWKNVSQEAKDL---IQGLLTVDPNKRLKMSGLRY 270
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.7 bits (234), Expect = 8e-23
Identities = 52/163 (31%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64
KH N+VK +V+V E L L+K L L+ A +F L + +
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDV-CEGGLESVTAKSFLLQLLNGIAY 115
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELY 121
H ++HRDLKP NLL+ + LK+ADFGLAR + T E T YR AP++
Sbjct: 116 CHDRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDV- 171
Query: 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
L K Y+ +D++S G + E++ F G+S
Sbjct: 172 ----LMGS--KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-22
Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 17/164 (10%)
Query: 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64
KH N+V+ D + +V E L+KY S LD + +F + + +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGF 116
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELY 121
H+ ++HRDLKP NLL+ LKLA+FGLAR + +AE T YR P++
Sbjct: 117 CHSRNVLHRDLKPQNLLIN-RNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDV- 172
Query: 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FEGMSNLQ 164
L K Y+ +D++S G + EL P F G
Sbjct: 173 ----LFGA--KLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 45/184 (24%), Positives = 80/184 (43%), Gaps = 18/184 (9%)
Query: 25 VTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
V ++ G +R ++ ++ A+ + I ++ LH II+RDLKP+N+LL
Sbjct: 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322
Query: 83 TPDQKSLKLADFGLAREETVTEMMTAET--GTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140
D +++++D GLA E + GT +MAPEL + Y+ VD
Sbjct: 323 D-DDGNVRISDLGLAVEL-KAGQTKTKGYAGTPGFMAPELL--------LGEEYDFSVDY 372
Query: 141 YSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFIVQSCWVED 197
++ G+ L+E++ R PF + + P+ SP ++ +D
Sbjct: 373 FALGVTLYEMIAARGPFRA-RGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKD 431
Query: 198 PNLR 201
P R
Sbjct: 432 PEKR 435
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 2e-22
Identities = 50/163 (30%), Positives = 77/163 (47%), Gaps = 16/163 (9%)
Query: 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64
H N+V + + + +V E + L+K L L + + R +
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAH 134
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELY 121
H + I+HRDLKP NLL+ +LKLADFGLAR + T E T YR AP++
Sbjct: 135 CHQHRILHRDLKPQNLLIN-SDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDV- 190
Query: 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
L G K Y+ VD++S G + E++T + F G+++
Sbjct: 191 ----L-MGS-KKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD 227
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-22
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 15/151 (9%)
Query: 54 FALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET-- 110
+ +I A+D LH+ +++RDLK +NL+L D +K+ DFGL +E + + T +T
Sbjct: 253 YGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEG-IKDGATMKTFC 310
Query: 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA 170
GT ++APE+ E Y VD + G+V++E++ RLPF + + +
Sbjct: 311 GTPEYLAPEVL--------EDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLF-EL 360
Query: 171 FKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
P + P+ ++ +DP R
Sbjct: 361 ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 5e-22
Identities = 46/182 (25%), Positives = 77/182 (42%), Gaps = 28/182 (15%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK-YLVS----------LRPNKL-DL 48
++ R+ HDN+VK + ++ L Y+V L L +
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 49 HVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTE 104
H L F + R + +H+ ++HRDLKP NL + + LK+ DFGLAR +
Sbjct: 121 HARL-FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179
Query: 105 MMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162
++ T YR +P L +Y +D+++ G + E+LT + F G
Sbjct: 180 HLSEGLVTKWYR--SPRLL-------LSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230
Query: 163 LQ 164
L+
Sbjct: 231 LE 232
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-21
Identities = 58/173 (33%), Positives = 82/173 (47%), Gaps = 25/173 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL-DLHVAL 52
++ +KH+N++ L + +VT L+ G L + KL D HV
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQF 136
Query: 53 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 112
I R + +H+ IIHRDLKP NL + D + LK+ DFGLAR + MT T
Sbjct: 137 -LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE-LKILDFGLAR--HTADEMTGYVAT 192
Query: 113 YRW-MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
RW APE+ HYN VD++S G ++ ELLT R F G ++
Sbjct: 193 -RWYRAPEIMLNW-------MHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 1e-21
Identities = 51/167 (30%), Positives = 87/167 (52%), Gaps = 19/167 (11%)
Query: 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYL----VSLRPNKLDLHVALNFALDIAR 60
KH+N+V+ + + +V E + L+KY+ V P L+L++ F + +
Sbjct: 61 KHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMA 117
+ H N I+HRDLKP NLL+ + LKL DFGLAR + ++E T YR A
Sbjct: 120 GLAFCHENKILHRDLKPQNLLIN-KRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--A 176
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
P++ + G + Y+ +D++S G +L E++T + F G ++ +
Sbjct: 177 PDVL----M--GS-RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-21
Identities = 49/163 (30%), Positives = 81/163 (49%), Gaps = 16/163 (9%)
Query: 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64
KH N+V + + +V E L L++YL N +++H F + R +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAY 115
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELY 121
H ++HRDLKP NLL+ ++ LKLADFGLAR +++ T+ E T YR P++
Sbjct: 116 CHRQKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--PPDI- 171
Query: 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
L Y+ ++D++ G + +E+ T R F G + +
Sbjct: 172 ----LLGS--TDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE 208
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 92.3 bits (229), Expect = 2e-21
Identities = 44/179 (24%), Positives = 83/179 (46%), Gaps = 14/179 (7%)
Query: 25 VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84
+ +L+ G L +L +A +I ++ +H +++RDLKP N+LL
Sbjct: 270 ILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD- 326
Query: 85 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144
+ ++++D GLA + + + + GT+ +MAPE+ L++G Y++ D +S G
Sbjct: 327 EHGHVRISDLGLACDFSKKKPHAS-VGTHGYMAPEV-----LQKGVA--YDSSADWFSLG 378
Query: 145 IVLWELLTNRLPF--EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+L++LL PF + LP+ SP+L +++ D N R
Sbjct: 379 CMLFKLLRGHSPFRQHKTKDKHEID-RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRR 436
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-21
Identities = 48/168 (28%), Positives = 75/168 (44%), Gaps = 22/168 (13%)
Query: 6 KHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMD 63
+H N+++ L ++ E L+KY+ + + V +F + ++
Sbjct: 91 QHRNIIELKSVIHHNHRLH-LIFEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVN 146
Query: 64 CLHANGIIHRDLKPDNLLLTPDQKS----LKLADFGLAREETV-TEMMTAETGT--YRWM 116
H+ +HRDLKP NLLL+ S LK+ DFGLAR + T E T YR
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR-- 204
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
PE+ L G +HY+ VD++S + E+L F G S +
Sbjct: 205 PPEIL----L--GS-RHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID 245
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-21
Identities = 49/179 (27%), Positives = 73/179 (40%), Gaps = 43/179 (24%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALN 53
+M V H N++ L + IV EL+ +L +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA---------------NLCQVIQ 121
Query: 54 FALD----------IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
LD + + LH+ GIIHRDLKP N+++ D LK+ DFGLAR +
Sbjct: 122 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTS 180
Query: 104 EMMTAETGTYRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161
MMT T R+ APE+ Y VD++S G ++ E++ + F G
Sbjct: 181 FMMTPYVVT-RYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 5e-21
Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 24/172 (13%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALN 53
++ ++H+N++ L + +V + L+K + + +
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM---GLKFSEEKIQY- 130
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
+ + + +H+ G++HRDLKP NL + D + LK+ DFGLAR MT T
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE-LKILDFGLAR--HADAEMTGYVVT- 186
Query: 114 RW-MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
RW APE+ HYN VD++S G ++ E+LT + F+G L
Sbjct: 187 RWYRAPEVI-------LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD 231
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-21
Identities = 49/173 (28%), Positives = 80/173 (46%), Gaps = 25/173 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKL-DLHVAL 52
++ ++H+N++ L + +V + G L K + + KL + +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM---KHEKLGEDRIQF 132
Query: 53 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 112
+ + + +HA GIIHRDLKP NL + D + LK+ DFGLAR MT T
Sbjct: 133 -LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE-LKILDFGLAR--QADSEMTGYVVT 188
Query: 113 YRWM-APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
RW APE+ Y VD++S G ++ E++T + F+G +L
Sbjct: 189 -RWYRAPEVI-------LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 233
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 7e-21
Identities = 42/225 (18%), Positives = 76/225 (33%), Gaps = 48/225 (21%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-----IVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
+ ++V+ + ++ IV E L G L + A
Sbjct: 64 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 123
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLL-TPDQKS-LKLADFGLAREETVTEMMTAETGTY 113
I A+ LH+ I HRD+KP+NLL + + LKL DFG A
Sbjct: 124 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---------------- 167
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF--EGMSNLQAAYAAAF 171
E + Y+ D++S G++++ LL PF +
Sbjct: 168 ----KET---------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214
Query: 172 KHARPGLPED----ISP---DLAFIVQSCWVEDPNLRPSFSQIIR 209
+ + P +S L +++ +P R + ++ +
Sbjct: 215 RMGQYEFPNPEWSEVSEEVKML---IRNLLKTEPTQRMTITEFMN 256
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-21
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 25/170 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-------IVTELLPGMSLRKYLVSLRPNKLDLHVALN 53
+M V H N++ L + +V EL+ +L + + + ++
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI---QMELDHERMSY- 168
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT- 112
+ + LH+ GIIHRDLKP N+++ D LK+ DFGLAR + MMT T
Sbjct: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT-LKILDFGLARTAGTSFMMTPYVVTR 227
Query: 113 -YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161
YR APE+ Y VD++S G ++ E++ +++ F G
Sbjct: 228 YYR--APEVILG--------MGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 55/177 (31%), Positives = 83/177 (46%), Gaps = 28/177 (15%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALN 53
++ R +H+N++ + P + IV +L+ L K L + L + H+
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT---QHLSNDHICY- 132
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAE 109
F I R + +H+ ++HRDLKP NLLL LK+ DFGLAR + T +T
Sbjct: 133 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEY 191
Query: 110 TGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
T YR APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 192 VATRWYR--APEIM-------LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 239
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-20
Identities = 50/163 (30%), Positives = 73/163 (44%), Gaps = 16/163 (9%)
Query: 6 KHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64
H N++ L A + +V + + L + L + L + ++
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEY 127
Query: 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGT--YRWMAPELY 121
LH + I+HRDLKP+NLLL + LKLADFGLA+ T + T YR APEL
Sbjct: 128 LHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYR--APEL- 183
Query: 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
L + Y VD+++ G +L ELL G S+L
Sbjct: 184 ----LFGA--RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 220
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-20
Identities = 51/181 (28%), Positives = 73/181 (40%), Gaps = 35/181 (19%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALN 53
++ KH+N++ + I+ EL+ L + + L D H+
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI---STQMLSDDHIQY- 116
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----------EETV 102
F RA+ LH + +IHRDLKP NLL+ + LK+ DFGLAR
Sbjct: 117 FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD-LKVCDFGLARIIDESAADNSEPTGQ 175
Query: 103 TEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160
M T YR APE+ Y+ +DV+S G +L EL R F G
Sbjct: 176 QSGMVEFVATRWYR--APEVM-------LTSAKYSRAMDVWSCGCILAELFLRRPIFPGR 226
Query: 161 S 161
Sbjct: 227 D 227
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 37/144 (25%), Positives = 63/144 (43%), Gaps = 17/144 (11%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDNL 80
+V+V E+L G +L + + L + + +D +H GIIH D+KP+N+
Sbjct: 105 VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENV 163
Query: 81 LLTPDQKS-----LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135
L+ +K+AD G A + +T YR +PE V L +
Sbjct: 164 LMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR--SPE----VLLGAP----WG 213
Query: 136 NKVDVYSFGIVLWELLTNRLPFEG 159
D++S +++EL+T FE
Sbjct: 214 CGADIWSTACLIFELITGDFLFEP 237
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-19
Identities = 45/144 (31%), Positives = 66/144 (45%), Gaps = 12/144 (8%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
+ + ELL M+L + + + L + FA I + +D LH N IIH DLKP+N+L
Sbjct: 174 ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENIL 232
Query: 82 LT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140
L + +K+ DFG + E ++ YR APE V L Y +D+
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APE----VILGAR----YGMPIDM 282
Query: 141 YSFGIVLWELLTNRLPFEGMSNLQ 164
+S G +L ELLT G
Sbjct: 283 WSLGCILAELLTGYPLLPGEDEGD 306
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-18
Identities = 48/182 (26%), Positives = 72/182 (39%), Gaps = 38/182 (20%)
Query: 4 RVKHDNLVKFLGACKDPLMVIVTELLPGMSLRK--YLV------------SLRPNKLDLH 49
+KH+N+V + + T+ P + YLV S K L
Sbjct: 72 LLKHENVVNLIE-------ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS 124
Query: 50 VALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-----ETVTE 104
+ + +H N I+HRD+K N+L+T LKLADFGLAR +
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPN 183
Query: 105 MMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162
T T YR PEL L GE + Y +D++ G ++ E+ T +G +
Sbjct: 184 RYTNRVVTLWYR--PPELL----L--GE-RDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 163 LQ 164
Sbjct: 235 QH 236
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 81.8 bits (202), Expect = 5e-18
Identities = 45/176 (25%), Positives = 72/176 (40%), Gaps = 31/176 (17%)
Query: 6 KHDNLVK----FLGACKDPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNF 54
KH N++ FL + ++ + L + R P +L + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVW-LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKS---LKLADFGLAREETV-TEMMTAET 110
I + LHAN ++HRDLKP N+L+ + +K+AD G AR + +
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193
Query: 111 GT-----YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161
YR APEL L G +HY +D+++ G + ELLT+ F
Sbjct: 194 PVVVTFWYR--APELL----L--GA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 47/188 (25%), Positives = 80/188 (42%), Gaps = 46/188 (24%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALN 53
+++R+K D +++ ++ IV E+ L+K + P L + H+
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKT--PIFLTEEHIKT- 133
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--------------- 98
++ + +H +GIIHRDLKP N LL D +K+ DFGLAR
Sbjct: 134 ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLE 192
Query: 99 --------EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148
+ + + +T+ T YR APEL +++Y +D++S G +
Sbjct: 193 ENEEPGPHNKNLKKQLTSHVVTRWYR--APELILL-------QENYTKSIDIWSTGCIFA 243
Query: 149 ELLTNRLP 156
ELL
Sbjct: 244 ELLNMLQS 251
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 4e-17
Identities = 64/271 (23%), Positives = 102/271 (37%), Gaps = 65/271 (23%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV------IVTELLPGMSLRKYLVSLRPNKL-DLHVALN 53
+++R+ HD++VK L + +V E+ +K + P L +LH+
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKT- 160
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--------------- 98
++ + +H+ GI+HRDLKP N L+ D S+K+ DFGLAR
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPIS 219
Query: 99 -------------EETVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143
+ + +T T YR APEL L Q ++Y +DV+S
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APEL----ILLQ---ENYTEAIDVWSI 270
Query: 144 GIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS 203
G + ELL A P P L+ ++ + R +
Sbjct: 271 GCIFAELLNM----------IKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGN 320
Query: 204 FSQIIRMLNAFLFTLRPPSPSVPESDTNEAA 234
Q+ + N L PS E+ E A
Sbjct: 321 RDQLNVIFN----ILGTPSEEDIEALEKEDA 347
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-17
Identities = 40/146 (27%), Positives = 69/146 (47%), Gaps = 14/146 (9%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--GIIHRDLKPDN 79
+ +V E+L +L L + + L++ FA + A+ L IIH DLKP+N
Sbjct: 131 LCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN 189
Query: 80 LLLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 138
+LL P + ++K+ DFG + + ++ YR +PE V L Y+ +
Sbjct: 190 ILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SPE----VLLGMP----YDLAI 239
Query: 139 DVYSFGIVLWELLTNRLPFEGMSNLQ 164
D++S G +L E+ T F G + +
Sbjct: 240 DMWSLGCILVEMHTGEPLFSGANEVD 265
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 43/183 (23%)
Query: 7 HDNLVKFLGACKDPLMV---IVTELLPGMSLRKYLVSLRPNKL-DLHVALNFALDIARAM 62
H+N+V L + +V + + L + + N L +H + + +
Sbjct: 68 HENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA---NILEPVHKQY-VVYQLIKVI 122
Query: 63 DCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----------------------EE 100
LH+ G++HRD+KP N+LL + +K+ADFGL+R +
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 101 TVTEMMTAETGT--YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158
++T T YR APE+ Y +D++S G +L E+L + F
Sbjct: 182 DDQPILTDYVATRWYR--APEILLGS-------TKYTKGIDMWSLGCILGEILCGKPIFP 232
Query: 159 GMS 161
G S
Sbjct: 233 GSS 235
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 3e-15
Identities = 43/194 (22%), Positives = 70/194 (36%), Gaps = 64/194 (32%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNL 80
+ +V E+L G L K+++ L L + + +D LH IIH D+KP+N+
Sbjct: 120 ICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI 178
Query: 81 LLTPDQKSL------------------------------------------------KLA 92
LL+ +++ + K+A
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238
Query: 93 DFGLAR--EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150
D G A + TE + T YR + E V + G YN D++S + +EL
Sbjct: 239 DLGNACWVHKHFTEDIQ--TRQYR--SLE----VLIGSG----YNTPADIWSTACMAFEL 286
Query: 151 LTNRLPFEGMSNLQ 164
T FE S +
Sbjct: 287 ATGDYLFEPHSGEE 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-15
Identities = 44/163 (26%), Positives = 64/163 (39%), Gaps = 33/163 (20%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81
M I ELL G + ++L L + A + A+ LH N + H DLKP+N+L
Sbjct: 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL 155
Query: 82 LT------------------PDQKSLKLADFGLA--REETVTEMMTAETGTYRWMAPELY 121
S+++ADFG A E T ++ T YR PE
Sbjct: 156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIV--ATRHYR--PPE-- 209
Query: 122 STVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
V L G + DV+S G +L+E F+ N +
Sbjct: 210 --VILELG----WAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-15
Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 35/164 (21%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78
+ IV ELL G+S ++ + N L A I ++++ LH+N + H DLKP+
Sbjct: 92 ICIVFELL-GLSTYDFI---KENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPE 147
Query: 79 NLLL------------------TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
N+L T +K+ DFG A + T YR APE
Sbjct: 148 NILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR--APE- 204
Query: 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
V L G ++ DV+S G +L E F + +
Sbjct: 205 ---VILALG----WSQPCDVWSIGCILIEYYLGFTVFPTHDSKE 241
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-14
Identities = 44/172 (25%), Positives = 70/172 (40%), Gaps = 45/172 (26%)
Query: 22 MVIVTELLPGMSLRKYLVSLRPNK---LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78
M ++ E L G SL + + N + + ++I +A++ L + H DLKP+
Sbjct: 111 MCLIFEPL-GPSLYEII---TRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE 166
Query: 79 NLLL------------------------TPDQKSLKLADFGLA--REETVTEMMTAETGT 112
N+LL +KL DFG A + + ++ T
Sbjct: 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSII--NTRQ 224
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ 164
YR APE V L G ++ D++SFG VL EL T L F +++
Sbjct: 225 YR--APE----VILNLG----WDVSSDMWSFGCVLAELYTGSLLFRTHEHME 266
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-12
Identities = 21/78 (26%), Positives = 35/78 (44%), Gaps = 4/78 (5%)
Query: 23 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
+V E L G+ L+K L + + ++ +H N +H D+K NLLL
Sbjct: 128 FMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184
Query: 83 -TPDQKSLKLADFGLARE 99
+ + LAD+GL+
Sbjct: 185 GYKNPDQVYLADYGLSYR 202
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 3e-12
Identities = 21/103 (20%), Positives = 37/103 (35%), Gaps = 11/103 (10%)
Query: 23 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
++ + G L+K + L +L I ++ +H + +H D+K NLLL
Sbjct: 128 FMIMDRF-GSDLQKIY-EANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185
Query: 83 -TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWM 116
+ + L D+GLA GT +
Sbjct: 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 6e-12
Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 2/90 (2%)
Query: 11 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGI 70
G +D +V L G SL+ L + L L A + A++ LH N
Sbjct: 122 CMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEY 180
Query: 71 IHRDLKPDNLLL-TPDQKSLKLADFGLARE 99
+H ++ +N+ + DQ + LA +G A
Sbjct: 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 9e-12
Identities = 45/154 (29%), Positives = 66/154 (42%), Gaps = 28/154 (18%)
Query: 23 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
V+V ELL G SL + L + K L L A + ++ +H+ IHRD+KPDN L+
Sbjct: 81 VMVMELL-GPSL-EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138
Query: 83 --TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPELYSTVTLRQGEKK 132
+ + DFGLA++ T + E TGT R+ S T
Sbjct: 139 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA-----SINT------- 186
Query: 133 HYNN----KVDVYSFGIVLWELLTNRLPFEGMSN 162
H + D+ S G VL LP++G+
Sbjct: 187 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 1e-11
Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 30/154 (19%)
Query: 23 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
+V ELL G SL + L L L L A+ + M+ +H+ +I+RD+KP+N L+
Sbjct: 81 AMVLELL-GPSL-EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138
Query: 83 ----TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPELYSTVTLRQGE 130
Q+ + + DF LA+E ET + E TGT R+M S T
Sbjct: 139 GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYM-----SINT----- 188
Query: 131 KKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 160
H + D+ + G + L LP++G+
Sbjct: 189 --HLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-11
Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 30/154 (19%)
Query: 23 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
V+V +LL G SL + L+ L K + A + + +H +++RD+KPDN L+
Sbjct: 82 VLVIDLL-GPSL-EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139
Query: 83 ----TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPELYSTVTLRQGE 130
+ + + + DFG+ + T + E +GT R+M S T
Sbjct: 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM-----SINT----- 189
Query: 131 KKHYNN----KVDVYSFGIVLWELLTNRLPFEGM 160
H + D+ + G V L LP++G+
Sbjct: 190 --HLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 3e-10
Identities = 45/152 (29%), Positives = 68/152 (44%), Gaps = 28/152 (18%)
Query: 23 VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82
V+V +LL G SL + L + KL L L A + ++ +H+ +HRD+KPDN L+
Sbjct: 79 VLVMDLL-GPSL-EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
Query: 83 --TPDQKSLKLADFGLARE----ETVTEMMTAE----TGTYRWMAPELYSTVTLRQGEKK 132
+ + DFGLA++ T + E TGT R+ S T
Sbjct: 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA-----SVNT------- 184
Query: 133 HYNN----KVDVYSFGIVLWELLTNRLPFEGM 160
H + D+ S G VL L LP++G+
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFLRGSLPWQGL 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 8e-07
Identities = 40/260 (15%), Positives = 79/260 (30%), Gaps = 63/260 (24%)
Query: 44 NKLDLH---VALNFALDIARAMDCLHANGIIHRDLKP---DNLLLTPDQKSLKLADFGLA 97
+ + F DC + L D+++++ D S L F
Sbjct: 12 GEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTL 71
Query: 98 R---EETVTEMM-TAETGTYRWMAPELYSTVTLRQGEKKHYN-------NKVDVYSFGIV 146
EE V + + Y+++ + + + Y N V++ V
Sbjct: 72 LSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 147 ------------LWELLTNR-LPFEGM-----SNLQAAYAAAFKHARPGLPEDISPDLAF 188
L EL + + +G+ + + ++K + F
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYK------VQCKMDFKIF 185
Query: 189 IVQSCWVEDPNLRPSFS--QIIRMLNAFLFTLRPPSPSVPESDTNEAAATSNGAMTEFSA 246
W+ NL+ S ++ ML L+ + P S + +N S
Sbjct: 186 -----WL---NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH-------SI 230
Query: 247 RARGKFAFLRQLFTAKRTKN 266
+A LR+L +K +N
Sbjct: 231 QAE-----LRRLLKSKPYEN 245
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 42.1 bits (98), Expect = 1e-04
Identities = 39/302 (12%), Positives = 79/302 (26%), Gaps = 85/302 (28%)
Query: 10 LVKFLG---------ACK-DPLMV-IVTELLPGMSLR-KYLVSLRPNKLD--LHVALNFA 55
L+K+L +P + I+ E + + +KL + +LN
Sbjct: 307 LLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN-V 365
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY-- 113
L+ A + P + + L L ++ ++ + Y
Sbjct: 366 LEPAEYRKMFDRLSVF-----PPSAHIPT--ILLSL--IWFDVIKSDVMVVVNKLHKYSL 416
Query: 114 --RWMAPELYS--------TVTLRQGEKKH------YN------------NKVDVYSFGI 145
+ S V L H YN +D Y +
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY-- 474
Query: 146 VLWEL---LTNRLPFEGMSNLQAAY------AAAFKHARPGL--PEDISPDLA------- 187
+ L N E M+ + + +H I L
Sbjct: 475 --SHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKP 532
Query: 188 FIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVPESDTNEAA-ATSNGAMTEFSA 246
+I + P + +++ + FL + +D A + A+ E +
Sbjct: 533 YICDND--------PKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAH 584
Query: 247 RA 248
+
Sbjct: 585 KQ 586
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 40.6 bits (94), Expect = 3e-04
Identities = 21/99 (21%), Positives = 32/99 (32%), Gaps = 5/99 (5%)
Query: 6 KHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCL 65
+ KD + IV E G L +R L A + + ++
Sbjct: 121 TKGSANDRPDFFKDDQLFIVLEFEFGGID---LEQMRTKLSSLATAKSILHQLTASLAVA 177
Query: 66 HAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT 103
A+ HRDL N+LL KL + T+
Sbjct: 178 EASLRFEHRDLHWGNVLLKK-TSLKKLHYTLNGKSSTIP 215
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.88 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.65 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.53 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.21 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.78 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.65 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.47 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.28 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.1 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 97.96 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.75 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.41 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.33 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.47 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 96.28 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 95.74 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.69 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 94.16 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.69 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 92.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 92.01 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.75 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.49 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.29 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 90.19 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 89.81 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 89.56 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.27 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 83.34 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 80.15 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=340.18 Aligned_cols=211 Identities=30% Similarity=0.513 Sum_probs=174.4
Q ss_pred CCCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+|++++|||||++++++.++.+++||||++||+|.+++.. ....+++.++..|+.|++.||+|||++||+||||||+||
T Consensus 85 il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~-~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NI 163 (307)
T 3omv_A 85 VLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHV-QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNI 163 (307)
T ss_dssp HHTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSE
T ss_pred HHHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHE
Confidence 3688999999999999988889999999999999999975 345699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|++.+ +.+||+|||+++..... .......||+.|+|||.+... ....++.++|||||||++|||++|+.||
T Consensus 164 Ll~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~-----~~~~y~~ksDVwS~Gvvl~Elltg~~Pf 237 (307)
T 3omv_A 164 FLHEG-LTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQ-----DNNPFSFQSDVYSYGIVLYELMTGELPY 237 (307)
T ss_dssp EEETT-EEEEECCCSSCBC------------CCCCTTSCCHHHHHCC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EECCC-CcEEEeeccCceecccCCcceeecccccCCCccCHHHhhcc-----CCCCCCcHHHhHhHHHHHHHHHHCCCCC
Confidence 99955 57999999999864332 223456899999999998531 1246889999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcC----CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 158 EGMSNLQAAYAAAFKHAR----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.+.++............. +..+..+++++.+|+.+||+.+|++|||+.++++.|+.+...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 238 SHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp TTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred CCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 987776655554444332 2345678999999999999999999999999999998765544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-52 Score=345.04 Aligned_cols=210 Identities=25% Similarity=0.305 Sum_probs=175.0
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++|||||++++++. ++.+||||||++||+|.+++... +.+++.++..|+.|++.||+|||++||+||||||+|
T Consensus 103 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 180 (336)
T 4g3f_A 103 ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADN 180 (336)
T ss_dssp TTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHH
Confidence 578999999999999985 55789999999999999999863 569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
||++.++..+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 181 ILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG 252 (336)
T 4g3f_A 181 VLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG--------KPCDAKVDIWSSCCMMLHMLNG 252 (336)
T ss_dssp EEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHS
T ss_pred EEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHC
Confidence 9999776569999999998643321 1233579999999999864 6789999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 154 RLPFEGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
+.||.+.+............. ...++..+++++.++|.+||++||.+|||+.|+++.|...+.....
T Consensus 253 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~ 320 (336)
T 4g3f_A 253 CHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGG 320 (336)
T ss_dssp SCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTS
T ss_pred cCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhh
Confidence 999987655433333222211 1246778999999999999999999999999999999988776544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=344.56 Aligned_cols=198 Identities=30% Similarity=0.460 Sum_probs=172.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++|+|||||++++++. ++.+|+|||||+||+|.+++...+...+++.+++.|+.||+.||+|||++||+||||||+||
T Consensus 77 l~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI 156 (350)
T 4b9d_A 77 LANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNI 156 (350)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGE
T ss_pred HHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence 56899999999999985 55799999999999999999875566789999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ +.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+
T Consensus 157 Ll~~~-g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~--------~~y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 157 FLTKD-GTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN--------KPYNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp EECTT-CCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EECCC-CCEEEcccccceeecCCcccccccCCCccccCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99966 469999999998765432 2345679999999999864 6789999999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+..+ ..........++.+..+++++.+||.+||++||.+|||++++++
T Consensus 228 ~~~~~-~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 228 GSMKN-LVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp SSHHH-HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 65544 34444555566777889999999999999999999999999987
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=337.35 Aligned_cols=207 Identities=27% Similarity=0.517 Sum_probs=177.5
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh-----------CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL-----------RPNKLDLHVALNFALDIARAMDCLHAN 68 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~-----------~~~~~~~~~~~~i~~ql~~~l~~lH~~ 68 (268)
+|++++|||||+++++|. ++..++||||++||+|.+++... ....+++.+++.|+.|++.||+|||++
T Consensus 68 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~ 147 (299)
T 4asz_A 68 LLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ 147 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 368899999999999995 45789999999999999999753 235699999999999999999999999
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
+|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||
T Consensus 148 ~iiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~k~DVwS~Gv 218 (299)
T 4asz_A 148 HFVHRDLATRNCLVGEN-LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY--------RKFTTESDVWSLGV 218 (299)
T ss_dssp TCCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred CcccCccCHhhEEECCC-CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcC--------CCCCchhhHHHHHH
Confidence 99999999999999955 569999999997543322 2233468999999999864 67899999999999
Q ss_pred HHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 146 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 146 i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
++|||++ |+.||.+.+..+ ..........++.|..+++++.+|+.+||+.||++|||++++.+.|+.+...
T Consensus 219 vl~Ellt~G~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 219 VLWEIFTYGKQPWYQLSNNE-VIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHHTTTCCTTTTSCHHH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCHHH-HHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 9999998 899999876544 3444555667788899999999999999999999999999999999987654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=336.94 Aligned_cols=207 Identities=29% Similarity=0.533 Sum_probs=171.5
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-------------PNKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
+|++++|||||+++++|. ++..++||||++||+|.+++.... ..++++.+++.|+.|++.||+|||
T Consensus 96 il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 175 (329)
T 4aoj_A 96 LLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA 175 (329)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 368899999999999995 457899999999999999997632 245999999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
+.+|+||||||+|||++.+ ..+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||
T Consensus 176 ~~~iiHRDLKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~--------~~~~~~sDvwS~ 246 (329)
T 4aoj_A 176 GLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY--------RKFTTESDVWSF 246 (329)
T ss_dssp HTTCCCSCCCGGGEEEETT-TEEEECCCC----------------CCCCGGGCCHHHHTT--------CCCCHHHHHHHH
T ss_pred cCCeecccccHhhEEECCC-CcEEEcccccceeccCCCcceecCcccccccccChhhhcC--------CCCCccccccch
Confidence 9999999999999999955 579999999998543322 2234578999999999864 678999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 144 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 144 G~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
||++|||++ |+.||.+.+..+. ........+++.|..+++++.+|+.+||+.||++|||+++|++.|+.+...
T Consensus 247 Gvvl~Ellt~G~~Pf~~~~~~~~-~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 247 GVVLWEIFTYGKQPWYQLSNTEA-IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHHHHTTSCCTTCSSCHHHH-HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCCCCCCCHHHH-HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 999999999 8999998766444 344455667888899999999999999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-51 Score=333.64 Aligned_cols=201 Identities=30% Similarity=0.583 Sum_probs=169.4
Q ss_pred CCCCCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--Ceec
Q 024401 1 MMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHR 73 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~ 73 (268)
+|++++|||||++++++.+ +.+|+||||++||+|.+++... ..+++..+..|+.||+.||+|||++| |+||
T Consensus 78 il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHR 155 (290)
T 3fpq_A 78 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 155 (290)
T ss_dssp HHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCC
T ss_pred HHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEec
Confidence 3678999999999999843 3589999999999999999863 56999999999999999999999999 9999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
||||+|||++..++.+||+|||+++.... .......||+.|+|||.+. ..++.++|||||||++|+|++|
T Consensus 156 DlKp~NILl~~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~---------~~y~~~~DiwSlGvilyelltg 225 (290)
T 3fpq_A 156 DLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATS 225 (290)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHS
T ss_pred ccChhheeEECCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcC---------CCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999985456799999999975432 2334568999999999874 3589999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCC-CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARP-GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
+.||.+..+.............+ .++..+++++.+|+.+||..||++|||++++++ +.++
T Consensus 226 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~--Hp~~ 286 (290)
T 3fpq_A 226 EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFF 286 (290)
T ss_dssp SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGG
T ss_pred CCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--Cccc
Confidence 99998777766665555444333 345678899999999999999999999999987 4444
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-51 Score=340.67 Aligned_cols=203 Identities=29% Similarity=0.498 Sum_probs=171.3
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++|||||++++++. ++.+|+|||||+||+|.+++.. ..+++.++..|+.||+.||+|||++||+||||||+|
T Consensus 124 il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 200 (346)
T 4fih_A 124 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 200 (346)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence 357889999999999985 5579999999999999999976 469999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.+ +.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 201 ILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 201 ILLTHD-GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp EEECTT-CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEECCC-CCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999966 46999999999865443 33456789999999999854 678999999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 159 GMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+.+..+... .......+ ..+..+++++.+||.+||..||++|||++++++ +.|+.+.
T Consensus 272 ~~~~~~~~~-~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~--Hp~~~~~ 330 (346)
T 4fih_A 272 NEPPLKAMK-MIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKA 330 (346)
T ss_dssp TSCHHHHHH-HHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGC
T ss_pred CcCHHHHHH-HHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhhcCC
Confidence 766544433 33333322 233568999999999999999999999999998 6666554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=335.08 Aligned_cols=203 Identities=27% Similarity=0.489 Sum_probs=174.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
|++++|||||+++|+|. ++..++||||+++|+|.+++.... ...+++.+++.|+.|++.||+|||
T Consensus 83 l~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH 162 (308)
T 4gt4_A 83 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS 162 (308)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 56799999999999995 557899999999999999996522 135899999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
+++|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.. ..++.++|||||
T Consensus 163 ~~~iiHRDLK~~NILl~~~-~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~~s~ksDVwSf 233 (308)
T 4gt4_A 163 SHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY--------GKFSIDSDIWSY 233 (308)
T ss_dssp HTTCCCSCCSGGGEEECGG-GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH--------CCCCHHHHHHHH
T ss_pred hCCCCCCCccccceEECCC-CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC--------CCCCccchhhhH
Confidence 9999999999999999955 569999999998643322 2334578999999999864 678999999999
Q ss_pred HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 144 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 144 G~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
||++|||++ |..||.+.+..+ ..........++.|..++.++.+|+.+||+.||.+|||+.+|++.|+.+
T Consensus 234 Gvvl~El~t~g~~Pf~~~~~~~-~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 234 GVVLWEVFSYGLQPYCGYSNQD-VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHHHHTTTCCTTTTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 999999998 899998876544 4444556667788899999999999999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-51 Score=334.30 Aligned_cols=196 Identities=26% Similarity=0.404 Sum_probs=167.9
Q ss_pred CCCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++|||||++++++.+ +.+|+||||++||+|.+++... +.+++.++..|+.||+.||+|||++||+||||||+|
T Consensus 85 il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeN 162 (311)
T 4aw0_A 85 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPEN 162 (311)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 3678999999999999964 5799999999999999999863 569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcc---cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
||++.+ +.+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 163 ILl~~~-g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~P 233 (311)
T 4aw0_A 163 ILLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPP 233 (311)
T ss_dssp EEECTT-SCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHH--------SCBCHHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEcCC-CCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999966 4699999999986532 223456689999999999864 6688999999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|.+.+...... .. ......++..+++++++||.+||.+||.+|||+++++.
T Consensus 234 F~~~~~~~~~~-~i-~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 234 FRAGNEGLIFA-KI-IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp SCCSSHHHHHH-HH-HHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred CCCCCHHHHHH-HH-HcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 98765443332 22 33456778899999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=329.97 Aligned_cols=201 Identities=29% Similarity=0.488 Sum_probs=169.1
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++|||||++++++. ++.+|+||||++||+|.+++... +.+++.++..++.|++.||+|||++||+||||||+|
T Consensus 79 il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 156 (304)
T 3ubd_A 79 ILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156 (304)
T ss_dssp CCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred HHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 578999999999999985 55799999999999999999863 569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.++ .+||+|||+++.... ........||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.
T Consensus 157 ILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 157 ILLDEEG-HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR--------RGHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp EEECTTS-CEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEEcCCC-CEEecccccceeccCCCccccccccCcccCCHHHhcc--------CCCCCCCcccchHHHHHHHHhCCCCCC
Confidence 9999664 599999999986433 333456789999999999854 678899999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~l~~l~~~~~ 216 (268)
+.+..+.... .......+|..+++++.+|+.+||+.||++|||+ +++++ +.++.
T Consensus 228 ~~~~~~~~~~--i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~--Hp~f~ 286 (304)
T 3ubd_A 228 GKDRKETMTM--ILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR--HSFFS 286 (304)
T ss_dssp CSSHHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT--SGGGT
T ss_pred CcCHHHHHHH--HHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc--Ccccc
Confidence 7665443333 2344567788999999999999999999999984 67766 44443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-50 Score=324.33 Aligned_cols=200 Identities=30% Similarity=0.496 Sum_probs=159.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||+ +|+|.+++.. ...+++.++..++.||+.||+|||++||+||||||+||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NI 143 (275)
T 3hyh_A 67 LRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENL 143 (275)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred HHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHe
Confidence 56789999999999985 45799999999 7799999976 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
|++.+ +.+||+|||+++............||+.|+|||.+.+ ....+.++|||||||++|+|++|+.||.+.
T Consensus 144 Ll~~~-~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 144 LLDEH-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISG-------KLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp EECTT-CCEEECCSSCC---------------CTTSCHHHHSS-------SSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCC-CCEEEeecCCCeecCCCCccCCeeECcccCChhhhcC-------CCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 99965 4699999999987666555566789999999999864 233467999999999999999999999875
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
+.. ..... .......++..+++++.+|+.+||+.||++|||++++++ +.|+.
T Consensus 216 ~~~-~~~~~-i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hpw~k 267 (275)
T 3hyh_A 216 SIP-VLFKN-ISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ--DDWFK 267 (275)
T ss_dssp SHH-HHHHH-HHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--CHHHH
T ss_pred CHH-HHHHH-HHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc--Ccccc
Confidence 543 33332 334556778889999999999999999999999999998 55553
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=342.07 Aligned_cols=203 Identities=29% Similarity=0.482 Sum_probs=171.6
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++|||||++++++. ++.+|||||||+||+|.+++.. ..+++.++..|+.||+.||+|||++||+||||||+|
T Consensus 201 il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~N 277 (423)
T 4fie_A 201 IMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDS 277 (423)
T ss_dssp HHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTT
T ss_pred HHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHH
Confidence 367899999999999985 5579999999999999999975 469999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.++ .+||+|||+++..... .......||+.|+|||++.+ ..|+.++|||||||++|+|++|..||.
T Consensus 278 ILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~--------~~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 278 ILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR--------LPYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp EEECTTC-CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEEcCCC-CEEEecCccceECCCCCccccccccCcCcCCHHHHCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999664 6999999999865433 33456789999999999854 678999999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 159 GMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+.+....... ...... ...+..+++++.+||.+||..||.+|||++++++ +.|+...
T Consensus 349 ~~~~~~~~~~-i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~--Hp~~~~~ 407 (423)
T 4fie_A 349 NEPPLKAMKM-IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK--HPFLAKA 407 (423)
T ss_dssp TSCHHHHHHH-HHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGGC
T ss_pred CcCHHHHHHH-HHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHHhcCC
Confidence 7765544433 233322 2334578999999999999999999999999998 6666543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=335.72 Aligned_cols=207 Identities=29% Similarity=0.560 Sum_probs=178.0
Q ss_pred CCCCCC-Ccccceeeeeec--CCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKH-DNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDC 64 (268)
Q Consensus 2 l~~l~H-p~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~ 64 (268)
|+++.| ||||+++++|.+ +.+++|||||++|+|.+++...+ ...+++.+++.++.|++.||+|
T Consensus 121 l~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~y 200 (353)
T 4ase_A 121 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEF 200 (353)
T ss_dssp HHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHH
T ss_pred HHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHh
Confidence 445655 999999999843 46899999999999999997532 2348999999999999999999
Q ss_pred HHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchH
Q 024401 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 141 (268)
Q Consensus 65 lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 141 (268)
||+++|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||
T Consensus 201 LH~~~iiHRDLK~~NILl~~~-~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~--------~~y~~ksDVw 271 (353)
T 4ase_A 201 LASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVW 271 (353)
T ss_dssp HHHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHH
T ss_pred HhhCCeecCccCccceeeCCC-CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc--------CCCCCcccEe
Confidence 999999999999999999955 569999999998643322 2334568999999999864 6789999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 142 SFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 142 slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
||||++|||++ |..||.+....+..........++..|..+++++.+++.+||+.||.+|||+.+++++|+.++..
T Consensus 272 S~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 272 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp HHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 99999999998 89999987766666666777788889999999999999999999999999999999999998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=314.61 Aligned_cols=204 Identities=30% Similarity=0.484 Sum_probs=151.6
Q ss_pred CCCCCCCCcccceeeeeecC-------------CceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHH
Q 024401 1 MMSRVKHDNLVKFLGACKDP-------------LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~-------------~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
+|++++|||||++++++.+. ++|+|||||+||+|.+++..... ...++..++.|+.||+.||+|||
T Consensus 56 il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH 135 (299)
T 4g31_A 56 ALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH 135 (299)
T ss_dssp HHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH
Confidence 36789999999999987321 36899999999999999986322 23566778999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc-------------ccCccCccceeccccccccccccccccC
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-------------MTAETGTYRWMAPELYSTVTLRQGEKKH 133 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~ 133 (268)
++||+||||||+|||++.+ +.+||+|||+++....... .....||+.|+|||.+.+ ..
T Consensus 136 ~~~IiHRDlKp~NILl~~~-~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--------~~ 206 (299)
T 4g31_A 136 SKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--------NS 206 (299)
T ss_dssp HTTCCCCCCCGGGEEECTT-CCEEECCCCCC--------------------------CCCTTSCHHHHTT--------CC
T ss_pred HCcCccccCcHHHeEECCC-CcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC--------CC
Confidence 9999999999999999966 4699999999975433211 123469999999999864 67
Q ss_pred CCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 134 YNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 134 ~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
++.++|||||||++|||++ ||....+.............++.....++.+.+|+.+||+.||.+|||+.++++ +.
T Consensus 207 y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~--h~ 281 (299)
T 4g31_A 207 YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE--NA 281 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT--SG
T ss_pred CCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc--CH
Confidence 8999999999999999996 775432222222222222222222345567889999999999999999999988 56
Q ss_pred hhhhc
Q 024401 214 FLFTL 218 (268)
Q Consensus 214 ~~~~~ 218 (268)
++..+
T Consensus 282 ~~~~~ 286 (299)
T 4g31_A 282 VFEDL 286 (299)
T ss_dssp GGCCC
T ss_pred hhCCC
Confidence 66544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=309.90 Aligned_cols=209 Identities=24% Similarity=0.383 Sum_probs=159.3
Q ss_pred CCCCCCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------
Q 024401 2 MSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-------- 68 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-------- 68 (268)
+.+++|||||++++++.++ .+|+||||++||+|.+++.. .++++..+.+++.|++.||+|||++
T Consensus 51 ~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~ 127 (303)
T 3hmm_A 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred HhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCC
Confidence 5688999999999998432 47999999999999999986 4699999999999999999999987
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
+|+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.+... .....++.++|||||
T Consensus 128 ~IiHRDlKp~NILl~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~--~~~~~~~~k~DVwS~ 204 (303)
T 3hmm_A 128 AIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAM 204 (303)
T ss_dssp CEECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHH
T ss_pred CEeeccCCcccEEECCC-CCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhccccc--ccCCccChhHhhhhH
Confidence 99999999999999965 569999999997543322 1223579999999999854110 011246779999999
Q ss_pred HHHHHHHHhCCCCCCCCC--------------cHHHHHHHH-HhhcCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCC
Q 024401 144 GIVLWELLTNRLPFEGMS--------------NLQAAYAAA-FKHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPS 203 (268)
Q Consensus 144 G~i~~~ll~g~~p~~~~~--------------~~~~~~~~~-~~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps 203 (268)
||++|||++|..||.... ......... ....++.+|.. .++.+.+|+.+||+.||++|||
T Consensus 205 Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt 284 (303)
T 3hmm_A 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC
Confidence 999999999976553211 122222222 22334455433 3357899999999999999999
Q ss_pred HHHHHHHHHhhhh
Q 024401 204 FSQIIRMLNAFLF 216 (268)
Q Consensus 204 ~~~~l~~l~~~~~ 216 (268)
+.++++.|+.+..
T Consensus 285 ~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 285 ALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=310.52 Aligned_cols=202 Identities=23% Similarity=0.357 Sum_probs=159.0
Q ss_pred CCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+.+ +||||+++++++. ++++|+||||++||+|.+++. .+++.++..++.||+.||+|||++||+||||||+||
T Consensus 74 ~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNi 148 (361)
T 4f9c_A 74 TVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNF 148 (361)
T ss_dssp HHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHe
Confidence 344 6999999999985 557999999999999999984 399999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-----------------------------ccccCccCccceeccccccccccccccc
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-----------------------------EMMTAETGTYRWMAPELYSTVTLRQGEK 131 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 131 (268)
|++.+.+.+||+|||+++..... .......||+.|+|||++.+ .
T Consensus 149 Ll~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~ 221 (361)
T 4f9c_A 149 LYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-------C 221 (361)
T ss_dssp EEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTT-------C
T ss_pred EEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcC-------C
Confidence 99977678999999999743221 11223479999999998863 2
Q ss_pred cCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh-------------------------------------h-
Q 024401 132 KHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK-------------------------------------H- 173 (268)
Q Consensus 132 ~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~-------------------------------------~- 173 (268)
..++.++||||+||++|+|++|+.||....+.......... .
T Consensus 222 ~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 301 (361)
T 4f9c_A 222 PNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGM 301 (361)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC--
T ss_pred CCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccc
Confidence 45788999999999999999999999655543322211110 0
Q ss_pred ---------------cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 174 ---------------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 174 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
........+++++.+|+.+||..||.+|+|++|+++ +.++.++
T Consensus 302 ~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~--Hp~f~~i 359 (361)
T 4f9c_A 302 DSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM 359 (361)
T ss_dssp --------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHT--SGGGTTC
T ss_pred cccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--CcccCCC
Confidence 000112457889999999999999999999999998 6666543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=312.04 Aligned_cols=206 Identities=26% Similarity=0.417 Sum_probs=166.1
Q ss_pred CCCCCCCCcccceeeeee-------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 1 MMSRVKHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
+|++++|||||++++++. .+.+|+||||++ |+|.+++.. .+.+++.++..|+.||+.||+|||++||+||
T Consensus 106 il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHR 182 (398)
T 4b99_A 106 ILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHR 182 (398)
T ss_dssp HHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCC
Confidence 357889999999999863 246899999995 689999975 4679999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCccc-----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
||||+|||++.+ +.+||+|||+++..... .......||+.|+|||++.+ ...++.++||||+||++|
T Consensus 183 DlKP~NIl~~~~-~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~-------~~~~~~~~DiWSlG~il~ 254 (398)
T 4b99_A 183 DLKPSNLLVNEN-CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLS-------LHEYTQAIDLWSVGCIFG 254 (398)
T ss_dssp CCCGGGEEECTT-CCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTT-------CSCCCTHHHHHHHHHHHH
T ss_pred CcCccccccCCC-CCEEEeecceeeecccCccccccccccceeChHhcCHHHhcC-------CCCCCChhheehhHHHHH
Confidence 999999999965 46999999999854322 22345689999999998753 245788999999999999
Q ss_pred HHHhCCCCCCCCCcHHHHHHHHHhhcCCC-----------------------------CCCCCcHHHHHHHHHhhhhCCC
Q 024401 149 ELLTNRLPFEGMSNLQAAYAAAFKHARPG-----------------------------LPEDISPDLAFIVQSCWVEDPN 199 (268)
Q Consensus 149 ~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~ 199 (268)
+|++|+.||.+.+..............+. ....+++++.+||.+||..||.
T Consensus 255 ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 334 (398)
T 4b99_A 255 EMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS 334 (398)
T ss_dssp HHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence 99999999998776554443332211111 0134688999999999999999
Q ss_pred CCCCHHHHHHHHHhhhhhcC
Q 024401 200 LRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 200 ~Rps~~~~l~~l~~~~~~~~ 219 (268)
+|||++++++ +.++....
T Consensus 335 ~R~ta~e~L~--Hp~f~~~~ 352 (398)
T 4b99_A 335 ARISAAAALR--HPFLAKYH 352 (398)
T ss_dssp TSCCHHHHTT--SGGGTTTC
T ss_pred HCcCHHHHhc--CHhhCcCC
Confidence 9999999998 67776544
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=323.77 Aligned_cols=202 Identities=23% Similarity=0.342 Sum_probs=168.8
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++|||||++++++.+ +.+|+||||++||+|.+++... ..+++..+..|+.||+.||+|||++||+||||||+||
T Consensus 246 l~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI 323 (689)
T 3v5w_A 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323 (689)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred HhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence 467899999999999964 5799999999999999999863 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
|++.++ .+||+|||++....... ..+.+||+.|+|||++.. +..++.++|+|||||++|+|++|..||.+.
T Consensus 324 Lld~~G-~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~-------~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 324 LLDEHG-HVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp EECTTS-CEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred EEeCCC-CEEecccceeeecCCCC-CCCccCCcCccCHHHHhC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999664 59999999998654332 345689999999999852 256889999999999999999999999753
Q ss_pred CcH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhhh
Q 024401 161 SNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~~ 216 (268)
... ..............++..+++++++||.+||..||.+|++ ++++++ +.++.
T Consensus 395 ~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~--HpfF~ 454 (689)
T 3v5w_A 395 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFFR 454 (689)
T ss_dssp GCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT--SGGGT
T ss_pred ChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc--Ccccc
Confidence 321 1122223345566778899999999999999999999997 788887 55543
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=323.14 Aligned_cols=204 Identities=27% Similarity=0.412 Sum_probs=171.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. ++.+|+||||++||+|.+++.. +...+++.++..++.||+.||+|||++||+||||||+||
T Consensus 208 l~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~-~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Ni 286 (573)
T 3uto_A 208 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 286 (573)
T ss_dssp HHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTC-TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhc
Confidence 56789999999999995 4579999999999999999975 345699999999999999999999999999999999999
Q ss_pred EEcCC-CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ .+.+||+|||+++............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 287 ll~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~--------~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 287 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp EESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99853 35699999999987766555566789999999999864 6788999999999999999999999988
Q ss_pred CCcHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+..+........... ......+++++.+||.+||..||.+|||+.++++ +.|+.
T Consensus 359 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~--Hpw~~ 415 (573)
T 3uto_A 359 ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLT 415 (573)
T ss_dssp SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTS
T ss_pred cCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcCcC
Confidence 7665444333222221 2223568999999999999999999999999998 55554
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=289.09 Aligned_cols=211 Identities=39% Similarity=0.694 Sum_probs=168.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANG--IIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dlk~ 77 (268)
|++++||||+++++++. ++..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.| |+||||||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp 167 (309)
T 3p86_A 88 MKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS 167 (309)
T ss_dssp HHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCG
T ss_pred HHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCCh
Confidence 56789999999999985 4578999999999999999976221 23999999999999999999999999 99999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
+||+++.+ +.++|+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..|
T Consensus 168 ~NIll~~~-~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~P 238 (309)
T 3p86_A 168 PNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRD--------EPSNEKSDVYSFGVILWELATLQQP 238 (309)
T ss_dssp GGEEECTT-CCEEECCCC-----------------CCTTSCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHCCCT
T ss_pred hhEEEeCC-CcEEECCCCCCccccccccccccCCCCccccChhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999955 569999999997543322 2344578999999999854 5678899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
|.....................+..+++++.+++.+||..+|.+|||++++++.|+.+.....++
T Consensus 239 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~ 303 (309)
T 3p86_A 239 WGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPP 303 (309)
T ss_dssp TTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-----
T ss_pred CCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCC
Confidence 99877666555555566677788899999999999999999999999999999999998765443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=286.81 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=170.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. ++..++||||++|++|.+++... ..+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 68 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NI 145 (328)
T 3fe3_A 68 MKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL 145 (328)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHE
Confidence 46789999999999985 45789999999999999999763 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............|++.|+|||.+.+ ....+.++|||||||++|+|++|..||.+.
T Consensus 146 ll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~ 217 (328)
T 3fe3_A 146 LLDAD-MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG-------KKYDGPEVDVWSLGVILYTLVSGSLPFDGQ 217 (328)
T ss_dssp EECTT-SCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHT-------CCCCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcCC-CCEEEeeccCceecCCCCccccccCCcceeCcccccC-------CCcCCchhhhhhhHHHHHHHHhCCCCCCCC
Confidence 99965 4699999999986655555566789999999999864 223357899999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+...... .........|..++.++.+++.+||..||.+|||++++++ +.++..
T Consensus 218 ~~~~~~~--~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~~ 270 (328)
T 3fe3_A 218 NLKELRE--RVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK--DRWINA 270 (328)
T ss_dssp SHHHHHH--HHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT--CTTTTT
T ss_pred CHHHHHH--HHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc--CHhhcC
Confidence 5433322 2333455667789999999999999999999999999998 555543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=286.48 Aligned_cols=208 Identities=28% Similarity=0.510 Sum_probs=172.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++|++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 104 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 182 (325)
T 3kul_A 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNV 182 (325)
T ss_dssp HTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceE
Confidence 57889999999999985 4578999999999999999975 345799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 155 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~ 155 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..
T Consensus 183 ll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 183 LVDSN-LVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF--------RTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp EECTT-CCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred EECCC-CCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcC--------CCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 99855 569999999997543321 1222345778999999854 567889999999999999999 999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
||.+..... ...........+.+..++..+.+++.+||..+|.+|||+.++++.|+.+......
T Consensus 254 p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~ 317 (325)
T 3kul_A 254 PYWNMTNRD-VISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES 317 (325)
T ss_dssp TTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred CcccCCHHH-HHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence 998766543 3344455566677788999999999999999999999999999999998876444
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=281.66 Aligned_cols=202 Identities=31% Similarity=0.475 Sum_probs=168.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||++|++|.+++.. ..+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni 147 (297)
T 3fxz_A 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (297)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHE
Confidence 45789999999999984 5578999999999999999986 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 148 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp EECTT-CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHC--------SCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EECCC-CCEEEeeCCCceecCCcccccCCccCCcCccChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99965 469999999987554332 2345579999999999854 5678999999999999999999999987
Q ss_pred CCcHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.............. .....+..++..+.+++.+||+.||.+|||++++++ +.++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--h~~~~~ 275 (297)
T 3fxz_A 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ--HQFLKI 275 (297)
T ss_dssp SCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CGGGGG
T ss_pred CCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh--Chhhcc
Confidence 76655444333222 233445678999999999999999999999999998 555543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=288.62 Aligned_cols=207 Identities=31% Similarity=0.610 Sum_probs=173.6
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
|+++ +||||+++++++. ++..|+||||++||+|.+++.... ...+++.+++.++.|++.||+||
T Consensus 140 l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 219 (370)
T 2psq_A 140 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL 219 (370)
T ss_dssp HHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 4556 8999999999984 557999999999999999998643 23589999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.||+||||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||
T Consensus 220 H~~~ivHrDlkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Dvws 290 (370)
T 2psq_A 220 ASQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWS 290 (370)
T ss_dssp HHTTEECSCCCGGGEEECTT-CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT--------CCCCHHHHHHH
T ss_pred HhCCeeccccchhhEEECCC-CCEEEccccCCcccCcccceecccCCCcccceECHhHhcC--------CCCCcHHHHHH
Confidence 99999999999999999965 469999999997543322 2233456788999998854 66889999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|||++|+|++ |..||.+.... ..............+..++.++.+++.+||..+|.+|||+.++++.|+.++...
T Consensus 291 lG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 291 FGVLMWEIFTLGGSPYPGIPVE-ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp HHHHHHHHHTTSCCSSTTCCGG-GHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCCHH-HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999999999 99999876543 334444555667778889999999999999999999999999999999987543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=286.17 Aligned_cols=205 Identities=27% Similarity=0.534 Sum_probs=171.0
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++||||+.+++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 147 (325)
T 3kex_A 69 IGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147 (325)
T ss_dssp HHTCCCTTBCCEEEEECBSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEE
T ss_pred HhcCCCCCcCeEEEEEcCCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEE
Confidence 4578999999999999888899999999999999999762 346999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 148 ~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~el~~~g~~p~ 218 (325)
T 3kex_A 148 LKSP-SQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF--------GKYTHQSDVWSYGVTVWELMTFGAEPY 218 (325)
T ss_dssp ESSS-SCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ECCC-CeEEECCCCcccccCcccccccccCCCCcccccChHHhcc--------CCCChhhHhHHhHHHHHHHHhCCCCCc
Confidence 9855 459999999998653322 2233467789999999854 568899999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.+...... ............+..++.++.+++.+||..+|.+|||+.++++.|..+...
T Consensus 219 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 219 AGLRLAEV-PDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TTSCTTHH-HHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred cccCHHHH-HHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 87654333 333444556666777889999999999999999999999999999987654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=278.27 Aligned_cols=205 Identities=29% Similarity=0.561 Sum_probs=164.4
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 148 (281)
T 1mp8_A 70 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 148 (281)
T ss_dssp HHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCccceEEEEEccCccEEEEecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEE
Confidence 467899999999999988889999999999999999986 3356999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||++........ .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 149 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~ell~~g~~pf~ 219 (281)
T 1mp8_A 149 VSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQ 219 (281)
T ss_dssp EEET-TEEEECC-------------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ECCC-CCEEECccccccccCcccccccccCCCcccccChhhccc--------CCCCCccCchHHHHHHHHHHhcCCCCCC
Confidence 9955 5699999999976543222 223356778999998853 567889999999999999996 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+...... ............+..+++.+.+++.+||..+|.+|||+.++++.|+.+...
T Consensus 220 ~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 220 GVKNNDV-IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp TCCGGGH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 7665433 333444556667788999999999999999999999999999999988654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=287.36 Aligned_cols=196 Identities=24% Similarity=0.374 Sum_probs=165.6
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++.+ +..++||||++|++|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 69 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI 146 (361)
T 2yab_A 69 LRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146 (361)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 578899999999999854 568999999999999999975 45699999999999999999999999999999999999
Q ss_pred EEcCCCC---ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.++. .++|+|||++.............||+.|+|||.+.. ..++.++||||||+++|+|++|..||
T Consensus 147 ll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp EESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred EEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC--------CCCCccccHHHHHHHHHHHHhCCCCC
Confidence 9986553 699999999987655544556679999999999853 56788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+.+....... ... ....+ ...++.++.++|.+||..||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~-i~~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 219 LGDTKQETLAN-ITA-VSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp CCSSHHHHHHH-HHT-TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCHHHHHHH-HHh-cCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 87654433322 222 22222 2568899999999999999999999999987
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=277.26 Aligned_cols=211 Identities=34% Similarity=0.652 Sum_probs=169.5
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHA---NGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dlk~ 77 (268)
|++++||||+++++++.+ ..++||||++|++|.+++..... ..+++..++.++.|++.||+|||+ .||+||||||
T Consensus 55 l~~l~hp~iv~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp 133 (307)
T 2eva_A 55 LSRVNHPNIVKLYGACLN-PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133 (307)
T ss_dssp HHHCCCTTBCCEEEBCTT-TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSG
T ss_pred HhcCCCCCcCeEEEEEcC-CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCCh
Confidence 467899999999998864 47999999999999999986332 247899999999999999999999 8999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+||+++.++..++|+|||++...... .....|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||
T Consensus 134 ~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~~p~ 203 (307)
T 2eva_A 134 PNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG--------SNYSEKCDVFSWGIILWEVITRRKPF 203 (307)
T ss_dssp GGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC--------CCCCTHHHHHHHHHHHHHHHHTCCTT
T ss_pred hHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC--------CCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 99999866656899999998754322 223468999999998853 56788999999999999999999999
Q ss_pred CCCCcH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCCCC
Q 024401 158 EGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSP 223 (268)
Q Consensus 158 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~~ 223 (268)
...... ............+..+..++..+.+++.+||..+|.+|||++++++.|..+.........
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~ 270 (307)
T 2eva_A 204 DEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270 (307)
T ss_dssp TTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTS
T ss_pred hhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCC
Confidence 865432 223333445556667788999999999999999999999999999999998877655443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=281.08 Aligned_cols=195 Identities=25% Similarity=0.416 Sum_probs=165.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. ++..++||||++||+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 59 l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 136 (337)
T 1o6l_A 59 LQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL 136 (337)
T ss_dssp HHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHE
Confidence 56789999999999985 45789999999999999999763 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.++ .++|+|||++..... ........||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+
T Consensus 137 ll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~ 207 (337)
T 1o6l_A 137 MLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYN 207 (337)
T ss_dssp EECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EECCCC-CEEEeeccchhhcccCCCcccccccChhhCChhhhcC--------CCCCchhhcccchhHHHHHhcCCCCCCC
Confidence 999664 699999999975332 333455678999999999853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.+..... .. .......++..++.++.+++.+||..||.+|| +++++++
T Consensus 208 ~~~~~~~-~~-i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 208 QDHERLF-EL-ILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp SSHHHHH-HH-HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCHHHHH-HH-HHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 6543332 22 22345567788999999999999999999999 8999988
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=295.18 Aligned_cols=207 Identities=34% Similarity=0.535 Sum_probs=176.5
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+.+|+|.+++.......+++..++.++.|++.||+|||+.||+||||||+|||
T Consensus 237 l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 316 (454)
T 1qcf_A 237 MKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316 (454)
T ss_dssp HTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred HhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 67899999999999998888999999999999999998644446899999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 317 l~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~~l~el~t~g~~P~~ 387 (454)
T 1qcf_A 317 VSAS-LVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF--------GSFTIKSDVWSFGILLMEIVTYGRIPYP 387 (454)
T ss_dssp ECTT-CCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ECCC-CcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc--------CCCCcHHHHHhHHHHHHHHHhCCCCCCC
Confidence 9955 569999999998654322 1223356778999999854 568899999999999999999 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+.+..+.. .......+.+.+..+++++.+++.+||..+|.+|||++++++.|+.+....
T Consensus 388 ~~~~~~~~-~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 388 GMSNPEVI-RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TCCHHHHH-HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CCCHHHHH-HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 77654433 344455667778889999999999999999999999999999999877543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-41 Score=272.12 Aligned_cols=205 Identities=28% Similarity=0.503 Sum_probs=173.9
Q ss_pred CCCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCC
Q 024401 1 MMSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDL 75 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dl 75 (268)
++++++||||+++++++.+ +..++||||+++++|.+++.......+++.+++.++.|++.||+|||+.| ++|+||
T Consensus 60 ~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~di 139 (271)
T 3kmu_A 60 RLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHAL 139 (271)
T ss_dssp GGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCC
T ss_pred HHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCC
Confidence 3678899999999999854 46899999999999999998754456999999999999999999999999 999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
||+||+++.+ +.++|+|||+...... ....+++.|+|||.+.+. ....++.++||||||+++|+|++|..
T Consensus 140 kp~Nil~~~~-~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~ 209 (271)
T 3kmu_A 140 NSRSVMIDED-MTARISMADVKFSFQS----PGRMYAPAWVAPEALQKK-----PEDTNRRSADMWSFAVLLWELVTREV 209 (271)
T ss_dssp SGGGEEECTT-SCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSC-----GGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred ccceEEEcCC-cceeEEeccceeeecc----cCccCCccccChhhhccC-----CCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999955 4589998887754322 234678999999998641 11233447999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
||.+................+..+..++.++.+++.+||+.+|.+|||++++++.|+.+.
T Consensus 210 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 210 PFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 999887766666666667777888899999999999999999999999999999998764
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=288.16 Aligned_cols=207 Identities=29% Similarity=0.551 Sum_probs=174.6
Q ss_pred CCC-CCCcccceeeeeec--CCceEEEEcCCCCCHHHHHhhhCC------------------------------------
Q 024401 3 SRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP------------------------------------ 43 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~------------------------------------ 43 (268)
+++ +||||+++++++.+ ...++||||++||+|.+++.....
T Consensus 80 ~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (359)
T 3vhe_A 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS 159 (359)
T ss_dssp HHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------
T ss_pred HhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcc
Confidence 345 78999999999843 358999999999999999976432
Q ss_pred ----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccC
Q 024401 44 ----------------------------NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 95 (268)
Q Consensus 44 ----------------------------~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg 95 (268)
..+++..++.++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kl~Dfg 238 (359)
T 3vhe_A 160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFG 238 (359)
T ss_dssp ------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCG
T ss_pred ccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC-CcEEEEecc
Confidence 128999999999999999999999999999999999999855 469999999
Q ss_pred CcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 024401 96 LAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAF 171 (268)
Q Consensus 96 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~ 171 (268)
++...... .......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.+............
T Consensus 239 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 310 (359)
T 3vhe_A 239 LARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 310 (359)
T ss_dssp GGSCTTSCTTCEEC--CEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH
T ss_pred ceeeecccccchhccccCCCceeEChhhhcC--------CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHH
Confidence 99754322 12234467889999998854 667899999999999999998 9999988776666666666
Q ss_pred hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 172 KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 172 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.......+..+++++.+++.+||..+|.+|||+.+++++|+.++...
T Consensus 311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 67777788889999999999999999999999999999999987643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=273.24 Aligned_cols=204 Identities=29% Similarity=0.552 Sum_probs=172.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 137 (269)
T 4hcu_A 59 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 137 (269)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHh-cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheE
Confidence 56789999999999985 4578999999999999999976 345699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||
T Consensus 138 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~~g~~p~ 208 (269)
T 4hcu_A 138 LVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPY 208 (269)
T ss_dssp EECGG-GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EEcCC-CCEEeccccccccccccccccccCcccccccCCHHHhcC--------CCCCchhhhHHHHHHHHHHhcCCCCCC
Confidence 99855 469999999997554322 2233456778999998854 567889999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
...... ..............+..++..+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 209 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 209 ENRSNS-EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTCCHH-HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHH-HHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 876543 3344445555666777899999999999999999999999999999998764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=286.99 Aligned_cols=210 Identities=18% Similarity=0.256 Sum_probs=167.9
Q ss_pred CCCCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 2 MSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
++.++||||+++++++.+ ...++||||+ |++|.+++.. ....+++.+++.++.|++.||+|||+.||+|||||
T Consensus 102 ~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlk 179 (364)
T 3op5_A 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIK 179 (364)
T ss_dssp HTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCC
Confidence 357899999999999733 3589999999 9999999986 34679999999999999999999999999999999
Q ss_pred CCCEEEc--CCCCceEEeccCCcccCcccccc--------cCccCccceeccccccccccccccccCCCcccchHHHHHH
Q 024401 77 PDNLLLT--PDQKSLKLADFGLAREETVTEMM--------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 146 (268)
Q Consensus 77 ~~Nil~~--~~~~~~~l~Dfg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 146 (268)
|+|||++ .+ +.++|+|||+++........ ....||+.|+|||.+.+ ..++.++||||||++
T Consensus 180 p~Nill~~~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 180 ASNLLLNYKNP-DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--------VAPSRRGDLEILGYC 250 (364)
T ss_dssp GGGEEEESSCT-TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--------CCCCHHHHHHHHHHH
T ss_pred HHHEEEecCCC-CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--------CCCCchhhHHHHHHH
Confidence 9999998 44 56999999999754432211 23358999999998854 568899999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHHhhcCC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 147 LWELLTNRLPFEGMSNLQAAYAAAFKHARP---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 147 ~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+|+|++|..||.+................. .....++.++.+++..||..+|.+||++.++++.|+.++..
T Consensus 251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 999999999998543322221111111000 01256889999999999999999999999999999999887
Q ss_pred cCCCC
Q 024401 218 LRPPS 222 (268)
Q Consensus 218 ~~~~~ 222 (268)
.....
T Consensus 331 ~~~~~ 335 (364)
T 3op5_A 331 IGSKD 335 (364)
T ss_dssp TTCCC
T ss_pred cCCCc
Confidence 65543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=277.00 Aligned_cols=207 Identities=29% Similarity=0.480 Sum_probs=167.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||++|++|.+++... ..+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 65 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni 142 (294)
T 4eqm_A 65 SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI 142 (294)
T ss_dssp HTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 56889999999999985 45689999999999999999864 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 143 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll~g~~pf~ 213 (294)
T 4eqm_A 143 LIDSN-KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG--------EATDECTDIYSIGIVLYEMLVGEPPFN 213 (294)
T ss_dssp EECTT-SCEEECCCSSSTTC-------------CCSSCCHHHHHT--------CCCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred EECCC-CCEEEEeCCCccccccccccccCccccCccccCHhHhcC--------CCCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 99965 469999999997654332 2234568999999998854 567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCC----CCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHhhhhhcCC
Q 024401 159 GMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~~~~~~ 220 (268)
+............ ...+ ..+..+++.+.+++.+||..+|.+|| ++.++.+.|..+......
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~ 279 (294)
T 4eqm_A 214 GETAVSIAIKHIQ-DSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRA 279 (294)
T ss_dssp SSCHHHHHHHHHS-SCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSST
T ss_pred CCChHHHHHHHhh-ccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccC
Confidence 7765544333322 2222 23467899999999999999999998 899999999887655443
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=275.31 Aligned_cols=200 Identities=38% Similarity=0.740 Sum_probs=164.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG---IIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dlk~ 77 (268)
++.++||||+++++++. ++..++||||++|++|.+++.. ..+++..++.++.|++.||+|||+.| ++||||||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp 136 (271)
T 3dtc_A 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS 136 (271)
T ss_dssp HHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSG
T ss_pred HHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCch
Confidence 45689999999999984 5578999999999999999864 57999999999999999999999999 89999999
Q ss_pred CCEEEcCC-------CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 78 DNLLLTPD-------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 78 ~Nil~~~~-------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
+||+++.+ .+.++|+|||.+........ ....+++.|+|||.+.+ ..++.++||||||+++|+|
T Consensus 137 ~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l 207 (271)
T 3dtc_A 137 SNILILQKVENGDLSNKILKITDFGLAREWHRTTK-MSAAGAYAWMAPEVIRA--------SMFSKGSDVWSYGVLLWEL 207 (271)
T ss_dssp GGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHH--------CCCSHHHHHHHHHHHHHHH
T ss_pred HHEEEecccccccccCcceEEccCCcccccccccc-cCCCCccceeCHHHhcc--------CCCCchhhHHHHHHHHHHH
Confidence 99999852 45699999999975443322 24478999999998854 5678899999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 151 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
++|..||.+.+.................+..+++.+.+++.+||..+|.+|||+.++++.|+.
T Consensus 208 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 208 LTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp HHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred HhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 999999998777666655555566667778899999999999999999999999999999875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-42 Score=283.84 Aligned_cols=209 Identities=32% Similarity=0.464 Sum_probs=167.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++|++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 61 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Ni 139 (310)
T 3s95_A 61 MRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNC 139 (310)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-CCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred HHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeE
Confidence 57889999999999984 5578999999999999999986 346699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc---------------cCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM---------------TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
+++.+ +.++|+|||++......... ....||+.|+|||.+.+ ..++.++||||||+
T Consensus 140 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~ 210 (310)
T 3s95_A 140 LVREN-KNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING--------RSYDEKVDVFSFGI 210 (310)
T ss_dssp EECTT-SCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHH
T ss_pred EECCC-CCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC--------CCCCcHHHHHHHHH
Confidence 99955 56999999999754332211 14578999999999854 66788999999999
Q ss_pred HHHHHHhCCCCCCCCCcHHHH-HHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 146 VLWELLTNRLPFEGMSNLQAA-YAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 146 i~~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
++|+|++|..||......... ............+..+++.+.+++.+||+.||.+|||+.++++.|+.+...+..
T Consensus 211 ~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 211 VLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp HHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 999999999988643221100 000000111223567888999999999999999999999999999998766543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=285.23 Aligned_cols=210 Identities=32% Similarity=0.613 Sum_probs=177.1
Q ss_pred CCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 024401 3 SRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
+++ +||||+++++++. ++..++||||+++++|.+++..... ..+++.+++.++.|++.||+|||
T Consensus 129 ~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 208 (382)
T 3tt0_A 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA 208 (382)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 455 8999999999985 5578999999999999999987432 45999999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
+.||+||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++|||||
T Consensus 209 ~~~ivH~Dlkp~NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Diwsl 279 (382)
T 3tt0_A 209 SKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSF 279 (382)
T ss_dssp HTTCCCSCCCGGGEEECTT-CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--------CCCCHHHHHHHH
T ss_pred hCCEecCCCCcceEEEcCC-CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC--------CCCCchhHHHHH
Confidence 9999999999999999965 469999999998654322 2233457789999998854 667899999999
Q ss_pred HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCCC
Q 024401 144 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 222 (268)
Q Consensus 144 G~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 222 (268)
|+++|+|++ |..||.+... ...............+..++.++.+++.+||+.+|.+|||+.++++.|+.+........
T Consensus 280 G~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 280 GVLLWEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp HHHHHHHHTTSCCSSTTCCH-HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred HHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 999999999 9999987654 44445555666777788899999999999999999999999999999999987665443
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=287.94 Aligned_cols=205 Identities=32% Similarity=0.547 Sum_probs=172.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+.|++||||||+||
T Consensus 166 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 244 (377)
T 3cbl_A 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNC 244 (377)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHE
Confidence 57889999999999985 45789999999999999999763 34599999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccc---cCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMM---TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
+++.+ +.++|+|||+++........ ....++..|+|||.+.. ..++.++||||||+++|||++ |..|
T Consensus 245 l~~~~-~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwslG~il~el~t~g~~p 315 (377)
T 3cbl_A 245 LVTEK-NVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNY--------GRYSSESDVWSFGILLWETFSLGASP 315 (377)
T ss_dssp EECTT-CCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCS
T ss_pred EEcCC-CcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99955 46999999999754332211 12235678999998854 567889999999999999998 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
|.+....+ ...........+.+..++.++.+++.+||..+|.+|||++++++.|+.+...
T Consensus 316 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 316 YPNLSNQQ-TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp STTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 98776543 3334455566777888999999999999999999999999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=278.95 Aligned_cols=206 Identities=28% Similarity=0.567 Sum_probs=173.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC----------------------CCCCHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP----------------------NKLDLHVALNFALDI 58 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~~i~~ql 58 (268)
|++++||||+++++++. ++..++||||++|++|.+++..... ..+++.+++.++.|+
T Consensus 80 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 159 (314)
T 2ivs_A 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI 159 (314)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHH
T ss_pred HhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHH
Confidence 57889999999999984 5578999999999999999986432 348999999999999
Q ss_pred HHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCC
Q 024401 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135 (268)
Q Consensus 59 ~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 135 (268)
+.||+|||+.||+|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++
T Consensus 160 ~~~l~~lH~~~ivH~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~ 230 (314)
T 2ivs_A 160 SQGMQYLAEMKLVHRDLAARNILVAEG-RKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--------HIYT 230 (314)
T ss_dssp HHHHHHHHHTTEECCCCSGGGEEEETT-TEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--------CEEC
T ss_pred HHHHHHHHHCCCcccccchheEEEcCC-CCEEEccccccccccccccceeccCCCCcccccChhhhcC--------CCcC
Confidence 999999999999999999999999955 569999999997543322 1233456788999998854 5678
Q ss_pred cccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 136 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 136 ~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.++||||||+++|+|++ |..||.+..... .............+..++.++.+++.+||..||.+|||+.++++.|+.+
T Consensus 231 ~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPER-LFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 89999999999999999 999998766533 3344445556677788999999999999999999999999999999998
Q ss_pred hhh
Q 024401 215 LFT 217 (268)
Q Consensus 215 ~~~ 217 (268)
+..
T Consensus 310 ~~~ 312 (314)
T 2ivs_A 310 MVK 312 (314)
T ss_dssp HHT
T ss_pred Hhh
Confidence 764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=287.56 Aligned_cols=208 Identities=29% Similarity=0.517 Sum_probs=173.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
+++++||||+++++++. ++..++||||++||+|.+++..... ..+++.+++.++.|++.||+|||+.||+||||
T Consensus 128 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 207 (367)
T 3l9p_A 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDI 207 (367)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 45789999999999985 4578999999999999999987432 45999999999999999999999999999999
Q ss_pred CCCCEEEcCCC--CceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 76 KPDNLLLTPDQ--KSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 76 k~~Nil~~~~~--~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
||+|||++.++ ..++|+|||+++..... .......+++.|+|||.+.+ ..++.++|||||||++|+|
T Consensus 208 kp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DvwslG~il~el 279 (367)
T 3l9p_A 208 AARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEI 279 (367)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred ChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcC--------CCCCcHHHHHHHHHHHHHH
Confidence 99999998432 35999999999743221 12233467889999998854 6688999999999999999
Q ss_pred Hh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 151 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 151 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
++ |..||..... ...............+..++..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus 280 lt~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 280 FSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HTTSCCSSTTCCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HhCCCCCCCCCCH-HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 98 9999987654 3444445555666777889999999999999999999999999999999876543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=275.60 Aligned_cols=210 Identities=24% Similarity=0.531 Sum_probs=178.1
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus 64 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 142 (287)
T 1u59_A 64 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 142 (287)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEE
Confidence 457899999999999988889999999999999999975 3456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|
T Consensus 143 i~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p 213 (287)
T 1u59_A 143 LVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKP 213 (287)
T ss_dssp EEET-TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred EcCC-CCEEECcccceeeeccCcceeeccccccccccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 9955 5699999999975433221 223356789999998853 557889999999999999998 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCCC
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 222 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 222 (268)
|....... ..........+..+..+++++.+++.+||..+|.+|||+.++++.|+.++.+...+.
T Consensus 214 ~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 214 YKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp TTTCCTHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred cccCCHHH-HHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 98766543 334444555677788999999999999999999999999999999999988766544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=293.64 Aligned_cols=209 Identities=30% Similarity=0.496 Sum_probs=173.1
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++|+|.+++.......+++.+++.++.|++.||+|||+.||+||||||+|||
T Consensus 233 l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nil 312 (452)
T 1fmk_A 233 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312 (452)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence 56789999999999998888999999999999999997644456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 313 l~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~ 383 (452)
T 1fmk_A 313 VGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYP 383 (452)
T ss_dssp ECGG-GCEEECCCCTTC--------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ECCC-CCEEECCCccceecCCCceecccCCcccccccCHhHHhc--------CCCCccccHHhHHHHHHHHHhCCCCCCC
Confidence 9855 569999999997654322 1223356788999998854 568899999999999999999 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
+....+. ........+.+.+..+++.+.+++.+||..+|.+|||++++++.|+.++....+
T Consensus 384 ~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~ 444 (452)
T 1fmk_A 384 GMVNREV-LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 444 (452)
T ss_dssp TCCHHHH-HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence 7765443 334455566777888999999999999999999999999999999998765443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=283.54 Aligned_cols=209 Identities=33% Similarity=0.539 Sum_probs=173.0
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC---------------------CCCCHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---------------------NKLDLHVALNFALDI 58 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~i~~ql 58 (268)
|+++ +||||+++++++. ++..++||||+++++|.+++..... ..+++..++.++.|+
T Consensus 102 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 181 (344)
T 1rjb_A 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181 (344)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence 3456 8999999999984 5578999999999999999986332 237999999999999
Q ss_pred HHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCC
Q 024401 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135 (268)
Q Consensus 59 ~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 135 (268)
+.||+|||+.||+||||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++
T Consensus 182 ~~aL~~LH~~~ivH~Dikp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~ 252 (344)
T 1rjb_A 182 AKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYT 252 (344)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCC
T ss_pred HHHHHHHHhCCcccCCCChhhEEEcCC-CcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc--------CCCC
Confidence 999999999999999999999999955 569999999997543322 1233456778999998854 5678
Q ss_pred cccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 136 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 136 ~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.++||||||+++|+|++ |..||.+...................+..++.++.+++.+||..+|.+|||+.++++.|+.+
T Consensus 253 ~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 332 (344)
T 1rjb_A 253 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 332 (344)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 99999999999999998 99999887765555555556666777788999999999999999999999999999999998
Q ss_pred hhhcC
Q 024401 215 LFTLR 219 (268)
Q Consensus 215 ~~~~~ 219 (268)
.....
T Consensus 333 ~~~~~ 337 (344)
T 1rjb_A 333 LADAE 337 (344)
T ss_dssp C----
T ss_pred HHHHH
Confidence 76543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=282.25 Aligned_cols=208 Identities=29% Similarity=0.511 Sum_probs=171.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC----------------------CCCCHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP----------------------NKLDLHVALNFALDI 58 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~----------------------~~~~~~~~~~i~~ql 58 (268)
+++++||||+++++++. ++..++||||+++++|.+++..... ..+++.+++.++.|+
T Consensus 104 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 183 (343)
T 1luf_A 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 183 (343)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHH
Confidence 56789999999999985 5578999999999999999986421 569999999999999
Q ss_pred HHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCC
Q 024401 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135 (268)
Q Consensus 59 ~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 135 (268)
+.||+|||+.||+||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++
T Consensus 184 ~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~ 254 (343)
T 1luf_A 184 AAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYT 254 (343)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCC
T ss_pred HHHHHHHHhCCeecCCCCcceEEECCC-CeEEEeecCCCcccccCccccccCCCcccceecChhhhcc--------CCcC
Confidence 999999999999999999999999855 469999999987543221 2234467889999998854 5678
Q ss_pred cccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 136 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 136 ~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.++||||||+++|+|++ |..||.+..... .............+..++.++.+++.+||..+|.+|||+.++++.|+.+
T Consensus 255 ~~~Di~slG~il~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~ 333 (343)
T 1luf_A 255 TESDVWAYGVVLWEIFSYGLQPYYGMAHEE-VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 333 (343)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred cccccHHHHHHHHHHHhcCCCcCCCCChHH-HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHH
Confidence 99999999999999999 999998765433 3344445556677788999999999999999999999999999999998
Q ss_pred hhhcC
Q 024401 215 LFTLR 219 (268)
Q Consensus 215 ~~~~~ 219 (268)
.....
T Consensus 334 ~~~~~ 338 (343)
T 1luf_A 334 CERAE 338 (343)
T ss_dssp TC---
T ss_pred Hhhhh
Confidence 76543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=275.88 Aligned_cols=209 Identities=31% Similarity=0.517 Sum_probs=174.9
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++++|.+++.......+++.+++.++.|++.||+|||+.|++|+||||+||+
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 141 (279)
T 1qpc_A 62 MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (279)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE
Confidence 46789999999999998888999999999999999997643346999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||.+....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 142 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~g~~p~~ 212 (279)
T 1qpc_A 142 VSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (279)
T ss_dssp ECTT-SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred EcCC-CCEEECCCcccccccCcccccccCCCCccCccChhhhcc--------CCCCchhhhHHHHHHHHHHHhCCCCCCc
Confidence 9955 569999999997654322 1223456778999998853 557889999999999999999 899998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
+..... .............+..++.++.+++.+||..+|.+|||++++++.|+.++.....
T Consensus 213 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 273 (279)
T 1qpc_A 213 GMTNPE-VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273 (279)
T ss_dssp TCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred ccCHHH-HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence 765533 3344445556666788999999999999999999999999999999999876544
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=278.39 Aligned_cols=208 Identities=33% Similarity=0.537 Sum_probs=175.2
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC----------------CCCCHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP----------------NKLDLHVALNFALDIARAMD 63 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~i~~ql~~~l~ 63 (268)
|+++ +||||+++++++. ++..++||||+++++|.+++..... ..+++.+++.++.|++.||+
T Consensus 80 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~ 159 (313)
T 1t46_A 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA 159 (313)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred HhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence 3456 8999999999984 5578999999999999999986432 24899999999999999999
Q ss_pred HHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccch
Q 024401 64 CLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDV 140 (268)
Q Consensus 64 ~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di 140 (268)
|||+.|++|+||||+||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||
T Consensus 160 ~lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di 230 (313)
T 1t46_A 160 FLASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDV 230 (313)
T ss_dssp HHHHTTCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHH
T ss_pred HHHHCCeecCCCccceEEEcCC-CCEEEccccccccccccccceeccCCCCcceeeChHHhcC--------CCCChHHHH
Confidence 9999999999999999999955 5699999999976543322 223456778999998854 567899999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 141 YSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 141 ~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
||||+++|+|++ |..||.+...................+..++.++.+++.+||..+|.+|||+.++++.|+..+.+.
T Consensus 231 ~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 999999999998 999998776655555555555566667789999999999999999999999999999999988664
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=283.24 Aligned_cols=203 Identities=19% Similarity=0.337 Sum_probs=167.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. ++..++||||++|++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NI 133 (321)
T 1tki_A 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTS-SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence 46789999999999985 5578999999999999999975 234699999999999999999999999999999999999
Q ss_pred EEcCC-CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ ++.++|+|||++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+
T Consensus 134 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 99852 45799999999987655544455678999999999853 4568899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
........... .. ...++ ..++.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 206 ~~~~~~~~~i~-~~-~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~--hp~~~~ 263 (321)
T 1tki_A 206 ETNQQIIENIM-NA-EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ--HPWLKQ 263 (321)
T ss_dssp SSHHHHHHHHH-HT-CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHHS
T ss_pred CCHHHHHHHHH-cC-CCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc--Chhhcc
Confidence 66544333222 22 22222 468999999999999999999999999998 555543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=281.85 Aligned_cols=205 Identities=27% Similarity=0.537 Sum_probs=169.2
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++|++++.+++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+
T Consensus 71 l~~l~hp~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 149 (327)
T 3lzb_A 71 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp HTTCCBTTBCCCCEEEESSSEEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCeeEEEEEEecCCceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEE
Confidence 5788999999999999888889999999999999999863 456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 150 ~~~~-~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~~g~~p~ 220 (327)
T 3lzb_A 150 VKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPY 220 (327)
T ss_dssp EEET-TEEEECCTTC----------------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EcCC-CCEEEccCcceeEccCccccccccCCCccccccCHHHHcC--------CCCChHHHHHHHHHHHHHHHHCCCCCC
Confidence 9855 5699999999976433221 223356778999998864 667899999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.+..... .............+..++.++.+++.+||..+|.+|||+.++++.|..+...
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 221 DGIPASE-ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTCCGGG-HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 8766543 3334445556667788999999999999999999999999999999998744
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=274.96 Aligned_cols=208 Identities=31% Similarity=0.576 Sum_probs=163.4
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+.+++|.+++.. ....+++.+++.++.|++.||+|||+.||+|+||||+||+
T Consensus 74 l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil 152 (289)
T 3og7_A 74 LRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHA-SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF 152 (289)
T ss_dssp HTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHTT-C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCcEEEEEeeccCCccEEEEEecCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 578999999999998888889999999999999999965 3466999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcc---cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
++.+ +.++|+|||++..... ........+++.|+|||.+... ....++.++||||||+++|+|++|..||.
T Consensus 153 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~el~~g~~p~~ 226 (289)
T 3og7_A 153 LHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DSNPYSFQSDVYAFGIVLYELMTGQLPYS 226 (289)
T ss_dssp EETT-TEEEECCCC------------------CCCTTCCHHHHC---------CCSCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred ECCC-CCEEEccceeccccccccccccccccCCCccccCchhhccc-----CCCCCCcccchHHHHHHHHHHHHCCCCcc
Confidence 9965 5699999999875432 2222345689999999987521 13567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.................. .....+++.+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 227 NINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp SCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 877666555444433322 2335788999999999999999999999999999998653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=284.60 Aligned_cols=206 Identities=29% Similarity=0.508 Sum_probs=162.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 100 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 178 (373)
T 2qol_A 100 MGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 178 (373)
T ss_dssp HTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceE
Confidence 57889999999999985 4578999999999999999976 345699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 155 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~ 155 (268)
+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|+|++ |..
T Consensus 179 ll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~SlG~il~ellt~g~~ 249 (373)
T 2qol_A 179 LINSN-LVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY--------RKFTSASDVWSYGIVLWEVMSYGER 249 (373)
T ss_dssp EECTT-CCEEECCC----------------------CTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTC-C
T ss_pred EEcCC-CCEEECcCccccccccCCccceeccCCCcCCCccChhhhcc--------CCcCchhcHHHHHHHHHHHHhCCCC
Confidence 99955 5699999999975443211 112234678999998854 668889999999999999998 999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
||....... ...........+.+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 250 P~~~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 250 PYWEMSNQD-VIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp TTTTCCHHH-HHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred CCCCCCHHH-HHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 998766533 33344444455667789999999999999999999999999999999987543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=289.09 Aligned_cols=202 Identities=23% Similarity=0.354 Sum_probs=166.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+.||+|.+++.. ...+++.++..++.||+.||+|||+.||+||||||+||
T Consensus 64 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NI 141 (444)
T 3soa_A 64 CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL 141 (444)
T ss_dssp HHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTE
T ss_pred HHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 56789999999999985 4578999999999999999986 35699999999999999999999999999999999999
Q ss_pred EEcC--CCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTP--DQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~--~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++. +++.++|+|||++....... ......|++.|+|||.+.. ..++.++|||||||++|+|++|..||
T Consensus 142 ll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilyell~G~~Pf 213 (444)
T 3soa_A 142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK--------DPYGKPVDLWACGVILYILLVGYPPF 213 (444)
T ss_dssp EESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC--------CCCCCccccHHHHHHHHHHHhCCCCC
Confidence 9984 23569999999997654432 2345679999999999853 56788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.+.+...............+ ....+++++.+++.+||..||.+|||+.++++ +.++
T Consensus 214 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~--hp~~ 271 (444)
T 3soa_A 214 WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK--HPWI 271 (444)
T ss_dssp CCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SCTT
T ss_pred CCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc--Cccc
Confidence 87665443333322222221 22468999999999999999999999999998 4444
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=284.89 Aligned_cols=198 Identities=26% Similarity=0.410 Sum_probs=164.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+.|++|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NI 159 (362)
T 2bdw_A 82 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 159 (362)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence 45789999999999985 4568999999999999999975 35699999999999999999999999999999999999
Q ss_pred EEcCCC--CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.++ ..++|+|||++.............|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 160 ll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 160 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp EESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc--------CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 998542 3599999999987655444455689999999999853 567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.+...............+. ...+++++.+++.+||..||.+|||+.++++
T Consensus 232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 232 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 76644333222222211111 1357899999999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=298.59 Aligned_cols=210 Identities=24% Similarity=0.527 Sum_probs=176.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+.+|+|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+|||
T Consensus 390 l~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NIL 468 (613)
T 2ozo_A 390 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVL 468 (613)
T ss_dssp HTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEE
Confidence 678999999999999988889999999999999999975 3456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.+||+|||+++....... .....++..|+|||.+.. ..++.++||||||+++|||++ |..|
T Consensus 469 l~~~-~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~P 539 (613)
T 2ozo_A 469 LVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKP 539 (613)
T ss_dssp EEET-TEEEECCCSTTTTCC--------------CCTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred EcCC-CcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC--------CCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 9955 5699999999986543221 122245678999999854 678899999999999999998 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCCC
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPS 222 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~~ 222 (268)
|.+....+. ........+...+..++.++.+++.+||..+|.+||++.++++.|+.++.......
T Consensus 540 f~~~~~~~~-~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~~ 604 (613)
T 2ozo_A 540 YKKMKGPEV-MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 604 (613)
T ss_dssp TTTCCSHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCSC
T ss_pred CCCCCHHHH-HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcccc
Confidence 988776443 34445566777888999999999999999999999999999999999987765533
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=271.79 Aligned_cols=202 Identities=34% Similarity=0.645 Sum_probs=168.8
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dlk~~N 79 (268)
+++++||||+++++++.+.. ++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.| ++|+||||+|
T Consensus 77 l~~l~h~~i~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~N 154 (287)
T 4f0f_A 77 MSNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPN 154 (287)
T ss_dssp HTTCCCTTBCCEEEEETTTT-EEEEECCTTCBHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGG
T ss_pred HHhCCCCCchhhheeecCCC-eEEEEecCCCCHHHHHhc-ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcce
Confidence 56789999999999986544 799999999999999875 3457999999999999999999999999 9999999999
Q ss_pred EEEcCCCC----ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 80 LLLTPDQK----SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 80 il~~~~~~----~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
|+++.++. .++|+|||++...... .....+++.|+|||.+.. ....++.++||||||+++|+|++|..
T Consensus 155 il~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~------~~~~~~~~~Di~slG~~l~~l~~g~~ 226 (287)
T 4f0f_A 155 IFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGA------EEESYTEKADTYSFAMILYTILTGEG 226 (287)
T ss_dssp EEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSC------SSCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred EEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhcc------CCCCcCchhhHHHHHHHHHHHHcCCC
Confidence 99985432 3899999999754432 344578999999998843 23556889999999999999999999
Q ss_pred CCCCCCcHHH--HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 156 PFEGMSNLQA--AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 156 p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
||........ ..........+..+..+++++.+++.+||+.||.+|||++++++.|+.
T Consensus 227 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp TTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 9987654443 223334455667778899999999999999999999999999999875
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=281.99 Aligned_cols=209 Identities=29% Similarity=0.535 Sum_probs=165.9
Q ss_pred CCCCCCCCcccceeeee--ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++++++||||+++++++ .++..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+
T Consensus 143 il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 221 (373)
T 3c1x_A 143 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAAR 221 (373)
T ss_dssp TSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred HHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchh
Confidence 47889999999999986 34578999999999999999975 3456899999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 152 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~- 152 (268)
||+++.+ +.++|+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 222 NIll~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwSlG~il~ellt~ 292 (373)
T 3c1x_A 222 NCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTR 292 (373)
T ss_dssp GEEECTT-CCEEECCC---------------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTT
T ss_pred eEEECCC-CCEEEeeccccccccccccccccccCCCCCcccccChHHhcC--------CCCCcHHHHHHHHHHHHHHHhC
Confidence 9999955 469999999997543221 1123356788999998854 667899999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|..||......+.. ...........+..++..+.+++.+||..+|.+|||+.++++.|+.+......
T Consensus 293 ~~~p~~~~~~~~~~-~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 293 GAPPYPDVNTFDIT-VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp SCCSCTTSCSSCHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred cCCCCCCCCHHHHH-HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 67788765543332 33344555666778999999999999999999999999999999999877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=280.19 Aligned_cols=205 Identities=27% Similarity=0.537 Sum_probs=172.1
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++|+||+.+|+|.+++.. ....+++..++.++.|++.||+|||+.||+||||||+||+
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl 149 (327)
T 3poz_A 71 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 149 (327)
T ss_dssp HHHCCBTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHH-STTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEE
Confidence 457899999999999988888999999999999999986 3456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 150 l~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~p~ 220 (327)
T 3poz_A 150 VKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPY 220 (327)
T ss_dssp EEET-TEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ECCC-CCEEEccCcceeEccCCcccccccCCCccccccChHHhcc--------CCCCchhhhhhhHHHHHHHHhcCCCCc
Confidence 9955 569999999997543222 1223356789999999864 678899999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.+..... .............+..++.++.+++.+||..+|.+|||+.++++.|..+...
T Consensus 221 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 221 DGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TTCCGGG-HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred cCCCHHH-HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 8765433 3334445556667788999999999999999999999999999999887643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=276.31 Aligned_cols=207 Identities=27% Similarity=0.484 Sum_probs=166.3
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++. ....++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.||+||||||+
T Consensus 65 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~ 143 (295)
T 3ugc_A 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 143 (295)
T ss_dssp HHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred HHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHh
Confidence 56789999999999873 34689999999999999999763 345999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 144 Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~ 214 (295)
T 3ugc_A 144 NILVENE-NRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYI 214 (295)
T ss_dssp GEEEEET-TEEEECCCCSCC-------------CTTCGGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHHTT
T ss_pred hEEEcCC-CeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC--------CCCChHHHHHHHHHHHHHHHhcc
Confidence 9999955 569999999997654322 1223456778999998854 56789999999999999999999
Q ss_pred CCCCCCCcH---------------HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 155 LPFEGMSNL---------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 155 ~p~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.||...... .............+.+..++.++.+++.+||..+|.+|||+.++++.|+.+..++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 215 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 887532211 0122223344566677889999999999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=282.58 Aligned_cols=200 Identities=29% Similarity=0.434 Sum_probs=168.2
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++.+ +..|+||||+.||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 69 l~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 146 (384)
T 4fr4_A 69 MQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI 146 (384)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence 567899999999999854 578999999999999999986 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............||+.|+|||.+... .+..++.++|||||||++|+|++|..||...
T Consensus 147 ll~~~-g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~-----~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 147 LLDEH-GHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSR-----KGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp EECTT-SCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCC-----SSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred EECCC-CCEEEeccceeeeccCCCceeccCCCccccCCeeeccC-----CCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 99965 46999999999876555555667899999999998531 1245788999999999999999999999754
Q ss_pred CcH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-HHHHHH
Q 024401 161 SNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-FSQIIR 209 (268)
Q Consensus 161 ~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-~~~~l~ 209 (268)
... ..............++..++.++.+++.+||..+|.+||+ ++++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 221 SSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp TTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred CCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 321 2222233445566778889999999999999999999997 777765
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=280.36 Aligned_cols=200 Identities=23% Similarity=0.384 Sum_probs=166.0
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++.+ +..++||||++|++|.+++.. ...+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 68 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI 145 (326)
T 2y0a_A 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145 (326)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHE
Confidence 467899999999999854 568999999999999999975 45699999999999999999999999999999999999
Q ss_pred EEcCCCC---ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.++. .++|+|||++.............|++.|+|||.+.. ..++.++||||||+++|+|++|..||
T Consensus 146 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf 217 (326)
T 2y0a_A 146 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPF 217 (326)
T ss_dssp EESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred EEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC--------CCCCcHHHHHHHHHHHHHHHHCcCCC
Confidence 9986542 699999999986654444455679999999998853 56788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.+............ ....+ ...++..+.+++.+||..||.+|||+.++++ +.++
T Consensus 218 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~ 275 (326)
T 2y0a_A 218 LGDTKQETLANVSA--VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWI 275 (326)
T ss_dssp CCSSHHHHHHHHHH--TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTT
T ss_pred CCCCHHHHHHHHHh--cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--CCCc
Confidence 87654433332222 12222 2468899999999999999999999999998 4444
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=273.47 Aligned_cols=208 Identities=29% Similarity=0.531 Sum_probs=170.8
Q ss_pred CCCCCCCcccceeeee--ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++++++ .++..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.|++||||||+|
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N 158 (298)
T 3f66_A 80 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN 158 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence 5678999999999986 34578999999999999999975 34568999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc-----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-C
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 153 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g 153 (268)
|+++.+ +.++|+|||++........ .....+++.|+|||.+.+ ..++.++||||||+++|+|++ |
T Consensus 159 il~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~~ 229 (298)
T 3f66_A 159 CMLDEK-FTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRG 229 (298)
T ss_dssp EEECTT-CCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EEECCC-CCEEECcccccccccccchhccccccCCCCCccccChHHhcC--------CCCChHHHHHHHHHHHHHHHhCC
Confidence 999855 5699999999975443221 223456788999998854 567889999999999999999 5
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
..||...... ..............+..++..+.+++.+||..+|.+|||+.++++.|..++.....
T Consensus 230 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 230 APPYPDVNTF-DITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp CCSSTTSCTT-THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred CCCCccCCHH-HHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 5666554433 33334455556666778999999999999999999999999999999998876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=271.59 Aligned_cols=205 Identities=30% Similarity=0.540 Sum_probs=170.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.|++|+||||+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 135 (268)
T 3sxs_A 57 MMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNC 135 (268)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGE
T ss_pred HHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceE
Confidence 45789999999999985 45789999999999999999763 34599999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 136 l~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (268)
T 3sxs_A 136 LVDRD-LCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHY--------FKYSSKSDVWAFGILMWEVFSLGKMPY 206 (268)
T ss_dssp EECTT-CCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHH--------SEEETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred EECCC-CCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhc--------cCCchhhhhHHHHHHHHHHHcCCCCCc
Confidence 99965 469999999997544332 2233456778999998854 567889999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
........ ............+..+++.+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus 207 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 207 DLYTNSEV-VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp TTSCHHHH-HHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred cccChHHH-HHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 87665443 333445555666777899999999999999999999999999999987543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=273.10 Aligned_cols=204 Identities=28% Similarity=0.510 Sum_probs=170.0
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus 67 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 145 (281)
T 3cc6_A 67 MKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145 (281)
T ss_dssp HHHHCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEE
T ss_pred HHhCCCCCcceEEEEEcCCCCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence 4567999999999999888889999999999999999763 356999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.
T Consensus 146 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 146 VASP-ECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF--------RRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp EEET-TEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ECCC-CcEEeCccCCCcccccccccccccCCCCcceeCchhhcc--------CCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 9955 569999999997654322 1233456788999998853 567889999999999999998 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
........ ...........+..+++.+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 217 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 217 WLENKDVI-GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp TSCGGGHH-HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCChHHHH-HHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 65554332 3334445566677899999999999999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=289.94 Aligned_cols=203 Identities=33% Similarity=0.586 Sum_probs=171.3
Q ss_pred CCCCCCCcccceeeeeec--CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|++++||||+++++++.+ +..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.||+||||||+|
T Consensus 240 l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 319 (450)
T 1k9a_A 240 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 319 (450)
T ss_dssp HHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence 568899999999999743 368999999999999999987655558999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
||++.+ +.+||+|||+++...... ....++..|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 320 ill~~~-~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 320 VLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp EEECTT-SCEEECCCTTCEECC--------CCCTTTSCHHHHHS--------SCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred EEECCC-CCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999955 469999999997543322 22356788999999854 668899999999999999998 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..+..+.. .......+...+..+++.+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 389 ~~~~~~~~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 389 RIPLKDVV-PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp TSCTTTHH-HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHH-HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 76654333 3344556777888999999999999999999999999999999998764
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=273.48 Aligned_cols=206 Identities=26% Similarity=0.510 Sum_probs=173.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+.|++|+||||+||+
T Consensus 72 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil 149 (291)
T 1xbb_A 72 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 149 (291)
T ss_dssp HHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhCCCCCEEEEEEEECCCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEE
Confidence 467899999999999988889999999999999999986 356999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..|
T Consensus 150 ~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p 220 (291)
T 1xbb_A 150 LVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKP 220 (291)
T ss_dssp EEET-TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred EeCC-CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc--------CCCChhhhHHHHHHHHHHHHhcCCCC
Confidence 9955 5699999999975433221 122345688999998854 456789999999999999999 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
|.+..... ..........+..+..++..+.+++.+||..+|.+|||+.++++.|+.++....
T Consensus 221 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 282 (291)
T 1xbb_A 221 YRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 282 (291)
T ss_dssp STTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred CCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 98766533 334444555677778899999999999999999999999999999999886543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=277.61 Aligned_cols=209 Identities=33% Similarity=0.578 Sum_probs=173.2
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
|+++ +||||+++++++. ++..++||||+++++|.+++.... ...+++.+++.++.|++.||+||
T Consensus 79 l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L 158 (327)
T 1fvr_A 79 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 158 (327)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 5677 8999999999985 557899999999999999997632 24699999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
|+.||+||||||+||+++.+ +.++|+|||++.............++..|+|||.+.. ..++.++||||||+
T Consensus 159 H~~~ivH~dlkp~NIl~~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~ 229 (327)
T 1fvr_A 159 SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGV 229 (327)
T ss_dssp HHTTEECSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHH
T ss_pred HhCCccCCCCccceEEEcCC-CeEEEcccCcCccccccccccCCCCCccccChhhhcc--------ccCCchhcchHHHH
Confidence 99999999999999999855 4699999999875444333344466788999998853 55788999999999
Q ss_pred HHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 146 VLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 146 i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
++|+|++ |..||.+..... .............+..++.++.+++.+||..+|.+|||++++++.|..+......
T Consensus 230 il~ellt~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 304 (327)
T 1fvr_A 230 LLWEIVSLGGTPYCGMTCAE-LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 304 (327)
T ss_dssp HHHHHHTTSCCTTTTCCHHH-HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred HHHHHHcCCCCCCCCCcHHH-HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcC
Confidence 9999998 999998765433 3334444455666778999999999999999999999999999999998876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=271.70 Aligned_cols=205 Identities=26% Similarity=0.526 Sum_probs=172.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.||+|+||||+||
T Consensus 73 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 151 (283)
T 3gen_A 73 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 151 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred HhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceE
Confidence 46789999999999985 45789999999999999999763 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||++....... ......+++.|+|||.+.. ..++.++||||||+++|+|++ |..||
T Consensus 152 li~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~~l~~l~t~g~~p~ 222 (283)
T 3gen_A 152 LVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPY 222 (283)
T ss_dssp EECTT-SCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred EEcCC-CCEEEccccccccccccccccccCCccCcccCCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99955 469999999997554322 2233456788999999864 567889999999999999998 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
....... .............+..+++.+.+++.+||+.+|.+|||+.++++.|..++.+
T Consensus 223 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 223 ERFTNSE-TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccChhH-HHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 8766543 3334445556666778899999999999999999999999999999988754
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=282.37 Aligned_cols=195 Identities=29% Similarity=0.422 Sum_probs=160.7
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.
T Consensus 82 ~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~ 159 (353)
T 3txo_A 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDH 159 (353)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECC
Confidence 7999999999985 45789999999999999999863 56999999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
+ +.++|+|||++..... ........||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+..
T Consensus 160 ~-g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 160 E-GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQE--------MLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp T-SCEEECCCTTCBCSCC---------CCGGGCCHHHHHH--------HHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred C-CCEEEccccceeecccCCccccccCCCcCeEChhhcCC--------CCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 6 4599999999975332 333455679999999999854 56788999999999999999999999876654
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHHHHHhhh
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIRMLNAFL 215 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~l~~l~~~~ 215 (268)
..... .......++..++.++.+++.+||..+|.+||++ +++++ +.++
T Consensus 231 ~~~~~--i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~--hp~f 284 (353)
T 3txo_A 231 DLFEA--ILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR--HPFF 284 (353)
T ss_dssp HHHHH--HHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT--SGGG
T ss_pred HHHHH--HHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh--CCcc
Confidence 33322 3344556778899999999999999999999998 77877 4444
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=283.44 Aligned_cols=204 Identities=22% Similarity=0.393 Sum_probs=168.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+.|++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 102 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI 180 (387)
T 1kob_A 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENI 180 (387)
T ss_dssp HTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHe
Confidence 57899999999999985 4578999999999999999975 334699999999999999999999999999999999999
Q ss_pred EEcCC-CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ .+.++|+|||++.............+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+
T Consensus 181 ll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 181 MCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp EESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred EEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC--------CCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 99743 35699999999986655444445578999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+............. .......++.++.+++.+||..||.+|||+.++++ +.++.
T Consensus 253 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~ 309 (387)
T 1kob_A 253 EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE--HPWLK 309 (387)
T ss_dssp SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT--STTTS
T ss_pred CCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh--Ccccc
Confidence 665443333222111 12233568999999999999999999999999998 45544
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=280.91 Aligned_cols=194 Identities=26% Similarity=0.429 Sum_probs=163.0
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.+||||+++++++. ++..++||||++||+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++
T Consensus 110 ~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~ 187 (396)
T 4dc2_A 110 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLD 187 (396)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEC
Confidence 38999999999985 45699999999999999999863 5699999999999999999999999999999999999999
Q ss_pred CCCCceEEeccCCcccC-cccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 84 PDQKSLKLADFGLAREE-TVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
.+ +.++|+|||+++.. ..........||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.....
T Consensus 188 ~~-g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~--------~~~~~~~DiwslGvllyell~G~~Pf~~~~~ 258 (396)
T 4dc2_A 188 SE-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGS 258 (396)
T ss_dssp TT-SCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC
T ss_pred CC-CCEEEeecceeeecccCCCccccccCCcccCCchhhcC--------CCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 66 46999999999853 33344556689999999999864 6678999999999999999999999964321
Q ss_pred -------HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 024401 163 -------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIR 209 (268)
Q Consensus 163 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~l~ 209 (268)
...............++..++.++.+++.+||..||.+||++ +++++
T Consensus 259 ~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 259 SDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 122233334456677888999999999999999999999985 56665
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=271.39 Aligned_cols=210 Identities=28% Similarity=0.436 Sum_probs=174.0
Q ss_pred CCCCCCCcccceeeeeec--CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++++++.+ ...+++|||+.+++|.+++.. ....+++.+++.++.|++.||+|||+.|++||||||+|
T Consensus 76 l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N 154 (298)
T 3pls_A 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARN 154 (298)
T ss_dssp HHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 567899999999999843 345899999999999999976 34678999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 155 ili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~ 225 (298)
T 3pls_A 155 CMLDES-FTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT--------YRFTTKSDVWSFGVLLWELLTRG 225 (298)
T ss_dssp EEECTT-CCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHTS
T ss_pred EEEcCC-CcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc--------CCCChhhchhhHHHHHHHHhhCC
Confidence 999955 469999999997543322 2233467889999999854 56788999999999999999966
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
.|+.....................+..++..+.+++.+||..+|.+|||+.++++.|+.+...+...
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 226 APPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp CCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred CCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 5554444444444555556666777889999999999999999999999999999999998876543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-40 Score=272.98 Aligned_cols=201 Identities=28% Similarity=0.420 Sum_probs=163.6
Q ss_pred CCCCcccceeeeeecC------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 5 VKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 5 l~Hp~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++||||+++++++.+. ..+++|||+. ++|.+++.......+++.+++.++.|++.||+|||+.||+||||||+
T Consensus 71 ~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~ 149 (308)
T 3g33_A 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 149 (308)
T ss_dssp HCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTT
T ss_pred cCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 4699999999998432 3789999995 59999998765566999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||+++.+ +.++|+|||++.............+|+.|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 150 Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~ 220 (308)
T 3g33_A 150 NILVTSG-GTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQ--------STYATPVDMWSVGCIFAEMFRRKPLFC 220 (308)
T ss_dssp TEEECTT-SCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT--------SCCCSTHHHHHHHHHHHHTTTSSCSCC
T ss_pred HEEEcCC-CCEEEeeCccccccCCCcccCCccccccccCchHHcC--------CCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9999855 4699999999987655555556678999999999854 567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCC-------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 159 GMSNLQAAYAAAFKHARPG-------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
+.+..............+. ....+++.+.+++.+||+.||.+|||+.++++ +.
T Consensus 221 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--h~ 298 (308)
T 3g33_A 221 GNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ--HS 298 (308)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--ST
T ss_pred CCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc--Cc
Confidence 7766554433322211110 11357889999999999999999999999998 55
Q ss_pred hhhh
Q 024401 214 FLFT 217 (268)
Q Consensus 214 ~~~~ 217 (268)
++..
T Consensus 299 ~~~~ 302 (308)
T 3g33_A 299 YLHK 302 (308)
T ss_dssp TC--
T ss_pred cccC
Confidence 5543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=275.85 Aligned_cols=206 Identities=28% Similarity=0.501 Sum_probs=167.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 100 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 178 (333)
T 1mqb_A 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 178 (333)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheE
Confidence 46789999999999985 4578999999999999999976 345799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRL 155 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~ 155 (268)
+++.+ +.++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|+|++ |..
T Consensus 179 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ellt~g~~ 249 (333)
T 1mqb_A 179 LVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGER 249 (333)
T ss_dssp EECTT-CCEEECCCCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred EECCC-CcEEECCCCcchhhccccccccccCCCCccccccCchhccc--------CCCCchhhhHHHHHHHHHHHcCCCC
Confidence 99955 5699999999975443211 122345778999998853 567889999999999999998 999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
||....... ...........+.+..++..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 250 pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 250 PYWELSNHE-VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp TTTTCCHHH-HHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred CcccCCHHH-HHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 998765533 33344445566667789999999999999999999999999999999987544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=275.09 Aligned_cols=198 Identities=30% Similarity=0.482 Sum_probs=154.8
Q ss_pred CCCCCCCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 1 MMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
++++++||||+++++++.+. ..++||||++|++|.+++... ..+++.+++.++.|++.||+|||+.||+||||
T Consensus 65 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl 142 (311)
T 3ork_A 65 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDV 142 (311)
T ss_dssp TCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCC
Confidence 46789999999999987432 249999999999999999863 46999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||+||+++.+ +.++|+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 143 kp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~ll 213 (311)
T 3ork_A 143 KPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVL 213 (311)
T ss_dssp CGGGEEEETT-SCEEECCCSCC------------------CCTTCCHHHHHT--------CCCCHHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCC-CCEEEeeccCcccccccccccccccccCcCcccCCHHHhcC--------CCCCchHhHHHHHHHHHHHH
Confidence 9999999965 459999999997543321 2233468999999998854 56788999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+|..||.+................+. ....++.++.+++.+||+.||.+||++.+++.
T Consensus 214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 214 TGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred hCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 99999987766554444333222221 12468999999999999999999997666655
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=274.77 Aligned_cols=197 Identities=27% Similarity=0.460 Sum_probs=166.7
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++.+ +..|+||||++||+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 60 l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 137 (318)
T 1fot_A 60 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 137 (318)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheE
Confidence 467899999999999864 478999999999999999986 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... .....||+.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.
T Consensus 138 ll~~~-g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~ 206 (318)
T 1fot_A 138 LLDKN-GHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDS 206 (318)
T ss_dssp EECTT-SCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EEcCC-CCEEEeecCcceecCCc--cccccCCccccCHhHhcC--------CCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 99965 46999999999764432 334578999999998854 56788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 215 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~ 215 (268)
+........ ......++..++.++.+++.+||..+|.+|| +++++++ +.++
T Consensus 207 ~~~~~~~~i--~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~--hp~f 262 (318)
T 1fot_A 207 NTMKTYEKI--LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN--HPWF 262 (318)
T ss_dssp SHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT--SGGG
T ss_pred CHHHHHHHH--HhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc--Cccc
Confidence 554333222 2334567788999999999999999999999 8999987 4444
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=285.13 Aligned_cols=201 Identities=25% Similarity=0.417 Sum_probs=168.5
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPD 78 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~ 78 (268)
+|+.++||||+++++++. ++..++||||++|++|.+++... ..+++..+..++.|++.||+|||+ .||+||||||+
T Consensus 201 ~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~ 278 (446)
T 4ejn_A 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278 (446)
T ss_dssp CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGG
T ss_pred HHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHH
Confidence 477899999999999985 55789999999999999999763 569999999999999999999998 99999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|||++.+ +.++|+|||++..... ........||+.|+|||.+.+ ..++.++|||||||++|+|++|..||
T Consensus 279 NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf 349 (446)
T 4ejn_A 279 NLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPF 349 (446)
T ss_dssp GEEECSS-SCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HEEECCC-CCEEEccCCCceeccCCCcccccccCCccccCHhhcCC--------CCCCCccchhhhHHHHHHHhhCCCCC
Confidence 9999965 4699999999975333 333455689999999999854 67889999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~ 216 (268)
.+.+....... .......++..+++++.+++.+||..||.+|| +++++++ +.++.
T Consensus 350 ~~~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~--hp~f~ 409 (446)
T 4ejn_A 350 YNQDHEKLFEL--ILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ--HRFFA 409 (446)
T ss_dssp CCSSHHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT--SGGGT
T ss_pred CCCCHHHHHHH--HHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh--Ccccc
Confidence 87654433322 33345567788999999999999999999999 9999998 45543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=279.61 Aligned_cols=191 Identities=27% Similarity=0.381 Sum_probs=161.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..|+||||++||+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 93 l~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 170 (373)
T 2r5t_A 93 LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI 170 (373)
T ss_dssp BCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 57789999999999985 45789999999999999999863 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.++ .++|+|||+++... .........||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+
T Consensus 171 ll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 171 LLDSQG-HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK--------QPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp EECTTS-CEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EECCCC-CEEEeeCccccccccCCCccccccCCccccCHHHhCC--------CCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 999664 59999999997533 2333455689999999999854 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.+.... ..... .....++..++.++.+++.+||..||.+||++.
T Consensus 242 ~~~~~~-~~~i~-~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 242 RNTAEM-YDNIL-NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp SBHHHH-HHHHH-HSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTT
T ss_pred CCHHHH-HHHHH-hcccCCCCCCCHHHHHHHHHHcccCHHhCCCCC
Confidence 654333 33322 334556778999999999999999999999874
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=284.09 Aligned_cols=203 Identities=24% Similarity=0.403 Sum_probs=155.8
Q ss_pred CCCCCcccceeeeee-----cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 4 RVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
..+||||+++++++. ++..|+||||++||+|.+++.......+++.++..|+.|++.||+|||+.||+||||||+
T Consensus 111 ~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 190 (400)
T 1nxk_A 111 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 190 (400)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred hcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence 458999999999874 346899999999999999998754556999999999999999999999999999999999
Q ss_pred CEEEcCC--CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 79 NLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 79 Nil~~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|||++.+ ++.+||+|||++.............||+.|+|||.+.+ ..++.++|||||||++|+|++|..|
T Consensus 191 Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~p 262 (400)
T 1nxk_A 191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPP 262 (400)
T ss_dssp GEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCC--------CCSSSHHHHHHHHHHHHHHHHSSCS
T ss_pred eEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCC--------CCCCCcccHHHHHHHHHHHHhCCCC
Confidence 9999853 45799999999986655444456678999999999853 6788999999999999999999999
Q ss_pred CCCCCcHH----HHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 157 FEGMSNLQ----AAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 157 ~~~~~~~~----~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|.+..... ............ .....++.++.+||.+||..||.+|||+.++++ +.++.
T Consensus 263 f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~ 326 (400)
T 1nxk_A 263 FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIM 326 (400)
T ss_dssp CCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--SHHHH
T ss_pred CCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Ccccc
Confidence 97644221 111111111111 112468999999999999999999999999998 44443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=266.76 Aligned_cols=204 Identities=30% Similarity=0.555 Sum_probs=171.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 57 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 135 (267)
T 3t9t_A 57 MMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 135 (267)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred HHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence 46789999999999985 45789999999999999999763 35689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||
T Consensus 136 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (267)
T 3t9t_A 136 LVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPY 206 (267)
T ss_dssp EECGG-GCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EECCC-CCEEEcccccccccccccccccccccccccccChhhhcC--------CCccchhchhhhHHHHHHHhccCCCCC
Confidence 99855 469999999987543322 2233456788999999853 567889999999999999999 89999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
...... ..............+..++..+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 207 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 207 ENRSNS-EVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTCCHH-HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHH-HHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 876543 3334444455566677889999999999999999999999999999998764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=298.96 Aligned_cols=205 Identities=26% Similarity=0.518 Sum_probs=173.5
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++|+|.+++.. ...+++.+++.|+.||+.||+|||+.||+||||||+|||
T Consensus 424 l~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NIL 501 (635)
T 4fl3_A 424 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 501 (635)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEE
Confidence 567899999999999988888999999999999999976 456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..|
T Consensus 502 l~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~sDvwSlGv~l~ellt~G~~P 572 (635)
T 4fl3_A 502 LVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKP 572 (635)
T ss_dssp EEET-TEEEECCTTHHHHTTC-------------CGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred EeCC-CCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC--------CCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9955 569999999997543322 1222346788999999854 678899999999999999998 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|.+..... .............+..++.++.+++..||..||.+||+++++++.|+.++.++
T Consensus 573 f~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 573 YRGMKGSE-VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp STTCCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 98766543 44445566677788899999999999999999999999999999999987654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=272.66 Aligned_cols=206 Identities=33% Similarity=0.566 Sum_probs=174.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||++|++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 142 (288)
T 3kfa_A 63 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 142 (288)
T ss_dssp HHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceE
Confidence 46789999999999985 45789999999999999999876667799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 143 l~~~~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~~g~~p~ 213 (288)
T 3kfa_A 143 LVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPY 213 (288)
T ss_dssp EECGG-GCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred EEcCC-CCEEEccCccceeccCCccccccCCccccCcCChhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99855 469999999997654322 2233356778999998854 567889999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
...+... .............+..+++.+.+++.+||..+|.+|||++++++.|+.++.+
T Consensus 214 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 214 PGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp TTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHH-HHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 8765433 3334445556677788999999999999999999999999999999988754
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=277.12 Aligned_cols=197 Identities=25% Similarity=0.368 Sum_probs=166.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. ++..|+||||++|++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 95 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 172 (350)
T 1rdq_E 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceE
Confidence 57889999999999985 45789999999999999999864 4599999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... .....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.
T Consensus 173 ll~~~-g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~ 241 (350)
T 1rdq_E 173 LIDQQ-GYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFAD 241 (350)
T ss_dssp EECTT-SCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCC-CCEEEcccccceeccCC--cccccCCccccCHHHhcC--------CCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence 99965 46999999999765432 234578999999999854 56788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFL 215 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~ 215 (268)
+...... . .......++..++.++.+++.+||..||.+||+ ++++++ +.++
T Consensus 242 ~~~~~~~-~-i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~--h~~f 297 (350)
T 1rdq_E 242 QPIQIYE-K-IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN--HKWF 297 (350)
T ss_dssp SHHHHHH-H-HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT--SGGG
T ss_pred CHHHHHH-H-HHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh--CcCc
Confidence 5433322 2 223456677889999999999999999999998 888887 4444
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=292.22 Aligned_cols=204 Identities=32% Similarity=0.571 Sum_probs=173.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+++|+|.+++.......+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 270 l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 349 (495)
T 1opk_A 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNC 349 (495)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 56789999999999985 45789999999999999999875556799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
|++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||
T Consensus 350 ll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlG~~l~el~t~g~~p~ 420 (495)
T 1opk_A 350 LVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPY 420 (495)
T ss_dssp EECGG-GCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred EECCC-CcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhc--------CCCCcHHhHHhHHHHHHHHHhCCCCCC
Confidence 99855 569999999998653322 1223345678999999854 567889999999999999999 99999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.+.+..+ .........+...+..++.++.+++.+||..+|.+|||+.++++.|+.++
T Consensus 421 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 421 PGIDLSQ-VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TTCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 8766543 33344555667778889999999999999999999999999999998865
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=278.31 Aligned_cols=203 Identities=29% Similarity=0.399 Sum_probs=159.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++|++|.+++.. ...+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 102 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI 179 (349)
T 2w4o_A 102 LLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL 179 (349)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccE
Confidence 45789999999999985 4568999999999999999975 35699999999999999999999999999999999999
Q ss_pred EEcC--CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++. +++.++|+|||++.............|++.|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 180 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 180 LYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG--------CAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp EESSSSTTCCEEECCCC----------------CGGGSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred EEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcC--------CCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 9974 245699999999986554444455678999999998853 567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.................. +....++.++.+++.+||..||.+|||+.++++ +.++.
T Consensus 252 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--hp~~~ 310 (349)
T 2w4o_A 252 DERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ--HPWVT 310 (349)
T ss_dssp CTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTT
T ss_pred CCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc--CcccC
Confidence 776655444444433222 233568999999999999999999999999998 55553
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=280.96 Aligned_cols=204 Identities=20% Similarity=0.282 Sum_probs=163.4
Q ss_pred CCCCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 2 MSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
++.++||||+++++++.+ ...++||||+ |++|.+++... ..+++.+++.++.|++.||+|||+.||+|||||
T Consensus 102 ~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 178 (345)
T 2v62_A 102 RKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIK 178 (345)
T ss_dssp HHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred hccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcC
Confidence 356799999999999743 4689999999 99999999763 379999999999999999999999999999999
Q ss_pred CCCEEEcCCC-CceEEeccCCcccCcccc--------cccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 77 PDNLLLTPDQ-KSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 77 ~~Nil~~~~~-~~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
|+||+++.++ ..++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++
T Consensus 179 p~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il 250 (345)
T 2v62_A 179 AANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--------VALSRRSDVEILGYCM 250 (345)
T ss_dssp GGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--------CCCCHHHHHHHHHHHH
T ss_pred HHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC--------CCCCchhhHHHHHHHH
Confidence 9999998553 269999999997543321 1134578999999998853 5678999999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCC---------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 148 WELLTNRLPFEGMSNLQAAYAAAFKHARPGLP---------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 148 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|+|++|..||.....................+ ..++.++.+++.+||..+|.+|||+.++++.|+....
T Consensus 251 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 251 LRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 99999999996432222222211111111122 2788999999999999999999999999999987654
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=277.36 Aligned_cols=193 Identities=26% Similarity=0.431 Sum_probs=160.9
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++++. ++..|+||||++||+|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++.
T Consensus 68 ~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 145 (345)
T 3a8x_A 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS 145 (345)
T ss_dssp TCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECT
T ss_pred CCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECC
Confidence 8999999999985 45799999999999999999763 46999999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc-
Q 024401 85 DQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN- 162 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~- 162 (268)
+ +.++|+|||+++... .........||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.....
T Consensus 146 ~-g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 216 (345)
T 3a8x_A 146 E-GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG--------EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS 216 (345)
T ss_dssp T-SCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-
T ss_pred C-CCEEEEeccccccccCCCCcccccCCCccccCccccCC--------CCCChHHhHHHHHHHHHHHHhCCCCcCCcccc
Confidence 6 469999999997533 2333455689999999999854 5678899999999999999999999965321
Q ss_pred ------HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH------HHHHH
Q 024401 163 ------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF------SQIIR 209 (268)
Q Consensus 163 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~------~~~l~ 209 (268)
...............++..++.++.+++.+||..||.+||++ +++++
T Consensus 217 ~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 217 DNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred cccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 112222233445666788899999999999999999999985 56665
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=295.20 Aligned_cols=208 Identities=30% Similarity=0.486 Sum_probs=176.8
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+.+|+|.+++.......+++.+++.++.||+.||+|||+.||+||||||+|||
T Consensus 316 l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 395 (535)
T 2h8h_A 316 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 395 (535)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEE
Confidence 56789999999999998888999999999999999997644456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 396 l~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwSlGv~l~el~t~g~~P~~ 466 (535)
T 2h8h_A 396 VGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYP 466 (535)
T ss_dssp ECGG-GCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHTTTTCCSST
T ss_pred EcCC-CcEEEcccccceecCCCceecccCCcCcccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9855 469999999998654322 1223356788999998854 568899999999999999999 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
+....+. ........+...+..++..+.+|+.+||..+|.+|||++++++.|+.++....
T Consensus 467 ~~~~~~~-~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 467 GMVNREV-LDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp TCCHHHH-HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCHHHH-HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 7765443 33445556667778899999999999999999999999999999999876543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=275.74 Aligned_cols=194 Identities=26% Similarity=0.408 Sum_probs=163.2
Q ss_pred CCC-CCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRV-KHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
..+ +||||+++++++.+ +..|+||||++||+|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 75 ~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI 152 (353)
T 2i0e_A 75 ALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152 (353)
T ss_dssp TCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred HhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHE
Confidence 444 79999999999854 5789999999999999999863 4599999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.++ .++|+|||++..... ........||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+
T Consensus 153 ll~~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 153 MLDSEG-HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp EECTTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEcCCC-cEEEEeCCcccccccCCcccccccCCccccChhhhcC--------CCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 999664 699999999976332 333455689999999999854 5678999999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
.+..... .. .......++..++.++.+++.+||..+|.+||+ ++++++
T Consensus 224 ~~~~~~~-~~-i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 224 EDEDELF-QS-IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp SSHHHHH-HH-HHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCHHHHH-HH-HHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 6543332 22 233456677889999999999999999999995 577776
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=283.00 Aligned_cols=209 Identities=21% Similarity=0.377 Sum_probs=163.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+++++|.+++.......+++..+..++.||+.||+|||+.||+||||||+||
T Consensus 80 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NI 159 (389)
T 3gni_B 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159 (389)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 56789999999999984 55789999999999999999876557799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc--------ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 81 LLTPDQKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|++.+ +.++|+|||.+...... .......|+..|+|||.+.+ ....++.++|||||||++|+|++
T Consensus 160 ll~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DiwslG~il~el~~ 232 (389)
T 3gni_B 160 LISVD-GKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ------NLQGYDAKSDIYSVGITACELAN 232 (389)
T ss_dssp EECTT-CCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHST------TSSCBCTHHHHHHHHHHHHHHHH
T ss_pred EEcCC-CCEEEcccccceeeccccccccccccccccccccccccCHHHHhc------cCCCCCcHhHHHHHHHHHHHHHH
Confidence 99965 46999999987643221 11223468899999999853 22467889999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhh--------------------------------------------cCCCCCCCCcHHHHH
Q 024401 153 NRLPFEGMSNLQAAYAAAFKH--------------------------------------------ARPGLPEDISPDLAF 188 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~--------------------------------------------~~~~~~~~~~~~l~~ 188 (268)
|..||.+.+............ ...+.+..+++.+.+
T Consensus 233 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 312 (389)
T 3gni_B 233 GHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHH 312 (389)
T ss_dssp SSCTTTTCCSTTHHHHC--------------------------------------------------------CCHHHHH
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHH
Confidence 999998755433322211000 011234567889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 189 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 189 li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
|+.+||+.||.+|||++++++ +.++....
T Consensus 313 li~~~L~~dP~~Rpta~ell~--hp~f~~~~ 341 (389)
T 3gni_B 313 FVEQCLQRNPDARPSASTLLN--HSFFKQIK 341 (389)
T ss_dssp HHHHHTCSCTTTSCCHHHHTT--SGGGGGC-
T ss_pred HHHHHhhcCcccCCCHHHHhc--CHHHHHHh
Confidence 999999999999999999998 55655443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=284.43 Aligned_cols=206 Identities=26% Similarity=0.385 Sum_probs=167.0
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++.+ +..|+||||++||+|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 123 l~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NI 199 (410)
T 3v8s_A 123 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM 199 (410)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 456899999999999964 468999999999999999976 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|++.++ .++|+|||++....... ......||+.|+|||.+... .....++.++|+|||||++|+|++|..||.
T Consensus 200 Ll~~~g-~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~----~~~~~~~~~~DiwSlGvilyell~G~~Pf~ 274 (410)
T 3v8s_A 200 LLDKSG-HLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ----GGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274 (410)
T ss_dssp EECTTS-CEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTT----TTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eECCCC-CEEEeccceeEeeccCCcccccCCcCCccccCHHHhhcc----CCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence 999664 69999999997654432 23456899999999998641 011237789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhh--cCCCCCCCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHhhhhh
Q 024401 159 GMSNLQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~l~~l~~~~~~ 217 (268)
+.+............ ...+....++.++.+||.+||..+|.+ |++++++++ +.++..
T Consensus 275 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~--Hp~f~~ 335 (410)
T 3v8s_A 275 ADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR--HLFFKN 335 (410)
T ss_dssp CSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT--SGGGCC
T ss_pred CCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc--CccccC
Confidence 766544443333222 222333479999999999999988888 999999998 555543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=281.51 Aligned_cols=199 Identities=26% Similarity=0.386 Sum_probs=165.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++|++|.+++.. ....+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 140 l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 218 (373)
T 2x4f_A 140 MNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIID-ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENI 218 (373)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHH-TGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence 57889999999999985 4578999999999999999875 234699999999999999999999999999999999999
Q ss_pred EEc-CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLT-PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~-~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
++. .+.+.++|+|||++.............|++.|+|||.+.. ..++.++|||||||++|+|++|..||.+
T Consensus 219 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~ 290 (373)
T 2x4f_A 219 LCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNY--------DFVSFPTDMWSVGVIAYMLLSGLSPFLG 290 (373)
T ss_dssp EEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTT--------CBCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccC--------CCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 994 2445799999999987655554555679999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+............... .....+++++.+++.+||..+|.+|||+.++++
T Consensus 291 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 291 DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp SSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 76544433332222111 122468999999999999999999999999998
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=279.53 Aligned_cols=207 Identities=30% Similarity=0.503 Sum_probs=172.7
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC------------CCCCCHHHHHHHHHHHHHHHHHHHh
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR------------PNKLDLHVALNFALDIARAMDCLHA 67 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~i~~ql~~~l~~lH~ 67 (268)
|+++ +||||+++++++. ++..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+
T Consensus 103 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 182 (333)
T 2i1m_A 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS 182 (333)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence 3456 8999999999985 557899999999999999997532 3458999999999999999999999
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
.||+||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||
T Consensus 183 ~~ivH~Dlkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 253 (333)
T 2i1m_A 183 KNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD--------CVYTVQSDVWSYG 253 (333)
T ss_dssp TTEECSCCSGGGCEEEGG-GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH--------CCCCHHHHHHHHH
T ss_pred CCcccCCcccceEEECCC-CeEEECccccccccccccceeecCCCCCCccccCHHHhcc--------CCCChHHHHHHHH
Confidence 999999999999999855 569999999997543322 1223456778999998854 5678999999999
Q ss_pred HHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 145 IVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 145 ~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+++|+|++ |..||.+...................+...+..+.+++.+||+.+|.+|||+.++++.|+.....
T Consensus 254 ~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 254 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 99999998 99999877665555555555556666778899999999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=274.34 Aligned_cols=208 Identities=28% Similarity=0.518 Sum_probs=165.6
Q ss_pred CCCCCCCcccceeeeeecC-C------ceEEEEcCCCCCHHHHHhhhCC----CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 2 MSRVKHDNLVKFLGACKDP-L------MVIVTELLPGMSLRKYLVSLRP----NKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-~------~~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
+++++||||+++++++.+. . .++||||+.+++|.+++..... ..+++.+++.++.|++.||+|||+.||
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i 158 (323)
T 3qup_A 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNF 158 (323)
T ss_dssp HTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 5788999999999998443 2 3899999999999999965321 259999999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCccccc---ccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
+||||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 159 vH~Dikp~NIli~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il 229 (323)
T 3qup_A 159 IHRDLAARNCMLAED-MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD--------NLYTVHSDVWAFGVTM 229 (323)
T ss_dssp CCSCCSGGGEEECTT-SCEEECCCCC-----------------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred ccCCCCcceEEEcCC-CCEEEeeccccccccccccccccccccCcccccCchhhcC--------CCCCCccchhhHHHHH
Confidence 999999999999955 5699999999975433221 223356778999998854 5678999999999999
Q ss_pred HHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 148 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 148 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
|+|++ |..||.+...... ............+..++.++.+++.+||..||.+|||+.++++.|+.++....
T Consensus 230 ~ell~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 230 WEIMTRGQTPYAGIENAEI-YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp HHHHTTSCCTTTTCCGGGH-HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHHHhCCCCCccccChHHH-HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 99999 8999987665443 33444555667778899999999999999999999999999999999886543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=273.12 Aligned_cols=199 Identities=26% Similarity=0.376 Sum_probs=160.2
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++.+ +..++||||+++++|.+++. ...+++.+++.++.|++.||+|||+.||+|+||||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 567899999999999853 46899999999999988654 357999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||++...... .......|++.|+|||.+.+. .....+.++||||||+++|+|++|..||
T Consensus 167 Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 167 NLLVGED-GHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSET-----RKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp GEEECTT-SCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTT-----CCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred HEEECCC-CCEEEecCCCccccccccccccCCcCCccccChhhhccC-----CCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 9999965 46999999999765432 223445789999999988531 0112467899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...................+....+++++.+++.+||..||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp CCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 8765433322222222222333578999999999999999999999999987
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=278.98 Aligned_cols=203 Identities=25% Similarity=0.435 Sum_probs=151.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. .+..++||||++|++|.+++... ..+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 70 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Ni 147 (361)
T 3uc3_A 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT 147 (361)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 45789999999999985 45789999999999999999763 4699999999999999999999999999999999999
Q ss_pred EEcCCCC-ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCC-CcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHY-NNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~-~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.++. .++|+|||+++............|++.|+|||.+.+ ..+ +.++|||||||++|+|++|..||.
T Consensus 148 ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~DiwslG~il~ell~g~~Pf~ 219 (361)
T 3uc3_A 148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLR--------QEYDGKIADVWSCGVTLYVMLVGAYPFE 219 (361)
T ss_dssp EECSSSSCCEEECCCCCC---------------CTTSCHHHHHC--------SSCCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcC--------CCCCCCeeeeehhHHHHHHHHhCCCCCC
Confidence 9985432 499999999975544444455679999999998853 333 345899999999999999999997
Q ss_pred CCCcH---HHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 159 GMSNL---QAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~---~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+.... ........ .....++ ..++.++.+|+.+||..+|.+|||+.++++ +.++..
T Consensus 220 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~--hp~f~~ 280 (361)
T 3uc3_A 220 DPEEPRDYRKTIQRIL-SVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKT--HSWFLK 280 (361)
T ss_dssp ----CCCHHHHHHHHH-TTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT--SHHHHT
T ss_pred CCccHHHHHHHHHHHh-cCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh--Ccchhc
Confidence 64432 12212211 2222223 368999999999999999999999999998 555533
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=269.07 Aligned_cols=199 Identities=30% Similarity=0.484 Sum_probs=158.2
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++.+ +..++||||+++++|.+++... ....+++..++.++.|++.||+|||+.||+|+||||+
T Consensus 74 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~ 153 (285)
T 3is5_A 74 LKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPE 153 (285)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred HHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHH
Confidence 567899999999999854 5689999999999999998652 2366999999999999999999999999999999999
Q ss_pred CEEEcC--CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 79 NLLLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 79 Nil~~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
||+++. ..+.++|+|||++.............+++.|+|||.+. ..++.++||||||+++|+|++|..|
T Consensus 154 NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~il~~ll~g~~p 224 (285)
T 3is5_A 154 NILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK---------RDVTFKCDIWSAGVVMYFLLTGCLP 224 (285)
T ss_dssp GEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT---------TCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred HEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc---------cCCCcccCeehHHHHHHHHHhCCCC
Confidence 999953 23569999999998665554455667899999999874 4578899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCC-CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|.+.................. ....+++++.+++.+||..||.+|||+.++++
T Consensus 225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 225 FTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp SCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 987665444333332222221 22347899999999999999999999999987
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=276.73 Aligned_cols=198 Identities=28% Similarity=0.414 Sum_probs=161.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
++.++||||+++++++. ++..|+||||++|++|.+++... ....+++..++.++.|++.||+|||+.||+||||||+
T Consensus 80 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~ 159 (351)
T 3c0i_A 80 CHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPH 159 (351)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChH
Confidence 45789999999999985 55789999999999999888652 2345899999999999999999999999999999999
Q ss_pred CEEEcCCC--CceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 79 NLLLTPDQ--KSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 79 Nil~~~~~--~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
||+++.++ ..++|+|||++........ .....||+.|+|||.+.. ..++.++|||||||++|+|++|..
T Consensus 160 NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~ 231 (351)
T 3c0i_A 160 CVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKR--------EPYGKPVDVWGCGVILFILLSGCL 231 (351)
T ss_dssp GEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred HeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcC--------CCCCchHhhHHHHHHHHHHHHCCC
Confidence 99997543 3499999999976544322 345579999999999853 567889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCC---CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGL---PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
||.+.. ............... ...++.++.+++.+||..||.+|||+.++++
T Consensus 232 pf~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 232 PFYGTK--ERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp SSCSSH--HHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCcH--HHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 998643 222222222222111 1468899999999999999999999999998
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=272.27 Aligned_cols=200 Identities=29% Similarity=0.467 Sum_probs=165.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||++|++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 172 (321)
T 2c30_A 96 MRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI 172 (321)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 57889999999999984 5578999999999999999864 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 173 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 173 LLTLD-GRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--------SLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp EECTT-CCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EECCC-CcEEEeeeeeeeecccCccccccccCCccccCHhhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99965 469999999987544322 2345578999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
........ .......+. ....++..+.+++.+||..||.+|||+.++++ +.++.
T Consensus 244 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--hp~~~ 299 (321)
T 2c30_A 244 DSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD--HPFLL 299 (321)
T ss_dssp SCHHHHHH-HHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT--SGGGG
T ss_pred CCHHHHHH-HHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc--Chhhc
Confidence 66544332 222222222 22458899999999999999999999999998 45554
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=277.86 Aligned_cols=203 Identities=28% Similarity=0.412 Sum_probs=164.1
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++.+ +..++||||++|++|.+++.. ...+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 59 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 136 (323)
T 3tki_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136 (323)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHE
Confidence 456899999999999854 468999999999999999875 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.+ +.++|+|||++...... .......|++.|+|||.+.+ ....+.++||||||+++|+|++|..||
T Consensus 137 ll~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf 208 (323)
T 3tki_A 137 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPW 208 (323)
T ss_dssp EECTT-CCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEeCC-CCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhcc-------CCCCCCcccHHHHHHHHHHHHhCCCCC
Confidence 99965 46999999999754322 22345578999999999853 123467899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
................. .......++..+.+++.+||..||.+|||+.++++ +.++.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~--h~~~~ 266 (323)
T 3tki_A 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWYN 266 (323)
T ss_dssp SSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTTT
T ss_pred CCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh--Chhhc
Confidence 87655433333332222 22223568999999999999999999999999988 55553
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=292.63 Aligned_cols=204 Identities=23% Similarity=0.384 Sum_probs=171.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||++||+|.+++.......+++..++.++.||+.||+|||+.||+||||||+||
T Consensus 238 L~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNI 317 (576)
T 2acx_A 238 LEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317 (576)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheE
Confidence 56789999999999985 45799999999999999999875555699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
|++.+ +.++|+|||++.............||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||...
T Consensus 318 Lld~~-g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~--------~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 318 LLDDH-GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN--------ERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp EECTT-SCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTT--------CEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred EEeCC-CCeEEEecccceecccCccccccCCCccccCHHHHcC--------CCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 99965 4699999999987655544455689999999999854 56788999999999999999999999865
Q ss_pred Cc--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhhh
Q 024401 161 SN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~~ 216 (268)
.. ...............++..++.++.+++.+||..||.+|| +++++++ +.++.
T Consensus 389 ~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~--HpfF~ 449 (576)
T 2acx_A 389 KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE--HPLFK 449 (576)
T ss_dssp SSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT--SGGGT
T ss_pred ccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh--Chhhc
Confidence 42 1222223344456667788999999999999999999999 7888887 45543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=272.34 Aligned_cols=205 Identities=30% Similarity=0.531 Sum_probs=171.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------PNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
+++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.||+|
T Consensus 82 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H 161 (322)
T 1p4o_A 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVH 161 (322)
T ss_dssp GGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 67889999999999985 457899999999999999997532 145799999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
|||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+
T Consensus 162 ~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~e 232 (322)
T 1p4o_A 162 RDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWE 232 (322)
T ss_dssp SCCSGGGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHH
T ss_pred CCCccceEEEcCC-CeEEECcCccccccccccccccccCCCCCCCccChhhhcc--------CCCCchhhHHHHHHHHHH
Confidence 9999999999965 469999999997543322 1233456788999998853 567889999999999999
Q ss_pred HHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 150 LLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 150 ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|++ |..||.+.... ..............+..++..+.+++.+||..+|.+|||+.++++.|+....
T Consensus 233 l~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 233 IATLAEQPYQGLSNE-QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHTSCCTTTTSCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHhcCCCccccCCHH-HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 999 88999876543 3334444555566778899999999999999999999999999999988643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=275.71 Aligned_cols=192 Identities=30% Similarity=0.484 Sum_probs=163.1
Q ss_pred CCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.+||||+++++++.+ +..|+||||++||+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||+++
T Consensus 75 ~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 152 (345)
T 1xjd_A 75 WEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152 (345)
T ss_dssp TTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred CCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEEC
Confidence 389999999999854 5789999999999999999863 4699999999999999999999999999999999999999
Q ss_pred CCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 84 PDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
.++ .++|+|||+++.... ........||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.
T Consensus 153 ~~g-~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 153 KDG-HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp TTS-CEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCC-CEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcC--------CCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 664 699999999975432 223455689999999999854 5678999999999999999999999987654
Q ss_pred HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 024401 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 209 (268)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~l~ 209 (268)
..... ......+.++..++.++.+++.+||..+|.+||++. ++++
T Consensus 224 ~~~~~--~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 224 EELFH--SIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp HHHHH--HHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHH--HHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 33322 223345667788999999999999999999999997 7765
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=271.15 Aligned_cols=206 Identities=26% Similarity=0.411 Sum_probs=163.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 73 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI 150 (311)
T 3niz_A 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDE-NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL 150 (311)
T ss_dssp HHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence 46789999999999985 4578999999965 88888876 345699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.+
T Consensus 151 l~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 151 LINSD-GALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMG-------SKKYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp EECTT-CCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EECCC-CCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcC-------CCCCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 99966 46999999999765432 22344578999999998753 25678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCC----------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPG----------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
................+. ....+++++.+|+.+||..||.+|||++++++
T Consensus 223 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-- 300 (311)
T 3niz_A 223 VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN-- 300 (311)
T ss_dssp SSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT--
T ss_pred CChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc--
Confidence 665443333221111100 11346789999999999999999999999998
Q ss_pred HhhhhhcC
Q 024401 212 NAFLFTLR 219 (268)
Q Consensus 212 ~~~~~~~~ 219 (268)
+.++.+..
T Consensus 301 hp~f~~~~ 308 (311)
T 3niz_A 301 HPYFKDLD 308 (311)
T ss_dssp SGGGTTSC
T ss_pred CcccccCC
Confidence 66665543
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=275.46 Aligned_cols=207 Identities=29% Similarity=0.553 Sum_probs=173.5
Q ss_pred CCC-CCCcccceeeeeec--CCceEEEEcCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHH
Q 024401 3 SRV-KHDNLVKFLGACKD--PLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~ql~~~l~~l 65 (268)
+++ +||||+++++++.+ ...++||||+++++|.+++..... ..+++..++.++.|++.||+||
T Consensus 85 ~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l 164 (316)
T 2xir_A 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL 164 (316)
T ss_dssp HHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH
T ss_pred HhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH
Confidence 345 69999999999843 358999999999999999986332 1289999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
|+.||+|+||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||
T Consensus 165 H~~~i~H~dikp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~s 235 (316)
T 2xir_A 165 ASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWS 235 (316)
T ss_dssp HHTTCCCSCCSGGGEEECGG-GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH--------CCCCHHHHHHH
T ss_pred HhCCcccccCccceEEECCC-CCEEECCCccccccccCccceeccCCCcceeecCchhhcc--------ccccchhHHHH
Confidence 99999999999999999855 469999999997543321 2233456788999998854 66789999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 143 FGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 143 lG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
||+++|+|++ |..||.+...................+..++..+.+++.+||..+|.+|||+.+++++|+.++...
T Consensus 236 lG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 236 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp HHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 9999999998 999998777656555556666667777889999999999999999999999999999999987653
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=274.70 Aligned_cols=208 Identities=31% Similarity=0.619 Sum_probs=172.7
Q ss_pred CCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 024401 3 SRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP--------------NKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~--------------~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
+++ +||||+++++++. ++..++||||+++++|.+++..... ..+++.+++.++.|++.||+|||
T Consensus 95 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 174 (334)
T 2pvf_A 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA 174 (334)
T ss_dssp HHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH
Confidence 445 8999999999984 5578999999999999999986432 34899999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
+.||+|+||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++|||||
T Consensus 175 ~~~ivH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~sl 245 (334)
T 2pvf_A 175 SQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD--------RVYTHQSDVWSF 245 (334)
T ss_dssp HTTEECSCCSGGGEEECTT-CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH--------CEECHHHHHHHH
T ss_pred hCCeeCCCCccceEEEcCC-CCEEEccccccccccccccccccCCCCcccceeChHHhcC--------CCcChHHHHHHH
Confidence 9999999999999999955 469999999997544322 2233456788999998854 557889999999
Q ss_pred HHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 144 GIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 144 G~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|+++|+|++ |..||.+... ...............+..++.++.+++.+||..+|.+|||+.++++.|+.+......
T Consensus 246 G~il~ellt~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~ 322 (334)
T 2pvf_A 246 GVLMWEIFTLGGSPYPGIPV-EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 322 (334)
T ss_dssp HHHHHHHHTTSCCSSTTCCH-HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHHhCCCCCcCcCCH-HHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence 999999999 9999987654 334444455556677788999999999999999999999999999999998866544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=273.14 Aligned_cols=199 Identities=26% Similarity=0.413 Sum_probs=162.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++|++|.+++... ..+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 75 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Ni 152 (327)
T 3a62_A 75 LEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENI 152 (327)
T ss_dssp HHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred HHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHe
Confidence 45789999999999985 55799999999999999999763 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++||||||+++|+|++|..||.+
T Consensus 153 ll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~~pf~~ 223 (327)
T 3a62_A 153 MLNHQ-GHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMR--------SGHNRAVDWWSLGALMYDMLTGAPPFTG 223 (327)
T ss_dssp EECTT-SCEEECCCSCC----------CTTSSCCTTSCHHHHTT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EECCC-CcEEEEeCCcccccccCCccccccCCCcCccCHhhCcC--------CCCCCcccchhHHHHHHHHHHCCCCCCC
Confidence 99965 4699999999875433 223345578999999999853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHHHHHhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIRMLNAFL 215 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~~l~~~~ 215 (268)
.+....... .......++..++.++.+++.+||..+|.+|| ++.++++ +.++
T Consensus 224 ~~~~~~~~~--i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~--hp~f 280 (327)
T 3a62_A 224 ENRKKTIDK--ILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA--HPFF 280 (327)
T ss_dssp SSHHHHHHH--HHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH--SGGG
T ss_pred CCHHHHHHH--HHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc--CCcc
Confidence 665433322 22345566778999999999999999999999 7778877 4454
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=271.57 Aligned_cols=203 Identities=30% Similarity=0.454 Sum_probs=163.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||++|++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 144 (289)
T 4fvq_A 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNI 144 (289)
T ss_dssp HHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceE
Confidence 56789999999999985 55789999999999999999862 34499999999999999999999999999999999999
Q ss_pred EEcCCCCc-------eEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 81 LLTPDQKS-------LKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 81 l~~~~~~~-------~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
+++.++.. ++|+|||++....... ...++..|+|||.+.+ ...++.++||||||+++|+|++|
T Consensus 145 ll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g 214 (289)
T 4fvq_A 145 LLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQERIPWVPPECIEN-------PKNLNLATDKWSFGTTLWEICSG 214 (289)
T ss_dssp EEEECCBGGGTBCCEEEECCCCSCTTTSCHH---HHHHTTTTSCHHHHHC-------GGGCCHHHHHHHHHHHHHHHHTT
T ss_pred EEecCCcccccccceeeeccCcccccccCcc---ccCCcCcccCHHHhCC-------CCCCCchhHHHHHHHHHHHHHcC
Confidence 99855432 9999999987554332 2346778999998853 25578899999999999999996
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
..|+........... ........+...+.++.+++.+||+.||.+|||+.++++.|+.++..
T Consensus 215 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 215 GDKPLSALDSQRKLQ--FYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp TCCTTTTSCHHHHHH--HHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred CCCCccccchHHHHH--HhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 544443333333222 22335556677788999999999999999999999999999987653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=271.61 Aligned_cols=205 Identities=31% Similarity=0.524 Sum_probs=169.5
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
+++++||||+++++++.++..++||||+.+++|.+++... ...+++.+++.++.|++.||+|||+.|++|+||||+||+
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil 153 (291)
T 1u46_A 75 MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 153 (291)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HHhCCCCCcccEEEEEccCCceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEE
Confidence 4568999999999999777789999999999999999763 356999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..|
T Consensus 154 i~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~~g~~p 224 (291)
T 1u46_A 154 LATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEP 224 (291)
T ss_dssp EEET-TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred EcCC-CCEEEccccccccccccccchhhhccCCCCceeeCchhhcC--------CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9855 569999999987543322 1223456778999998854 456789999999999999999 9999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|.....................+..++.++.+++.+||..+|.+|||+.++++.|.....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 225 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp TTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred cccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 987765554444434444556667899999999999999999999999999999987653
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=266.52 Aligned_cols=202 Identities=24% Similarity=0.471 Sum_probs=166.4
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++.+ +..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.||+|+||||+||
T Consensus 63 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Ni 140 (279)
T 3fdn_A 63 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 140 (279)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGE
T ss_pred HHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhE
Confidence 567899999999999854 4689999999999999999864 4599999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++....... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 141 li~~~-~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 141 LLGSA-GELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp EECTT-SCEEECSCCEESCC---------CCCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EEcCC-CCEEEEeccccccCCccc-ccccCCCCCccCHhHhcc--------CCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 99855 469999999886543322 234578999999998854 56788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
...... .........++..++..+.+++.+||..+|.+|||++++++ +.++....
T Consensus 211 ~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--h~~~~~~~ 265 (279)
T 3fdn_A 211 TYQETY--KRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITANS 265 (279)
T ss_dssp SHHHHH--HHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH--CHHHHHHC
T ss_pred cHHHHH--HHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhh--CccccCCc
Confidence 543332 22334555677889999999999999999999999999999 56665543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=268.10 Aligned_cols=205 Identities=24% Similarity=0.411 Sum_probs=162.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++ +|.+++.. ....+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 55 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Ni 132 (292)
T 3o0g_A 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132 (292)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 57889999999999984 5578999999965 67666654 346799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+.+ ...++.++||||||+++|+|++|..||..
T Consensus 133 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 133 LINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp EECTT-SCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred EEcCC-CCEEEeecccceecCCccccccCCccccCCcChHHHcC-------CCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 99965 46999999999765432 22344578999999998853 23478899999999999999998888655
Q ss_pred CCcHHHHHHHHHhhcC----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHAR----------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
................ ......++.++.+++.+||+.||.+|||++++++
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-- 282 (292)
T 3o0g_A 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ-- 282 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT--
T ss_pred CCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc--
Confidence 4544444333322111 0112357889999999999999999999999998
Q ss_pred Hhhhhhc
Q 024401 212 NAFLFTL 218 (268)
Q Consensus 212 ~~~~~~~ 218 (268)
+.++.+.
T Consensus 283 hp~f~~~ 289 (292)
T 3o0g_A 283 HPYFSDF 289 (292)
T ss_dssp SGGGTTC
T ss_pred CcccccC
Confidence 6666544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=267.28 Aligned_cols=205 Identities=25% Similarity=0.396 Sum_probs=168.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||++|++|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni 136 (284)
T 3kk8_A 59 CRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL 136 (284)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHE
Confidence 45789999999999985 44689999999999999998763 5699999999999999999999999999999999999
Q ss_pred EEcCCC--CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.++ ..++|+|||.+.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~pf~ 208 (284)
T 3kk8_A 137 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK--------DPYSKPVDIWACGVILYILLVGYPPFW 208 (284)
T ss_dssp EESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC--------CCCCcccchHHHHHHHHHHHHCCCCCC
Confidence 997443 3499999999976655555555679999999999854 567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 159 GMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+................. +....+++++.+++.+||+.+|.+|||++++++ +.++...
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~~ 268 (284)
T 3kk8_A 209 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK--VPWICNR 268 (284)
T ss_dssp CSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT--SHHHHSC
T ss_pred CCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc--CccccCC
Confidence 766544433333222222 222468999999999999999999999999998 5555443
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=271.22 Aligned_cols=208 Identities=31% Similarity=0.557 Sum_probs=167.5
Q ss_pred CCCCCCCcccceeeeeecC------CceEEEEcCCCCCHHHHHhhh----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 2 MSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSL----RPNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
+++++||||+++++++.+. ..++||||+++++|.+++... ....+++..++.++.|++.||+|||+.||+
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 169 (313)
T 3brb_A 90 MKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFL 169 (313)
T ss_dssp HHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCC
T ss_pred HhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4678999999999998432 359999999999999998532 235699999999999999999999999999
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
||||||+||+++.+ +.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|
T Consensus 170 H~dikp~NIli~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 240 (313)
T 3brb_A 170 HRDLAARNCMLRDD-MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD--------RVYTSKSDVWAFGVTMW 240 (313)
T ss_dssp CCCCSGGGEEECTT-SCEEECSCSCC----------------CCGGGSCHHHHHS--------SCCCHHHHHHHHHHHHH
T ss_pred cCCCCcceEEEcCC-CcEEEeecCcceecccccccCcccccCCCccccCchhhcC--------CCccchhhhHHHHHHHH
Confidence 99999999999955 469999999997543322 1223456788999999853 66788999999999999
Q ss_pred HHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 149 ELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 149 ~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
+|++ |..||........ ............+..++..+.+++.+||..+|.+|||+.++++.|+.++..++
T Consensus 241 el~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 241 EIATRGMTPYPGVQNHEM-YDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HHHTTSCCSSTTCCGGGH-HHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HHHhcCCCCCccCCHHHH-HHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 9999 8899987665433 33445555667778899999999999999999999999999999999887654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=269.08 Aligned_cols=208 Identities=18% Similarity=0.247 Sum_probs=167.2
Q ss_pred CCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+.+ +||||+++++++. +...++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 60 ~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 345 7999999999985 55789999999 99999999863 45699999999999999999999999999999999999
Q ss_pred EEcCCCC----ceEEeccCCcccCcccc--------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 81 LLTPDQK----SLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 81 l~~~~~~----~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
+++.++. .++|+|||++....... ......|+..|+|||.+.+ ..++.++||||||+++|
T Consensus 138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 209 (298)
T 1csn_A 138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFM 209 (298)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHH
T ss_pred EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC--------CCCChHHHHHHHHHHHH
Confidence 9975432 39999999997543321 1234568999999998854 56789999999999999
Q ss_pred HHHhCCCCCCCCCc--HHHHHHHHH-h---hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 149 ELLTNRLPFEGMSN--LQAAYAAAF-K---HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 149 ~ll~g~~p~~~~~~--~~~~~~~~~-~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
+|++|..||.+... ......... . .........+++++.+++.+||+.+|.+|||++++++.|+.+..+...
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 210 YFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 99999999987432 222221111 1 111223357899999999999999999999999999999999877644
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=269.44 Aligned_cols=203 Identities=27% Similarity=0.436 Sum_probs=166.9
Q ss_pred CCCCCCCcccceeeeeec-----------------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACKD-----------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-----------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~ 64 (268)
+++++||||+++++++.+ ...++||||+++++|.+++.......+++..++.++.|++.||+|
T Consensus 58 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 137 (284)
T 2a19_B 58 LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDY 137 (284)
T ss_dssp HHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 457899999999998732 347899999999999999987555679999999999999999999
Q ss_pred HHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 65 lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
||+.||+|+||||+||+++.+ +.++|+|||++.............+++.|+|||.+.+ ..++.++||||||
T Consensus 138 lH~~~i~H~dlkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG 208 (284)
T 2a19_B 138 IHSKKLINRDLKPSNIFLVDT-KQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS--------QDYGKEVDLYALG 208 (284)
T ss_dssp HHHTTEECSCCSGGGEEEEET-TEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC--------SCCCTHHHHHHHH
T ss_pred HHhCCeeeccCCHHHEEEcCC-CCEEECcchhheeccccccccccCCcccccChhhhcc--------CCCcchhhhHHHH
Confidence 999999999999999999955 5699999999986655444455678999999998853 5678899999999
Q ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 145 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
+++|+|++|..|+... ...... ......+..++..+.+++.+||..||.+|||+.++++.|..+.....
T Consensus 209 ~il~~l~~~~~~~~~~---~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 209 LILAELLHVCDTAFET---SKFFTD---LRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp HHHHHHHSCCSSHHHH---HHHHHH---HHTTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred HHHHHHHhcCCcchhH---HHHHHH---hhcccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 9999999998886421 111111 12234556789999999999999999999999999999998765543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=275.95 Aligned_cols=210 Identities=29% Similarity=0.520 Sum_probs=170.3
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++.+ ...++||||+++++|.+++.. ..+++.+++.++.|++.||+|||+.||+|+||||+
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~ 163 (318)
T 3lxp_A 87 LRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAAR 163 (318)
T ss_dssp HHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchh
Confidence 467899999999999854 457899999999999999976 45999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 164 Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~ 234 (318)
T 3lxp_A 164 NVLLDND-RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKE--------YKFYYASDVWSFGVTLYELLTHC 234 (318)
T ss_dssp GEEECTT-CCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTT
T ss_pred eEEEcCC-CCEEECCccccccccccccccccccCCCCCceeeChHHhcC--------CCCCcHHHHHHHHHHHHHHHhCC
Confidence 9999955 569999999997654322 2233467888999999854 55678999999999999999999
Q ss_pred CCCCCCCcH--------------HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 155 LPFEGMSNL--------------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 155 ~p~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
.||...... ...............+..++.++.+++.+||..+|.+|||+.++++.|+.+....+.
T Consensus 235 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 235 DSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp CGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred CcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 998643211 111222334455667788999999999999999999999999999999999877665
Q ss_pred CCC
Q 024401 221 PSP 223 (268)
Q Consensus 221 ~~~ 223 (268)
..|
T Consensus 315 ~~p 317 (318)
T 3lxp_A 315 QAP 317 (318)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-41 Score=280.12 Aligned_cols=200 Identities=29% Similarity=0.460 Sum_probs=165.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. .+..++||||+ +|+|.+++... ..+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 63 l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 139 (336)
T 3h4j_B 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENL 139 (336)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhE
Confidence 57889999999999985 45689999999 78999998763 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............|++.|+|||.+.+ ....+.++||||||+++|+|++|..||.+.
T Consensus 140 ll~~~-~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~Pf~~~ 211 (336)
T 3h4j_B 140 LLDDN-LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-------KLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211 (336)
T ss_dssp EECTT-CCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCC-------SGGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred EEcCC-CCEEEEEeccceeccCCcccccccCCcCcCCHHHHcC-------CCCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence 99955 5699999999987666555566789999999999863 123367999999999999999999999764
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
...... ..........+..+++++.+++.+||..||.+|||++++++ +.++.
T Consensus 212 ~~~~~~--~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~--hp~~~ 263 (336)
T 3h4j_B 212 FIPNLF--KKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR--DPWFN 263 (336)
T ss_dssp SSTTCB--CCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT--CHHHH
T ss_pred cHHHHH--HHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh--Chhhc
Confidence 321110 01122234556778999999999999999999999999998 45543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=267.63 Aligned_cols=204 Identities=27% Similarity=0.424 Sum_probs=160.4
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++++||||+++++++. ++..++||||+++ +|.+++.. ....+++.++..++.|++.||+|||+.||+||||||+|
T Consensus 53 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 130 (288)
T 1ob3_A 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDV-CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130 (288)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHT-STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 367899999999999985 4578999999965 99999875 34569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++.+ +.++|+|||++...... .......+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.
T Consensus 131 il~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~ 202 (288)
T 1ob3_A 131 LLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (288)
T ss_dssp EEECTT-SCEEECCTTHHHHHCC---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEEcCC-CCEEEeECccccccCccccccccccccccccCchheeC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 999965 46999999998754322 22234468999999998853 2457889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
+.+..............+ .....++.++.+++.+||..||.+|||++++++
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~-- 280 (288)
T 1ob3_A 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE-- 280 (288)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT--
T ss_pred CCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc--
Confidence 776544433322211000 112457899999999999999999999999987
Q ss_pred Hhhhh
Q 024401 212 NAFLF 216 (268)
Q Consensus 212 ~~~~~ 216 (268)
+.++.
T Consensus 281 hp~f~ 285 (288)
T 1ob3_A 281 HAYFK 285 (288)
T ss_dssp SGGGG
T ss_pred Ccchh
Confidence 44443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=274.08 Aligned_cols=213 Identities=26% Similarity=0.407 Sum_probs=166.5
Q ss_pred CCCCCCCcccceeeeeecC---CceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
|++++||||+++++++.+. ..++||||++|++|.+++..... ..+++.+++.++.|++.||+|||+.||+||||||
T Consensus 61 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 140 (319)
T 4euu_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140 (319)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 4678999999999988432 67999999999999999976332 3499999999999999999999999999999999
Q ss_pred CCEEE----cCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 78 DNLLL----TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 78 ~Nil~----~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
+||++ + ....++|+|||++.............++..|+|||.+............++.++|||||||++|+|++|
T Consensus 141 ~NIll~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g 219 (319)
T 4euu_A 141 GNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (319)
T ss_dssp GGEEEEECTT-SCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHS
T ss_pred HHEEEeccCC-CCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhC
Confidence 99998 4 334699999999987655555556679999999998753222222246788999999999999999999
Q ss_pred CCCCCCCCc---HHHHHHHHHhhcCC------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 024401 154 RLPFEGMSN---LQAAYAAAFKHARP------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206 (268)
Q Consensus 154 ~~p~~~~~~---~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 206 (268)
..||..... .............. .++..++..+.+++.+||+.||.+|||+++
T Consensus 220 ~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (319)
T 4euu_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (319)
T ss_dssp SCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHH
Confidence 999964332 12222222222221 112234567999999999999999999999
Q ss_pred HHHHHHhhh
Q 024401 207 IIRMLNAFL 215 (268)
Q Consensus 207 ~l~~l~~~~ 215 (268)
++++.....
T Consensus 300 ll~h~~d~~ 308 (319)
T 4euu_A 300 FFAETSDIL 308 (319)
T ss_dssp HHHHHHHHT
T ss_pred hhhccHHHh
Confidence 999887654
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=268.59 Aligned_cols=199 Identities=25% Similarity=0.410 Sum_probs=165.5
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++.+ +..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.|++|+||||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni 137 (277)
T 3f3z_A 60 MKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF 137 (277)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHE
Confidence 567899999999999854 4689999999999999999763 4599999999999999999999999999999999999
Q ss_pred EE---cCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LL---TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~---~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
++ + .++.++|+|||++.............+++.|+|||.+. ..++.++||||||+++|+|++|..||
T Consensus 138 l~~~~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~ 207 (277)
T 3f3z_A 138 LFLTDS-PDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE---------GLYGPECDEWSAGVMMYVLLCGYPPF 207 (277)
T ss_dssp EESSSS-TTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTTHHHHHHHHHHHHHHHSSCSS
T ss_pred EEecCC-CCCcEEEEecccceeccCccchhccCCCCCccChHHhc---------ccCCchhhehhHHHHHHHHHHCCCCC
Confidence 99 4 34569999999998665555555667999999999874 34788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
............. ......+ ..+++.+.+++.+||+.+|.+|||+.++++ +.++.
T Consensus 208 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~--h~~~~ 266 (277)
T 3f3z_A 208 SAPTDSEVMLKIR--EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE--HEWFE 266 (277)
T ss_dssp CCSSHHHHHHHHH--HCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHHH
T ss_pred CCCCHHHHHHHHH--hCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc--CHHHh
Confidence 8766544333322 2222233 268899999999999999999999999997 44443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=273.06 Aligned_cols=208 Identities=22% Similarity=0.329 Sum_probs=165.9
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++ +||||+++++++. ++..++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+.||+||||||+|
T Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N 135 (330)
T 2izr_A 58 YKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPEN 135 (330)
T ss_dssp HHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 3456 8999999999985 45689999999 99999999863 4679999999999999999999999999999999999
Q ss_pred EEEcCCCC----ceEEeccCCcccCccccc--------ccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 80 LLLTPDQK----SLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 80 il~~~~~~----~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
|+++.++. .++|+|||++........ .....||+.|+|||.+.+ ..++.++||||||+++
T Consensus 136 ill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il 207 (330)
T 2izr_A 136 FLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG--------KEQSRRDDLEALGHMF 207 (330)
T ss_dssp EEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHH
T ss_pred eeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC--------CCCCchhHHHHHHHHH
Confidence 99985432 299999999975433221 235578999999999864 6678899999999999
Q ss_pred HHHHhCCCCCCCCCc--HHHHHHHHHhhcC----CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 148 WELLTNRLPFEGMSN--LQAAYAAAFKHAR----PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 148 ~~ll~g~~p~~~~~~--~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|+|++|..||.+... ............. ......++ ++.+++..||..+|.+||+++++.+.|+.+..+...
T Consensus 208 ~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 208 MYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp HHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 999999999987542 2222222211111 11123456 999999999999999999999999999988876543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=285.95 Aligned_cols=205 Identities=26% Similarity=0.430 Sum_probs=167.0
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++.+ +..++||||+.|++|.+++... ..+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 75 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni 152 (486)
T 3mwu_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152 (486)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence 567899999999999854 4689999999999999998763 5699999999999999999999999999999999999
Q ss_pred EEcCC--CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.. ...++|+|||++.............|++.|+|||.+. ..++.++|||||||++|+|++|..||.
T Consensus 153 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp EESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGG---------SCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhC---------CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99632 3469999999998665555555668999999999985 347889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 159 GMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
+................... ...+++++.+++.+||..+|.+|||+.++++ +.++....
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~--hp~~~~~~ 284 (486)
T 3mwu_A 224 GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQKYS 284 (486)
T ss_dssp CSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH--CHHHHHTC
T ss_pred CCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc--CHhhccCc
Confidence 77654443333322222222 2468899999999999999999999999998 56665543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=270.75 Aligned_cols=204 Identities=28% Similarity=0.519 Sum_probs=168.3
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++.+ ...++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.||+|+||||+
T Consensus 77 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 155 (302)
T 4e5w_A 77 LRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAAR 155 (302)
T ss_dssp HHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchh
Confidence 567899999999999843 4589999999999999999653 356999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 156 Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~ 226 (302)
T 4e5w_A 156 NVLVESE-HQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQ--------SKFYIASDVWSFGVTLHELLTYC 226 (302)
T ss_dssp GEEEEET-TEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTT
T ss_pred eEEEcCC-CCEEECcccccccccCCCcceeccCCCCCCccccCCeeecC--------CCCCcchhHHHHHHHHHHHHHcc
Confidence 9999855 569999999997544322 2234567888999998854 55678999999999999999998
Q ss_pred CCCCC--------------CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 155 LPFEG--------------MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 155 ~p~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.|+.. ...................+..+++.+.+++.+||..+|.+|||+.++++.|+.++
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 227 DSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp CGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 87532 11222333344455566777889999999999999999999999999999998865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=283.67 Aligned_cols=201 Identities=24% Similarity=0.406 Sum_probs=168.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. .+..++||||++|++|.+++.. ...+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI 147 (476)
T 2y94_A 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147 (476)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence 57889999999999985 4578999999999999999975 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............|++.|+|||.+.+ ....+.++|||||||++|+|++|..||.+.
T Consensus 148 ll~~~-~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~elltG~~Pf~~~ 219 (476)
T 2y94_A 148 LLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSSGVILYALLCGTLPFDDD 219 (476)
T ss_dssp EECTT-CCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEecC-CCeEEEeccchhhccccccccccCCCcCeEChhhccC-------CCCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence 99965 4599999999987655554556689999999999863 123467999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
...... ... .......+..++.++.+++.+||..||.+|||++++++ +.++.
T Consensus 220 ~~~~~~-~~i-~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~--hp~~~ 271 (476)
T 2y94_A 220 HVPTLF-KKI-CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE--HEWFK 271 (476)
T ss_dssp SSHHHH-HHH-HTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--CHHHH
T ss_pred CHHHHH-HHH-hcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh--CHHhh
Confidence 544332 222 23344566789999999999999999999999999998 44443
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=270.75 Aligned_cols=209 Identities=27% Similarity=0.459 Sum_probs=166.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR----PNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
|++++||||+++++++. ++..++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+.||+|||||
T Consensus 57 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk 135 (317)
T 2pmi_A 57 MKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLK 135 (317)
T ss_dssp HTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred HHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 57889999999999985 457899999996 59999987532 2459999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
|+||+++.+ +.++|+|||++...... .......+++.|+|||.+.+ ...++.++|||||||++|+|++|..
T Consensus 136 p~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~ 207 (317)
T 2pmi_A 136 PQNLLINKR-GQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMG-------SRTYSTSIDIWSCGCILAEMITGKP 207 (317)
T ss_dssp GGGEEECTT-CCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred hHHeEEcCC-CCEEECcCccceecCCCcccCCCCcccccccCchHhhC-------CCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999965 46999999999765432 22344578999999998853 2457889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcC--------------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCC
Q 024401 156 PFEGMSNLQAAYAAAFKHAR--------------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPS 203 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps 203 (268)
||.+................ +.....++.++.+++.+||+.||.+|||
T Consensus 208 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 287 (317)
T 2pmi_A 208 LFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS 287 (317)
T ss_dssp SCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC
Confidence 99877654433322211100 0112357889999999999999999999
Q ss_pred HHHHHHHHHhhhhhcCCC
Q 024401 204 FSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 204 ~~~~l~~l~~~~~~~~~~ 221 (268)
++++++ +.++......
T Consensus 288 ~~e~l~--hp~f~~~~~~ 303 (317)
T 2pmi_A 288 AKQALH--HPWFAEYYHH 303 (317)
T ss_dssp HHHHTT--SGGGGGGCC-
T ss_pred HHHHhC--Chhhhcccch
Confidence 999998 6666655443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=268.97 Aligned_cols=203 Identities=33% Similarity=0.590 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++++++. ++..++||||+++++|.+++.......+++..++.++.|++.||+|||+.|++|+||||+|
T Consensus 68 l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (278)
T 1byg_A 68 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 147 (278)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcce
Confidence 57889999999999863 3468999999999999999986433448999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
|+++.+ +.++|+|||++....... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.
T Consensus 148 il~~~~-~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 148 VLVSED-NVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp EEECTT-SCEEECCCCC--------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred EEEeCC-CcEEEeeccccccccccc--cCCCccccccCHHHhCC--------CCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 999955 469999999987544322 23356788999998853 567889999999999999998 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
...... .............+..+++.+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 217 ~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 217 RIPLKD-VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp TSCGGG-HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHH-HHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 765433 333344445566778899999999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=275.07 Aligned_cols=210 Identities=27% Similarity=0.427 Sum_probs=162.2
Q ss_pred CCCCCCCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-------
Q 024401 1 MMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN------- 68 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~------- 68 (268)
+|++++||||+++++++.+. ..++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+.
T Consensus 71 ~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~ 147 (322)
T 3soc_A 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147 (322)
T ss_dssp TSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTE
T ss_pred HHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccc
Confidence 47889999999999998432 36999999999999999976 4599999999999999999999999
Q ss_pred ---CCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 69 ---GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 69 ---~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
||+||||||+||+++.+ +.+||+|||++....... ......|++.|+|||.+.+... ....++.++||||
T Consensus 148 ~~~~ivH~Dlkp~Nill~~~-~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~Diws 223 (322)
T 3soc_A 148 HKPAISHRDIKSKNVLLKNN-LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAIN---FQRDAFLRIDMYA 223 (322)
T ss_dssp EECEEECSCCSGGGEEECTT-CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCC---CCHHHHHHHHHHH
T ss_pred cCCCEEeCCCChHhEEECCC-CeEEEccCCcccccccccCccccccCccCccccCHhhcccccc---cCcCCCccchhHH
Confidence 99999999999999955 569999999997543322 2233578999999998853110 0134566889999
Q ss_pred HHHHHHHHHhCCCCCCCCCc---------------HHHHHHHHHh-hcCCCCCC-----CCcHHHHHHHHHhhhhCCCCC
Q 024401 143 FGIVLWELLTNRLPFEGMSN---------------LQAAYAAAFK-HARPGLPE-----DISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 143 lG~i~~~ll~g~~p~~~~~~---------------~~~~~~~~~~-~~~~~~~~-----~~~~~l~~li~~~l~~~p~~R 201 (268)
|||++|+|++|..||.+... .......... ...+..+. ..+.++.+++.+||+.||.+|
T Consensus 224 lG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 303 (322)
T 3soc_A 224 MGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303 (322)
T ss_dssp HHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGS
T ss_pred HHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhC
Confidence 99999999999999965322 1111111111 12222222 124569999999999999999
Q ss_pred CCHHHHHHHHHhhhhh
Q 024401 202 PSFSQIIRMLNAFLFT 217 (268)
Q Consensus 202 ps~~~~l~~l~~~~~~ 217 (268)
||+.++++.|+.+...
T Consensus 304 ps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 304 LSAGCVGERITQMQRL 319 (322)
T ss_dssp CCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHH
Confidence 9999999999987643
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=286.14 Aligned_cols=197 Identities=26% Similarity=0.376 Sum_probs=165.2
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++.+ +..++||||+.||+|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 90 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 167 (494)
T 3lij_A 90 LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL 167 (494)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhE
Confidence 678999999999999964 4689999999999999998763 5699999999999999999999999999999999999
Q ss_pred EEcCC--CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.. ...++|+|||++.............||+.|+|||.+. ..++.++|||||||++|+|++|..||.
T Consensus 168 l~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwslG~il~~ll~g~~pf~ 238 (494)
T 3lij_A 168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR---------KKYDEKCDVWSIGVILFILLAGYPPFG 238 (494)
T ss_dssp EESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc---------ccCCCchhHHHHHHHHHHHHhCCCCCC
Confidence 99743 2359999999998766555556668999999999874 457889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCC--CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPG--LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.................. ....+++.+.+++.+||..+|.+|||+.++++
T Consensus 239 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 239 GQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 7765444333322222221 12468999999999999999999999999998
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=272.97 Aligned_cols=209 Identities=26% Similarity=0.365 Sum_probs=166.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..++||||+++ +|.+++.. ....+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 66 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 143 (346)
T 1ua2_A 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143 (346)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHE
Confidence 45689999999999984 5578999999965 99998876 345689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......+++.|+|||.+.+ ...++.++||||||+++|+|++|..||.+
T Consensus 144 l~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~~~~~ 215 (346)
T 1ua2_A 144 LLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPG 215 (346)
T ss_dssp EECTT-CCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEcCC-CCEEEEecccceeccCCcccCCcccccccccCchHhhC-------CCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99965 46999999999765432 22344578999999998853 24578899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCC--------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 160 MSNLQAAYAAAFKHARPG--------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
.+..............+. ....++.++.+++.+||..||.+|||++++++ +.
T Consensus 216 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--h~ 293 (346)
T 1ua2_A 216 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MK 293 (346)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SG
T ss_pred CCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc--Ch
Confidence 766554443332211110 01346789999999999999999999999998 66
Q ss_pred hhhhcCCCC
Q 024401 214 FLFTLRPPS 222 (268)
Q Consensus 214 ~~~~~~~~~ 222 (268)
++.....+.
T Consensus 294 ~f~~~~~~~ 302 (346)
T 1ua2_A 294 YFSNRPGPT 302 (346)
T ss_dssp GGTSSSCCC
T ss_pred hhhcCCCCC
Confidence 766554433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=274.86 Aligned_cols=209 Identities=29% Similarity=0.460 Sum_probs=168.1
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++++. +...++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.||+|+||||+
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~ 156 (327)
T 3lxl_A 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAAR 156 (327)
T ss_dssp HHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChh
Confidence 56789999999999873 345889999999999999997632 45999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 157 NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ll~g~ 227 (327)
T 3lxl_A 157 NILVESE-AHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD--------NIFSRQSDVWSFGVVLYELFTYC 227 (327)
T ss_dssp GEEEEET-TEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTT
T ss_pred hEEECCC-CCEEEcccccceecccCCccceeeccCCccccccCHHHhcc--------CCCChHHhHHHHHHHHHHHHhCC
Confidence 9999855 569999999997543322 2233467888999998854 55688999999999999999999
Q ss_pred CCCCCCCc--------------HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 155 LPFEGMSN--------------LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 155 ~p~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
.||..... ................+..+++.+.+++.+||+.+|.+|||+.++++.|+.++.....
T Consensus 228 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~ 307 (327)
T 3lxl_A 228 DKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307 (327)
T ss_dssp CGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred CCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence 99854221 1222333444556667788999999999999999999999999999999998765543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-40 Score=273.18 Aligned_cols=196 Identities=24% Similarity=0.370 Sum_probs=164.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++|++|.+++.. ...+++..++.++.|++.||+|||+.||+|+||||+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NI 146 (321)
T 2a2a_A 69 LRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146 (321)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHE
Confidence 45789999999999985 4568999999999999999975 45699999999999999999999999999999999999
Q ss_pred EEcCCCC---ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.++. .++|+|||++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus 147 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf 218 (321)
T 2a2a_A 147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPF 218 (321)
T ss_dssp EESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred EEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC--------CCCCCccccHHHHHHHHHHHHCCCCC
Confidence 9986653 699999999986655444455678999999998853 56788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+......... ... ..... +..++..+.+++.+||..||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~-i~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 219 LGDTKQETLAN-ITS-VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp CCSSHHHHHHH-HHT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred CCCCHHHHHHH-HHh-cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 87654433322 222 22222 2568899999999999999999999999998
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=283.76 Aligned_cols=209 Identities=21% Similarity=0.333 Sum_probs=167.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++. ++..|+||||++||+|.+++.. ....+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 128 l~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~-~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NI 206 (437)
T 4aw2_A 128 LVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSK-FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206 (437)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHH-ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHe
Confidence 45679999999999985 4578999999999999999976 245699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|++.+ +.+||+|||+++...... ......||+.|+|||.+.... .....++.++|||||||++|+|++|+.||.
T Consensus 207 Ll~~~-g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~~~~~~DvwSlGvil~elltG~~Pf~ 282 (437)
T 4aw2_A 207 LMDMN-GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME---GGKGRYGPECDWWSLGVCMYEMLYGETPFY 282 (437)
T ss_dssp EECTT-SCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHH---TSCCEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eEcCC-CCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcc---cCCCCCCCcCeeHHHHHHHHHHHhCCCCCC
Confidence 99965 469999999997543322 223457999999999885210 012567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhh---cCCCCCCCCcHHHHHHHHHhhhhCCCC--CCCHHHHHHHHHhhhhh
Q 024401 159 GMSNLQAAYAAAFKH---ARPGLPEDISPDLAFIVQSCWVEDPNL--RPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~--Rps~~~~l~~l~~~~~~ 217 (268)
+.+..+......... ..+.....+++++.+||.+||..+|++ |++++++++ +.++..
T Consensus 283 ~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~--Hpff~~ 344 (437)
T 4aw2_A 283 AESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK--HPFFSG 344 (437)
T ss_dssp CSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT--SGGGTT
T ss_pred CCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC--CCccCC
Confidence 776554444333222 223333458999999999999888877 999999998 666543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=287.24 Aligned_cols=204 Identities=26% Similarity=0.418 Sum_probs=168.7
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++.+ +..++||||++||+|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 100 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 177 (504)
T 3q5i_A 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI 177 (504)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence 567899999999999964 4689999999999999999763 5699999999999999999999999999999999999
Q ss_pred EEcCCCC--ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.++. .++|+|||++.............|++.|+|||.+. ..++.++|||||||++|+|++|..||.
T Consensus 178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~ 248 (504)
T 3q5i_A 178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK---------KKYNEKCDVWSCGVIMYILLCGYPPFG 248 (504)
T ss_dssp EESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT---------TCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc---------cCCCchHHHHHHHHHHHHHHhCCCCCC
Confidence 9986543 58999999998766555555668999999999874 457889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 159 GMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+.+................. ...+++++.+++.+||..+|.+|||++++++ +.++...
T Consensus 249 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~--h~~~~~~ 308 (504)
T 3q5i_A 249 GQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN--SRWIKKY 308 (504)
T ss_dssp CSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHHT
T ss_pred CCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc--CHhhhhc
Confidence 76654433332222111111 1568999999999999999999999999998 5555543
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=275.13 Aligned_cols=208 Identities=25% Similarity=0.407 Sum_probs=163.6
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
++++++||||+++++++. ++..++||||+++++|.+++.... ...+++.+++.++.|++.||+|||+.|++||||||
T Consensus 88 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp 167 (321)
T 2qkw_B 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKS 167 (321)
T ss_dssp GGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCS
T ss_pred HHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCH
Confidence 367889999999999984 557899999999999999986532 23599999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
+||+++.+ +.++|+|||++...... .......|++.|+|||.+.+ ..++.++||||||+++|+|++|+
T Consensus 168 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ell~g~ 238 (321)
T 2qkw_B 168 INILLDEN-FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK--------GRLTEKSDVYSFGVVLFEVLCAR 238 (321)
T ss_dssp TTEEECTT-CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHH--------CBCCTHHHHHHHHHHHHHHHHCC
T ss_pred HHEEECCC-CCEEEeecccccccccccccccccccCCCccccCHHHhcC--------CCCCcccchHhHHHHHHHHHhCC
Confidence 99999955 56999999998753321 12233458899999998854 56788999999999999999999
Q ss_pred CCCCCCCcHH-----HHHHHHHhhc----------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 155 LPFEGMSNLQ-----AAYAAAFKHA----------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 155 ~p~~~~~~~~-----~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.||....... .......... ....+...+..+.+++.+||..+|.+|||+.++++.|+.+...
T Consensus 239 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 239 SAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 9996543211 1000111110 0112223456799999999999999999999999999987653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=270.27 Aligned_cols=216 Identities=26% Similarity=0.498 Sum_probs=165.7
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++++||||+++++++. ++..++||||++|++|.+++.. ....+++.+++.++.|++.||+|||+.|++||||||+|
T Consensus 82 ~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~N 160 (319)
T 2y4i_B 82 AYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKN 160 (319)
T ss_dssp GGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTS-SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTT
T ss_pred HHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhh
Confidence 367889999999999985 4578999999999999999976 33469999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcc------cccccCccCccceecccccccccccc-ccccCCCcccchHHHHHHHHHHHh
Q 024401 80 LLLTPDQKSLKLADFGLAREETV------TEMMTAETGTYRWMAPELYSTVTLRQ-GEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~------~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|+++ + +.++|+|||++..... ........++..|+|||.+....... .....++.++||||||+++|+|++
T Consensus 161 Il~~-~-~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~ 238 (319)
T 2y4i_B 161 VFYD-N-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA 238 (319)
T ss_dssp EEEC----CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH
T ss_pred EEEe-C-CCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 9998 4 4699999999764321 11223345889999999885421100 013457889999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|..||........... ......+.. ...++.++.+++.+||..+|.+|||+.++++.|+.+......
T Consensus 239 g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~ 306 (319)
T 2y4i_B 239 REWPFKTQPAEAIIWQ-MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRR 306 (319)
T ss_dssp SSCSSSSCCHHHHHHH-HHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC------
T ss_pred CCCCCCCCCHHHHHHH-hccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 9999987665443333 333333333 346889999999999999999999999999999988765433
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=283.24 Aligned_cols=205 Identities=27% Similarity=0.406 Sum_probs=159.0
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++++|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+||+
T Consensus 194 l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIl 271 (419)
T 3i6u_A 194 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 271 (419)
T ss_dssp HHHCCCTTBCCCCEEEESSEEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCEeeEEEEEecCceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence 567899999999999987788999999999999998875 456999999999999999999999999999999999999
Q ss_pred EcCCC--CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 82 LTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 82 ~~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
++.++ ..++|+|||++.............|++.|+|||.+.+. ....++.++||||||+++|+|++|..||..
T Consensus 272 l~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp ESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC---------CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecC-----CCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 97432 35999999999876655555566899999999988531 125677899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 160 MSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.................. ....++..+.+++.+||..+|.+|||++++++ +.++
T Consensus 347 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~ 403 (419)
T 3i6u_A 347 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR--HPWL 403 (419)
T ss_dssp CSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGG
T ss_pred CcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC--Cccc
Confidence 544322222222222221 12468899999999999999999999999998 4444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=266.49 Aligned_cols=200 Identities=30% Similarity=0.569 Sum_probs=166.2
Q ss_pred CCCCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CeecC
Q 024401 2 MSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~d 74 (268)
|++++||||+++++++.+ ...++||||+++++|.+++... ..+++..++.++.|++.||+|||+.| ++|+|
T Consensus 79 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~d 156 (290)
T 1t4h_A 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRD 156 (290)
T ss_dssp HTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSC
T ss_pred HHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECC
Confidence 578899999999998732 3589999999999999999863 56999999999999999999999999 99999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+.+.++|+|||++...... ......+++.|+|||.+. ..++.++||||||+++|+|++|.
T Consensus 157 ikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~ 226 (290)
T 1t4h_A 157 LKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATSE 226 (290)
T ss_dssp CCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh---------ccCCCcchHHHHHHHHHHHHhCC
Confidence 99999999855567999999998654332 223456899999999874 34788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 155 LPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
.||.................. ...+...++++.+++.+||..+|.+|||+.++++ +.++
T Consensus 227 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~f 286 (290)
T 1t4h_A 227 YPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN--HAFF 286 (290)
T ss_dssp CTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT--SGGG
T ss_pred CCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh--Cccc
Confidence 999887766665554443332 2344567889999999999999999999999997 4444
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=272.20 Aligned_cols=208 Identities=29% Similarity=0.518 Sum_probs=171.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
+++++||||+++++++. ++..++||||++|++|.+++..... ..+++.+++.++.|++.||+|||+.||+||||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dl 166 (327)
T 2yfx_A 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDI 166 (327)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcC
Confidence 45689999999999985 4578999999999999999987432 34899999999999999999999999999999
Q ss_pred CCCCEEEcCC--CCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 76 KPDNLLLTPD--QKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 76 k~~Nil~~~~--~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
||+||+++.+ +..++|+|||++...... .......++..|+|||.+.. ..++.++||||||+++|+|
T Consensus 167 kp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el 238 (327)
T 2yfx_A 167 AARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME--------GIFTSKTDTWSFGVLLWEI 238 (327)
T ss_dssp CGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHH
T ss_pred CHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcC--------CCCCchhhHHHHHHHHHHH
Confidence 9999999843 335999999998643221 12233467889999998853 5678899999999999999
Q ss_pred Hh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 151 LT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 151 l~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
++ |..||..... ...............+..++..+.+++.+||..+|.+|||+.++++.|+.+....
T Consensus 239 lt~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 239 FSLGYMPYPSKSN-QEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HTTSCCSSTTCCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HcCCCCCCCCcCH-HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 98 9999987654 3334444555566677889999999999999999999999999999999876543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=264.63 Aligned_cols=201 Identities=23% Similarity=0.383 Sum_probs=167.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 68 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 145 (284)
T 2vgo_A 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL 145 (284)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred HhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 46789999999999985 45789999999999999999864 4599999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 146 l~~~~-~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 146 LMGYK-GELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEG--------KTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp EECTT-CCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred EEcCC-CCEEEecccccccCccc-ccccccCCCCcCCHHHhcc--------CCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 99855 46999999998654332 2234578999999998854 56788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
....... ........++..++.++.+++.+||..+|.+|||++++++ +.++...
T Consensus 216 ~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--h~~~~~~ 269 (284)
T 2vgo_A 216 SHTETHR--RIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME--HPWVKAN 269 (284)
T ss_dssp SHHHHHH--HHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT--CHHHHHH
T ss_pred CHhHHHH--HHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh--CHHHHhh
Confidence 5443322 2233445667789999999999999999999999999998 4555443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=278.43 Aligned_cols=208 Identities=25% Similarity=0.340 Sum_probs=165.3
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
|+.++||||+++++++.. .++++||||+++ +|.+++.. .....+++..++.++.||+.||+|||+.||+|
T Consensus 101 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 179 (420)
T 1j1b_A 101 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICH 179 (420)
T ss_dssp HHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 567899999999998721 136799999965 77776653 23467999999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|||||+|||++.++..+||+|||+++............+++.|+|||.+.+ ...++.++|||||||++|+|++
T Consensus 180 rDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~ 252 (420)
T 1j1b_A 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLL 252 (420)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHH
T ss_pred cCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcC-------CCCCCchhhhHHHHHHHHHHHh
Confidence 999999999997767789999999986554444455678999999998853 2467889999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhc----------C-----CC------------CCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHA----------R-----PG------------LPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~----------~-----~~------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
|+.||.+.+............. . .. ++..++.++.+|+.+||..||.+|||+.
T Consensus 253 G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~ 332 (420)
T 1j1b_A 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 332 (420)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHH
Confidence 9999988765544433322100 0 01 2245688999999999999999999999
Q ss_pred HHHHHHHhhhhhcC
Q 024401 206 QIIRMLNAFLFTLR 219 (268)
Q Consensus 206 ~~l~~l~~~~~~~~ 219 (268)
++++ +.++..+.
T Consensus 333 e~l~--hp~f~~~~ 344 (420)
T 1j1b_A 333 EACA--HSFFDELR 344 (420)
T ss_dssp HHHT--SGGGGGGG
T ss_pred HHhC--CHhhcccc
Confidence 9998 56665543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=288.01 Aligned_cols=204 Identities=25% Similarity=0.445 Sum_probs=168.7
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++.+ +..++||||+.|++|.+++.. ...+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 80 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni 157 (484)
T 3nyv_A 80 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL 157 (484)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence 578899999999999854 578999999999999999975 45699999999999999999999999999999999999
Q ss_pred EEcC--CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++. ..+.++|+|||++.............|++.|+|||.+. ..++.++|||||||++|+|++|..||.
T Consensus 158 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~~ll~g~~pf~ 228 (484)
T 3nyv_A 158 LLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLH---------GTYDEKCDVWSTGVILYILLSGCPPFN 228 (484)
T ss_dssp EESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHH---------TCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeec---------CCCCCcceeHHHHHHHHHHHHCCCCCC
Confidence 9952 34569999999997655544445567999999999874 357889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 159 GMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+.+.................+ ..+++++.+++.+||..+|.+|||+.++++ +.++...
T Consensus 229 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~--h~~~~~~ 288 (484)
T 3nyv_A 229 GANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD--HEWIQTY 288 (484)
T ss_dssp CSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT--SHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh--Chhhccc
Confidence 876544443333322222222 468999999999999999999999999998 5555544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=272.84 Aligned_cols=202 Identities=27% Similarity=0.409 Sum_probs=165.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+. |+|.+++... ...+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 108 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 185 (348)
T 1u5q_A 108 LQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 185 (348)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred HHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence 46789999999999984 557899999996 5888888653 35799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++...... ....|++.|+|||.+.+. ....++.++||||||+++|+|++|..||...
T Consensus 186 ll~~~-~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~ 256 (348)
T 1u5q_A 186 LLSEP-GLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFNM 256 (348)
T ss_dssp EEETT-TEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTT-----SSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred EECCC-CCEEEeeccCceecCCC---CcccCCcceeCHhhhccc-----cCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99955 56999999999765432 345789999999987421 1356788999999999999999999999877
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..................+..++..+.+++.+||..+|.+|||++++++ +.++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~--h~~~~ 310 (348)
T 1u5q_A 257 NAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVL 310 (348)
T ss_dssp CHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHH
T ss_pred ChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh--Chhhh
Confidence 6655544443333333445678999999999999999999999999998 44443
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=268.47 Aligned_cols=207 Identities=26% Similarity=0.370 Sum_probs=158.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||++|++|.+++... ..+++.+++.++.|++.||+|||+.||+|+||||+||
T Consensus 88 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI 165 (309)
T 2h34_A 88 AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI 165 (309)
T ss_dssp HTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence 56889999999999984 56789999999999999999863 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 166 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 166 LVSAD-DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE--------SHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp EECTT-SCEEECSCCC----------------CCGGGCCGGGTCC------------CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred EEcCC-CCEEEecCccCccccccccccccccCCCcCccCHHHHcC--------CCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 99965 469999999987544322 2234568999999998853 567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHhhhhhcCC
Q 024401 159 GMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~~~~~~ 220 (268)
..... .......... ....+..++.++.+++.+||..+|.+|| +++++++.|+..+.....
T Consensus 237 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~~ 300 (309)
T 2h34_A 237 GDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATADQ 300 (309)
T ss_dssp SCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC----
T ss_pred CchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhcc
Confidence 65432 2222222111 1134567899999999999999999999 999999999987765543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=267.26 Aligned_cols=208 Identities=25% Similarity=0.415 Sum_probs=161.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++ ++|.+++.. ....+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 54 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NI 131 (324)
T 3mtl_A 54 LKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD-CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL 131 (324)
T ss_dssp HSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGE
T ss_pred HHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHE
Confidence 57889999999999985 557899999996 599999876 345699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+
T Consensus 132 l~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 132 LINER-GELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLG-------STDYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp EECTT-CCEEECSSSEEECC------------CGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EECCC-CCEEEccCcccccccCCccccccccCcccccChhhhcC-------CCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99966 46999999998754432 22334578999999998753 25678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCC----------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPG----------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
.+..............+. ....++.++.+|+.+||+.||.+|||++++++
T Consensus 204 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~-- 281 (324)
T 3mtl_A 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK-- 281 (324)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--
T ss_pred CCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc--
Confidence 665443332222111110 11246788999999999999999999999999
Q ss_pred HhhhhhcCCC
Q 024401 212 NAFLFTLRPP 221 (268)
Q Consensus 212 ~~~~~~~~~~ 221 (268)
+.++.+....
T Consensus 282 hp~f~~~~~~ 291 (324)
T 3mtl_A 282 HPFFLSLGER 291 (324)
T ss_dssp SGGGGGGCST
T ss_pred Chhhhhcccc
Confidence 7777666543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=263.45 Aligned_cols=207 Identities=24% Similarity=0.436 Sum_probs=166.8
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++++. ....++||||+.++ |.+++.......+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 138 (305)
T 2wtk_C 60 LRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPG 138 (305)
T ss_dssp HTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred HHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcc
Confidence 57889999999999872 34689999999765 888887766678999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcc---cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETV---TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
||+++.+ +.++|+|||.+..... ........++..|+|||.+.+ .....+.++||||||+++|+|++|..
T Consensus 139 NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~ 211 (305)
T 2wtk_C 139 NLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG------LDTFSGFKVDIWSAGVTLYNITTGLY 211 (305)
T ss_dssp GEEECTT-CCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC------CSCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred cEEEcCC-CcEEeeccccccccCccccccccccCCCCCCCcChhhccC------cccCCcchhhHHHHHHHHHHHHhCCC
Confidence 9999955 5699999999975432 222344578999999998853 12334679999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
||.+...... .. .........+..++..+.+++.+||..||.+|||+.++++ +.++.....
T Consensus 212 p~~~~~~~~~-~~-~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--~~~~~~~~~ 272 (305)
T 2wtk_C 212 PFEGDNIYKL-FE-NIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ--HSWFRKKHP 272 (305)
T ss_dssp SCCCSSHHHH-HH-HHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH--SHHHHSCCC
T ss_pred CCCCchHHHH-HH-HHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhc--CcccccCCC
Confidence 9987554332 22 2334455677889999999999999999999999999998 555554433
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=271.50 Aligned_cols=203 Identities=21% Similarity=0.343 Sum_probs=162.8
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++++. ++..++||||+.|++|.+++.......+++.+++.++.|++.||+|||+.||+||||||+||+++.
T Consensus 87 ~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~ 166 (327)
T 3lm5_A 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS 166 (327)
T ss_dssp TCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESC
T ss_pred CCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEec
Confidence 5799999999985 456899999999999999987644567999999999999999999999999999999999999985
Q ss_pred --CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCc
Q 024401 85 --DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162 (268)
Q Consensus 85 --~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~ 162 (268)
..+.++|+|||++.............+++.|+|||.+.. ..++.++||||||+++|+|++|..||...+.
T Consensus 167 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 167 IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY--------DPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp BTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC--------CCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 245699999999987655544555679999999998853 6678899999999999999999999987665
Q ss_pred HHHHHHHHHhh--cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 163 LQAAYAAAFKH--ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 163 ~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
........... ........++..+.+++.+||..+|.+|||++++++ +.++...
T Consensus 239 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~--h~~~~~~ 294 (327)
T 3lm5_A 239 QETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS--HSWLQQW 294 (327)
T ss_dssp HHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--CGGGCCC
T ss_pred hHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC--CHhhccc
Confidence 44433332222 222334568999999999999999999999999998 5565443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=275.61 Aligned_cols=210 Identities=25% Similarity=0.358 Sum_probs=166.0
Q ss_pred CCCCCCCcccceeeeee-cC------CceEEEEcCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACK-DP------LMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
|+.++||||+++++++. .+ ..++||||+++ ++.+.+.. .....+++..+..++.|++.||+|||+.||+|
T Consensus 86 l~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 164 (394)
T 4e7w_A 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICH 164 (394)
T ss_dssp HHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 56789999999999872 11 27899999976 54444432 23467999999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|||||+||+++..++.++|+|||+++............+++.|+|||.+.+ ...++.++|||||||++|+|++
T Consensus 165 rDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlG~il~ell~ 237 (394)
T 4e7w_A 165 RDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG-------ATNYTTNIDIWSTGCVMAELMQ 237 (394)
T ss_dssp SCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC-------CCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999985556799999999987655555556678999999998853 2457899999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCC---------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHARP---------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
|+.||.+.+..............+ .++..++.++.+|+.+||..||.+|||+.
T Consensus 238 g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 317 (394)
T 4e7w_A 238 GQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317 (394)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHH
Confidence 999999877655444332211000 12234788999999999999999999999
Q ss_pred HHHHHHHhhhhhcCCC
Q 024401 206 QIIRMLNAFLFTLRPP 221 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~~ 221 (268)
++++ +.++..+...
T Consensus 318 e~l~--hp~f~~~~~~ 331 (394)
T 4e7w_A 318 EALC--HPFFDELRTG 331 (394)
T ss_dssp HHHT--SGGGSTTTSS
T ss_pred HHhc--Chhhhhhccc
Confidence 9998 7777665543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=272.13 Aligned_cols=202 Identities=27% Similarity=0.454 Sum_probs=145.3
Q ss_pred CCCC-CCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRVK-HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l~-Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+.+. ||||+++++++.+ ...++||||++|++|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 60 ~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 137 (325)
T 3kn6_A 60 KLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENL 137 (325)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHE
Confidence 3455 9999999999854 468999999999999999986 35699999999999999999999999999999999999
Q ss_pred EEcCCCC--ceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQK--SLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~--~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.++. .++|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus 138 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwslG~il~~ll~g~~pf 209 (325)
T 3kn6_A 138 LFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ--------NGYDESCDLWSLGVILYTMLSGQVPF 209 (325)
T ss_dssp EEEC----CEEEECCCTTCEECCC------------------------------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC--------CCCCCccchHHHHHHHHHHHhCCCCC
Confidence 9985432 6999999999754432 22344568999999999854 56788999999999999999999999
Q ss_pred CCCCc------HHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 158 EGMSN------LQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 158 ~~~~~------~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
..... ....... .......++ ..+++++.+++.+||..||.+|||++++++ +.++..
T Consensus 210 ~~~~~~~~~~~~~~~~~~-i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--h~w~~~ 276 (325)
T 3kn6_A 210 QSHDRSLTCTSAVEIMKK-IKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY--NEWLQD 276 (325)
T ss_dssp C-------CCCHHHHHHH-HTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT--CGGGCT
T ss_pred CCCccccccccHHHHHHH-HHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc--Chhhcc
Confidence 76432 1222222 222222222 358899999999999999999999999987 566544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=271.24 Aligned_cols=194 Identities=24% Similarity=0.385 Sum_probs=162.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|++++||||+++++++. ++..++||||+.+| +|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+|
T Consensus 83 l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 160 (335)
T 3dls_A 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN 160 (335)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHH
Confidence 57889999999999985 45689999999766 99999976 4569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.++|+|||++.............|++.|+|||.+.+ ....+.++||||||+++|+|++|..||..
T Consensus 161 Ill~~~-~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 161 IVIAED-FTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG-------NPYRGPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp EEECTT-SCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTT-------CCBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred EEEcCC-CcEEEeecccceECCCCCceeccCCCccccChhhhcC-------CCCCCCcccchhHHHHHHHHHhCCCchhh
Confidence 999965 5699999999986655544455678999999998853 12337889999999999999999999975
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
... ........+..++.++.+++.+||..+|.+|||++++++ +.++
T Consensus 233 ~~~--------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~--hp~~ 278 (335)
T 3dls_A 233 LEE--------TVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT--DPWV 278 (335)
T ss_dssp GGG--------GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH--CTTT
T ss_pred HHH--------HHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhc--Cccc
Confidence 322 112233445678999999999999999999999999998 4554
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=274.36 Aligned_cols=209 Identities=26% Similarity=0.402 Sum_probs=163.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------------------------------
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-------------------------------------- 42 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-------------------------------------- 42 (268)
|++++||||+++++++. ++..++||||++|++|.+++....
T Consensus 82 l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (345)
T 3hko_A 82 MKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESL 161 (345)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEEC
T ss_pred HHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 45789999999999985 446899999999999999985210
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCC-ceEEeccCCcccCcccc-----cccCccCcccee
Q 024401 43 PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTE-----MMTAETGTYRWM 116 (268)
Q Consensus 43 ~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~-~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~ 116 (268)
...+++..++.++.|++.||+|||+.||+||||||+||+++.++. .++|+|||++....... ......+++.|+
T Consensus 162 ~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~ 241 (345)
T 3hko_A 162 DFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFV 241 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGC
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcccc
Confidence 112467889999999999999999999999999999999985542 69999999997543211 233457899999
Q ss_pred ccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhh
Q 024401 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCW 194 (268)
Q Consensus 117 aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l 194 (268)
|||.+.+ ....++.++||||||+++|+|++|..||.+...................+ ..++.++.+++.+||
T Consensus 242 aPE~~~~------~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 315 (345)
T 3hko_A 242 APEVLNT------TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLL 315 (345)
T ss_dssp CHHHHTC------SSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHS
T ss_pred Cchhhcc------CCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHc
Confidence 9998853 23567889999999999999999999998877655544443333222222 247899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 195 VEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
..+|.+|||+.++++ +.++...
T Consensus 316 ~~~p~~Rps~~~~l~--hp~~~~~ 337 (345)
T 3hko_A 316 NRNVDERFDAMRALQ--HPWISQF 337 (345)
T ss_dssp CSCTTTSCCHHHHHH--SHHHHTT
T ss_pred CCChhHCCCHHHHhc--ChhhccC
Confidence 999999999999998 5555443
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=265.59 Aligned_cols=211 Identities=24% Similarity=0.424 Sum_probs=160.7
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
+++++||||+++++++ .++..++||||+++++|.+++... ....+++..++.++.|++.||+|||+.|++|+||||+
T Consensus 86 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~ 165 (310)
T 2wqm_A 86 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPA 165 (310)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred HHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHH
Confidence 4678999999999998 456789999999999999999752 3456999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||++....... ......++..|+|||.+.. ..++.++||||||+++|+|++|..||
T Consensus 166 NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Dv~slG~il~~l~~g~~p~ 236 (310)
T 2wqm_A 166 NVFITAT-GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE--------NGYNFKSDIWSLGCLLYEMAALQSPF 236 (310)
T ss_dssp GEEECTT-SCEEECCC------------------CCSSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred HEEEcCC-CCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC--------CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 9999955 469999999987544322 2234468899999998853 56788999999999999999999999
Q ss_pred CCCCc-HHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 158 EGMSN-LQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 158 ~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
.+... .............+.. ...++.++.+++.+||..||.+|||+.++++.|+.+......+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 237 YGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp C---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred cccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 76442 2223333333333333 3578999999999999999999999999999999988765543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=270.37 Aligned_cols=201 Identities=30% Similarity=0.461 Sum_probs=167.6
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++.+ +..++||||+.+++|.+++... ..+++.+++.++.|++.||+|||+.||+|+||||+||
T Consensus 95 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 172 (335)
T 2owb_A 95 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 172 (335)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence 467899999999999854 4689999999999999998763 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++..... ........++..|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 173 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 173 FLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp EECTT-CCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEcCC-CCEEEeeccCceecccCcccccccCCCccccCHHHhcc--------CCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 99965 4699999999976542 222344578999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
........ ........++..++..+.+++.+||..||.+|||++++++ +.++..
T Consensus 244 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--~~~~~~ 297 (335)
T 2owb_A 244 SCLKETYL--RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTS 297 (335)
T ss_dssp SSHHHHHH--HHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred CCHHHHHH--HHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc--CccccC
Confidence 65433322 2233445567789999999999999999999999999998 455543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=275.48 Aligned_cols=204 Identities=24% Similarity=0.400 Sum_probs=160.1
Q ss_pred CCCCC-CCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVK-HDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
|+++. ||||+++++++.. ...|+||||++ ++|.+++.. ..+++..+..++.|++.||+|||+.||+||||||
T Consensus 62 l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp 137 (388)
T 3oz6_A 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKP 137 (388)
T ss_dssp HHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCH
Confidence 34565 9999999999842 25899999996 599999976 4699999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcc----------------------cccccCccCccceeccccccccccccccccCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETV----------------------TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 135 (268)
+|||++.+ +.++|+|||+++.... ........||+.|+|||.+.+ ...++
T Consensus 138 ~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~ 209 (388)
T 3oz6_A 138 SNILLNAE-CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-------STKYT 209 (388)
T ss_dssp GGEEECTT-CCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-------CCCCC
T ss_pred HHeEEcCC-CCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC-------CCCCC
Confidence 99999965 4699999999975322 111233478999999998853 25678
Q ss_pred cccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCC--------------------------------------
Q 024401 136 NKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG-------------------------------------- 177 (268)
Q Consensus 136 ~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------------- 177 (268)
.++|||||||++|+|++|+.||.+.+..............+.
T Consensus 210 ~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (388)
T 3oz6_A 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWK 289 (388)
T ss_dssp THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHH
T ss_pred ChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchh
Confidence 899999999999999999999988765544333221111110
Q ss_pred -------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 178 -------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 178 -------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
....+++++.+|+.+||..||.+|||++++++ +.++....
T Consensus 290 ~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~--Hp~~~~~~ 336 (388)
T 3oz6_A 290 NLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALK--HPFVSIFH 336 (388)
T ss_dssp HHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTT--STTTTTTC
T ss_pred hhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhC--CHHHHHhc
Confidence 11267889999999999999999999999998 56654443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=261.42 Aligned_cols=201 Identities=25% Similarity=0.421 Sum_probs=158.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 142 (276)
T 2h6d_A 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV 142 (276)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGE
T ss_pred HhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhE
Confidence 46789999999999985 45789999999999999999764 4599999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............+++.|+|||.+.+ ....+.++||||||+++|+|++|..||...
T Consensus 143 l~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 214 (276)
T 2h6d_A 143 LLDAH-MNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG-------RLYAGPEVDIWSCGVILYALLCGTLPFDDE 214 (276)
T ss_dssp EECTT-SCEEECCCCGGGCCCC-------------CCTGGGTT-------SCCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCC-CCEEEeecccccccCCCcceecccCCccccCHHHHcC-------CCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 99965 4699999999987655444455678999999999853 123367999999999999999999999875
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..... . ..........+..++..+.+++.+||..+|.+|||++++++ +.++.
T Consensus 215 ~~~~~-~-~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~--h~~~~ 266 (276)
T 2h6d_A 215 HVPTL-F-KKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE--HEWFK 266 (276)
T ss_dssp SHHHH-H-HHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHH
T ss_pred cHHHH-H-HHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh--Chhhc
Confidence 54332 2 22334455567788999999999999999999999999998 45543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=270.86 Aligned_cols=198 Identities=25% Similarity=0.453 Sum_probs=160.0
Q ss_pred CCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++++.+ +..|+||||++||+|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+||++..
T Consensus 74 ~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151 (342)
T ss_dssp TSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred CCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEec
Confidence 79999999999864 468999999999999999975 456999999999999999999999999999999999999854
Q ss_pred CCC---ceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 85 DQK---SLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 85 ~~~---~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++ .++|+|||++...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER--------QGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH--------HHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred CCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC--------CCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 332 4999999999754432 23345678999999999854 44678999999999999999999999753
Q ss_pred C--cHHHHHHHHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 161 S--NLQAAYAAAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 161 ~--~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
. ............... .....+++++.+++.+||..||.+|||+.++++ +.++
T Consensus 224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~--hp~~ 281 (342)
T 2qr7_A 224 PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR--HPWI 281 (342)
T ss_dssp TTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT--SHHH
T ss_pred CcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc--CCee
Confidence 2 223333322222211 123568999999999999999999999999998 4444
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=269.25 Aligned_cols=204 Identities=23% Similarity=0.379 Sum_probs=158.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++ ++|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+||
T Consensus 87 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NI 163 (329)
T 3gbz_A 87 LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNL 163 (329)
T ss_dssp GGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHE
Confidence 67889999999999985 557899999996 599999986 34699999999999999999999999999999999999
Q ss_pred EEcC----CCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 81 LLTP----DQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 81 l~~~----~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
+++. +...++|+|||++...... .......++..|+|||.+.+ ...++.++|||||||++|+|++|..
T Consensus 164 ll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~~ 236 (329)
T 3gbz_A 164 LLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG-------SRHYSTSVDIWSIACIWAEMLMKTP 236 (329)
T ss_dssp EEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcC-------CCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9963 2335999999999754322 22334567999999998853 2457899999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCCCC----------------------------CCCCcHHHHHHHHHhhhhCCCCCCCHHHH
Q 024401 156 PFEGMSNLQAAYAAAFKHARPGL----------------------------PEDISPDLAFIVQSCWVEDPNLRPSFSQI 207 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~~ 207 (268)
||.+................+.. +..++.++.+|+.+||..||.+|||++++
T Consensus 237 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~ 316 (329)
T 3gbz_A 237 LFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNA 316 (329)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred CcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHH
Confidence 99887765554443322111110 01167899999999999999999999999
Q ss_pred HHHHHhhhhh
Q 024401 208 IRMLNAFLFT 217 (268)
Q Consensus 208 l~~l~~~~~~ 217 (268)
++ +.++..
T Consensus 317 l~--hp~f~~ 324 (329)
T 3gbz_A 317 LE--HPYFSH 324 (329)
T ss_dssp HT--SGGGSS
T ss_pred hC--CcccCC
Confidence 98 555544
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=264.94 Aligned_cols=204 Identities=25% Similarity=0.412 Sum_probs=167.3
Q ss_pred CCCCCcccceeeeee------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 4 RVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
.++||||+++++++. +...++||||+. ++|.+++.......+++..++.++.|++.||+|||+.||+|+||||
T Consensus 70 ~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp 148 (326)
T 1blx_A 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 148 (326)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred ccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCH
Confidence 358999999999874 236899999996 6999999876556699999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+||+++.+ +.++|+|||++.............++..|+|||.+.+ ..++.++||||||+++|+|++|..||
T Consensus 149 ~Nili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf 219 (326)
T 1blx_A 149 QNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLF 219 (326)
T ss_dssp GGEEECTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HHeEEcCC-CCEEEecCcccccccCCCCccccccccceeCHHHHhc--------CCCCcchhHHHHHHHHHHHHcCCCCC
Confidence 99999965 4699999999987655544556678999999998854 56788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
.+................ ..+...++..+.+++.+||..||.+|||+.++++ +
T Consensus 220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~--h 297 (326)
T 1blx_A 220 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--H 297 (326)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--S
T ss_pred CCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc--C
Confidence 877655443333221110 1123568899999999999999999999999997 6
Q ss_pred hhhhhcC
Q 024401 213 AFLFTLR 219 (268)
Q Consensus 213 ~~~~~~~ 219 (268)
.++....
T Consensus 298 p~~~~~~ 304 (326)
T 1blx_A 298 PYFQDLE 304 (326)
T ss_dssp GGGTTCC
T ss_pred ccccccc
Confidence 6665544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=278.74 Aligned_cols=210 Identities=22% Similarity=0.345 Sum_probs=164.8
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|..++||||+++++++.+ +..|+||||++||+|.+++... ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 115 l~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NI 193 (412)
T 2vd5_A 115 LVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNI 193 (412)
T ss_dssp HHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHe
Confidence 456799999999999864 5689999999999999999763 24699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|++.++ .+||+|||++........ .....||+.|+|||.+...... .....++.++|+|||||++|+|++|..||.
T Consensus 194 Lld~~g-~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~-~~~~~~~~~~DiwSlGvilyelltG~~Pf~ 271 (412)
T 2vd5_A 194 LLDRCG-HIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG-PGTGSYGPECDWWALGVFAYEMFYGQTPFY 271 (412)
T ss_dssp EECTTS-CEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTC-TTCSEECTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred eecCCC-CEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccC-cCCCCCChHHhhhHHhHHHHHHHhCCCCCC
Confidence 999654 599999999976543322 2345799999999998531100 012467889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhh---cCCCCCCCCcHHHHHHHHHhhhhCCCCC---CCHHHHHHHHHhhhhh
Q 024401 159 GMSNLQAAYAAAFKH---ARPGLPEDISPDLAFIVQSCWVEDPNLR---PSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~R---ps~~~~l~~l~~~~~~ 217 (268)
+.+............ ..+..+..++.+++++|.+||. +|.+| |+++++++ +.++..
T Consensus 272 ~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~--Hpff~~ 333 (412)
T 2vd5_A 272 ADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT--HPFFFG 333 (412)
T ss_dssp CSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT--SGGGTT
T ss_pred CCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc--CCCcCC
Confidence 766544433332211 2233346799999999999999 99998 58999987 555543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=264.75 Aligned_cols=209 Identities=22% Similarity=0.309 Sum_probs=165.3
Q ss_pred CCCCCCCcccceeeee--ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++.++|++++..+..+ .++..++||||+ +++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 135 (296)
T 3uzp_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 3567888877777665 355689999999 9999999975 34579999999999999999999999999999999999
Q ss_pred EEEc--CCCCceEEeccCCcccCccccc--------ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 80 LLLT--PDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 80 il~~--~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
|+++ .+++.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+
T Consensus 136 Il~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred eEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcC--------CCCCcchhhHHHHHHHHH
Confidence 9994 2445699999999975443221 234578999999999854 567889999999999999
Q ss_pred HHhCCCCCCCCCcH------HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 150 LLTNRLPFEGMSNL------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 150 ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|++|+.||...... ..................+++++.+++.+||+.+|.+|||++++++.|+.+..+...
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 208 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 99999999764321 111111111111223367899999999999999999999999999999998877544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=290.36 Aligned_cols=205 Identities=29% Similarity=0.558 Sum_probs=171.8
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.||+||||||+||+
T Consensus 445 l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NIL 523 (656)
T 2j0j_A 445 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV-RKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 523 (656)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHH-TTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCCCCeEEEEEecCceEEEEEcCCCCcHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEE
Confidence 457899999999999988889999999999999999986 3346999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccccc--ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTEM--MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.++|+|||++........ .....+++.|+|||.+.. ..++.++||||||+++|+|++ |..||.
T Consensus 524 l~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ellt~g~~Pf~ 594 (656)
T 2j0j_A 524 VSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQ 594 (656)
T ss_dssp EEET-TEEEECCCCCCCSCCC----------CCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred EeCC-CCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcC--------CCCCchhhHHHHHHHHHHHHHcCCCCCC
Confidence 9955 5699999999986543322 223356788999998854 567889999999999999997 999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+....+ .............+..++..+.+++.+||..||.+|||+.++++.|..++..
T Consensus 595 ~~~~~~-~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 595 GVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp TCCHHH-HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHH-HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 766544 3334445566777889999999999999999999999999999999987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=284.39 Aligned_cols=198 Identities=25% Similarity=0.419 Sum_probs=164.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++. ++..|+||||++||+|.+++.... ...+++..++.++.||+.||+|||+.||+||||||+
T Consensus 239 L~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~ 318 (543)
T 3c4z_A 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE 318 (543)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChH
Confidence 45789999999999985 456899999999999999997633 346999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccccc-ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEM-MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
||+++.+ +.++|+|||++........ .....||+.|+|||.+.+ ..++.++|+|||||++|+|++|..||
T Consensus 319 NILl~~~-g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiwSlGvilyelltG~~PF 389 (543)
T 3c4z_A 319 NVLLDDD-GNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG--------EEYDFSVDYFALGVTLYEMIAARGPF 389 (543)
T ss_dssp GEEECTT-SCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred HEEEeCC-CCEEEeecceeeeccCCCcccccccCCccccChhhhcC--------CCCChHHhcCcchHHHHHHHhCCCCC
Confidence 9999966 4699999999986544332 334589999999999854 56789999999999999999999999
Q ss_pred CCCCc---HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 024401 158 EGMSN---LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 209 (268)
Q Consensus 158 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~l~ 209 (268)
..... ...... ........++..++.++.+++.+||..+|.+||++ +++++
T Consensus 390 ~~~~~~~~~~~~~~-~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 390 RARGEKVENKELKQ-RVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp CCTTCCCCHHHHHH-HHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred CCCccchhHHHHHH-HHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 76532 222222 23344566778899999999999999999999964 67766
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=273.28 Aligned_cols=207 Identities=26% Similarity=0.397 Sum_probs=167.4
Q ss_pred CCCCCCCcccceeeeeec---------------------------------------CCceEEEEcCCCCCHHHHHhh--
Q 024401 2 MSRVKHDNLVKFLGACKD---------------------------------------PLMVIVTELLPGMSLRKYLVS-- 40 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---------------------------------------~~~~lv~e~~~~~~L~~~~~~-- 40 (268)
|+.++||||+++++++.. .+.++||||++ ++|.+.+..
T Consensus 54 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 132 (383)
T 3eb0_A 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI 132 (383)
T ss_dssp HTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHH
T ss_pred HHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH
Confidence 678999999999998721 13789999996 588887764
Q ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceecccc
Q 024401 41 LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120 (268)
Q Consensus 41 ~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~ 120 (268)
.....+++..+..++.|++.||+|||+.||+||||||+||+++.+++.++|+|||++.............++..|+|||.
T Consensus 133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~ 212 (383)
T 3eb0_A 133 RSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPEL 212 (383)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHH
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHH
Confidence 23567999999999999999999999999999999999999986566799999999986655555556678999999998
Q ss_pred ccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCC------------------------
Q 024401 121 YSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------------------------ 176 (268)
Q Consensus 121 ~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------------------ 176 (268)
+.+ ...++.++||||+||++|+|++|..||.+.+..+...........+
T Consensus 213 ~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (383)
T 3eb0_A 213 MLG-------ATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKD 285 (383)
T ss_dssp HTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCC
T ss_pred hcC-------CCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCccc
Confidence 753 2457899999999999999999999999877655444433211110
Q ss_pred ---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 177 ---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 177 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.++..++.++.+|+.+||..+|.+|||+.++++ +.++...
T Consensus 286 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~--hp~f~~~ 328 (383)
T 3eb0_A 286 WRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMA--HPFFDHL 328 (383)
T ss_dssp HHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SGGGHHH
T ss_pred HHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhc--CHHHHHH
Confidence 134568899999999999999999999999998 5555443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=265.39 Aligned_cols=196 Identities=24% Similarity=0.390 Sum_probs=159.2
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++.+ +..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.|++|+||||+||
T Consensus 62 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 139 (283)
T 3bhy_A 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139 (283)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHE
Confidence 457899999999999854 5689999999999999999763 4699999999999999999999999999999999999
Q ss_pred EEcCCCC---ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.++. .++|+|||.+.............+++.|+|||.+.. ..++.++||||||+++|+|++|..||
T Consensus 140 l~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~ 211 (283)
T 3bhy_A 140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPF 211 (283)
T ss_dssp EESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC--------CCCCcchhhhhHHHHHHHHHHCCCCC
Confidence 9986542 699999999986655444455678999999998853 56788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
............ . ...... ...++..+.+++.+||..+|.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 212 LGETKQETLTNI-S-AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCSSHHHHHHHH-H-TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCcchHHHHHHh-H-hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 876543332222 1 122222 2467899999999999999999999999998
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=264.39 Aligned_cols=207 Identities=29% Similarity=0.510 Sum_probs=168.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++.++||||+++++++. ++..++||||+++++|.+++.... ...+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus 73 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 152 (295)
T 2clq_A 73 HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDN 152 (295)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhh
Confidence 46789999999999985 557899999999999999998642 2357799999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|+++..++.++|+|||.+....... ......++..|+|||.+.. ....++.++||||||+++|+|++|..||.
T Consensus 153 il~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 153 VLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK------GPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp EEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHH------GGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred EEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcC------CCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 9999745679999999997654322 2344578999999999853 12346889999999999999999999997
Q ss_pred CCCcHHHHH-HHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAY-AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
......... ........+..+..++.++.+++.+||..+|.+|||++++++ +.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--~~~~~ 283 (295)
T 2clq_A 227 ELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV--DEFLK 283 (295)
T ss_dssp GGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT--SGGGC
T ss_pred CCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc--Chhhh
Confidence 655433322 223344556777889999999999999999999999999987 55554
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=264.89 Aligned_cols=200 Identities=27% Similarity=0.429 Sum_probs=145.4
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++.+ +..++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 65 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 143 (278)
T 3cok_A 65 HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNL 143 (278)
T ss_dssp HTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHT-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGE
T ss_pred HHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 567899999999999854 468999999999999999986 345799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+...... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 144 li~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 144 LLTRN-MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR--------SAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp EECTT-CCEEECCCTTCEECC------------------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEcCC-CCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99955 46999999999765432 22234568899999998853 5678899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
......... ........+..++.++.+++.+||..||.+|||++++++ +.++
T Consensus 215 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~ 266 (278)
T 3cok_A 215 DTVKNTLNK--VVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD--HPFM 266 (278)
T ss_dssp CSCC-------CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT--STTT
T ss_pred hhHHHHHHH--HhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc--Cccc
Confidence 553332211 112233456778999999999999999999999999987 4444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=273.27 Aligned_cols=204 Identities=30% Similarity=0.438 Sum_probs=160.0
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CCeecC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHAN---GIIHRD 74 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~d 74 (268)
++++++||||+++++++. ++..++||||+.+++|.+++.... ...+++..++.++.|++.||+|||+. ||+|||
T Consensus 80 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~D 159 (326)
T 3uim_A 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRD 159 (326)
T ss_dssp GGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCC
T ss_pred HHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCC
Confidence 367889999999999984 557899999999999999998643 23499999999999999999999999 999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcc--cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|||+||+++.+ +.++|+|||++..... ........|++.|+|||.+.+ ..++.++||||||+++|+|++
T Consensus 160 lkp~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~ 230 (326)
T 3uim_A 160 VKAANILLDEE-FEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--------GKSSEKTDVFGYGVMLLELIT 230 (326)
T ss_dssp CSGGGEEECTT-CCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH--------SEECHHHHHHHHHHHHHHHHH
T ss_pred CchhhEEECCC-CCEEeccCccccccCcccccccccccCCcCccCHHHhcc--------CCCCccccchhHHHHHHHHHh
Confidence 99999999955 5699999999975432 222334568999999998854 557889999999999999999
Q ss_pred CCCCCCCC-----C--cHHHHHHHHHhhc----------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 153 NRLPFEGM-----S--NLQAAYAAAFKHA----------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 153 g~~p~~~~-----~--~~~~~~~~~~~~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
|..||... . ............. ....+...+..+.+++.+||+.+|.+|||+.+++++|+.
T Consensus 231 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 231 GQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp CCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred CCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 99999511 0 0011000000000 011112234779999999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=266.43 Aligned_cols=189 Identities=27% Similarity=0.398 Sum_probs=153.4
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.+||||+++++++. ++..++||||+ +++|.+++... ...+++..++.++.|++.||+|||+.||+||||||+||+++
T Consensus 114 ~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 114 GQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 48999999999985 55789999999 77999998764 35699999999999999999999999999999999999998
Q ss_pred CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 84 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
.+ +.++|+|||++.............||+.|+|||.+. ..++.++||||||+++|+|++|..++.....
T Consensus 192 ~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwslG~il~el~~g~~~~~~~~~- 260 (311)
T 3p1a_A 192 PR-GRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQ---------GSYGTAADVFSLGLTILEVACNMELPHGGEG- 260 (311)
T ss_dssp GG-GCEEECCCTTCEECC------CCCCCGGGCCGGGGG---------TCCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-
T ss_pred CC-CCEEEccceeeeecccCCCCcccCCCccccCHhHhc---------CCCCchhhHHHHHHHHHHHHhCCCCCCCccH-
Confidence 55 469999999998765555555667999999999874 3578899999999999999999776654221
Q ss_pred HHHHHHHHh-hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 164 QAAYAAAFK-HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 164 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...... ...+.++..+++++.+++.+||..+|.+|||++++++
T Consensus 261 ---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 261 ---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---HHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111111 1122334578999999999999999999999999997
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=274.17 Aligned_cols=210 Identities=20% Similarity=0.271 Sum_probs=167.1
Q ss_pred CCCCCCCcccc---------------eeeeee--cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVK---------------FLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDC 64 (268)
Q Consensus 2 l~~l~Hp~i~~---------------~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~ 64 (268)
+++++||||++ +++++. ++..++||||+ +++|.+++.......+++.+++.++.|++.||+|
T Consensus 96 l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 96 FQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp HHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHH
Confidence 34567888887 566653 46789999999 9999999987444679999999999999999999
Q ss_pred HHhCCCeecCCCCCCEEEcCCC-CceEEeccCCcccCccccc--------ccCccCccceeccccccccccccccccCCC
Q 024401 65 LHANGIIHRDLKPDNLLLTPDQ-KSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYN 135 (268)
Q Consensus 65 lH~~~i~H~dlk~~Nil~~~~~-~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 135 (268)
||+.||+||||||+||+++.++ ..++|+|||++........ .....+++.|+|||.+.+ ..++
T Consensus 175 LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~ 246 (352)
T 2jii_A 175 LHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--------CGPS 246 (352)
T ss_dssp HHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--------CCCC
T ss_pred HHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--------CCCC
Confidence 9999999999999999999654 1699999999975543221 123478999999998853 5678
Q ss_pred cccchHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHH--HhhcCCCCC------CCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 024401 136 NKVDVYSFGIVLWELLTNRLPFEGMS-NLQAAYAAA--FKHARPGLP------EDISPDLAFIVQSCWVEDPNLRPSFSQ 206 (268)
Q Consensus 136 ~~~Di~slG~i~~~ll~g~~p~~~~~-~~~~~~~~~--~~~~~~~~~------~~~~~~l~~li~~~l~~~p~~Rps~~~ 206 (268)
.++||||||+++|+|++|..||.... ......... .......+. ..++.++.+++.+||..||.+|||+++
T Consensus 247 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 326 (352)
T 2jii_A 247 RRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAM 326 (352)
T ss_dssp HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHH
Confidence 89999999999999999999998754 222222211 122222222 246899999999999999999999999
Q ss_pred HHHHHHhhhhhcCC
Q 024401 207 IIRMLNAFLFTLRP 220 (268)
Q Consensus 207 ~l~~l~~~~~~~~~ 220 (268)
+++.|+.++.....
T Consensus 327 l~~~L~~~~~~~~~ 340 (352)
T 2jii_A 327 LRNNLEALLQDLRV 340 (352)
T ss_dssp HHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHhcCC
Confidence 99999999877654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=268.32 Aligned_cols=201 Identities=27% Similarity=0.405 Sum_probs=163.2
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+.||+|+||||+||+
T Consensus 69 l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl 146 (322)
T 2ycf_A 69 LKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146 (322)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCCceEeeEEcCCceEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 457899999999999977779999999999999999875 457999999999999999999999999999999999999
Q ss_pred EcCCCC--ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 82 LTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 82 ~~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
++.++. .++|+|||++.............++..|+|||.+... ....++.++||||||+++|+|++|..||..
T Consensus 147 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 147 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSV-----GTAGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp ESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHT-----TTTTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred EecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccC-----CCCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 985432 4999999999866554434445689999999987421 135678899999999999999999999976
Q ss_pred CCcHHHHHHHHHhhcCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.................. ....++..+.+++.+||..||.+|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 222 HRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp TTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 543322222222222211 22468899999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=263.81 Aligned_cols=208 Identities=22% Similarity=0.311 Sum_probs=165.0
Q ss_pred CCCCCCCcccceeeee--ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++.++|++++..+..+ .++..++||||+ +++|.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+|
T Consensus 58 l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~N 135 (296)
T 4hgt_A 58 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135 (296)
T ss_dssp HHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 3457888877777765 355689999999 9999999975 34569999999999999999999999999999999999
Q ss_pred EEE---cCCCCceEEeccCCcccCcccc--------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 80 LLL---TPDQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 80 il~---~~~~~~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
|++ + +++.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|
T Consensus 136 Il~~~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~ 206 (296)
T 4hgt_A 136 FLMGLGK-KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLM 206 (296)
T ss_dssp EEECCGG-GTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTT--------CCCCHHHHHHHHHHHHH
T ss_pred eeeeccC-CCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcC--------CCCCchhHHHHHHHHHH
Confidence 999 5 44569999999997543322 1234578999999999864 56788999999999999
Q ss_pred HHHhCCCCCCCCCcH------HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 149 ELLTNRLPFEGMSNL------QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 149 ~ll~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
+|++|..||.+.... ..................+++++.+++.+||+.+|.+|||++++++.|+.+..+...
T Consensus 207 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 207 YFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred HHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 999999999764321 111111111111222356889999999999999999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=263.57 Aligned_cols=202 Identities=25% Similarity=0.438 Sum_probs=154.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~ 77 (268)
++.++||||+++++++. ++..++||||++ ++|.+++.. .....+++..++.++.|++.||+|||+. |++||||||
T Consensus 60 ~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp 138 (290)
T 3fme_A 60 MRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138 (290)
T ss_dssp HTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSG
T ss_pred HHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCH
Confidence 46789999999999985 557899999996 599888764 2346799999999999999999999998 999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+||+++.+ +.++|+|||++.............+++.|+|||.+... .....++.++||||||+++|+|++|..||
T Consensus 139 ~Nil~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p~ 213 (290)
T 3fme_A 139 SNVLINAL-GQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE----LNQKGYSVKSDIWSLGITMIELAILRFPY 213 (290)
T ss_dssp GGCEECTT-CCEEBCCC---------------CCCCCCSCHHHHSCC----TTC--CCHHHHHHHHHHHHHHHHHTSCSS
T ss_pred HHEEECCC-CCEEEeecCCcccccccccccccCCCccccChhhcChh----hcCcCCCcHHHHHHHHHHHHHHHHCCCCc
Confidence 99999965 46999999999866555444555789999999986320 12356788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCC-CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGL-PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..................+.. ...++.++.+++.+||+.+|.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 214 DSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 875554444444444444443 3568999999999999999999999999998
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=262.56 Aligned_cols=201 Identities=30% Similarity=0.462 Sum_probs=167.5
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++.+ +..++||||+++++|.+++... ..+++.+++.++.|++.||+|||+.|++|+||||+||
T Consensus 69 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni 146 (294)
T 2rku_A 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL 146 (294)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 467899999999999854 4689999999999999998763 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 147 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 147 FLNED-LEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK--------KGHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp EECTT-CCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT--------SCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred EEcCC-CCEEEEeccCceecccCccccccccCCCCcCCcchhcc--------CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99955 46999999999764422 22344578999999998853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
........ .........+..++..+.+++.+||..+|.+|||++++++ +.++.+
T Consensus 218 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~--~~~~~~ 271 (294)
T 2rku_A 218 SCLKETYL--RIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLN--DEFFTS 271 (294)
T ss_dssp SSHHHHHH--HHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG--SHHHHT
T ss_pred CCHHHHHH--HHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhh--Chheec
Confidence 65433322 2233445667789999999999999999999999999998 455543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=267.16 Aligned_cols=205 Identities=28% Similarity=0.491 Sum_probs=157.0
Q ss_pred CCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCC
Q 024401 4 RVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--------ANGI 70 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH--------~~~i 70 (268)
.++||||+++++++.+ ...++||||+++|+|.+++.. ..+++..++.++.|++.||+||| +.||
T Consensus 58 ~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 58 MLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp CCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred hccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 4799999999998622 358899999999999999964 56999999999999999999999 9999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCccccc-----ccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
+||||||+||+++.+ +.++|+|||++........ .....||+.|+|||.+.+... .....++.++||||||+
T Consensus 135 vH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~DvwslG~ 211 (301)
T 3q4u_A 135 AHRDLKSKNILVKKN-GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQ--VDCFDSYKRVDIWAFGL 211 (301)
T ss_dssp ECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCC--TTCHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCC-CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCC--CCcccCCchhhHHHHHH
Confidence 999999999999955 4699999999864332211 223478999999999864110 00003457899999999
Q ss_pred HHHHHHhC----------CCCCCCCCc----HHHHHHHH-HhhcCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 146 VLWELLTN----------RLPFEGMSN----LQAAYAAA-FKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 146 i~~~ll~g----------~~p~~~~~~----~~~~~~~~-~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
++|+|++| ..||..... ........ .....+..+. ..+..+.+++.+||+.||.+|||+.
T Consensus 212 il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ 291 (301)
T 3q4u_A 212 VLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291 (301)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHH
Confidence 99999999 888854322 12222111 1222333332 2557899999999999999999999
Q ss_pred HHHHHHHhh
Q 024401 206 QIIRMLNAF 214 (268)
Q Consensus 206 ~~l~~l~~~ 214 (268)
++++.|+.+
T Consensus 292 ~i~~~L~~i 300 (301)
T 3q4u_A 292 RIKKTLTKI 300 (301)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHhcc
Confidence 999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=266.62 Aligned_cols=207 Identities=26% Similarity=0.389 Sum_probs=161.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Ni 133 (311)
T 4agu_A 56 LKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI 133 (311)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhE
Confidence 45789999999999985 4578999999999999998875 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+...... .......++..|+|||.+.+ ...++.++||||||+++|+|++|..||.+
T Consensus 134 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 134 LITKH-SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVG-------DTQYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp EECTT-SCEEECCCTTCEECC------------GGGCCHHHHHT-------CSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEcCC-CCEEEeeCCCchhccCcccccCCCcCCccccChHHHhc-------CCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 99955 46999999999765432 22344578999999998853 25678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhc-------------------CCCC----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHA-------------------RPGL----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~-------------------~~~~----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
............... ..+. ...++.++.+++.+||..||.+|||++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~- 284 (311)
T 4agu_A 206 KSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH- 284 (311)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT-
T ss_pred CCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc-
Confidence 765544332211100 0000 1357888999999999999999999999998
Q ss_pred HHhhhhhcCC
Q 024401 211 LNAFLFTLRP 220 (268)
Q Consensus 211 l~~~~~~~~~ 220 (268)
+.++...+.
T Consensus 285 -hp~f~~~~~ 293 (311)
T 4agu_A 285 -HPYFENIRE 293 (311)
T ss_dssp -SGGGTTCC-
T ss_pred -ChHHHhccC
Confidence 677766544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=272.05 Aligned_cols=202 Identities=24% Similarity=0.385 Sum_probs=163.4
Q ss_pred CCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++ +||||+++++++. .+..++||||++|++|.+++... ..+++..+..++.|++.||+|||+.|++|+||||+||
T Consensus 154 ~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NI 231 (365)
T 2y7j_A 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENI 231 (365)
T ss_dssp HHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 344 7999999999985 55789999999999999999863 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||++.............|++.|+|||.+.+... .....++.++||||||+++|+|++|..||...
T Consensus 232 l~~~~-~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 308 (365)
T 2y7j_A 232 LLDDN-MQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMD--ETHPGYGKEVDLWACGVILFTLLAGSPPFWHR 308 (365)
T ss_dssp EECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTC--TTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EECCC-CCEEEEecCcccccCCCcccccCCCCCCccChhhcccccc--ccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence 99955 4699999999986655544556689999999998753110 01235788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.................. ...++..+.+++.+||..||.+|||++++++
T Consensus 309 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 309 RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp SHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 544433322222211111 1467889999999999999999999999998
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=267.47 Aligned_cols=208 Identities=26% Similarity=0.421 Sum_probs=160.1
Q ss_pred CCC-CCCcccceeeeee-------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 3 SRV-KHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+++ +||||+++++++. ++..++||||+++++|.+++.......+++..++.++.|++.||+|||+.|++|+|
T Consensus 75 ~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 154 (326)
T 2x7f_A 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 154 (326)
T ss_dssp HHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 344 7999999999984 34689999999999999999875556799999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
|||+||+++.+ +.++|+|||++...... .......++..|+|||.+.... .....++.++||||||+++|+|++|
T Consensus 155 lkp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g 230 (326)
T 2x7f_A 155 IKGQNVLLTEN-AEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDE---NPDATYDFKSDLWSLGITAIEMAEG 230 (326)
T ss_dssp CSGGGEEECTT-CCEEECCCTTTC-------------CCGGGCCHHHHC-----------CCTTHHHHHHHHHHHHHHHS
T ss_pred CcHHHEEEcCC-CCEEEeeCcCceecCcCccccccccCCccccChhhhcccc---ccCcCCCccchHHHHHHHHHHHHhC
Confidence 99999999855 46999999998764432 2233457899999999885311 1135678899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..||.....................+..++..+.+++.+||..+|.+|||++++++ +.++.
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--hp~~~ 291 (326)
T 2x7f_A 231 APPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK--HPFIR 291 (326)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT--SHHHH
T ss_pred CCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh--ChHHh
Confidence 99998776554443333333333334678999999999999999999999999998 44443
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=266.61 Aligned_cols=204 Identities=29% Similarity=0.425 Sum_probs=162.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+++++||||+++++++. ++..++||||+++++|.+++.... ...+++..++.++.|++.||+|||+.|++|+||||+|
T Consensus 84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~N 163 (307)
T 2nru_A 84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSAN 163 (307)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHH
Confidence 45789999999999985 457899999999999999997532 3569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|+++.+ +.++|+|||++...... .......|++.|+|||.+. ..++.++||||||+++|+|++|..|
T Consensus 164 ili~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---------~~~~~~~Dv~slG~il~~l~~g~~p 233 (307)
T 2nru_A 164 ILLDEA-FTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR---------GEITPKSDIYSFGVVLLEIITGLPA 233 (307)
T ss_dssp EEECTT-CCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT---------TEECTHHHHHHHHHHHHHHHHCCCS
T ss_pred EEEcCC-CcEEEeecccccccccccccccccccCCCcCcCChHHhc---------CCCCccchhHHHHHHHHHHHHCCCC
Confidence 999955 56999999998754332 1223457899999999874 3467899999999999999999999
Q ss_pred CCCCCcHH---HHHHHHH----------hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 157 FEGMSNLQ---AAYAAAF----------KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 157 ~~~~~~~~---~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
|....... ....... .......+...+..+.+++.+||..+|.+|||+.++++.|+.+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 234 VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp BCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred cccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 97644321 1111111 11112223345677999999999999999999999999998864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=267.73 Aligned_cols=203 Identities=26% Similarity=0.425 Sum_probs=164.4
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
|++++||||+++++++... ..|+||||+ +++|.+++.. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 78 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~D 153 (367)
T 1cm8_A 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 153 (367)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 5678999999999998432 369999999 8899999986 4699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||+++..... .....+|..|+|||.+.+ ...++.++|||||||++|+|++|+
T Consensus 154 lkp~NIll~~~-~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~ 223 (367)
T 1cm8_A 154 LKPGNLAVNED-CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGK 223 (367)
T ss_dssp CCGGGEEECTT-CCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cCHHHEEEcCC-CCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhC-------CCCCChhhhHHHHHHHHHHHHhCC
Confidence 99999999965 46999999999864432 334578999999998753 246788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcC-----------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHAR-----------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+.+.............. .......++.+.+|+.+||..||.+|||++
T Consensus 224 ~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~ 303 (367)
T 1cm8_A 224 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 303 (367)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHH
Confidence 999877654443322211110 112345789999999999999999999999
Q ss_pred HHHHHHHhhhhhcCC
Q 024401 206 QIIRMLNAFLFTLRP 220 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~ 220 (268)
++++ +.++.....
T Consensus 304 e~l~--hp~f~~~~~ 316 (367)
T 1cm8_A 304 EALA--HPYFESLHD 316 (367)
T ss_dssp HHHH--SGGGTTTC-
T ss_pred HHhc--ChHHHhhcC
Confidence 9998 667665544
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=267.50 Aligned_cols=211 Identities=22% Similarity=0.314 Sum_probs=166.4
Q ss_pred CCCCCCcccceeeeeec-C-------CceEEEEcCCCCCHHHHHhh--hCCCCCCHHHHHHHHHHHHHHHHHHH--hCCC
Q 024401 3 SRVKHDNLVKFLGACKD-P-------LMVIVTELLPGMSLRKYLVS--LRPNKLDLHVALNFALDIARAMDCLH--ANGI 70 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~~-~-------~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~l~~lH--~~~i 70 (268)
+.++||||+++++++.+ + ..++||||+.+ +|.+.+.. .....+++..+..++.|++.||.||| +.||
T Consensus 74 ~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~i 152 (360)
T 3e3p_A 74 AVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNV 152 (360)
T ss_dssp HHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCC
T ss_pred HhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence 45789999999998732 1 27899999965 66655543 23466999999999999999999999 9999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
+||||||+||+++..++.++|+|||++.............+++.|+|||.+.+ ...++.++||||||+++|+|
T Consensus 153 vH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el 225 (360)
T 3e3p_A 153 CHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFG-------NQHYTTAVDIWSVGCIFAEM 225 (360)
T ss_dssp BCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHHHHH
T ss_pred ecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcC-------CCCCCcHHHHHHHHHHHHHH
Confidence 99999999999996456799999999987665555556678999999998853 24578999999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHhh------------------------------cCCCCCCCCcHHHHHHHHHhhhhCCCC
Q 024401 151 LTNRLPFEGMSNLQAAYAAAFKH------------------------------ARPGLPEDISPDLAFIVQSCWVEDPNL 200 (268)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~ 200 (268)
++|..||.+.+............ .........+.++.+|+.+||+.||.+
T Consensus 226 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 305 (360)
T 3e3p_A 226 MLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEE 305 (360)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGG
T ss_pred HhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccc
Confidence 99999998766544433322111 111222336789999999999999999
Q ss_pred CCCHHHHHHHHHhhhhhcCCCCC
Q 024401 201 RPSFSQIIRMLNAFLFTLRPPSP 223 (268)
Q Consensus 201 Rps~~~~l~~l~~~~~~~~~~~~ 223 (268)
|||+.++++ +.++.+...+..
T Consensus 306 Rpt~~e~l~--hp~f~~~~~~~~ 326 (360)
T 3e3p_A 306 RMKPYEALC--HPYFDELHDPAT 326 (360)
T ss_dssp SCCHHHHTT--SGGGGGGGCTTC
T ss_pred cCCHHHHhc--CccccccCCccc
Confidence 999999998 777776655443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=262.57 Aligned_cols=203 Identities=26% Similarity=0.396 Sum_probs=163.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||++|++|.+++... ..+++.+++.++.|++.||+|||+.|++|+||||+||
T Consensus 60 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NI 137 (304)
T 2jam_A 60 LKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL 137 (304)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGC
T ss_pred HHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 45789999999999985 45689999999999999999763 4699999999999999999999999999999999999
Q ss_pred EEc--CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLT--PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~--~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
++. .+++.++|+|||++...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 138 l~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~ 208 (304)
T 2jam_A 138 LYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVITYILLCGYPPFY 208 (304)
T ss_dssp EESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS--------CSCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred EEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc--------CCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 993 24456999999998754332 2233468899999999853 567889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 159 GMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
................ .......++.++.+++.+||..||.+|||++++++ +.++..
T Consensus 209 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~--h~~~~~ 267 (304)
T 2jam_A 209 EETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS--HPWIDG 267 (304)
T ss_dssp TSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT--SHHHHS
T ss_pred CCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CccccC
Confidence 7654433222222111 22334678999999999999999999999999998 455543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=263.01 Aligned_cols=206 Identities=25% Similarity=0.420 Sum_probs=157.4
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
++||||+++++++. ++..++||||++|++|.+++... ..+++.++..++.|++.||+|||+.||+||||||+||+++
T Consensus 68 ~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE 145 (316)
T ss_dssp CCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred cCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEc
Confidence 47999999999985 55789999999999999999863 4699999999999999999999999999999999999998
Q ss_pred CCCC--ceEEeccCCcccCcccc--------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 84 PDQK--SLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 84 ~~~~--~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
.++. .++|+|||++....... ......|+..|+|||.+..... ....++.++||||||+++|+|++|
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~~~~~DiwslG~il~~l~~g 222 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE---EASIYDKRCDLWSLGVILYILLSG 222 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSH---HHHHHTTTHHHHHHHHHHHHHHHS
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccc---cccCCCcccccHhHHHHHHHHHHC
Confidence 6543 38999999987543211 1223458999999998853110 113467899999999999999999
Q ss_pred CCCCCCCCcH-------------HHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 154 RLPFEGMSNL-------------QAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 154 ~~p~~~~~~~-------------~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..||.+.... ..............++ ..++.++.+++.+||..||.+|||++++++ +.++.
T Consensus 223 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~--hp~~~ 300 (316)
T 2ac3_A 223 YPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ--HPWVQ 300 (316)
T ss_dssp SCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--STTCC
T ss_pred CCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc--Chhhc
Confidence 9999765421 1111122223333333 358899999999999999999999999998 55554
Q ss_pred h
Q 024401 217 T 217 (268)
Q Consensus 217 ~ 217 (268)
.
T Consensus 301 ~ 301 (316)
T 2ac3_A 301 G 301 (316)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=261.61 Aligned_cols=202 Identities=27% Similarity=0.452 Sum_probs=163.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. .+..++||||+.+++|.+++... ..+++.+++.++.|++.||+|||+.|++|+||||+||
T Consensus 75 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI 152 (287)
T 2wei_A 75 LKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI 152 (287)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhE
Confidence 46789999999999985 45689999999999999998763 4699999999999999999999999999999999999
Q ss_pred EEcCCC--CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQ--KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~--~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.++ ..++|+|||++.............++..|+|||.+. ..++.++||||||+++|+|++|..||.
T Consensus 153 lv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLR---------GTYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp EESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHT---------TCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred EEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhc---------CCCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 997543 369999999987655444334456788999999875 347889999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
+...................+ ..++.++.+++.+||..+|.+|||+.++++ +.++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~--hp~~~ 281 (287)
T 2wei_A 224 GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE--HPWIQ 281 (287)
T ss_dssp CSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH--SHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc--CHHHh
Confidence 766543332222222222222 468999999999999999999999999998 44443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=264.65 Aligned_cols=203 Identities=27% Similarity=0.500 Sum_probs=158.7
Q ss_pred CCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CC
Q 024401 4 RVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN--------GI 70 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~--------~i 70 (268)
.++||||+++++++.+ ...++||||+++++|.+++.. ..+++..++.++.|++.||+|||+. ||
T Consensus 87 ~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp TCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred hhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 4699999999999743 468999999999999999976 4699999999999999999999999 99
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCccccc-----ccCccCccceeccccccccccccccccCCCc------ccc
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNN------KVD 139 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~------~~D 139 (268)
+||||||+||+++.+ +.++|+|||++........ .....|++.|+|||.+.+ ..... ++|
T Consensus 164 vH~Dikp~Nill~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~~~~~~~D 234 (337)
T 3mdy_A 164 AHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE--------SLNRNHFQSYIMAD 234 (337)
T ss_dssp ECSCCCGGGEEECTT-SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT--------CCCTTCTHHHHHHH
T ss_pred EecccchHHEEECCC-CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc--------ccCCccccCccccc
Confidence 999999999999955 4699999999965433221 224578999999998854 22233 489
Q ss_pred hHHHHHHHHHHHhC----------CCCCCCCCc----HHHHHHH-HHhhcCCCCCC-----CCcHHHHHHHHHhhhhCCC
Q 024401 140 VYSFGIVLWELLTN----------RLPFEGMSN----LQAAYAA-AFKHARPGLPE-----DISPDLAFIVQSCWVEDPN 199 (268)
Q Consensus 140 i~slG~i~~~ll~g----------~~p~~~~~~----~~~~~~~-~~~~~~~~~~~-----~~~~~l~~li~~~l~~~p~ 199 (268)
||||||++|+|++| ..||..... ....... ......+..+. .++.++.+++.+||+.||.
T Consensus 235 iwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 314 (337)
T 3mdy_A 235 MYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPA 314 (337)
T ss_dssp HHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGG
T ss_pred hHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChh
Confidence 99999999999999 677754321 1111111 12223333332 4567799999999999999
Q ss_pred CCCCHHHHHHHHHhhhhhc
Q 024401 200 LRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 200 ~Rps~~~~l~~l~~~~~~~ 218 (268)
+|||+.++++.|+.+..+.
T Consensus 315 ~Rps~~ell~~L~~l~~~~ 333 (337)
T 3mdy_A 315 SRLTALRVKKTLAKMSESQ 333 (337)
T ss_dssp GSCCHHHHHHHHHHHHHTT
T ss_pred hCCCHHHHHHHHHHHHhhc
Confidence 9999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=269.08 Aligned_cols=195 Identities=26% Similarity=0.361 Sum_probs=156.9
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.+.||||+++++++. .+..++||||+ +++|.+++.......+++.++..++.||+.||+|||+.||+||||||+|||+
T Consensus 92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 170 (360)
T 3llt_A 92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILL 170 (360)
T ss_dssp STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEE
Confidence 346999999999984 55789999999 9999999987665679999999999999999999999999999999999999
Q ss_pred cC------------------------CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCccc
Q 024401 83 TP------------------------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKV 138 (268)
Q Consensus 83 ~~------------------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~ 138 (268)
+. ....++|+|||++...... .....|++.|+|||.+.+ ..++.++
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~ 240 (360)
T 3llt_A 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILN--------LGWDVSS 240 (360)
T ss_dssp SCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTT--------CCCCTTH
T ss_pred ccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcC--------CCCCCcc
Confidence 74 2456999999999754332 234578999999999864 5688999
Q ss_pred chHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCC------------------------CCC---------------
Q 024401 139 DVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP------------------------GLP--------------- 179 (268)
Q Consensus 139 Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------------------~~~--------------- 179 (268)
|||||||++|+|++|+.||...+............... .++
T Consensus 241 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 320 (360)
T 3llt_A 241 DMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKC 320 (360)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTC
T ss_pred chHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhc
Confidence 99999999999999999998766543332221110000 000
Q ss_pred -----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 180 -----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 180 -----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
...++.+.+|+.+||+.||.+|||++++++
T Consensus 321 ~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 321 LPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 112367889999999999999999999987
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=262.62 Aligned_cols=196 Identities=30% Similarity=0.478 Sum_probs=166.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 74 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 150 (303)
T 3a7i_A 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV 150 (303)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheE
Confidence 45789999999999984 5578999999999999999975 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 151 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 151 LLSEH-GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ--------SAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp EECTT-SCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EECCC-CCEEEeecccceecCccccccCccCCCcCccCHHHHhc--------CCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 99855 469999999997654332 2344578999999999853 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
....... ........+..+..++..+.+++.+||..+|.+|||+.+++++
T Consensus 222 ~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 222 LHPMKVL-FLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp SCHHHHH-HHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred cCHHHHH-HHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 6554333 3334455566777899999999999999999999999999983
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=269.28 Aligned_cols=176 Identities=30% Similarity=0.457 Sum_probs=136.9
Q ss_pred ceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccC
Q 024401 22 MVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 22 ~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
.++||||++|++|.+++..... ...++..++.++.|++.||+|||+.||+||||||+||+++.+ +.++|+|||++...
T Consensus 136 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~-~~~kL~DfG~a~~~ 214 (332)
T 3qd2_B 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD-DVVKVGDFGLVTAM 214 (332)
T ss_dssp EEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTT-CCEEECCCTTCEEC
T ss_pred EEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCC-CCEEEeecCccccc
Confidence 7899999999999999986332 336677899999999999999999999999999999999955 46999999999755
Q ss_pred cccc-------------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 024401 101 TVTE-------------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 167 (268)
Q Consensus 101 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~ 167 (268)
.... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|..|+.. .....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~~~~~~~~---~~~~~ 283 (332)
T 3qd2_B 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG--------NNYSHKVDIFSLGLILFELLYSFSTQME---RVRII 283 (332)
T ss_dssp SCC--------------CCCSCC-CGGGSCHHHHHC--------CCCCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHH
T ss_pred ccchhhccccccccccccccccCCCcCccChHHhcC--------CCCcchhhHHHHHHHHHHHHHcCCChhH---HHHHH
Confidence 4321 1233468999999999854 5678999999999999999998766421 11111
Q ss_pred HHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 168 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
........+......++++.+++.+||+.||.+|||++++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 284 TDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 222222222222345678899999999999999999999997
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-39 Score=267.79 Aligned_cols=207 Identities=28% Similarity=0.488 Sum_probs=167.1
Q ss_pred CCCCCCCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 2 MSRVKHDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
|++++||||+++++++.+ ...++||||+++++|.+++... ...+++.+++.++.|++.||+|||+.||+|+||||+
T Consensus 96 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~ 174 (326)
T 2w1i_A 96 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATR 174 (326)
T ss_dssp HHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred HHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcc
Confidence 567899999999998732 3689999999999999999863 356999999999999999999999999999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||+++.+ +.++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 175 NIli~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~tg~ 245 (326)
T 2w1i_A 175 NILVENE-NRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE--------SKFSVASDVWSFGVVLYELFTYI 245 (326)
T ss_dssp GEEEEET-TEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEcCC-CcEEEecCcchhhccccccccccccCCCCceeEECchhhcC--------CCCCchhhHHHHHHHHHHHHhcC
Confidence 9999955 5699999999975443221 223456778999998854 45678999999999999999999
Q ss_pred CCCCCCCcH-----------H----HHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 155 LPFEGMSNL-----------Q----AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 155 ~p~~~~~~~-----------~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.||...... . ............+.+..++.++.+++.+||..+|.+|||+.++++.|+.+...+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 246 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp CGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 887532100 0 111222334455667889999999999999999999999999999999887653
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=267.83 Aligned_cols=215 Identities=25% Similarity=0.432 Sum_probs=159.9
Q ss_pred CCCCCCCcccceeeeee------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-------
Q 024401 2 MSRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN------- 68 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~------- 68 (268)
++.++||||+++++.+. ....++||||+++|+|.+++.. ...++..++.++.|++.||+|||+.
T Consensus 61 ~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~ 137 (336)
T 3g2f_A 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHY 137 (336)
T ss_dssp STTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGC
T ss_pred HHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhcccccc
Confidence 45689999999998541 1246899999999999999976 3468999999999999999999999
Q ss_pred --CCeecCCCCCCEEEcCCCCceEEeccCCcccCccc---------ccccCccCccceeccccccccccccccccCCCcc
Q 024401 69 --GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNK 137 (268)
Q Consensus 69 --~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~---------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~ 137 (268)
||+||||||+||+++.+ +.++|+|||++...... .......||+.|+|||.+.+... ......++.+
T Consensus 138 ~~~ivH~Dikp~Nill~~~-~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~~~~ 215 (336)
T 3g2f_A 138 KPAISHRDLNSRNVLVKND-GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVN-LRDXESALKQ 215 (336)
T ss_dssp BCCEECSSCSGGGEEECTT-SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCC-GGGHHHHHHH
T ss_pred ccceeecccccceEEEcCC-CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcc-cccccccccc
Confidence 99999999999999965 46999999999754321 11224468999999998854110 0011345678
Q ss_pred cchHHHHHHHHHHHhCCCCCCCCCc-----------------HHHHHH-HHHhhcCCCCCCC------CcHHHHHHHHHh
Q 024401 138 VDVYSFGIVLWELLTNRLPFEGMSN-----------------LQAAYA-AAFKHARPGLPED------ISPDLAFIVQSC 193 (268)
Q Consensus 138 ~Di~slG~i~~~ll~g~~p~~~~~~-----------------~~~~~~-~~~~~~~~~~~~~------~~~~l~~li~~~ 193 (268)
+|||||||++|+|++|..||..... ...... .......+.++.. +++.+.+++.+|
T Consensus 216 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 295 (336)
T 3g2f_A 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295 (336)
T ss_dssp HHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHH
Confidence 9999999999999999766532211 111111 1112223344433 345799999999
Q ss_pred hhhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 194 WVEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 194 l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
|..||.+|||+.++++.|+.++......
T Consensus 296 l~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 296 WDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp SCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred hcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 9999999999999999999988665543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=268.77 Aligned_cols=203 Identities=25% Similarity=0.451 Sum_probs=161.7
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPD 78 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~ 78 (268)
+|++++||||+++++++. ++..++||||++|++|.+++... ..+++..+..++.|++.||+|||+. ||+|+||||+
T Consensus 84 ~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~ 161 (360)
T 3eqc_A 84 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161 (360)
T ss_dssp GGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGG
T ss_pred HHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHH
Confidence 367889999999999984 55789999999999999999863 4699999999999999999999996 9999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||+++.+ +.++|+|||++...... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.
T Consensus 162 Nil~~~~-~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~pf~ 231 (360)
T 3eqc_A 162 NILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIP 231 (360)
T ss_dssp GEEECTT-CCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTT--------CCCSHHHHHHHHHHHHHHHHHTSCCSS
T ss_pred HEEECCC-CCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcC--------CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999966 45999999998644222 2234578999999999854 567889999999999999999999997
Q ss_pred CCCcHHHHH-----------------------------------------HHHHhhcCCCCC-CCCcHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAY-----------------------------------------AAAFKHARPGLP-EDISPDLAFIVQSCWVE 196 (268)
Q Consensus 159 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~~-~~~~~~l~~li~~~l~~ 196 (268)
..+...... ........+..+ ..++.++.+|+.+||..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 311 (360)
T 3eqc_A 232 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 311 (360)
T ss_dssp CCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCS
T ss_pred CCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhc
Confidence 655322111 111112222222 34789999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhhh
Q 024401 197 DPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 197 ~p~~Rps~~~~l~~l~~~~~~ 217 (268)
||.+|||++++++ +.++..
T Consensus 312 dP~~Rpt~~ell~--hp~~~~ 330 (360)
T 3eqc_A 312 NPAERADLKQLMV--HAFIKR 330 (360)
T ss_dssp STTTSCCHHHHHT--SHHHHH
T ss_pred ChhhCCCHHHHhh--ChHhhc
Confidence 9999999999998 455443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=286.76 Aligned_cols=191 Identities=26% Similarity=0.424 Sum_probs=163.4
Q ss_pred CCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
+||||+++++++.+ +.+|+||||++||+|.+++... ..+++..+..|+.||+.||+|||+.||+||||||+|||++.
T Consensus 400 ~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~ 477 (674)
T 3pfq_A 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDS 477 (674)
T ss_dssp CCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECS
T ss_pred CCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcC
Confidence 79999999999864 5789999999999999999864 46999999999999999999999999999999999999996
Q ss_pred CCCceEEeccCCcccCc-ccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 85 DQKSLKLADFGLAREET-VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
+ +.++|+|||+++... .........||+.|+|||.+.. ..++.++|+||||+++|||++|..||.+.+..
T Consensus 478 ~-g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~ 548 (674)
T 3pfq_A 478 E-GHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY--------QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548 (674)
T ss_dssp S-SCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC--------CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred C-CcEEEeecceeeccccCCcccccccCCCcccCHhhhcC--------CCCCccceEechHHHHHHHHcCCCCCCCCCHH
Confidence 6 469999999998533 2333456689999999999854 67899999999999999999999999876543
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCH-----HHHHH
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSF-----SQIIR 209 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~-----~~~l~ 209 (268)
+.. .. .......++..++.++.+||.+||..||.+|+++ +++++
T Consensus 549 ~~~-~~-i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 549 ELF-QS-IMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp HHH-HH-HHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred HHH-HH-HHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 333 22 3345567788999999999999999999999987 77766
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=260.90 Aligned_cols=190 Identities=19% Similarity=0.332 Sum_probs=158.3
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--PNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
+||||+++++++. ++..++||||++|++|.+++.... ...+++.+++.++.|++.||+|||+.||+|+||||+||++
T Consensus 69 ~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~ 148 (289)
T 1x8b_A 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFI 148 (289)
T ss_dssp SCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred CCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEE
Confidence 8999999999984 567899999999999999997632 2569999999999999999999999999999999999999
Q ss_pred cCC------------------CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 83 TPD------------------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 83 ~~~------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
+.+ ...++|+|||.+...... ....++..|+|||.+.+ ...++.++||||||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG 218 (289)
T 1x8b_A 149 SRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQE-------NYTHLPKADIFALA 218 (289)
T ss_dssp C--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTT-------CCTTHHHHHHHHHH
T ss_pred cCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcC-------CCCCCchhhHHHHH
Confidence 843 235899999998765432 23358999999998853 23556799999999
Q ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 145 IVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+++|+|++|..++.... ..........+..+..++.++.+++.+||..||.+|||+.++++
T Consensus 219 ~il~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 219 LTVVCAAGAEPLPRNGD----QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp HHHHHHTTCCCCCSSSH----HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHhcCCCCCcchh----HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 99999999987765432 22334455666778889999999999999999999999999987
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=268.81 Aligned_cols=198 Identities=26% Similarity=0.399 Sum_probs=161.2
Q ss_pred CCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++ +||||+++++++. ++..++||||+++++|.+++... ..+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 113 ~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI 190 (355)
T 1vzo_A 113 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 190 (355)
T ss_dssp HHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 345 6999999999984 55789999999999999999863 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc--ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT--EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.++|+|||++...... .......||+.|+|||.+.+ ....++.++|||||||++|+|++|..||.
T Consensus 191 ll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~~DvwslG~il~ell~g~~pf~ 263 (355)
T 1vzo_A 191 LLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPFT 263 (355)
T ss_dssp EECTT-SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred EECCC-CcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcC------CCCCCCchhhHHHHHHHHHHHHHCCCCCc
Confidence 99965 46999999999754332 22334578999999999853 22456789999999999999999999997
Q ss_pred CCCc--HHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 159 GMSN--LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 159 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.... .............+..+..++..+.+++.+||..||.+|| +++++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 264 VDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp CTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred cCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 4332 1222222334456677788999999999999999999999 8999988
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=264.72 Aligned_cols=203 Identities=20% Similarity=0.332 Sum_probs=163.1
Q ss_pred CCCCC-CCcccceeeeeec---CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVK-HDNLVKFLGACKD---PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
|++++ ||||+++++++.+ ...++||||+.+++|.+++.. +++.++..++.|++.||+|||+.||+||||||
T Consensus 84 l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 158 (330)
T 3nsz_A 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 158 (330)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 34565 9999999999854 468999999999999999864 89999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+||+++.++..++|+|||++.............++..|+|||.+.+ ...++.++|||||||++|+|++|..||
T Consensus 159 ~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 159 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred HHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcC-------CCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999997766899999999986655555556678999999998753 256788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHh------------hcC------------------------CCCCCCCcHHHHHHHHHhhhhCCCCC
Q 024401 158 EGMSNLQAAYAAAFK------------HAR------------------------PGLPEDISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~------------~~~------------------------~~~~~~~~~~l~~li~~~l~~~p~~R 201 (268)
............... ... ...+..++.++.+|+.+||..||.+|
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 311 (330)
T 3nsz_A 232 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311 (330)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGS
T ss_pred ccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccC
Confidence 654433222211110 000 11112378999999999999999999
Q ss_pred CCHHHHHHHHHhhhhhc
Q 024401 202 PSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 202 ps~~~~l~~l~~~~~~~ 218 (268)
||++++++ +.++...
T Consensus 312 pta~e~l~--hp~f~~~ 326 (330)
T 3nsz_A 312 LTAREAME--HPYFYTV 326 (330)
T ss_dssp CCHHHHHT--SGGGTTC
T ss_pred CCHHHHhc--CccHhhh
Confidence 99999998 5665543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=263.45 Aligned_cols=200 Identities=28% Similarity=0.396 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----Ce
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANG-----II 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~-----i~ 71 (268)
+++++||||+++++++. ++..++||||+++++|.+++... ....+++..++.++.|++.||+|||+.| ++
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv 138 (279)
T 2w5a_A 59 LRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL 138 (279)
T ss_dssp HHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------C
T ss_pred HHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE
Confidence 45789999999999872 45689999999999999999763 2345999999999999999999999999 99
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWEL 150 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~l 150 (268)
|+||||+||+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++||||||+++|+|
T Consensus 139 H~dl~p~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l 209 (279)
T 2w5a_A 139 HRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYEL 209 (279)
T ss_dssp CCCCSGGGEEECSS-SCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHC--------C-CCHHHHHHHHHHHHHHH
T ss_pred EeccchhhEEEcCC-CCEEEecCchheeeccccccccccCCCccccChHHhcc--------CCCCchhhHHHHHHHHHHH
Confidence 99999999999955 469999999987544322 1233468899999998854 5678899999999999999
Q ss_pred HhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 151 LTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 151 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
++|..||...+.. ..............+..++.++.+++.+||..+|.+|||+.++++.+
T Consensus 210 ~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 210 CALMPPFTAFSQK-ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HHSSCSSCCSSHH-HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred HHCCCCCcccCHH-HHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 9999999876543 33344445555677788999999999999999999999999999843
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=262.00 Aligned_cols=203 Identities=28% Similarity=0.432 Sum_probs=166.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++.. ....+++.+++.++.|++.||+|||+.|++|+||+|+||
T Consensus 78 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Ni 156 (314)
T 3com_A 78 MQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL-RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156 (314)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHE
Confidence 46789999999999984 5678999999999999999974 246799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||.+....... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||..
T Consensus 157 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 157 LLNTE-GHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE--------IGYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp EECTT-CCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSS--------SCBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EECCC-CCEEEeecccchhhhhhccccCccCCCCCccChhhcCC--------CCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 99965 469999999997544322 2344578999999998854 5678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.......... .....+ ..+..++..+.+++.+||..+|.+|||+.++++ +.++..
T Consensus 228 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~--~~~~~~ 284 (314)
T 3com_A 228 IHPMRAIFMI-PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ--HPFVRS 284 (314)
T ss_dssp SCHHHHHHHH-HHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT--SHHHHT
T ss_pred CChHHHHHHH-hcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh--CHHHhc
Confidence 6654443322 222222 234567899999999999999999999999998 455543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=260.19 Aligned_cols=198 Identities=28% Similarity=0.415 Sum_probs=160.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+.|++|+||||+||
T Consensus 59 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 136 (276)
T 2yex_A 59 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 136 (276)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHE
Confidence 45789999999999985 4568999999999999999865 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.+ +.++|+|||.+...... .......++..|+|||.+.+ ....+.++||||||+++|+|++|..||
T Consensus 137 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~p~ 208 (276)
T 2yex_A 137 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPW 208 (276)
T ss_dssp EECTT-CCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTC-------SSBCHHHHHHHHHHHHHHHHHHSSCCC
T ss_pred EEccC-CCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhc-------CCCCCCcchHHHHHHHHHHHHhCCCCC
Confidence 99955 46999999998754322 22344578999999998853 123467899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
................. .......++..+.+++.+||..||.+|||++++++
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 209 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp SCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 87654333332222221 12223468999999999999999999999999987
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-39 Score=266.28 Aligned_cols=208 Identities=24% Similarity=0.360 Sum_probs=161.9
Q ss_pred CCCCCCCcccceeeeee-----cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
++.++||||+++++++. ....++||||+.+++|.+++... ....+++.+++.++.|++.||+|||+.||+|+|
T Consensus 80 l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~d 159 (317)
T 2buj_A 80 HRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRD 159 (317)
T ss_dssp HHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 46789999999999873 22688999999999999999763 345699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCccccc----------ccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEM----------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
|||+||+++.+ +.++|+|||.+........ .....++..|+|||.+... ....++.++||||||
T Consensus 160 lkp~NIl~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~~~Di~slG 233 (317)
T 2buj_A 160 LKPTNILLGDE-GQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQ-----SHCVIDERTDVWSLG 233 (317)
T ss_dssp CCGGGEEECTT-SCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCC-----SEEEECTHHHHHHHH
T ss_pred CCHHHEEEcCC-CCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccC-----CCcCCCchhhHHHHH
Confidence 99999999855 4599999998875432111 1223578999999988531 112367899999999
Q ss_pred HHHHHHHhCCCCCCCCCcH-HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 145 IVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
+++|+|++|..||...... .............+.+..++.++.+++.+||..+|.+|||+.++++.|+.+.
T Consensus 234 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 234 CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp HHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred HHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 9999999999998531100 0111112222233444678999999999999999999999999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=270.50 Aligned_cols=202 Identities=26% Similarity=0.358 Sum_probs=161.8
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
...||||+++++.+. .+..++||||+. ++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||+
T Consensus 155 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl 233 (429)
T 3kvw_A 155 KDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL 233 (429)
T ss_dssp TTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE
T ss_pred ccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 357899999999985 567899999994 699999988666679999999999999999999999999999999999999
Q ss_pred cCCCC-ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 83 TPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 83 ~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
+.++. .++|+|||++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 234 ~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 234 KQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILG--------ARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHT--------BCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhC--------CCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 96543 3999999999654322 334578999999999864 567899999999999999999999998776
Q ss_pred cHHHHHHHHHhhcCCC---------------------------------------------------------CCCCCcH
Q 024401 162 NLQAAYAAAFKHARPG---------------------------------------------------------LPEDISP 184 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~---------------------------------------------------------~~~~~~~ 184 (268)
..............+. ++...++
T Consensus 304 ~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 383 (429)
T 3kvw_A 304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDP 383 (429)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCH
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchH
Confidence 5444332221100000 1123478
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 185 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 185 ~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.+.+|+.+||..||.+|||++++++ +.|+...
T Consensus 384 ~~~dli~~~L~~dP~~Rpta~e~L~--Hpw~~~~ 415 (429)
T 3kvw_A 384 LFLDFLKQCLEWDPAVRMTPGQALR--HPWLRRR 415 (429)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHT--STTTC--
T ss_pred HHHHHHHHHCCCChhhCCCHHHHhC--ChhhccC
Confidence 8999999999999999999999998 6666543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=260.92 Aligned_cols=206 Identities=27% Similarity=0.493 Sum_probs=161.3
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL------RPNKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~------~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
++++++||||+++++++. ++..++||||++|++|.+++... ....+++..++.++.|++.||+|||+.|++|+
T Consensus 66 ~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 145 (303)
T 2vwi_A 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHR 145 (303)
T ss_dssp CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCC
Confidence 467889999999999984 55789999999999999999741 23569999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCccc------ccccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVT------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
||||+||+++.+ +.++|+|||.+...... .......+++.|+|||.+.. ...++.++||||||+++
T Consensus 146 dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il 217 (303)
T 2vwi_A 146 DVKAGNILLGED-GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ-------VRGYDFKADIWSFGITA 217 (303)
T ss_dssp CCSGGGEEECTT-CCEEECCCHHHHHCC---------------CCCTTCCHHHHHH-------HHCCCTHHHHHHHHHHH
T ss_pred CCChhhEEEcCC-CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhcc-------ccCCCchhhHHHHHHHH
Confidence 999999999965 46999999988644322 11233468899999998753 13578899999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHhhcCC---------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 148 WELLTNRLPFEGMSNLQAAYAAAFKHARP---------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 148 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
|+|++|..||............. ....+ .....++.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 218 ~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 293 (303)
T 2vwi_A 218 IELATGAAPYHKYPPMKVLMLTL-QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR--HKFFQK 293 (303)
T ss_dssp HHHHHSSCTTTTSCGGGHHHHHH-TSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT--STTC--
T ss_pred HHHHhCCCCCccCchhhHHHHHh-ccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh--Chhhhc
Confidence 99999999998766544433222 22111 223567899999999999999999999999998 444443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=279.51 Aligned_cols=215 Identities=26% Similarity=0.412 Sum_probs=166.3
Q ss_pred CCCCCCCcccceeeeeecC---CceEEEEcCCCCCHHHHHhhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRP-NKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
|++++||||+++++++.+. ..++||||++|++|.+++..... ..+++.+++.++.|++.||+|||+.||+||||||
T Consensus 61 l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 140 (396)
T 4eut_A 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP 140 (396)
T ss_dssp HHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred HHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCH
Confidence 4678999999999998432 57999999999999999976332 3499999999999999999999999999999999
Q ss_pred CCEEE----cCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 78 DNLLL----TPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 78 ~Nil~----~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
+||++ + +...++|+|||++.............|+..|+|||.+............++.++|||||||++|+|++|
T Consensus 141 ~NIll~~~~~-~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg 219 (396)
T 4eut_A 141 GNIMRVIGED-GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219 (396)
T ss_dssp GGEEEEECTT-SCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHEEEeecCC-CceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHC
Confidence 99998 4 334699999999987665555556679999999998753211111124567899999999999999999
Q ss_pred CCCCCCCCc---HHHHHHHHHhhcCCC------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 024401 154 RLPFEGMSN---LQAAYAAAFKHARPG------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206 (268)
Q Consensus 154 ~~p~~~~~~---~~~~~~~~~~~~~~~------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 206 (268)
..||..... .............+. ++..++..+.+++.+||..||++||++.+
T Consensus 220 ~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 220 SLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp SCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred CCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 999964322 222222232222111 11234567899999999999999999999
Q ss_pred HHHHHHhhhhh
Q 024401 207 IIRMLNAFLFT 217 (268)
Q Consensus 207 ~l~~l~~~~~~ 217 (268)
+++.+..++..
T Consensus 300 ~l~~l~~il~~ 310 (396)
T 4eut_A 300 FFAETSDILHR 310 (396)
T ss_dssp HHHHHHHHHTC
T ss_pred HHHHHHHHhhc
Confidence 99999887643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=276.46 Aligned_cols=198 Identities=27% Similarity=0.435 Sum_probs=152.4
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
|+.++||||+++++++.+. ..|+||||+++ +|.+.+.. .+++..+..++.|++.||+|||+.||+|||
T Consensus 115 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrD 189 (464)
T 3ttj_A 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 189 (464)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 5678999999999998432 36999999965 67776643 499999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+|||++.+ +.+||+|||+++............||+.|+|||.+.+ ..++.++|||||||++|+|++|+
T Consensus 190 lkp~NIll~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ell~g~ 260 (464)
T 3ttj_A 190 LKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHK 260 (464)
T ss_dssp CCGGGEEECTT-SCEEECCCCCC-----CCCC----CCCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CChHhEEEeCC-CCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcC--------CCCCHHHHHHHHHHHHHHHHhCC
Confidence 99999999965 4699999999987655544556689999999999864 56889999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhc--------------------CCCCCC---------C-----------CcHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQAAYAAAFKHA--------------------RPGLPE---------D-----------ISPDLAFIVQSCW 194 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~--------------------~~~~~~---------~-----------~~~~l~~li~~~l 194 (268)
.||.+.+............. .+.... . .+.++.+|+.+||
T Consensus 261 ~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL 340 (464)
T 3ttj_A 261 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 340 (464)
T ss_dssp CSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHc
Confidence 99988765544333221111 010000 0 1567999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhh
Q 024401 195 VEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~~l~~~~ 215 (268)
..||.+|||++++++ +.++
T Consensus 341 ~~dP~~R~ta~e~L~--Hp~~ 359 (464)
T 3ttj_A 341 VIDPAKRISVDDALQ--HPYI 359 (464)
T ss_dssp CSSTTTSCCHHHHHT--STTT
T ss_pred CCChhhCCCHHHHhc--Chhh
Confidence 999999999999998 4444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=260.96 Aligned_cols=208 Identities=24% Similarity=0.383 Sum_probs=166.2
Q ss_pred CCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++ +||||+++++++. ++..++||||+++++|.+++... ..+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus 78 ~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 155 (298)
T 1phk_A 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENI 155 (298)
T ss_dssp HHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceE
Confidence 345 4999999999985 45689999999999999999863 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|+|||.+.............++..|+|||.+.+... .....++.++||||||+++|+|++|..||...
T Consensus 156 l~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 156 LLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp EECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred EEcCC-CcEEEecccchhhcCCCcccccccCCccccCHHHhccccc--cccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 99965 4599999999986655444555678999999998753110 11245788999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 161 SNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.................. ...++..+.+++.+||..+|.+|||+.++++ +.++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~~ 289 (298)
T 1phk_A 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA--HPFFQQ 289 (298)
T ss_dssp SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT--SGGGCT
T ss_pred cHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh--ChHhhh
Confidence 654433322222222211 2458899999999999999999999999987 555543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-38 Score=265.27 Aligned_cols=203 Identities=25% Similarity=0.445 Sum_probs=157.6
Q ss_pred CCCCC--Ccccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 3 SRVKH--DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 3 ~~l~H--p~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++| |||+++++++. ++..++|||+ .+++|.+++.. ...+++.++..++.|++.||+|||+.||+||||||+|
T Consensus 62 ~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~N 138 (343)
T 3dbq_A 62 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 138 (343)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcce
Confidence 45555 99999999985 5578999995 48899999986 3569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc---ccCccCccceecccccccccccc---ccccCCCcccchHHHHHHHHHHHhC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM---MTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~---~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
||++ + +.++|+|||++........ .....|++.|+|||.+.+..... .....++.++||||||+++|+|++|
T Consensus 139 Ill~-~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g 216 (343)
T 3dbq_A 139 FLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 216 (343)
T ss_dssp EEEE-T-TEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHS
T ss_pred EEEE-C-CcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence 9997 3 4599999999986543221 23457899999999985321110 0125678899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHH-HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAA-FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~ 210 (268)
..||............. .......++...+.++.+++.+||..||.+|||+.+++++
T Consensus 217 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 217 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp SCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 99998765543333332 3344556677788999999999999999999999999983
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=268.71 Aligned_cols=202 Identities=24% Similarity=0.457 Sum_probs=157.2
Q ss_pred CCCC--CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 3 SRVK--HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 3 ~~l~--Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++ ||||+++++++. ++..++|||+ .+++|.+++.. ...+++.++..++.||+.||+|||+.||+||||||+|
T Consensus 109 ~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~N 185 (390)
T 2zmd_A 109 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 185 (390)
T ss_dssp HHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGG
T ss_pred HHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHH
Confidence 3454 699999999884 5578999995 58899999986 3468999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc---cccCccCccceecccccccccccc---ccccCCCcccchHHHHHHHHHHHhC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~---~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
||++ + +.++|+|||++....... ......||+.|+|||.+.+..... .....++.++|||||||++|+|++|
T Consensus 186 Ill~-~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G 263 (390)
T 2zmd_A 186 FLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263 (390)
T ss_dssp EEES-S-SCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHS
T ss_pred EEEE-C-CeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHC
Confidence 9996 3 469999999998654322 223457999999999885421100 0124678899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHH-hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
..||.............. ......++...+.++.+++.+||..||.+|||+.++++
T Consensus 264 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 264 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp SCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 999987654433333332 33444566777899999999999999999999999998
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=266.66 Aligned_cols=203 Identities=23% Similarity=0.390 Sum_probs=165.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHH------HhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeec
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKY------LVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHR 73 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~ 73 (268)
+++++||||+++++++. ++..++||||+++++|.++ +.......+++..++.++.|++.||+|||+ .|++|+
T Consensus 97 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~ 176 (348)
T 2pml_X 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHR 176 (348)
T ss_dssp HTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECC
T ss_pred HHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeec
Confidence 57889999999999985 4578999999999999998 654335779999999999999999999999 999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCc-ccchHHHHHHHHHHHh
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNN-KVDVYSFGIVLWELLT 152 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~-~~Di~slG~i~~~ll~ 152 (268)
||+|+||+++.+ +.++|+|||.+...... ......++..|+|||.+.+ ...++. ++||||||+++|+|++
T Consensus 177 dl~p~Nil~~~~-~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-------~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 177 DVKPSNILMDKN-GRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSN-------ESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp CCCGGGEEECTT-SCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSS-------CCCEEHHHHHHHHHHHHHHHHHH
T ss_pred CCChHhEEEcCC-CcEEEeccccccccccc-cccCCCCCcCccCchhhcC-------CCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999965 46999999999765433 3345678999999999863 113444 8999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCC-------------------CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHARPGLP-------------------EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
|..||.............. ......+ ..++.++.+++.+||..||.+|||++++++ +.
T Consensus 248 g~~pf~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~--hp 324 (348)
T 2pml_X 248 NVVPFSLKISLVELFNNIR-TKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK--HE 324 (348)
T ss_dssp SSCSSCCSSCSHHHHHHHT-SCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT--SG
T ss_pred CCCCCCCCCcHHHHHHHHh-ccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc--Cc
Confidence 9999987766344333332 2233333 568999999999999999999999999998 44
Q ss_pred hhh
Q 024401 214 FLF 216 (268)
Q Consensus 214 ~~~ 216 (268)
++.
T Consensus 325 ~f~ 327 (348)
T 2pml_X 325 WLA 327 (348)
T ss_dssp GGT
T ss_pred ccc
Confidence 443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=261.67 Aligned_cols=207 Identities=29% Similarity=0.461 Sum_probs=161.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus 70 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 148 (302)
T 2j7t_A 70 LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNV 148 (302)
T ss_dssp HHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred HhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHE
Confidence 45689999999999984 55789999999999999998763 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+.... .....++.++||||||+++|+|++|..||..
T Consensus 149 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 149 LMTLE-GDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCET---MKDTPYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp EECTT-SCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHH---TTSTTTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EECCC-CCEEEEECCCCccccccccccccccCChhhcCCeeecccc---CCCCCCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 99955 45999999987533221 2223457899999999874210 0135678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+......... ....+ ..+..++..+.+++.+||..+|.+|||+.++++ +.++.
T Consensus 225 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~--h~~~~ 280 (302)
T 2j7t_A 225 LNPMRVLLKIA-KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE--HPFVS 280 (302)
T ss_dssp SCHHHHHHHHH-HSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT--STTTT
T ss_pred CCHHHHHHHHh-ccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc--ChHHh
Confidence 66544433322 22222 234568899999999999999999999999987 44443
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=274.73 Aligned_cols=207 Identities=23% Similarity=0.338 Sum_probs=161.0
Q ss_pred CCCCCCCc-ccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDN-LVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~-i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++.++|++ |..+..++ .++..++||||+ +++|.+++.. ....+++.+++.|+.||+.||+|||+.||+||||||+|
T Consensus 56 l~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~-~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N 133 (483)
T 3sv0_A 56 YRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNF-CSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133 (483)
T ss_dssp HHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcce
Confidence 34567755 44444444 455789999999 9999999975 34579999999999999999999999999999999999
Q ss_pred EEEc--CCCCceEEeccCCcccCccccc--------ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 80 LLLT--PDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 80 il~~--~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
||++ .+.+.++|+|||++........ .....|+..|+|||.+.+ ..++.++|||||||++|+
T Consensus 134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~s~~sDvwSlGvil~e 205 (483)
T 3sv0_A 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLG--------IEQSRRDDLESLGYVLMY 205 (483)
T ss_dssp EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcC--------CCCChHHHHHHHHHHHHH
Confidence 9994 2445699999999975443221 225578999999999864 567899999999999999
Q ss_pred HHhCCCCCCCCCcH--HHHHHHH----HhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 150 LLTNRLPFEGMSNL--QAAYAAA----FKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 150 ll~g~~p~~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|++|..||.+.... ....... .......+...++.++.+++..||..+|.+||++.+|++.|+.++...
T Consensus 206 lltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 206 FLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 99999999865431 1111111 111112233578899999999999999999999999999999986543
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=270.53 Aligned_cols=206 Identities=28% Similarity=0.429 Sum_probs=154.5
Q ss_pred CCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
|+.++||||+++++++.. ...|+||||+ +++|.+++.. ...+++..+..++.||+.||+|||+.||+||||
T Consensus 106 l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDl 182 (458)
T 3rp9_A 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDL 182 (458)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 567899999999999721 3589999998 6799999975 456999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc----------------------------cccCccCccceeccccccccccc
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE----------------------------MMTAETGTYRWMAPELYSTVTLR 127 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~ 127 (268)
||+|||++.+ +.+||+|||+++...... ......||++|+|||++..
T Consensus 183 Kp~NILl~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~---- 257 (458)
T 3rp9_A 183 KPANCLVNQD-CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL---- 257 (458)
T ss_dssp CGGGEEECTT-CCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTT----
T ss_pred ChhhEEECCC-CCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhC----
Confidence 9999999966 469999999997543211 1233467999999997642
Q ss_pred cccccCCCcccchHHHHHHHHHHHh-----------CCCCCCCCCcH-------------------HHHHHHHH------
Q 024401 128 QGEKKHYNNKVDVYSFGIVLWELLT-----------NRLPFEGMSNL-------------------QAAYAAAF------ 171 (268)
Q Consensus 128 ~~~~~~~~~~~Di~slG~i~~~ll~-----------g~~p~~~~~~~-------------------~~~~~~~~------ 171 (268)
...++.++|||||||++|||++ |..+|.+.+.. ........
T Consensus 258 ---~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p 334 (458)
T 3rp9_A 258 ---QENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTP 334 (458)
T ss_dssp ---CCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCC
T ss_pred ---CCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCC
Confidence 3568899999999999999998 66666553310 00000000
Q ss_pred -----------------hhcC-------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 172 -----------------KHAR-------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 172 -----------------~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
.... .......+.++.+|+.+||..||.+|||++++++ +.++.....
T Consensus 335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~--Hp~f~~~~~ 405 (458)
T 3rp9_A 335 SEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA--HPFFKEVRI 405 (458)
T ss_dssp CHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SGGGTTTCC
T ss_pred CHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhc--CHhhhhcCC
Confidence 0000 0112346889999999999999999999999999 777766544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=263.19 Aligned_cols=206 Identities=28% Similarity=0.408 Sum_probs=161.8
Q ss_pred CCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
|++++||||+++++++.. ...++||||+. ++|.+++.. ..+++..+..++.|++.||+|||+.||+||||
T Consensus 63 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dl 138 (353)
T 2b9h_A 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDL 138 (353)
T ss_dssp HHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 457899999999998742 46899999995 699999976 46999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc-----------cccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE-----------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
||+||+++.+ +.++|+|||++....... ......|+..|+|||.+.. ...++.++||||||
T Consensus 139 kp~Nil~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG 210 (353)
T 2b9h_A 139 KPSNLLINSN-CDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLT-------SAKYSRAMDVWSCG 210 (353)
T ss_dssp CGGGEEECTT-CCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHS-------CCCCCHHHHHHHHH
T ss_pred CHHHeEEcCC-CcEEEEecccccccccccccccCccccccchhhccccccccCCeeecc-------CCCccchhhHHHHH
Confidence 9999999965 469999999997543211 1123468999999998742 35678899999999
Q ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHhhcC----------------------CC--------CCCCCcHHHHHHHHHhh
Q 024401 145 IVLWELLTNRLPFEGMSNLQAAYAAAFKHAR----------------------PG--------LPEDISPDLAFIVQSCW 194 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~----------------------~~--------~~~~~~~~l~~li~~~l 194 (268)
+++|+|++|..||.+.+.............. +. ....++.++.+++.+||
T Consensus 211 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (353)
T 2b9h_A 211 CILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRML 290 (353)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhc
Confidence 9999999999999876644332222111000 00 11367889999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 195 VEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
..||.+|||++++++ +.++.....+
T Consensus 291 ~~dP~~Rpt~~ell~--hp~~~~~~~~ 315 (353)
T 2b9h_A 291 VFDPAKRITAKEALE--HPYLQTYHDP 315 (353)
T ss_dssp CSSGGGSCCHHHHHT--SGGGTTTCCT
T ss_pred CcCcccCCCHHHHhc--CccccccCCc
Confidence 999999999999998 6777655443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=265.16 Aligned_cols=198 Identities=29% Similarity=0.507 Sum_probs=156.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||
T Consensus 78 l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni 155 (331)
T 4aaa_A 78 LKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI 155 (331)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheE
Confidence 46789999999999985 4568999999999999988764 45699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
+++.+ +.++|+|||++...... .......++..|+|||.+.+ ...++.++||||||+++|+|++|..||..
T Consensus 156 l~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 156 LVSQS-GVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG-------DVKYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp EECTT-SCEEECCCTTC------------CCCCCTTCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred EEcCC-CcEEEEeCCCceeecCCccccCCCcCCccccCcccccC-------CCCcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99965 46999999999754432 23344578999999998853 24678899999999999999999999988
Q ss_pred CCcHHHHHHHHHhhc--------------------CCC---------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHA--------------------RPG---------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~--------------------~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
............... .+. ....+++.+.+++.+||..||.+|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 228 DSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 765544433221100 000 01257899999999999999999999999998
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=261.72 Aligned_cols=205 Identities=24% Similarity=0.364 Sum_probs=160.5
Q ss_pred CCCCCCCcccceeeeeec---------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
|++++||||+++++++.+ +..++||||+++ +|.+.+.. ....+++.+++.++.|++.||+|||+.||+|
T Consensus 70 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 147 (351)
T 3mi9_A 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSN-VLVKFTLSEIKRVMQMLLNGLYYIHRNKILH 147 (351)
T ss_dssp HHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeC
Confidence 457899999999998843 357999999965 88888765 3356999999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCcc-----cccccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETV-----TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
|||||+||+++.+ +.++|+|||++..... ........+++.|+|||.+.+ ...++.++||||||+++
T Consensus 148 ~Dlkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il 219 (351)
T 3mi9_A 148 RDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIM 219 (351)
T ss_dssp CCCSGGGEEECTT-SCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTT-------CCSCCTHHHHHHHHHHH
T ss_pred CCCCHHHEEEcCC-CCEEEccchhcccccccccccccccCCcccccCccCchhhcC-------CCCCCcHhHHHHHHHHH
Confidence 9999999999965 4699999999975432 222234578999999998853 24578899999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHhhc--CCCCCCC----------------------------CcHHHHHHHHHhhhhC
Q 024401 148 WELLTNRLPFEGMSNLQAAYAAAFKHA--RPGLPED----------------------------ISPDLAFIVQSCWVED 197 (268)
Q Consensus 148 ~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~----------------------------~~~~l~~li~~~l~~~ 197 (268)
|+|++|..||.+............... .+..... .++.+.+|+.+||..|
T Consensus 220 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 299 (351)
T 3mi9_A 220 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 299 (351)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCC
Confidence 999999999987665443333222111 1111111 2677999999999999
Q ss_pred CCCCCCHHHHHHHHHhhhhhc
Q 024401 198 PNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 198 p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|.+|||++++++ +.++.+.
T Consensus 300 P~~R~t~~e~l~--hp~f~~~ 318 (351)
T 3mi9_A 300 PAQRIDSDDALN--HDFFWSD 318 (351)
T ss_dssp GGGSCCHHHHHT--SGGGGSS
T ss_pred hhhCCCHHHHhC--CCCcCCC
Confidence 999999999998 6776543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.46 Aligned_cols=203 Identities=28% Similarity=0.415 Sum_probs=162.1
Q ss_pred CCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
|++++||||+++++++.. ...++||||+. ++|.+++.. ..+++.+++.++.|++.||+|||+.||+||||
T Consensus 79 l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 154 (364)
T 3qyz_A 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDL 154 (364)
T ss_dssp HHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 467899999999999843 25899999995 599999976 46999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCccccc----ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTEM----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||+||+++.+ +.++|+|||++........ .....|++.|+|||.+.. ...++.++||||||+++|+|+
T Consensus 155 kp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell 226 (364)
T 3qyz_A 155 KPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEML 226 (364)
T ss_dssp CGGGEEECTT-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT-------BCSCSTHHHHHHHHHHHHHHH
T ss_pred ChHhEEECCC-CCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC-------CCCCCcchhHHHHHHHHHHHH
Confidence 9999999965 4599999999976543322 234578999999998643 245788999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhcCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|..||.+.+..............+ .....++.++.+|+.+||..||.+||
T Consensus 227 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 306 (364)
T 3qyz_A 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 306 (364)
T ss_dssp HSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC
T ss_pred HCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC
Confidence 9999998766544333222110000 01245788999999999999999999
Q ss_pred CHHHHHHHHHhhhhhc
Q 024401 203 SFSQIIRMLNAFLFTL 218 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~ 218 (268)
|++++++ +.++...
T Consensus 307 t~~e~l~--hp~~~~~ 320 (364)
T 3qyz_A 307 EVEQALA--HPYLEQY 320 (364)
T ss_dssp CHHHHHT--SGGGTTT
T ss_pred CHHHHhc--Ccchhhc
Confidence 9999998 6666543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-38 Score=270.57 Aligned_cols=209 Identities=23% Similarity=0.337 Sum_probs=152.3
Q ss_pred CCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 2 MSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLR-------PNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
|++++||||+++++++. +...++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.||+
T Consensus 72 l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 150 (405)
T 3rgf_A 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 150 (405)
T ss_dssp HHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 56789999999999983 346899999995 58888886321 23499999999999999999999999999
Q ss_pred ecCCCCCCEEEc---CCCCceEEeccCCcccCccc----ccccCccCccceeccccccccccccccccCCCcccchHHHH
Q 024401 72 HRDLKPDNLLLT---PDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFG 144 (268)
Q Consensus 72 H~dlk~~Nil~~---~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG 144 (268)
||||||+|||+. .+.+.++|+|||++...... .......||+.|+|||.+.+ ...++.++||||||
T Consensus 151 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlG 223 (405)
T 3rgf_A 151 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG-------ARHYTKAIDIWAIG 223 (405)
T ss_dssp CCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTT-------CCSCCHHHHHHHHH
T ss_pred CCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcC-------CCcccchhhhHHHH
Confidence 999999999993 23457999999999765432 22234578999999998853 24578999999999
Q ss_pred HHHHHHHhCCCCCCCCCcH---------HHHHHHHHhhcCCC------------------------------------CC
Q 024401 145 IVLWELLTNRLPFEGMSNL---------QAAYAAAFKHARPG------------------------------------LP 179 (268)
Q Consensus 145 ~i~~~ll~g~~p~~~~~~~---------~~~~~~~~~~~~~~------------------------------------~~ 179 (268)
|++|+|++|..||.+.... ............+. ..
T Consensus 224 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (405)
T 3rgf_A 224 CIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 303 (405)
T ss_dssp HHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTT
T ss_pred HHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcC
Confidence 9999999999999755431 11111111000000 01
Q ss_pred CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 180 ~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
...+..+.+|+.+||..||.+|||++++++ +.++.....
T Consensus 304 ~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~--hp~f~~~~~ 342 (405)
T 3rgf_A 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQ--DPYFLEDPL 342 (405)
T ss_dssp CCTTSHHHHHHHHHSCSSGGGSCCHHHHHT--SGGGTSSSC
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHHHHhc--ChhhccCCC
Confidence 122677899999999999999999999998 777765443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=273.14 Aligned_cols=197 Identities=17% Similarity=0.247 Sum_probs=148.9
Q ss_pred CCCCCCCccccee-------eeeecC------------------CceEEEEcCCCCCHHHHHhhhCC-----CCCCHHHH
Q 024401 2 MSRVKHDNLVKFL-------GACKDP------------------LMVIVTELLPGMSLRKYLVSLRP-----NKLDLHVA 51 (268)
Q Consensus 2 l~~l~Hp~i~~~~-------~~~~~~------------------~~~lv~e~~~~~~L~~~~~~~~~-----~~~~~~~~ 51 (268)
|++++||||++++ +++.+. ..|++|||+ +|+|.+++..... ..+++..+
T Consensus 130 l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~ 208 (377)
T 3byv_A 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHAR 208 (377)
T ss_dssp STTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHH
T ss_pred ccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHH
Confidence 5678999999998 444322 378999999 6799999976321 12334888
Q ss_pred HHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccc---ccc
Q 024401 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVT---LRQ 128 (268)
Q Consensus 52 ~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~ 128 (268)
+.|+.|++.||+|||+.||+||||||+|||++.+ +.+||+|||++..... ......| +.|+|||.+.+.. ...
T Consensus 209 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~ 284 (377)
T 3byv_A 209 LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-GGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHR 284 (377)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT-CCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccc
Confidence 8999999999999999999999999999999966 4699999999986433 2334466 9999999986410 000
Q ss_pred ccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 024401 129 GEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208 (268)
Q Consensus 129 ~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l 208 (268)
.....++.++|||||||++|+|++|..||.+....... .........+++++.+++.+||..||.+|||+.+++
T Consensus 285 ~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGS------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp CCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCS------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred cccccCChhhhHHHHHHHHHHHHHCCCCCcccccccch------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 00126789999999999999999999999754321110 111122357899999999999999999999999999
Q ss_pred H
Q 024401 209 R 209 (268)
Q Consensus 209 ~ 209 (268)
+
T Consensus 359 ~ 359 (377)
T 3byv_A 359 E 359 (377)
T ss_dssp T
T ss_pred h
Confidence 7
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=262.95 Aligned_cols=208 Identities=25% Similarity=0.452 Sum_probs=161.3
Q ss_pred CCCCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCC
Q 024401 4 RVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--------ANGI 70 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH--------~~~i 70 (268)
.++||||+++++++.+. ..++||||+++++|.+++.. ..+++.+++.++.|++.||+||| +.||
T Consensus 92 ~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 168 (342)
T 1b6c_B 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168 (342)
T ss_dssp CCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred hcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCe
Confidence 37999999999998433 68999999999999999976 46999999999999999999999 8999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
+||||||+||+++.+ +.++|+|||++....... ......++..|+|||.+.+.... ....++.++||||||+
T Consensus 169 vH~Dlkp~NIll~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~~~~~~Di~slG~ 245 (342)
T 1b6c_B 169 AHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINM--KHFESFKRADIYAMGL 245 (342)
T ss_dssp ECSCCSGGGEEECTT-SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCT--TCHHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEECCC-CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccc--cccccCCcccHHHHHH
Confidence 999999999999965 469999999997543322 22445789999999988541100 0012336899999999
Q ss_pred HHHHHHhC----------CCCCCCCCc----HHHHHHHHH-hhcCCCCCC-----CCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 146 VLWELLTN----------RLPFEGMSN----LQAAYAAAF-KHARPGLPE-----DISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 146 i~~~ll~g----------~~p~~~~~~----~~~~~~~~~-~~~~~~~~~-----~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
++|+|++| ..||..... ......... ....+.++. ..+..+.+++.+||..+|.+|||+.
T Consensus 246 il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ 325 (342)
T 1b6c_B 246 VFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325 (342)
T ss_dssp HHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred HHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence 99999999 788865432 222222222 222333332 2446799999999999999999999
Q ss_pred HHHHHHHhhhhh
Q 024401 206 QIIRMLNAFLFT 217 (268)
Q Consensus 206 ~~l~~l~~~~~~ 217 (268)
++++.|+.+..+
T Consensus 326 ~i~~~L~~i~~~ 337 (342)
T 1b6c_B 326 RIKKTLSQLSQQ 337 (342)
T ss_dssp HHHHHHHHHHHT
T ss_pred HHHHHHHHHHHH
Confidence 999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=268.54 Aligned_cols=207 Identities=29% Similarity=0.378 Sum_probs=155.8
Q ss_pred CCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
|++++||||+++++++.. ...|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||+.||+||||
T Consensus 79 l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDl 155 (432)
T 3n9x_A 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDL 155 (432)
T ss_dssp HHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 567899999999999832 35899999995 699999975 456999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc-----------------------cccCccCccceecccccccccccccccc
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE-----------------------MMTAETGTYRWMAPELYSTVTLRQGEKK 132 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 132 (268)
||+|||++.+ +.++|+|||+++...... ......||++|+|||.+.. ..
T Consensus 156 kp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-------~~ 227 (432)
T 3n9x_A 156 KPANCLLNQD-CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-------QE 227 (432)
T ss_dssp CGGGEEECTT-CCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT-------CS
T ss_pred CHHHeEECCC-CCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc-------CC
Confidence 9999999966 469999999998543321 1245578999999998642 35
Q ss_pred CCCcccchHHHHHHHHHHHhCC-----------CCCCCCCc-----------------HHHHHH----------------
Q 024401 133 HYNNKVDVYSFGIVLWELLTNR-----------LPFEGMSN-----------------LQAAYA---------------- 168 (268)
Q Consensus 133 ~~~~~~Di~slG~i~~~ll~g~-----------~p~~~~~~-----------------~~~~~~---------------- 168 (268)
.++.++|||||||++|+|++|. .+|.+.+. ......
T Consensus 228 ~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~ 307 (432)
T 3n9x_A 228 NYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307 (432)
T ss_dssp CCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhc
Confidence 6889999999999999999743 33333221 000000
Q ss_pred ------HHHhhcCCCC-------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCCC
Q 024401 169 ------AAFKHARPGL-------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221 (268)
Q Consensus 169 ------~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~~ 221 (268)
.......... ...+++++.+|+.+||..||.+|||++++++ +.++.....+
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~--Hp~f~~~~~~ 371 (432)
T 3n9x_A 308 NKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD--HPYLKDVRKK 371 (432)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT--CGGGTTTCCT
T ss_pred cCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc--ChhhhhccCc
Confidence 0000011111 1357899999999999999999999999998 7777666543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.17 Aligned_cols=204 Identities=25% Similarity=0.374 Sum_probs=160.9
Q ss_pred CCCCCCCcccceeeeee---------------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK---------------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH 66 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~---------------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH 66 (268)
+++++||||+++++++. ....++||||+. ++|.+++.. ..+++..++.++.|++.||+|||
T Consensus 62 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH 137 (320)
T 2i6l_A 62 IRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH 137 (320)
T ss_dssp HHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH
Confidence 56789999999999862 235789999996 599999864 56999999999999999999999
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccc----ccccCccCccceeccccccccccccccccCCCcccchHH
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYS 142 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~s 142 (268)
+.||+|+||||+||+++.++..++|+|||++...... .......++..|+|||.+.. ...++.++||||
T Consensus 138 ~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~s 210 (320)
T 2i6l_A 138 SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-------PNNYTKAIDMWA 210 (320)
T ss_dssp HTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHC-------TTCCCHHHHHHH
T ss_pred hCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcC-------cccCCchhhhHh
Confidence 9999999999999999866678999999999764322 12233457889999998752 256788999999
Q ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhc-----------------------CC-----CCCCCCcHHHHHHHHHhh
Q 024401 143 FGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-----------------------RP-----GLPEDISPDLAFIVQSCW 194 (268)
Q Consensus 143 lG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~-----------------------~~-----~~~~~~~~~l~~li~~~l 194 (268)
||+++|+|++|..||.+............... .+ .....++.++.+++.+||
T Consensus 211 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 290 (320)
T 2i6l_A 211 AGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL 290 (320)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTS
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHc
Confidence 99999999999999987765443322211100 00 112458899999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 195 VEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
..||.+|||++++++ +.++...
T Consensus 291 ~~dP~~Rpt~~ell~--hp~~~~~ 312 (320)
T 2i6l_A 291 TFSPMDRLTAEEALS--HPYMSIY 312 (320)
T ss_dssp CSSGGGSCCHHHHHT--SHHHHTT
T ss_pred CCCccccCCHHHHhC--Ccccccc
Confidence 999999999999998 5555543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=264.44 Aligned_cols=206 Identities=23% Similarity=0.337 Sum_probs=146.4
Q ss_pred CCCC-CCcccceeeeee---------cCCceEEEEcCCCCCHHHHHhh-hCCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 024401 3 SRVK-HDNLVKFLGACK---------DPLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANG-- 69 (268)
Q Consensus 3 ~~l~-Hp~i~~~~~~~~---------~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~l~~lH~~~-- 69 (268)
+++. ||||+++++++. ....+++|||+ +|+|.+++.. .....+++.+++.++.|++.||+|||+.|
T Consensus 80 ~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ 158 (337)
T 3ll6_A 80 KKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPP 158 (337)
T ss_dssp HHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSC
T ss_pred HHhccCCChhhccccccccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 3454 999999999872 11378999999 5699998865 23456999999999999999999999999
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCcccCccccc-------------ccCccCccceeccccccccccccccccCCCc
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM-------------MTAETGTYRWMAPELYSTVTLRQGEKKHYNN 136 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~ 136 (268)
|+|+||||+||+++.+ +.++|+|||++........ .....+++.|+|||.+... ....++.
T Consensus 159 ivH~Dikp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~~~~~~ 232 (337)
T 3ll6_A 159 IIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLY-----SNFPIGE 232 (337)
T ss_dssp CBCCCCCGGGCEECTT-SCEEBCCCTTCBCCSSCC-------------------------------CC-----TTSCSSH
T ss_pred EEEccCCcccEEECCC-CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhcc-----ccCCCCh
Confidence 9999999999999965 4699999999975443211 1134588999999987321 2356788
Q ss_pred ccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 137 KVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 137 ~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
++||||||+++|+|++|..||........ .............+..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 233 ~~Dv~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 233 KQDIWALGCILYLLCFRQHPFEDGAKLRI----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp HHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhHHHHHHHHHHHHhCCCCCcchhHHHh----hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999976443221 12222333445677889999999999999999999999999999876
Q ss_pred hcC
Q 024401 217 TLR 219 (268)
Q Consensus 217 ~~~ 219 (268)
...
T Consensus 309 ~~~ 311 (337)
T 3ll6_A 309 ARN 311 (337)
T ss_dssp HTT
T ss_pred ccC
Confidence 543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=263.70 Aligned_cols=203 Identities=24% Similarity=0.383 Sum_probs=142.0
Q ss_pred CCCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 3 SRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
+.++||||+++++++.. ...++||||++|++|.+++.......+++.+++.++.|++.||+|||+.||+||||||
T Consensus 77 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp 156 (336)
T 3fhr_A 77 QASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKP 156 (336)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred HhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 35689999999998742 3489999999999999999875556799999999999999999999999999999999
Q ss_pred CCEEEcCC--CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 78 DNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 78 ~Nil~~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
+||+++.+ ...++|+|||++...... ......+++.|+|||.+.. ..++.++||||||+++|+|++|..
T Consensus 157 ~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~~l~~g~~ 227 (336)
T 3fhr_A 157 ENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGFP 227 (336)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEEC-------------------------------CHHHHHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCC--------CCCCchhhHHHHHHHHHHHHHCCC
Confidence 99999753 345999999999754432 2234567999999998853 566789999999999999999999
Q ss_pred CCCCCCcHHHHH--HHHHh----hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 156 PFEGMSNLQAAY--AAAFK----HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 156 p~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
||.......... ..... .........++.++.+++.+||..||.+|||++++++ +.++.
T Consensus 228 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~--hp~~~ 292 (336)
T 3fhr_A 228 PFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN--HPWIN 292 (336)
T ss_dssp CC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH--SHHHH
T ss_pred CCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc--Ccccc
Confidence 997654322111 00011 1112222568999999999999999999999999998 44443
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-38 Score=265.96 Aligned_cols=203 Identities=29% Similarity=0.419 Sum_probs=149.9
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
|+.++||||+++++++.. ...++++|++ +++|.+++.. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 82 l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~D 157 (367)
T 2fst_X 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRD 157 (367)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCC
Confidence 467899999999999742 3579999999 7899999875 5699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||+++..... .....++..|+|||.+.+ ...++.++|||||||++|+|++|+
T Consensus 158 lkp~NIll~~~-~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~ell~g~ 227 (367)
T 2fst_X 158 LKPSNLAVNED-CELKILDFGLARHTADE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGR 227 (367)
T ss_dssp CCGGGEEECTT-CCEEECC-----------------CCCTTCCHHHHTT-------CCSCCTTHHHHHHHHHHHHHHHSS
T ss_pred CCHhhEEECCC-CCEEEeecccccccccc--CCCcCcCcCccChHHHcC-------CcCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999965 46999999999764432 234578999999998753 256788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhc---------------------CCCC--------CCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHA---------------------RPGL--------PEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~---------------------~~~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+.+............. .+.. ....+..+.+|+.+||..||.+|||++
T Consensus 228 ~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~ 307 (367)
T 2fst_X 228 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 307 (367)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHH
Confidence 99988765443332221110 0111 124678899999999999999999999
Q ss_pred HHHHHHHhhhhhcCC
Q 024401 206 QIIRMLNAFLFTLRP 220 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~ 220 (268)
++++ +.++.....
T Consensus 308 e~L~--hp~~~~~~~ 320 (367)
T 2fst_X 308 QALA--HAYFAQYHD 320 (367)
T ss_dssp HHHT--SGGGTTTCC
T ss_pred HHhc--ChhhhhccC
Confidence 9998 666665443
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=263.83 Aligned_cols=207 Identities=23% Similarity=0.337 Sum_probs=155.7
Q ss_pred CCCCCCCcccceeeeeec------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACKD------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
|++++||||+++++++.. ...++||||+. ++|.+++.. ....+++..+..++.|++.||+|||+.||+|+||
T Consensus 83 l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 160 (362)
T 3pg1_A 83 LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDL 160 (362)
T ss_dssp HHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCC
Confidence 467899999999998721 14799999996 689988875 3457999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
||+||+++.+ +.++|+|||++.............++..|+|||.+.+ ...++.++||||||+++|+|++|..
T Consensus 161 kp~NIl~~~~-~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~ 232 (362)
T 3pg1_A 161 HPGNILLADN-NDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ-------FKGFTKLVDMWSAGCVMAEMFNRKA 232 (362)
T ss_dssp CGGGEEECTT-CCEEECCTTC---------------CGGGCCHHHHTT-------CTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred ChHHEEEcCC-CCEEEEecCcccccccccccceecccceecCcHHhcC-------CCCCCcHhHHHhHHHHHHHHHhCCC
Confidence 9999999855 4699999999986555444555678999999998753 2557889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhc----------------------CCC--------CCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 156 PFEGMSNLQAAYAAAFKHA----------------------RPG--------LPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~----------------------~~~--------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
||.+............... ... ....+++.+.+++.+||..||.+|||+.
T Consensus 233 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 312 (362)
T 3pg1_A 233 LFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTE 312 (362)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred CCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHH
Confidence 9987665443332221111 111 1234678899999999999999999999
Q ss_pred HHHHHHHhhhhhcCC
Q 024401 206 QIIRMLNAFLFTLRP 220 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~ 220 (268)
++++ +.++.....
T Consensus 313 ell~--hp~f~~~~~ 325 (362)
T 3pg1_A 313 QALR--HPYFESLFD 325 (362)
T ss_dssp HHHT--SGGGTTTCC
T ss_pred HHHc--CchhhhccC
Confidence 9998 677665543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=266.05 Aligned_cols=199 Identities=27% Similarity=0.407 Sum_probs=148.3
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
++.++||||+++++++.+. ..++||||++ ++|.+++. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 78 l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~D 152 (371)
T 2xrw_A 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 152 (371)
T ss_dssp HHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 4578999999999998432 5799999996 58888885 3489999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||++.............+++.|+|||.+.+ ..++.++|||||||++|+|++|.
T Consensus 153 lkp~NIl~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~el~~g~ 223 (371)
T 2xrw_A 153 LKPSNIVVKSD-CTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMIKGG 223 (371)
T ss_dssp CCGGGEEECTT-SCEEECCCCC----------------CTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEEEcCC-CCEEEEEeecccccccccccCCceecCCccCHHHhcC--------CCCCchHhHHHHHHHHHHHHhCC
Confidence 99999999965 4699999999986654444445678999999999864 56788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhh--------------------cCCCCC--------------C------CCcHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQAAYAAAFKH--------------------ARPGLP--------------E------DISPDLAFIVQSCW 194 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~--------------------~~~~~~--------------~------~~~~~l~~li~~~l 194 (268)
.||.+.+............ ..+... . ..+.++.+|+.+||
T Consensus 224 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 303 (371)
T 2xrw_A 224 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303 (371)
T ss_dssp CSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHC
Confidence 9998766544332221110 011110 0 01567999999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhh
Q 024401 195 VEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..||.+|||++++++ +.++.
T Consensus 304 ~~dP~~R~t~~e~l~--hp~~~ 323 (371)
T 2xrw_A 304 VIDASKRISVDEALQ--HPYIN 323 (371)
T ss_dssp CSSGGGSCCHHHHHH--SHHHH
T ss_pred cCChhhCCCHHHHhC--Ccchh
Confidence 999999999999998 55543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=262.83 Aligned_cols=200 Identities=19% Similarity=0.185 Sum_probs=160.4
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL---RPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
...|+||+++++++. ++..++||||++||+|.+++... ....+++.+++.|+.|++.||+|||+.||+||||||+|
T Consensus 123 ~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~N 202 (365)
T 3e7e_A 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDN 202 (365)
T ss_dssp GGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred hhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence 445999999999984 56789999999999999999752 24569999999999999999999999999999999999
Q ss_pred EEEcCC----------CCceEEeccCCcccCc---ccccccCccCccceeccccccccccccccccCCCcccchHHHHHH
Q 024401 80 LLLTPD----------QKSLKLADFGLAREET---VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 146 (268)
Q Consensus 80 il~~~~----------~~~~~l~Dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 146 (268)
||++.+ .+.++|+|||++.... .........||..|+|||.+.+ ..++.++|||||||+
T Consensus 203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~i 274 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--------KPWNYQIDYFGVAAT 274 (365)
T ss_dssp EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--------CCBSTHHHHHHHHHH
T ss_pred EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC--------CCCCccccHHHHHHH
Confidence 999851 4569999999996432 2333455679999999999864 568899999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCC-CCHHHHHHHHHhhhhh
Q 024401 147 LWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLR-PSFSQIIRMLNAFLFT 217 (268)
Q Consensus 147 ~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R-ps~~~~l~~l~~~~~~ 217 (268)
+|+|++|+.||....... ............++.+.+++..|+..+|.+| |++.++.+.|+.++..
T Consensus 275 l~elltg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 275 VYCMLFGTYMKVKNEGGE------CKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp HHHHHHSSCCCEEEETTE------EEECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHhCCCccccCCCCc------eeechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 999999999985432210 0000000111346789999999999999999 5889999999988765
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=257.18 Aligned_cols=202 Identities=26% Similarity=0.450 Sum_probs=154.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~N 79 (268)
++.++||||+++++++. ++..++||||+ ++.+..+... ....+++..++.++.|++.||+|||+. |++|+||||+|
T Consensus 78 ~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~N 155 (318)
T 2dyl_A 78 LKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 155 (318)
T ss_dssp HHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGG
T ss_pred HHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHH
Confidence 45679999999999985 45789999999 6677776654 346799999999999999999999995 99999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.++|+|||++.............+++.|+|||.+.... .....++.++||||||+++|+|++|..||..
T Consensus 156 il~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 156 ILLDER-GQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPD---PTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp EEECTT-SCEEECCCTTC--------------CCTTCCHHHHC-----------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEECCC-CCEEEEECCCchhccCCccccccCCCccccChhhccccc---ccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 999965 469999999997655444444557899999999984311 0135678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCC--CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
................+..+ ..++.++.+++.+||..||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 232 CKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp CCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred CCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 66555555555555444444 358999999999999999999999999998
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=260.35 Aligned_cols=202 Identities=28% Similarity=0.497 Sum_probs=140.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhh---hCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCC
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVS---LRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk 76 (268)
++.++||||+++++++. ++..++||||+.+ +|.+++.. .....+++..+..++.|++.||+|||+. |++|+|||
T Consensus 75 ~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk 153 (327)
T 3aln_A 75 MRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153 (327)
T ss_dssp HSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC
T ss_pred HHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC
Confidence 46789999999999985 5578999999965 88888763 2246799999999999999999999999 99999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|+||+++.+ +.++|+|||++.............++..|+|||.+... .....++.++||||||+++|+|++|..|
T Consensus 154 p~NIll~~~-~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~~~~Di~slG~il~~l~~g~~p 228 (327)
T 3aln_A 154 PSNILLDRS-GNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS----ASRQGYDVRSDVWSLGITLYELATGRFP 228 (327)
T ss_dssp GGGEEEETT-TEEEECCCSSSCC----------------------------------CCSHHHHHHHHHHHHHHHHSCCC
T ss_pred HHHEEEcCC-CCEEEccCCCceecccccccccCCCCccccCceeeccc----cCcCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999955 56999999999866544444445789999999998421 0125578899999999999999999999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|..................+.++ ..++..+.+++.+||..||.+|||+.++++
T Consensus 229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 229 YPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp SSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 98654322222112222222222 358899999999999999999999999988
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=254.50 Aligned_cols=200 Identities=23% Similarity=0.283 Sum_probs=158.6
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
.|++|+++++++. ++..++||||+ +++|.+++.......+++.++..++.|++.||+|||+.||+||||||+||+++.
T Consensus 75 ~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 153 (339)
T 1z57_A 75 STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQ 153 (339)
T ss_dssp CTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC
T ss_pred CceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEec
Confidence 4567999999984 56799999999 889999998755567999999999999999999999999999999999999985
Q ss_pred C------------------CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHH
Q 024401 85 D------------------QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV 146 (268)
Q Consensus 85 ~------------------~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i 146 (268)
+ +..++|+|||++...... .....++..|+|||.+.+ ..++.++||||||++
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~i 223 (339)
T 1z57_A 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILA--------LGWSQPCDVWSIGCI 223 (339)
T ss_dssp CCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTT--------SCCCTHHHHHHHHHH
T ss_pred cccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhC--------CCCCcchhhHHHHHH
Confidence 3 346999999998754332 234578999999999854 567899999999999
Q ss_pred HHHHHhCCCCCCCCCcHHHHHHHHHhhcC------------------------------------------CCCCCCCcH
Q 024401 147 LWELLTNRLPFEGMSNLQAAYAAAFKHAR------------------------------------------PGLPEDISP 184 (268)
Q Consensus 147 ~~~ll~g~~p~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~ 184 (268)
+|+|++|..||...+.............. .......++
T Consensus 224 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (339)
T 1z57_A 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303 (339)
T ss_dssp HHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHH
Confidence 99999999999876654332221110000 001122357
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 185 DLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 185 ~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
++.+++.+||..||.+|||+.++++ +.++...
T Consensus 304 ~l~~li~~~L~~dP~~Rpt~~ell~--hp~f~~~ 335 (339)
T 1z57_A 304 RLFDLIQKMLEYDPAKRITLREALK--HPFFDLL 335 (339)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHTT--SGGGGGG
T ss_pred HHHHHHHHHhCcCcccccCHHHHhc--CHHHHHH
Confidence 7999999999999999999999998 5555543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=259.77 Aligned_cols=202 Identities=27% Similarity=0.427 Sum_probs=157.5
Q ss_pred CCCCCCCcccceeeeeecC-C------ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-L------MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-~------~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
++.++||||+++++++.+. . .++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 95 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~D 169 (371)
T 4exu_A 95 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 169 (371)
T ss_dssp HHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCC
Confidence 4578999999999998433 2 399999995 69988874 3499999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||++...... .....+++.|+|||.+.+ ...++.++||||||+++|+|++|.
T Consensus 170 ikp~NIll~~~-~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~el~~g~ 239 (371)
T 4exu_A 170 LKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGK 239 (371)
T ss_dssp CCGGGEEECTT-CCEEECSTTCC----------CTTCCCTTSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cCHHHeEECCC-CCEEEEecCcccccccC--cCCcccCccccCHHHhcC-------CCCCCcHHhHHHHHHHHHHHHhCC
Confidence 99999999965 46999999999754332 334578999999998853 256788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhcCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+.+..+...........+ .....+++.+.+|+.+||+.||.+|||++
T Consensus 240 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 319 (371)
T 4exu_A 240 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 319 (371)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHH
Confidence 9998766544433322111110 01235789999999999999999999999
Q ss_pred HHHHHHHhhhhhcCC
Q 024401 206 QIIRMLNAFLFTLRP 220 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~ 220 (268)
++++ +.++.....
T Consensus 320 ell~--hp~f~~~~~ 332 (371)
T 4exu_A 320 QALT--HPFFEPFRD 332 (371)
T ss_dssp HHHT--SGGGTTTCC
T ss_pred HHhc--CcccccCCC
Confidence 9998 667655443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=255.67 Aligned_cols=196 Identities=26% Similarity=0.438 Sum_probs=150.3
Q ss_pred CCCCCCCcccceeeeeec--------------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 024401 2 MSRVKHDNLVKFLGACKD--------------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA 67 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~ 67 (268)
+++++||||+++++++.+ +..++||||++|++|.+++.. ....+++..++.++.|++.||+|||+
T Consensus 56 l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~ 134 (303)
T 1zy4_A 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHS 134 (303)
T ss_dssp HTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHH-SCGGGCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhc-cccccchHHHHHHHHHHHHHHHHHHh
Confidence 578899999999998732 357899999999999999986 34568899999999999999999999
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcccCccc---------------ccccCccCccceecccccccccccccccc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---------------EMMTAETGTYRWMAPELYSTVTLRQGEKK 132 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~ 132 (268)
.|++|+||||+||+++.+ +.++|+|||.+...... .......++..|+|||.+.+ ..
T Consensus 135 ~~i~H~dlkp~Nil~~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~ 206 (303)
T 1zy4_A 135 QGIIHRDLKPMNIFIDES-RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-------TG 206 (303)
T ss_dssp TTCCCSCCCGGGEEECTT-SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTS-------CS
T ss_pred CCeecccCCHHhEEEcCC-CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccC-------CC
Confidence 999999999999999865 46999999998754321 11234468899999998853 24
Q ss_pred CCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHh---hcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 133 HYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK---HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 133 ~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.++.++||||||+++|+|++ ||............... ...+.++...+..+.+++.+||..||.+|||+.++++
T Consensus 207 ~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 207 HYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 67889999999999999998 55432222222222221 1223344567788999999999999999999999998
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=254.88 Aligned_cols=193 Identities=26% Similarity=0.445 Sum_probs=157.6
Q ss_pred CCCcccceeeeee-cCCceEEEEc-CCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTEL-LPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~-~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
+||||+++++++. ++..++|||+ +.+++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++
T Consensus 96 ~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~ 173 (312)
T 2iwi_A 96 GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILID 173 (312)
T ss_dssp CCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEE
T ss_pred CCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEe
Confidence 8999999999984 5578999999 7889999999863 4599999999999999999999999999999999999998
Q ss_pred CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 84 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
.+++.++|+|||++....... .....++..|+|||.+.. ....+.++||||||+++|+|++|+.||.....
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-------~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~- 244 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISR-------HQYHALPATVWSLGILLYDMVCGDIPFERDQE- 244 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-
T ss_pred CCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeec-------CCCCCccchHHHHHHHHHHHHHCCCCCCChHH-
Confidence 555679999999987654332 334568999999998753 12334589999999999999999999975321
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.......++..++..+.+++.+||..+|.+|||++++++ +.++...
T Consensus 245 -------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~--~~~~~~~ 290 (312)
T 2iwi_A 245 -------ILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL--DPWMQTP 290 (312)
T ss_dssp -------HHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH--STTTCC-
T ss_pred -------HhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc--ChhhcCc
Confidence 122345567789999999999999999999999999998 5555443
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.01 Aligned_cols=202 Identities=27% Similarity=0.410 Sum_probs=157.2
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+++++||||+++++++.+. ..++||||+. ++|.+++. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 77 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~d 151 (353)
T 3coi_A 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRD 151 (353)
T ss_dssp HHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSS
T ss_pred HHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 4578999999999998433 2499999996 58887764 3499999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ +.++|+|||++...... .....++..|+|||.+.+ ...++.++||||||+++|+|++|.
T Consensus 152 lkp~NIl~~~~-~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~ 221 (353)
T 3coi_A 152 LKPGNLAVNED-CELKILDFGLARHADAE--MTGYVVTRWYRAPEVILS-------WMHYNQTVDIWSVGCIMAEMLTGK 221 (353)
T ss_dssp CCGGGEEECTT-CCEEECSTTCTTC----------CCSBCCSCHHHHSC-------CSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CCHHHEeECCC-CcEEEeecccccCCCCC--ccccccCcCcCCHHHHhC-------cCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999965 46999999999764332 234578999999998753 246788999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhh-----------------------------cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKH-----------------------------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+.+............ ........++.++.+++.+||..||.+|||++
T Consensus 222 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~ 301 (353)
T 3coi_A 222 TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAA 301 (353)
T ss_dssp CSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHH
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHH
Confidence 9998766543332221100 01122346789999999999999999999999
Q ss_pred HHHHHHHhhhhhcCC
Q 024401 206 QIIRMLNAFLFTLRP 220 (268)
Q Consensus 206 ~~l~~l~~~~~~~~~ 220 (268)
++++ +.++.....
T Consensus 302 e~l~--hp~f~~~~~ 314 (353)
T 3coi_A 302 QALT--HPFFEPFRD 314 (353)
T ss_dssp HHHT--SGGGTTTCC
T ss_pred HHhc--CcchhhccC
Confidence 9998 666654433
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=251.90 Aligned_cols=207 Identities=24% Similarity=0.458 Sum_probs=157.5
Q ss_pred CCCC--CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 3 SRVK--HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 3 ~~l~--Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++++ ||||+++++++. ++..++|||+ .+++|.+++.. ...+++.+++.++.|++.||+|||+.||+||||||+|
T Consensus 81 ~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 157 (313)
T 3cek_A 81 NKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPAN 157 (313)
T ss_dssp HHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCccc
Confidence 3454 699999999984 5578999995 48899999986 3569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc---cccCccCccceecccccccccccc---ccccCCCcccchHHHHHHHHHHHhC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQ---GEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~---~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
|+++ + +.++|+|||++....... ......+++.|+|||.+.+..... .....++.++||||||+++|+|++|
T Consensus 158 Il~~-~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g 235 (313)
T 3cek_A 158 FLIV-D-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 235 (313)
T ss_dssp EEEE-T-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHS
T ss_pred EEEE-C-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhC
Confidence 9997 3 569999999997654322 123446899999999885421100 0124678899999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHH-hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 154 RLPFEGMSNLQAAYAAAF-KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
..||.............. ......++...+.++.+++.+||..+|.+|||+.++++ +.++.
T Consensus 236 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~--h~~~~ 297 (313)
T 3cek_A 236 KTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA--HPYVQ 297 (313)
T ss_dssp SCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHH
T ss_pred CCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc--Ccccc
Confidence 999987654433333322 33444566778899999999999999999999999998 44443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=257.50 Aligned_cols=200 Identities=21% Similarity=0.334 Sum_probs=155.5
Q ss_pred CCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCC
Q 024401 6 KHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDN 79 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~N 79 (268)
.||||+++++++.+. ..+++||++ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 84 ~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N 162 (373)
T 1q8y_A 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 162 (373)
T ss_dssp HHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred ccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence 489999999997432 689999999 88999999876667799999999999999999999998 99999999999
Q ss_pred EEEcC-----CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 80 LLLTP-----DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 80 il~~~-----~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|+++. +...++|+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|.
T Consensus 163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~Di~slG~il~el~~g~ 232 (373)
T 1q8y_A 163 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGD 232 (373)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhC--------CCCCchHhHHHHHHHHHHHHhCC
Confidence 99953 2236999999999765432 234578999999999864 56789999999999999999999
Q ss_pred CCCCCCCcH-----HHHHHHHHh-----------------------------------------hcCCCCCCCCcHHHHH
Q 024401 155 LPFEGMSNL-----QAAYAAAFK-----------------------------------------HARPGLPEDISPDLAF 188 (268)
Q Consensus 155 ~p~~~~~~~-----~~~~~~~~~-----------------------------------------~~~~~~~~~~~~~l~~ 188 (268)
.||...... ......... .....++..++.++.+
T Consensus 233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (373)
T 1q8y_A 233 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 312 (373)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHH
Confidence 999754321 111111100 0111233445678999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 189 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 189 li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|+.+||..||.+|||++++++ +.++...
T Consensus 313 li~~~L~~dP~~Rpt~~ell~--hp~f~~~ 340 (373)
T 1q8y_A 313 FLSPMLQLDPRKRADAGGLVN--HPWLKDT 340 (373)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT--CGGGTTC
T ss_pred HHHHHhccCccccCCHHHHhh--Chhhhcc
Confidence 999999999999999999998 6666544
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=265.16 Aligned_cols=199 Identities=23% Similarity=0.364 Sum_probs=147.9
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|+.+ +||||+++++++. +...|+||||+. ++|.+++... ...+++.+++.++.|++.||+|||+.||+||||||+|
T Consensus 71 l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~N 148 (432)
T 3p23_A 71 LRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHN 148 (432)
T ss_dssp HHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTS
T ss_pred HHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHH
Confidence 3455 7999999999985 456899999995 6999999863 3345566778999999999999999999999999999
Q ss_pred EEEcCCC----CceEEeccCCcccCccc----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 80 LLLTPDQ----KSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 80 il~~~~~----~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
|+++.++ ..++|+|||++...... .......||+.|+|||.+... ....++.++|||||||++|+|+
T Consensus 149 Ill~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~t~~~DiwSlG~il~ell 223 (432)
T 3p23_A 149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSED-----CKENPTYTVDIFSAGCVFYYVI 223 (432)
T ss_dssp EEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC--------CCCTHHHHHHHHHHHHHHH
T ss_pred EEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcc-----cccCCCcHHHHHHHHHHHHHHH
Confidence 9995322 24789999999765432 223345799999999998531 1255677999999999999999
Q ss_pred h-CCCCCCCCCcHHHHHHHHHhhcCCC---CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 152 T-NRLPFEGMSNLQAAYAAAFKHARPG---LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 152 ~-g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+ |..||......... ......... .....+..+.+++.+||+.||.+|||++++++
T Consensus 224 t~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 224 SEGSHPFGKSLQRQAN--ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTSCBTTBSTTTHHHH--HHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCCCCCcchhhHHHHH--HHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 9 89999755433322 111111111 11224566899999999999999999999996
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=259.22 Aligned_cols=193 Identities=23% Similarity=0.342 Sum_probs=151.3
Q ss_pred CCCcccceeeeee-----cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCCC
Q 024401 6 KHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPDN 79 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~N 79 (268)
.||||+++++.+. ....++||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 4899999999874 23689999999 66777777664556799999999999999999999998 99999999999
Q ss_pred EEEcCCC------------------------------------------------CceEEeccCCcccCcccccccCccC
Q 024401 80 LLLTPDQ------------------------------------------------KSLKLADFGLAREETVTEMMTAETG 111 (268)
Q Consensus 80 il~~~~~------------------------------------------------~~~~l~Dfg~~~~~~~~~~~~~~~~ 111 (268)
||++.++ ..++|+|||.+...... .....+
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~g 255 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQ 255 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCC
Confidence 9998654 26999999999765432 334578
Q ss_pred ccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH-----HHHHHHHHh--hc----------
Q 024401 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-----QAAYAAAFK--HA---------- 174 (268)
Q Consensus 112 ~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~-----~~~~~~~~~--~~---------- 174 (268)
|..|+|||.+.+ ..++.++|||||||++|+|++|..||...+.. ......... ..
T Consensus 256 t~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 327 (397)
T 1wak_A 256 TRQYRSLEVLIG--------SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGK 327 (397)
T ss_dssp CGGGCCHHHHHT--------SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCT
T ss_pred CCcccCChhhcC--------CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccc
Confidence 999999999864 56788999999999999999999999754421 111111110 00
Q ss_pred -----------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 175 -----------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 175 -----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
....+...+..+.+|+.+||..||.+|||++++++
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 328 YSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp TGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00112234567899999999999999999999997
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=264.99 Aligned_cols=177 Identities=14% Similarity=0.188 Sum_probs=137.0
Q ss_pred ceEEEEcCCCCCHHHHHhhhCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccC
Q 024401 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVA------LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 95 (268)
Q Consensus 22 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~------~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg 95 (268)
.++||||++ ++|.+++.... ..++...+ +.++.|++.||+|||++||+||||||+|||++.+ +.+||+|||
T Consensus 163 ~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~-~~~kL~DFG 239 (371)
T 3q60_A 163 YLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD-GRLMLGDVS 239 (371)
T ss_dssp EEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTT-SCEEECCGG
T ss_pred EEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCC-CCEEEEecc
Confidence 799999997 79999998632 23455555 6778999999999999999999999999999965 469999999
Q ss_pred CcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHH-----H
Q 024401 96 LAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA-----A 170 (268)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~-----~ 170 (268)
++....... ....+++.|+|||.+.+ ....++.++|||||||++|+|++|+.||............ .
T Consensus 240 ~a~~~~~~~--~~~~~t~~y~aPE~~~~------~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 311 (371)
T 3q60_A 240 ALWKVGTRG--PASSVPVTYAPREFLNA------STATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRV 311 (371)
T ss_dssp GEEETTCEE--EGGGSCGGGCCHHHHTC------SEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTS
T ss_pred eeeecCCCc--cCccCCcCCcChhhccC------CCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhh
Confidence 998654332 13456699999999853 2256789999999999999999999999765322110000 0
Q ss_pred H--hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 171 F--KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 171 ~--~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
. .....+....+++.+.+++.+||..||.+|||+.++++
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 312 PGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred ccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 01111222478999999999999999999999999987
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-36 Score=250.39 Aligned_cols=191 Identities=23% Similarity=0.403 Sum_probs=158.0
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.||||+++++++. ++..++|||++.+ ++|.+++... ..+++..++.++.|++.||+|||+.||+||||||+||+++
T Consensus 106 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~ 183 (320)
T 3a99_A 106 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 183 (320)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred CCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEe
Confidence 4699999999985 4568999999976 8999999863 5699999999999999999999999999999999999998
Q ss_pred CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 84 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
.+.+.++|+|||++...... ......++..|+|||.+.. ....+.++||||||+++|+|++|..||.....
T Consensus 184 ~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~-------~~~~~~~~Di~slG~il~el~~g~~pf~~~~~- 254 (320)
T 3a99_A 184 LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE- 254 (320)
T ss_dssp TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-
T ss_pred CCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhcc-------CCCCCccchHHhHHHHHHHHHHCCCCCCChhh-
Confidence 65567999999998765432 2234568999999998853 23346789999999999999999999975321
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
........+..+++++.+++.+||..+|.+|||++++++ +.++.
T Consensus 255 -------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~--hp~~~ 298 (320)
T 3a99_A 255 -------IIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQ 298 (320)
T ss_dssp -------HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGS
T ss_pred -------hhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhc--CHhhc
Confidence 122334556789999999999999999999999999988 44443
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=255.83 Aligned_cols=199 Identities=23% Similarity=0.255 Sum_probs=155.2
Q ss_pred CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC-
Q 024401 7 HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP- 84 (268)
Q Consensus 7 Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~- 84 (268)
|++++.+++++. ++..++||||+ +++|.+++.......+++.+++.++.|++.||+|||+.||+||||||+||+++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 81 KFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp CSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCC
T ss_pred ceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecc
Confidence 444899999874 56789999999 678888887655567999999999999999999999999999999999999932
Q ss_pred -----------------CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 85 -----------------DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 85 -----------------~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
....++|+|||++...... .....+++.|+|||.+.+ ..++.++||||||+++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~slG~il 229 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILE--------LGWAQPCDVWSIGCIL 229 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeec--------CCCCCccchHHHHHHH
Confidence 3456999999999754332 234578999999999854 5678899999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHhhcCC------------------------------------------CCCCCCcHH
Q 024401 148 WELLTNRLPFEGMSNLQAAYAAAFKHARP------------------------------------------GLPEDISPD 185 (268)
Q Consensus 148 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------------------~~~~~~~~~ 185 (268)
|+|++|..||................... ......+.+
T Consensus 230 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (355)
T 2eu9_A 230 FEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQ 309 (355)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHH
Confidence 99999999998766543322211111000 001112457
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 186 LAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 186 l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+.+|+.+||..||.+|||++++++ +.++...
T Consensus 310 l~~li~~~L~~dP~~Rpt~~e~l~--hp~f~~~ 340 (355)
T 2eu9_A 310 LFDLMRRMLEFDPAQRITLAEALL--HPFFAGL 340 (355)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHTT--SGGGGGC
T ss_pred HHHHHHHHhcCChhhCcCHHHHhc--ChhhcCC
Confidence 899999999999999999999998 6666554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=253.74 Aligned_cols=198 Identities=22% Similarity=0.296 Sum_probs=155.4
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCeecCCCCCCEEE
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH--ANGIIHRDLKPDNLLL 82 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH--~~~i~H~dlk~~Nil~ 82 (268)
.|++|+++++++. ++..++||||+. ++|.+++.......+++..+..++.|++.||+||| +.||+||||||+|||+
T Consensus 114 ~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll 192 (382)
T 2vx3_A 114 MKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192 (382)
T ss_dssp GGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEE
T ss_pred cceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEE
Confidence 3456999999884 567999999995 59999998755567999999999999999999999 5799999999999999
Q ss_pred cC-CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 83 TP-DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 83 ~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
+. +.+.++|+|||++...... .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+.+
T Consensus 193 ~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 193 CNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLG--------MPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp SSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcC--------CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 63 3456999999999765432 334578999999999864 568899999999999999999999998776
Q ss_pred cHHHHHHHHHhhcCCC----------------CCC---------------------------------------------
Q 024401 162 NLQAAYAAAFKHARPG----------------LPE--------------------------------------------- 180 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~----------------~~~--------------------------------------------- 180 (268)
..............++ ++.
T Consensus 263 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 342 (382)
T 2vx3_A 263 EVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHT 342 (382)
T ss_dssp HHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCC
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCcccccccccc
Confidence 5544333222111000 000
Q ss_pred -CCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 181 -DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 181 -~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
....++.+|+.+||..||.+|||++++++ +.++.
T Consensus 343 ~~~~~~~~dli~~mL~~dP~~Rpta~e~L~--hp~f~ 377 (382)
T 2vx3_A 343 VADYLKFKDLILRMLDYDPKTRIQPYYALQ--HSFFK 377 (382)
T ss_dssp HHHHHHHHHHHHHHTCSCTTTSCCHHHHTT--SGGGC
T ss_pred chhhHHHHHHHHHhcCCChhhCCCHHHHhc--Ccccc
Confidence 00147899999999999999999999998 55553
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=256.94 Aligned_cols=201 Identities=23% Similarity=0.404 Sum_probs=145.4
Q ss_pred CCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 5 VKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNK-----LDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 5 l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~-----~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
.+||||+++++++. ++..++||||+. |+|.+++....... .++..++.++.|++.||+|||+.||+||||||+
T Consensus 66 ~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp TTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 38999999999985 456899999995 69999997632211 133356789999999999999999999999999
Q ss_pred CEEEcCC------------CCceEEeccCCcccCccccc-----ccCccCccceeccccccccccccccccCCCcccchH
Q 024401 79 NLLLTPD------------QKSLKLADFGLAREETVTEM-----MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 141 (268)
Q Consensus 79 Nil~~~~------------~~~~~l~Dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 141 (268)
||+++.+ ...++|+|||++........ .....||+.|+|||.+.+.... .....++.++|||
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~~~~~Diw 223 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL-QTKRRLTRSIDIF 223 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTT-SCCCCCCTHHHHH
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccc-ccccCcchhhhhH
Confidence 9999743 24699999999986543221 2234789999999988542110 1125678999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcC-CCC----CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 142 SFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHAR-PGL----PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 142 slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
||||++|+|++ |..||......... ....... ... ...++.++.+++.+||..||.+|||+.++++
T Consensus 224 SlG~il~ellt~g~~Pf~~~~~~~~~--i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 224 SMGCVFYYILSKGKHPFGDKYSRESN--IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHHHHHHHHHTTSCCTTCSTTTHHHH--HHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHHHHHHHHHhCCCCCCCCchhhHHH--HhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 99999999999 99999765543321 1111111 111 1124678999999999999999999999987
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=241.70 Aligned_cols=184 Identities=24% Similarity=0.453 Sum_probs=144.1
Q ss_pred CCCCCCcccceeeeee-----cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 3 SRVKHDNLVKFLGACK-----DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
+.++||||+++++++. +...++||||++|++|.+++.......+++.+++.++.|++.||+|||+.||+|+||||
T Consensus 66 ~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 145 (299)
T 3m2w_A 66 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 145 (299)
T ss_dssp HHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 3468999999999874 34689999999999999999875556799999999999999999999999999999999
Q ss_pred CCEEEcCC--CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 78 DNLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 78 ~Nil~~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
+||+++.+ ++.++|+|||++.... ...++.++||||||+++|+|++|..
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~-----------------------------~~~~~~~~DiwslG~il~el~tg~~ 196 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT-----------------------------GEKYDKSCDMWSLGVIMYILLCGYP 196 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT-----------------------------TCGGGGHHHHHHHHHHHHHHHHSSC
T ss_pred HHEEEecCCCCCcEEEeccccccccc-----------------------------cccCCchhhHHHHHHHHHHHHHCCC
Confidence 99999863 4569999999885422 1345679999999999999999999
Q ss_pred CCCCCCcHHHHHHH--HHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 156 PFEGMSNLQAAYAA--AFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 156 p~~~~~~~~~~~~~--~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
||............ .........+ ..++.++.+++.+||..||.+|||+.++++ +.++..
T Consensus 197 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~--hp~~~~ 262 (299)
T 3m2w_A 197 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIMQ 262 (299)
T ss_dssp SCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT--SHHHHT
T ss_pred CCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc--Chhhcc
Confidence 99764432211000 0001111122 467899999999999999999999999998 455543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=265.26 Aligned_cols=199 Identities=30% Similarity=0.370 Sum_probs=154.7
Q ss_pred CCCCCCCcccceeeeee-------cCCceEEEEcCCCCCHHHHHhhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 2 MSRVKHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLR-PNKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
|++++||||+++++++. ++..++||||++|++|.+++.... ...+++..++.++.|++.||+|||+.||+||
T Consensus 66 L~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHr 145 (676)
T 3qa8_A 66 MKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHR 145 (676)
T ss_dssp HHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCC
T ss_pred HHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 46789999999999863 346899999999999999998633 2369999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCC--ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 74 DLKPDNLLLTPDQK--SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 74 dlk~~Nil~~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||||+||+++.++. .++|+|||.+.............++..|+|||.+.+ ..++.++||||||+++|+|+
T Consensus 146 DLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~s~ksDIwSLGviLyeLl 217 (676)
T 3qa8_A 146 DLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ--------KKYTVTVDYWSFGTLAFECI 217 (676)
T ss_dssp CCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC--------SCCSTTHHHHHHHHHHHHHH
T ss_pred CCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc--------CCCCchhHHHHHHHHHHHHH
Confidence 99999999986543 489999999987665555556689999999999853 67889999999999999999
Q ss_pred hCCCCCCCCCcHHHHHH-------H-HH-h---h----------cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH
Q 024401 152 TNRLPFEGMSNLQAAYA-------A-AF-K---H----------ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQII 208 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~-------~-~~-~---~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l 208 (268)
+|..||........... . .. . . ........++..+.+++.+||..||.+|||+++++
T Consensus 218 tG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL 296 (676)
T 3qa8_A 218 TGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP 296 (676)
T ss_dssp SSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred HCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence 99999975432211000 0 00 0 0 00112233678899999999999999999998843
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=239.71 Aligned_cols=177 Identities=19% Similarity=0.215 Sum_probs=139.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..|+||||++|++|.+++.. .....++.+++.|++.||+|||+.||+||||||+||
T Consensus 85 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NI 160 (286)
T 3uqc_A 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRV 160 (286)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred HhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc----CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccE
Confidence 45789999999999985 5578999999999999999954 246668899999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
+++.+ +.++|++++ |++ .++.++||||||+++|+|++|+.||.+.
T Consensus 161 ll~~~-g~~kl~~~~-------------------~~~---------------~~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 161 RVSID-GDVVLAYPA-------------------TMP---------------DANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp EEETT-SCEEECSCC-------------------CCT---------------TCCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred EEcCC-CCEEEEecc-------------------ccC---------------CCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 99965 458887443 222 2467999999999999999999999865
Q ss_pred CcHHHHHH--HHHhhcCC---CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 161 SNLQAAYA--AAFKHARP---GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 161 ~~~~~~~~--~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
+....... ........ .....++.++.+++.+||+.||.+| |+.++++.|+......
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~ 267 (286)
T 3uqc_A 206 GVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVA 267 (286)
T ss_dssp SBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred CcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence 43211000 00000000 1235689999999999999999999 9999999999976544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=262.35 Aligned_cols=187 Identities=26% Similarity=0.327 Sum_probs=147.6
Q ss_pred CCCCCCCCcccceeeeeec-CC-----ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 1 MMSRVKHDNLVKFLGACKD-PL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
+|++++||||+++++++.+ +. .|+||||++|++|.+++.. .+++.+++.++.||+.||+|||+.||+|||
T Consensus 132 ~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrD 207 (681)
T 2pzi_A 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYND 207 (681)
T ss_dssp GGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecc
Confidence 3678999999999999843 23 6999999999999987753 699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+||+++.+ .++|+|||++...... ....||+.|+|||.+.+ ..+.++||||||+++|+|++|.
T Consensus 208 lkp~NIll~~~--~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~---------~~~~~sDi~slG~~l~~l~~g~ 273 (681)
T 2pzi_A 208 LKPENIMLTEE--QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRT---------GPTVATDIYTVGRTLAALTLDL 273 (681)
T ss_dssp CSGGGEEECSS--CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHH---------CSCHHHHHHHHHHHHHHHHSCC
T ss_pred cChHHeEEeCC--cEEEEecccchhcccC---CccCCCccccCHHHHcC---------CCCCceehhhhHHHHHHHHhCC
Confidence 99999999854 5999999999765433 34578999999998753 2378999999999999999998
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCC--CCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHhhh
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGL--PEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAFL 215 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~l~~l~~~~ 215 (268)
.||.+.... ..+.. ....++.+.+++.+||..||.+|| +++++...|....
T Consensus 274 ~~~~~~~~~----------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 274 PTRNGRYVD----------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CEETTEECS----------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCcccccc----------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 887642110 00000 011356799999999999999999 5677777666654
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=243.03 Aligned_cols=178 Identities=15% Similarity=0.195 Sum_probs=136.4
Q ss_pred CceEEEEcCCCCCHHHHHhh-----hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccC
Q 024401 21 LMVIVTELLPGMSLRKYLVS-----LRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFG 95 (268)
Q Consensus 21 ~~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg 95 (268)
..+++|++. +++|.+++.. .....+++..++.++.|++.||+|||+.||+||||||+|||++.++ .+||+|||
T Consensus 179 ~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DFG 256 (413)
T 3dzo_A 179 SRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFE 256 (413)
T ss_dssp SEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGG
T ss_pred ceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEecc
Confidence 356777777 7799999852 2234578889999999999999999999999999999999999664 59999999
Q ss_pred CcccCcccccccCccCccceeccccccccc--cccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhh
Q 024401 96 LAREETVTEMMTAETGTYRWMAPELYSTVT--LRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173 (268)
Q Consensus 96 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~ 173 (268)
++...... .....| +.|+|||.+.... ........++.++|||||||++|+|++|+.||..........
T Consensus 257 ~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~------ 327 (413)
T 3dzo_A 257 HLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSE------ 327 (413)
T ss_dssp GCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSG------
T ss_pred ceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHH------
Confidence 98765443 344466 9999999884311 000023557889999999999999999999997654322110
Q ss_pred cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 174 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
........+++++.+++.+||..+|.+||++.++++
T Consensus 328 ~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 328 WIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp GGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 011112468899999999999999999999877755
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=224.18 Aligned_cols=170 Identities=16% Similarity=0.129 Sum_probs=128.5
Q ss_pred cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCCEEEcCCC-----------
Q 024401 19 DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQ----------- 86 (268)
Q Consensus 19 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~dlk~~Nil~~~~~----------- 86 (268)
++..|+||||+++|++.+.+.. ..+++.++..++.||+.||+||| +.||+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~ 210 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred cCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCc
Confidence 4679999999999976666643 56899999999999999999999 99999999999999998654
Q ss_pred --------CceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHH-HHHHHhCCCCC
Q 024401 87 --------KSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIV-LWELLTNRLPF 157 (268)
Q Consensus 87 --------~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i-~~~ll~g~~p~ 157 (268)
..+||+|||+++..... ...||+.|+|||.+.+ . .+.++|||||+++ .++++.|..||
T Consensus 211 ~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g--------~-~~~~~Diwsl~~~~~~~~~~g~~p~ 277 (336)
T 2vuw_A 211 SSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG--------D-GDYQFDIYRLMKKENNNRWGEYHPY 277 (336)
T ss_dssp EEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC--------C-SSHHHHHHHHHHHHHTTCTTSCCTH
T ss_pred cccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC--------C-CccceehhhhhCCCCcccccccCCC
Confidence 26999999999865432 3378999999999863 2 2789999998777 66788899888
Q ss_pred CCCCcHHHHHHHHHhh-cCCC-----CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHH-H
Q 024401 158 EGMSNLQAAYAAAFKH-ARPG-----LPEDISPDLAFIVQSCWVEDPNLRPSFSQII-R 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l-~ 209 (268)
.+.............. .... .+..+++++.+|+.+||+.+ |+++++ +
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 278 SNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHH
T ss_pred cchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhc
Confidence 5321111111121211 1111 11246788999999999977 899988 5
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-32 Score=239.61 Aligned_cols=137 Identities=18% Similarity=0.227 Sum_probs=100.1
Q ss_pred CCCC-CCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRV-KHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|+++ .|+||+++++++++ +..||||||++|++|.+++.. ..++++. +|+.||+.||+|+|++||+||||||+|
T Consensus 295 l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeN 369 (569)
T 4azs_A 295 LTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWN 369 (569)
T ss_dssp HHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGG
T ss_pred HHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHh
Confidence 5566 79999999999965 479999999999999999986 3557764 588999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
||++.+ +.+||+|||+++..... .......||+.|+|||.+. +.+..++|+|++|++++++.++
T Consensus 370 ILL~~d-g~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~---------g~~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 370 VMVDAR-QHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFA---------ENKSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp EEECTT-SCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC--------------------------CCCCTT
T ss_pred EEECCC-CCEEEeecccCeeCCCCCccccCceechhhccHHHhC---------CCCCCcccccccccchhhhccc
Confidence 999966 46999999999865433 2334567999999999985 3456789999999998877554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-24 Score=189.94 Aligned_cols=137 Identities=20% Similarity=0.251 Sum_probs=110.8
Q ss_pred CCCCCCCcccceeeee-ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++..++ .++..++||||++|++|.+++.. +..++.|++.||+|||++||+||||||+||
T Consensus 393 l~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NI 462 (540)
T 3en9_A 393 LALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNF 462 (540)
T ss_dssp HHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSE
T ss_pred HHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHE
Confidence 5678999999544443 45567999999999999999874 578999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccccc--------ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEM--------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|++. .++|+|||+++....... .....||+.|+|||++... ...|+...|+|+..+-..+-+.
T Consensus 463 Ll~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~------~~~Y~~~~d~ws~vl~~l~~v~ 533 (540)
T 3en9_A 463 IFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERF------LEGYKSVYDRWEIILELMKDVE 533 (540)
T ss_dssp EESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHH------HHHHHHHCTTHHHHHHHHHHHH
T ss_pred EECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHH------HHHHHHHHhHHHHHHHHHHHHH
Confidence 9995 699999999987654322 1345789999999998642 1346677899998888887777
Q ss_pred CCCCC
Q 024401 153 NRLPF 157 (268)
Q Consensus 153 g~~p~ 157 (268)
++.+|
T Consensus 534 ~r~rY 538 (540)
T 3en9_A 534 RRARY 538 (540)
T ss_dssp TCSCC
T ss_pred hcccc
Confidence 66655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-17 Score=134.04 Aligned_cols=88 Identities=17% Similarity=0.128 Sum_probs=71.5
Q ss_pred cceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcCCCCceE
Q 024401 11 VKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLK 90 (268)
Q Consensus 11 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~ 90 (268)
+++.+.+..+..++||||++|++|.+ +.. .....++.|++.||+|||+.||+||||||+||+++ + +.++
T Consensus 164 ~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~-~~vk 232 (282)
T 1zar_A 164 LAVPKVYAWEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-E-EGIW 232 (282)
T ss_dssp SSSCCEEEEETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-T-TEEE
T ss_pred CCcCeEEeccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-C-CcEE
Confidence 56666666677899999999999988 421 23457999999999999999999999999999999 4 5699
Q ss_pred EeccCCcccCcccccccCccCccceeccccc
Q 024401 91 LADFGLAREETVTEMMTAETGTYRWMAPELY 121 (268)
Q Consensus 91 l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~ 121 (268)
|+|||++... ..+.|||.+
T Consensus 233 l~DFG~a~~~------------~~~~a~e~l 251 (282)
T 1zar_A 233 IIDFPQSVEV------------GEEGWREIL 251 (282)
T ss_dssp ECCCTTCEET------------TSTTHHHHH
T ss_pred EEECCCCeEC------------CCCCHHHHH
Confidence 9999998632 235677766
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=2e-15 Score=121.57 Aligned_cols=73 Identities=18% Similarity=0.170 Sum_probs=60.8
Q ss_pred CCceEEEEcCCC-C----CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCeecCCCCCCEEEcCCCCceEEec
Q 024401 20 PLMVIVTELLPG-M----SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLH-ANGIIHRDLKPDNLLLTPDQKSLKLAD 93 (268)
Q Consensus 20 ~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH-~~~i~H~dlk~~Nil~~~~~~~~~l~D 93 (268)
+..++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.||+||||||+|||++. .++|+|
T Consensus 141 ~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~liD 212 (258)
T 1zth_A 141 MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFID 212 (258)
T ss_dssp ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEECC
T ss_pred CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEEE
Confidence 356999999932 3 78887543 235567899999999999999 999999999999999985 599999
Q ss_pred cCCcccC
Q 024401 94 FGLAREE 100 (268)
Q Consensus 94 fg~~~~~ 100 (268)
||++...
T Consensus 213 FG~a~~~ 219 (258)
T 1zth_A 213 MGQAVTL 219 (258)
T ss_dssp CTTCEET
T ss_pred CcccccC
Confidence 9999653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.21 E-value=2.6e-12 Score=108.14 Aligned_cols=85 Identities=15% Similarity=0.218 Sum_probs=63.8
Q ss_pred CCcccceeeee-------ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 7 HDNLVKFLGAC-------KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 7 Hp~i~~~~~~~-------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|+|+.+++... .....++||||++|++|.++.. ......++.|++.+|.+||+.|||||||||.|
T Consensus 164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~N 235 (397)
T 4gyi_A 164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFN 235 (397)
T ss_dssp HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred HHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 66666665432 1123479999999988765422 12346788999999999999999999999999
Q ss_pred EEEcCCCC---------ceEEeccCCccc
Q 024401 80 LLLTPDQK---------SLKLADFGLARE 99 (268)
Q Consensus 80 il~~~~~~---------~~~l~Dfg~~~~ 99 (268)
||++.++. .+.|+||+.+..
T Consensus 236 ILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 236 ILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEEeCCCCcccccccccceEEEEeCCccc
Confidence 99985542 278999998754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.78 E-value=9.6e-09 Score=82.37 Aligned_cols=84 Identities=15% Similarity=0.105 Sum_probs=65.2
Q ss_pred CCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q 024401 7 HDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA------------------ 67 (268)
Q Consensus 7 Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~------------------ 67 (268)
|..+.++++++. ++..|+||||++|.+|.+.+.. ......++.+++.+|+.||+
T Consensus 69 ~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~ 141 (263)
T 3tm0_A 69 KLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp TSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred CCCCCeEEEEEecCCceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence 566778888774 4578999999999999876321 12235788899999999998
Q ss_pred -----------------------------------------CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 -----------------------------------------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 -----------------------------------------~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
..++|||+++.||+++. +..+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKD-GKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEEC-CcEEEEEEchhcc
Confidence 34899999999999984 4445699998663
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.65 E-value=5.9e-08 Score=81.49 Aligned_cols=89 Identities=20% Similarity=0.355 Sum_probs=70.3
Q ss_pred CCcccceeeeeecC----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh---------------
Q 024401 7 HDNLVKFLGACKDP----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------------- 67 (268)
Q Consensus 7 Hp~i~~~~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~--------------- 67 (268)
+..+.+++..+.+. ..|+||||++|.++.+.. ...++..+...++.+++..|+.||+
T Consensus 97 ~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~ 172 (359)
T 3dxp_A 97 DVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPG 172 (359)
T ss_dssp SSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCS
T ss_pred CCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCC
Confidence 45577888887543 478999999998775411 2347888899999999999999997
Q ss_pred -------------------------------------------CCCeecCCCCCCEEEcCCCC-ceEEeccCCccc
Q 024401 68 -------------------------------------------NGIIHRDLKPDNLLLTPDQK-SLKLADFGLARE 99 (268)
Q Consensus 68 -------------------------------------------~~i~H~dlk~~Nil~~~~~~-~~~l~Dfg~~~~ 99 (268)
.+++|||+++.||+++.++. .+.|+||+.+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 173 NYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999986543 358999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.57 E-value=7e-09 Score=85.14 Aligned_cols=132 Identities=20% Similarity=0.235 Sum_probs=82.1
Q ss_pred ceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------
Q 024401 22 MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA---------------------------------- 67 (268)
Q Consensus 22 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~---------------------------------- 67 (268)
.|+||++++|.+|.+... ..++..+...++.+++..++.||+
T Consensus 91 ~~~vm~~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELK 166 (304)
T ss_dssp SCEEEECCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSC
T ss_pred ceEEEcccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCC
Confidence 579999999998876433 237888888999999999999986
Q ss_pred ------------------------CCCeecCCCCCCEEEcCC-CCceEEeccCCcccCcccccccCccCccceecccccc
Q 024401 68 ------------------------NGIIHRDLKPDNLLLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYS 122 (268)
Q Consensus 68 ------------------------~~i~H~dlk~~Nil~~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 122 (268)
..++|||+++.||+++.+ +..+.|+||+.+.................-..|+...
T Consensus 167 ~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~ 246 (304)
T 3sg8_A 167 GPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHH
T ss_pred cccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHH
Confidence 136999999999999964 4557899999886432211000000000001122111
Q ss_pred ccccccc------cccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 123 TVTLRQG------EKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 123 ~~~~~~~------~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
..-...+ .........+.|+++.++|.+.+|..+|
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0000000 0011122358899999999999997664
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.47 E-value=1.6e-07 Score=74.81 Aligned_cols=78 Identities=19% Similarity=0.145 Sum_probs=57.0
Q ss_pred ccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------
Q 024401 10 LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG------------------- 69 (268)
Q Consensus 10 i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~------------------- 69 (268)
+.+++++.. ++..++||||++|.+|. ... .+. ..++.+++..|+.||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~ 146 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERART 146 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHH
Confidence 555777764 34689999999998884 211 122 356777888888888643
Q ss_pred ---------------------------------------CeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 70 ---------------------------------------IIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 70 ---------------------------------------i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
++|||++|.||+++. +..+.|+||+.+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~-~~~~~liD~~~a~ 213 (264)
T 1nd4_A 147 RMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVEN-GRFSGFIDCGRLG 213 (264)
T ss_dssp HHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEET-TEEEEECCCTTCE
T ss_pred HHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEEC-CcEEEEEcchhcc
Confidence 999999999999984 3445699999763
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.28 E-value=1.8e-05 Score=60.58 Aligned_cols=123 Identities=16% Similarity=0.165 Sum_probs=79.4
Q ss_pred CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCcc
Q 024401 32 MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAET 110 (268)
Q Consensus 32 ~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 110 (268)
.+|.+.+.. .+.+++++++|.++.|.+.+|.-+-. ..-...=+.|..|++..+|. |.+.+ +.+ ..
T Consensus 33 vSL~eIL~~-~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~-V~f~~-~~s-----------~~ 98 (229)
T 2yle_A 33 LSLEEILRL-YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA-VTLAP-AAD-----------DA 98 (229)
T ss_dssp EEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC-EEECC-C---------------
T ss_pred ccHHHHHHH-cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc-eeccc-ccc-----------cc
Confidence 389999987 46789999999999999999887722 11122334468899987754 54432 110 01
Q ss_pred CccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHH
Q 024401 111 GTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIV 190 (268)
Q Consensus 111 ~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 190 (268)
....+.+||... ...+.+.-|||||+++|..+--..| ...+..++++|.+||
T Consensus 99 ~~~~~~~pe~~~---------~~~te~~~IysLG~tLY~ALDygL~-------------------e~eE~eLS~~LE~LL 150 (229)
T 2yle_A 99 GEPPPVAGKLGY---------SQCMETEVIESLGIIIYKALDYGLK-------------------ENEERELSPPLEQLI 150 (229)
T ss_dssp --------CCSS---------SSSCHHHHHHHHHHHHHHHHTTTCC-------------------TTEEECCCHHHHHHH
T ss_pred cccCCCChhhcc---------ccchHHHHHHHHHHHHHHHhhcCCC-------------------cccchhhCHHHHHHH
Confidence 233567888652 3446788999999999999863332 112356899999999
Q ss_pred HHhhhh
Q 024401 191 QSCWVE 196 (268)
Q Consensus 191 ~~~l~~ 196 (268)
..|...
T Consensus 151 ~~Mt~~ 156 (229)
T 2yle_A 151 DHMANT 156 (229)
T ss_dssp HHHTTC
T ss_pred HHHHhc
Confidence 999866
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2.7e-05 Score=63.71 Aligned_cols=86 Identities=26% Similarity=0.249 Sum_probs=59.7
Q ss_pred ccceeeeee--cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------
Q 024401 10 LVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN------------------- 68 (268)
Q Consensus 10 i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~------------------- 68 (268)
+.+.+.++. ++..++|||+++|.+|.+... ..++..+...++.++...|+.||+.
T Consensus 74 VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~ 149 (306)
T 3tdw_A 74 IPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKI 149 (306)
T ss_dssp CCCEEEEEECTTSCEEEEEECCCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHH
T ss_pred CCCeEeecccCCCceEEEEeccCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHH
Confidence 445555552 446789999999998877432 1245666666666666666666643
Q ss_pred -----------------------------------------CCeecCCCCCCEEEcC---CCCceEEeccCCccc
Q 024401 69 -----------------------------------------GIIHRDLKPDNLLLTP---DQKSLKLADFGLARE 99 (268)
Q Consensus 69 -----------------------------------------~i~H~dlk~~Nil~~~---~~~~~~l~Dfg~~~~ 99 (268)
.++|||+++.||+++. ++..+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 150 LLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3499999999999986 244457999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.75 E-value=7.7e-05 Score=59.65 Aligned_cols=82 Identities=21% Similarity=0.204 Sum_probs=58.0
Q ss_pred ccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------
Q 024401 10 LVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-------------------- 68 (268)
Q Consensus 10 i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-------------------- 68 (268)
+.++++++. ++..++|||+++|.++.+..... ......+..++...|+.||..
T Consensus 82 VP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~ 155 (272)
T 4gkh_A 82 LPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQS 155 (272)
T ss_dssp CCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHH
T ss_pred cCeEEEEEEECCeEEEEEEeeCCccccccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHH
Confidence 556677764 45689999999999988865431 122345566677777777731
Q ss_pred --------------------------------------CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 --------------------------------------GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 --------------------------------------~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.++|||+++.||+++. ++.+-|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~-~~~~~viDwe~a~ 222 (272)
T 4gkh_A 156 RMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDE-GKLIGCIDVGRVG 222 (272)
T ss_dssp HHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEET-TEEEEECCCTTCE
T ss_pred HHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEEC-CeEEEEEECcccc
Confidence 1689999999999984 3445699998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00015 Score=60.38 Aligned_cols=30 Identities=17% Similarity=0.327 Sum_probs=24.7
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
..++|||+++.||+++ ++..+.|+||+.+.
T Consensus 222 ~~l~HgDl~~~Nil~~-~~~~~~vIDwe~a~ 251 (357)
T 3ats_A 222 PVLLWGDARVGNVLYR-DFQPVAVLDWEMVA 251 (357)
T ss_dssp CEEECSSCSGGGEEEE-TTEEEEECCGGGCE
T ss_pred ceEEeCCCCCCeEEEe-CCcEEEEEcccccc
Confidence 4689999999999998 44446899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.0067 Score=49.86 Aligned_cols=32 Identities=31% Similarity=0.484 Sum_probs=26.1
Q ss_pred CCCeecCCCCCCEEEcCC---CCceEEeccCCccc
Q 024401 68 NGIIHRDLKPDNLLLTPD---QKSLKLADFGLARE 99 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~---~~~~~l~Dfg~~~~ 99 (268)
..++|||+++.||+++.+ ...+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999853 14588999998864
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=96.28 E-value=0.006 Score=50.13 Aligned_cols=30 Identities=20% Similarity=0.343 Sum_probs=25.0
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
.+++|||+++.||+++.+ +.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~-~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGEN-EQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGG-GCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCC-CcEEEEehhhcc
Confidence 579999999999999744 358999998663
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.031 Score=45.17 Aligned_cols=29 Identities=21% Similarity=0.232 Sum_probs=23.3
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
.++|+|+.+.||+.+ ++ .+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~~-~~-~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLDT-GE-RMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEEC-SS-CEEECCCTTCEE
T ss_pred eeeccCCCcCCEEEC-CC-CEEEEecccccC
Confidence 379999999999954 43 479999987753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.0079 Score=51.23 Aligned_cols=33 Identities=24% Similarity=0.382 Sum_probs=27.4
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccC
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREE 100 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~ 100 (268)
+...++|||+++.||+++.++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC--EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC--CEEEeCcccccC
Confidence 456799999999999998553 899999988643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=94.16 E-value=0.039 Score=45.01 Aligned_cols=28 Identities=29% Similarity=0.312 Sum_probs=24.0
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
..++|||+++.||+++ + .+.|+||+.+.
T Consensus 195 ~~l~HgD~~~~Nil~~-~--~~~lIDfe~a~ 222 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D--GPMFVDLDDAR 222 (328)
T ss_dssp CEECCSSCSGGGEEES-S--SEEECCCTTCC
T ss_pred eeeeeCCCCcccEeEc-C--CCEEEECCCCC
Confidence 4589999999999998 4 58999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.69 E-value=0.027 Score=45.81 Aligned_cols=29 Identities=41% Similarity=0.568 Sum_probs=23.8
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
+++|+|+++.||+++.+ ..+.|+||+.+.
T Consensus 188 ~liHgDl~~~Nil~~~~-~~~~lIDf~~a~ 216 (322)
T 2ppq_A 188 GVIHADLFQDNVFFLGD-ELSGLIDFYFAC 216 (322)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred ccCCCCCCccCEEEeCC-ceEEEecchhcc
Confidence 68999999999999854 334799998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=92.40 E-value=0.11 Score=43.74 Aligned_cols=30 Identities=27% Similarity=0.377 Sum_probs=25.0
Q ss_pred hCCCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 67 ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 67 ~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
...++|||+++.||+++.+ .+.++||..+.
T Consensus 226 ~~~L~HGDl~~~Nil~~~~--~~~lID~e~a~ 255 (397)
T 2olc_A 226 AETLIHGDLHTGSIFASEH--ETKVIDPEFAF 255 (397)
T ss_dssp CCEEECSCCSGGGEEECSS--CEEECCCTTCE
T ss_pred CCceeeCCCCcCcEEEeCC--CeEEEeCcccc
Confidence 3579999999999999854 38899998765
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=92.01 E-value=0.12 Score=42.96 Aligned_cols=28 Identities=32% Similarity=0.494 Sum_probs=23.5
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
+++|+|+++.||+++.+ . +.|+||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~-~-~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK-C-LRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC--C-EEECCCTTCE
T ss_pred EEEeCCCCcccEEecCC-c-EEEEEecCCC
Confidence 58999999999999743 3 8999998775
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.75 E-value=0.1 Score=43.01 Aligned_cols=31 Identities=19% Similarity=0.334 Sum_probs=25.2
Q ss_pred CCCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 68 NGIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 68 ~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
..++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~-~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNE-ESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGG-GCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCC-CeEEEEECCCCee
Confidence 368999999999999844 3489999987653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.49 E-value=0.39 Score=36.64 Aligned_cols=117 Identities=11% Similarity=0.059 Sum_probs=72.1
Q ss_pred CCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEcC
Q 024401 5 VKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTP 84 (268)
Q Consensus 5 l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~~ 84 (268)
..||+.++.--.-.++. +++.|-...+...|-.. +..+..+.++++.+|+....+++.. +|--++|+|++++.
T Consensus 42 ~~~~~Fl~~~I~e~eD~--v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~r--~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 42 QHSPYFIDAELTELRDS--FQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRTR--YTFVLAPDELFFTR 114 (215)
T ss_dssp SCCTTBCCEEEEECSSE--EEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGSS--EECCCSGGGEEECT
T ss_pred ccCCcccceEEEEcccE--EEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcCc--eEEEEecceEEEcC
Confidence 35777776632223443 44444333333333322 3488999999999999988555444 78889999999996
Q ss_pred CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 85 DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 85 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+ +.+++.-.|+... ++|.. .+...-.-.+=|++..++.++..|+
T Consensus 115 ~-~~p~i~~RGik~~----------------l~P~~-------------~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 115 D-GLPIAKTRGLQNV----------------VDPLP-------------VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp T-SCEEESCCEETTT----------------BSCCC-------------CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred C-CCEEEEEccCccC----------------CCCCC-------------CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 6 4577766554322 12221 1222233467788899999988774
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.33 E-value=0.53 Score=35.99 Aligned_cols=114 Identities=10% Similarity=0.128 Sum_probs=70.7
Q ss_pred CCCcccceeeeeecCCceEEEEcCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCeecCCCCCCEEEc
Q 024401 6 KHDNLVKFLGACKDPLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMD-CLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~-~lH~~~i~H~dlk~~Nil~~ 83 (268)
.||++ ..--...++.+.+.++.-++ .++.. ++ .++..+.++++.+|+.... +++. -+|--++|+|++++
T Consensus 48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~-i~-----~~~~~eKlrll~nl~~L~~~~~~~--r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAA-IR-----KTTLLSRIRAAIHLVSKVKHHSAR--RLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS-EEEEEECSSEEEEEEECCTTCEEHHH-HH-----TSCHHHHHHHHHHHHHHHSSCCSS--SEECCCCGGGEEEC
T ss_pred cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHH-HH-----hcCHHHHHHHHHHHHHHHHHhhhC--ceeEEEeCceEEEe
Confidence 56666 22222344455555555433 34443 33 3889999999999988776 5544 47888999999999
Q ss_pred CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 84 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
.+ +.+++.-.|+-.. ++|..+ +...=.-.+=|++..++.++..|+
T Consensus 119 ~~-~~p~i~hRGi~~~----------------lpP~e~-------------~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 119 RA-LEPFFLHVGVKES----------------LPPDEW-------------DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp TT-CCEEESCCEETTT----------------BSSCSC-------------CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred CC-CcEEEEEcCCccc----------------CCCCCC-------------CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 55 5588876664322 233322 212223367788888988887763
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.29 E-value=0.21 Score=42.94 Aligned_cols=15 Identities=33% Similarity=0.414 Sum_probs=14.1
Q ss_pred CCeecCCCCCCEEEc
Q 024401 69 GIIHRDLKPDNLLLT 83 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~ 83 (268)
.++|+|+.+.||+++
T Consensus 291 v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 291 VLCHCDLLSSNIINT 305 (458)
T ss_dssp EEECSCCCGGGEEEC
T ss_pred eEEecCCCCCcEEee
Confidence 589999999999998
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=90.19 E-value=0.11 Score=44.42 Aligned_cols=17 Identities=35% Similarity=0.563 Sum_probs=14.8
Q ss_pred CCeecCCCCCCEEEcCC
Q 024401 69 GIIHRDLKPDNLLLTPD 85 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~ 85 (268)
.++|+|+.+.||+++.+
T Consensus 250 v~~H~Dl~~gNiL~~~~ 266 (429)
T 1nw1_A 250 TFCHNDLQEGNILLPKA 266 (429)
T ss_dssp EEECSCCCGGGEEEEC-
T ss_pred EEEeCCCCCCeEEeeCC
Confidence 48999999999999864
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=89.56 E-value=0.15 Score=42.72 Aligned_cols=30 Identities=33% Similarity=0.544 Sum_probs=25.0
Q ss_pred CCeecCCCCCCEEEcCC---CCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPD---QKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~---~~~~~l~Dfg~~~ 98 (268)
.++|+|+.+.||+++.+ .+.+.++||..+.
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 58999999999999865 2468999998775
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.06 E-value=0.29 Score=41.27 Aligned_cols=30 Identities=30% Similarity=0.500 Sum_probs=24.4
Q ss_pred CeecCCCCCCEEEc-----CCCCceEEeccCCccc
Q 024401 70 IIHRDLKPDNLLLT-----PDQKSLKLADFGLARE 99 (268)
Q Consensus 70 i~H~dlk~~Nil~~-----~~~~~~~l~Dfg~~~~ 99 (268)
++|+|+.+.||++. .+...+.++||-++..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 68999999999994 2345689999998864
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=83.34 E-value=0.64 Score=37.00 Aligned_cols=24 Identities=33% Similarity=0.313 Sum_probs=19.3
Q ss_pred CCeecCCCCCCEEEcCCCCceEEecc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADF 94 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Df 94 (268)
.++|||+++.||+++.++ ..+.|-
T Consensus 189 ~LvHGDlw~gNvl~~~~g--~~~iDp 212 (288)
T 3f7w_A 189 ARIHGDLWNGNVLWQDDG--AVVIDP 212 (288)
T ss_dssp EEECSCCSGGGEEEETTE--EEECSC
T ss_pred eeeecCCCCCcEEEcCCC--eEEEec
Confidence 589999999999999664 456664
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=80.15 E-value=0.6 Score=37.91 Aligned_cols=25 Identities=20% Similarity=0.331 Sum_probs=21.4
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccC
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFG 95 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg 95 (268)
.++|||+.+.|++++.++ +.|+|++
T Consensus 208 ~l~HgD~~~~N~l~~~~~--~~~iD~~ 232 (312)
T 3jr1_A 208 SILHGNLWIENCIQVDDK--IFVCNPA 232 (312)
T ss_dssp EEECSSCSGGGEEEETTE--EEECSCC
T ss_pred eeEeCCCCcCcEeecCCC--eEEEcCc
Confidence 589999999999998653 7789974
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 268 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-59 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 7e-56 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-54 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-53 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-53 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-52 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-52 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-51 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-49 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-48 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-48 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-47 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-47 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-47 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-46 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-42 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-40 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 8e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-33 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 8e-31 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-25 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 3e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 4e-67
Identities = 66/225 (29%), Positives = 114/225 (50%), Gaps = 14/225 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++ + +H N++ F+G P + IVT+ G SL +L + K ++ ++ A A+
Sbjct: 57 VLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQ 115
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMA 117
MD LHA IIHRDLK +N+ L D ++K+ DFGLA + + +G+ WMA
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR-- 175
PE+ +R +K Y+ + DVY+FGIVL+EL+T +LP+ ++N +
Sbjct: 175 PEV-----IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSP 229
Query: 176 --PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
+ + + ++ C + + RP F QI+ + +L
Sbjct: 230 DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 9e-59
Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 11/217 (5%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M +++H LV+ + I+TE + SL +L + KL ++ L+ A IA
Sbjct: 61 LMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAP 118
M + IHRDL+ N+L+ D S K+ADFGLAR E+ +W AP
Sbjct: 121 GMAFIEERNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E + + K DV+SFGI+L E++T+ + R
Sbjct: 180 EAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR 231
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
P++ +L +++ CW E P RP+F + +L F
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-58
Identities = 66/213 (30%), Positives = 104/213 (48%), Gaps = 13/213 (6%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M++++H NLV+ LG + + IVTE + SL YL S + L L F+LD+
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
AM+ L N +HRDL N+L++ D K++DFGL +E + +W AP
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKE--ASSTQDTGKLPVKWTAP 169
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E K ++ K DV+SFGI+LWE+ + L+ K +
Sbjct: 170 EALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA 221
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
P+ P + ++++CW D +RPSF Q+ L
Sbjct: 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 3e-58
Identities = 60/217 (27%), Positives = 106/217 (48%), Gaps = 20/217 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
M+ ++H N+V+F + + + +V+VTEL+ +L+ YL R + + V ++
Sbjct: 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--RFKVMKIKVLRSWC 118
Query: 56 LDIARAMDCLHANG--IIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
I + + LH IIHRDLK DN+ +T S+K+ D GLA + A GT
Sbjct: 119 RQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTP 177
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
+MAPE+Y ++ Y+ VDVY+FG+ + E+ T+ P+ N Y
Sbjct: 178 EFMAPEMY---------EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 228
Query: 174 ARPG-LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+P + P++ I++ C ++ + R S ++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-58
Identities = 51/223 (22%), Positives = 107/223 (47%), Gaps = 16/223 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M ++ + +V+ +G C+ +++V E+ G L K+LV + ++ + ++
Sbjct: 62 IMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSM 120
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWM 116
M L +HRDL N+LL K++DFGL++ +++ +A +W
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 175
APE + + ++++ DV+S+G+ +WE L+ + P++ M + A + R
Sbjct: 180 APECINF--------RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-VMAFIEQGKR 230
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
P + P+L ++ CW+ RP F + + + A ++L
Sbjct: 231 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (456), Expect = 2e-56
Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ S ++H N+++ G D + ++ E P ++ + L + +K D + ++A
Sbjct: 59 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQ--KLSKFDEQRTATYITELA 116
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A+ H+ +IHRD+KP+NLLL LK+ADFG + + T GT ++ PE
Sbjct: 117 NALSYCHSKRVIHRDIKPENLLLGSA-GELKIADFGWSVHAPSSRRTT-LCGTLDYLPPE 174
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ + ++ KVD++S G++ +E L + PFE + + P
Sbjct: 175 MIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI--SRVEFTFP 224
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ ++ ++ +P+ RP +++
Sbjct: 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 7e-56
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 8/212 (3%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+++ H N+VK L A + I+ E G ++ ++ L L
Sbjct: 62 ILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTL 120
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAP 118
A++ LH N IIHRDLK N+L T D +KLADFG++ + T T + + GT WMAP
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLD-GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAP 179
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA-AAFKHARPG 177
E+ T + + Y+ K DV+S GI L E+ P ++ ++ A +
Sbjct: 180 EVVMCETSKD---RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA 236
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P S + ++ C ++ + R + SQ+++
Sbjct: 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (451), Expect = 1e-55
Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 17/221 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M ++ + +V+ +G C+ ++V E+ L KYL R + + ++
Sbjct: 61 VMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSM 118
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWM 116
M L + +HRDL N+LL K++DFGL++ +E + T +W
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 175
APE + +++K DV+SFG+++WE + + P+ GM + A K R
Sbjct: 178 APECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-VTAMLEKGER 228
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216
G P ++ ++ CW D RP F+ + L + +
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (449), Expect = 7e-55
Identities = 58/227 (25%), Positives = 96/227 (42%), Gaps = 14/227 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ +++H N +++ G +V E G + V +P L
Sbjct: 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGAL 125
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
+ + LH++ +IHRD+K N+LL+ +KL DFG A GT WMAPE
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSFV---GTPYWMAPE 181
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ + ++ Y+ KVDV+S GI EL + P M+ + A Y A +
Sbjct: 182 V-----ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
S V SC + P RP+ +++ + F+ RPP+ +
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVLRERPPTVIMD 281
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 3e-54
Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 15/216 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
M + H NL++ G P M +VTEL P SL L L +A+ +A
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK-HQGHFLLGTLSRYAVQVAE 122
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRWM 116
M L + IHRDL NLLL +K+ DFGL R + M + W
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHAR 175
APE T + +++ D + FG+ LWE+ T + P+ G++ Q + + R
Sbjct: 182 APESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
PED D+ ++ CW P RP+F + L
Sbjct: 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-54
Identities = 59/220 (26%), Positives = 90/220 (40%), Gaps = 21/220 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNK--LDLHVALNFA 55
++ +KH N+V++ D + IV E G L + + LD L
Sbjct: 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVM 115
Query: 56 LDIARAMDCLH-----ANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAE 109
+ A+ H + ++HRDLKP N+ L Q ++KL DFGLAR T A
Sbjct: 116 TQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKAF 174
Query: 110 TGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAA 169
GT +M+PE + YN K D++S G +L+EL PF S +
Sbjct: 175 VGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGK 225
Query: 170 AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ +P S +L I+ RPS +I+
Sbjct: 226 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 7e-54
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 11/223 (4%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M +++H+ LV+ + + IVTE + SL +L L L ++ A IA
Sbjct: 65 VMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAP 118
M + +HRDL+ N+L+ + K+ADFGLAR E+ +W AP
Sbjct: 125 GMAYVERMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E + K DV+SFGI+L EL T + + R
Sbjct: 184 EAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 235
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPP 221
P + L ++ CW ++P RP+F + L + + P
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 278
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 1e-53
Identities = 56/217 (25%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
M + H ++VK +G + + I+ EL LR +L R LDL + +A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLST 119
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMAP 118
A+ L + +HRD+ N+L++ +KL DFGL+R E++ + +WMAP
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E + + + + DV+ FG+ +WE+L + + R +
Sbjct: 179 ESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM 230
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
P + P L ++ CW DP+ RP F+++ L+ L
Sbjct: 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 7e-53
Identities = 68/241 (28%), Positives = 98/241 (40%), Gaps = 35/241 (14%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRP---------------- 43
M H+N+V LGAC + ++ E L YL S R
Sbjct: 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153
Query: 44 -----NKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98
N L L FA +A+ M+ L +HRDL N+L+T K +K+ DFGLAR
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLAR 212
Query: 99 ---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-R 154
++ + +WMAPE Y K DV+S+GI+LWE+ +
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYTIKSDVWSYGILLWEIFSLGV 264
Query: 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214
P+ G+ Y + P + ++ I+QSCW D RPSF + L
Sbjct: 265 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324
Query: 215 L 215
L
Sbjct: 325 L 325
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-52
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 17/229 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M K+ N+V +L + + +V E L G SL + +D +
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECL 126
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAP 118
+A++ LH+N +IHRD+K DN+LL D S+KL DFG + T + + GT WMAP
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAP 185
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA-RPG 177
E+ + K Y KVD++S GI+ E++ P+ + L+A Y A
Sbjct: 186 EVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRPPSPSVP 226
PE +S + C D R S ++++ + FL +P S P
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLKIAKPLSSLTP 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 2e-52
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M + H+ LV+ G C + I+TE + L YL ++ L D+
Sbjct: 52 VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVC 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWMA 117
AM+ L + +HRDL N L+ +K++DFGL+R + RW
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 169
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 176
PE+ +++K D+++FG+++WE+ + ++P+E +N + A A + R
Sbjct: 170 PEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRL 220
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
P S + I+ SCW E + RP+F ++ +
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 169 bits (429), Expect = 4e-52
Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 12/218 (5%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M +KH NLV+ LG C ++P I+TE + +L YL ++ V L A I+
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 125
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMA 117
AM+ L IHRDL N L+ + +K+ADFGL+R +W A
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE + ++ K DV++FG++LWE+ T + +L Y K R
Sbjct: 185 PESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 236
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
PE + ++++CW +P+ RPSF++I +
Sbjct: 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 1e-51
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 17/222 (7%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+M H N++ LG C + ++V + LR ++ + + + + F L +
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQV 139
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMMTAETGTY 113
A+ M L + +HRDL N +L +K+ADFGLAR E T
Sbjct: 140 AKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
+WMA E T + + K DV+SFG++LWEL+T P N +
Sbjct: 199 KWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 250
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
R PE L ++ CW +RPSFS+++ ++A
Sbjct: 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 168 bits (427), Expect = 5e-51
Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
MS ++H LV A +D MV++ E + G L + + NK+ A+ + +
Sbjct: 76 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVC 134
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ + +H N +H DLKP+N++ T + + LKL DFGL + + TGT + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHARP 176
E+ K D++S G++ + LL+ PF G ++ + + +
Sbjct: 195 EVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD 246
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
IS D ++ + DPN R + Q +
Sbjct: 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 6e-51
Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 15/214 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ + H+N+VKF G ++ + + E G L + + A F +
Sbjct: 56 INKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE--PDIGMPEPDAQRFFHQLM 113
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWM 116
+ LH GI HRD+KP+NLLL +LK++DFGLA ++ GT ++
Sbjct: 114 AGVVYLHGIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAA-FKHAR 175
APEL ++ + VDV+S GIVL +L LP++ S+ Y+ K
Sbjct: 173 APELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY 225
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ I ++ VE+P+ R + I +
Sbjct: 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 6e-51
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 13/214 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M ++ H LV+ G C + + +V E + L YL + + L LD+
Sbjct: 53 VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVC 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR--EETVTEMMTAETGTYRWMA 117
M L +IHRDL N L+ + + +K++DFG+ R + T +W +
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWAS 170
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE++S Y++K DV+SFG+++WE+ + + R
Sbjct: 171 PEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 222
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
P S + I+ CW E P RP+FS+++R L
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 167 bits (424), Expect = 1e-50
Identities = 45/213 (21%), Positives = 95/213 (44%), Gaps = 13/213 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M+++ H L+ A +D MV++ E L G L + + K+ +N+
Sbjct: 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQAC 137
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQK-SLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ +H + I+H D+KP+N++ + S+K+ DFGLA + E++ T T + AP
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-- 176
E+ +++ D+++ G++ + LL+ PF G +L+
Sbjct: 198 EIV--------DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE 249
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+SP+ +++ ++P R + +
Sbjct: 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (412), Expect = 1e-49
Identities = 51/213 (23%), Positives = 88/213 (41%), Gaps = 9/213 (4%)
Query: 1 MMSRVK-HDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
++ +V H N+++ + +V +L+ L YL L +
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT--EKVTLSEKETRKIMRAL 119
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ LH I+HRDLKP+N+LL D +KL DFG + + E + GT ++AP
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ Y +VD++S G++++ LL PF + + + G
Sbjct: 179 EIIE--CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS 236
Query: 179 PE--DISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
PE D S + +V V P R + + +
Sbjct: 237 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-49
Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 26/231 (11%)
Query: 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYL--------------VSLRPNK 45
+ H N++ LGAC+ + + E P +L +L + +
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 46 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEM 105
L L+FA D+AR MD L IHRDL N+L+ + K+ADFGL+R + V
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV-AKIADFGLSRGQEVYVK 182
Query: 106 MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQ 164
T RWMA E + Y DV+S+G++LWE+++ P+ GM
Sbjct: 183 KTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-TCA 233
Query: 165 AAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
Y + R P + ++ +++ CW E P RPSF+QI+ LN L
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (412), Expect = 4e-49
Identities = 38/213 (17%), Positives = 96/213 (45%), Gaps = 13/213 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+++ +H N++ + + +V++ E + G+ + + + + +L+ +++ +
Sbjct: 54 ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVC 112
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKS-LKLADFGLAREETVTEMMTAETGTYRWMAP 118
A+ LH++ I H D++P+N++ + S +K+ +FG AR+ + + AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP-- 176
E++ + + D++S G +++ LL+ PF +N Q
Sbjct: 173 EVH--------QHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE 224
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
++IS + V V++ R + S+ ++
Sbjct: 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 5e-49
Identities = 60/243 (24%), Positives = 108/243 (44%), Gaps = 16/243 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+M+ V + ++ + LG C + ++T+L+P L Y+ + + LN+ + IA+
Sbjct: 64 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAK 122
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWMA 117
M+ L ++HRDL N+L+ + +K+ DFGLA+ E +WMA
Sbjct: 123 GMNYLEDRRLVHRDLAARNVLVKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN-RLPFEGMSNLQAAYAAAFKHARP 176
E + Y ++ DV+S+G+ +WEL+T P++G+ + K R
Sbjct: 182 LESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSILEKGERL 232
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL-RPPSPSVPESDTNEAAA 235
P + D+ I+ CW+ D + RP F ++I + R E +
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPT 292
Query: 236 TSN 238
SN
Sbjct: 293 DSN 295
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (407), Expect = 9e-49
Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 17/211 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+MSR+ H VK +D + L KY+ + D + +I
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR--KIGSFDETCTRFYTAEIV 118
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTYRWM 116
A++ LH GIIHRDLKP+N+LL D +++ DFG A+ E+ + GT +++
Sbjct: 119 SALEYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARP 176
+PEL + K D+++ G ++++L+ PF +
Sbjct: 178 SPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ--KIIKLEY 227
Query: 177 GLPEDISPDLAFIVQSCWVEDPNLRPSFSQI 207
PE P +V+ V D R ++
Sbjct: 228 DFPEKFFPKARDLVEKLLVLDATKRLGCEEM 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 161 bits (407), Expect = 1e-48
Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 19/223 (8%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M + H N++ G ++I+TE + SL +L + + + IA
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIA 138
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR------EETVTEMMTAETGTY 113
M L +HRDL N+L+ + K++DFGL+R +
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFK 172
RW APE + + + DV+S+GIV+WE+++ P+ M+N Q A +
Sbjct: 198 RWTAPEAIQY--------RKFTSASDVWSYGIVMWEVMSYGERPYWDMTN-QDVINAIEQ 248
Query: 173 HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
R P D L ++ CW +D N RP F QI+ L+ +
Sbjct: 249 DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-48
Identities = 55/220 (25%), Positives = 96/220 (43%), Gaps = 15/220 (6%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+M + H N+++ G M+I+TE + +L K+L + + + + IA
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIA 120
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETGTYRW 115
M L +HRDL N+L+ + K++DFGL+R + T + RW
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 116 MAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHAR 175
APE S + + + DV+SFGIV+WE++T + A R
Sbjct: 180 TAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR 231
Query: 176 PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
P D + ++ CW ++ RP F+ I+ +L+ +
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 1e-47
Identities = 48/253 (18%), Positives = 90/253 (35%), Gaps = 56/253 (22%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +V F GA + I E + G SL + L + ++ + ++ +
Sbjct: 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVI 114
Query: 60 RAMDCLH-ANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAP 118
+ + L + I+HRD+KP N+L+ + +KL DFG++ + + M + GT +M+P
Sbjct: 115 KGLTYLREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQ-LIDSMANSFVGTRSYMSP 172
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN---------------- 162
E HY+ + D++S G+ L E+ R P
Sbjct: 173 ERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224
Query: 163 -------------------------LQAAYAAAFKHARPGLPED-ISPDLAFIVQSCWVE 196
+ P LP S + V C ++
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284
Query: 197 DPNLRPSFSQIIR 209
+P R Q++
Sbjct: 285 NPAERADLKQLMV 297
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 1e-47
Identities = 62/238 (26%), Positives = 100/238 (42%), Gaps = 37/238 (15%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN--------------- 44
+M+ + N+VK LG C M ++ E + L ++L S+ P+
Sbjct: 69 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 45 -------KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLA 97
L L A +A M L +HRDL N L+ + +K+ADFGL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLS 187
Query: 98 R---EETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-N 153
R + + RWM PE Y + DV+++G+VLWE+ +
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYTTESDVWAYGVVLWEIFSYG 239
Query: 154 RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
P+ GM++ + Y PE+ +L +++ CW + P RPSF I R+L
Sbjct: 240 LQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 5e-47
Identities = 49/222 (22%), Positives = 92/222 (41%), Gaps = 21/222 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-----MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
+ ++V+ + ++ ++IV E L G L + A
Sbjct: 58 HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM 117
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLT--PDQKSLKLADFGLAREETVTEMMTAETGTY 113
I A+ LH+ I HRD+KP+NLL T LKL DFG A+E T +T T
Sbjct: 118 KSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTP 177
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAF 171
++APE+ + Y+ D++S G++++ LL PF L +
Sbjct: 178 YYVAPEVLG--------PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 229
Query: 172 KHARPGLPE----DISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ + P ++S ++ ++++ +P R + ++ +
Sbjct: 230 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 7e-47
Identities = 53/250 (21%), Positives = 95/250 (38%), Gaps = 44/250 (17%)
Query: 1 MMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
++H+N++ F+ A + +V++ SL YL + + + A
Sbjct: 50 QTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLA 106
Query: 56 LDIARAMDCLHA--------NGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETV 102
L A + LH I HRDLK N+L+ + + +AD GLA +T+
Sbjct: 107 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTI 165
Query: 103 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162
GT R+MAPE+ + + + D+Y+ G+V WE+ +
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFE--SFKRADIYAMGLVFWEIARRCSIGGIHED 223
Query: 163 LQAAY---------------AAAFKHARPGLPE-----DISPDLAFIVQSCWVEDPNLRP 202
Q Y + RP +P + +A I++ CW + R
Sbjct: 224 YQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 203 SFSQIIRMLN 212
+ +I + L+
Sbjct: 284 TALRIKKTLS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-46
Identities = 68/233 (29%), Positives = 106/233 (45%), Gaps = 31/233 (13%)
Query: 1 MMSRVK-HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPN-------------- 44
++S + H N+V LGAC +++TE L +L R +
Sbjct: 79 VLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138
Query: 45 --KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---E 99
LDL L+F+ +A+ M L + IHRDL N+LLT + + K+ DFGLAR
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKN 197
Query: 100 ETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP-FE 158
++ + +WMAPE Y + DV+S+GI LWEL + +
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVWSYGIFLWELFSLGSSPYP 249
Query: 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
GM Y + R PE ++ I+++CW DP RP+F QI++++
Sbjct: 250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 154 bits (389), Expect = 8e-46
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 15/214 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++KH N+V + + ++ +L+ G L +V A +
Sbjct: 60 VLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV--EKGFYTERDASRLIFQVL 117
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKS--LKLADFGLAREETVTEMMTAETGTYRWMA 117
A+ LH GI+HRDLKP+NLL + + ++DFGL++ E +++ GT ++A
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVA 177
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE+ + K Y+ VD +S G++ + LL PF ++ +
Sbjct: 178 PEVLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD 229
Query: 178 LP--EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P +DIS ++ +DP R + Q ++
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-45
Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 1 MMSRVKHDNLVKFLGAC-KDPLMVIVTELLPGMSLRKYLVSLRP--------NKLDLHVA 51
+M ++V+ LG + +++ EL+ L+ YL SLRP L
Sbjct: 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTA 108
+ A +IA M L+AN +HRDL N ++ D ++K+ DFG+ R E
Sbjct: 136 IQMAGEIADGMAYLNANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 109 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAY 167
RWM+PE + DV+SFG+VLWE+ T P++G+SN Q
Sbjct: 195 GLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-L 245
Query: 168 AAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211
+ P++ L +++ CW +P +RPSF +II +
Sbjct: 246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-45
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 15/211 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ +H L + + V E L G L ++ +K DL A +A +I
Sbjct: 56 LSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ--SCHKFDLSRATFYAAEII 113
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 118
+ LH+ GI++RDLK DN+LL D K+ADFG+ +E GT ++AP
Sbjct: 114 LGLQFLHSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAP 172
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ + YN+ VD +SFG++L+E+L + PF G + + + + P
Sbjct: 173 EILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH--SIRMDNPFY 222
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P + + ++ +V +P R IR
Sbjct: 223 PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 9e-45
Identities = 65/233 (27%), Positives = 107/233 (45%), Gaps = 27/233 (11%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMV-IVTELLPGMSLRKYLVSLRP--------------NK 45
M KH N++ LGAC + ++ E +LR+YL + RP +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 46 LDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETV 102
L ++ A +AR M+ L + IHRDL N+L+T D K+ADFGLAR
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHHIDY 190
Query: 103 TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSN 162
+ T +WMAPE + Y ++ DV+SFG++LWE+ T
Sbjct: 191 YKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 163 LQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
++ + + R P + + +L +++ CW P+ RP+F Q++ L+ +
Sbjct: 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-44
Identities = 44/212 (20%), Positives = 91/212 (42%), Gaps = 20/212 (9%)
Query: 1 MMSRVK--HDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
++ +V +++ L + P V++ E + ++ L +A +F
Sbjct: 60 LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT-ERGALQEELARSFFWQ 118
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
+ A+ H G++HRD+K +N+L+ ++ LKL DFG T + T GT +
Sbjct: 119 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSP 177
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPG 177
PE +++ V+S GI+L++++ +PFE + +
Sbjct: 178 PEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------IRGQVF 222
Query: 178 LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ +S + +++ C P+ RP+F +I
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 8e-44
Identities = 62/235 (26%), Positives = 107/235 (45%), Gaps = 29/235 (12%)
Query: 1 MMSRVKHDNLVKFLGACKDP--LMVIVTELLPGMSLRKYLVS--------------LRPN 44
++ H N+V LGAC P ++++ E +L YL S L +
Sbjct: 70 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129
Query: 45 KLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EET 101
L L + ++ +A+ M+ L + IHRDL N+LL+ +K+ DFGLAR ++
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP 188
Query: 102 VTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFEGM 160
+WMAPE + Y + DV+SFG++LWE+ + P+ G+
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240
Query: 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215
+ + R P+ +P++ + CW +P+ RP+FS+++ L L
Sbjct: 241 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 145 bits (367), Expect = 5e-43
Identities = 55/219 (25%), Positives = 90/219 (41%), Gaps = 20/219 (9%)
Query: 1 MMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
+ + H +V + PL IV E + G++LR + + A+
Sbjct: 60 NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH--TEGPMTPKRAIEVI 117
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQK---SLKLADFGLAREETVTEMMTAETGT 112
D +A++ H NGIIHRD+KP N++++ +A A GT
Sbjct: 118 ADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK 172
++++PE + + DVYS G VL+E+LT PF G S + AY +
Sbjct: 178 AQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
Query: 173 HARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
P E +S DL +V ++P R + +R
Sbjct: 230 DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR 268
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 2e-42
Identities = 46/215 (21%), Positives = 89/215 (41%), Gaps = 16/215 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ ++H N++ ++ ++++ EL+ G L +L L A F I
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA--EKESLTEEEATEFLKQIL 123
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPD---QKSLKLADFGLAREETVTEMMTAETGTYRWM 116
+ LH+ I H DLKP+N++L + +K+ DFGLA + GT ++
Sbjct: 124 NGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFV 183
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA--AAFKHA 174
APE+ + + D++S G++ + LL+ PF G + + A
Sbjct: 184 APEIV--------NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
+ S ++ V+DP R + ++
Sbjct: 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 7e-42
Identities = 56/207 (27%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
M+S V H +++ G +D + ++ + + G L L + + VA +A ++
Sbjct: 57 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR--KSQRFPNPVAKFYAAEVC 114
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
A++ LH+ II+RDLKP+N+LL + +K+ DFG A+ V ++ GT ++APE
Sbjct: 115 LALEYLHSKDIIYRDLKPENILLDKN-GHIKITDFGFAKY--VPDVTYTLCGTPDYIAPE 171
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ ST K YN +D +SFGI+++E+L PF + ++ +A P
Sbjct: 172 VVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE--KILNAELRFP 221
Query: 180 EDISPDLAFIVQSCWVEDPNLRPSFSQ 206
+ D+ ++ D + R Q
Sbjct: 222 PFFNEDVKDLLSRLITRDLSQRLGNLQ 248
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (361), Expect = 3e-41
Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 24/247 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++S +V A P + + +L+ G L +L +A +I
Sbjct: 60 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD--MRFYAAEII 117
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
++ +H +++RDLKP N+LL + ++++D GLA + + A GT+ +MAPE
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPE 175
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL-QAAYAAAFKHARPGL 178
+ Y++ D +S G +L++LL PF + L
Sbjct: 176 VLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL 228
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPSFSQI----------IRMLN-AFLFTLRPPSPSVPE 227
P+ SP+L +++ D N R R L+ +F + P P +P
Sbjct: 229 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 288
Query: 228 SDTNEAA 234
AA
Sbjct: 289 RGEVNAA 295
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (348), Expect = 5e-40
Identities = 43/236 (18%), Positives = 81/236 (34%), Gaps = 28/236 (11%)
Query: 1 MMSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
+ ++ + + C + V+V ELL + K L L A +
Sbjct: 55 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQM 112
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKL--ADFGLAR--------EETVTEMMTA 108
++ +H+ IHRD+KPDN L+ +K + DFGLA+ +
Sbjct: 113 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172
Query: 109 ETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA 168
TGT R+ + + + + D+ S G VL LP++G+
Sbjct: 173 LTGTARYASINTHLG--------IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK 224
Query: 169 AAFKHAR------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218
+ L + + A + C + +P +S + ++
Sbjct: 225 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-38
Identities = 58/261 (22%), Positives = 96/261 (36%), Gaps = 44/261 (16%)
Query: 1 MMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNK-LDLHVAL 52
+M ++ H N+V+ + +V + +P R R + L +
Sbjct: 66 IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVK 125
Query: 53 NFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGT 112
+ + R++ +H+ GI HRD+KP NLLL PD LKL DFG A++ E + +
Sbjct: 126 LYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 113 YRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA---- 168
+ APEL Y + +DV+S G VL ELL + F G S +
Sbjct: 186 RYYRAPELIF-------GATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 238
Query: 169 -----------AAFKHARPGLPE------------DISPDLAFIVQSCWVEDPNLRPSFS 205
+ P+ P+ + P R +
Sbjct: 239 LGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298
Query: 206 QIIRMLNAFLFTLRPPSPSVP 226
+ ++F LR P+ +P
Sbjct: 299 EACA--HSFFDELRDPNVKLP 317
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-38
Identities = 49/205 (23%), Positives = 86/205 (41%), Gaps = 15/205 (7%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +H L A + + V E G L +L R A + +I
Sbjct: 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS--RERVFTEERARFYGAEIV 115
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE-ETVTEMMTAETGTYRWMAP 118
A++ LH+ +++RD+K +NL+L D +K+ DFGL +E + M GT ++AP
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
E+ Y VD + G+V++E++ RLPF + +
Sbjct: 175 EVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--LMEEIRF 224
Query: 179 PEDISPDLAFIVQSCWVEDPNLRPS 203
P +SP+ ++ +DP R
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 4e-37
Identities = 52/240 (21%), Positives = 87/240 (36%), Gaps = 41/240 (17%)
Query: 1 MMSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 54
+ +H N+V+ C + +V E + YL + + +
Sbjct: 63 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDM 121
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 114
+ R +D LH++ ++HRDLKP N+L+T +KLADFGLAR + +T+ T
Sbjct: 122 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLW 180
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHA 174
+ APE+ Y VD++S G + E+ + F G S++
Sbjct: 181 YRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 232
Query: 175 RPG-------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
PG DI ++ C +P R S +
Sbjct: 233 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 129 bits (325), Expect = 1e-36
Identities = 34/238 (14%), Positives = 74/238 (31%), Gaps = 28/238 (11%)
Query: 1 MMSRVKH-DNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
+ + ++ L ++ L G SL L K + A +
Sbjct: 53 TYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL-CGRKFSVKTVAMAAKQML 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLT----PDQKSLKLADFGLAR--------EETVTEMMT 107
+ +H +++RD+KPDN L+ + + + DFG+ + +
Sbjct: 112 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 108 AETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY 167
+GT R+M+ + + + + D+ + G V L LP++G+
Sbjct: 172 NLSGTARYMSINTH--------LGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 223
Query: 168 A------AAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219
L + + + P + + + + L L
Sbjct: 224 KYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 1e-35
Identities = 57/253 (22%), Positives = 102/253 (40%), Gaps = 38/253 (15%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
++ + H N+VK L + + L+K++ + + L + ++ + +
Sbjct: 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQ 113
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPE 119
+ H++ ++HRDLKP NLL+ + ++KLADFGLAR V T E T + APE
Sbjct: 114 GLAFCHSHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYA----------- 168
+ K+Y+ VD++S G + E++T R F G S + +
Sbjct: 173 ILL-------GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV 225
Query: 169 -----AAFKHARPGLPE-----------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
+ +P P+ + D ++ DPN R S +
Sbjct: 226 VWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH-- 283
Query: 213 AFLFTLRPPSPSV 225
F + P P +
Sbjct: 284 PFFQDVTKPVPHL 296
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-35
Identities = 57/247 (23%), Positives = 89/247 (36%), Gaps = 49/247 (19%)
Query: 1 MMSRVKHDNLVKFLGACKDPLM-----VIVTELLPGMSLRKYLVSLRPNKLDLHVALNFA 55
++ R +H+N++ + P + V + L G L K L + L F
Sbjct: 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL---KTQHLSNDHICYFL 115
Query: 56 LDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR----EETVTEMMTAETG 111
I R + +H+ ++HRDLKP NLLL LK+ DFGLAR + T +T
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVA 174
Query: 112 TYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAF 171
T + APE+ K Y +D++S G +L E+L+NR F G L
Sbjct: 175 TRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227
Query: 172 KHARPG-----------------------------LPEDISPDLAFIVQSCWVEDPNLRP 202
P L + ++ +P+ R
Sbjct: 228 ILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287
Query: 203 SFSQIIR 209
Q +
Sbjct: 288 EVEQALA 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-35
Identities = 56/252 (22%), Positives = 96/252 (38%), Gaps = 40/252 (15%)
Query: 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ + H N++ L A + +V + + ++ L + L
Sbjct: 53 LLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV--IIKDNSLVLTPSHIKAYMLMTL 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAP 118
+ ++ LH + I+HRDLKP+NLLL + LKLADFGLA+ T + T + AP
Sbjct: 111 QGLEYLHQHWILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAP 169
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGL 178
EL + Y VD+++ G +L ELL G S+L P
Sbjct: 170 ELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222
Query: 179 PE--------------------------DISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212
+ DL ++Q ++ +P R + +Q ++M
Sbjct: 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM-- 280
Query: 213 AFLFTLRPPSPS 224
+ P+P
Sbjct: 281 KYFSNRPGPTPG 292
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 1e-34
Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 15/212 (7%)
Query: 1 MMSRVKH-DNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDI 58
++ ++ LV A + + ++ + + G L +L + + H + +I
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS--QRERFTEHEVQIYVGEI 138
Query: 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLARE--ETVTEMMTAETGTYRWM 116
A++ LH GII+RD+K +N+LL + + L DFGL++E TE GT +M
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 117 APELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS--NLQAAYAAAFKHA 174
AP++ +G ++ VD +S G++++ELLT PF N QA + +
Sbjct: 198 APDIV------RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251
Query: 175 RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206
P P+++S ++Q ++DP R
Sbjct: 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 121 bits (305), Expect = 8e-34
Identities = 53/238 (22%), Positives = 86/238 (36%), Gaps = 39/238 (16%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +KH N+VK +V+V E L + V L+ A +F L +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFLLQLL 110
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRW-MAP 118
+ H ++HRDLKP NLL+ + LK+ADFGLAR + W AP
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQ-------------- 164
++ K Y+ +D++S G + E++ F G+S
Sbjct: 170 DVLM-------GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222
Query: 165 ---------AAYAAAFKHARPG----LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
Y F P + + ++ DPN R + Q +
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 122 bits (307), Expect = 2e-33
Identities = 52/215 (24%), Positives = 89/215 (41%), Gaps = 21/215 (9%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVI-VTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ V LVK + KD + V E + G + +L R + A +A I
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR--RIGRFSEPHARFYAAQIV 151
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPE 119
+ LH+ +I+RDLKP+NLL+ +++ DFG A+ GT +APE
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQ-GYIQVTDFGFAKRV--KGRTWTLCGTPEALAPE 208
Query: 120 LYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKHARPGLP 179
+ + K YN VD ++ G++++E+ PF +Q + P
Sbjct: 209 IILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE--KIVSGKVRFP 258
Query: 180 EDISPDLAFIVQSCWVEDP-----NLRPSFSQIIR 209
S DL ++++ D NL+ + I
Sbjct: 259 SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 121 bits (304), Expect = 3e-33
Identities = 40/248 (16%), Positives = 83/248 (33%), Gaps = 51/248 (20%)
Query: 1 MMSRVKHDNLVKFLGACKDP---LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+ + N++ KDP +V E + ++ L + + +
Sbjct: 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYE 137
Query: 58 IARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMA 117
I +A+D H+ GI+HRD+KP N+++ + + L+L D+GLA + + +
Sbjct: 138 ILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG 197
Query: 118 PELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK----- 172
PEL + + Y+ +D++S G +L ++ + PF + K
Sbjct: 198 PELLV-------DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250
Query: 173 -------------------------------HARPGLPEDISPDLAFIVQSCWVEDPNLR 201
+SP+ + D R
Sbjct: 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310
Query: 202 PSFSQIIR 209
+ + +
Sbjct: 311 LTAREAME 318
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 1e-31
Identities = 50/267 (18%), Positives = 90/267 (33%), Gaps = 56/267 (20%)
Query: 1 MMSRVKHDNLVKFLGACKDP---------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVA 51
++ +KH+N+V + C+ + +V + L K L
Sbjct: 62 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEI 119
Query: 52 LNFALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAR-----EETVTEMM 106
+ + +H N I+HRD+K N+L+T D LKLADFGLAR + +
Sbjct: 120 KRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRY 178
Query: 107 TAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQA- 165
T T + PEL ++ Y +D++ G ++ E+ T +G +
Sbjct: 179 TNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231
Query: 166 ------------------------AYAAAFKHARPGLPEDI-----SPDLAFIVQSCWVE 196
K + + + + P ++ V
Sbjct: 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291
Query: 197 DPNLRPSFSQIIRMLNAFLFTLRPPSP 223
DP R + + F ++ PS
Sbjct: 292 DPAQRIDSDDALN--HDFFWSDPMPSD 316
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 8e-31
Identities = 44/251 (17%), Positives = 93/251 (37%), Gaps = 42/251 (16%)
Query: 1 MMSRVKHDNLVKFLGACKDPL-MVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIA 59
++ +KH N+V+ + +V E + + + + +F +
Sbjct: 54 LLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE--IVKSFLFQLL 111
Query: 60 RAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAP 118
+ + H+ ++HRDLKP NLL+ + + KLA+FGLAR + +AE T + P
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPP 170
Query: 119 ELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFK------ 172
++ K Y+ +D++S G + EL P +++ F+
Sbjct: 171 DVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 223
Query: 173 ----------------------HARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRM 210
+ + ++ ++Q+ +P R S + ++
Sbjct: 224 EEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ- 282
Query: 211 LNAFLFTLRPP 221
+ + PP
Sbjct: 283 -HPYFSDFCPP 292
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-29
Identities = 57/269 (21%), Positives = 101/269 (37%), Gaps = 54/269 (20%)
Query: 1 MMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 53
++ ++H+N++ L +V + + ++ KL
Sbjct: 70 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKL----MKHEKLGEDRIQF 125
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
+ + + +HA GIIHRDLKP NL + D + K+ DFGLAR+ MT T
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQ--ADSEMTGYVVTR 182
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY------ 167
+ APE+ Y VD++S G ++ E++T + F+G +L
Sbjct: 183 WYRAPEVIL-------NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 168 ------------AAAFKHARPGLPE-----------DISPDLAFIVQSCWVEDPNLRPSF 204
+ K+ GLPE + SP +++ V D R +
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295
Query: 205 SQIIRMLNAFLFTLRPPS--PSVPESDTN 231
+ + + +L P V + D +
Sbjct: 296 GEALAH--PYFESLHDTEDEPQVQKYDDS 322
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99 bits (248), Expect = 5e-25
Identities = 60/258 (23%), Positives = 97/258 (37%), Gaps = 50/258 (19%)
Query: 1 MMSRVKHDNLVKFLGACKDP------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNF 54
++ +KH+N++ L V + L G L + + KL
Sbjct: 70 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV---KCQKLTDDHVQFL 126
Query: 55 ALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYR 114
I R + +H+ IIHRDLKP NL + LK+ DFGLAR + MT T
Sbjct: 127 IYQILRGLKYIHSADIIHRDLKPSNLA-VNEDCELKILDFGLARH--TDDEMTGYVATRW 183
Query: 115 WMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAY------- 167
+ APE+ HYN VD++S G ++ ELLT R F G ++
Sbjct: 184 YRAPEIML-------NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 168 --------------AAAFKHARPGLPE--------DISPDLAFIVQSCWVEDPNLRPSFS 205
A + + +P+ +P +++ V D + R + +
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 206 QIIRMLNAFLFTLRPPSP 223
Q + +A+ P
Sbjct: 297 QALA--HAYFAQYHDPDD 312
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.7 bits (242), Expect = 3e-24
Identities = 48/216 (22%), Positives = 83/216 (38%), Gaps = 22/216 (10%)
Query: 1 MMSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALN 53
+M V H N++ L + +V EL+ + +LD
Sbjct: 69 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-----MELDHERMSY 123
Query: 54 FALDIARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTY 113
+ + LH+ GIIHRDLKP N+++ D K+ DFGLAR + MMT T
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTR 182
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNLQAAYAAAFKH 173
+ APE+ Y VD++S G ++ E++ +++ F G + + +
Sbjct: 183 YYRAPEVIL--------GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQ 233
Query: 174 ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209
PE + + +F ++
Sbjct: 234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFP 269
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 78.9 bits (193), Expect = 1e-17
Identities = 37/262 (14%), Positives = 80/262 (30%), Gaps = 62/262 (23%)
Query: 2 MSRVKHDNLVKFLGAC----KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALD 57
+ ++++K L + + V++ + G +L + + L +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 58 IARAMDCLHAN-GIIHRDLKPDNLLLTPDQKSLKLADFGLAR---EETVTEMMTAETGTY 113
+ +D +H GIIH D+KP+N+L+ L +A E T T
Sbjct: 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 114 RWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG-------------- 159
+ +PE+ + D++S +++EL+T FE
Sbjct: 194 EYRSPEVLLG--------APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245
Query: 160 --------------------------------MSNLQAAYAAAFKHARPGLPEDISPDLA 187
+S L+ + +D + +++
Sbjct: 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS 305
Query: 188 FIVQSCWVEDPNLRPSFSQIIR 209
+ DP R ++
Sbjct: 306 DFLSPMLQLDPRKRADAGGLVN 327
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 65.6 bits (159), Expect = 1e-13
Identities = 19/144 (13%), Positives = 45/144 (31%), Gaps = 28/144 (19%)
Query: 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIAR 60
+ +++ + K + ++ EL+ L + + I
Sbjct: 67 ALQKLQGLAVPKVYAWEGN---AVLMELIDAKELYRV---------RVENPDEVLDMILE 114
Query: 61 AMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPEL 120
+ + GI+H DL N+L++ + + + DF + E E+
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG--IWIIDFPQSVE------------VGEEGWREI 160
Query: 121 Y--STVTLRQGEKKHYNNKVDVYS 142
+ + Y + D+ S
Sbjct: 161 LERDVRNIITYFSRTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 268 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.98 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.7 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 97.37 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 96.55 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.23 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 93.18 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 83.54 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=325.91 Aligned_cols=211 Identities=31% Similarity=0.531 Sum_probs=174.9
Q ss_pred CCCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 1 MMSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+|++++||||+++++++.++..++||||++||+|.+++.. ....+++.++..++.|++.||+|||++||+||||||+||
T Consensus 57 ~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~Ni 135 (276)
T d1uwha_ 57 VLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHI-IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNI 135 (276)
T ss_dssp HHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHHT-SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHE
Confidence 3678999999999999988889999999999999999975 345699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|++.+ +.+||+|||+++..... .......||+.|+|||.+... ....++.++|||||||++|||++|+.||
T Consensus 136 Ll~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-----~~~~~~~~sDiwS~Gv~l~el~tg~~Pf 209 (276)
T d1uwha_ 136 FLHED-LTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-----DKNPYSFQSDVYAFGIVLYELMTGQLPY 209 (276)
T ss_dssp EEETT-SSEEECCCCCSCC------------CCCCGGGCCHHHHTTC-----SSCCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred EEcCC-CCEEEccccceeeccccCCcccccccccCcccCCHHHHhcc-----cCCCCCchhhhhhhHHHHHHHHHCCCCC
Confidence 99955 56999999999765432 223455789999999998531 1245788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCC----CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 158 EGMSNLQAAYAAAFKHARP----GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.+.+............... ..+..+++++.+++.+||+.||.+|||++++++.|+.+..++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 210 SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp TTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 9877766655554444332 345678999999999999999999999999999999887654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=317.88 Aligned_cols=194 Identities=26% Similarity=0.504 Sum_probs=167.1
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++.+ +..|+||||++||+|.+++... ..+++.++..++.|++.||+|||++||+||||||+||
T Consensus 60 l~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Ni 137 (263)
T d2j4za1 60 QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 137 (263)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccc
Confidence 568999999999999854 4789999999999999999863 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
|++.+ +.+||+|||++....... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 138 ll~~~-~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~~ 207 (263)
T d2j4za1 138 LLGSA-GELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEG--------RMHDEKVDLWSLGVLCYEFLVGKPPFEAN 207 (263)
T ss_dssp EECTT-SCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eecCC-CCEeecccceeeecCCCc-ccccCCCCcccCHHHHcC--------CCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence 99965 469999999997654332 344579999999999864 56789999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+..+. .. ........++..+++++.+|+.+||+.||.+|||++++++
T Consensus 208 ~~~~~-~~-~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 208 TYQET-YK-RISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp SHHHH-HH-HHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CHHHH-HH-HHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 54333 22 2334556678889999999999999999999999999998
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-49 Score=321.23 Aligned_cols=207 Identities=29% Similarity=0.437 Sum_probs=178.3
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++|+|.+++.......+++.+++.|+.|++.||+|||+.||+||||||+|||
T Consensus 62 l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl 141 (272)
T d1qpca_ 62 MKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (272)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence 56789999999999998888899999999999999887644456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
++.+ +.+||+|||+++...... ......+++.|+|||.+.. ..++.++|||||||++|||++|..|+..
T Consensus 142 l~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~--------~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 142 VSDT-LSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY--------GTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp ECTT-SCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred eecc-cceeeccccceEEccCCccccccccCCcccccChHHHhC--------CCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 9955 569999999998654322 2344578899999999854 5678999999999999999997666555
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
...............++..+..+++++.+|+.+||+.||++|||++++++.|+.++.+
T Consensus 213 ~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 213 GMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp TCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 5555666666667778888899999999999999999999999999999999988754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=321.97 Aligned_cols=208 Identities=25% Similarity=0.539 Sum_probs=178.9
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++|||||++++++.++..|+||||++||+|.+++.. ....+++.++..++.|++.||+|||++||+||||||+||+
T Consensus 63 l~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nil 141 (285)
T d1u59a_ 63 MHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL 141 (285)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred HHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhee
Confidence 567899999999999988889999999999999999865 3456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.+||+|||+++...... ......||+.|+|||.+.. ..++.++|||||||++|||++ |..|
T Consensus 142 l~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDVwS~Gv~l~E~lt~G~~P 212 (285)
T d1u59a_ 142 LVNR-HYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF--------RKFSSRSDVWSYGVTMWEALSYGQKP 212 (285)
T ss_dssp EEET-TEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHH--------CEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred eccC-CceeeccchhhhcccccccccccccccccCccccChHHHhC--------CCCCccchhhcchHHHHHHHhCCCCC
Confidence 9955 569999999998554322 1233468899999999854 567899999999999999998 8999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
|.+....+ .........+++.|..+++++.+|+.+||+.+|++|||+.++.+.|+..+.++..
T Consensus 213 f~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~ 275 (285)
T d1u59a_ 213 YKKMKGPE-VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 275 (285)
T ss_dssp TTTCCTHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred CCCCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhh
Confidence 98876543 4445556677888899999999999999999999999999999999988765533
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=319.89 Aligned_cols=204 Identities=25% Similarity=0.511 Sum_probs=175.1
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+.||+||||||+|||
T Consensus 62 l~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nil 139 (277)
T d1xbba_ 62 MQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL 139 (277)
T ss_dssp HHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred HHhCCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhc
Confidence 578999999999999987788999999999999999986 456999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCccc----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.++|+|||+++..... .......||+.|+|||.+.. ..++.++||||||+++|||++ |..|
T Consensus 140 l~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv~l~ellt~g~~P 210 (277)
T d1xbba_ 140 LVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY--------YKFSSKSDVWSFGVLMWEAFSYGQKP 210 (277)
T ss_dssp EEET-TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cccc-CcccccchhhhhhccccccccccccccCCCceecCchhhcC--------CCCCchhhhccchhhhhHHhhCCCCC
Confidence 9955 56999999999754322 12233468899999999864 567889999999999999998 8999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
|.+.+.. ..........+++.+..+++++.+|+.+||+.||.+|||++++.+.|+.++.+
T Consensus 211 f~~~~~~-~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 211 YRGMKGS-EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp STTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 9887654 34444556677888899999999999999999999999999999999987654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-48 Score=320.55 Aligned_cols=206 Identities=28% Similarity=0.499 Sum_probs=167.2
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++|||||++++++. ++..++||||++||+|.+++.. ....+++.+++.++.|++.||+|||++||+||||||+|
T Consensus 80 ~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~-~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~N 158 (299)
T d1jpaa_ 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ-NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARN 158 (299)
T ss_dssp HHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeecc-ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccce
Confidence 367899999999999984 5579999999999999998875 34569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccccc------ccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEM------MTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT- 152 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~- 152 (268)
||++.+ +.+||+|||+++....... .....+++.|+|||.+.. ..++.++|||||||++|||++
T Consensus 159 ILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~~sDvwS~Gvvl~el~t~ 229 (299)
T d1jpaa_ 159 ILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--------RKFTSASDVWSYGIVMWEVMSY 229 (299)
T ss_dssp EEECTT-CCEEECCC-----------------------CGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTT
T ss_pred EEECCC-CcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--------CCCCcccccccchHHHHHHHhC
Confidence 999965 5699999999975433221 122357889999998853 678899999999999999998
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
|..||.+.... ..........+++.+..+++++.+|+.+||+.||.+|||+.++++.|+.++.+
T Consensus 230 g~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 230 GERPYWDMTNQ-DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp SCCTTTTCCHH-HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCHH-HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 89999877654 34444556667778889999999999999999999999999999999988754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-49 Score=320.05 Aligned_cols=201 Identities=31% Similarity=0.474 Sum_probs=170.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||++||+|.+++.. ..+++.++..++.||+.||+|||++||+||||||+||
T Consensus 71 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 147 (293)
T d1yhwa1 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI 147 (293)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHe
Confidence 56789999999999984 5579999999999999998875 4699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ +.+||+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.+
T Consensus 148 Ll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~ 218 (293)
T d1yhwa1 148 LLGMD-GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR--------KAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (293)
T ss_dssp EECTT-CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS--------SCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EECCC-CcEeeccchhheeeccccccccccccCCCccChhhhcC--------CCCCchhceehHhHHHHHHhhCCCCCCC
Confidence 99965 46999999999865433 33455679999999999864 6678999999999999999999999988
Q ss_pred CCcHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+............ .....+..+++++++|+.+||..||.+|||++++++ +.++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--Hp~~~ 274 (293)
T d1yhwa1 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ--HQFLK 274 (293)
T ss_dssp SCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT--CGGGG
T ss_pred CCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc--CHhhC
Confidence 77655544433322 233445679999999999999999999999999987 55554
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.6e-49 Score=319.41 Aligned_cols=206 Identities=32% Similarity=0.530 Sum_probs=177.9
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||+++|+|.+++.......+++..++.++.|++.||+|||++||+||||||+||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NI 146 (287)
T d1opja_ 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146 (287)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred HHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeE
Confidence 56889999999999985 55789999999999999999876667899999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++|||||||++|||++|..||.
T Consensus 147 Ll~~~-~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 147 LVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY--------NKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp EECGG-GCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred EECCC-CcEEEccccceeecCCCCceeeccccccccccChHHHcC--------CCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 99955 569999999998654322 2233457889999999864 678999999999999999999877766
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
...+.............++.+..+++++.+|+.+||+.||.+|||++++++.|+.+..
T Consensus 218 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 218 PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 6666666666666677788889999999999999999999999999999999987653
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=315.00 Aligned_cols=205 Identities=27% Similarity=0.483 Sum_probs=165.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+|+||||||+||
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~-~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Ni 132 (263)
T d1sm2a_ 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 132 (263)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGE
T ss_pred HHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhc-cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhhe
Confidence 56789999999999984 5679999999999999999876 346689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
+++.+ +.+||+|||+++...... ......||..|+|||.+.+ ..++.++||||||+++|||+++..|+.
T Consensus 133 ll~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~k~DVwS~Gvil~el~t~~~~~~ 203 (263)
T d1sm2a_ 133 LVGEN-QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF--------SRYSSKSDVWSFGVLMWEVFSEGKIPY 203 (263)
T ss_dssp EECGG-GCEEECSCC------------------CTTSCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred eecCC-CCeEecccchheeccCCCceeecceecCcccCChHHhcC--------CCCCchhhhcchHHHHHHHHHCCCCCC
Confidence 99955 469999999997654332 2234568899999999864 678999999999999999999544444
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
................+...|..+++++.+++.+||+.||++|||++++++.|+.+..
T Consensus 204 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 204 ENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 4444455555666677777888899999999999999999999999999999998754
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=315.84 Aligned_cols=197 Identities=29% Similarity=0.564 Sum_probs=167.2
Q ss_pred CCCCCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--Ceec
Q 024401 1 MMSRVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANG--IIHR 73 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~ 73 (268)
+|++++||||+++++++.+ ..+|+||||++||+|.+++... ..+++.++..++.|++.||+|||++| |+||
T Consensus 61 il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHr 138 (270)
T d1t4ha_ 61 MLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHR 138 (270)
T ss_dssp HHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCS
T ss_pred HHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeC
Confidence 3688999999999999742 3478999999999999999863 56999999999999999999999998 9999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
||||+|||++.+++.+||+|||+++..... ......||+.|+|||.+. ..++.++|||||||++|+|++|
T Consensus 139 DiKp~NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~---------~~~~~~~DIwSlGvilyel~~g 208 (270)
T d1t4ha_ 139 DLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE---------EKYDESVDVYAFGMCMLEMATS 208 (270)
T ss_dssp CCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG---------TCCCTHHHHHHHHHHHHHHHHS
T ss_pred CcChhhceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhC---------CCCCCcCchhhHHHHHHHHHHC
Confidence 999999999755567999999999754332 234568999999999874 3578999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhhcC-CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKHAR-PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.||.+..+............. ..++..+++++.+++.+||+.||++|||++|+++
T Consensus 209 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 209 EYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp SCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 9999887776666555544433 2345678899999999999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=323.89 Aligned_cols=203 Identities=33% Similarity=0.558 Sum_probs=173.5
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC---------------------CCCCHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP---------------------NKLDLHVALNFALDI 58 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~i~~ql 58 (268)
|+++ +|||||++++++. ++..++||||++||+|.+++...+. ..+++.+++.++.|+
T Consensus 94 l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 173 (325)
T d1rjba_ 94 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 173 (325)
T ss_dssp HHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred HHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence 3455 8999999999985 5579999999999999999976321 348999999999999
Q ss_pred HHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCC
Q 024401 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135 (268)
Q Consensus 59 ~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 135 (268)
+.||+|||++||+||||||+||+++.+ +.+||+|||+++...... ......||+.|+|||.+.. ..++
T Consensus 174 ~~gl~yLH~~~IiHRDlKp~Nill~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~ 244 (325)
T d1rjba_ 174 AKGMEFLEFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--------GIYT 244 (325)
T ss_dssp HHHHHHHHHTTEEETTCSGGGEEEETT-TEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--------CCCC
T ss_pred HHHHHHHHhCCeeeccCchhccccccC-CeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC--------CCCC
Confidence 999999999999999999999999955 569999999997544332 2234467899999998864 6789
Q ss_pred cccchHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 136 NKVDVYSFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 136 ~~~Di~slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
.++|||||||++|||++ |..||.+.+.............+++.+..+++++.+|+.+||+.||++|||+++|+++|..
T Consensus 245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 99999999999999997 8999988776666666666777788888999999999999999999999999999999864
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=316.21 Aligned_cols=199 Identities=28% Similarity=0.413 Sum_probs=159.1
Q ss_pred CCCCCCCCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC-----C
Q 024401 1 MMSRVKHDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSL--RPNKLDLHVALNFALDIARAMDCLHANG-----I 70 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~-----i 70 (268)
+|++++||||+++++++. ++.+|+||||++||+|.+++... ....+++.+++.++.|++.||+|||+.| |
T Consensus 56 il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~I 135 (269)
T d2java1 56 LLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTV 135 (269)
T ss_dssp HTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC-----
T ss_pred HHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCE
Confidence 478899999999999884 34689999999999999998652 2457999999999999999999999976 9
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|+
T Consensus 136 iHrDiKp~NIll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~~DIwSlGvilye 206 (269)
T d2java1 136 LHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR--------MSYNEKSDIWSLGCLLYE 206 (269)
T ss_dssp ----CCGGGEEECTT-SCEEECCHHHHHHC-----------CCCSCCCHHHHTT--------CCCCHHHHHHHHHHHHHH
T ss_pred EeCcCchhhcCcCCC-CcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC--------CCCChHHHHHhhCHHHHH
Confidence 999999999999965 569999999998654432 3345678999999999853 668899999999999999
Q ss_pred HHhCCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 150 LLTNRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 150 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
|++|..||.+.+.. ..............+..+++++.+|+.+||+.||.+|||++++++
T Consensus 207 l~tg~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 207 LCALMPPFTAFSQK-ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHSSCSCCCSSHH-HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HhhCCCCCCCCCHH-HHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 99999999876553 334444555566778889999999999999999999999999986
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-49 Score=316.33 Aligned_cols=202 Identities=28% Similarity=0.417 Sum_probs=165.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||++||+|.+++.. ...+++.++..++.|++.||+|||++||+||||||+||
T Consensus 57 l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NI 134 (271)
T d1nvra_ 57 NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL 134 (271)
T ss_dssp HHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred HHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHE
Confidence 57899999999999985 5578999999999999999975 45799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|++.+ +.+||+|||+++..... .......||+.|+|||.+.+ ...++.++|||||||++|+|++|+.||
T Consensus 135 Ll~~~-~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-------~~~~~~~~DiwSlGvilyeml~G~~pf 206 (271)
T d1nvra_ 135 LLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR-------REFHAEPVDVWSCGIVLTAMLAGELPW 206 (271)
T ss_dssp EECTT-CCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHC-------SSBCHHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EECCC-CCEEEccchhheeeccCCccccccceeeCcCccCHhHhcC-------CCCCCCceeeeHhHHHHHHHHhCCCCC
Confidence 99965 46999999999865332 22345679999999999853 123467899999999999999999999
Q ss_pred CCCCcHHHHHHHHHhh-cCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 158 EGMSNLQAAYAAAFKH-ARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
................ ........+++++.+|+.+||+.||++|||++++++ +.|+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hpwf 263 (271)
T d1nvra_ 207 DQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK--DRWY 263 (271)
T ss_dssp SSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT--CTTT
T ss_pred CCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc--CHhh
Confidence 7665443333333322 222233568999999999999999999999999987 4444
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-48 Score=315.19 Aligned_cols=210 Identities=28% Similarity=0.410 Sum_probs=176.4
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++|||||++++++.++..++||||+++|+|..++.......+++.+++.++.|++.||+|||+.||+||||||+|||
T Consensus 66 l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIl 145 (285)
T d1fmka3 66 MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 145 (285)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhcccCCEeEEEEEEecCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEE
Confidence 56789999999999998888999999999999999987654567999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
++.+ +.+||+|||+++...... ......+++.|+|||.+.. ..++.++||||||+++|||++|..|+..
T Consensus 146 l~~~-~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 146 VGEN-LVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY--------GRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp ECGG-GCEEECCCCTTC--------------CCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ECCC-CcEEEcccchhhhccCCCceeeccccccccccChHHHhC--------CCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 9955 569999999998653322 2234568999999999854 6788999999999999999997777666
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcCC
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLRP 220 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~~ 220 (268)
.................+.+..+++++.+++.+||+.||++|||+++|++.|+.++.+..+
T Consensus 217 ~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p 277 (285)
T d1fmka3 217 GMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277 (285)
T ss_dssp TCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred CCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCC
Confidence 6666666666666777788899999999999999999999999999999999998866543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.5e-48 Score=318.71 Aligned_cols=203 Identities=25% Similarity=0.410 Sum_probs=157.4
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||++||+|.+++.. ...+++.++..++.||+.||+|||+.||+||||||+||
T Consensus 61 l~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Ni 138 (307)
T d1a06a_ 61 LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL 138 (307)
T ss_dssp HHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccce
Confidence 57899999999999985 4579999999999999999975 45799999999999999999999999999999999999
Q ss_pred EEcC--CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 81 LLTP--DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 81 l~~~--~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
++.. +++.+||+|||+++............||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 139 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ--------KPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp EESSSSTTCCEEECCC------------------CTTSCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC--------CCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 9963 345699999999987665555566789999999999854 568899999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
+................ .+.+..+++++.+|+.+||..||++|||++++++ +.++.
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 268 (307)
T d1a06a_ 211 DENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ--HPWIA 268 (307)
T ss_dssp CSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH--STTTT
T ss_pred CCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhC
Confidence 76654443333322222 2334679999999999999999999999999988 45543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-48 Score=316.33 Aligned_cols=203 Identities=27% Similarity=0.418 Sum_probs=170.0
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++|||||++++++. ++..|+||||+.||+|..++.. ..++++.++..++.||+.||+|||++||+||||||+|
T Consensus 68 il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~N 145 (309)
T d1u5ra_ 68 FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGN 145 (309)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGG
T ss_pred HHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence 367899999999999985 5579999999999999877765 3579999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
||++.+ +.+||+|||++...... ....||+.|+|||++.+. ....++.++|||||||++|+|++|..||.+
T Consensus 146 ILl~~~-~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~-----~~~~y~~~~DiwSlGvilyel~~g~~Pf~~ 216 (309)
T d1u5ra_ 146 ILLSEP-GLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAM-----DEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (309)
T ss_dssp EEEETT-TEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTT-----TSCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEECCC-CCEEEeecccccccCCC---CccccCccccCHHHHhcc-----CCCCcCchhhhhhHHHHHHHHHHCCCCCCC
Confidence 999955 56999999999765432 345799999999998531 124678899999999999999999999988
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
....+..............+..+++++.+|+.+||..||.+|||++++++ +.++.
T Consensus 217 ~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~--Hp~~~ 271 (309)
T d1u5ra_ 217 MNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK--HRFVL 271 (309)
T ss_dssp SCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT--CHHHH
T ss_pred CCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh--CHHhc
Confidence 77665555444444444445678999999999999999999999999988 44543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-48 Score=317.04 Aligned_cols=203 Identities=29% Similarity=0.432 Sum_probs=168.1
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..++||||++||+|.+++... ...+++.++..++.||+.||+|||++||+||||||+||
T Consensus 63 l~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NI 141 (288)
T d2jfla1 63 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNI 141 (288)
T ss_dssp HHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhhe
Confidence 56789999999999984 56799999999999999998753 35699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.++ .+||+|||++...... .......||+.|+|||.+... ......++.++|||||||++|+|++|..||.+
T Consensus 142 ll~~~~-~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~---~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 142 LFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE---TSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp EECTTS-CEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTC---STTTSSTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred eECCCC-CEEEEechhhhccCCCcccccccccccccCCHHHHhhc---ccCCCCCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 999664 6999999999765433 233456899999999988531 11235678999999999999999999999988
Q ss_pred CCcHHHHHHHHHhhc-CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHA-RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+..+.......... ....+..+++++.+|+.+||+.||.+|||++++++
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 218 LNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 776555443332221 22344678999999999999999999999999987
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-47 Score=309.00 Aligned_cols=206 Identities=26% Similarity=0.449 Sum_probs=171.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++|||||++++++. .+..++||||+.++++.+++.. ....+++.+++.++.|++.||+|||+.||+||||||+||
T Consensus 63 l~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NI 141 (283)
T d1mqba_ 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNI 141 (283)
T ss_dssp HHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHH-TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred HHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhc-ccccccHHHHHHHHHHHHHhhhhccccccccCccccceE
Confidence 57899999999999984 5678999999999999998876 346799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|++.+ +.+||+|||+++...... ......||+.|+|||.+.. ..++.++|||||||++|||+++..|
T Consensus 142 Ll~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~--------~~~~~~sDI~S~Gvil~el~t~~~~ 212 (283)
T d1mqba_ 142 LVNSN-LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY--------RKFTSASDVWSFGIVMWEVMTYGER 212 (283)
T ss_dssp EECTT-CCEEECCCCC-----------------CCCGGGSCHHHHHS--------CCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred EECCC-CeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc--------CCCCCcccccccHHHHHHHHhCCCC
Confidence 99965 569999999998643321 2233467899999998854 6788999999999999999997666
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+.................+++.+..++.++.+|+.+||+.+|++|||+.++++.|+.+...
T Consensus 213 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 213 PYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 6555555666666677778888899999999999999999999999999999999987753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-47 Score=319.27 Aligned_cols=205 Identities=27% Similarity=0.408 Sum_probs=170.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++.+|+||||++||+|.+++.. ....+++.++..|+.||+.||+|||++||+||||||+||
T Consensus 77 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NI 155 (350)
T d1koaa2 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVAD-EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENI 155 (350)
T ss_dssp HHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTC-TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHe
Confidence 56789999999999985 5579999999999999999965 245699999999999999999999999999999999999
Q ss_pred EEcCC-CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ ++.+||+|||++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 156 ll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~--------~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 156 MFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG--------KPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp EESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHT--------CCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcC--------CCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 99643 45799999999987666555566789999999999854 6678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 160 MSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
.+..+............ .....+++++.+||.+||..||.+|||++++++ +.++..
T Consensus 228 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~--hp~~~~ 285 (350)
T d1koaa2 228 ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE--HPWLTP 285 (350)
T ss_dssp SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH--STTTSC
T ss_pred CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccCC
Confidence 66544433332222211 222468999999999999999999999999998 555543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=314.73 Aligned_cols=195 Identities=26% Similarity=0.417 Sum_probs=163.8
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||++||+|.+++... +.+++..+..++.|++.||+|||+.||+||||||+||
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NI 139 (288)
T d1uu3a_ 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139 (288)
T ss_dssp HHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred HHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccc
Confidence 56789999999999985 45789999999999999998763 5699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.+ +.++|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||
T Consensus 140 ll~~~-~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf 210 (288)
T d1uu3a_ 140 LLNED-MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE--------KSACKSSDLWALGCIIYQLVAGLPPF 210 (288)
T ss_dssp EECTT-SCEEECCCTTCEECC----------CCCCGGGCCHHHHHT--------CCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred ccCCC-ceEEecccccceecccCCcccccccccCCccccCceeecc--------CCCCcccceehhhHHHHHHhhCCCCC
Confidence 99965 45999999999865432 22344579999999999864 66889999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+.+..... .. .......++..+++++.+||.+||+.||.+|||++|+++
T Consensus 211 ~~~~~~~~~-~~-i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 211 RAGNEYLIF-QK-IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp CCSSHHHHH-HH-HHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred CCcCHHHHH-HH-HHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 876544333 22 233456678889999999999999999999999998754
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-47 Score=318.33 Aligned_cols=200 Identities=22% Similarity=0.396 Sum_probs=169.7
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++||||+++++++. ++.+|+||||++||+|.+++.. ...++++.+++.|+.||+.||+|||+.||+||||||+|
T Consensus 79 il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~N 157 (352)
T d1koba_ 79 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN 157 (352)
T ss_dssp HHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccc
Confidence 367899999999999985 4578999999999999998865 34569999999999999999999999999999999999
Q ss_pred EEEcC-CCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTP-DQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~-~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++. +.+.+||+|||++.............+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.
T Consensus 158 ILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR--------EPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT--------CCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred ccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC--------CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 99973 345799999999987766655666789999999999854 668899999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhc--CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHA--RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.+............. .......+++++.+||.+||..||.+|||++++++
T Consensus 230 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 230 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 8766554433332222 22234578999999999999999999999999988
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-47 Score=307.45 Aligned_cols=205 Identities=29% Similarity=0.559 Sum_probs=167.2
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.||+||||||+||+
T Consensus 62 l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~-~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIl 140 (273)
T d1mp8a_ 62 MRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV-RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVL 140 (273)
T ss_dssp HHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHH-TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred HHhCCCCCEeeEEEEEecCeEEEEEEeccCCcHHhhhhc-cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhee
Confidence 578999999999999988889999999999999998875 3467999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
++.+ +.+||+|||+++...... ......+|+.|+|||.+.. ..++.++|||||||++|||++ |..||.
T Consensus 141 l~~~-~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~--------~~~~~~~DiwSlGvil~e~lt~g~~P~~ 211 (273)
T d1mp8a_ 141 VSSN-DCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINF--------RRFTSASDVWMFGVCMWEILMHGVKPFQ 211 (273)
T ss_dssp EEET-TEEEECC-------------------CCGGGCCHHHHHH--------CCCSHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred ecCC-CcEEEccchhheeccCCcceeccceecCcccchhhHhcc--------CCCCCccccccchHHHHHHHhcCCCCCC
Confidence 9955 569999999998644322 2234567899999999864 678899999999999999998 889998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
+.+..+ ..........++.+..+++++.+|+.+||..||.+|||+.++++.|+.++..
T Consensus 212 ~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 212 GVKNND-VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp TCCGGG-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCHHH-HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 766544 3344556667788899999999999999999999999999999999887643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=311.40 Aligned_cols=203 Identities=22% Similarity=0.364 Sum_probs=169.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||++||+|.+++... +.+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 67 l~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Ni 144 (293)
T d1jksa_ 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144 (293)
T ss_dssp HHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceE
Confidence 56789999999999985 45689999999999999999863 4699999999999999999999999999999999999
Q ss_pred EEcCCCC---ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 81 LLTPDQK---SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 81 l~~~~~~---~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+++.++. .+||+|||++.............+++.|+|||.+.+ ..++.++|||||||++|+|++|..||
T Consensus 145 ll~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~--------~~~~~~~DiwSlGvilyell~g~~Pf 216 (293)
T d1jksa_ 145 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY--------EPLGLEADMWSIGVITYILLSGASPF 216 (293)
T ss_dssp EESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred EEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC--------CCCCCcccchhhhHHHHHHHcCCCCC
Confidence 9986543 599999999987666555666789999999999854 56789999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcC--CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHAR--PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+.+..+........... ...+..++.++++||.+||..||.+|||++++++ +.++.
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 275 (293)
T d1jksa_ 217 LGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ--HPWIK 275 (293)
T ss_dssp CCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH--STTTC
T ss_pred CCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc--CcccC
Confidence 876654443332221111 1123578999999999999999999999999988 55554
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-47 Score=313.70 Aligned_cols=202 Identities=25% Similarity=0.454 Sum_probs=162.0
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCeecCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHAN-GIIHRDLKPD 78 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dlk~~ 78 (268)
+|++++|||||++++++. ++..|+||||++||+|.+++... ..+++.++..++.|++.||+|||++ ||+||||||+
T Consensus 57 il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~ 134 (322)
T d1s9ja_ 57 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134 (322)
T ss_dssp GGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGG
T ss_pred HHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHH
Confidence 478899999999999985 55799999999999999999763 4699999999999999999999974 9999999999
Q ss_pred CEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 79 NLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 79 Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
|||++.+ +.+||+|||++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 135 NILl~~~-~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~--------~~y~~~~DiWSlGvil~ell~G~~Pf~ 204 (322)
T d1s9ja_ 135 NILVNSR-GEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQG--------THYSVQSDIWSMGLSLVEMAVGRYPIP 204 (322)
T ss_dssp GEEECTT-CCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHC--------SCCCTTHHHHHHHHHHHHHHHSSCCSS
T ss_pred HeeECCC-CCEEEeeCCCccccCCC-ccccccCCccccCchHHcC--------CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999965 46999999999854332 2345689999999999964 678999999999999999999999997
Q ss_pred CCCcHHHHH-----------------------------------------HHHHhhcCCCCC-CCCcHHHHHHHHHhhhh
Q 024401 159 GMSNLQAAY-----------------------------------------AAAFKHARPGLP-EDISPDLAFIVQSCWVE 196 (268)
Q Consensus 159 ~~~~~~~~~-----------------------------------------~~~~~~~~~~~~-~~~~~~l~~li~~~l~~ 196 (268)
+.+...... ........+..+ ..++.++.+|+.+||..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~ 284 (322)
T d1s9ja_ 205 PPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284 (322)
T ss_dssp CCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCC
Confidence 654322110 011111122222 24688999999999999
Q ss_pred CCCCCCCHHHHHHHHHhhhh
Q 024401 197 DPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 197 ~p~~Rps~~~~l~~l~~~~~ 216 (268)
||.+|||++++++ +.++.
T Consensus 285 dP~~R~ta~e~L~--Hpf~~ 302 (322)
T d1s9ja_ 285 NPAERADLKQLMV--HAFIK 302 (322)
T ss_dssp STTTSCCHHHHHT--SHHHH
T ss_pred ChhHCcCHHHHhh--CHhhC
Confidence 9999999999998 44443
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=301.64 Aligned_cols=201 Identities=27% Similarity=0.532 Sum_probs=172.5
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+++++||||+++++++. ++.+++||||+++|+|.+++.. ....+++..+.+++.|++.||+|||+.||+||||||+||
T Consensus 53 ~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Ni 131 (258)
T d1k2pa_ 53 MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNC 131 (258)
T ss_dssp HHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGE
T ss_pred HHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhc-cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeE
Confidence 56889999999999985 5679999999999999999865 345689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc--cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE--MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
+++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|||++ |+.||
T Consensus 132 ll~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~~~ksDiwS~G~~l~el~t~g~~Pf 202 (258)
T d1k2pa_ 132 LVNDQ-GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY--------SKFSSKSDIWAFGVLMWEIYSLGKMPY 202 (258)
T ss_dssp EECTT-CCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred EEcCC-CcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcC--------CCCCcceeecccchhhHhHHhcCCCCC
Confidence 99965 569999999997543322 2234568899999999864 678899999999999999998 89999
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
.+.+..+ .........+...|...+.++.+|+.+||+.||++|||++++++.|..
T Consensus 203 ~~~~~~~-~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 203 ERFTNSE-TAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TTSCHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCHHH-HHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 8877544 444455666778889999999999999999999999999999998854
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=309.57 Aligned_cols=196 Identities=24% Similarity=0.428 Sum_probs=168.5
Q ss_pred CCCCCCCCcccceeeeeecC-CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACKDP-LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++||||+++++++.+. .+|+||||++||+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|
T Consensus 58 il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~N 135 (337)
T d1o6la_ 58 VLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135 (337)
T ss_dssp HHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred HHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHH
Confidence 36789999999999999654 789999999999999999873 569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.++ .+||+|||+++.... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.
T Consensus 136 ILl~~~g-~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~--------~~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 136 LMLDKDG-HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED--------NDYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp EEECTTS-CEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSS--------SCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred eEecCCC-CEEEeecccccccccCCcccccceeCHHHhhhhhccC--------CCCChhhcccchhhHHHHHHHCCCCCC
Confidence 9999664 699999999986543 334455689999999999864 678999999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
+.+.... .. ........+|..+++++.+||.+||++||.+|++ ++++++
T Consensus 207 ~~~~~~~-~~-~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 207 NQDHERL-FE-LILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CSSHHHH-HH-HHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CcCHHHH-HH-HHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 7665333 22 3334557788899999999999999999999994 888887
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=305.62 Aligned_cols=203 Identities=31% Similarity=0.537 Sum_probs=172.6
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++||||+++++++.++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 65 l~~l~H~nIv~~~g~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIl 143 (273)
T d1u46a_ 65 MHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL 143 (273)
T ss_dssp HHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred HHhCCCCCEEEEEEEEeecchheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhc
Confidence 5678999999999999878889999999999999988763 356999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLP 156 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p 156 (268)
++.+ +.+||+|||+++...... ......++..|+|||.+.. ..++.++||||||+++|||++ |..|
T Consensus 144 l~~~-~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~--------~~~~~~~Di~S~Gvil~emlt~G~~P 214 (273)
T d1u46a_ 144 LATR-DLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT--------RTFSHASDTWMFGVTLWEMFTYGQEP 214 (273)
T ss_dssp EEET-TEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH--------CEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred cccc-cceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC--------CCCCcchhhhhhHHHHHHHHhCCCCC
Confidence 9965 569999999998643321 1233457889999999864 667889999999999999998 8999
Q ss_pred CCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 157 FEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
|.+.+..+...........++.+..+++++.+|+.+||..||++|||+.++.+.|...
T Consensus 215 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 215 WIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 9987766655555555567777889999999999999999999999999999988763
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=303.76 Aligned_cols=204 Identities=30% Similarity=0.552 Sum_probs=168.1
Q ss_pred CCCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhC
Q 024401 5 VKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHAN 68 (268)
Q Consensus 5 l~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~lH~~ 68 (268)
.+||||+.+++++. +...++||||+++|+|.+++...+ ...+++.+++.++.|++.||+|||++
T Consensus 74 ~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~ 153 (299)
T d1ywna1 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR 153 (299)
T ss_dssp CCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 47899999999873 346899999999999999997532 23489999999999999999999999
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
||+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||
T Consensus 154 ~ivHrDlKp~NILl~~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDiwS~Gv 224 (299)
T d1ywna1 154 KCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--------RVYTIQSDVWSFGV 224 (299)
T ss_dssp TCCCSCCCGGGEEECGG-GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH--------CCCCHHHHHHHHHH
T ss_pred CCcCCcCCccceeECCC-CcEEEccCcchhhccccccccccCceeeCccccchhHhhc--------CCCCcccceeehHH
Confidence 99999999999999955 569999999997543322 2334578999999999864 67899999999999
Q ss_pred HHHHHHhC-CCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 146 VLWELLTN-RLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 146 i~~~ll~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
++|||++| ..||.+................+..+..+++++.+++.+||+.||++|||+++++++|+.++.+
T Consensus 225 il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 99999986 5678877666666666677778888899999999999999999999999999999999987654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-46 Score=305.61 Aligned_cols=208 Identities=33% Similarity=0.561 Sum_probs=175.0
Q ss_pred CCCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhh--------------CCCCCCHHHHHHHHHHHHHHHHHH
Q 024401 2 MSRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSL--------------RPNKLDLHVALNFALDIARAMDCL 65 (268)
Q Consensus 2 l~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~~~i~~ql~~~l~~l 65 (268)
|+++ +||||+++++++. ++..++||||++||+|.+++... ....+++..++.++.|++.||.||
T Consensus 64 l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l 143 (309)
T d1fvra_ 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 143 (309)
T ss_dssp HTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred HHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence 5677 6999999999985 55799999999999999999642 235699999999999999999999
Q ss_pred HhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHH
Q 024401 66 HANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGI 145 (268)
Q Consensus 66 H~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~ 145 (268)
|+.||+||||||+|||++.+ ..+||+|||+++............+|..|+|||.+.. ..++.++||||||+
T Consensus 144 H~~~iiHrDlkp~NIL~~~~-~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~sDvwSfGv 214 (309)
T d1fvra_ 144 SQKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY--------SVYTTNSDVWSYGV 214 (309)
T ss_dssp HHTTEECSCCSGGGEEECGG-GCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH--------CEECHHHHHHHHHH
T ss_pred hcCCccccccccceEEEcCC-CceEEccccccccccccccccceecCCcccchHHhcc--------CCCCccceeehhHH
Confidence 99999999999999999965 4699999999987665555555678999999999854 67889999999999
Q ss_pred HHHHHHhCCC-CCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 146 VLWELLTNRL-PFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 146 i~~~ll~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
++|||++|.. ||.+. +............+++.+..+++++.+|+.+||+.||++|||++++++.|+.+.....
T Consensus 215 il~ell~~~~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 215 LLWEIVSLGGTPYCGM-TCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp HHHHHHTTSCCTTTTC-CHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHHHHHhcCCCCCCCC-CHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCc
Confidence 9999999765 56654 4444555555667788888999999999999999999999999999999999886543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-46 Score=300.74 Aligned_cols=202 Identities=34% Similarity=0.590 Sum_probs=166.0
Q ss_pred CCCCCCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|++++||||+++++++. ++.+++||||+++|+|.+++.......+++..++.|+.||+.||+|||+.+|+||||||+|
T Consensus 54 l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~N 133 (262)
T d1byga_ 54 MTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133 (262)
T ss_dssp HTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHh
Confidence 67899999999999883 3468999999999999999976444569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~~ 158 (268)
|+++.+ +.++|+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++ |..||.
T Consensus 134 il~~~~-~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~--------~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 134 VLVSED-NVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALRE--------KKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp EEECTT-SCEEECCCCC--------------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred heecCC-CCEeecccccceecCCC--CccccccccCCChHHHhC--------CCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 999965 46999999999865433 234467889999999854 678999999999999999998 678877
Q ss_pred CCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 159 GMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
..+.. ..........+++++..+++++.+|+.+||..||.+|||+.++++.|+.+.
T Consensus 203 ~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 203 RIPLK-DVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TSCGG-GHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCHH-HHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 65543 334445566788889999999999999999999999999999999998754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-45 Score=310.05 Aligned_cols=201 Identities=23% Similarity=0.347 Sum_probs=167.6
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
++.++||||+++++++. ++..|+||||++||+|.+++... ..+++.++..++.||+.||+|||++||+||||||+||
T Consensus 61 l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NI 138 (364)
T d1omwa3 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 138 (364)
T ss_dssp HSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeecccee
Confidence 56789999999999985 45799999999999999999863 5689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
|++.+ +.+||+|||+++...... .....||+.|+|||.+.. +..++.++|||||||++|+|++|..||.+.
T Consensus 139 Ll~~~-g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~-------~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 209 (364)
T d1omwa3 139 LLDEH-GHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQK-------GVAYDSSADWFSLGCMLFKLLRGHSPFRQH 209 (364)
T ss_dssp EECSS-SCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHST-------TCCCCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred EEcCC-CcEEEeeeceeeecCCCc-ccccccccccchhHHhhc-------CCCCCcccchhHHHHHHHHHHhCCCCCCCC
Confidence 99965 469999999998654432 345579999999999852 256789999999999999999999999865
Q ss_pred CcHHH-HHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHHHHHhhh
Q 024401 161 SNLQA-AYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIRMLNAFL 215 (268)
Q Consensus 161 ~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~~l~~~~ 215 (268)
..... ............++..+++++.+||.+||..||.+||| ++++++ +.++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~--Hp~f 268 (364)
T d1omwa3 210 KTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE--SPFF 268 (364)
T ss_dssp CSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT--SGGG
T ss_pred CHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc--Cccc
Confidence 43222 22223334556677889999999999999999999998 788887 4444
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.8e-46 Score=301.62 Aligned_cols=203 Identities=24% Similarity=0.367 Sum_probs=167.8
Q ss_pred CCCCC-CCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVK-HDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|++++ ||||+++++++.+ +..|+||||++||+|.+++... ..+++.++..++.||+.||+|||+.||+||||||+|
T Consensus 63 l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~N 140 (277)
T d1phka_ 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 140 (277)
T ss_dssp HHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred HHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccce
Confidence 34565 9999999999964 4789999999999999999863 569999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|+++.+ +.+||+|||++.............||..|+|||.+.+... .....++.++||||+||++|+|++|+.||.+
T Consensus 141 ill~~~-~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~--~~~~~~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 141 ILLDDD-MNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMN--DNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp EEECTT-CCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHC--TTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEcCC-CCeEEccchheeEccCCCceeeeeccCCCCCHHHhhcccc--ccCCCCCchheEcccchhhhhhccCCCCCCC
Confidence 999955 5699999999987666555566789999999998864221 1234568899999999999999999999998
Q ss_pred CCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+............... +....+|+++++|+.+||+.+|++|||++++++
T Consensus 218 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 218 RKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp SSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred CCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 76544443333332222 223479999999999999999999999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=307.41 Aligned_cols=203 Identities=24% Similarity=0.448 Sum_probs=164.7
Q ss_pred CCCCCcccceeeeeec-----CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCC
Q 024401 4 RVKHDNLVKFLGACKD-----PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPD 78 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~ 78 (268)
.++||||+++++++.+ ..+|+|||||+||+|.+++.......+++.++..|+.||+.||+|||+.||+||||||+
T Consensus 61 ~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~ 140 (335)
T d2ozaa1 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE 140 (335)
T ss_dssp HTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred hcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence 3589999999998843 46899999999999999998755567999999999999999999999999999999999
Q ss_pred CEEEcCC--CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCC
Q 024401 79 NLLLTPD--QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLP 156 (268)
Q Consensus 79 Nil~~~~--~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p 156 (268)
|||++.+ .+.+||+|||+++............||+.|+|||.+.+ ..++.++|||||||++|+|++|+.|
T Consensus 141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~y~~~~DiwSlGvily~lltg~~P 212 (335)
T d2ozaa1 141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP--------EKYDKSCDMWSLGVIMYILLCGYPP 212 (335)
T ss_dssp GEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG--------GGGSHHHHHHHHHHHHHHHTTSSCS
T ss_pred ccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC--------CCCCHHHHHHhhchhHHHHhhCCCC
Confidence 9999853 34699999999987666666667789999999999854 6688999999999999999999999
Q ss_pred CCCCCcHHHHHHHH--HhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 157 FEGMSNLQAAYAAA--FKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 157 ~~~~~~~~~~~~~~--~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|.+.+......... .......++ ..+++++.+|+.+||..||++|||+.++++ +.++.
T Consensus 213 f~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~--hp~~~ 276 (335)
T d2ozaa1 213 FYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN--HPWIM 276 (335)
T ss_dssp CEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH--SHHHH
T ss_pred CCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc--CHHhh
Confidence 97655433222111 111122222 247899999999999999999999999988 44443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.3e-45 Score=302.05 Aligned_cols=193 Identities=27% Similarity=0.448 Sum_probs=166.2
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||+.||+|..++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 58 l~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 135 (316)
T d1fota_ 58 LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135 (316)
T ss_dssp HHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchhe
Confidence 57899999999999985 4579999999999999999986 45689999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGM 160 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~ 160 (268)
|++.+ +.+||+|||+++..... .....||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.
T Consensus 136 Ll~~~-g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~--------~~y~~~~DiwSlGvilyemltG~~Pf~~~ 204 (316)
T d1fota_ 136 LLDKN-GHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST--------KPYNKSIDWWSFGILIYEMLAGYTPFYDS 204 (316)
T ss_dssp EECTT-SCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT--------CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred eEcCC-CCEEEecCccceEeccc--cccccCcccccCHHHHcC--------CCCCchhhccccchhHHHHHhCCCCCCCc
Confidence 99965 46999999999865433 335689999999999854 56789999999999999999999999876
Q ss_pred CcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 161 SNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
+..+..... ......++..+++++.+++.+||.+||.+|+ |++++++
T Consensus 205 ~~~~~~~~i--~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 205 NTMKTYEKI--LNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp SHHHHHHHH--HHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CHHHHHHHH--HcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 654443332 2344567788999999999999999999996 8999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=305.07 Aligned_cols=204 Identities=27% Similarity=0.539 Sum_probs=173.1
Q ss_pred CCCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEE
Q 024401 2 MSRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLL 81 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil 81 (268)
|++++|||||++++++.++..++++|++.+++|.+++.. ....+++..++.++.|++.||+|||++||+||||||+||+
T Consensus 65 l~~l~HpnIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~~-~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIl 143 (317)
T d1xkka_ 65 MASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE-HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVL 143 (317)
T ss_dssp HHHCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHH-TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred HHhCCCCCEeeEEEEEecCCeeEEEEeccCCcccccccc-cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcce
Confidence 567899999999999988888999999999999998876 4567999999999999999999999999999999999999
Q ss_pred EcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh-CCCCC
Q 024401 82 LTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT-NRLPF 157 (268)
Q Consensus 82 ~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~-g~~p~ 157 (268)
++.+ +.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++ |..||
T Consensus 144 l~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~sDvwS~Gvil~el~t~g~~p~ 214 (317)
T d1xkka_ 144 VKTP-QHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH--------RIYTHQSDVWSYGVTVWELMTFGSKPY 214 (317)
T ss_dssp EEET-TEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred eCCC-CCeEeeccccceecccccccccccccccCccccChHHHhc--------CCCChhhhhhhHHHHHHHHHHCCCCCC
Confidence 9955 569999999998543322 2233468999999998864 678999999999999999998 78888
Q ss_pred CCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 158 EGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
.+.+..+ .........+++.+..+++++.+++.+||..+|.+|||+.++++.|..+..
T Consensus 215 ~~~~~~~-~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 215 DGIPASE-ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp TTSCGGG-HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHH-HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 8765433 344555667778888999999999999999999999999999999887654
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-45 Score=301.15 Aligned_cols=209 Identities=26% Similarity=0.332 Sum_probs=167.0
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++..|+||||+.|+++..+... ...+++.++..++.||+.||+|||++||+||||||+||
T Consensus 54 l~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NI 131 (299)
T d1ua2a_ 54 LQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131 (299)
T ss_dssp HHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceE
Confidence 56789999999999984 5579999999988777766543 46699999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ +.+||+|||++....... ......||+.|+|||.+.. ...++.++|||||||++|+|++|..||.+
T Consensus 132 li~~~-~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~el~~g~~pf~~ 203 (299)
T d1ua2a_ 132 LLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG-------ARMYGVGVDMWAVGCILAELLLRVPFLPG 203 (299)
T ss_dssp EECTT-CCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT-------CSCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EecCC-CccccccCccccccCCCcccccceecChhhccHHHHcc-------CCCCChhhhhhhcchHHHHHHhCcCCCCC
Confidence 99955 569999999997654432 3345678999999998853 35678999999999999999999999988
Q ss_pred CCcHHHHHHHHHhhcCCC--------------------------CCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHh
Q 024401 160 MSNLQAAYAAAFKHARPG--------------------------LPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNA 213 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~ 213 (268)
.++.+...........+. ....+++++.+|+.+||..||++|||++|+++ +.
T Consensus 204 ~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~--Hp 281 (299)
T d1ua2a_ 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK--MK 281 (299)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT--SG
T ss_pred CCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC--CH
Confidence 776554443322111100 01246789999999999999999999999998 66
Q ss_pred hhhhcCCCC
Q 024401 214 FLFTLRPPS 222 (268)
Q Consensus 214 ~~~~~~~~~ 222 (268)
++.+.+.+.
T Consensus 282 ~f~~~p~p~ 290 (299)
T d1ua2a_ 282 YFSNRPGPT 290 (299)
T ss_dssp GGTSSSCCC
T ss_pred hhCCCCCCC
Confidence 766544433
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-45 Score=302.18 Aligned_cols=207 Identities=29% Similarity=0.499 Sum_probs=173.4
Q ss_pred CCCCCCCcccceeeeee--cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGACK--DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|++++||||+++++++. ++..++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.||+||||||+|
T Consensus 82 l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~N 160 (311)
T d1r0pa_ 82 MKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 160 (311)
T ss_dssp HHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred HHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHh
Confidence 57899999999999973 3468999999999999999876 44568899999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||++.+ ..+||+|||+++...... ......|+..|+|||.+.. ..++.++||||||+++|||++|.
T Consensus 161 ILl~~~-~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~ksDI~SfGivl~El~t~~ 231 (311)
T d1r0pa_ 161 CMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT--------QKFTTKSDVWSFGVLLWELMTRG 231 (311)
T ss_dssp EEECTT-CCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH--------CCCCHHHHHHHHHHHHHHHHTTS
T ss_pred EeECCC-CCEEEecccchhhccccccccceecccccccccccChHHHhc--------CCCCChhHhhhhHHHHHHHHHCC
Confidence 999955 569999999998643322 1223468899999998854 67899999999999999999988
Q ss_pred CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 155 LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
.||...............+.++..+..+++++.+|+.+||..||++|||+.++++.|+.+..+.
T Consensus 232 ~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 232 APPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 8877655555555556667788888899999999999999999999999999999999987653
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=295.95 Aligned_cols=201 Identities=33% Similarity=0.631 Sum_probs=173.0
Q ss_pred CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 024401 6 KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------------PNKLDLHVALNFALDIARAMDCLHANGI 70 (268)
Q Consensus 6 ~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------------~~~~~~~~~~~i~~ql~~~l~~lH~~~i 70 (268)
+||||+++++++. ++..++||||+++|+|.+++.... ...+++.+++.++.|++.||+|||+.||
T Consensus 77 ~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~i 156 (299)
T d1fgka_ 77 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKC 156 (299)
T ss_dssp CCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCE
Confidence 7999999999994 557999999999999999997532 2458999999999999999999999999
Q ss_pred eecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 71 IHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 71 ~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
+||||||+|||++.+ +.+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++
T Consensus 157 vHrDiKp~NiLl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--------~~y~~k~DiwS~Gvvl 227 (299)
T d1fgka_ 157 IHRDLAARNVLVTED-NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--------RIYTHQSDVWSFGVLL 227 (299)
T ss_dssp CCSCCSGGGEEECTT-CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--------CCCCHHHHHHHHHHHH
T ss_pred EeeeecccceeecCC-CCeEeccchhhccccccccccccccCCCChhhhhhhHhcC--------CCCCchhhhHHhHHHH
Confidence 999999999999966 459999999998654432 2334578899999999864 6789999999999999
Q ss_pred HHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhh
Q 024401 148 WELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLF 216 (268)
Q Consensus 148 ~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~ 216 (268)
|||++ |..||.+.+. ............++.+..+++++.+|+.+||+.||++|||+.++++.|+.+.+
T Consensus 228 ~ell~~g~~p~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 228 WEIFTLGGSPYPGVPV-EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHTTSCCSSTTCCH-HHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHhccCCCCCCCCCCH-HHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 99998 6888876554 44555566677888889999999999999999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=305.75 Aligned_cols=197 Identities=19% Similarity=0.339 Sum_probs=166.3
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|++++||||+++++++. ++.+|+||||++||+|.+++... ...+++.++..|+.||+.||+|||+.||+||||||+||
T Consensus 55 l~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NI 133 (321)
T d1tkia_ 55 LNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENI 133 (321)
T ss_dssp HHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccce
Confidence 56789999999999985 56799999999999999999762 34699999999999999999999999999999999999
Q ss_pred EEcCC-CCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPD-QKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ ...++|+|||++.............+++.|+|||.+.+ ..++.++|||||||++|+|++|..||.+
T Consensus 134 ll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~--------~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 134 IYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH--------DVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp EESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT--------CEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred eecCCCceEEEEcccchhhccccCCcccccccccccccchhccC--------CCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 99753 34689999999987665555556678999999998854 6678899999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCC----CCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLP----EDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
.+......... . ....++ ..+++++.+|+.+||..||.+|||++++++
T Consensus 206 ~~~~~~~~~i~-~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 206 ETNQQIIENIM-N-AEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp SSHHHHHHHHH-H-TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHH-h-CCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 66544333322 2 222222 368999999999999999999999999998
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.3e-45 Score=298.36 Aligned_cols=204 Identities=30% Similarity=0.530 Sum_probs=170.7
Q ss_pred CCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC----------------------CCCCCHHHHHHHHHHH
Q 024401 2 MSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR----------------------PNKLDLHVALNFALDI 58 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~----------------------~~~~~~~~~~~i~~ql 58 (268)
|++++||||+++++++. .+..+++|||+++|+|.+++.... ...+++..++.|+.|+
T Consensus 70 l~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 149 (301)
T d1lufa_ 70 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQV 149 (301)
T ss_dssp HHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHH
T ss_pred HHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHH
Confidence 57899999999999984 557899999999999999996522 1348999999999999
Q ss_pred HHHHHHHHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCC
Q 024401 59 ARAMDCLHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYN 135 (268)
Q Consensus 59 ~~~l~~lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~ 135 (268)
+.||+|||+.|++||||||+|||++.+ +.+||+|||+++..... .......+++.|+|||.+.. ..++
T Consensus 150 ~~gl~ylH~~~ivHrDlKp~NILld~~-~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~t 220 (301)
T d1lufa_ 150 AAGMAYLSERKFVHRDLATRNCLVGEN-MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--------NRYT 220 (301)
T ss_dssp HHHHHHHHHTTCCCSCCSGGGEEECGG-GCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--------CCCC
T ss_pred HHHhhhcccCCeEeeEEcccceEECCC-CcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc--------CCCC
Confidence 999999999999999999999999965 46999999999744322 22234568899999999864 6789
Q ss_pred cccchHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhh
Q 024401 136 NKVDVYSFGIVLWELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAF 214 (268)
Q Consensus 136 ~~~Di~slG~i~~~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~ 214 (268)
.++|||||||++|||++|. .||.+.+. .+..........++.+..+++++.+|+.+||+.+|++|||+.+|++.|+.+
T Consensus 221 ~ksDVwS~Gvvl~ell~~~~~p~~~~~~-~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i 299 (301)
T d1lufa_ 221 TESDVWAYGVVLWEIFSYGLQPYYGMAH-EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299 (301)
T ss_dssp HHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred hhhhhccchhhHHHHHccCCCCCCCCCH-HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999999999999999986 56766544 444455666777888899999999999999999999999999999999875
Q ss_pred h
Q 024401 215 L 215 (268)
Q Consensus 215 ~ 215 (268)
.
T Consensus 300 ~ 300 (301)
T d1lufa_ 300 C 300 (301)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-45 Score=303.29 Aligned_cols=194 Identities=26% Similarity=0.372 Sum_probs=166.4
Q ss_pred CCCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++||||+++++++.+ ...++||||+.||+|.+++... +.+++.++..++.||+.||+|||++||+||||||+|
T Consensus 94 il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~N 171 (350)
T d1rdqe_ 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 171 (350)
T ss_dssp HHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred HHHHcCCCcEeecccccccccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHH
Confidence 3678999999999999854 4689999999999999999763 469999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
||++.+ +.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+
T Consensus 172 ILl~~~-g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~--------~~~~~~~DiwSlGvilyemltG~~Pf~~ 240 (350)
T d1rdqe_ 172 LLIDQQ-GYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILS--------KGYNKAVDWWALGVLIYEMAAGYPPFFA 240 (350)
T ss_dssp EEECTT-SCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccCCC-CCEEeeeceeeeecccc--cccccCccccCCHHHHcC--------CCCCccccccchhHHHHHHHhCCCCCCC
Confidence 999966 46999999999865432 335679999999999864 6678999999999999999999999987
Q ss_pred CCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCC-----CHHHHHH
Q 024401 160 MSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRP-----SFSQIIR 209 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp-----s~~~~l~ 209 (268)
.+....... ........+..+++++.+++.+||..||.+|+ |++++++
T Consensus 241 ~~~~~~~~~--i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 241 DQPIQIYEK--IVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp SSHHHHHHH--HHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred cCHHHHHHH--HhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 654433332 33445667788999999999999999999994 8999988
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-45 Score=302.01 Aligned_cols=193 Identities=30% Similarity=0.479 Sum_probs=165.6
Q ss_pred CCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 4 RVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.++||||+++++++. ++..|+||||++||+|.+++... ..+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 59 ~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp HTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred hCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence 589999999999985 45799999999999999999863 569999999999999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCC
Q 024401 83 TPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMS 161 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~ 161 (268)
+.+ +.++|+|||+++..... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+
T Consensus 137 ~~~-~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 137 DKD-GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG--------QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp CTT-SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT--------CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cCC-CceeccccchhhhcccccccccccCCCCCcCCHHHHcC--------CCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 955 56999999999865432 33344679999999999864 678899999999999999999999998766
Q ss_pred cHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHH-HHHH
Q 024401 162 NLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFS-QIIR 209 (268)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~-~~l~ 209 (268)
..+.... .....+.++..+++++.+|+.+||..||.+||++. ++++
T Consensus 208 ~~~~~~~--i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 208 EEELFHS--IRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHHHH--HHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHHHHH--HHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 5443332 23456677888999999999999999999999995 7766
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=7.1e-45 Score=295.49 Aligned_cols=202 Identities=29% Similarity=0.475 Sum_probs=160.8
Q ss_pred CCCCCCCcccceeeeeec-C----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCC
Q 024401 2 MSRVKHDNLVKFLGACKD-P----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLK 76 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk 76 (268)
|+.++||||+++++++.+ + ..|+||||++|++|.+++... +.+++.++..++.|++.||+|||+.||+|||||
T Consensus 61 l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiK 138 (277)
T d1o6ya_ 61 AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 138 (277)
T ss_dssp HHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcccc
Confidence 567899999999998732 2 378999999999999999763 569999999999999999999999999999999
Q ss_pred CCCEEEcCCCCceEEeccCCcccCccc----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHh
Q 024401 77 PDNLLLTPDQKSLKLADFGLAREETVT----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLT 152 (268)
Q Consensus 77 ~~Nil~~~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~ 152 (268)
|+||+++.++ .++++|||.+...... .......||+.|+|||.+.+ ..++.++|||||||++|+|++
T Consensus 139 P~NIll~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--------~~~~~~~DiwSlGvilyellt 209 (277)
T d1o6ya_ 139 PANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG--------DSVDARSDVYSLGCVLYEVLT 209 (277)
T ss_dssp GGGEEEETTS-CEEECCCTTCEECC----------------TTCCHHHHTT--------CCCCHHHHHHHHHHHHHHHHH
T ss_pred CcccccCccc-cceeehhhhhhhhccccccccccccccCcccccCHHHHcC--------CCCCcceecccchHHHHHHHh
Confidence 9999999654 5899999988643322 22344578999999999853 568899999999999999999
Q ss_pred CCCCCCCCCcHHHHHHHHHhhcCC--CCCCCCcHHHHHHHHHhhhhCCCCCC-CHHHHHHHHHhh
Q 024401 153 NRLPFEGMSNLQAAYAAAFKHARP--GLPEDISPDLAFIVQSCWVEDPNLRP-SFSQIIRMLNAF 214 (268)
Q Consensus 153 g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp-s~~~~l~~l~~~ 214 (268)
|..||.+.+..+...........+ .....+|+++.++|.+||++||.+|| |++++++.|..+
T Consensus 210 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~ 274 (277)
T d1o6ya_ 210 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 274 (277)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence 999998776655544443333222 23467999999999999999999999 899998887764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-44 Score=295.72 Aligned_cols=206 Identities=33% Similarity=0.544 Sum_probs=174.1
Q ss_pred CCC-CCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCC----------------CCCCHHHHHHHHHHHHHHHHH
Q 024401 3 SRV-KHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRP----------------NKLDLHVALNFALDIARAMDC 64 (268)
Q Consensus 3 ~~l-~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~~~i~~ql~~~l~~ 64 (268)
+++ +||||+++++++. +...++||||+++|+|.+++..... ..+++.++..++.|++.||+|
T Consensus 81 ~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~ 160 (311)
T d1t46a_ 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAF 160 (311)
T ss_dssp HHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHH
T ss_pred HhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 345 6999999999985 4468999999999999999976321 258999999999999999999
Q ss_pred HHhCCCeecCCCCCCEEEcCCCCceEEeccCCcccCccc---ccccCccCccceeccccccccccccccccCCCcccchH
Q 024401 65 LHANGIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVT---EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVY 141 (268)
Q Consensus 65 lH~~~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~ 141 (268)
||++|++||||||+||+++.+ +.++++|||.++..... .......+|+.|+|||.+.. ..++.++|||
T Consensus 161 LH~~~ivHrDLKp~NIl~~~~-~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DIw 231 (311)
T d1t46a_ 161 LASKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN--------CVYTFESDVW 231 (311)
T ss_dssp HHHTTCCCSCCSGGGEEEETT-TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH--------CCCCHHHHHH
T ss_pred HHhCCeeeccccccccccccc-CcccccccchheeccCCCcceEeeecccChHHcCHHHhcC--------CCCCCccccc
Confidence 999999999999999999965 56999999999854432 22234578999999999854 6789999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 142 SFGIVLWELLT-NRLPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 142 slG~i~~~ll~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
|||+++|||++ |..||.................++..+..++.++.+|+.+||+.||.+|||++++++.|+..+.+
T Consensus 232 S~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence 99999999998 66667666665655566666777888888999999999999999999999999999999987654
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=291.15 Aligned_cols=212 Identities=28% Similarity=0.466 Sum_probs=168.7
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++||||+++++++. ++..|+||||+.+ ++.+++.......+++.++..++.|++.||+|||+.||+||||||+|
T Consensus 54 il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeN 132 (298)
T d1gz8a_ 54 LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN 132 (298)
T ss_dssp HHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchh
Confidence 368899999999999995 4578999999954 66666655456779999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcc-cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETV-TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.++ .++|+|||.++.... ........|++.|+|||.+.. ...++.++|||||||++|+|++|+.||.
T Consensus 133 Il~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~-------~~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 133 LLINTEG-AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG-------CKYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp EEECTTS-CEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeecccC-cceeccCCcceeccCCcccceeecccceeeehhhhcc-------ccCCCccccccccchhhhHHhhCCCCCC
Confidence 9999664 699999999975543 233445579999999998753 3456789999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcCCC----------------C-----------CCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHARPG----------------L-----------PEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~----------------~-----------~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
+.+..............+. . ...+++++.+|+.+||..||.+|||++++++
T Consensus 205 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~-- 282 (298)
T d1gz8a_ 205 GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA-- 282 (298)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT--
T ss_pred CCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC--
Confidence 7765554443322111100 0 1246788999999999999999999999998
Q ss_pred HhhhhhcCCCCC
Q 024401 212 NAFLFTLRPPSP 223 (268)
Q Consensus 212 ~~~~~~~~~~~~ 223 (268)
+.++.+...|.|
T Consensus 283 H~ff~~~~~p~p 294 (298)
T d1gz8a_ 283 HPFFQDVTKPVP 294 (298)
T ss_dssp SGGGTTCCCCCC
T ss_pred CHhhccCCCCCC
Confidence 677776655543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-43 Score=290.75 Aligned_cols=204 Identities=24% Similarity=0.366 Sum_probs=166.4
Q ss_pred CCCCCcccceeeeee------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 4 RVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 4 ~l~Hp~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
.++||||+++++++. +...+++|||+.++++..... .....+++..+..++.|++.||+|||++||+||||||
T Consensus 66 ~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~-~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp 144 (305)
T d1blxa_ 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 144 (305)
T ss_dssp HTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHH-SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred hcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCc
Confidence 458999999999873 235899999997766654443 3557799999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+|||++.+ +.++|+|||.+.............||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||
T Consensus 145 ~NILi~~~-~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~--------~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 145 QNILVTSS-GQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ--------SSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp GGEEECTT-CCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT--------CCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cEEEEcCC-CCeeecchhhhhhhcccccCCCcccChhhcCcchhcC--------CCCChhehhhchHHHHHHHHHCCCCC
Confidence 99999955 4699999999987766666677889999999999854 67899999999999999999999999
Q ss_pred CCCCcHHHHHHHHHhhcC-------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHH
Q 024401 158 EGMSNLQAAYAAAFKHAR-------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLN 212 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~ 212 (268)
.+.+..+........... ..+...+++.+.+|+.+||+.||++|||++|+++ +
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~--H 293 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS--H 293 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT--S
T ss_pred CCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc--C
Confidence 887665544433221110 1123467899999999999999999999999998 6
Q ss_pred hhhhhcC
Q 024401 213 AFLFTLR 219 (268)
Q Consensus 213 ~~~~~~~ 219 (268)
.++.++.
T Consensus 294 pff~~i~ 300 (305)
T d1blxa_ 294 PYFQDLE 300 (305)
T ss_dssp GGGTTCC
T ss_pred hhhcCch
Confidence 6665543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=291.64 Aligned_cols=192 Identities=22% Similarity=0.400 Sum_probs=160.5
Q ss_pred CCCcccceeeeeec-CCceEEEEcCCC-CCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEEc
Q 024401 6 KHDNLVKFLGACKD-PLMVIVTELLPG-MSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLLT 83 (268)
Q Consensus 6 ~Hp~i~~~~~~~~~-~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~~ 83 (268)
.||||+++++++.+ +..++||||+.+ +++.+++... ..+++.++..++.|++.||+|||+.||+||||||+||+++
T Consensus 67 ~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~ 144 (273)
T d1xwsa_ 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID 144 (273)
T ss_dssp SSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred CCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe
Confidence 39999999999854 578999999976 6888888763 5699999999999999999999999999999999999999
Q ss_pred CCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCCCCcH
Q 024401 84 PDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEGMSNL 163 (268)
Q Consensus 84 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~~~~~ 163 (268)
.+++.++|+|||++...... ......||+.|+|||.+.+ ...++.++|||||||++|+|++|+.||...+
T Consensus 145 ~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~-------~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-- 214 (273)
T d1xwsa_ 145 LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRY-------HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-- 214 (273)
T ss_dssp TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHH-------SCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred cCCCeEEECccccceecccc-cccccccCCCcCCHHHHcC-------CCCCCcccccccceeeehhHhhCCCCCCCch--
Confidence 77678999999999754332 2345679999999998853 2334678999999999999999999997532
Q ss_pred HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhh
Q 024401 164 QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
........++..+++++.+|+.+||..||++|||++++++ +.++.+
T Consensus 215 ------~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~--hp~~~~ 260 (273)
T d1xwsa_ 215 ------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN--HPWMQD 260 (273)
T ss_dssp ------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT--SGGGSS
T ss_pred ------HHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc--CHhhCC
Confidence 1223445677889999999999999999999999999988 455543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-43 Score=289.45 Aligned_cols=205 Identities=30% Similarity=0.541 Sum_probs=172.6
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCe
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLR--------PNKLDLHVALNFALDIARAMDCLHANGII 71 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--------~~~~~~~~~~~i~~ql~~~l~~lH~~~i~ 71 (268)
++++++||||+++++++. ++..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+.+|+
T Consensus 76 il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv 155 (308)
T d1p4oa_ 76 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155 (308)
T ss_dssp HGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred HHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 367899999999999984 567899999999999999986521 13478999999999999999999999999
Q ss_pred ecCCCCCCEEEcCCCCceEEeccCCcccCcccc---cccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 72 HRDLKPDNLLLTPDQKSLKLADFGLAREETVTE---MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 72 H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
||||||+|||++.+ ..+||+|||+++...... ......+++.|+|||.+.+ ..++.++||||||+++|
T Consensus 156 HrDlk~~NiLld~~-~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~--------~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 156 HRDLAARNCMVAED-FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD--------GVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp CSCCSGGGEEECTT-CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH--------CCCCHHHHHHHHHHHHH
T ss_pred eceEcCCceeecCC-ceEEEeecccceeccCCcceeeccceecccccCCHHHHcc--------CCCCcccccccHHHHHH
Confidence 99999999999955 569999999998544322 2233468899999999854 67788999999999999
Q ss_pred HHHhCC-CCCCCCCcHHHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhh
Q 024401 149 ELLTNR-LPFEGMSNLQAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFL 215 (268)
Q Consensus 149 ~ll~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~ 215 (268)
||++|. .||.+.+. ............++.+..++..+.+++.+||+.+|++|||+.++++.|+...
T Consensus 227 El~t~~~~p~~~~~~-~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~ 293 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSN-EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293 (308)
T ss_dssp HHHHTSCCTTTTSCH-HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred HHHhCCCCCCCCCCH-HHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 999985 66766544 4445556667778888899999999999999999999999999999988754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-42 Score=289.59 Aligned_cols=210 Identities=26% Similarity=0.322 Sum_probs=165.7
Q ss_pred CCCCCCCcccceeeeeec-------CCceEEEEcCCCCCHHHHHhh-hCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeec
Q 024401 2 MSRVKHDNLVKFLGACKD-------PLMVIVTELLPGMSLRKYLVS-LRPNKLDLHVALNFALDIARAMDCLHANGIIHR 73 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~ 73 (268)
|++++||||+++++++.. .++++||||++++.+..+... .....+++.++..++.||+.||+|||++||+||
T Consensus 67 l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHr 146 (350)
T d1q5ka_ 67 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR 146 (350)
T ss_dssp HHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred HHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCccc
Confidence 567899999999998721 147899999966543333321 235679999999999999999999999999999
Q ss_pred CCCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhC
Q 024401 74 DLKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTN 153 (268)
Q Consensus 74 dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g 153 (268)
||||+|||++.++..+||+|||++.............|+..|+|||.+.+ ...++.++||||+||++|||++|
T Consensus 147 DiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DIwSlG~il~el~~g 219 (350)
T d1q5ka_ 147 DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFG-------ATDYTSSIDVWSAGCVLAELLLG 219 (350)
T ss_dssp CCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTT-------CSSCCTHHHHHHHHHHHHHHHHT
T ss_pred CCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhc-------ccCCCcceeecccceEEEehhhC
Confidence 99999999997776799999999987666555666789999999998753 35688999999999999999999
Q ss_pred CCCCCCCCcHHHHHHHHHhhc---------------CC------------CCCCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 024401 154 RLPFEGMSNLQAAYAAAFKHA---------------RP------------GLPEDISPDLAFIVQSCWVEDPNLRPSFSQ 206 (268)
Q Consensus 154 ~~p~~~~~~~~~~~~~~~~~~---------------~~------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ 206 (268)
..||...+............. .. .....+++++.+|+.+||..||.+|||+.|
T Consensus 220 ~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 299 (350)
T d1q5ka_ 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999987765444333221100 00 112347889999999999999999999999
Q ss_pred HHHHHHhhhhhcCC
Q 024401 207 IIRMLNAFLFTLRP 220 (268)
Q Consensus 207 ~l~~l~~~~~~~~~ 220 (268)
+++ +.++.+...
T Consensus 300 ~L~--Hp~f~~~~~ 311 (350)
T d1q5ka_ 300 ACA--HSFFDELRD 311 (350)
T ss_dssp HHT--SGGGGGGGC
T ss_pred Hhc--CHhhccccC
Confidence 998 666665544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.7e-42 Score=280.08 Aligned_cols=199 Identities=26% Similarity=0.383 Sum_probs=158.1
Q ss_pred CCCCCCCCcccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 1 MMSRVKHDNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
+|++++||||+++++++. ++..+++||++.++.+..+... ...+++.++..++.||+.||+|||+.||+||||||+|
T Consensus 53 il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~N 130 (286)
T d1ob3a_ 53 ILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQN 130 (286)
T ss_dssp GGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred HHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCce
Confidence 478899999999999984 5678999999977666666553 4679999999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCccc-ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETVT-EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFE 158 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~ 158 (268)
||++.+ +.+||+|||.+...... .......+++.|+|||.+.. ...++.++|||||||++|+|++|+.||.
T Consensus 131 Ill~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~-------~~~~~~~~DiwslGv~l~el~~G~~pf~ 202 (286)
T d1ob3a_ 131 LLINRE-GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG-------SKKYSTTIDIWSVGCIFAEMVNGTPLFP 202 (286)
T ss_dssp EEECTT-SCEEECCTTHHHHHCC---------CCCTTCCHHHHTT-------CCSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred eeEcCC-CCEEecccccceecccCccccceecccchhhhHHHHhC-------CCCCCcceeehhcCcHHHHHHHCCCCCC
Confidence 999966 45999999998754432 22344468899999998853 3567899999999999999999999998
Q ss_pred CCCcHHHHHHHHHhhcC---------------------------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHH
Q 024401 159 GMSNLQAAYAAAFKHAR---------------------------PGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIR 209 (268)
Q Consensus 159 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 209 (268)
+.+..+........... ......+++++.+|+.+||+.||++|||++|+++
T Consensus 203 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 203 GVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 77665544433221111 0123457889999999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-42 Score=282.34 Aligned_cols=210 Identities=24% Similarity=0.383 Sum_probs=159.4
Q ss_pred CCCCCCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh--------C
Q 024401 2 MSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA--------N 68 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~--------~ 68 (268)
+++++||||+++++++.+. ..++||||+++|+|.+++.. .++++..++.++.|++.||+|+|+ .
T Consensus 51 ~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~ 127 (303)
T d1vjya_ 51 TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127 (303)
T ss_dssp STTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC
T ss_pred HhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCC
Confidence 5678999999999998422 47899999999999999986 469999999999999999999996 5
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcccCcccc-----cccCccCccceeccccccccccccccccCCCcccchHHH
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAREETVTE-----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSF 143 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~sl 143 (268)
||+||||||+|||++.+ +.+||+|||+++...... ......||+.|+|||.+.+... .....++.++|||||
T Consensus 128 ~IvHrDlKp~NILl~~~-~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~~~k~Di~S~ 204 (303)
T d1vjya_ 128 AIAHRDLKSKNILVKKN-GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSIN--MKHFESFKRADIYAM 204 (303)
T ss_dssp EEECSCCCGGGEEECTT-SCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSC--TTCHHHHHHHHHHHH
T ss_pred CeeccccCccceEEcCC-CCeEEEecCccccccCCCcceeccccceecccCcCChhhcccccc--ccCCCcCcchhhhhh
Confidence 99999999999999965 569999999997543321 2334579999999998854110 011235678999999
Q ss_pred HHHHHHHHhCCCCCCCCC--------------cHHHHHHHHH-hhcCCCCCCC-----CcHHHHHHHHHhhhhCCCCCCC
Q 024401 144 GIVLWELLTNRLPFEGMS--------------NLQAAYAAAF-KHARPGLPED-----ISPDLAFIVQSCWVEDPNLRPS 203 (268)
Q Consensus 144 G~i~~~ll~g~~p~~~~~--------------~~~~~~~~~~-~~~~~~~~~~-----~~~~l~~li~~~l~~~p~~Rps 203 (268)
||++|||++|..||.... .......... ...++.++.. ....+.+++.+||+.||.+|||
T Consensus 205 Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps 284 (303)
T d1vjya_ 205 GLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC
Confidence 999999999987663211 1122222222 2233444332 2346899999999999999999
Q ss_pred HHHHHHHHHhhhhh
Q 024401 204 FSQIIRMLNAFLFT 217 (268)
Q Consensus 204 ~~~~l~~l~~~~~~ 217 (268)
+.++++.|+.+...
T Consensus 285 ~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 285 ALRIKKTLSQLSQQ 298 (303)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999987644
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-41 Score=279.91 Aligned_cols=205 Identities=28% Similarity=0.424 Sum_probs=160.9
Q ss_pred CCCCCCCCcccceeeeeecC-----CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 1 MMSRVKHDNLVKFLGACKDP-----LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 1 ~l~~l~Hp~i~~~~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
+|++++||||+++++++... ..+++++++.||+|.+++.. ..+++..+..++.|++.||+|||++||+||||
T Consensus 59 il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDI 135 (345)
T d1pmea_ 59 ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDL 135 (345)
T ss_dssp HHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 35788999999999998432 23556666779999999976 46999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccc----cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHH
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTE----MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELL 151 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll 151 (268)
||+|||++.+ +.+||+|||++....... ......|++.|+|||.+.. ...++.++||||+||++|+|+
T Consensus 136 Kp~NILl~~~-~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~~DiwSlG~il~eml 207 (345)
T d1pmea_ 136 KPSNLLLNTT-CDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN-------SKGYTKSIDIWSVGCILAEML 207 (345)
T ss_dssp CGGGEEECTT-CCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT-------BCSCSTHHHHHHHHHHHHHHH
T ss_pred CcceEEECCC-CCEEEcccCceeeccCCCccceeeccccccceechHHHhhc-------CCCCCchhhhhccCceehHHh
Confidence 9999999955 569999999997544322 2344578999999998853 356688999999999999999
Q ss_pred hCCCCCCCCCcHHHHHHHHHhhcCC-----------------------------CCCCCCcHHHHHHHHHhhhhCCCCCC
Q 024401 152 TNRLPFEGMSNLQAAYAAAFKHARP-----------------------------GLPEDISPDLAFIVQSCWVEDPNLRP 202 (268)
Q Consensus 152 ~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp 202 (268)
+|+.||.+.+..............+ .....++.++.+|+.+||..||.+||
T Consensus 208 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 287 (345)
T d1pmea_ 208 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI 287 (345)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred hCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc
Confidence 9999998766543333222111000 01235678899999999999999999
Q ss_pred CHHHHHHHHHhhhhhc
Q 024401 203 SFSQIIRMLNAFLFTL 218 (268)
Q Consensus 203 s~~~~l~~l~~~~~~~ 218 (268)
|++++++ +.++...
T Consensus 288 ta~e~L~--hpf~~~~ 301 (345)
T d1pmea_ 288 EVEQALA--HPYLEQY 301 (345)
T ss_dssp CHHHHHT--SGGGTTT
T ss_pred CHHHHhc--CHhhccC
Confidence 9999998 5555443
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=278.91 Aligned_cols=202 Identities=26% Similarity=0.425 Sum_probs=164.1
Q ss_pred CCCCCCCcccceeeeeecC-------CceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACKDP-------LMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
|++++||||+++++++.+. .+|+||||+ +.+|..++.. ..+++..++.++.|++.||+|||++||+|||
T Consensus 71 l~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrD 146 (346)
T d1cm8a_ 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 146 (346)
T ss_dssp HHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccc
Confidence 5678999999999998432 479999999 7789988865 5699999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+|||++.+ +.++++|||++...... .....+++.|+|||.+.+ ...++.++||||+||++|+|++|.
T Consensus 147 iKp~NIL~~~~-~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwSlGvil~ell~g~ 216 (346)
T d1cm8a_ 147 LKPGNLAVNED-CELKILDFGLARQADSE--MTGYVVTRWYRAPEVILN-------WMRYTQTVDIWSVGCIMAEMITGK 216 (346)
T ss_dssp CCGGGEEECTT-CCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHT-------TTCCCTTHHHHHHHHHHHHHHHSS
T ss_pred cCcchhhcccc-cccccccccceeccCCc--cccccccccccCHHHHcC-------CCCCCccchhhcchHHHHHHHHCc
Confidence 99999999966 45999999999865433 345678999999998853 245688999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhhc---------------------C--------CCCCCCCcHHHHHHHHHhhhhCCCCCCCHH
Q 024401 155 LPFEGMSNLQAAYAAAFKHA---------------------R--------PGLPEDISPDLAFIVQSCWVEDPNLRPSFS 205 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~~---------------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ 205 (268)
.||.+.+............. . ......+++++.+|+.+||..||.+|||++
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (346)
T d1cm8a_ 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296 (346)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred CCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHH
Confidence 99987765443322211110 0 112345789999999999999999999999
Q ss_pred HHHHHHHhhhhhcC
Q 024401 206 QIIRMLNAFLFTLR 219 (268)
Q Consensus 206 ~~l~~l~~~~~~~~ 219 (268)
++++ +.++....
T Consensus 297 eiL~--Hp~f~~~~ 308 (346)
T d1cm8a_ 297 EALA--HPYFESLH 308 (346)
T ss_dssp HHHH--SGGGTTTC
T ss_pred HHhc--ChhhCcCC
Confidence 9998 66766554
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-41 Score=281.11 Aligned_cols=202 Identities=19% Similarity=0.329 Sum_probs=162.4
Q ss_pred CCCCC-CCcccceeeeee---cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCC
Q 024401 2 MSRVK-HDNLVKFLGACK---DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKP 77 (268)
Q Consensus 2 l~~l~-Hp~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~ 77 (268)
|++++ ||||+++++++. +...++||||+.+++|..+. +.+++.++..++.||+.||+|||++||+||||||
T Consensus 83 l~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp 157 (328)
T d3bqca1 83 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKP 157 (328)
T ss_dssp HHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccc
Confidence 45664 999999999984 33689999999999987653 4599999999999999999999999999999999
Q ss_pred CCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 78 DNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 78 ~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
+|||++.++..++|+|||++.............+|+.|+|||.+.+ ...++.++||||+||++|+|++|..||
T Consensus 158 ~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~~l~e~~~g~~pf 230 (328)
T d3bqca1 158 HNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD-------YQMYDYSLDMWSLGCMLASMIFRKEPF 230 (328)
T ss_dssp GGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTT-------CCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccC-------CCCCCcccchhhhhhhhHHhccCCCCC
Confidence 9999997777799999999987666555666789999999998753 245788999999999999999999999
Q ss_pred CCCCcHHHHHHHHHh------------h------------------------cCCCCCCCCcHHHHHHHHHhhhhCCCCC
Q 024401 158 EGMSNLQAAYAAAFK------------H------------------------ARPGLPEDISPDLAFIVQSCWVEDPNLR 201 (268)
Q Consensus 158 ~~~~~~~~~~~~~~~------------~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~R 201 (268)
............... . ........+++++.+||.+||..||.+|
T Consensus 231 ~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R 310 (328)
T d3bqca1 231 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 310 (328)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGS
T ss_pred CCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHC
Confidence 766543322211110 0 0001112367899999999999999999
Q ss_pred CCHHHHHHHHHhhhhh
Q 024401 202 PSFSQIIRMLNAFLFT 217 (268)
Q Consensus 202 ps~~~~l~~l~~~~~~ 217 (268)
||++++++ +.++.+
T Consensus 311 ~ta~e~L~--Hp~F~~ 324 (328)
T d3bqca1 311 LTAREAME--HPYFYT 324 (328)
T ss_dssp CCHHHHHT--SGGGTT
T ss_pred cCHHHHhc--CcccCC
Confidence 99999998 666544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.2e-41 Score=274.08 Aligned_cols=207 Identities=22% Similarity=0.309 Sum_probs=159.4
Q ss_pred CCCCCCCcccceeeee--ecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKHDNLVKFLGAC--KDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
++.++|+|++..+..+ .++..++||||+ +++|.+.+.. ....+++.++..++.|++.||+|||++||+||||||+|
T Consensus 56 ~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~N 133 (299)
T d1ckia_ 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 133 (299)
T ss_dssp HHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred HHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhh
Confidence 4567777766655554 445688999999 6688777765 35679999999999999999999999999999999999
Q ss_pred EEEcC--CCCceEEeccCCcccCcccc--------cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHH
Q 024401 80 LLLTP--DQKSLKLADFGLAREETVTE--------MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWE 149 (268)
Q Consensus 80 il~~~--~~~~~~l~Dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ 149 (268)
|+++. .+..++|+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++||
T Consensus 134 Il~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~e 205 (299)
T d1ckia_ 134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG--------IEQSRRDDLESLGYVLMY 205 (299)
T ss_dssp EEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTT--------BCCCHHHHHHHHHHHHHH
T ss_pred ccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhC--------CCCCChhhEEecCHHHHH
Confidence 99863 33469999999998543321 2234579999999998864 668999999999999999
Q ss_pred HHhCCCCCCCCCcHHHHHHH------HHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 150 LLTNRLPFEGMSNLQAAYAA------AFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 150 ll~g~~p~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|++|..||............ ......+.....+|+++.+++..||+.+|++||+++++.+.|+.++.+.
T Consensus 206 l~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 206 FNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 99999999765543222111 1111122234678999999999999999999999999999999876543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-41 Score=277.02 Aligned_cols=199 Identities=27% Similarity=0.410 Sum_probs=162.4
Q ss_pred CCCCCC-Ccccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCC
Q 024401 2 MSRVKH-DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDN 79 (268)
Q Consensus 2 l~~l~H-p~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~N 79 (268)
|++++| |||+++++++. ....+++|||+.||+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|
T Consensus 82 l~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~N 159 (322)
T d1vzoa_ 82 LEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 159 (322)
T ss_dssp HHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred HHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccc
Confidence 456766 89999999985 55789999999999999999874 458899999999999999999999999999999999
Q ss_pred EEEcCCCCceEEeccCCcccCcc--cccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCC
Q 024401 80 LLLTPDQKSLKLADFGLAREETV--TEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPF 157 (268)
Q Consensus 80 il~~~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~ 157 (268)
|+++.+ +.++|+|||+++.... ........|++.|++||.+.+ ....++.++|||||||++|+|++|..||
T Consensus 160 ill~~~-~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~------~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 160 ILLDSN-GHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG------GDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp EEECTT-SCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTT------CC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred eeecCC-CCEEEeeccchhhhcccccccccccccccccchhHHhhc------CCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 999966 5699999999975433 233445678999999998854 2345788999999999999999999999
Q ss_pred CCCCcH--HHHHHHHHhhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCC-----HHHHHH
Q 024401 158 EGMSNL--QAAYAAAFKHARPGLPEDISPDLAFIVQSCWVEDPNLRPS-----FSQIIR 209 (268)
Q Consensus 158 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps-----~~~~l~ 209 (268)
.+.... ............+.++..+++++.+|+.+||.+||.+||| ++|+++
T Consensus 233 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 233 TVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 765432 2222233345566777889999999999999999999994 788876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-40 Score=268.49 Aligned_cols=205 Identities=22% Similarity=0.360 Sum_probs=164.7
Q ss_pred CCCCCCCcccceeeeeec-CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 2 MSRVKHDNLVKFLGACKD-PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
|+.++||||+++++++.+ ...+++++++.|++|..++.. .+.+++..+..++.|++.||+|||++||+||||||+||
T Consensus 55 l~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NI 132 (292)
T d1unla_ 55 LKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL 132 (292)
T ss_dssp HTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred HHhcCcCCEEeeccccccccceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccc
Confidence 678999999999999854 468899999999998888765 46799999999999999999999999999999999999
Q ss_pred EEcCCCCceEEeccCCcccCcccc-cccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCCCCCC
Q 024401 81 LLTPDQKSLKLADFGLAREETVTE-MMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRLPFEG 159 (268)
Q Consensus 81 l~~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~p~~~ 159 (268)
|++.+ +.++|+|||.+....... ......++..|.|||.+.. ...++.++|||||||++|+|++|..||..
T Consensus 133 li~~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 133 LINRN-GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG-------AKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp EECTT-CCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTT-------CSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred ccccC-CceeeeecchhhcccCCCccceeeccccchhhhhHhcc-------CCCCCchhhccccchHHHHHhhCCCCCCC
Confidence 99965 469999999998655433 2334467788999998753 24568899999999999999999999766
Q ss_pred CCcHHHHHHHHHhhc----------------------------CCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHH
Q 024401 160 MSNLQAAYAAAFKHA----------------------------RPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRML 211 (268)
Q Consensus 160 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l 211 (268)
..+............ .......+++.+.+|+.+||+.||.+|||++|+++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~-- 282 (292)
T d1unla_ 205 GNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ-- 282 (292)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT--
T ss_pred CCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc--
Confidence 665554443322111 11122356789999999999999999999999988
Q ss_pred Hhhhhhc
Q 024401 212 NAFLFTL 218 (268)
Q Consensus 212 ~~~~~~~ 218 (268)
+.++.+.
T Consensus 283 Hp~f~~~ 289 (292)
T d1unla_ 283 HPYFSDF 289 (292)
T ss_dssp SGGGSSC
T ss_pred ChhhcCC
Confidence 5565543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1e-39 Score=266.77 Aligned_cols=207 Identities=18% Similarity=0.254 Sum_probs=164.6
Q ss_pred CCCCC-Ccccceeeeee-cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCE
Q 024401 3 SRVKH-DNLVKFLGACK-DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNL 80 (268)
Q Consensus 3 ~~l~H-p~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Ni 80 (268)
+.++| +||+.+++++. +...++||||+ +++|.+++.. ....+++.++..++.|++.||+|||+.||+||||||+||
T Consensus 55 ~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~-~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Ni 132 (293)
T d1csna_ 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL-CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 132 (293)
T ss_dssp HHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred HHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh-hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccce
Confidence 34555 89999999884 55789999999 7899999876 345799999999999999999999999999999999999
Q ss_pred EEcC----CCCceEEeccCCcccCccc--------ccccCccCccceeccccccccccccccccCCCcccchHHHHHHHH
Q 024401 81 LLTP----DQKSLKLADFGLAREETVT--------EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLW 148 (268)
Q Consensus 81 l~~~----~~~~~~l~Dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~ 148 (268)
+++. ..+.++|+|||+++..... .......||+.|+|||.+.+ ..++.++||||||+++|
T Consensus 133 li~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~--------~~~~~~~DiwSlG~~l~ 204 (293)
T d1csna_ 133 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG--------REQSRRDDLEALGHVFM 204 (293)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT--------CCCCHHHHHHHHHHHHH
T ss_pred eecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC--------CCCChHHHHHHhhHHHH
Confidence 9974 2346999999999754321 12234579999999999864 67899999999999999
Q ss_pred HHHhCCCCCCCCCcH--HHHHHHHH----hhcCCCCCCCCcHHHHHHHHHhhhhCCCCCCCHHHHHHHHHhhhhhcC
Q 024401 149 ELLTNRLPFEGMSNL--QAAYAAAF----KHARPGLPEDISPDLAFIVQSCWVEDPNLRPSFSQIIRMLNAFLFTLR 219 (268)
Q Consensus 149 ~ll~g~~p~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~~l~~~~~~~~ 219 (268)
+|++|..||.+.... ........ ..........+|+++.+++..|+..+|++||+++.+.+.|+.++.+..
T Consensus 205 elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 205 YFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcC
Confidence 999999999754432 21111111 111122346788999999999999999999999999999998876553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-39 Score=269.72 Aligned_cols=204 Identities=23% Similarity=0.333 Sum_probs=157.9
Q ss_pred CCCCCCCcccceeeeeec---------CCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCee
Q 024401 2 MSRVKHDNLVKFLGACKD---------PLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIH 72 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H 72 (268)
|++++||||+++++++.. +..++||||+.++.+..+... ...+++..+..++.|++.||.|||+.||+|
T Consensus 63 l~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivH 140 (318)
T d3blha1 63 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILH 140 (318)
T ss_dssp HHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEe
Confidence 568899999999998732 357899999977666554433 467999999999999999999999999999
Q ss_pred cCCCCCCEEEcCCCCceEEeccCCcccCccc-----ccccCccCccceeccccccccccccccccCCCcccchHHHHHHH
Q 024401 73 RDLKPDNLLLTPDQKSLKLADFGLAREETVT-----EMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVL 147 (268)
Q Consensus 73 ~dlk~~Nil~~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~ 147 (268)
|||||+|||++.+ +.++|+|||++...... .......||+.|+|||.+.+ ...++.++|||||||++
T Consensus 141 rDlKp~NILl~~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-------~~~~~~k~DiwSlGvil 212 (318)
T d3blha1 141 RDMKAANVLITRD-GVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLG-------ERDYGPPIDLWGAGCIM 212 (318)
T ss_dssp CCCCGGGEEECTT-SCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTT-------CSSCCTHHHHHHHHHHH
T ss_pred cCcCchheeecCC-CcEEeeecceeeecccccccccccccceecCHHHhhHHHHcC-------CCCCCcHHHcccCCcee
Confidence 9999999999966 46999999999754321 22234578999999998853 24678999999999999
Q ss_pred HHHHhCCCCCCCCCcHHHHHHHHHhhcC--CCCCC----------------------------CCcHHHHHHHHHhhhhC
Q 024401 148 WELLTNRLPFEGMSNLQAAYAAAFKHAR--PGLPE----------------------------DISPDLAFIVQSCWVED 197 (268)
Q Consensus 148 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~----------------------------~~~~~l~~li~~~l~~~ 197 (268)
|+|++|+.||.+.+.............. +.... ..++++.+|+.+||+.|
T Consensus 213 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~d 292 (318)
T d3blha1 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292 (318)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSS
T ss_pred eeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCC
Confidence 9999999999876654443332221111 11000 02567889999999999
Q ss_pred CCCCCCHHHHHHHHHhhhhh
Q 024401 198 PNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 198 p~~Rps~~~~l~~l~~~~~~ 217 (268)
|++|||++++++ +.++..
T Consensus 293 P~~R~sa~elL~--Hpff~~ 310 (318)
T d3blha1 293 PAQRIDSDDALN--HDFFWS 310 (318)
T ss_dssp TTTSCCHHHHHH--SGGGSS
T ss_pred hhHCcCHHHHHc--Chhhcc
Confidence 999999999998 777754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-40 Score=274.03 Aligned_cols=204 Identities=29% Similarity=0.409 Sum_probs=159.8
Q ss_pred CCCCCCCcccceeeeee------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCC
Q 024401 2 MSRVKHDNLVKFLGACK------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDL 75 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dl 75 (268)
|++++||||+++++++. +...+++++++.||+|.+++.. +++++.++..++.||+.||+|||++||+||||
T Consensus 71 l~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDi 147 (348)
T d2gfsa1 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDL 147 (348)
T ss_dssp HHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCccccc
Confidence 56889999999999873 2245677788889999999964 56999999999999999999999999999999
Q ss_pred CCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCCC
Q 024401 76 KPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNRL 155 (268)
Q Consensus 76 k~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~~ 155 (268)
||+|||++.+ +.++++|||.+...... .....|+..|+|||.+.+ ...++.++|||||||++|+|++|..
T Consensus 148 Kp~NILi~~~-~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~-------~~~~~~~~DiwSlGv~l~~ll~g~~ 217 (348)
T d2gfsa1 148 KPSNLAVNED-CELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLN-------WMHYNQTVDIWSVGCIMAELLTGRT 217 (348)
T ss_dssp CGGGEEECTT-CCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTT-------CSCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred CCcccccccc-ccccccccchhcccCcc--cccccccccccCchhhcC-------CccCCcccchhhhhHHHHHHHhCCC
Confidence 9999999966 46999999998765432 345678999999998653 2456889999999999999999999
Q ss_pred CCCCCCcHHHHHHHHHhhcCC---------------------CC--------CCCCcHHHHHHHHHhhhhCCCCCCCHHH
Q 024401 156 PFEGMSNLQAAYAAAFKHARP---------------------GL--------PEDISPDLAFIVQSCWVEDPNLRPSFSQ 206 (268)
Q Consensus 156 p~~~~~~~~~~~~~~~~~~~~---------------------~~--------~~~~~~~l~~li~~~l~~~p~~Rps~~~ 206 (268)
||.+.+..............+ .. ...+++++.+||.+||..||.+|||+++
T Consensus 218 pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e 297 (348)
T d2gfsa1 218 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297 (348)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 998776544433322211111 11 1357889999999999999999999999
Q ss_pred HHHHHHhhhhhcCC
Q 024401 207 IIRMLNAFLFTLRP 220 (268)
Q Consensus 207 ~l~~l~~~~~~~~~ 220 (268)
+++ +.++.....
T Consensus 298 lL~--Hp~f~~~~~ 309 (348)
T d2gfsa1 298 ALA--HAYFAQYHD 309 (348)
T ss_dssp HHT--SGGGTTTCC
T ss_pred Hhc--CHhhCCCCC
Confidence 998 567665443
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-40 Score=274.64 Aligned_cols=200 Identities=28% Similarity=0.420 Sum_probs=148.6
Q ss_pred CCCCCCCcccceeeeee-------cCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecC
Q 024401 2 MSRVKHDNLVKFLGACK-------DPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRD 74 (268)
Q Consensus 2 l~~l~Hp~i~~~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 74 (268)
|++++||||+++++++. ....|+||||+.++ +.+.+. ..+++..+..++.|++.||+|||+.||+|||
T Consensus 70 l~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrD 144 (355)
T d2b1pa1 70 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRD 144 (355)
T ss_dssp HHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 56789999999999983 24689999999665 444443 4589999999999999999999999999999
Q ss_pred CCCCCEEEcCCCCceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 75 LKPDNLLLTPDQKSLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 75 lk~~Nil~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
|||+|||++.++ .++++|||+++............+|+.|+|||.+.+ ..++.++||||+||++|+|++|+
T Consensus 145 lKP~Nil~~~~~-~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~--------~~~~~~~DiwSlG~~l~ell~g~ 215 (355)
T d2b1pa1 145 LKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG--------MGYKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_dssp CCGGGEEECTTC-CEEECCCCC---------------CCTTCCHHHHTT--------CCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CCcccccccccc-ceeeechhhhhccccccccccccccccccChhhhcC--------CCCCCCcccccccchHHHHhhCC
Confidence 999999999665 589999999987766666666789999999999864 67888999999999999999999
Q ss_pred CCCCCCCcHHHHHHHHHhh--------------------cCCCC--------------C------CCCcHHHHHHHHHhh
Q 024401 155 LPFEGMSNLQAAYAAAFKH--------------------ARPGL--------------P------EDISPDLAFIVQSCW 194 (268)
Q Consensus 155 ~p~~~~~~~~~~~~~~~~~--------------------~~~~~--------------~------~~~~~~l~~li~~~l 194 (268)
.||.+.+............ ..... + ...+.++.+|+++||
T Consensus 216 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL 295 (355)
T d2b1pa1 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295 (355)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 9998766544332221100 00000 0 113567899999999
Q ss_pred hhCCCCCCCHHHHHHHHHhhhhh
Q 024401 195 VEDPNLRPSFSQIIRMLNAFLFT 217 (268)
Q Consensus 195 ~~~p~~Rps~~~~l~~l~~~~~~ 217 (268)
..||++|||++++++ +.++..
T Consensus 296 ~~dP~~R~ta~elL~--Hpw~~~ 316 (355)
T d2b1pa1 296 VIDPAKRISVDDALQ--HPYINV 316 (355)
T ss_dssp CSSTTTSCCHHHHHT--STTTGG
T ss_pred cCChhHCcCHHHHhc--CcccCC
Confidence 999999999999998 566654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.98 E-value=1e-32 Score=231.67 Aligned_cols=202 Identities=18% Similarity=0.253 Sum_probs=146.8
Q ss_pred CCCCcccceeeeeec---CCceEEEEcCCCC-CHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCeecCCCCCC
Q 024401 5 VKHDNLVKFLGACKD---PLMVIVTELLPGM-SLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHA-NGIIHRDLKPDN 79 (268)
Q Consensus 5 l~Hp~i~~~~~~~~~---~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~-~~i~H~dlk~~N 79 (268)
+.||||+++++++.. ...+++++++.++ +...+........+++..+..++.|++.||+|||+ .||+||||||+|
T Consensus 77 ~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~N 156 (362)
T d1q8ya_ 77 MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN 156 (362)
T ss_dssp HHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred cCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhH
Confidence 358999999998732 3455666665454 44444444456779999999999999999999998 899999999999
Q ss_pred EEEcCCCC-----ceEEeccCCcccCcccccccCccCccceeccccccccccccccccCCCcccchHHHHHHHHHHHhCC
Q 024401 80 LLLTPDQK-----SLKLADFGLAREETVTEMMTAETGTYRWMAPELYSTVTLRQGEKKHYNNKVDVYSFGIVLWELLTNR 154 (268)
Q Consensus 80 il~~~~~~-----~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~~Di~slG~i~~~ll~g~ 154 (268)
||++.++. .++++|||.+..... ......|++.|+|||.+.. ..++.++||||+||++++|++|+
T Consensus 157 Ill~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~el~~g~ 226 (362)
T d1q8ya_ 157 VLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG--------APWGCGADIWSTACLIFELITGD 226 (362)
T ss_dssp EEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT--------CCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccc--------cCCCccccccchHHHHHHHHHCC
Confidence 99975432 489999999875443 2345679999999998864 56788999999999999999999
Q ss_pred CCCCCCCcHH------HHHHHHHh--h--------------------------------------cCCCCCCCCcHHHHH
Q 024401 155 LPFEGMSNLQ------AAYAAAFK--H--------------------------------------ARPGLPEDISPDLAF 188 (268)
Q Consensus 155 ~p~~~~~~~~------~~~~~~~~--~--------------------------------------~~~~~~~~~~~~l~~ 188 (268)
.||...+... ........ . .........++++.+
T Consensus 227 ~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 306 (362)
T d1q8ya_ 227 FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306 (362)
T ss_dssp CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHH
T ss_pred CCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHH
Confidence 9996433210 00000000 0 011112234678999
Q ss_pred HHHHhhhhCCCCCCCHHHHHHHHHhhhhhc
Q 024401 189 IVQSCWVEDPNLRPSFSQIIRMLNAFLFTL 218 (268)
Q Consensus 189 li~~~l~~~p~~Rps~~~~l~~l~~~~~~~ 218 (268)
|+.+||..||.+|||++++++ +.++.+.
T Consensus 307 ll~~mL~~dP~~Rpta~e~L~--Hp~f~~~ 334 (362)
T d1q8ya_ 307 FLSPMLQLDPRKRADAGGLVN--HPWLKDT 334 (362)
T ss_dssp HHGGGGCSSTTTCBCHHHHHT--CGGGTTC
T ss_pred HHHHHCCCChhHCcCHHHHhc--CcccCCC
Confidence 999999999999999999998 6666533
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.70 E-value=5.8e-19 Score=134.06 Aligned_cols=85 Identities=18% Similarity=0.207 Sum_probs=68.5
Q ss_pred CCCCCCcccceeeeeecCCceEEEEcCCCCCHHHHHhhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCCeecCCCCCCEEE
Q 024401 3 SRVKHDNLVKFLGACKDPLMVIVTELLPGMSLRKYLVSLRPNKLDLHVALNFALDIARAMDCLHANGIIHRDLKPDNLLL 82 (268)
Q Consensus 3 ~~l~Hp~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dlk~~Nil~ 82 (268)
.++.|++++..+++.. .+++|||+++..+.+ ++...+..++.|++.+|+|||+.||+||||||+|||+
T Consensus 69 ~~l~~~~v~~~~~~~~---~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv 136 (191)
T d1zara2 69 QKLQGLAVPKVYAWEG---NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV 136 (191)
T ss_dssp HHTTTSSSCCEEEEET---TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred HHccCCCcceEEEecC---CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee
Confidence 4577888888776542 389999998755432 4555677899999999999999999999999999999
Q ss_pred cCCCCceEEeccCCcccCc
Q 024401 83 TPDQKSLKLADFGLAREET 101 (268)
Q Consensus 83 ~~~~~~~~l~Dfg~~~~~~ 101 (268)
+.+ + ++|+|||++....
T Consensus 137 ~~~-~-~~liDFG~a~~~~ 153 (191)
T d1zara2 137 SEE-G-IWIIDFPQSVEVG 153 (191)
T ss_dssp ETT-E-EEECCCTTCEETT
T ss_pred eCC-C-EEEEECCCcccCC
Confidence 843 3 8999999986543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=97.37 E-value=0.00015 Score=55.75 Aligned_cols=28 Identities=25% Similarity=0.393 Sum_probs=22.6
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
++|+|+.|.||+++.+ ..+-|+||+.+.
T Consensus 185 l~HgD~~~~Nil~~~~-~~~~lIDwe~a~ 212 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDG-KVSGFIDLGRSG 212 (263)
T ss_dssp EECSCCCTTSEEEETT-EEEEECCCTTCE
T ss_pred EEEeeccCcceeecCC-ceEEEeechhcc
Confidence 7899999999999843 434599998764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=96.55 E-value=0.0011 Score=50.24 Aligned_cols=28 Identities=18% Similarity=0.234 Sum_probs=22.9
Q ss_pred CeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 70 IIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 70 i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
++|||+.|.||+++.+ ..+-|+||+.+.
T Consensus 177 liHgD~~~~Nvl~~~~-~~~~iID~~~~~ 204 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENG-RFSGFIDCGRLG 204 (255)
T ss_dssp EECSSCCGGGEEEETT-EEEEECCCTTCE
T ss_pred EEeCCCCCcceEEeCC-ceEEEEEchhcc
Confidence 7999999999999854 445699998663
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.23 E-value=0.0026 Score=51.73 Aligned_cols=29 Identities=24% Similarity=0.338 Sum_probs=24.4
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCccc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLARE 99 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~~ 99 (268)
.++|||+++.|||++.++ ++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv~~~~--~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE--TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC--EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc--eEEechhhccc
Confidence 589999999999998543 89999987753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.62 E-value=0.0044 Score=48.56 Aligned_cols=29 Identities=41% Similarity=0.568 Sum_probs=24.2
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
|++|+|+.++||+++.+ ...-|+||+.+.
T Consensus 184 giIHgDl~~dNvl~~~~-~v~gvIDF~~~~ 212 (316)
T d2ppqa1 184 GVIHADLFQDNVFFLGD-ELSGLIDFYFAC 212 (316)
T ss_dssp EEECSCCCGGGEEEETT-EEEEECCCTTCE
T ss_pred ccccCCcchhhhhcccc-cceeEecccccc
Confidence 79999999999999954 345799999773
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=93.18 E-value=0.036 Score=43.43 Aligned_cols=27 Identities=30% Similarity=0.333 Sum_probs=22.5
Q ss_pred CCeecCCCCCCEEEcCCCCceEEeccCCcc
Q 024401 69 GIIHRDLKPDNLLLTPDQKSLKLADFGLAR 98 (268)
Q Consensus 69 ~i~H~dlk~~Nil~~~~~~~~~l~Dfg~~~ 98 (268)
+++|||+++.|||++ ++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~-~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWR-DG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEES-SS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEe-CC--ceEEechhcc
Confidence 689999999999997 32 4589999775
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=83.54 E-value=0.2 Score=40.04 Aligned_cols=15 Identities=40% Similarity=0.669 Sum_probs=13.3
Q ss_pred CeecCCCCCCEEEcC
Q 024401 70 IIHRDLKPDNLLLTP 84 (268)
Q Consensus 70 i~H~dlk~~Nil~~~ 84 (268)
++|+|+.+.||++..
T Consensus 220 ~CHnDL~~~NiL~~~ 234 (395)
T d1nw1a_ 220 FCHNDLQEGNILLPK 234 (395)
T ss_dssp EECSCCCGGGEEEEC
T ss_pred EEecCCCcccEeecc
Confidence 689999999999853
|